steroids	beta2-agonists	effect	corticosteroids , methylxanthines and diuretics : concomitant treatment with xanthine derivatives , steroids , or diuretics may potentiate a possible hypokalemic effect of beta2-agonists .
Anticoagulants	ardeparin	effect	anticoagulants including coumarin derivatives , indandione derivatives , and platelet aggregation inhibitors such as nonsteroidal anti inflammatory drugs ( nsaids ) , and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin .
phenytoin	SULAR	mechanism	coadministration of phenytoin with dg mg sular tablets in epileptic patients lowered the nisoldipine plasma concentrations to undetectable levels .
enalapril	antihypertensive agents	effect	agents causing renin release : the antihypertensive effect of enalapril and enalapril iv is augmented by antihypertensive agents that cause renin release ( e.g. , diuretics ) .
nonsteroidal anti-inflammatory drugs	enalapril	effect	non steroidal anti inflammatory agents : in some patients with compromised renal function who are being treated with nonsteroidal anti-inflammatory drugs , the co administration of enalapril may result in a further deterioration of renal function .
Isocarboxazid	Antabuse	advise	isocarboxazid should be administered with caution to patients receiving antabuse ( disulfiram , wyeth ayerst laboratories ) .
STRATTERA	albuterol	advise	drug drug interactions albuterol strattera should be administered with caution to patients being treated with systemically administered ( oral or intravenous ) albuterol ( or other beta2 agonists ) because the action of albuterol on the cardiovascular system can be potentiated resulting in increases in heart rate and blood pressure .
norepinephrine	monoamine oxidase inhibitors	effect	the administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors , tricyclic antidepressants or phenothiazines may produce severe , prolonged hypotension or hypertension .
interleukin-2	radiographic iodinated contrast media	effect	delayed adverse reactions to iodinated contrast media : a review of the literature revealed that dg % ( range dg dg % ) of dg patients treated with various interleukin-2 containing regimens who were subsequently administered radiographic iodinated contrast media experienced acute , atypical adverse reactions .
FORADIL	tricyclic antidepressants	advise	monoamine oxidase inhibitors and tricyclic antidepressants : foradil should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents .
Fenfluramine	methyldopa	effect	fenfluramine may increase slightly the effect of antihypertensive drugs , e.g. , guanethidine , methyldopa , reserpine .
Fenfluramine	reserpine	effect	fenfluramine may increase slightly the effect of antihypertensive drugs , e.g. , guanethidine , methyldopa , reserpine .
Quinidine	nisoldipine	mechanism	quinidine at dg mg bid decreased the bioavailability ( auc ) of nisoldipine by dg % , but not the peak concentration .
enalapril	thiazide-type diuretics	effect	agents increasing serum potassium : enalapril and enalapril iv attenuate potassium loss caused by thiazide-type diuretics .
STRATTERA	fluoxetine	advise	dosage adjustment of strattera may be necessary when coadministered with cyp2d6 inhibitors , e.g. , paroxetine , fluoxetine , and quinidine .
meclofenamate sodium	warfarin	advise	therefore , when meclofenamate sodium is given to a patient receiving warfarin , the dosage of warfarin should be reduced to prevent excessive prolongation of the prothrombin time .
glucocorticoids	PROLEUKIN	effect	although glucocorticoids have been shown to reduce proleukin induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with proleukin may reduce the antitumor effectiveness of proleukin and thus should be avoided. dg beta blockers and other antihypertensives may potentiate the hypotension seen with proleukin .
asparaginase	PROLEUKIN	effect	concurrent administration of drugs possessing nephrotoxic ( e.g. , aminoglycosides , indomethacin ) , myelotoxic ( e.g. , cytotoxic chemotherapy ) , cardiotoxic ( e.g. , doxorubicin ) or hepatotoxic ( e.g. , methotrexate , asparaginase ) effects with proleukin may increase toxicity in these organ systems .
diuretics	beta2-agonists	effect	corticosteroids , methylxanthines and diuretics : concomitant treatment with xanthine derivatives , steroids , or diuretics may potentiate a possible hypokalemic effect of beta2-agonists .
Fenfluramine	guanethidine	effect	fenfluramine may increase slightly the effect of antihypertensive drugs , e.g. , guanethidine , methyldopa , reserpine .
SULAR	phenytoin	advise	coadministration of sular with phenytoin or any known cyp3a4 inducer should be avoided and alternative antihypertensive therapy should be considered .
enalaprilat	diuretic	effect	the possibility of hypotensive effects with enalapril or enalaprilat can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with enalapril or enalaprilat .
lithium	ACE inhibitors	effect	lithium : lithium toxicity has been reported in patients receiving lithium concomitantly with drugs which cause elimination of sodium , including ace inhibitors .
NSAIDs	ACE inhibitors	advise	this interaction should be given consideration in patients taking nsaids concomitantly with ace inhibitors .
Isocarboxazid	disulfiram	advise	isocarboxazid should be administered with caution to patients receiving antabuse ( disulfiram , wyeth ayerst laboratories ) .
fluoxetine	atomoxetine	mechanism	in em individuals treated with paroxetine or fluoxetine , the auc of atomoxetine is approximately dg to dg fold and css , max is about dg to dg fold greater than atomoxetine alone .
norepinephrine	tricyclic antidepressants	effect	the administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors , tricyclic antidepressants or phenothiazines may produce severe , prolonged hypotension or hypertension .
anesthetic solutions	tricyclic antidepressants	effect	the administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors , tricyclic antidepressants or phenothiazines may produce severe , prolonged hypotension or hypertension .
cytotoxic	PROLEUKIN	effect	concurrent administration of drugs possessing nephrotoxic ( e.g. , aminoglycosides , indomethacin ) , myelotoxic ( e.g. , cytotoxic chemotherapy ) , cardiotoxic ( e.g. , doxorubicin ) or hepatotoxic ( e.g. , methotrexate , asparaginase ) effects with proleukin may increase toxicity in these organ systems .
PROLEUKIN	antineoplastic agents	effect	hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose proleukin and antineoplastic agents , specifically , dacarbazine , cis platinum , tamoxifen and interferon alfa .
lovastatin	fibrate	effect	for these reasons , it is felt that , in most subjects who have had an unsatisfactory lipid response to either drug alone , the possible benefits of combined therapy with lovastatin and a fibrate do not outweigh the risks of severe myopathy , rhabdomyolysis , and acute renal failure .
probenecid	cefprozil	mechanism	concomitant administration of probenecid doubled the auc for cefprozil .
cephalosporins	furosemide	effect	nephrotoxicity has been reported following concomitant administration of cephalosporins with aminoglycoside antibiotics or potent diuretics such as furosemide .
quinolones	theophylline	mechanism	theophylline : as with some other quinolones , concurrent administration of ciprofloxacin with theophylline may lead to elevated serum concentrations of theophylline and prolongation of its elimination half life .
ciprofloxacin	glyburide	effect	glyburide : the concomitant administration of ciprofloxacin with the sulfonylurea glyburide has , on rare occasions , resulted in severe hypoglycemia .
quinolone	magnesium	mechanism	multivalent cation containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation containing products such as magnesium or aluminum antacids , sucralfate , videx chewable / buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
quinolone	iron	mechanism	multivalent cation containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation containing products such as magnesium or aluminum antacids , sucralfate , videx chewable / buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
acetaminophen	Gleevec	mechanism	systemic exposure to acetaminophen is expected to be increased when coadministered with gleevec .
Gleevec	cyclosporine	advise	particular caution is recommended when administering gleevec with cyp3a4 substrates that have a narrow therapeutic window ( e.g. , cyclosporine or pimozide ) .
cephalosporins	diuretics	effect	nephrotoxicity has been reported following concomitant administration of cephalosporins with aminoglycoside antibiotics or potent diuretics such as furosemide .
phenytoin	ciprofloxacin	mechanism	phenytoin : altered serum levels of phenytoin ( increased and decreased ) have been reported in patients receiving concomitant ciprofloxacin .
ciprofloxacin	ciprofloxacin	mechanism	multivalent cation containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation containing products such as magnesium or aluminum antacids , sucralfate , videx chewable / buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
fentanyl	saquinavir	mechanism	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
triazolam	saquinavir	mechanism	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
quinine	saquinavir	mechanism	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
epinephrine	phenothiazines	effect	the administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors , tricyclic antidepressants or phenothiazines may produce severe , prolonged hypotension or hypertension .
L-tyrosine	MAO inhibitors	effect	non selective mao inhibitors including tranylcypromine sulfate , phenelzine sulfate , and pargyline hc1 : concomitant use of l-tyrosine and non selective mao inhibitors may cause hypertension .
Gleevec	itraconazole	advise	drugs that may alter imatinib plasma concentrations drugs that may increase imatinib plasma concentrations : caution is recommended when administering gleevec with inhibitors of the cyp3a4 family ( e.g. , ketoconazole , itraconazole , erythromycin , clarithromycin ) .
Gleevec	HMG-CoA reductase inhibitors	mechanism	gleevec will increase plasmaconcentration of other cyp3a4 metabolized drugs ( e.g. , triazolo benzodiazepines , dihydropyridine calcium channel blockers , certain hmg-coa reductase inhibitors , etc. ) .
anticoagulants	Atromid-S	advise	caution should be exercised when anticoagulants are given in conjunction with atromid-s .
Atromid-S	phenytoin	mechanism	atromid-s may displace acidic drugs such as phenytoin or tolbutamide from their binding sites .
aminoglycoside antibiotics	cephalosporin antibiotics	effect	nephrotoxicity has been reported following concomitant administration of aminoglycoside antibiotics and cephalosporin antibiotics .
Probenecid	ciprofloxacin	mechanism	probenecid : probenecid interferes with renal tubular secretion of ciprofloxacin and produces an increase in the level of ciprofloxacin in serum .
Quinolones	warfarin	effect	warfarin : quinolones have been reported to enhance the effects of the oral anticoagulant warfarin or its derivatives .
ciprofloxacin	sulfonylurea	effect	glyburide : the concomitant administration of ciprofloxacin with the sulfonylurea glyburide has , on rare occasions , resulted in severe hypoglycemia .
disopyramide	saquinavir	mechanism	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
amiodarone	saquinavir	mechanism	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
INVIRASE	ritonavir	advise	since invirase is coadministered with ritonavir , the ritonavir label should be reviewed for additional drugs that should not be coadministered .
Flupenthixol	MAOI	int	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics arecoline eproxindine ethanol : flupenthixol and ethanol cause additive cns depression tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants
MAOI	flupenthixol	effect	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics arecoline eproxindine ethanol : flupenthixol and ethanol cause additive cns depression tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants
Lincomycin	neuromuscular blocking agents	effect	lincomycin has been shown to have neuromuscular blocking properties that may enhance the action of other neuromuscular blocking agents .
alprazolam	nifedipine	int	data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following : ergotamine , cyclosporine , amiodarone , nicardipine , and nifedipine .
benzodiazepines	amiodarone	int	data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following : ergotamine , cyclosporine , amiodarone , nicardipine , and nifedipine .
phenobarbital	saquinavir	mechanism	coadministration with compounds that are potent inducers of cyp3a4 ( eg , phenobarbital , phenytoin , dexamethasone , carbamazepine ) may result in decreased plasma levels of saquinavir .
carbamazepine	saquinavir	mechanism	coadministration with compounds that are potent inducers of cyp3a4 ( eg , phenobarbital , phenytoin , dexamethasone , carbamazepine ) may result in decreased plasma levels of saquinavir .
lincomycin	erythromycin	effect	antagonism between lincomycin and erythromycin in vitro has been demonstrated .
imipramine	alprazolam	mechanism	the steady state plasma concentrations of imipramine and desipramine have been reported to be increased an average of dg % and dg % , respectively , by the concomitant administration of alprazolam tablets in doses up to dg mg / day .
benzodiazepines	nicardipine	int	data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following : ergotamine , cyclosporine , amiodarone , nicardipine , and nifedipine .
alprazolam	amiodarone	int	data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following : ergotamine , cyclosporine , amiodarone , nicardipine , and nifedipine .
propoxyphene	alprazolam	mechanism	coadministration of propoxyphene decreased the maximum plasma concentration of alprazolam by dg % , decreased clearance by dg % , and increased half life by dg % .
diflunisal	acetaminophen	mechanism	acetaminophen : in normal volunteers , concomitant administration of diflunisal and acetaminophen resulted in an approximate dg % increase in plasma levels of acetaminophen .
Nonsteroidal anti-inflammatory drugs	methotrexate	mechanism	nonsteroidal anti-inflammatory drugs have been reported to decrease the tubular secretion of methotrexate and to potentiate its toxicity .
Diflunisal	hydrochlorothiazide	effect	diflunisal decreased the hyperuricemic effect of hydrochlorothiazide .
ciprofloxacin	magnesium	mechanism	multivalent cation containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation containing products such as magnesium or aluminum antacids , sucralfate , videx chewable / buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
quinolone	VIDEX	mechanism	multivalent cation containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation containing products such as magnesium or aluminum antacids , sucralfate , videx chewable / buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
androgens	insulin	effect	in diabetic patients , the metabolic effects of androgens may decrease blood glucose and therefore , insulin requirements .
fluoxetine	alprazolam	mechanism	drugs demonstrated to be cyp 3a inhibitors of possible clinical significance on the basis of clinical studies involving alprazolam ( caution is recommended during coadministration with alprazolam ) : coadministration of fluoxetine with alprazolam increased the maximum plasma concentration of alprazolam by dg % , decreased clearance by dg % , increased half life by dg % , and decreased measured psychomotor performance .
alprazolam	isoniazid	int	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
alprazolam	macrolide antibiotics	int	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
contraceptives	alprazolam	mechanism	coadministration of oral contraceptives increased the maximum plasma concentration of alprazolam by dg % , decreased clearance by dg % , and increased half life by dg % .
NSAIDs	cyclosporine	advise	nsaids should be used with caution in patients taking cyclosporine , and renal function should be carefully monitored .
BOTOX	aminoglycosides	advise	co administration of botox and aminoglycosides or other agents interfering with neuromuscular transmission ( e.g. , curare like compounds ) should only be performed with caution as the effect of the toxin may be potentiated .
tricyclic anti-depressants	bepridil hydrochloride	effect	anti arrhythmics and tricyclic anti-depressants could exaggerate the prolongation of the qt interval observed with bepridil hydrochloride .
mineral oil	vitamin K	mechanism	mineral oil concomitant intake of mineral oil and vitamin k may reduce the absorption of vitamin k .
atorvastatin	erythromycin	mechanism	erythromycin : in healthy individuals , plasma concentrations of atorvastatin increased approximately dg % with coadministration of atorvastatin and erythromycin , a known inhibitor of cytochrome p450 dg .
LEVSIN	haloperidol	effect	additive adverse effects resulting from cholinergic blockade may occur when levsin is administered concomitantly with other antimuscarinics , amantadine , haloperidol , phenothiazines , monoamine oxidase ( mao ) inhibitors , tricyclic antidepressants or some antihistamines .
ketoconazole	budesonide	advise	if treatment with inhibitors of cyp3a4 activity ( such as ketoconazole , intraconazole , ritonavir , indinavir , saquinavir , erythromycin , etc. ) is indicated , reduction of the budesonide dose should be considered .
Colchicine	CNS depressants	effect	colchicine may increase sensitivity to the cns depressants .
FLEXERIL	alcohol	effect	flexeril may enhance the effects of alcohol , barbiturates , and other cns depressants .
Tricyclic antidepressants	tramadol	effect	tricyclic antidepressants may enhance the seizure risk in patients taking tramadol
botulinum toxin	botulinum toxin	effect	excessive neuromuscular weakness may be exacerbated by administration of another botulinum toxin prior to the resolution of the effects of a previously administered botulinum toxin .
ketoconazole	lapatinib	mechanism	ketoconazole : in healthy subjects receiving ketoconazole , a cyp3a4 inhibitor , at dg mg twice daily for dg days , systemic exposure ( auc ) to lapatinib was increased to approximately dg fold of control and half life increased to dg fold of control .
cholestyramine	vitamin K	mechanism	cholestyramine concomitant intake of cholestyramine and vitamin k may reduce the absorption of vitamin k .
LEVSIN	amantadine	effect	additive adverse effects resulting from cholinergic blockade may occur when levsin is administered concomitantly with other antimuscarinics , amantadine , haloperidol , phenothiazines , monoamine oxidase ( mao ) inhibitors , tricyclic antidepressants or some antihistamines .
intraconazole	budesonide	advise	if treatment with inhibitors of cyp3a4 activity ( such as ketoconazole , intraconazole , ritonavir , indinavir , saquinavir , erythromycin , etc. ) is indicated , reduction of the budesonide dose should be considered .
indinavir	budesonide	advise	if treatment with inhibitors of cyp3a4 activity ( such as ketoconazole , intraconazole , ritonavir , indinavir , saquinavir , erythromycin , etc. ) is indicated , reduction of the budesonide dose should be considered .
colchicine	alkalinizing agents	mechanism	the action of colchicine is potentiated by alkalinizing agents .
Argatroban	thrombolytics	effect	co administration : concomitant use of argatroban with antiplatelet agents , thrombolytics , and other anticoagulants may increase the risk of bleeding .
Argatroban	anticoagulants	effect	co administration : concomitant use of argatroban with antiplatelet agents , thrombolytics , and other anticoagulants may increase the risk of bleeding .
Phenothiazines	epinephrine	effect	phenothiazines and butyrophenones may reduce or reverse the pressor effect of epinephrine .
diflunisal	warfarin	effect	oral anticoagulants : in some normal volunteers , the concomitant administration of diflunisal and warfarin , acenocoumarol , or phenprocoumon resulted in prolongation of prothrombin time .
diflunisal	methotrexate	advise	methotrexate : caution should be used if diflunisal is administered concomitantly with methotrexate .
Tricyclic antidepressants	clonidine	effect	tricyclic antidepressants have been reported to blunt the hypotensive effect of systemic clonidine.it is not known whether the concurrent use of these agents with alphagan p in humans can lead to resulting interference with the iop lowering effect .
colestipol	vitamin K	mechanism	colestipol concomitant intake of colestipol and vitamin k may reduce the absorption of vitamin k .
Vitamin K	warfarin	effect	warfarin vitamin k can antagonize the effect of warfarin
nitroglycerin	vasodilators	effect	the vasodilating effects of nitroglycerin may be additive with those of other vasodilators .
calcium channel blockers	nitrates	effect	marked symptomatic orthostatic hypotension has been reported when calcium channel blockers and organic nitrates were used in combination .
atorvastatin	Maalox TC	mechanism	antacid : when atorvastatin and maalox tc suspension were coadministered , plasma concentrations of atorvastatin decreased approximately dg % .
atorvastatin	ethinyl estradiol	mechanism	oral contraceptives : coadministration of atorvastatin and an oral contraceptive increased auc values for norethindrone and ethinyl estradiol by approximately dg % and dg % .
colestipol	atorvastatin	mechanism	colestipol : plasma concentrations of atorvastatin decreased approximately dg % when colestipol and atorvastatin were coadministered .
cerivastatin sodium	cholestyramine	mechanism	in the first study , concomitant administration of dg mg cerivastatin sodium and dg g cholestyramine resulted in decreases of more than dg % for auc and dg % for cmax when compared to dosing cerivastatin sodium alone .
naltrexone	Acamprosate	mechanism	co administration of naltrexone with acamprosate produced a dg % increase in auc and a dg % increase in the cmax of acamprosate .
nonsteroidal anti-inflammatory drugs	ardeparin	effect	anticoagulants including coumarin derivatives , indandione derivatives , and platelet aggregation inhibitors such as nonsteroidal anti-inflammatory drugs ( nsaids ) , and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin .
enalapril	diuretic	effect	the possibility of hypotensive effects with enalapril or enalaprilat can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with enalapril or enalaprilat .
enalapril	lithium	advise	it is recommended that serum lithium levels be monitored frequently if enalapril is administered concomitantly with lithium .
norepinephrine	phenothiazines	effect	the administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors , tricyclic antidepressants or phenothiazines may produce severe , prolonged hypotension or hypertension .
anesthetic solutions	phenothiazines	effect	the administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors , tricyclic antidepressants or phenothiazines may produce severe , prolonged hypotension or hypertension .
epinephrine	monoamine oxidase inhibitors	effect	the administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors , tricyclic antidepressants or phenothiazines may produce severe , prolonged hypotension or hypertension .
Beta-blockers	PROLEUKIN	effect	although glucocorticoids have been shown to reduce proleukin induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with proleukin may reduce the antitumor effectiveness of proleukin and thus should be avoided. dg beta-blockers and other antihypertensives may potentiate the hypotension seen with proleukin .
cephalosporins	aminoglycoside antibiotics	effect	increased nephrotoxicity has been reported following concomitant administration of cephalosporins and aminoglycoside antibiotics .
sympathomimetic agents	FORADIL	effect	concomitant administration of other sympathomimetic agents may potentiate the undesirable effects of foradil .
Fenfluramine	antihypertensive drugs	effect	fenfluramine may increase slightly the effect of antihypertensive drugs , e.g. , guanethidine , methyldopa , reserpine .
CNS depressant drugs	fenfluramine	advise	other cns depressant drugs should be used with caution in patients taking fenfluramine , since the effects may be additive .
diuretics	enalapril	effect	hypotension : patients on diuretic therapy : patients on diuretics and especially those in whom diuretic therapy was recently instituted , may occasionally experience an excessive reduction of blood pressure after initiation of therapy with enalapril or enalaprilat .
enalapril	antihypertensive agents	effect	agents causing renin release : the antihypertensive effect of enalapril and enalapril iv is augmented by antihypertensive agents that cause renin release ( e.g. , diuretics ) .
paroxetine	atomoxetine	mechanism	in em individuals treated with paroxetine or fluoxetine , the auc of atomoxetine is approximately dg to dg fold and css , max is about dg to dg fold greater than atomoxetine alone .
epinephrine	tricyclic antidepressants	effect	the administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors , tricyclic antidepressants or phenothiazines may produce severe , prolonged hypotension or hypertension .
vasopressor drugs	ergot-type oxytocic drugs	effect	concurrent administration of vasopressor drugs ( for the treatment of hypotension related to obstetric blocks ) and ergot-type oxytocic drugs may cause severe , persistent hypertension or cerebrovascular accidents .
probenecid	penciclovir	mechanism	concurrent use with probenecid or other drugs significantly eliminated by active renal tubular secretion may result in increased plasma concentrations of penciclovir .
FORADIL	monoamine oxidase inhibitors	advise	monoamine oxidase inhibitors and tricyclic antidepressants : foradil should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents .
platelet aggregation inhibitors	ardeparin	effect	anticoagulants including coumarin derivatives , indandione derivatives , and platelet aggregation inhibitors such as nonsteroidal anti inflammatory drugs ( nsaids ) , and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin .
nisoldipine	cimetidine 400 mg	mechanism	a dg to dg % increase in auc and cmax of nisoldipine was observed with concomitant administration of cimetidine 400 mg twice daily .
nisoldipine	quinidine	mechanism	the immediate release , but not the coat core formulation of nisoldipine increased plasma quinidine concentrations by about dg % .
diuretics	enalaprilat	effect	hypotension : patients on diuretic therapy : patients on diuretics and especially those in whom diuretic therapy was recently instituted , may occasionally experience an excessive reduction of blood pressure after initiation of therapy with enalapril or enalaprilat .
Enalapril	thiazide-type diuretics	effect	agents increasing serum potassium : enalapril and enalapril iv attenuate potassium loss caused by thiazide-type diuretics .
enalapril	diuretics	effect	agents causing renin release : the antihypertensive effect of enalapril and enalapril iv is augmented by antihypertensive agents that cause renin release ( e.g. , diuretics ) .
NSAIDs	ACE inhibitors	effect	however , reports suggest that nsaids may diminish the antihypertensive effect of ace inhibitors .
MAO inhibitor	disulfiram	effect	in a single study , rats given high intraperitoneal doses of an mao inhibitor plus disulfiram experienced severe toxicity , including convulsions and death .
STRATTERA	paroxetine	advise	dosage adjustment of strattera may be necessary when coadministered with cyp2d6 inhibitors , e.g. , paroxetine , fluoxetine , and quinidine .
xanthine derivatives	beta2-agonists	effect	corticosteroids , methylxanthines and diuretics : concomitant treatment with xanthine derivatives , steroids , or diuretics may potentiate a possible hypokalemic effect of beta2-agonists .
NSAIDs	ardeparin	effect	anticoagulants including coumarin derivatives , indandione derivatives , and platelet aggregation inhibitors such as nonsteroidal anti inflammatory drugs ( nsaids ) , and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin .
aspirin	ardeparin	effect	anticoagulants including coumarin derivatives , indandione derivatives , and platelet aggregation inhibitors such as nonsteroidal anti inflammatory drugs ( nsaids ) , and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin .
enalapril	diuretics	effect	agents causing renin release : the antihypertensive effect of enalapril and enalapril iv is augmented by antihypertensive agents that cause renin release ( e.g. , diuretics ) .
Isocarboxazid	psychotropic agents	advise	concomitant use of isocarboxazid and other psychotropic agents is generally not recommended because of possible potentiating effects .
STRATTERA	quinidine	advise	dosage adjustment of strattera may be necessary when coadministered with cyp2d6 inhibitors , e.g. , paroxetine , fluoxetine , and quinidine .
Warfarin	Meclofenamate sodium	effect	warfarin : meclofenamate sodium enhances the effect of warfarin .
aspirin	meclofenamate sodium	mechanism	aspirin : concurrent administration of aspirin may lower meclofenamate sodium plasma levels , possibly by competing for protein binding sites .
indomethacin	PROLEUKIN	effect	concurrent administration of drugs possessing nephrotoxic ( e.g. , aminoglycosides , indomethacin ) , myelotoxic ( e.g. , cytotoxic chemotherapy ) , cardiotoxic ( e.g. , doxorubicin ) or hepatotoxic ( e.g. , methotrexate , asparaginase ) effects with proleukin may increase toxicity in these organ systems .
methotrexate	PROLEUKIN	effect	concurrent administration of drugs possessing nephrotoxic ( e.g. , aminoglycosides , indomethacin ) , myelotoxic ( e.g. , cytotoxic chemotherapy ) , cardiotoxic ( e.g. , doxorubicin ) or hepatotoxic ( e.g. , methotrexate , asparaginase ) effects with proleukin may increase toxicity in these organ systems .
Acamprosate	antidepressants	effect	patients taking acamprosate concomitantly with antidepressants more commonly reported both weight gain and weight loss , compared with patients taking either medication alone .
Betaseron	antipyrine	mechanism	betaseron administration to three cancer patients over a dose range of dg mg to dg mg led to a dose dependent inhibition of antipyrine elimination.14 the effect of alternate day administration of dg mg of betaseron on drug metabolism in ms patients is unknown .
Propranolol	nisoldipine	effect	propranolol attenuated the heart rate increase following administration of immediate release nisoldipine .
SULAR	atenolol	effect	the blood pressure effect of sular tended to be greater in patients on atenolol than in patients on no other antihypertensive therapy .
PROLEUKIN	dacarbazine	effect	hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose proleukin and antineoplastic agents , specifically , dacarbazine , cis platinum , tamoxifen and interferon alfa .
PROLEUKIN	interferon-alfa	effect	myocardial injury , including myocardial infarction , myocarditis , ventricular hypokinesia , and severe rhabdomyolysis appear to be increased in patients receiving proleukin and interferon-alfa concurrently .
lovastatin	fibrates	advise	therefore , the combined use of lovastatin with fibrates should generally be avoided .
Chloramphenicol	beta-lactam antibiotics	effect	chloramphenicol has been shown to be antagonistic to beta-lactam antibiotics , including ceftazidime , based on in vitro studies and time kill curves with enteric gram negative bacilli .
quinolones	caffeine	mechanism	some quinolones , including ciprofloxacin , have also been shown to interfere with the metabolism of caffeine .
Probenecid	ciprofloxacin	mechanism	probenecid : probenecid interferes with renal tubular secretion of ciprofloxacin and produces an increase in the level of ciprofloxacin in serum .
fenoprofen	aspirin	mechanism	although the mechanism of interaction between fenoprofen and aspirin is not totally known , enzyme induction and displacement of fenoprofen from plasma albumin binding sites are possibilities .
Femara	tamoxifen	mechanism	( see clinical pharmacology ) coadministration of femara and tamoxifen dg mg daily resulted in a reduction of letrozole plasma levels by dg % on average .
sodium acid phosphate	amphetamine	mechanism	urinary acidifying agents these agents ( ammonium chloride , sodium acid phosphate , etc. ) increase the concentration of the ionized species of the amphetamine molecule , thereby increasing urinary excretion .
amphetamines	methenamine	mechanism	methenamine therapy urinary excretion of amphetamines is increased , and efficacy is reduced by acidifying agents used in methenamine therapy .
Amphetamines	tricyclic antidepressants	effect	antidepressants , tricyclic amphetamines may enhance the activity of tricyclic antidepressants or sympathomimetic agents ;
d-amphetamine	tricyclics	mechanism	d-amphetamine with desipramine or protriptyline and possibly other tricyclics cause striking and sustained increases in the concentration of d-amphetamine in the brain ;
Diuretic agents	lithium	effect	diuretic agents reduce the renal clearance of lithium and add a high risk of lithium toxicity .
lithium	Hydrochlorothiazide	advise	refer to the package insert for lithium preparations before use of such preparations with hydrochlorothiazide .
hydrochlorothiazide	anionic exchange resins	mechanism	cholestyramine and colestipol resins : absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins .
Itraconazole	cyclosporine	mechanism	coadministration of itraconazole and cyclosporine , tacrolimus or digoxin has led to increased plasma concentrations of the latter three drugs .
Itraconazole	tacrolimus	mechanism	coadministration of itraconazole and cyclosporine , tacrolimus or digoxin has led to increased plasma concentrations of the latter three drugs .
aminoglycosides	PROLEUKIN	effect	concurrent administration of drugs possessing nephrotoxic ( e.g. , aminoglycosides , indomethacin ) , myelotoxic ( e.g. , cytotoxic chemotherapy ) , cardiotoxic ( e.g. , doxorubicin ) or hepatotoxic ( e.g. , methotrexate , asparaginase ) effects with proleukin may increase toxicity in these organ systems .
interferon-alfa	PROLEUKIN	effect	exacerbation or the initial presentation of a number of autoimmune and inflammatory disorders has been observed following concurrent use of interferon-alfa and proleukin , including crescentic iga glomerulonephritis , oculo bulbar myasthenia gravis , inflammatory arthritis , thyroiditis , bullous pemphigoid , and stevens johnson syndrome .
Atromid-S	tolbutamide	mechanism	atromid-s may displace acidic drugs such as phenytoin or tolbutamide from their binding sites .
cephalosporins	aminoglycoside antibiotics	effect	nephrotoxicity has been reported following concomitant administration of cephalosporins with aminoglycoside antibiotics or potent diuretics such as furosemide .
ciprofloxacin	caffeine	mechanism	some quinolones , including ciprofloxacin , have also been shown to interfere with the metabolism of caffeine .
ciprofloxacin	calcium	mechanism	multivalent cation containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation containing products such as magnesium or aluminum antacids , sucralfate , videx chewable / buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
calcium channel blockers	saquinavir	mechanism	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
Flupenthixol	Tricyclic antidepressants	effect	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics arecoline eproxindine ethanol : flupenthixol and ethanol cause additive cns depression tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants
butyrophenones	epinephrine	effect	phenothiazines and butyrophenones may reduce or reverse the pressor effect of epinephrine .
Chlorpromazine	amphetamines	effect	chlorpromazine : chlorpromazine blocks dopamine and norepinephrine receptors , thus inhibiting the central stimulant effects of amphetamines and can be used to treat amphetamine poisoning .
non-steroidal anti-inflammatory agent	loop diuretics	effect	non steroidal anti inflammatory drugs : in some patients , the administration of a non-steroidal anti-inflammatory agent can reduce the diuretic , natriuretic , and antihypertensive effects of loop , potassium sparing and thiazide diuretics .
colestipol	hydrochlorothiazide	mechanism	single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to dg and dg percent , respectively .
Accutane	vitamin A	effect	vitamin a : because of the relationship of accutane to vitamin a , patients should be advised against taking vitamin supplements containing vitamin a to avoid additive toxic effects
Accutane	tetracyclines	advise	tetracyclines : concomitant treatment with accutane and tetracyclines should be avoided because accutane use has been associated with a number of cases of pseudotumor cerebri ( benign intracranial hypertension ) , some of which involved concomitant use of tetracyclines
HMG-CoA reductase inhibitors	cyclosporine	effect	rhabdomyolysis has been observed in patients receiving hmg-coa reductase inhibitors administered alone ( at recommended dosages ) or concomitantly with immunosuppressive drugs including cyclosporine .
Itraconazole	isoniazid	advise	itraconazole plasma concentrations should be monitored when itraconazole and isoniazid are coadministered .
itraconazole	cisapride	mechanism	in vitro data suggest that itraconazole also markedly inhibits the biotransformation system mainly responsible for the metabolism of cisapride ;
ethionamide	cycloserine	effect	in particular , convulsions have been reported when ethionamide is administered with cycloserine and special care should be taken when the treatment regimen includes both of these drugs .
steroidal anti-inflammatory agent	thiazide diuretics	effect	( in some patients , the steroidal anti-inflammatory agent can reduce the diuretic , natriuretic , and antihypertensive effects of loop , potassium sparing , and thiazide diuretics .
erythromycin	fentanyl	mechanism	the concomitant use of other cyp3a4 inhibitors such as diltiazem and erythromycin with transdermal fentanyl may also result in an increase in fentanyl plasma concentrations , which could increase or prolong adverse drug effects and may cause serious respiratory depression .
DURAGESIC	central nervous system depressants	effect	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
DURAGESIC	benzodiazepines	effect	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
DURAGESIC	skeletal muscle relaxants	effect	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
DURAGESIC	alcohol	effect	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
ciprofloxacin	theophylline	mechanism	theophylline : as with some other quinolones , concurrent administration of ciprofloxacin with theophylline may lead to elevated serum concentrations of theophylline and prolongation of its elimination half life .
quinolone	calcium	mechanism	multivalent cation containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation containing products such as magnesium or aluminum antacids , sucralfate , videx chewable / buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
cyclosporine	saquinavir	mechanism	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
ergot derivatives	saquinavir	mechanism	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
tacrolimus	saquinavir	mechanism	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
dexamethasone	saquinavir	mechanism	coadministration with compounds that are potent inducers of cyp3a4 ( eg , phenobarbital , phenytoin , dexamethasone , carbamazepine ) may result in decreased plasma levels of saquinavir .
benzodiazepines	antihistaminics	effect	the benzodiazepines , including alprazolam , produce additive cns depressant effects when co administered with other psychotropic medications , anticonvulsants , antihistaminics , ethanol , and other drugs which themselves produce cns depression .
diflunisal	acenocoumarol	effect	oral anticoagulants : in some normal volunteers , the concomitant administration of diflunisal and warfarin , acenocoumarol , or phenprocoumon resulted in prolongation of prothrombin time .
diflunisal	phenprocoumon	effect	oral anticoagulants : in some normal volunteers , the concomitant administration of diflunisal and warfarin , acenocoumarol , or phenprocoumon resulted in prolongation of prothrombin time .
diflunisal	coumarins	mechanism	this may occur because diflunisal competitively displaces coumarins from protein binding sites .
carbamazepine	lapatinib	mechanism	carbamazepine : in healthy subjects receiving the cyp3a4 inducer , carbamazepine , at dg mg twice daily for dg days and dg mg twice daily for dg days , systemic exposure ( auc ) to lapatinib was decreased approximately dg % .
ALPHAGAN P	alcohol	advise	although specific drug interaction studies have not been conducted with alphagan p , the possibility of an additive or potentiating effect with cns depressants ( alcohol , barbiturates , opiates , sedatives , or anesthetics ) should be considered .
ALPHAGAN P	anesthetics	advise	although specific drug interaction studies have not been conducted with alphagan p , the possibility of an additive or potentiating effect with cns depressants ( alcohol , barbiturates , opiates , sedatives , or anesthetics ) should be considered .
atorvastatin	norethindrone	mechanism	oral contraceptives : coadministration of atorvastatin and an oral contraceptive increased auc values for norethindrone and ethinyl estradiol by approximately dg % and dg % .
atorvastatin	colestipol	effect	however , ldl c reduction was greater when atorvastatin and colestipol were coadministered than when either drug was given alone .
LEVSIN	tricyclic antidepressants	effect	additive adverse effects resulting from cholinergic blockade may occur when levsin is administered concomitantly with other antimuscarinics , amantadine , haloperidol , phenothiazines , monoamine oxidase ( mao ) inhibitors , tricyclic antidepressants or some antihistamines .
LEVSIN	antimuscarinics	effect	additive adverse effects resulting from cholinergic blockade may occur when levsin is administered concomitantly with other antimuscarinics , amantadine , haloperidol , phenothiazines , monoamine oxidase ( mao ) inhibitors , tricyclic antidepressants or some antihistamines .
amiodarone	indinavir	mechanism	a case report of one patient taking amiodarone dg mg and indinavir dg mg three times a day resulted in increases in amiodarone concentrations from dg mg / l to dg mg / l .
anticonvulsant agents	cisplatin	mechanism	plasma levels of anticonvulsant agents may become subtherapeutic during cisplatin therapy .
sympathomimetic agents	colchicine	effect	response to sympathomimetic agents may be enhanced by colchicine .
Nalfon	salicylates	advise	because nalfon has not been shown to produce any additional effect beyond that obtained with aspirin alone and because aspirin increases the rate of excretion of nalfon , the concomitant use of nalfon and salicylates is not recommended .
ammonium chloride	amphetamine	mechanism	urinary acidifying agents these agents ( ammonium chloride , sodium acid phosphate , etc. ) increase the concentration of the ionized species of the amphetamine molecule , thereby increasing urinary excretion .
Amphetamines	norepinephrine	effect	norepinephrine : amphetamines enhance the adrenergic effect of norepinephrine .
Amphetamines	phenobarbital	mechanism	phenobarbital : amphetamines may delay intestinal absorption of phenobarbital ;
cholestyramine	hydrochlorothiazide	mechanism	single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to dg and dg percent , respectively .
tacrolimus	Itraconazole	advise	cyclosporine , tacrolimus and digoxin concentrations should be monitored at the initiation of itraconazole therapy and frequently thereafter , and the dose of these three drug products adjusted appropriately .
Trecator	antituberculous drugs	effect	trecator may potentiate the adverse effects of other antituberculous drugs administered concomitantly .
DURAGESIC	sedatives	effect	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
DURAGESIC	hypnotics	effect	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
DURAGESIC	phenothiazines	effect	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
fentanyl	sedatives	effect	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
celecoxib	lithium	int	clinical studies with celecoxib have identified potentially significant interactions with fluconazole and lithium .
nonsteroidal anti-inflammatory drugs	furosemide	int	experience with nonsteroidal anti-inflammatory drugs ( nsaids ) suggests the potential for interactions with furosemide and ace inhibitors .
NSAIDs	Angiotensin Converting Enzyme (ACE) inhibitors	effect	ace inhibitors : reports suggest that nsaids may diminish the antihypertensive effect of angiotensin converting enzyme (ace) inhibitors .
vitamin K antagonists	nilutamide	advise	for example , when vitamin k antagonists are administered concomitantly with nilutamide , prothrombin time should be carefully monitored and if necessary , the dosage of vitamin k antagonists should be reduced .
sulfonylureas	beta adrenergic blocking agents	effect	the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
Sulfapyridine	Acetaminophen	int	sulfapyridine may interact with any of the following : acetaminophen ( e.g. , tylenol ) ( with long term , high dose use ) or
Lorazepam	ethyl alcohol	effect	injection : lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , mao inhibitors , and other antidepressants.when scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .
Oxytocin	dinoprost	effect	oxytocin or other oxytocics ( concurrent use with dinoprost may result in uterine hypertonus , possibly causing uterine rupture or cervical laceration , especially in the absence of adequate cervical dilatation ;
antipsychotic agents	alcohol	effect	as with other antipsychotic agents , it should be noted that haldol may be capable of potentiating cns depressants such as anesthetics , opiates , and alcohol .
DISULFIRAM	PHENYTOIN	advise	disulfiram should be used with caution in those patients reveiving phenytoin and its congeners .
Edetate calcium disodium	zinc insulin	mechanism	steroids enhance the renal toxicity of edetate calcium disodium in animals. dg edetate calcium disodium interferes with the action of zinc insulin preparations by chelating the zinc. dg
ETOPOPHOS	levamisole hydrochloride	advise	caution should be exercised when administering etopophos with drugs that are known to inhibit phosphatase activities ( e.g. , levamisole hydrochloride ) .
PEGASYS	theophylline	mechanism	treatment with pegasys once weekly for dg weeks in healthy subjects was associated with an inhibition of p450 dg and a dg % increase in theophylline auc .
nifedipine	Vardenafil	effect	in these patients whose hypertension was controlled with nifedipine , vardenafil dg mg produced mean additional supine systolic / diastolic blood pressure reductions of dg / dg mm hg compared to placebo .
Vardenafil	terazosin	effect	with simultaneous dosing of vardenafil dg mg and terazosin dg mg , dg of dg subjects experienced a standing systolic blood pressure of less than dg mm hg .
Vardenafil	tamsulosin	effect	in a similar study with tamsulosin in healthy volunteers , dg of dg subjects dosed with vardenafil dg mg and tamsulosin dg mg separated by dg hours experienced a standing systolic blood pressure below dg mm hg .
itraconazole	gefitinib	mechanism	substances that are potent inhibitors of cyp3a4 activity ( eg , ketoconazole and itraconazole ) decrease gefitinib metabolism and increase gefitinib plasma concentrations .
Benzthiazide	decongestant drugs	int	benzthiazide may interact with alcohol , blood thinners , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , nsaids like aleve or ibuprofen , and high blood pressure medications .
methotrexate	ELSPAR	advise	these results would seem to dictate against the clinical use of methotrexate with elspar , or during the period following elspar therapy when plasma asparagine levels are below normal .
NSAIDs	thiazides	effect	furosemide : clinical studies , as well as post marketing observations , have shown that nsaids can reduce the natriuretic effect of furosemide and thiazides in some patients .
VIOXX	theophylline	advise	adequate monitoring of theophylline plasma concentrations should be considered when therapy with vioxx is initiated or changed in patients receiving theophylline .
aspirin	VIOXX	effect	aspirin : concomitant administration of low dose aspirin with vioxx may result in an increased rate of gi ulceration or other complications , compared to use of vioxx alone .
anileridine	opioids	advise	caution should be observed when anileridine is coadministered with other opioids , sedatives , phenothiazines , or anesthetics , as these agents may increase respiratory and circulatory depression .
theophylline	quinolone	mechanism	elevated plasma levels of theophylline have been reported with concomitant quinolone use .
warfarin	NSAIDs	effect	warfarin : the effects of warfarin and nsaids on gi bleeding are synergistic , such that users of both drugs together have a risk of serious gi bleeding higher than that of users of either drug alone .
warfarin	etodolac	mechanism	short term pharmacokinetic studies have demonstrated that concomitant administration of warfarin and lodine ( etodolac capsules and tablets ) results in reduced protein binding of warfarin , but there was no change in the clearance of free warfarin .
Lodine	cyclosporine	mechanism	cyclosporine , digoxin , methotrexate lodine , like other nsaids , through effects on renal prostaglandins , may cause changes in the elimination of these drugs leading to elevated serum levels of cyclosporine , digoxin , methotrexate , and increased toxicity .
digoxin	aminosalicylic acid	advise	in the case that you are taking digoxin while taking aminosalicylic acid , higher doses of digoxin may be needed .
phenytoin	Mefloquine	effect	in patients taking an anticonvulsant ( eg , valproic acid , carbamazepine , phenobarbital or phenytoin ) , the concomitant use of mefloquine may reduce seizure control by lowering the plasma levels of the anticonvulsant .
Mefloquine	beta-adrenergic blocking agents	effect	this appears to be the only clinically relevant interaction of this kind with mefloquine , although theoretically , coadministration of other drugs known to alter cardiac conduction ( eg , anti arrhythmic or beta-adrenergic blocking agents , calcium channel blockers , antihistamines or h1 blocking agents , tricyclic antidepressants and phenothiazines ) might also contribute to a prolongation of the qtc interval .
Mefloquine	tricyclic antidepressants	effect	this appears to be the only clinically relevant interaction of this kind with mefloquine , although theoretically , coadministration of other drugs known to alter cardiac conduction ( eg , anti arrhythmic or beta adrenergic blocking agents , calcium channel blockers , antihistamines or h1 blocking agents , tricyclic antidepressants and phenothiazines ) might also contribute to a prolongation of the qtc interval .
atropine	pralidoxime	effect	when atropine and pralidoxime are used together , the signs of atropinization ( flushing , mydriasis , tachycardia , dryness of the mouth and nose ) may occur earlier than might be expected than when atropine is used alone because pralidoxime may potentiate the effect of atropine .
barbiturates	anticholinesterases	advise	since barbiturates are potentiated by the anticholinesterases , they should be used cautiously in the treatment of convulsions .
MAO inhibitors	SINEQUAN	advise	therefore , mao inhibitors should be discontinued at least two weeks prior to the cautious initiation of therapy with sinequan .
IOPIDINE	opiates	advise	although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of iopidine dg % ophthalmic solution , the possibility of an additive or potentiating effect with cns depressants ( alcohol , barbiturates , opiates , sedatives , anesthetics ) should be considered .
sulfonylureas	azoles	effect	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti inflammatory agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
sulfonylureas	monoamine oxidase inhibitors	effect	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti inflammatory agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
Digoxin	Adenocard	effect	digoxin and verapamil use may be rarely associated with ventricular fibrillation when combined with adenocard .
ethanol	Antizol	mechanism	similarly , ethanol decreased the rate of elimination of antizol ( by approximately dg % ) by the same mechanism .
cromolyn sodium	isoproterenol	effect	the addition of dg mg / kg / day of cromolyn sodium ( approximately dg times the maximum recommended daily inhalation dose in adults on a mg / m2 basis ) to dg mg / kg / day of isoproterenol ( approximately dg times the maximum recommended daily inhalation dose in adults on a mg / m2 basis ) appears to have increased the incidence of both resorptions and malformations .
Furosemide	aminoglycoside antibiotics	effect	furosemide may increase the ototoxic potential of aminoglycoside antibiotics , especially in the presence of impaired renal function .
AVONEX	TYSABRI	mechanism	after multiple dosing , interferon beta 1a ( avonex dg mcg im once weekly ) reduced tysabri clearance by approximately dg % .
furazolidone	amphetamine	mechanism	mao inhibitors : maoi antidepressants , as well as a metabolite of furazolidone , slow amphetamine metabolism .
amphetamines	acidifying agents	mechanism	methenamine therapy : urinary excretion of amphetamines is increased , and efficacy is reduced , by acidifying agents used in methenamine therapy .
thiazides	amphetamine	mechanism	urinary alkalinizing agents ( acetazolamide , some thiazides ) increase the concentration of the non ionized species of the amphetamine molecule , thereby decreasing urinary excretion .
d-amphetamine	desipramine	mechanism	d-amphetamine with desipramine or protriptyline and possibly other tricyclics cause striking and sustained increases in the concentration of d-amphetamine in the brain ;
d-amphetamine	protriptyline	mechanism	d-amphetamine with desipramine or protriptyline and possibly other tricyclics cause striking and sustained increases in the concentration of d-amphetamine in the brain ;
ritonavir	cisapride	mechanism	protease inhibitors : in vitro data indicate that indinavir and ritonavir markedly inhibit the metabolism of cisapride which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
troleandomycin	cisapride	mechanism	antibiotics : in vitro and / or in vivo data show that clarithromycin , erythromycin , and troleandomycin markedly inhibit the metabolism of cisapride , which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
itraconazole	cisapride	mechanism	antifungals : in vitro and / or in vivo data indicate that fluconazole , itraconazole , and oral ketoconazole markedly inhibit the metabolism of cisapride , which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
ketoconazole	cisapride	mechanism	human pharmacokinetic data indicate that oral ketoconazole markedly inhibits the metabolism of cisapride , resulting in a mean eight fold increase in auc of cisapride .
tricyclic antidepressants	clonidine	effect	several tricyclic antidepressants have been reported to block the pharmacologic effects of guanethidine , clonidine , or similar agents , and such an effect may be anticipated with cmi because of its structural similarity to other tricyclic antidepressants .
barbiturates	CMI	mechanism	plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors ( e.g. , cimetidine , fluoxetine ) and decreased by the concomitant administration of hepatic enzyme inducers ( e.g. , barbiturates , phenytoin ) , and such an effect may be anticipated with cmi as well .
tricyclic antidepressants	fluoxetine	mechanism	plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors ( e.g. , cimetidine , fluoxetine ) and decreased by the concomitant administration of hepatic enzyme inducers ( e.g. , barbiturates , phenytoin ) , and such an effect may be anticipated with cmi as well .
STADOL NS	sumatriptan	mechanism	when the stadol ns was administered dg minutes after the sumatriptan nasal spray , the auc of butorphanol increased dg % and cmax decreased dg % .
Epinephrine	sympathomimetic drugs	advise	epinephrine should not be administered concomitantly with other sympathomimetic drugs ( such as isoproterenol ) because of possible additive effects and increased toxicity .
fentanyl	tranquilizers	effect	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
fentanyl	phenothiazines	effect	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
Tagamet	tricyclic antidepressants	mechanism	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
Tagamet	lidocaine	mechanism	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
NSAIDs	ACE inhibitors	int	experience with nonsteroidal anti inflammatory drugs ( nsaids ) suggests the potential for interactions with furosemide and ace inhibitors .
nitroglycerin	captopril	advise	therefore , nitroglycerin or other nitrates ( as used for management of angina ) or other drugs having vasodilator activity should , if possible , be discontinued before starting captopril .
sulfonylureas	coumarins	effect	the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
benzodiazepines	alcohol	effect	tablets : the benzodiazepines , including lorazepam , produce cns depressant effects when administered with such medications as barbiturates or alcohol .
lorazepam	barbiturates	effect	tablets : the benzodiazepines , including lorazepam , produce cns depressant effects when administered with such medications as barbiturates or alcohol .
Lorazepam	MAO inhibitors	effect	injection : lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , mao inhibitors , and other antidepressants.when scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .
Digitalis	Bretylium Tosylate	effect	digitalis toxicity may be aggravated by the initial release of norepinephrine caused by bretylium tosylate injection .
nitric oxide donor compounds	INOmax	effect	although there are no study data to evaluate the possibility , nitric oxide donor compounds , including sodium nitroprusside and nitroglycerin , may have an additive effect with inomax on the risk of developing methemoglobinemia .
antipsychotic agents	CNS depressants	effect	as with other antipsychotic agents , it should be noted that haldol may be capable of potentiating cns depressants such as anesthetics , opiates , and alcohol .
haloperidol	rifampin	mechanism	in a study of dg schizophrenic patients coadministered oral haloperidol and rifampin , plasma haloperidol levels were decreased by a mean of dg % and mean scores on the brief psychiatric rating scale were increased from baseline .
PRECEDEX	sedative	advise	however , due to possible pharmacodynamic interactions , when co administered with precedex , a reduction in dosage of precedex on the concomitant anesthetic , sedative , hypnotic or opioid may be required .
PRECEDEX	hypnotic	advise	however , due to possible pharmacodynamic interactions , when co administered with precedex , a reduction in dosage of precedex on the concomitant anesthetic , sedative , hypnotic or opioid may be required .
PRECEDEX	opioid	advise	however , due to possible pharmacodynamic interactions , when co administered with precedex , a reduction in dosage of precedex on the concomitant anesthetic , sedative , hypnotic or opioid may be required .
Ritonavir	vardenafil	mechanism	ritonavir significantly prolonged the half life of vardenafil to dg hours .
Vardenafil	nitrates	advise	potentiation of the hypotensive effects of nitrates for patients with ischemic heart disease has not been evaluated , and concomitant use of vardenafil and nitrates is contraindicated .
Ketoconazole	vardenafil	mechanism	ketoconazole ( dg mg once daily ) produced a dg fold increase in vardenafil auc and a dg fold increase in cmax when co administered with vardenafil ( dg mg ) in healthy volunteers .
INSPRA	enalapril	effect	in a study in diabetics with microalbuminuria inspra dg mg combined with the ace inhibitor enalapril dg mg increased the frequency of hyperkalemia ( serum potassium dg meq / l ) from dg % on enalapril alone to dg % .
probenecid	acyclovir	mechanism	co administration of probenecid with acyclovir has been shown to increase the mean half life and the area under the concentration time curve .
tricyclic antidepressants	flecainide	advise	therefore , co administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme , including other antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( eg , propafenone , flecainide , and encainide ) , or that inhibit this enzyme ( eg , quinidine ) , should be approached with caution .
tricyclic antidepressants	cimetidine	effect	the therapeutic efficacy of tricyclic antidepressants may be compromised in these patients when cimetidine is discontinued .
antidepressants	fluoxetine hydrochloride	mechanism	there have been greater than dg fold increases in previously stable plasma levels of other antidepressants , including nortriptyline , when fluoxetine hydrochloride has been administered in combination with these agents .
nortriptyline hydrochloride	anticholinergic drugs	advise	close supervision and careful adjustment of the dosage are required when nortriptyline hydrochloride is used with other anticholinergic drugs or sympathomimetic drugs .
ranitidine	IRESSA	mechanism	drugs that cause significant sustained elevation in gastric ph ( histamine h2 receptor antagonists such as ranitidine or cimetidine ) may reduce plasma concentrations of iressa and therefore potentially may reduce efficacy .
Antacids	LEVSIN	mechanism	antacids may interfere with the absorption of levsin .
ketoconazole	budesonide	mechanism	concomitant oral administration of ketoconazole ( a known inhibitor of cyp3a4 activity in the liver and in the intestinal mucosa ) caused an eight fold increase of the systemic exposure to oral budesonide .
Argatroban	warfarin	effect	however , the concomitant use of argatroban and warfarin ( dg dg mg initial oral dose followed by dg dg mg / day orally for dg dg days ) results in prolongation of the prothrombin time ( pt ) and international normalized ratio ( inr ) .
HUMORSOL	anticholinesterase agents	int	possible drug interactions of humorsol with succinylcholine or with other anticholinesterase agents .
Tricyclic antidepressants	guanethidine	effect	tricyclic antidepressants may block the antihypertensive action of guanethidine and similarly acting compounds .
Folic acid	primidone	effect	folic acid in large amounts may counteract the antiepileptic effect of phenobarbital , phenytoin and primidone , and increase the frequency of seizures in susceptible pediatric patients .
norepinephrine	monoamine oxidase inhibitors	effect	the administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe , prolonged hypertension .
Amphetamines	antihistamines	effect	antihistamines : amphetamines may counteract the sedative effect of antihistamines .
Amphetamines	antihypertensives	effect	antihypertensives : amphetamines may antagonize the hypotensive effects of antihypertensives .
Amphetamines	ethosuximide	mechanism	ethosuximide : amphetamines may delay intestinal absorption of ethosuximide .
Haloperidol	amphetamines	effect	haloperidol : haloperidol blocks dopamine receptors , thus inhibiting the central stimulant effects of amphetamines .
hydroxyurea	uricosuric medication	effect	since hydroxyurea may raise the serum uric acid level , dosage adjustment of uricosuric medication may be necessary
non-steroidal anti-inflammatory agent	thiazide diuretics	effect	non steroidal anti inflammatory drugs : in some patients , the administration of a non-steroidal anti-inflammatory agent can reduce the diuretic , natriuretic , and antihypertensive effects of loop , potassium sparing and thiazide diuretics .
Lithium	diuretics	advise	lithium : generally should not be given with diuretics .
Accutane	tetracyclines	effect	tetracyclines : concomitant treatment with accutane and tetracyclines should be avoided because accutane use has been associated with a number of cases of pseudotumor cerebri ( benign intracranial hypertension ) , some of which involved concomitant use of tetracyclines
Itraconazole	midazolam	mechanism	coadministration of itraconazole with oral midazolam or triazolam has resulted in elevated plasma concentrations of the latter two drugs .
Itraconazole	phenytoin	mechanism	when itraconazole was coadministered with phenytoin , rifampin , or h2antagonists , reduced plasma concentrations of itraconazole were reported .
Itraconazole	phenytoin	mechanism	although no studies have been conducted , concomitant administration of itraconazole and phenytoin may alter the metabolism of phenytoin ;
Itraconazole	coumarin	effect	it has been reported that itraconazole enhances the anticoagulant effect of coumarin like drugs .
Itraconazole	coumarin	advise	therefore , prothrombin time should be carefully monitored in patients receiving itraconazole and coumarin like drugs simultaneously .
steroidal anti-inflammatory agent	potassium sparing diuretics	effect	( in some patients , the steroidal anti-inflammatory agent can reduce the diuretic , natriuretic , and antihypertensive effects of loop , potassium sparing , and thiazide diuretics .
hydroflumethiazide	nonsteroidal anti-inflammatory agents	advise	therefore , when hydroflumethiazide and nonsteroidal anti-inflammatory agents are used concomitantly , the patient should be observed closely to determine if the desired effect of the diuretic is obtained . )
Thiazide drugs	tubocurarine	effect	( thiazide drugs may increase the responsiveness to tubocurarine . )
fentanyl	ritonavir	mechanism	the concomitant use of transdermal fentanyl with ritonavir or other potent dg inhibitors such as ketoconazole , itraconazole , troleandomycin , clarithromycin , nelfinavir , and nefazadone may result in an increase in fentanyl plasma concentrations .
fentanyl	troleandomycin	mechanism	the concomitant use of transdermal fentanyl with ritonavir or other potent dg inhibitors such as ketoconazole , itraconazole , troleandomycin , clarithromycin , nelfinavir , and nefazadone may result in an increase in fentanyl plasma concentrations .
NSAIDs	furosemide	effect	furosemide : clinical studies , as well as post marketing observations , have shown that nsaids can reduce the natriuretic effect of furosemide and thiazides in some patients .
NSAIDs	thiazides	effect	furosemide : clinical studies , as well as post marketing observations , have shown that nsaids can reduce the natriuretic effect of furosemide and thiazides in some patients .
celecoxib	fluconazole	mechanism	this increase is due to the inhibition of celecoxib metabolism via p450 dg by fluconazole ( see clinical pharmacology pharmacokinetics : metabolism ) .
CELEBREX	fluconazole	advise	celebrex should be introduced at the lowest recommended dose in patients receiving fluconazole .
warfarin	NSAIDs	int	caution should be exercised when administering nabumetone with warfarin since interactions have been seen with other nsaids .
nitrates	captopril	advise	therefore , nitroglycerin or other nitrates ( as used for management of angina ) or other drugs having vasodilator activity should , if possible , be discontinued before starting captopril .
diuretics	fosinopril sodium	effect	diuretics : patients on diuretics , especially those with intravascular volume depletion , may occasionally experience an excessive reduction of blood pressure after initiation of therapy with fosinopril sodium .
simethicone	fosinopril	mechanism	antacids : in a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .
sulfonylureas	chloramphenicol	effect	the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
sulfonylureas	monoamine oxidase inhibitors	effect	the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
glyburide	ciprofloxacin	int	a possible interaction between glyburide and ciprofloxacin , a fluoroquinolone antibiotic , has been reported , resulting in a potentiation of the hypoglycemic action of glyburide .
Sulfapyridine	Tylenol	int	sulfapyridine may interact with any of the following : acetaminophen ( e.g. , tylenol ) ( with long term , high dose use ) or
antidiabetics	sulfapyridine	effect	antidiabetics , oral ( diabetes medicine you take by mouth ) use of oral antidiabetics with sulfapyridine may increase the chance of side effects affecting the blood and / or the side effects or oral antidiabetics
methotrexate	sulfapyridine	effect	methotrexate ( e.g. , mexate ) use of methotrexate with sulfapyridine may increase the chance of side effects affecting the liver and / or the side effects of methotrexate
Lorazepam	barbiturates	effect	injection : lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , mao inhibitors , and other antidepressants.when scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .
diclofenac	aspirin	advise	aspirin : concomitant administration of diclofenac and aspirin is not recommended because diclofenac is displaced from its binding sites during the concomitant administration of aspirin , resulting in lower plasma concentrations , peak plasma levels , and auc values .
insulin	diclofenac	effect	there are rare reports , however , from marketing experiences , of changes in effects of insulin or oral hypoglycemic agents in the presence of diclofenac that necessitated changes in the doses of such agents .
diclofenac	methotrexate	mechanism	ingestion of diclofenac may increase serum concentrations of digoxin and methotrexate and increase cyclosporine s nephrotoxicity .
Diclofenac	lithium	mechanism	lithium : diclofenac decreases lithium renal clearance and increases lithium plasma levels .
Curariform muscle relaxants	Coly-Mycin M	effect	curariform muscle relaxants ( eg , tubocurarine ) and other drugs , including ether , succinylcholine , gallamine , decamethonium and sodium citrate , potentiate the neuromuscular blocking effect and should be used with extreme caution in patients being treated with coly-mycin m parenteral .
Beta-adrenergic blocking agents	arbutamine	advise	beta-adrenergic blocking agents should be withdrawn at least dg hours before conducting an arbutamine mediated stress test .
Clindamycin	neuromuscular blocking agents	effect	clindamycin has been shown to have neuromuscular blocking properties that may enhance the action of other neuromuscular blocking agents .
clindamycin	erythromycin	effect	antagonism has been demonstrated between clindamycin and erythromycin in vitro .
Levo-Dromoran	skeletal muscle relaxants	effect	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
Levo-Dromoran	barbiturates	effect	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
Levo-Dromoran	phenothiazines	effect	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
Levo-Dromoran	MAO inhibitors	advise	although no interaction between mao inhibitors and levo-dromoran has been observed , it is not recommended for use with mao inhibitors .
anesthetics	DILAUDID	effect	patients receiving other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative hypnotics , tricyclic antidepressants or other cns depressants ( including alcohol ) concomitantly with dilaudid may exhibit an additive cns depression .
Probenecid	aminosalicylic acid	mechanism	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti inflammatory agents , theophylline , and zidovudine ) .
Zidovudine	probenecid	advise	zidovudine should either be temporarily discontinued or decreased by dg % when coadministered with probenecid on the day of vistide infusion .
pentamidine	HIVID	advise	if intravenous pentamidine is required to treat pneumocystis carinii pneumonia , treatment with hivid should be interrupted .
Doxorubicin	zalcitabine	effect	doxorubicin : doxorubicin caused a decrease in zalcitabine phosphorylation ( dg % inhibition of total phosphate formation ) in u937 / molt dg cells .
lamivudine	zalcitabine	effect	lamivudine : in vitro studies in peripheral blood mononuclear cells , u937 and molt dg cells revealed that lamivudine significantly inhibited zalcitabine phosphorylation in a dose dependent manner .
Zalcitabine	lamivudine	effect	zalcitabine inhibited lamivudine phosphorylation at high concentration ratios ( dg and dg ) ;
benzodiazepines	ethanol	effect	the benzodiazepines , including alprazolam , produce additive cns depressant effects when co administered with other psychotropic medications , anticonvulsants , antihistaminics , ethanol , and other drugs which themselves produce cns depression .
alprazolam	anticonvulsants	effect	the benzodiazepines , including alprazolam , produce additive cns depressant effects when co administered with other psychotropic medications , anticonvulsants , antihistaminics , ethanol , and other drugs which themselves produce cns depression .
alprazolam	antihistaminics	effect	the benzodiazepines , including alprazolam , produce additive cns depressant effects when co administered with other psychotropic medications , anticonvulsants , antihistaminics , ethanol , and other drugs which themselves produce cns depression .
benzodiazepines	cyclosporine	int	data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following : ergotamine , cyclosporine , amiodarone , nicardipine , and nifedipine .
alprazolam	cyclosporine	int	data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following : ergotamine , cyclosporine , amiodarone , nicardipine , and nifedipine .
alprazolam	clarithromycin	int	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
diflunisal	acetaminophen	advise	since acetaminophen in high doses has been associated with hepatotoxicity , concomitant administration of diflunisal and acetaminophen should be used cautiously , with careful monitoring of patients .
diflunisal	indomethacin	mechanism	nonsteroidal anti inflammatory drugs : the administration of diflunisal to normal volunteers receiving indomethacin decreased the renal clearance and significantly increased the plasma levels of indomethacin .
NUROMAX	antibiotics	effect	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
NUROMAX	colistin	effect	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
nondepolarizing neuromuscular blocking agents	phenytoin	effect	as with some other nondepolarizing neuromuscular blocking agents , the time of onset of neuromuscular block induced by nuromax is lengthened and the duration of block is shortened in patients receiving phenytoin or carbamazepine .
NUROMAX	phenytoin	effect	as with some other nondepolarizing neuromuscular blocking agents , the time of onset of neuromuscular block induced by nuromax is lengthened and the duration of block is shortened in patients receiving phenytoin or carbamazepine .
agents with b-blocking properties	reserpine	effect	catecholamine depleting agents : patients taking both agents with b-blocking properties and a drug that can deplete catecholamines ( e.g. , reserpine and monoamine oxidase inhibitors ) should be observed closely for signs of hypotension and / or severe bradycardia .
agents with b-blocking properties	monoamine oxidase inhibitors	effect	catecholamine depleting agents : patients taking both agents with b-blocking properties and a drug that can deplete catecholamines ( e.g. , reserpine and monoamine oxidase inhibitors ) should be observed closely for signs of hypotension and / or severe bradycardia .
nevirapine	warfarin	int	the in vitro interaction between nevirapine and the antithrombotic agent warfarin is complex .
alcohol	bromocriptine mesylate	effect	the risk of using bromocriptine mesylate in combination with other drugs has not been systematically evaluated , but alcohol may potentiate the side effects of bromocriptine mesylate .
magnesium trisilicate	nitrofurantoin	mechanism	antacids containing magnesium trisilicate , when administered concomitantly with nitrofurantoin , reduce both the rate and extent of absorption .
nitrofurantoin	magnesium trisilicate	mechanism	the mechanism for this interaction probably is adsorption of nitrofurantoin onto the surface of magnesium trisilicate .
tiagabine	carbamazepine	mechanism	effects of other antiepilepsy drugs ( aeds ) on gabitril : carbamazepine : population pharmacokinetic analyses indicate that tiagabine clearance is dg % greater in patients taking carbamazepine with or without other enzyme inducing aeds .
prochlorperazine	CAMPTOSAR	effect	the incidence of akathisia in clinical trials of the weekly dosage schedule was greater ( dg % , dg / dg patients ) when prochlorperazine was administered on the same day as camptosar than when these drugs were given on separate days ( dg % , dg / dg patients ) .
DOSTINEX	phenothiazines	advise	dostinex should not be administered concurrently with d2 antagonists , such as phenothiazines , butyrophenones , thioxanthines , or metoclopramide .
DOSTINEX	butyrophenones	advise	dostinex should not be administered concurrently with d2 antagonists , such as phenothiazines , butyrophenones , thioxanthines , or metoclopramide .
TRICOR	HMG-CoA reductase inhibitors	advise	hmg-coa reductase inhibitors : the combined use of tricor and hmg-coa reductase inhibitors should be avoided unless the benefit of further alterations in lipid levels is likely to outweigh the increased risk of this drug combination .
cyclosporine	fibrate drugs	effect	cyclosporine : because cyclosporine can produce nephrotoxicity with decreases in creatinine clearance and rises in serum creatinine , and because renal excretion is the primary elimination route of fibrate drugs including tricor , there is a risk that an interaction will lead to deterioration .
Ethoxzolamide	amphetamines	effect	ethoxzolamide may increase the action of tricyclics , amphetamines , procainamide , and quinidine .
Ethoxzolamide	quinidine	effect	ethoxzolamide may increase the action of tricyclics , amphetamines , procainamide , and quinidine .
Bosentan	statins	mechanism	bosentan is also expected to reduce plasma concentrations of other statins that have significant metabolism by cyp3a4 , such as lovastatin and atorvastatin .
Bezalip	anticoagulants of the coumarin type	effect	when bezalip or bezalip retard is used at the same time as other medicines or substances the following interactions must be taken into account : bezalip and bezalip retard may enhance the action of anticoagulants of the coumarin type .
MAO-inhibitors	Bezalip retard	advise	perhexiline hydrogen maleate or mao-inhibitors ( with hepatotoxic potential ) must not be administered together with bezalip or bezalip retard .
insulin	Bezalip	effect	the action of sulphonylureas and insulin may be enhanced by bezalip or bezalip retard .
Bezalip retard	anion-exchange resins	advise	when bezalip or bezalip retard is used concurrently with anion-exchange resins ( e.g. cholestryramine ) , an interval of at least dg hours should be maintained between the two medicines , since the absorption of bezalip or bezalip retard is impaired
Diphenhydramine hydrochloride	hypnotics	effect	diphenhydramine hydrochloride has additive effects with alcohol and other cns depressants ( hypnotics , sedatives , tranquilizers , etc ) .
ORENCIA	TNF antagonists	advise	concurrent therapy with orencia and tnf antagonists is not recommended .
ORENCIA	anakinra	advise	there is insufficient experience to assess the safety and efficacy of orencia administered concurrently with anakinra , and therefore such use is not recommended .
losartan	indomethacin	effect	as with other antihypertensive agents , the antihypertensive effect of losartan may be blunted by the non steroidal anti inflammatory drug indomethacin
cephalexin	metformin	mechanism	although not observed in this study , adverse effects could potentially arise from co administration of cephalexin and metformin by inhibition of tubular secretion via organic cationic transporter systems .
cephalexin	probenecid	mechanism	probenecid : as with other b lactams , the renal excretion of cephalexin is inhibited by probenecid .
dapsone	pyrimethamine	effect	with oral dapsone treatment , folic acid antagonists such as pyrimethamine have been noted to possibly increase the likelihood of hematologic reactions
HALDOL	CNS depressants	effect	as with other antipsychotic agents , it should be noted that haldol may be capable of potentiating cns depressants such as anesthetics , opiates , and alcohol .
rifampin	haloperidol	advise	thus , careful monitoring of clinical status is warranted when rifampin is administered or discontinued in haloperidol treated patients .
Isoniazid	carbamazepine	mechanism	carbamazepine : isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels carbamazepine levels should be determined prior to concurrent administration with isoniazid , signs and symptoms of carbamazepine toxicity should be monitored closely , and appropriate dosage adjustment of the anticonvulsant should be made .
Cimetidine	altretamine	mechanism	concurrent administration of hexalen and antidepressants of the mao inhibitor class may cause severe orthostatic hypotension.cimetidine , an inhibitor of microsomal drug metabolism , increased altretamines half life and toxicity in a rat model .
disulfiram	nitrite	effect	in rats , simultaneous ingestion of disulfiram and nitrite in the diet for dg weeks has been reported to cause tumors , and it has been suggested that disulfiram may react with nitrites in the rat stomach to form a nitrosamine , which is tumorigenic .
Dexbrompheniramine	alcohol	effect	dexbrompheniramine can interact with alcohol or other cns depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
cyclosporin A	etoposide	mechanism	high dose cyclosporin a resulting in concentrations above dg ng / ml administered with oral etoposide has led to an dg % increase in etoposide exposure with a dg % decrease in total body clearance of etoposide compared to etoposide alone .
Ribavirin	stavudine	effect	stavudine and zidovudine ribavirin can antagonize the in vitro antiviral activity of stavudine and zidovudine against hiv .
Ritonavir	Vardenafil	mechanism	ritonavir ( dg mg b.i.d. ) co administered with vardenafil dg mg resulted in a dg fold increase in vardenafil auc and a dg fold increase in vardenafil cmax .
Vardenafil	terazosin	effect	alpha blockers : when vardenafil dg or dg mg was given to healthy volunteers either simultaneously or dg hours after a dg mg dose of terazosin , significant hypotension developed in a substantial number of subjects .
Vardenafil	erythromycin	advise	it is recommended not to exceed a single dg mg dose of vardenafil in a dg hour period when used in combination with erythromycin .
INSPRA	ACE inhibitors	effect	ace inhibitors and angiotensin ii receptor antagonists ( hypertension ) in clinical studies of patients with hypertension , the addition of inspra dg to dg mg to ace inhibitors and angiotensin ii receptor antagonists increased mean serum potassium slightly ( about dg dg meq / l ) .
tricyclic antidepressants	cimetidine	mechanism	steady state serum concentrations of tricyclic antidepressants are reported to fluctuate significantly when cimetidine is either added or deleted from the drug regimen .
cimetidine	IRESSA	mechanism	drugs that cause significant sustained elevation in gastric ph ( histamine h2 receptor antagonists such as ranitidine or cimetidine ) may reduce plasma concentrations of iressa and therefore potentially may reduce efficacy .
IRESSA	vinorelbine	effect	phase ii clinical trial data , where iressa and vinorelbine have been used concomitantly , indicate that iressa may exacerbate the neutropenic effect of vinorelbine .
Benzthiazide	Aleve	int	benzthiazide may interact with alcohol , blood thinners , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , nsaids like aleve or ibuprofen , and high blood pressure medications .
Benzthiazide	Ibuprofen	int	benzthiazide may interact with alcohol , blood thinners , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , nsaids like aleve or ibuprofen , and high blood pressure medications .
VIOXX	lithium	advise	thus , when vioxx and lithium are administered concurrently , subjects should be observed carefully for signs of lithium toxicity .
VIOXX	warfarin	advise	warfarin : anticoagulant activity should be monitored , particularly in the first few days after initiating or changing vioxx therapy in patients receiving warfarin or similar agents , since these patients are at an increased risk of bleeding complications .
warfarin	rofecoxib	effect	in single and multiple dose studies in healthy subjects receiving both warfarin and rofecoxib , prothrombin time ( measured as inr ) was increased by approximately dg % to dg % .
erythromycins	penicillins	effect	bacteriostatic antibiotics : chloramphenicol , erythromycins , sulfonamides , or tetracyclines may interfere with the bactericidal effect of penicillins .
digitoxin	antithyroid agents	mechanism	serum concentration of digoxin and digitoxin may increase when patients take antithyroid agents .
anileridine	phenothiazines	advise	caution should be observed when anileridine is coadministered with other opioids , sedatives , phenothiazines , or anesthetics , as these agents may increase respiratory and circulatory depression .
eszopiclone	olanzapine	effect	olanzapine : coadministration of eszopiclone dg mg and olanzapine dg mg produced a decrease in dsst scores .
eszopiclone	ketoconazole	mechanism	the auc of eszopiclone was increased dg fold by coadministration of ketoconazole , a potent inhibitor of cyp3a4 , dg mg daily for dg days .
quinolones	caffeine	mechanism	some quinolones have also been shown to interfere with the metabolism of caffeine .
norfloxacin	warfarin	effect	quinolones , including norfloxacin , may enhance the effects of oral anticoagulants , including warfarin or its derivatives or similar agents .
warfarin	Lodine	mechanism	short term pharmacokinetic studies have demonstrated that concomitant administration of warfarin and lodine ( etodolac capsules and tablets ) results in reduced protein binding of warfarin , but there was no change in the clearance of free warfarin .
Lodine	digoxin	mechanism	cyclosporine , digoxin , methotrexate lodine , like other nsaids , through effects on renal prostaglandins , may cause changes in the elimination of these drugs leading to elevated serum levels of cyclosporine , digoxin , methotrexate , and increased toxicity .
Aminosalicylic acid	Lanoxin	mechanism	aminosalicylic acid may decrease the amount of digoxin ( lanoxin , lanoxicaps ) that gets absorbed into your body .
vitamin B12	aminosalicylic acid	advise	therefore you may need to take a vitamin b12 supplement while taking aminosalicylic acid .
carbamazepine	Mefloquine	effect	in patients taking an anticonvulsant ( eg , valproic acid , carbamazepine , phenobarbital or phenytoin ) , the concomitant use of mefloquine may reduce seizure control by lowering the plasma levels of the anticonvulsant .
Mefloquine	quinine	effect	concomitant administration of mefloquine and other related compounds ( eg , quinine , quinidine and chloroquine ) may produce electrocardiographic abnormalities and increase the risk of convulsions .
Mefloquine	antihistamines	effect	this appears to be the only clinically relevant interaction of this kind with mefloquine , although theoretically , coadministration of other drugs known to alter cardiac conduction ( eg , anti arrhythmic or beta adrenergic blocking agents , calcium channel blockers , antihistamines or h1 blocking agents , tricyclic antidepressants and phenothiazines ) might also contribute to a prolongation of the qtc interval .
SSRIs	doxepin	mechanism	inhibitors or substrates of cyp2d6 ( i.e. , quinidine , selective serotonin reuptake inhibitors [ ssris ] ) may increase the plasma concentration of doxepin when administered concomitantly .
Cimetidine	tricyclic antidepressants	mechanism	cimetidine : cimetidine has been reported to produce clinically significant fluctuations in steady state serum concentrations of various tricyclic antidepressants .
tricyclic antidepressant	cimetidine	effect	serious anticholinergic symptoms ( i.e. , severe dry mouth , urinary retention and blurred vision ) have been associated with elevations in the serum levels of tricyclic antidepressant when cimetidine therapy is initiated .
dantrolene	vecuronium	effect	administration of dantrolene may potentiate vecuronium induced neuromuscular block .
phenytoin	Trileptal	mechanism	dg nc denotes a mean change of less than dg % dg pediatrics dg mean increase in adults at high trileptal doses in vivo , the plasma levels of phenytoin increased by up to dg % , when trileptal was given at doses above dg mg / day .
Trileptal	phenytoin	advise	therefore , when using doses of trileptal greater than dg mg / day during adjunctive therapy , a decrease in the dose of phenytoin may be required .
Trileptal	hormonal contraceptives	effect	therefore , concurrent use of trileptal with hormonal contraceptives may render these contraceptives less effective .
HYDROXYZINE	CENTRAL NERVOUS SYSTEM DEPRESSANTS	effect	the potentiating action of hydroxyzine must be considered when the drug is used in conjunction with central nervous system depressants such as narcotics , non narcotic analgesics and barbiturates .
HYDROXYZINE	NON-NARCOTIC ANALGESICS	effect	the potentiating action of hydroxyzine must be considered when the drug is used in conjunction with central nervous system depressants such as narcotics , non-narcotic analgesics and barbiturates .
antihistamines	alcohol	effect	additive cns depression may occur when antihistamines are administered concomitantly with other cns depressants including barbiturates , tranquilizers , and alcohol .
NSAIDs	hydralazine	effect	nsaids may decrease the hemodynamic effects of hydralazine ;
rauwolfia alkaloid	MAO inhibitors	effect	taking a rauwolfia alkaloid while you are taking or within dg weeks of taking mao inhibitors may increase the risk of central nervous system depression or may cause a severe high blood pressure reaction .
ketoconazole	corticosteroid	effect	in addition , ketoconazole alone can inhibit adrenal corticosteroid synthesis and may cause adrenal insufficiency during corticosteroid withdrawal .
aspirin	corticosteroids	effect	nonsteroidal anti inflammatory agents ( nsaids ) : concomitant use of aspirin ( or other nonsteroidal antiinflammatory agents ) and corticosteroids increases the risk of gastrointestinal side effects .
felodipine	anticonvulsant	mechanism	anticonvulsants : in a pharmacokinetic study , maximum plasma concentrations of felodipine were considerably lower in epileptic patients on long term anticonvulsant therapy ( eg , phenytoin , carbamazepine , or phenobarbital ) than in healthy volunteers .
amphotericin B	skeletal muscle relaxants	effect	skeletal muscle relaxants : amphotericin b induced hypokalemia may enhance the curariform effect of skeletal muscle relaxants ( e.g. , tubocurarine ) .
Corticosteroids	amphotericin B	effect	corticosteroids and corticotropin ( acth ) : may potentiate amphotericin b induced hypokalemia which may predispose the patient to cardiac dysfunction .
Corticotropin	amphotericin B	effect	corticosteroids and corticotropin ( acth ) : may potentiate amphotericin b induced hypokalemia which may predispose the patient to cardiac dysfunction .
ACTH	amphotericin B	effect	corticosteroids and corticotropin ( acth ) : may potentiate amphotericin b induced hypokalemia which may predispose the patient to cardiac dysfunction .
Chirocaine	anesthetics	advise	chirocaine should be used with caution in patients receiving other local anesthetics or agents structurally related to amide type local anesthetics since the toxic effects of these drugs could be additive .
MAOIs	clidinium	effect	amantadine , tricyclic antidepressants , and maois may increase anticholinergic effect of clidinium .
Butyrophenones	dopamine	effect	butyrophenones ( such as haloperidol ) and phenothiazines can suppress the dopaminergic renal and mesenteric vasodilation induced with low dose dopamine infusion .
Cyclopropane	catecholamines	effect	cyclopropane or halogenated hydrocarbon anesthetics increase cardiac autonomic irritability and may sensitize the myocardium to the action of certain intravenously administered catecholamines , such as dopamine .
piperazine	phenothiazine	effect	phenothiazines taking piperazine and a phenothiazine together may increase the risk of convulsions ( seizures ) .
antihypertensives	PROLEUKIN	effect	although glucocorticoids have been shown to reduce proleukin induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with proleukin may reduce the antitumor effectiveness of proleukin and thus should be avoided. dg beta blockers and other antihypertensives may potentiate the hypotension seen with proleukin .
PROLEUKIN	tamoxifen	effect	hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose proleukin and antineoplastic agents , specifically , dacarbazine , cis platinum , tamoxifen and interferon alfa .
ciprofloxacin	cyclosporine	effect	some quinolones , including ciprofloxacin , have been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly .
ciprofloxacin	sucralfate	mechanism	multivalent cation containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation containing products such as magnesium or aluminum antacids , sucralfate , videx chewable / buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
ciprofloxacin	iron	mechanism	multivalent cation containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation containing products such as magnesium or aluminum antacids , sucralfate , videx chewable / buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
quinolone	aluminum	mechanism	multivalent cation containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation containing products such as magnesium or aluminum antacids , sucralfate , videx chewable / buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
carbamazepine	saquinavir	mechanism	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
valdecoxib	Ortho-Novum	mechanism	coadministration of valdecoxib and ortho-novum dg / dg increased the exposure of norethindrone and ethinyl estradiol by dg % and dg % , respectively .
NSAIDs	ACE-inhibitors	effect	ace-inhibitors : reports suggest that nsaids may diminish the antihypertensive effect of ace-inhibitors .
probenecid	ertapenem	mechanism	when ertapenem is co administered with probenecid ( dg mg p.o. every dg hours ) , probenecid competes for active tubular secretion and reduces the renal clearance of ertapenem .
doxapram	monoamine oxidase inhibiting drugs	effect	administration of doxapram to patients who are receiving sympathomimetic or monoamine oxidase inhibiting drugs may result in an additive pressor effect .
diuretic	PRINIVIL	effect	the possibility of hypotensive effects with prinivil can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with prinivil .
PRINIVIL	triamterene	effect	use of prinivil with potassium sparing diuretics ( e.g. , spironolactone , triamterene , or amiloride ) , potassium supplements , or potassium containing salt substitutes may lead to significant increases in serum potassium .
PRINIVIL	amiloride	effect	use of prinivil with potassium sparing diuretics ( e.g. , spironolactone , triamterene , or amiloride ) , potassium supplements , or potassium containing salt substitutes may lead to significant increases in serum potassium .
benzodiazepines	barbiturates	effect	the action of the benzodiazepines may be potentiated by anticonvulsants , antihistamines , alcohol , barbiturates , monoamine oxidase inhibitors , narcotics , phenothiazines , psychotropic medications , or other drugs that produce cns depression .
benzodiazepines	monoamine oxidase inhibitors	effect	the action of the benzodiazepines may be potentiated by anticonvulsants , antihistamines , alcohol , barbiturates , monoamine oxidase inhibitors , narcotics , phenothiazines , psychotropic medications , or other drugs that produce cns depression .
estazolam	estazolam	mechanism	while no in vivo drug drug interaction studies were conducted between estazolam and inducers of cyp3a , compounds that are potent cyp3a inducers ( such as carbamazepine , phenytoin , rifampin , and barbiturates ) would be expected to decrease estazolam concentrations .
benzodiazepines	cimetidine	mechanism	the following are examples of drugs known to inhibit the metabolism of other related benzodiazepines , presumably through inhibition of cyp3a : nefazodone , fluvoxamine , cimetidine , diltiazem , isoniazide , and some macrolide antibiotics .
benzodiazepines	diltiazem	mechanism	the following are examples of drugs known to inhibit the metabolism of other related benzodiazepines , presumably through inhibition of cyp3a : nefazodone , fluvoxamine , cimetidine , diltiazem , isoniazide , and some macrolide antibiotics .
Warfarin	cefixime	effect	warfarin and anticoagulants : increased prothrombin time , with or without clinical bleeding , has been reported when cefixime is administered concomitantly .
VIRACEPT	terfenadine	advise	therefore , viracept should not be administered concurrently with terfenadine because of the potential for serious and / or life threatening cardiac arrhythmias .
indinavir	VIRACEPT	mechanism	indinavir : coadministration of indinavir with viracept resulted in an dg % increase in nelfinavir plasma auc and a dg % increase in indinavir plasma a.c .
zidovudine	VIRACEPT	advise	a dose adjustment is not needed when zidovudine is administered with viracept .
VIRACEPT	midazolam	advise	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
VIRACEPT	astemizole	advise	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
gemfibrozil	colestipol hydrochloride	mechanism	the absorption of tetracycline , furosemide , penicillin g , hydrochlorothiazide , and gemfibrozil was significantly decreased when given simultaneously with colestipol hydrochloride ;
tetracycline	colestipol hydrochloride	mechanism	the absorption of tetracycline , furosemide , penicillin g , hydrochlorothiazide , and gemfibrozil was significantly decreased when given simultaneously with colestipol hydrochloride ;
REVIA	opioid analgesics	effect	patients taking revia may not benefit from opioid containing medicines , such as cough and cold preparations , antidiarrheal preparations , and opioid analgesics .
ferrous sulfate	FACTIVE	advise	magnesium and / or aluminum containing antacids , products containing ferrous sulfate ( iron ) , multivitamin preparations containing zinc or other metal cations , or videx ( didanosine ) chewable / buffered tablets or the pediatric powder for oral solution should not be taken within dg hours before or dg hours after factive .
Magnesium	FACTIVE	advise	magnesium and / or aluminum containing antacids , products containing ferrous sulfate ( iron ) , multivitamin preparations containing zinc or other metal cations , or videx ( didanosine ) chewable / buffered tablets or the pediatric powder for oral solution should not be taken within dg hours before or dg hours after factive .
EPA	non-steroidal anti-inflammatory drugs	int	interactions may occur between epa supplements and aspirin and other non-steroidal anti-inflammatory drugs and herbs such as garlic ( allium sativum ) and ginkgo ( ginkgo biloba ) .
CANCIDAS	nevirapine	advise	when cancidas is co administered with inducers of drug clearance , such as efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine , use of a daily dose of dg mg of cancidas should be considered
acitretin	phenytoin	mechanism	phenytoin : if acitretin is given concurrently with phenytoin , the protein binding of phenytoin may be reduced .
progestin	Soriatane	advise	microdosed minipill progestin preparations are not recommended for use with soriatane .
amiloride	angiotensin-converting enzyme inhibitor	effect	when amiloride hcl is administered concomitantly with an angiotensin-converting enzyme inhibitor , the risk of hyperkalemia may be increased .
apomorphine	5HT3 antagonist class	advise	5ht3 antagonists : based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron , the concomitant use of apomorphine with drugs of the 5ht3 antagonist class ( including , for example , ondansetron , granisetron , dolasetron , palonosetron , and alosetron ) is contraindicated .
apomorphine	alosetron	advise	5ht3 antagonists : based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron , the concomitant use of apomorphine with drugs of the 5ht3 antagonist class ( including , for example , ondansetron , granisetron , dolasetron , palonosetron , and alosetron ) is contraindicated .
thioxanthenes	APOKYN	effect	dopamine antagonists : since apomorphine is a dopamine agonist , it is possible that dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
omeprazole	cilostazol	mechanism	pharmacokinetic studies have demonstrated that omeprazole and erythromycin significantly increased the systemic exposure of cilostazol and / or its major metabolites .
phenytoin	coumarin anticoagulants	mechanism	presumably , phenytoin acts as a stimulator of coumarin metabolism and has been reported to cause decreased serum levels of the coumarin anticoagulants and increased prothrombin proconvertin concentrations .
PEGANONE	coumarin anticoagulants	advise	caution is therefore advised when administering peganone to patients receiving coumarin anticoagulants .
alosetron	procainamide	effect	although not studied with alosetron , inhibition of n acetyltransferase may have clinically relevant consequences for drugs such as isoniazid , procainamide , and hydralazine .
alosetron	quinolone antibiotics	advise	concomitant administration of alosetron and moderate cyp1a2 inhibitors , including quinolone antibiotics and cimetidine , has not been evaluated , but should be avoided unless clinically necessary because of similar potential drug interactions .
Acetazolamide	amphetamine	mechanism	acetazolamide decreases urinary excretion of amphetamine and may enhance the magnitude and duration of their effect .
docetaxel	terfenadine	mechanism	in vitro studies have shown that the metabolism of docetaxel may be modified by the concomitant administration of compounds that induce , inhibit , or are metabolized by cytochrome p450 dg , such as cyclosporine , terfenadine , ketoconazole , erythromycin , and troleandomycin .
cimetidine	nifedipine	mechanism	cimetidine : a study in dg healthy volunteers has shown a significant increase in peak nifedipine plasma levels ( dg % ) and area under the curve ( dg % ) after a dg week course of cimetidine at dg mg per day and nifedipine at dg mg per day .
digoxin	nifedipine	advise	since there have been isolated reports of patients with elevated digoxin levels , it is recommended that digoxin levels be monitored when initiating , adjusting , and discontinuing nifedipine to avoid possible over or under digitalization .
cephalosporins	diuretics	effect	nephrotoxicity has been reported following concomitant administration of other cephalosporins with potent diuretics such as furosemide .
cephalosporins	furosemide	effect	nephrotoxicity has been reported following concomitant administration of other cephalosporins with potent diuretics such as furosemide .
sulfonylureas	LEVULAN KERASTICK	effect	it is , however , possible that concomitant use of other known photosensitizing agents such as griseofulvin , thiazide diuretics , sulfonylureas , phenothiazines , sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the levulan kerastick for topical solution .
photosensitizing agents	LEVULAN KERASTICK	effect	it is , however , possible that concomitant use of other known photosensitizing agents such as griseofulvin , thiazide diuretics , sulfonylureas , phenothiazines , sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the levulan kerastick for topical solution .
dexamethasone	Aprepitant	mechanism	the daily dose of dexamethasone administered in clinical studies with aprepitant reflects an approximate dg % reduction of the dose of dexamethasone .
methylprednisolone	Aprepitant	advise	the iv methylprednisolone dose should be reduced by approximately dg % , and the oral methylprednisolone dose should be reduced by approximately dg % when coadministered with aprepitant to achieve exposures of methylprednisolone similar to those obtained when it is given without aprepitant .
Aprepitant	ethinyl estradiol	mechanism	oral contraceptives : aprepitant , when given once daily for dg days as a dg mg capsule with an oral contraceptive containing dg mcg of ethinyl estradiol and dg mg of norethindrone , decreased the auc of ethinyl estradiol by dg % , and decreased the auc of norethindrone by dg % ;
Aprepitant	nelfinavir	advise	consequently , concomitant administration of aprepitant with strong cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , nefazodone , troleandomycin , clarithromycin , ritonavir , nelfinavir ) should be approached with caution .
Aprepitant	S(-) warfarin	mechanism	aprepitant has been shown to induce the metabolism of s(-) warfarin and tolbutamide , which are metabolized through cyp2c9 .
desipramine hydrochloride	sedative	effect	if desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative / hypnotics , careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines ( e.g. , chlordiazepoxide or diazepam ) are additive .
Antihistamines	tricyclic antidepressants	effect	antihistamines may enhance the effects of tricyclic antidepressants , barbiturates , alcohol , and other cns depressants .
Antihistamines	alcohol	effect	antihistamines may enhance the effects of tricyclic antidepressants , barbiturates , alcohol , and other cns depressants .
Antihistamines	CNS depressants	effect	antihistamines may enhance the effects of tricyclic antidepressants , barbiturates , alcohol , and other cns depressants .
Sympathomimetic amines	methyldopa	effect	sympathomimetic amines may reduce the antihypertensive effects of reserpine , veratrum alkaloids , methyldopa and mecamylamine .
sympathomimetics	MAO inhibitors	effect	effects of sympathomimetics are increased with mao inhibitors and beta adrenergic blockers .
Panretin	N-diethyl-m-toluamide	advise	patients who are applying panretin gel should not concurrently use products that contain deet ( n , n-diethyl-m-toluamide ) , a common component of insect repellent products .
sodium nitroprusside	ganglionic blocking agents	effect	the hypotensive effect of sodium nitroprusside is augmented by that of most other hypotensive drugs , including ganglionic blocking agents , negative inotropic agents , and inhaled anesthetics .
enoxacin	bismuth subsalicylate	advise	thus , concomitant administration of enoxacin and bismuth subsalicylate should be avoided .
cimetidine	rofecoxib	mechanism	cimetidine : co administration with high doses of cimetidine [ dg mg twice daily ] increased the cmax of rofecoxib by dg % , the auc0 120hr by dg % and the t1 / dg by dg % .
methotrexate	rofecoxib	mechanism	at dg hours postdose , a similar proportion of patients treated with methotrexate alone ( dg % ) and subsequently treated with methotrexate co administered with dg mg of rofecoxib ( dg % ) had methotrexate plasma concentrations below the measurable limit ( dg ng / ml ) .
VIOXX	theophylline	mechanism	theophylline vioxx dg , dg , and dg mg administered once daily for dg days increased plasma theophylline concentrations ( auc ( dg ) ) by dg to dg % in healthy subjects administered a single dg mg dose of theophylline .
Iodine	Carbimazole	effect	iodine or iodine excess may decrease the effect of carbimazole , and an iodine deficiency can increase the effect of carbimazole .
digoxin	antithyroid agents	mechanism	serum concentration of digoxin and digitoxin may increase when patients take antithyroid agents .
Didanosine	norfloxacin	advise	videx ( didanosine ) chewable / buffered tablets or the pediatric powder for oral solution should not be administered concomitantly with , or within dg hours of , the administration of norfloxacin , because these products may interfere with absorption resulting in lower serum and urine levels of norfloxacin .
Quinolones	anticoagulants	effect	quinolones , including norfloxacin , may enhance the effects of oral anticoagulants , including warfarin or its derivatives or similar agents .
etodolac	phenylbutazone	advise	although in vivo studies have not been done to see if etodolac clearance is changed by coadministration of phenylbutazone , it is not recommended that they be coadministered .
Lodine	aspirin	mechanism	aspirin : when lodine is administered with aspirin , its protein binding is reduced , although the clearance of free etodolac is not altered .
valproic acid	Mefloquine	effect	in patients taking an anticonvulsant ( eg , valproic acid , carbamazepine , phenobarbital or phenytoin ) , the concomitant use of mefloquine may reduce seizure control by lowering the plasma levels of the anticonvulsant .
Mefloquine	quinidine	effect	concomitant administration of mefloquine and other related compounds ( eg , quinine , quinidine and chloroquine ) may produce electrocardiographic abnormalities and increase the risk of convulsions .
clonidine	neuroleptic	effect	an additive hypotensive effect has been reported with the combination of systemic clonidine and neuroleptic therapy .
apraclonidine	antihypertensives	advise	since apraclonidine may reduce pulse and blood pressure , caution in using drugs such as beta blockers ( ophthalmic and systemic ) , antihypertensives , and cardiac glycosides is advised .
sulfonylureas	sulfonamides	effect	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti inflammatory agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
adenosine	methylxanthines	effect	the effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline .
adenosine	theophylline	effect	the effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline .
Furosemide	ethacrynic acid	advise	furosemide should not be used concomitantly with ethacrynic acid because of the possibility of ototoxicity .
salicylates	furosemide	effect	patients receiving high doses of salicylates concomitantly with furosemide , as in rheumatic disease , may experience salicylate toxicity at lower doses because of competitive renal excretory sites .
Lithium	diuretics	advise	lithium generally should not be given with diuretics because they reduce lithiums renal clearance and add a high risk of lithium toxicity .
azathioprine	allopurinol	advise	patients receiving azathioprine and allopurinol concomitantly should have a dose reduction of azathioprine , to approximately dg / dg to dg / dg the usual dose .
Enoxacin	theophylline	mechanism	enoxacin interferes with the metabolism of theophylline resulting in a dg % to dg % dose related decrease in theophylline clearance and a subsequent dg % to dg % increase in serum theophylline levels .
enoxacin	R-warfarin	mechanism	warfarin : quinolones , including enoxacin , decrease the clearance of r-warfarin , the less active isomer of racemic warfarin .
cyclosporine	quinolone class	mechanism	cyclosporine : elevated serum levels of cyclosporine have been reported with concomitant use of cyclosporine with other members of the quinolone class .
enoxacin	digoxin	effect	if signs and symptoms suggestive of digoxin toxicity occur when enoxacin and digoxin are given concomitantly , physicians are advised to obtain serum digoxin levels and adjust digoxin doses appropriately .
antipsychotics	hydrocodone	effect	patients receiving other narcotic analgesics , antipsychotics , antianxiety agents , or other cns depressants ( including alcohol ) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive cns depression .
anticholinergics	hydrocodone	effect	the concurrent use of anticholinergics with hydrocodone may produce paralytic ileus .
erythromycin	digoxin	mechanism	concomitant administration of erythromycin and digoxin has been reported to result in elevated digoxin serum levels .
Erythromycin	midazolam	mechanism	erythromycin has been reported to decrease the clearance of triazolam and midazolam and thus may increase the pharmacologic effect of these benzodiazepines .
Erythromycin	benzodiazepines	effect	erythromycin has been reported to decrease the clearance of triazolam and midazolam and thus may increase the pharmacologic effect of these benzodiazepines .
erythromycin	carbamazepine	int	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
dextromethorphan	MAOIs	effect	serious toxicity may result if dextromethorphan is coadministered with monoamine oxidase inhibitors ( maois ) .
dapsone	Lamprene	effect	preliminary data which suggest that dapsone may inhibit the anti inflammatory activity of lamprene have not been confirmed .
phenytoin	phenylbutazone	mechanism	the most commonly occurring drug interactions are listed below : drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2 antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
phenytoin	sulfonamides	mechanism	the most commonly occurring drug interactions are listed below : drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2 antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
phenytoin	trazodone	mechanism	the most commonly occurring drug interactions are listed below : drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2 antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
phenytoin	disulfiram	mechanism	the most commonly occurring drug interactions are listed below : drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2 antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
phenytoin	reserpine	mechanism	drugs that may decrease plasma phenytoin concentrations include : carbamazepine , chronic alcohol abuse , reserpine
phenytoin	phenobarbital	mechanism	drugs that may either increase or decrease plasma phenytoin concentrations include : phenobarbital , vaiproic acid , and sodium valproate .
phenytoin	valproic acid	effect	similarly , the effects of phenytoin on phenobarbital , valproic acid and sodium plasma valproate concentrations are unpredictable
tricyclic antidepressants	Cerebyx	effect	although not a true drug interaction , tricyclic antidepressants may precipitate seizures in susceptible patients and cerebyx dosage may need to be adjusted
phenytoin	furosemide	effect	drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
magnesium hydroxide	mefenamic acid	mechanism	antacids : in a single dose study ( n=6 ) , ingestion of an antacid containing dg gram of magnesium hydroxide with dg mg of mefenamic acid increased the cmax and auc of mefenamic acid by dg % and dg % , respectively. a number of compounds are inhibitors of cyp2c9 including fluconazole , lovastatin and trimethoprim .
NSAIDs	ACE inhibitors	advise	this interaction should be given consideration in patients taking nsaids concomitantly with ace inhibitors .
anticholinergic	antipsychotics	effect	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
Magnesium	vitamin D	effect	magnesium : magnesium containing preparations ( eg , antacids ) may cause hypermagnesemia and should therefore not be taken during therapy with vitamin d by patients on chronic renal dialysis .
Vitamin D	digitalis	advise	digitalis : vitamin d dosage must be determined with care in patients undergoing treatment with digitalis , as hypercalcemia in such patients may precipitate cardiac arrhythmias .
barbiturates	ethchlorvynol	effect	other depressasnts such as alcohol , barbiturates , and maois may enhance cns depression when administered with ethchlorvynol .
MAOIs	ethchlorvynol	effect	other depressasnts such as alcohol , barbiturates , and maois may enhance cns depression when administered with ethchlorvynol .
tetracyclines	anticoagulant	advise	because the tetracyclines have been shown to depress plasma prothrombin activity , patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage .
levothyroxine sodium	phenylbutazone	mechanism	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen containing compounds , dg fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
levothyroxine sodium	tamoxifen	mechanism	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen containing compounds , dg fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
levothyroxine sodium	furosemide	mechanism	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen containing compounds , dg fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
levothyroxine sodium	glucocorticoids	mechanism	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen containing compounds , dg fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
levothyroxine sodium	meclofenamic acid	mechanism	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen containing compounds , dg fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
Allopurinol	mercaptopurine	mechanism	mercaptopurine / azathioprine : allopurinol inhibits the enzymatic oxidation of mercaptopurine and azathioprine to dg thiouric acid .
cyclosporine	allopurinol sodium	mechanism	cyclosporin : reports indicate that cyclosporine levels may be increased during concomitant treatment with allopurinol sodium for injection .
non- steroidal antiinflammatory agent	potassium- sparing diuretics	effect	in some patients , the administration of a non- steroidal antiinflammatory agent can reduce the diuretic , natriuretic , and antihypertensive effects of loop , potassium sparing and thiazide diuretics .
EDECRIN	non- steroidal anti- inflammatory agents	effect	therefore , when edecrin and non- steroidal anti- inflammatory agents are used concomitantly , the patient should be observed closely to determine if the desired effect of the diuretic is obtained .
ibuprofen	lithium	advise	thus , when ibuprofen and lithium are administered concurrently , subjects should be observed carefully for signs of lithium toxicity .
aspirin	ibuprofen	effect	aspirin : animal studies wshow that aspirin given with nonsteroidal anti inflammatory agents , including ibuprofen , yields a net decrease in anti inflammatory activity with lowered blood levels of the non aspirin drug .
dolasetron mesylate	atenolol	mechanism	clearance of hydrodolasetron decreased by about dg % when dolasetron mesylate was administered intravenously concomitantly with atenolol .
BREVIBLOC	epinephrine	advise	additionally , brevibloc should not be used to control supraventricular tachycardia in the presence of agents which are vasoconstrictive and inotropic such as dopamine , epinephrine , and norepinephrine because of the danger of blocking cardiac contractility when systemic vascular resistance is high .
succinylcholine	BREVIBLOC	effect	the onset of neuromuscular blockade by succinylcholine was unaffected by brevibloc , but the duration of neuromuscular blockade was prolonged from dg minutes to dg minutes .
selegiline hydrochloride	serotoninergic agents	effect	in patients receiving nonselective monoamine oxidase inhibitors ( maois ) ( e.g. , selegiline hydrochloride ) in combination with serotoninergic agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
selegiline hydrochloride	fluvoxamine	effect	in patients receiving nonselective monoamine oxidase inhibitors ( maois ) ( e.g. , selegiline hydrochloride ) in combination with serotoninergic agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
monoamine oxidase inhibitors	serotoninergic agents	effect	in patients receiving nonselective monoamine oxidase inhibitors ( maois ) ( e.g. , selegiline hydrochloride ) in combination with serotoninergic agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
selective serotonin reuptake inhibitors	sumatriptan succinate	effect	a rare , but serious , constellation of symptoms , termed serotonin syndrome , has been reported with the concomitant use of selective serotonin reuptake inhibitors ( ssris ) and agents for migraine therapy , such as imitrex ( sumatriptan succinate ) and dihydroergotamine .
Dexfenfluramine	serotoninergic agents	advise	dexfenfluramine should not be administered with other serotoninergic agents .
dihydroergotamine	FROVA	advise	due to a theoretical risk of a pharmacodynamic interaction , use of ergotamine containing or ergot type medications ( like dihydroergotamine or methysergide ) and frova within dg hours of each other should be avoided ( see a href= frova_od.htm # ci contraindications ) .
Selective serotonin reuptake inhibitors	5-HT1 agonists	effect	selective serotonin reuptake inhibitors ( ssris ) ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1 agonists .
quinolone antibiotics	magnesium	mechanism	plasma concentrations of quinolone antibiotics are decreased when administered with antacids containing magnesium , calcium , or aluminum .
allopurinol	VIDEX	mechanism	allopurinol : the auc of didanosine was increased about dg fold when allopurinol at dg mg / day was coadministered with a single dg mg dose of videx to two patients with renal impairment ( clcr=15 and dg ml / min ) .
ciprofloxacin	VIDEX	mechanism	in eight hiv infected patients , the steady state auc of ciprofloxacin was decreased an average of dg % ( dg % ci = dg % , dg % ) when ciprofloxacin was administered dg hours prior to a marketed chewable / dispersible tablet formulation of videx .
lansoprazole	digoxin	mechanism	therefore , it is theoretically possible that lansoprazole may interfere with the absorption of drugs where gastric ph is an important determinant of bioavailability ( e.g. ketoconazole , ampicillin esters , iron salts , digoxin ) .
theophylline	lansoprazole	advise	nonetheless , individual patients may require additional titration of their theophylline dosage when lansoprazole is started or stopped to ensure clinically effective blood levels .
proton pump inhibitors	sucralfate	mechanism	in a single dose crossover study examining lansoprazole dg mg and omeprazole dg mg each administered alone and concomitantly with sucralfate dg gram , absorption of the proton pump inhibitors was delayed and their bioavailability was reduced by dg % and dg % , respectively , when administered concomitantly with sucralfate .
phenytoin	Felbatol	mechanism	effects of other antiepileptic drugs on felbatol phenytoin : phenytoin causes an approximate doubling of the clearance of felbatol ( felbamate ) at steady state and , therefore , the addition of phenytoin causes an approximate dg % decrease in the steady state trough concentrations of felbatol as compared to the same dose of felbatol given as monotherapy .
Amprenavir	ritonavir	effect	laboratory tests : the combination of amprenavir and low dose ritonavir has been associated with elevations of cholesterol and triglycerides , sgot ( ast ) , and sgpt ( alt ) in some patients .
Nelfinavir	amprenavir	mechanism	nelfinavir steady state cmax , a.c. and cmin were increased by dg % , dg % , and dg % , respectively , by concomitant amprenavir .
amprenavir	methadone	effect	methadone : coadministration of amprenavir and methadone can decrease plasma levels of methadone .
Maalox	gabapentin	mechanism	antacid ( maalox ) : maalox reduced the bioavailability of gabapentin ( n=16 ) by about dg % .
live vaccines	RAPTIVA	advise	acellular , live and live attenuated vaccines should not be administered during raptiva treatment .
live-attenuated vaccines	RAPTIVA	advise	acellular , live and live-attenuated vaccines should not be administered during raptiva treatment .
aluminum	Ibandronate	mechanism	products containing calcium and other multivalent cations ( such as aluminum , magnesium , iron ) are likely to interfere with absorption of ibandronate .
linezolid	serotonergic agents	int	therefore , linezolid has the potential for interaction with adrenergic and serotonergic agents .
ZYVOX	dopaminergic agents	effect	adrenergic agents : some individuals receiving zyvox may experience a reversible enhancement of the pressor response to indirect acting sympathomimetic agents , vasopressor or dopaminergic agents .
ZYVOX	SSRIs	effect	spontaneous reports of serotonin syndrome associated with co administration of zyvox and serotonergic agents , including antidepressants such as selective serotonin reuptake inhibitors ( ssris ) , have been reported .
Aspirin	probenecid	effect	uricosuric agents : aspirin may decrease the effects of probenecid , sulfinpyrazone , and phenylbutazone .
Alcohol	aspirin	effect	alcohol : has a synergistic effect with aspirin in causing gastrointestinal bleeding .
Chlorotrianisene	barbiturates	int	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
Chlorotrianisene	corticotropin	int	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
reserpine	sympathomimetics	effect	the antihypertensive effects of methyldopa , mecamylamine , reserpine , and veratrum alkaloids may be reduced by sympathomimetics .
cimetidine	Xanax	advise	nafazodone , fluvoxamine , cimetidine ( consider xanax dose reduction ) .
etanercept	anakinra	effect	concurrent administration of etanercept ( another tnf blocking agent ) and anakinra ( an interleukin dg antagonist ) has been associated with an increased risk of serious infections , and increased risk of neutropenia and no additional benefit compared to these medicinal products alone .
digoxin	sympathomimetics	effect	concomitant use of digoxin and sympathomimetics increases the risk of cardiac arrhythmias .
calcium channel blockers	digoxin	effect	although beta adrenergic blockers or calcium channel blockers and digoxin may be useful in combination to control atrial fibrillation , their additive effects on av node conduction can result in advanced or complete heart block .
itraconazole	digoxin	mechanism	quinidine , verapamil , amiodarone , propafenone , indomethacin , itraconazole , alprazolam , and spironolactone raise the serum digoxin concentration due to a reduction in clearance and / or in volume of distribution of the drug , with the implication that digitalis intoxication may result .
cholestyramine	digoxin	mechanism	antacids , kaolin pectin , sulfasalazine , neomycin , cholestyramine , certain anticancer drugs , and metoclopramide may interfere with intestinal digoxin absorption , resulting in unexpectedly low serum concentrations .
Rifampin	digoxin	mechanism	rifampin may decrease serum digoxin concentration , especially in patients with renal dysfunction , by increasing the non renal clearance of digoxin .
tricyclic antidepressants	lofexidine	effect	concomitant use of tricyclic antidepressants may reduce the efficacy of lofexidine .
TARCEVA	ketoconazole	advise	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
Barbiturates	corticosteroids	effect	barbiturates may decrease the effectiveness of oral contraceptives , certain antibiotics , quinidine , theophylline , corticosteroids , anticoagulants , and beta blockers .
Barbiturates	beta blockers	effect	barbiturates may decrease the effectiveness of oral contraceptives , certain antibiotics , quinidine , theophylline , corticosteroids , anticoagulants , and beta blockers .
Ketoconazole	cyclosporine	mechanism	ketoconazole tablets may alter the metabolism of cyclosporine , tacrolimus , and methylprednisolone , resulting in elevated plasma concentrations of the latter drugs .
INH	ketoconazole	mechanism	inh ( isoniazid ) is also reported to affect ketoconazole concentrations adversely .
Isoniazid	ketoconazole	mechanism	inh ( isoniazid ) is also reported to affect ketoconazole concentrations adversely .
ketoconazole	cisapride	mechanism	human pharmacokinetics data indicate that oral ketoconazole potently inhibits the metabolism of cisapride resulting in a mean eight fold increase in auc of cisapride .
ENABLEX	itraconazole	advise	the daily dose of enablex should not exceed dg mg when coadministered with potent cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , ritonavir , nelfinavir , clarithromycin and nefazadone ) .
ENABLEX	ritonavir	advise	the daily dose of enablex should not exceed dg mg when coadministered with potent cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , ritonavir , nelfinavir , clarithromycin and nefazadone ) .
ENABLEX	anticholinergic agents	effect	the concomitant use of enablex with other anticholinergic agents may increase the frequency and / or severity of dry mouth , constipation , blurred vision and other anticholinergic pharmacological effects .
Lithium	diuretics	advise	lithium : generally should not be given with diuretics .
lithium	chlorothiazide	advise	refer to the package insert for lithium preparations before use of such preparations with chlorothiazide
chlorothiazide	non-steroidal anti-inflammatory agents	advise	therefore , when chlorothiazide and non-steroidal anti-inflammatory agents are used concomitantly , the patient should be observed closely to determine if the desired effect of the diuretic is obtained
sympathomimetics	antidiabetic drugs	effect	certain drugs including thiazides , corticosteroids , thyroid products , and sympathomimetics may reduce the hypoglycemic action of starlix and other oral antidiabetic drugs .
corticosteroids	Starlix	effect	certain drugs including thiazides , corticosteroids , thyroid products , and sympathomimetics may reduce the hypoglycemic action of starlix and other oral antidiabetic drugs .
buspirone hydrochloride	MAO inhibitors	advise	it is recommended that buspirone hydrochloride not be used concomitantly with mao inhibitors because the effects of concomitant administration of buspirone hcl with most other psychotropic drugs have not been studied , the concomitant use of buspirone hcl with other cns active drugs should be approached with caution .
trazodone hydrochloride	buspirone HCl	effect	there is one report suggesting that the concomitant use of trazodone hydrochloride ( desyrel ) and buspirone hcl may have caused dg to dg fold elevations on sgpt ( alt ) in a few patients .
buspirone HCl	haloperidol	mechanism	in a study in normal volunteers , concomitant administration of buspirone hcl and haloperidol resulted in increased serum haloperidol concentrations .
Codeine	anesthetics	effect	codeine in combination with other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative hypnotics , or other cns depressants ( including alcohol ) has additive depressant effects .
Codeine	phenothiazines	effect	codeine in combination with other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative hypnotics , or other cns depressants ( including alcohol ) has additive depressant effects .
ketoconazole	fexofenadine	mechanism	these studies indicate that ketoconazole or erythromycin co administration enhances fexofenadine gastrointestinal absorption .
gemfibrozil	bexarotene	mechanism	on the basis of the metabolism of bexarotene by cytochrome p450 dg , ketoconazole , itraconazole , erythromycin , gemfibrozil , grapefruit juice , and other inhibitors of cytochrome p450 dg would be expected to lead to an increase in plasma bexarotene concentrations .
ketoconazole	bexarotene	mechanism	on the basis of the metabolism of bexarotene by cytochrome p450 dg , ketoconazole , itraconazole , erythromycin , gemfibrozil , grapefruit juice , and other inhibitors of cytochrome p450 dg would be expected to lead to an increase in plasma bexarotene concentrations .
phenobarbital	bexarotene	mechanism	furthermore , rifampin , phenytoin , phenobarbital , and other inducers of cytochrome p450 dg may cause a reduction in plasma bexarotene concentrations .
TRACRIUM	enflurane	effect	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ;
TRACRIUM	magnesium	effect	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
TRACRIUM	quinidine	effect	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
reserpine	ZEBETA	effect	patients receiving catecholamine depleting drugs , such as reserpine or guanethidine , should be closely monitored , because the added beta adrenergic blocking action of zebeta may produce excessive reduction of sympathetic activity .
ZEBETA	antiarrhythmic agents	advise	zebeta should be used with care when myocardial depressants or inhibitors of av conduction , such as certain calcium antagonists ( particularly of the phenylalkylamine [ verapamil ] and benzothiazepine [ diltiazem ] classes ) , or antiarrhythmic agents , such as disopyramide , are used concurrently .
ZEBETA	disopyramide	advise	zebeta should be used with care when myocardial depressants or inhibitors of av conduction , such as certain calcium antagonists ( particularly of the phenylalkylamine [ verapamil ] and benzothiazepine [ diltiazem ] classes ) , or antiarrhythmic agents , such as disopyramide , are used concurrently .
DIDREX	CNS stimulants	advise	didrex should not be used concomitantly with other cns stimulants .
dihydroergotamine	naratriptan	advise	because there is a theoretical basis that these effects may be additive , use of ergotamine containing or ergot type medications ( like dihydroergotamine or methysergide ) and naratriptan within dg hours is contraindicated .
methysergide	naratriptan	advise	because there is a theoretical basis that these effects may be additive , use of ergotamine containing or ergot type medications ( like dihydroergotamine or methysergide ) and naratriptan within dg hours is contraindicated .
SPRYCEL	clarithromycin	mechanism	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
SPRYCEL	saquinavir	mechanism	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
famotidine	dasatinib	effect	h2 blockers / proton pump inhibitors : long term suppression of gastric acid secretion by h2 blockers or proton pump inhibitors ( eg , famotidine and omeprazole ) is likely to reduce dasatinib exposure .
tacrolimus	SPRYCEL	advise	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
SPRYCEL	antacids	advise	simultaneous administration of sprycel with antacids should be avoided .
rifampin	Clozapine	mechanism	phenytoin , nicotine , and rifampin may decrease clozapine plasma levels , resulting in a decrease in effectiveness of a previously effective clozapine dose .
Cimetidine	Clozapine	mechanism	cimetidine , caffeine , and erythromycin may increase plasma levels of clozapine , potentially resulting in adverse effects .
clozapine	phenothiazines	advise	therefore , co administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide and encainide ) , or that inhibit this enzyme ( e.g. , quinidine ) , should be approached with caution .
Clozapine	alcohol	effect	given the primary cns effects of clozapine , caution is advised in using it concomitantly with other cns active drugs or alcohol .
Clozapine	atropine	effect	clozapine may potentiate the hypotensive effects of antihypertensive drugs and the anticholinergic effects of atropine type drugs .
Etonogestrel	Sporanox	int	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo dur ) , and vitamin c .
Etonogestrel	cyclosporine	int	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo dur ) , and vitamin c .
Etonogestrel	protease inhibitors	int	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo dur ) , and vitamin c .
Etonogestrel	rifampin	int	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo dur ) , and vitamin c .
hormonal contraceptives	coumarin derivatives	effect	anticoagulants : combination hormonal contraceptives may increase or decrease the effects of coumarin derivatives .
phenobarbital	progestins	mechanism	anticonvulsants ( carbamazepine , felbamate , phenobarbital , phenytoin , topiramate ) : increase the metabolism of ethinyl estradiol and / or some progestins , leading to possible decrease in contraceptive effectiveness .
phenytoin	progestins	mechanism	anticonvulsants ( carbamazepine , felbamate , phenobarbital , phenytoin , topiramate ) : increase the metabolism of ethinyl estradiol and / or some progestins , leading to possible decrease in contraceptive effectiveness .
phenobarbital	corticosteroid	advise	drugs that induce hepatic enzymes such as phenobarbital , phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response .
phenytoin	corticosteroids	mechanism	drugs that induce hepatic enzymes such as phenobarbital , phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response .
corticosteroids	anticoagulants	effect	the effect of corticosteroids on oral anticoagulants is variable .
heparin	antithrombin III	advise	thus in order to avoid bleeding , reduced dosage of heparin is recommended during treatment with antithrombin iii ( human ) .
nicotine	heparin sodium	effect	drugs decreasing heparin effect : digitalis , tetracyclines , nicotine , or antihistamines may partially counteract the anticoagulant action of heparin sodium .
beta-blockers	clonidine	advise	should it be decided to discontinue therapy in patients receiving beta-blockers and clonidine concurrently , the beta blocker should be discontinued slowly over several days before the gradual withdrawal of clonidine .
Antihistamines	hypnotics	effect	antihistamines may have additive effects with alcohol and other cns depressants , e.g. , hypnotics , sedatives , tranquilizers , antianxiety agents .
calcium acetate	digitalis glycosides	effect	using calcium acetate with digitalis glycosides ( heart medicine ) may cause hypercalcemia ( too much calcium in the blood ) , which could increase the chance of developing an irregular heartbeat .
clonidine hydrochloride	tricyclic antidepressants	effect	tablet if a patient receiving clonidine hydrochloride is also taking tricyclic antidepressants , the effect of clonidine may be reduced , thus necessitating an increase in dosage .
Clonidine hydrochloride	alcohol	effect	clonidine hydrochloride may enhance the cns depressive effects of alcohol , barbiturates or other sedatives .
clonidine	anesthetics	effect	epidural clonidine may prolong the duration of pharmacologic effects of epidural local anesthetics , including both sensory and motor blockade .
Tricyclic antidepressants	clonidine	effect	tricyclic antidepressants may antagonize the hypotensive effects of clonidine .
clonidine	digitalis	advise	also , due to the potential for additive effects such as bradycardia and av block , caution is warranted in patients receiving clonidine with agents known to affect sinus node function or av nodal conduction ( e.g. , digitalis , calcium channel blockers , and beta blockers . )
bupropion	desipramine	advise	therefore , co administration of bupropion with drugs that are metabolized by cyp2d6 isoenzyme including certain antidepressants ( e.g. , nortriptyline , imipramine , desipramine , paroxetine , fluoxetine , sertraline ) , antipsychotics ( e.g. , haloperidol , risperidone , thioridazine ) , beta blockers ( e.g. , metoprolol ) , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution and should be initiated at the lower end of the dose range of the concomitant medication .
bupropion	haloperidol	advise	therefore , co administration of bupropion with drugs that are metabolized by cyp2d6 isoenzyme including certain antidepressants ( e.g. , nortriptyline , imipramine , desipramine , paroxetine , fluoxetine , sertraline ) , antipsychotics ( e.g. , haloperidol , risperidone , thioridazine ) , beta blockers ( e.g. , metoprolol ) , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution and should be initiated at the lower end of the dose range of the concomitant medication .
tetracycline	bismuth subsalicylate	mechanism	absorption of tetracycline is impaired by bismuth subsalicylate .
carbamazepine	doxycycline	mechanism	barbiturates , carbamazepine , and phenytoin decrease the half life of doxycycline .
tetracycline	methoxyflurane	effect	the concurrent use of tetracycline and penthrane ( methoxyflurane ) has been reported to result in fatal renal toxicity .
Abciximab	Activase	effect	in addition to bleeding associated with heparin and vitamin k antagonists , drugs that alter platelet function ( such as acetylsalicylic acid , dipyridamole and abciximab ) may increase the risk of bleeding if administered prior to , during , or after activase therapy .
quinidine	aripiprazole	advise	aripiprazole dose should be reduced to one half of its normal dose when concomitant administration of quinidine with aripiprazole occurs .
FOSCAVIR	pentamidine	int	a possible drug interaction of foscavir and intravenous pentamidine has been described .
heroin	Valium	effect	toxicology studies of heroin related deaths reveal frequent involvement of other central nervous system depressants , including alcohol , benzodiazepines such as diazepam ( valium ) , and , to a rising degree , methadone .
heroin	methadone	effect	toxicology studies of heroin related deaths reveal frequent involvement of other central nervous system depressants , including alcohol , benzodiazepines such as diazepam ( valium ) , and , to a rising degree , methadone .
Quinolones	warfarin	effect	warfarin : quinolones may enhance the effects of the oral anticoagulant , warfarin , or its derivatives .
Videx	lomefloxacin	mechanism	antacids and sucralfate : sucralfate and antacids containing magnesium or aluminum , as well as formulations containing divalent and trivalent cations such as videx ( didanosine ) , chewable / buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability .
barbiturates	ketamine	effect	prolonged recovery time may occur if barbiturates and / or narcotics are used concurrently with ketamine .
glimepiride	bismuth subsalicylate	advise	before taking glimepiride , tell your doctor if you are taking any of the following medicines : aspirin or another salicylate such as magnesium / choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto bismol ) ;
glimepiride	Pepto-Bismol	advise	before taking glimepiride , tell your doctor if you are taking any of the following medicines : aspirin or another salicylate such as magnesium / choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
glimepiride	Disalcid	advise	before taking glimepiride , tell your doctor if you are taking any of the following medicines : aspirin or another salicylate such as magnesium / choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto bismol ) ;
erythromycin	dihydroergotamine	effect	ergotamine : concurrent use of erythromycin and ergotamine or dihydroergotamine has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia .
ascorbic acid	amphetamines	mechanism	acidifying agents : gastrointestinal acidifying agents ( guanethidine , reserpine , glutamic acid hcl , ascorbic acid , fruit juices , etc. ) lower absorption of amphetamines .
Amphetamines	meperidine	effect	meperidine : amphetamines potentiate the analgesic effect of meperidine .
Amphetamines	veratrum alkaloids	effect	veratrum alkaloids : amphetamines inhibit the hypotensive effect of veratrum alkaloids .
ranitidine	cisapride	mechanism	the gastrointestinal absorption of cimetidine and ranitidine is accelerated when they are coadministered with cisapride .
Cisapride	procainamide	advise	cisapride should not be used concomitantly with other drugs known to prolong the qt interval : certain antiarrhythmics , including those of class ia ( such as quinidine and procainamide ) and class iii ( such as sotalol ) ;
erythromycin	cisapride	mechanism	antibiotics : in vitro and / or in vivo data show that clarithromycin , erythromycin , and troleandomycin markedly inhibit the metabolism of cisapride , which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
ketoconazole	cisapride	mechanism	antifungals : in vitro and / or in vivo data indicate that fluconazole , itraconazole , and oral ketoconazole markedly inhibit the metabolism of cisapride , which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
antiplatelet agents	FLOLAN	effect	when other antiplatelet agents or anticoagulants are used concomitantly , there is the potential for flolan to increase the risk of bleeding .
digoxin	FLOLAN	mechanism	in clinical trials , flolan was used with digoxin , diuretics , anticoagulants , oral vasodilators , and supplemental oxygen.in a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with flolan was initiated , apparent oral clearance values for furosemide ( n = dg ) and digoxin ( n = dg ) were decreased by dg % and dg % , respectively , on the second day of therapy and had returned to baseline values by day dg .
quinolones	cyclosporine	effect	however , the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline , interfere with the metabolism of caffeine , and enhance the effects of the oral anticoagulant warfarin and its derivatives , and has been associated with transient elevations in serum creatinine in patients receiving systemic cyclosporine concomitantly .
butorphanol	central nervous system depressants	effect	concurrent use of butorphanol with central nervous system depressants ( e.g. , alcohol , barbiturates , tranquilizers , and antihistamines ) may result in increased central nervous system depressant effects .
butorphanol	barbiturates	effect	concurrent use of butorphanol with central nervous system depressants ( e.g. , alcohol , barbiturates , tranquilizers , and antihistamines ) may result in increased central nervous system depressant effects .
STADOL NS	sumatriptan	effect	these results suggest that the analgesic effect of stadol ns may be diminished when it is administered shortly after sumatriptan nasal spray , but by dg minutes any such reduction in effect should be minimal .
Epinephrine	glycosides	advise	epinephrine also should be used cautiously with other drugs ( e.g. , digitalis , glycosides ) that sensitize the myocardium to the actions of sympathomimetic drugs .
diclofenac	NSAIDs	advise	anticoagulants : while studies have not shown diclofenac to interact with anticoagulants of the warfarin type , caution should be exercised , nonetheless , since interactions have been seen with other nsaids .
diclofenac	salicylic acid	mechanism	protein binding in vitro , diclofenac interferes minimally or not at all with the protein binding of salicylic acid ( dg % decrease in binding ) , tolbutamide , prednisolone ( dg % decrease in binding ) , or warfarin .
diclofenac	warfarin	advise	because prostaglandins play an important role in hemostasis , and nsaids affect platelet function as well , concurrent therapy with all nsaids , including diclofenac , and warfarin requires close monitoring of patients to be certain that no change in their anticoagulant dosage is required .
diclofenac	digoxin	mechanism	ingestion of diclofenac may increase serum concentrations of digoxin and methotrexate and increase cyclosporine s nephrotoxicity .
erythromycin	lovastatin	int	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
nonsteroidal anti-inflammatory drugs	anti-coagulants	effect	anticoagulants : flurbiprofen like other nonsteroidal anti-inflammatory drugs , has been shown to affect bleeding parameters in patients receiving anti-coagulants , and serious clinical bleeding has been reported .
fluconazole	azithromycin	mechanism	co administration with efavirenz or fluconazole had a modest effect on the pharmacokinetics of azithromycin .
indinavir	SUSTIVA	mechanism	when indinavir at an increased dose ( dg mg every dg hours ) was given with sustiva ( dg mg once daily ) , the indinavir auc and cmin were decreased on average by dg dg % and dg dg % , respectively , compared to when indinavir ( dg mg every dg hours ) was given alone .
ketoconazole	aliskiren	mechanism	ketoconazole : co administration of dg mg twice daily ketoconazole with aliskiren resulted in an approximate dg % increase in plasma levels of aliskiren .
amylase	Acarbose	mechanism	intestinal adsorbents ( e. g. , charcoal ) and digestive enzyme preparations containing carbohydrate splitting enzymes ( e. g. , amylase , pancreatin ) may reduce the effect of acarbose and should not be taken concomitantly .
Bentiromide	Chloromycetin	int	bentiromide may interact with acetaminophen ( e.g. , tylenol ) , chloramphenicol ( e.g. , chloromycetin ) , local anesthetics ( e.g. , benzocaine and lidocaine ) , para aminobenzoic acid ( paba ) containing preparations ( e.g. , sunscreens and some multivitamins ) , procainamide ( e.g. , pronestyl ) , sulfonamides ( sulfa medicines ) , thiazide diuretics ( use of these medicines during the test period will affect the test results ) , and pancreatic supplements ( use of pancreatic supplements may give false test results ) .
Bentiromide	lidocaine	int	bentiromide may interact with acetaminophen ( e.g. , tylenol ) , chloramphenicol ( e.g. , chloromycetin ) , local anesthetics ( e.g. , benzocaine and lidocaine ) , para aminobenzoic acid ( paba ) containing preparations ( e.g. , sunscreens and some multivitamins ) , procainamide ( e.g. , pronestyl ) , sulfonamides ( sulfa medicines ) , thiazide diuretics ( use of these medicines during the test period will affect the test results ) , and pancreatic supplements ( use of pancreatic supplements may give false test results ) .
thyroid	estrogens	advise	therefore , patients without a functioning thyroid gland who are on thyroid replacement therapy may need to increase their thyroid dose if estrogens or estrogen containing oral contraceptives are given .
Cholestyramine	T4	mechanism	cholestyramine : cholestyramine binds both t4 and t3 in the intestine , thus impairing absorption of these thyroid hormones .
Nicotinic acid	ganglionic blocking agents	effect	interactions for vitamin b3 ( niacin ) : antihypertensive therapy : nicotinic acid may potentiate the effects of ganglionic blocking agents and vasoactive drugs resulting in postural hypotension .
Simulect	azathioprine	mechanism	total body clearance of simulect was reduced by an average dg % and dg % when azathioprine and mycophenolate mofetil , respectively , were added to a regimen consisting of cyclosporine , usp ( modified ) and corticosteroids .
lithium	ACE inhibitors	mechanism	lithium reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with ace inhibitors , and with some angiotensin ii receptor antagonists .
TCA	Duloxetine	advise	plasma tca concentrations may need to be monitored and the dose of the tca may need to be reduced if a tca is co administered with duloxetine .
duloxetine	desipramine	mechanism	when duloxetine was administered ( at a dose of dg mg bid ) in conjunction with a single dg mg dose of desipramine , a cyp2d6 substrate , the auc of desipramine increased dg fold .
Duloxetine	antidepressants	advise	therefore , co administration of duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain antidepressants ( tricyclic antidepressants [ tcas ] , such as nortriptyline , amitriptyline , and imipramine ) , phenothiazines and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution .
Duloxetine	flecainide	advise	therefore , co administration of duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain antidepressants ( tricyclic antidepressants [ tcas ] , such as nortriptyline , amitriptyline , and imipramine ) , phenothiazines and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution .
iloprost	vasodilators	effect	however , iloprost has the potential to increase the hypotensive effect of vasodilators and antihypertensive agents .
iloprost	anticoagulants	effect	since iloprost inhibits platelet function , there is a potential for increased risk of bleeding , particularly in patients maintained on anticoagulants .
cefditoren pivoxil	antacids	advise	although the clinical significance is not known , it is not recommended that cefditoren pivoxil be taken concomitantly with antacids .
WelChol	Calan SR	mechanism	welchol decreased the cmax and auc of sustained release verapamil ( calan sr ) by approximately dg % and dg % , respectively .
Nabilone	alcohol	advise	nabilone should be administered with caution to patients who are taking other psychoactive drugs or cns depressants , including alcohol , barbiturates and narcotic analgesics , or to those with a history of psychiatric disorder ( including manic depressive illness and schizophrenia ) .
Nabilone	diazepam	effect	nabilone has been shown to have an additive cns depressant effect when given with either diazepam , secobarbitone sodium , alcohol or codeine .
metformin	dofetilide	advise	in addition , drugs that are actively secreted via this route ( e.g. , triamterene , metformin and amiloride ) should be co administered with care as they might increase dofetilide levels .
macrolide antibiotics	TIKOSYN	advise	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
Cimetidine	dofetilide	mechanism	cimetidine at doses of dg mg bid ( otc dose ) resulted in a dg % increase in dofetilide plasma levels ( dg mcg single dose ) .
acetaminophen	alcohol	effect	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative hypnotics , or other cns depressants , causing increased cns depression .
caffeine	chlordiazepoxide	effect	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative hypnotics , or other cns depressants , causing increased cns depression .
steroid	bitolterol	advise	if you are also using a steroid inhaler , take bitolterol first and then wait about dg minutes before using the steroid inhaler .
diuretic	lithium	effect	if a diuretic is also used , the risk of lithium toxicity may be increased .
theophylline	quinolones	mechanism	elevated plasma levels of theophylline have been reported with concomitant use of some quinolones .
butyrophenones	epinephrine	effect	phenothiazines and butyrophenones may reduce or reverse the pressor effect of epinephrine .
midazolam	diltiazem	mechanism	the elimination half life of midazolam and triazolam also increased ( dg dg fold ) during coadministration with diltiazem .
diltiazem	midazolam	effect	these pharmacokinetic effects seen during diltiazem coadministration can result in increased clinical effects ( e.g. , prolonged sodation ) of both midazolam and triazolam .
SSRI	sumatriptan	effect	sumatriptan there have been rare postmarketing reports describing patients with weakness , hyperreflexia , and incoordination following the use of a selective serotonin reuptake inhibitor ( ssri ) and sumatriptan .
sumatriptan	paroxetine	advise	if concomitant treatment with sumatriptan and an ssri ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , citalopram , escitalopram ) is clinically warranted , appropriate observation of the patient is advised .
citalopram	ketoconazole	mechanism	ketoconazole combined administration of racemic citalopram ( dg mg ) and ketoconazole ( dg mg ) decreased the cmax and auc of ketoconazole by dg % and dg % , respectively , and did not significantly affect the pharmacokinetics of citalopram .
Angiomax	warfarin	effect	in clinical trials in patients undergoing ptca / pci , co administration of angiomax with heparin , warfarin , thrombolytics or glycoprotein iib / iiia inhibitors was associated with increased risks of major bleeding events compared to patients not receiving these concomitant medications .
Angiomax	thrombolytics	effect	in clinical trials in patients undergoing ptca / pci , co administration of angiomax with heparin , warfarin , thrombolytics or glycoprotein iib / iiia inhibitors was associated with increased risks of major bleeding events compared to patients not receiving these concomitant medications .
cholestyramine	ezetimibe	mechanism	cholestyramine : concomitant cholestyramine administration decreased the mean auc of total ezetimibe approximately dg % .
Salicylates	antidiabetic drugs	effect	salicylates may enhance the hypoglycemic effect of oral antidiabetic drugs of the sulfonylurea class .
Sulfonamides	methotrexate	mechanism	sulfonamides can also displace methotrexate from plasma protein binding sites , thus increasing free methotrexate concentrations .
rifampin	methylprednisolone	advise	drugs that induce hepatic enzymes such as phenobarbital , phenytoin , and rifampin may increase the clearance of methylprednisolone and may require increased in methylprednisolone dose to achieve the desired response .
anticholinergic drugs	tricyclic antidepressants	effect	the following agents may increase certain actions or side effects of anticholinergic drugs : amantadine , antiarrhythmic agents of class i ( e.g. , quinidine ) , antihistamines , antipsychotic agents ( e.g. , phenothiazines ) , benzodiazepines , mao inhibitors , narcotic analgesics ( e.g. , meperidine ) , nitrates and nitrites , sympathomimetic agents , tricyclic antidepressants , and other drugs having anticholinergic activity .
anticholinergic drugs	antihistamines	effect	the following agents may increase certain actions or side effects of anticholinergic drugs : amantadine , antiarrhythmic agents of class i ( e.g. , quinidine ) , antihistamines , antipsychotic agents ( e.g. , phenothiazines ) , benzodiazepines , mao inhibitors , narcotic analgesics ( e.g. , meperidine ) , nitrates and nitrites , sympathomimetic agents , tricyclic antidepressants , and other drugs having anticholinergic activity .
anticholinergic drugs	MAO inhibitors	effect	the following agents may increase certain actions or side effects of anticholinergic drugs : amantadine , antiarrhythmic agents of class i ( e.g. , quinidine ) , antihistamines , antipsychotic agents ( e.g. , phenothiazines ) , benzodiazepines , mao inhibitors , narcotic analgesics ( e.g. , meperidine ) , nitrates and nitrites , sympathomimetic agents , tricyclic antidepressants , and other drugs having anticholinergic activity .
MYKROX	antihypertensive drugs	advise	other antihypertensives : when mykrox tablets are used with other antihypertensive drugs , care must be taken , especially during initial therapy .
Metolazone	norepinephrine	effect	sympathomimetics : metolazone may decrease arterial responsiveness to norepinephrine , but this diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use .
triacetyloleandomycin	ergotamine	mechanism	the effects of ergomar may be potentiated by triacetyloleandomycin which inhibits the metabolism of ergotamine .
NSAIDs	furosemide	effect	furosemide : clinical studies , as well as post marketing observations , have shown that nsaids can reduce the natriuretic effect of furosemide and thiazide diuretics in some patients .
NIMBEX	succinylcholine	effect	the time to onset of maximum block following nimbex is approximately dg minutes faster with prior administration of succinylcholine .
NIMBEX	polymyxins	effect	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
NIMBEX	sodium colistemethate	effect	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
nondepolarizing agents	bacitracin	effect	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
nondepolarizing agents	colistin	effect	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
enflurane	NIMBEX	advise	in long surgical procedures during enflurane or isoflurane anesthesia , less frequent maintenance dosing , lower maintenance doses , or reduced infusion rates of nimbex may be necessary .
ephedrine	ProAmatine	effect	the use of drugs that stimulate alpha adrenergic receptors ( e.g. , phenylephrine , pseudoephedrine , ephedrine , phenylpropanolamine or dihydroergotamine ) may enhance or potentiate the pressor effects of proamatine . therefore , caution should be used when proamatine is administered concomitantly with agents that cause vasoconstriction .
dihydroergotamine	ProAmatine	effect	the use of drugs that stimulate alpha adrenergic receptors ( e.g. , phenylephrine , pseudoephedrine , ephedrine , phenylpropanolamine or dihydroergotamine ) may enhance or potentiate the pressor effects of proamatine . therefore , caution should be used when proamatine is administered concomitantly with agents that cause vasoconstriction .
SKELAXIN	barbiturates	effect	skelaxin may enhance the effects of alcohol , barbiturates and other cns depressants .
nonsteroidal anti-inflammatory drugs	methotrexate	mechanism	tolectin and other nonsteroidal anti-inflammatory drugs have been reported to reduce the tubular secretion of methotrexate in an animal model , possibly enhancing the toxicity of methotrexate .
beta adrenergic aerosol bronchodilators	metaproterenol sulfate	advise	other beta adrenergic aerosol bronchodilators should not be used concomitantly with alupent ( metaproterenol sulfate usp ) because they may have additive effects .
vigabatrin	phenytoin	mechanism	in dg , drs rimmer and richens at the university of wales reported that administering vigabatrin with phenytoin lowered the serum phenytoin concentration in patients with treatment resistant epilepsy .
heparin	Retavase	effect	in addition to bleeding associated with heparin and vitamin k antagonists , drugs that alter platelet function ( such as aspirin , dipyridamole , and abciximab ) may increase the risk of bleeding if administered prior to or after retavase therapy .
selegiline	ephedrine	effect	one case of hypertensive crisis has been reported in a patient taking the recommended doses of selegiline and a sympathomimetic medication ( ephedrine ) .
Dexbrompheniramine	anticholinergics	int	dexbrompheniramine can interact with alcohol or other cns depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
barbiturates	anticholinesterases	effect	dg dg the following precautions should be kept in mind in the treatment of anticholinesterase poisoning , although they do not bear directly on the use of pralidoxime : since barbiturates are potentiated by the anticholinesterases , they should be used cautiously in the treatment of convulsions ;
Aminoglutethimide	depo-subQ provera 104	mechanism	aminoglutethimide administered concomitantly with depo-subq provera 104 may significantly decrease the serum concentrations of mpa .
DIPRIVAN	morphine	effect	the induction dose requirements of diprivan injectable emulsion may be reduced in patients with intramuscular or intravenous premedication , particularly with narcotics ( eg , morphine , meperidine , and fentanyl , etc . )
lorazepam	pyrimethamine	effect	mild hepatotoxicity has been reported in some patients when lorazepam and pyrimethamine were administered concomitantly .
SYMLIN	alpha glucosidase inhibitors	advise	due to its effects on gastric emptying , symlin therapy should not be considered for patients taking drugs that alter gastrointestinal motility ( e.g. , anticholinergic agents such as atropine ) and agents that slow the intestinal absorption of nutrients ( e.g. , alpha glucosidase inhibitors ) .
chloroprocaine	sulfonamide drug	advise	therefore , chloroprocaine should not be used in any condition in which a sulfonamide drug is being employed .
doxorubicin	PROLEUKIN	effect	concurrent administration of drugs possessing nephrotoxic ( e.g. , aminoglycosides , indomethacin ) , myelotoxic ( e.g. , cytotoxic chemotherapy ) , cardiotoxic ( e.g. , doxorubicin ) or hepatotoxic ( e.g. , methotrexate , asparaginase ) effects with proleukin may increase toxicity in these organ systems .
PROLEUKIN	cis-platinum	effect	hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose proleukin and antineoplastic agents , specifically , dacarbazine , cis-platinum , tamoxifen and interferon alfa .
Gleevec	erythromycin	advise	drugs that may alter imatinib plasma concentrations drugs that may increase imatinib plasma concentrations : caution is recommended when administering gleevec with inhibitors of the cyp3a4 family ( e.g. , ketoconazole , itraconazole , erythromycin , clarithromycin ) .
Gleevec	clarithromycin	advise	drugs that may alter imatinib plasma concentrations drugs that may increase imatinib plasma concentrations : caution is recommended when administering gleevec with inhibitors of the cyp3a4 family ( e.g. , ketoconazole , itraconazole , erythromycin , clarithromycin ) .
Gleevec	benzodiazepines	mechanism	gleevec will increase plasmaconcentration of other cyp3a4 metabolized drugs ( e.g. , triazolo benzodiazepines , dihydropyridine calcium channel blockers , certain hmg coa reductase inhibitors , etc. ) .
tolbutamide	Atromid-S	effect	the hypoglycemic effect of tolbutamide has been reported to increase when atromid-s is given concurrently .
diphenidol	apomorphine	effect	apomorphine prior ingestion of diphenidol may decrease the emetic response to apomorphine in the treatment of poisoning .
Chloramphenicol	ceftazidime	effect	chloramphenicol has been shown to be antagonistic to beta lactam antibiotics , including ceftazidime , based on in vitro studies and time kill curves with enteric gram negative bacilli .
quinolones	cyclosporine	effect	some quinolones , including ciprofloxacin , have been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly .
ciprofloxacin	aluminum	mechanism	multivalent cation containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation containing products such as magnesium or aluminum antacids , sucralfate , videx chewable / buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
ciprofloxacin	antacids	mechanism	multivalent cation containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation containing products such as magnesium or aluminum antacids , sucralfate , videx chewable / buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
ciprofloxacin	VIDEX	mechanism	multivalent cation containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation containing products such as magnesium or aluminum antacids , sucralfate , videx chewable / buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
quinolone	zinc	mechanism	multivalent cation containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation containing products such as magnesium or aluminum antacids , sucralfate , videx chewable / buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
Flupenthixol	Monoamine oxidase inhibitors	int	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics arecoline eproxindine ethanol : flupenthixol and ethanol cause additive cns depression tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants
benzodiazepines	psychotropic medications	effect	the benzodiazepines , including alprazolam , produce additive cns depressant effects when co administered with other psychotropic medications , anticonvulsants , antihistaminics , ethanol , and other drugs which themselves produce cns depression .
benzodiazepines	nifedipine	int	data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following : ergotamine , cyclosporine , amiodarone , nicardipine , and nifedipine .
alprazolam	ergotamine	int	data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following : ergotamine , cyclosporine , amiodarone , nicardipine , and nifedipine .
alprazolam	sertraline	int	data from in vitro studies of alprazolam suggest a possible drug interaction with alprazolam for the following : sertraline and paroxetine .
diflunisal	anticoagulants	advise	accordingly , when diflunisal is administered with oral anticoagulants , the prothrombin time should be closely monitored during and for several days after concomitant drug administration .
diflunisal	NSAIDs	effect	the concomitant use of diflunisal tablets and other nsaids is not recommended due to the increased possibility of gastrointestinal toxicity , with little or no increase in efficacy .
diflunisal	naproxen	mechanism	naproxen : the concomitant administration of diflunisal and naproxen in normal volunteers had no effect on the plasma levels of naproxen , but significantly decreased the urinary excretion of naproxen and its glucuronide metabolite .
ALPHAGAN P	opiates	advise	although specific drug interaction studies have not been conducted with alphagan p , the possibility of an additive or potentiating effect with cns depressants ( alcohol , barbiturates , opiates , sedatives , or anesthetics ) should be considered .
Orlistat	vitamin K	mechanism	orlistat orlistat may decrease the absorption of vitamin k .
atorvastatin	contraceptive	mechanism	oral contraceptives : coadministration of atorvastatin and an oral contraceptive increased auc values for norethindrone and ethinyl estradiol by approximately dg % and dg % .
atorvastatin	digoxin	mechanism	digoxin : when multiple doses of atorvastatin and digoxin were coadministered , steady state plasma digoxin concentrations increased by approximately dg % .
analgesics	SYMLIN	advise	when the rapid onset of a concomitant orally administered agent is a critical determinant of effectiveness ( such as analgesics ) , the agent should be administered at least dg hour prior to or dg hours after symlin injection .
SYMLIN	human insulin	mechanism	mixing symlin and insulin the pharmacokinetic parameters of symlin were altered when mixed with regular , nph , and dg / dg premixed formulations of recombinant human insulin immediately prior to injection .
Mephenytoin	warfarin	effect	mephenytoin may also affect the effects of other drugs , which include some steroid medications , warfarin , certain heart medicines , birth control pills , anti infective medicines , furosemide and theophylline please note that mephenytoin may interact with other drugs that are not listed here .
Ritalin	anticonvulsants	mechanism	human pharmacologic studies have shown that ritalin may inhibit the metabolism of coumarin anticoagulants , anticonvulsants ( phenobarbital , diphenylhydantoin , primidone ) , phenylbutazone , and tricyclic drugs ( imipramine , clomipramine , desipramine ) .
Ritalin	phenylbutazone	mechanism	human pharmacologic studies have shown that ritalin may inhibit the metabolism of coumarin anticoagulants , anticonvulsants ( phenobarbital , diphenylhydantoin , primidone ) , phenylbutazone , and tricyclic drugs ( imipramine , clomipramine , desipramine ) .
Ritalin	imipramine	mechanism	human pharmacologic studies have shown that ritalin may inhibit the metabolism of coumarin anticoagulants , anticonvulsants ( phenobarbital , diphenylhydantoin , primidone ) , phenylbutazone , and tricyclic drugs ( imipramine , clomipramine , desipramine ) .
SUTENT	voriconizole	mechanism	co administration of sutent with strong inhibitors of the cyp3a4 family ( e.g. , ketoconazole , itraconazole , clarithromycin , atazanavir , indinavir , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , voriconizole ) may increases sunitinib concentrations .
SUTENT	clarithromycin	mechanism	co administration of sutent with strong inhibitors of the cyp3a4 family ( e.g. , ketoconazole , itraconazole , clarithromycin , atazanavir , indinavir , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , voriconizole ) may increases sunitinib concentrations .
cholestyramine	cerivastatin sodium	mechanism	however , in the second study , administration of dg g cholestyramine dg hour before the evening meal and dg mg cerivastatin sodium approximately dg hours after the same evening meal resulted in a decrease in the cerivastatin auc of less than dg % , and a decrease in cmax of about dg % when compared to dosing cerivastatin sodium alone .
amiodarone	protease inhibitor	advise	monitoring for amiodarone toxicity and serial measurement of amiodarone serum concentration during concomitant protease inhibitor therapy should be considered .
Colchicine	acidifying agents	mechanism	colchicine is inhibited by acidifying agents .
Argatroban	antiplatelet agents	effect	co administration : concomitant use of argatroban with antiplatelet agents , thrombolytics , and other anticoagulants may increase the risk of bleeding .
HUMORSOL	succinylcholine	int	possible drug interactions of humorsol with succinylcholine or with other anticholinesterase agents .
Folic acid	phenytoin	effect	folic acid in large amounts may counteract the antiepileptic effect of phenobarbital , phenytoin and primidone , and increase the frequency of seizures in susceptible pediatric patients .
Leucovorin	5-fluorouracil	effect	leucovorin may enhance the toxicity of 5-fluorouracil .
Nalfon	steroid	advise	in patients receiving nalfon and a steroid concomitantly , any reduction in steroid dosage should be gradual in order to avoid the possible complications of sudden steroid withdrawal .
phenobarbital	Nalfon	advise	when phenobarbital is added to or withdrawn from treatment , dosage adjustment of nalfon may be required .
Amphetamines	sympathomimetic agents	effect	antidepressants , tricyclic amphetamines may enhance the activity of tricyclic antidepressants or sympathomimetic agents ;
d-amphetamine	protriptyline	mechanism	d-amphetamine with desipramine or protriptyline and possibly other tricyclics cause striking and sustained increases in the concentration of d-amphetamine in the brain ;
furazolidone	amphetamine	mechanism	mao inhibitors maoi antidepressants , as well as a metabolite of furazolidone , slow amphetamine metabolism .
ethambutol	aluminum hydroxide	advise	it is recommended to avoid concurrent administration of ethambutol with aluminum hydroxide containing antacids for at least dg hours following ethambutol administration .
non-steroidal anti-inflammatory agent	potassium-sparing diuretics	effect	non steroidal anti inflammatory drugs : in some patients , the administration of a non-steroidal anti-inflammatory agent can reduce the diuretic , natriuretic , and antihypertensive effects of loop , potassium sparing and thiazide diuretics .
progesterone	Accutane	effect	micro dosed progesterone preparations : micro dosed progesterone preparations ( minipills that do not contain an estrogen ) may be an inadequate method of contraception during accutane therapy .
Trecator	isoniazid	mechanism	trecator has been found to temporarily raise serum concentrations of isoniazid .
Thiazides	norepinephrine	effect	( thiazides may decrease arterial responsiveness to norepinephrine .
fentanyl	nelfinavir	mechanism	the concomitant use of transdermal fentanyl with ritonavir or other potent dg inhibitors such as ketoconazole , itraconazole , troleandomycin , clarithromycin , nelfinavir , and nefazadone may result in an increase in fentanyl plasma concentrations .
fentanyl	anesthetics	effect	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
Tagamet	warfarin-type anticoagulants	mechanism	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
Tagamet	nifedipine	mechanism	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
Tagamet	chlordiazepoxide	mechanism	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
CELEBREX	ACE-inhibitors	advise	this interaction should be given consideration in patients taking celebrex concomitantly with ace-inhibitors .
aluminum hydroxide	fosinopril	mechanism	antacids : in a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .
benzodiazepines	barbiturates	effect	tablets : the benzodiazepines , including lorazepam , produce cns depressant effects when administered with such medications as barbiturates or alcohol .
Lorazepam	phenothiazines	effect	injection : lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , mao inhibitors , and other antidepressants.when scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .
norepinephrine	Bretylium Tosylate	effect	the pressor effects of catecholamines such as dopamine or norepinephrine are enhanced by bretylium tosylate .
dapsone	folic acid antagonists	effect	with oral dapsone treatment , folic acid antagonists such as pyrimethamine have been noted to possibly increase the likelihood of hematologic reactions
antipsychotic agents	anesthetics	effect	as with other antipsychotic agents , it should be noted that haldol may be capable of potentiating cns depressants such as anesthetics , opiates , and alcohol .
isoniazid	disulfiram	advise	patients taking isoniazid when disulfiram is given should be observed for the appearance of unsteady gait or marked changes in mental status ;
Dexbrompheniramine	CNS depressants	effect	dexbrompheniramine can interact with alcohol or other cns depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
PRECEDEX	anesthetics	effect	anesthetics / sedatives / hypnotics / opioids : co administration of precedex with anesthetics , sedatives , hypnotics , and opioids is likely to lead to an enhancement of effects .
PRECEDEX	hypnotics	effect	anesthetics / sedatives / hypnotics / opioids : co administration of precedex with anesthetics , sedatives , hypnotics , and opioids is likely to lead to an enhancement of effects .
Vardenafil	terazosin	effect	when vardenafil dosing was separated from terazosin dg mg by dg hours , dg of dg subjects who received dg mg of vardenafil experienced a decrease in standing systolic blood pressure below dg mm hg .
Vardenafil	ritonavir	mechanism	ritonavir and indinavir : upon concomitant administration of dg mg of vardenafil with dg mg bid ritonavir , the cmax and auc of ritonavir were reduced by approximately dg % .
Vardenafil	indinavir	mechanism	upon administration of dg mg of vardenafil with dg mg tid indinavir , the cmax and auc of indinavir were reduced by dg % and dg % , respectively .
Vardenafil	ketoconazole	advise	a dg mg vardenafil dose should not be exceeded when used in combination with dg mg once daily ketoconazole .
MONUROL	metoclopramide	mechanism	metoclopramide : when coadministered with monurol , metoclopramide , a drug which increases gastrointestinal motility , lowers the serum concentration and urinary excretion of fosfomycin .
INSPRA	ketoconazole	mechanism	a pharmacokinetic study evaluating the administration of a single dose of inspra dg mg with ketoconazole dg mg bid , a potent inhibitor of the cyp3a4 pathway , showed a dg fold increase in cmax of eplerenone and a dg fold increase in auc of eplerenone .
tricyclic antidepressants	antidepressants	advise	therefore , co administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme , including other antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( eg , propafenone , flecainide , and encainide ) , or that inhibit this enzyme ( eg , quinidine ) , should be approached with caution .
tricyclic antidepressants	carbamazepine	advise	therefore , co administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme , including other antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( eg , propafenone , flecainide , and encainide ) , or that inhibit this enzyme ( eg , quinidine ) , should be approached with caution .
nortriptyline hydrochloride	sympathomimetic drugs	advise	close supervision and careful adjustment of the dosage are required when nortriptyline hydrochloride is used with other anticholinergic drugs or sympathomimetic drugs .
ethosuximide	phenytoin	mechanism	since zarontin ( ethosuximide ) may interact with concurrently administered antiepileptic drugs , periodic serum level determinations of these drugs may be necessary ( eg , ethosuximide may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels ) .
valproic acid	ethosuximide	mechanism	since zarontin ( ethosuximide ) may interact with concurrently administered antiepileptic drugs , periodic serum level determinations of these drugs may be necessary ( eg , ethosuximide may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels ) .
NSAIDs	Angiotensin Converting Enzyme (ACE) inhibitors	effect	ace inhibitors : reports suggest that nsaids may diminish the antihypertensive effect of angiotensin converting enzyme (ace) inhibitors .
NSAIDs	lithium	mechanism	lithium : nsaids have produced an elevation of plasma lithium levels and a reduction in renal lithium clearance .
norfloxacin	anticoagulants	effect	quinolones , including norfloxacin , may enhance the effects of oral anticoagulants , including warfarin or its derivatives or similar agents .
Lodine	thiazides	effect	nevertheless , clinical studies , as well as postmarketing observations have shown that lodine can reduce the natriuretic effect of furosemide and thiazides in some patients .
NSAIDs	lithium	mechanism	lithium : nsaids have produced an elevation of plasma lithium levels and a reduction in renal lithium clearance .
Lodine	aspirin	advise	however , as with other nsaids , concomitant administration of lodine and aspirin is not generally recommended because of the potential of increased adverse effects .
NSAIDs	cyclosporine	mechanism	cyclosporine , digoxin , methotrexate lodine , like other nsaids , through effects on renal prostaglandins , may cause changes in the elimination of these drugs leading to elevated serum levels of cyclosporine , digoxin , methotrexate , and increased toxicity .
Aminosalicylic acid	digoxin	mechanism	aminosalicylic acid may decrease the amount of digoxin ( lanoxin , lanoxicaps ) that gets absorbed into your body .
Aminosalicylic acid	vitamin B12	mechanism	aminosalicylic acid may also decrease the absorption of vitamin b12 , which can lead to a deficiency .
Mefloquine	anticoagulants	advise	nevertheless , the effects of mefloquine on travelers receiving comedication , particularly diabetics or patients using anticoagulants , should be checked before departure .
Mefloquine	chloroquine	effect	concomitant administration of mefloquine and other related compounds ( eg , quinine , quinidine and chloroquine ) may produce electrocardiographic abnormalities and increase the risk of convulsions .
Mefloquine	calcium channel blockers	effect	this appears to be the only clinically relevant interaction of this kind with mefloquine , although theoretically , coadministration of other drugs known to alter cardiac conduction ( eg , anti arrhythmic or beta adrenergic blocking agents , calcium channel blockers , antihistamines or h1 blocking agents , tricyclic antidepressants and phenothiazines ) might also contribute to a prolongation of the qtc interval .
TCAs	SSRIs	advise	nevertheless , caution is indicated in the co administration of tcas with any of the ssris and also in switching from one class to the other .
alcohol	SINEQUAN	mechanism	alcohol : it should be borne in mind that alcohol ingestion may increase the danger inherent in any intentional or unintentional sinequan overdosage .
IOPIDINE	sedatives	advise	although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of iopidine dg % ophthalmic solution , the possibility of an additive or potentiating effect with cns depressants ( alcohol , barbiturates , opiates , sedatives , anesthetics ) should be considered .
sulfonylureas	salicylates	effect	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti inflammatory agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
Isoflurane	nondepolarizing muscle relaxants	effect	isoflurane potentiates the muscle relaxant effect of all muscle relaxants , most notably nondepolarizing muscle relaxants , and mac ( minimum alveolar concentration ) is reduced by concomitant administration of n 2o .
glutamic acid HCl	amphetamines	mechanism	acidifying agents : gastrointestinal acidifying agents ( guanethidine , reserpine , glutamic acid hcl , ascorbic acid , fruit juices , etc. ) lower absorption of amphetamines .
Urinary acidifying agents	amphetamine	mechanism	urinary acidifying agents ( ammonium chloride , sodium acid phosphate , etc. ) increase the concentration of the ionized species of the amphetamine molecule , thereby increasing urinary excretion .
Chlorpromazine	amphetamines	effect	chlorpromazine : chlorpromazine blocks dopamine and norepinephrine reuptake , thus inhibiting the central stimulant effects of amphetamines , and can be used to treat amphetamine poisoning .
Amphetamines	ethosuximide	mechanism	ethosuximide : amphetamines may delay intestinal absorption of ethosuximide .
Amphetamines	phenobarbital	mechanism	phenobarbital : amphetamines may delay intestinal absorption of phenobarbital ;
Adrenergic blockers	amphetamines	effect	adrenergic blockers : adrenergic blockers are inhibited by amphetamines .
sodium bicarbonate	amphetamines	mechanism	alkalinizing agents : gastrointestinal alkalinizing agents ( sodium bicarbonate , etc. ) increase absorption of amphetamines .
Cisapride	antiarrhythmics	advise	cisapride should not be used concomitantly with other drugs known to prolong the qt interval : certain antiarrhythmics , including those of class ia ( such as quinidine and procainamide ) and class iii ( such as sotalol ) ;
clarithromycin	cisapride	mechanism	antibiotics : in vitro and / or in vivo data show that clarithromycin , erythromycin , and troleandomycin markedly inhibit the metabolism of cisapride , which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
cisapride	anticoagulant	advise	it is advisable to check coagulation time within the first few days after the start and discontinuation of cisapride therapy , with an appropriate adjustment of the anticoagulant dose , if necessary .
nefazodone	cisapride	mechanism	antidepressants : in vitro data indicate that nefazodone inhibits the metabolism of cisapride , which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
tricyclic antidepressants	tricyclic antidepressants	effect	several tricyclic antidepressants have been reported to block the pharmacologic effects of guanethidine , clonidine , or similar agents , and such an effect may be anticipated with cmi because of its structural similarity to other tricyclic antidepressants .
CMI	phenobarbital	mechanism	administration of cmi has been reported to increase the plasma levels of phenobarbital , if given concomitantly .
FLOLAN	vasodilators	effect	additional reductions in blood pressure may occur when flolan is administered with diuretics , antihypertensive agents , or other vasodilators .
digoxin	FLOLAN	mechanism	however , patients on digoxin may show elevations of digoxin concentrations after initiation of therapy with flolan , which may be clinically significant in patients prone to digoxin toxicity .
sulfonylurea	beta adrenergic blocking agents	effect	the hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
epinephrine	halogenated hydrocarbon general anesthetics	effect	administration of epinephrine to patients receiving cyclopropane or halogenated hydrocarbon general anesthetics such as halothane which sensitize the myocardium , may induce cardiac arrhythmia..
diclofenac	aspirin	mechanism	aspirin : concomitant administration of diclofenac and aspirin is not recommended because diclofenac is displaced from its binding sites during the concomitant administration of aspirin , resulting in lower plasma concentrations , peak plasma levels , and auc values .
diclofenac	insulin	effect	a direct causal relationship has not been established , but physicians should consider the possibility that diclofenac may alter a diabetic patient s response to insulin or oral hypoglycemic agents .
NSAIDs	diuretics	effect	diuretics : diclofenac and other nsaids can inhibit the activity of diuretics .
diclofenac	lithium	effect	in patients taking diclofenac and lithium concomitantly , lithium toxicity may develop .
beta-adrenergic blocking agents	calcium antagonist	effect	the concomitant use of beta-adrenergic blocking agents with digitalis and calcium antagonists may have additive effects on prolonging atrioventricular conduction time .
Levo-Dromoran	central nervous system depressants	effect	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
Levo-Dromoran	tricyclic antidepressants	effect	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
Levo-Dromoran	tranquilizers	effect	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
pentazocine	Levo-Dromoran	advise	interactions with mixed agonist / antagonist opioid analgesics : agonist / antagonist analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as levo-dromoran .
Probenecid	theophylline	mechanism	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti inflammatory agents , theophylline , and zidovudine ) .
Tetracycline	penicillin	effect	tetracycline , a bacteriostatic antibiotic , may antagonize the bactericidal effect of penicillin and concurrent use of these drugs should be avoided .
pentamidine	HIVID	effect	death due to fulminant pancreatitis possibly related to intravenous pentamidine and hivid has been reported .
aminoglycosides	HIVID	effect	amphotericin , foscarnet , and aminoglycosides : drugs such as amphotericin , foscarnet , and aminoglycosides may increase the risk of developing peripheral neuropathy or other hivid associated adverse events by interfering with the renal clearance of zalcitabine ( thereby raising systemic exposure ) .
probenecid	zalcitabine	mechanism	probenecid or cimetidine : concomitant administration of probenecid or cimetidine decreases the elimination of zalcitabine , most likely by inhibition of renal tubular secretion of zalcitabine .
zalcitabine	metoclopramide	mechanism	metoclopramide : bioavailability is mildly reduced ( approximately dg % ) when zalcitabine and metoclopramide are coadministered .
NUROMAX	quinidine	effect	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
carvedilol	cyclosporine	advise	due to wide interindividual variability in the dose adjustment required , it is recommended that cyclosporine concentrations be monitored closely after initiation of carvedilol therapy and that the dose of cyclosporine be adjusted as appropriate .
Agents with b-blocking properties	hypoglycemics	effect	insulin or oral hypoglycemics : agents with b-blocking properties may enhance the blood sugar reducing effect of insulin and oral hypoglycemics .
warfarin	nevirapine	advise	when warfarin is co administered with nevirapine , anticoagulation levels should be monitored frequently .
lopinavir	nevirapine	advise	a dose increase of lopinavir / ritonavir to dg / dg mg twice daily with food isrecommended in combination with nevirapine .
Bromocriptine mesylate	butyrophenones	int	bromocriptine mesylate may interact with dopamine antagonists , butyrophenones , and certain other agents .
Uricosuric drugs	nitrofurantoin	mechanism	uricosuric drugs , such as probenecid and sulfinpyrazone , can inhibit renal tubular secretion of nitrofurantoin .
sulfinpyrazone	nitrofurantoin	mechanism	uricosuric drugs , such as probenecid and sulfinpyrazone , can inhibit renal tubular secretion of nitrofurantoin .
DOSTINEX	thioxanthines	advise	dostinex should not be administered concurrently with d2 antagonists , such as phenothiazines , butyrophenones , thioxanthines , or metoclopramide .
TRICOR	bile acid binding resin	mechanism	resins : since bile acid sequestrants may bind other drugs given concurrently , patients should take tricor at least dg hour before or dg dg hours after a bile acid binding resin to avoid impeding its absorption .
adrenergic drugs	BROVANA	advise	if additional adrenergic drugs are to be administered by any route , they should be used with caution because the pharmacologically predictable sympathetic effects of brovana may be potentiated .
thiazide diuretics	beta-agonists	effect	the ecg changes and / or hypokalemia that may result from the administration of non potassium sparing diuretics ( such as loop or thiazide diuretics ) can be acutely worsened by beta-agonists , especially when the recommended dose of the beta agonist is exceeded .
ethoxzolamide	amphotericin B	effect	coadministration of ethoxzolamide with other diuretics , amphotericin b , and corticosteroids may cause hypokalemia .
TAXOL	cisplatin	mechanism	pharmacokinetic data from these patients demonstrated a decrease in paclitaxel clearance of approximately dg % when taxol was administered following cisplatin .
paclitaxel	doxorubicin	mechanism	reports in the literature suggest that plasma levels of doxorubicin ( and its active metabolite doxorubicinol ) may be increased when paclitaxel and doxorubicin are used in combination .
bosentan	cyclosporine A	mechanism	co administration of bosentan decreased the plasma concentrations of cyclosporine a ( a cyp3a4 substrate ) by approximately dg % .
bosentan	simvastatin	mechanism	simvastatin and other statins : co administration of bosentan decreased the plasma concentrations of simvastatin ( a cyp3a4 substrate ) , and its active hydroxy acid metabolite , by approximately dg % .
bosentan	R-warfarin	mechanism	warfarin : co administration of bosentan dg mg b.i.d. for dg days decreased the plasma concentrations of both s warfarin ( a cyp2c9 substrate ) and r-warfarin ( a cyp3a4 substrate ) by dg and dg % , respectively .
esomeprazole	iron	mechanism	therefore , esomeprazole may interfere with the absorption of drugs where gastric ph is an important determinant of bioavailability ( eg , ketoconazole , iron salts and digoxin ) .
proton pump inhibitors	warfarin	effect	patients treated with proton pump inhibitors and warfarin concomitantly may need to be monitored for increases in inr and prothrombin time .
Bezalip retard	anticoagulants of the coumarin type	effect	when bezalip or bezalip retard is used at the same time as other medicines or substances the following interactions must be taken into account : bezalip and bezalip retard may enhance the action of anticoagulants of the coumarin type .
MAO-inhibitors	Bezalip	advise	perhexiline hydrogen maleate or mao-inhibitors ( with hepatotoxic potential ) must not be administered together with bezalip or bezalip retard .
Bezalip	cholestryramine	advise	when bezalip or bezalip retard is used concurrently with anion exchange resins ( e.g. cholestryramine ) , an interval of at least dg hours should be maintained between the two medicines , since the absorption of bezalip or bezalip retard is impaired
MAO inhibitors	antihistamines	effect	mao inhibitors prolong and intensify the anticholinergic ( drying ) effects of antihistamines .
ergotamine	AXERT	advise	because there is a theoretical basis that these effects may be additive , use of ergotamine containing or ergot type medications ( like dihydroergotamine or methysergide ) and axert within dg hours of each other should be avoided .
ritonavir	almotriptan	advise	although the interaction between almotriptan and other potent cyp3a4 inhibitors ( e.g. , itraconazole , ritonavir , and erythromycin ) has not been studied , increased exposures to almotriptan may be expected when almotriptan is used concomitantly with these medications .
moclobemide	almotriptan	mechanism	monoamine oxidase inhibitors : coadministration of moclobemide resulted in a dg % decrease in almotriptan clearance and an increase in cmax of approximately dg % .
TORADOL	carbamazepine	effect	antiepileptic drugs : sporadic cases of seizures have been reported during concomitant use of toradol and antiepileptic drugs ( phenytoin , carbamazepine ) .
TORADOL	fluoxetine	effect	psychoactive drugs : hallucinations have been reported when toradol was used in patients taking psychoactive drugs ( fluoxetine , thiothixene , alprazolam ) .
cholestyramine	thiazide diuretics	effect	may interact with the following : cholestyramine , colestipol ( use with thiazide diuretics may prevent the diuretic from working properly ;
dantrolene sodium	verapamil	advise	it is recommended that the combination of intravenous dantrolene sodium and calcium channel blockers , such as verapamil , not be used together during the management of malignant hyperthermia crisis until the relevance of these findings to humans is established .
central nervous system depressants	hydroxyzine	advise	therefore when central nervous system depressants are administered concomitantly with hydroxyzine their dosage should be reduced .
calcium channel blockers	Nimotop	effect	it is possible that the cardiovascular action of other calcium channel blockers could be enhanced by the addition of nimotop .
Estrogens	corticosteroids	mechanism	estrogens , including oral contraceptives : estrogens may decrease the hepatic metabolism of certain corticosteroids , thereby increasing their effect .
barbiturates	corticosteroids	mechanism	hepatic enzyme inducers , inhibitors and substrates : drugs which induce cytochrome p450 dg ( cyp dg ) enzyme activity ( e.g. , barbiturates , phenytoin , carbamazepine , rifampin ) may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased .
ketoconazole	corticosteroids	mechanism	drugs which inhibit cyp dg ( e.g. , ketoconazole , macrolide antibiotics such as erythromycin ) have the potential to result in increased plasma concentrations of corticosteroids .
Ketoconazole	corticosteroids	mechanism	ketoconazole : ketoconazole has been reported to decrease the metabolism of certain corticosteroids by up to dg % , leading to increased risk of corticosteroid side effects .
amphotericin B	tubocurarine	effect	skeletal muscle relaxants : amphotericin b induced hypokalemia may enhance the curariform effect of skeletal muscle relaxants ( e.g. , tubocurarine ) .
ranitidine	ceftibuten	mechanism	however , dg mg of ranitidine q12h for dg days increased the ceftibuten c max by dg % and ceftibuten auc by dg % .
levobupivacaine	rifampin	mechanism	although no clinical studies have been conducted , it is likely that the metabolism of levobupivacaine may be affected by the known cyp3a4 inducers ( such as phenytoin , phenobarbital , rifampin ) , cyp3a4 inhibitors ( azole antimycotics e.g. , ketoconazole ;
Albendazole sulfoxide	cimetidine	mechanism	cimetidine : albendazole sulfoxide concentrations in bile and cystic fluid were increased ( about dg fold ) in hydatid cyst patients treated with cimetidine ( dg mg / kg / day ) ( n=7 ) compared with albendazole ( dg mg / kg / day ) alone ( n=12 ) .
tricyclic antidepressants	clidinium	effect	amantadine , tricyclic antidepressants , and maois may increase anticholinergic effect of clidinium .
zaleplon	erythromycin	mechanism	coadministration of single , oral doses of zaleplon with erythromycin ( dg mg and dg mg , respectively ) , a strong , selective cyp3a4 inhibitor produced a dg % increase in zaleplons maximal plasma concentrations and a dg % increase in the area under the plasma concentration time curve .
Cimetidine	zaleplon	mechanism	drugs that inhibit both aldehyde oxidase and cyp3a4 cimetidine : cimetidine inhibits both aldehyde oxidase ( in vitro ) and cyp3a4 ( in vitro and in vivo ) , the primary and secondary enzymes , respectively , responsible for zaleplon metabolism .
MAO inhibitors	dopamine HCl	advise	patients who have been treated with mao inhibitors within two to three weeks prior to the administration of dopamine hcl should receive initial doses of dopamine hcl no greater than one tenth ( dg / dg ) of the usual dose .
dopamine	propranolol	effect	cardiac effects of dopamine are antagonized by beta adrenergic blocking agents , such as propranolol and metoprolol .
halogenated hydrocarbon anesthetics	catecholamines	effect	cyclopropane or halogenated hydrocarbon anesthetics increase cardiac autonomic irritability and may sensitize the myocardium to the action of certain intravenously administered catecholamines , such as dopamine .
valdecoxib	phenytoin	advise	patients already stabilized on valdecoxib should be closely monitored for loss of symptom control with phenytoin coadministration .
Valdecoxib	lithium	mechanism	lithium : valdecoxib dg mg bid for dg days produced significant decreases in lithium serum clearance ( dg % ) and renal clearance ( dg % ) with a dg % higher serum exposure compared to lithium alone .
valdecoxib	ketoconazole	mechanism	concomitant single dose administration of valdecoxib dg mg with multiple doses of ketoconazole and fluconazole produced a significant increase in exposure of valdecoxib .
ertapenem	probenecid	mechanism	based on total ertapenem concentrations , probenecid increased the auc by dg % and reduced the plasma and renal clearances by dg % and dg % , respectively .
neomycin	5-fluorouracil	mechanism	oral neomycin inhibits the gastrointestinal absorption of penicillin v , oral vitamin b dg , methotrexate and 5-fluorouracil .
bumetanide	aminoglycoside antibiotics	advise	drugs with ototoxic potential : especially in the presence of impaired renal function , the use of parenterally administered bumetanide in patients to whom aminoglycoside antibiotics are also being given should be avoided , except in life threatening conditions .
Lithium	diuretics	advise	lithium : lithium should generally not be given with diuretics ( such as bumetanide ) because they reduce its renal clearance and add a high risk of lithium toxicity .
Lithium	bumetanide	advise	lithium : lithium should generally not be given with diuretics ( such as bumetanide ) because they reduce its renal clearance and add a high risk of lithium toxicity .
probenecid	bumetanide	advise	thus , probenecid should not be administered concurrently with bumetanide .
Bumetanide	antihypertensive drugs	effect	antihypertensives : bumetanide may potentiate the effect of various antihypertensive drugs , necessitating a reduction in the dosage of these drugs .
benzodiazepine class	thioxanthene classes of antipsychotic agents	effect	pharmacodynamic interactions : the cns depressant action of the benzodiazepine class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate hypnotics , antianxiety agents , the phenothiazines , thioxanthene and butyrophenone classes of antipsychotic agents , monoamine oxidase inhibitors and the tricyclic antidepressants , and by other anticonvulsant drugs .
PRINIVIL	potassium-sparing diuretics	effect	use of prinivil with potassium-sparing diuretics ( e.g. , spironolactone , triamterene , or amiloride ) , potassium supplements , or potassium containing salt substitutes may lead to significant increases in serum potassium .
PRINIVIL	potassium	effect	use of prinivil with potassium sparing diuretics ( e.g. , spironolactone , triamterene , or amiloride ) , potassium supplements , or potassium containing salt substitutes may lead to significant increases in serum potassium .
benzodiazepines	antidepressants	effect	the actions of the benzodiazepines may be potentiated by barbiturates , narcotics , phenothiazines , monoamine oxidase inhibitors or other antidepressants .
estazolam	rifampin	mechanism	while no in vivo drug drug interaction studies were conducted between estazolam and inducers of cyp3a , compounds that are potent cyp3a inducers ( such as carbamazepine , phenytoin , rifampin , and barbiturates ) would be expected to decrease estazolam concentrations .
benzodiazepines	macrolide antibiotics	mechanism	the following are examples of drugs known to inhibit the metabolism of other related benzodiazepines , presumably through inhibition of cyp3a : nefazodone , fluvoxamine , cimetidine , diltiazem , isoniazide , and some macrolide antibiotics .
rifampin	VIRACEPT	mechanism	rifampin : coadministration of rifampin and viracept resulted in an dg % decrease in nelfinavir plasma a.c .
VIRACEPT	quinidine	advise	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
calcium	L-lysine	mechanism	concomitant use of calcium supplements and l-lysine may increase calcium absorption
REVIA	opioid	effect	patients taking revia may not benefit from opioid containing medicines , such as cough and cold preparations , antidiarrheal preparations , and opioid analgesics .
FACTIVE	calcium carbonate	mechanism	concomitant administration of factive and calcium carbonate , cimetidine , omeprazole , or an estrogen / progesterone oral contraceptive produced minor changes in the pharmacokinetics of gemifloxacin , which were considered to be without clinical significance .
FACTIVE	omeprazole	mechanism	concomitant administration of factive and calcium carbonate , cimetidine , omeprazole , or an estrogen / progesterone oral contraceptive produced minor changes in the pharmacokinetics of gemifloxacin , which were considered to be without clinical significance .
NSAID	cyclosporine	effect	patients who begin taking diclofenac or who increase their diclofenac dose or any other nsaid while taking digoxin , methotrexate , or cyclosporine may develop toxicity characteristics for these drugs .
diclofenac	digoxin	effect	patients who begin taking diclofenac or who increase their diclofenac dose or any other nsaid while taking digoxin , methotrexate , or cyclosporine may develop toxicity characteristics for these drugs .
Corticotropin	diuretic	effect	corticotropin may accentuate the electrolyte loss associated with diuretic therapy .
succinylcholine	Coly-Mycin M	effect	curariform muscle relaxants ( eg , tubocurarine ) and other drugs , including ether , succinylcholine , gallamine , decamethonium and sodium citrate , potentiate the neuromuscular blocking effect and should be used with extreme caution in patients being treated with coly-mycin m parenteral .
Sodium cephalothin	Coly-Mycin M	effect	sodium cephalothin may enhance the nephrotoxicity of coly-mycin m parenteral .
sodium cephalothin	Coly-Mycin M	advise	the concomitant use of sodium cephalothin and coly-mycin m parenteral should be avoided .
beta-blocker	reserpine	advise	close observation of the patient is recommended when a beta-blocker is administered to patients receiving catecholamine depleting drugs such as reserpine , because of possible additive effects and the production of hypotension and / or marked bradycardia , which may produce vertigo , syncope or postural hypotension .
CNS depressant drugs	INAPSINE	effect	other cns depressant drugs ( e.g. barbiturates , tranquilizers , opioids and general anesthetics ) have additive or potentiating effects with inapsine .
INAPSINE	CNS depressant drugs	advise	following the administration of inapsine , the dose of other cns depressant drugs should be reduced .
erythromycin	loratadine	mechanism	plasma concentrations ( auc dg dg hrs ) of erythromycin decreased dg % with coadministration of loratadine relative to that observed with erythromycin alone .
cimetidine	tricyclic antidepressant	mechanism	in patients who have been reported to be well controlled on tricyclic antidepressants receiving concurrent cimetidine therapy , discontinuation of cimetidine has been reported to decrease established steady state serum tricyclic antidepressant levels and compromise their therapeutic effects .
SSRI	TCA	int	the extent to which ssri tca interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the ssri involved .
IOPIDINE	CNS depressants	advise	although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of iopidine dg % ophthalmic solution , the possibility of an additive or potentiating effect with cns depressants ( alcohol , barbiturates , opiates , sedatives , anesthetics ) should be considered .
IOPIDINE	anesthetics	advise	although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of iopidine dg % ophthalmic solution , the possibility of an additive or potentiating effect with cns depressants ( alcohol , barbiturates , opiates , sedatives , anesthetics ) should be considered .
sulfonylureas	nonsteroidal anti-inflammatory agents	effect	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
sulfonylureas	beta adrenergic blocking agents	effect	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti inflammatory agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
miconazole	hypoglycemic agents	int	a potential interaction between oral miconazole and oral hypoglycemic agents leading to severe hypoglycemia has been reported .
Isoflurane	muscle relaxants	effect	isoflurane potentiates the muscle relaxant effect of all muscle relaxants , most notably nondepolarizing muscle relaxants , and mac ( minimum alveolar concentration ) is reduced by concomitant administration of n 2o .
Antizol	ketoconazole	mechanism	reciprocal interactions may occur with concomitant use of antizol and drugs that increase or inhibit the cytochrome p450 system ( e.g. , phenytoin , carbamazepine , cimetidine , ketoconazole ) , though this has not been studied
indomethacin	furosemide	advise	patients receiving both indomethacin and furosemide should be observed closely to determine if the desired diuretic and / or antihypertensive effect of furosemide is achieved .
Gastrointestinal acidifying agents	amphetamines	mechanism	acidifying agents : gastrointestinal acidifying agents ( guanethidine , reserpine , glutamic acid hcl , ascorbic acid , fruit juices , etc. ) lower absorption of amphetamines .
ammonium chloride	amphetamine	mechanism	urinary acidifying agents ( ammonium chloride , sodium acid phosphate , etc. ) increase the concentration of the ionized species of the amphetamine molecule , thereby increasing urinary excretion .
sodium acid phosphate	amphetamine	mechanism	urinary acidifying agents ( ammonium chloride , sodium acid phosphate , etc. ) increase the concentration of the ionized species of the amphetamine molecule , thereby increasing urinary excretion .
Amphetamines	antihistamines	effect	antihistamines : amphetamines may counteract the sedative effect of antihistamines .
Amphetamines	phenytoin	mechanism	phenytoin : amphetamines may delay intestinal absorption of phenytoin ;
propoxyphene	amphetamine	effect	propoxyphene : in cases of propoxyphene overdosage , amphetamine cns stimulation is potentiated and fatal convulsions can occur .
Amphetamines	corticosteroid	None	drug / laboratory test interactions : amphetamines can cause a significant elevation in plasma corticosteroid levels .
acetazolamide	amphetamine	mechanism	urinary alkalinizing agents ( acetazolamide , some thiazides ) increase the concentration of the non ionized species of the amphetamine molecule , thereby decreasing urinary excretion .
Amphetamines	tricyclic	effect	antidepressants , tricyclic : amphetamines may enhance the activity of tricyclic or sympathomimetic agents ;
Amphetamines	sympathomimetic agents	effect	antidepressants , tricyclic : amphetamines may enhance the activity of tricyclic or sympathomimetic agents ;
d-amphetamine	tricyclics	mechanism	d-amphetamine with desipramine or protriptyline and possibly other tricyclics cause striking and sustained increases in the concentration of d-amphetamine in the brain ;
indinavir	cisapride	mechanism	protease inhibitors : in vitro data indicate that indinavir and ritonavir markedly inhibit the metabolism of cisapride which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
anticholinergic compounds	cisapride	effect	anticholinergics : concurrent administration of certain anticholinergic compounds , such as belladonna alkaloids and dicyclomine , would be expected to compromise the beneficial effects of cisapride .
belladonna alkaloids	cisapride	effect	anticholinergics : concurrent administration of certain anticholinergic compounds , such as belladonna alkaloids and dicyclomine , would be expected to compromise the beneficial effects of cisapride .
cisapride	ketoconazole	effect	a study in dg normal male and female volunteers suggests that coadministration of cisapride and ketoconazole can result in prolongation of the qt interval on the ecg .
SSRI	TCA	int	the extent to which ssri tcainteractions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the ssri involved .
Anafranil	sympathomimetic drugs	advise	close supervision and careful adjustment of dosage are required when anafranil is administered with anticholinergic or sympathomimetic drugs .
cimetidine	CMI	mechanism	plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors ( e.g. , cimetidine , fluoxetine ) and decreased by the concomitant administration of hepatic enzyme inducers ( e.g. , barbiturates , phenytoin ) , and such an effect may be anticipated with cmi as well .
FLOLAN	antihypertensive agents	effect	additional reductions in blood pressure may occur when flolan is administered with diuretics , antihypertensive agents , or other vasodilators .
quinolones	warfarin	effect	however , the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline , interfere with the metabolism of caffeine , and enhance the effects of the oral anticoagulant warfarin and its derivatives , and has been associated with transient elevations in serum creatinine in patients receiving systemic cyclosporine concomitantly .
sulfonylurea	nonsteroidal anti-inflammatory agents	effect	the hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
sulfonylurea	sulfonamides	effect	the hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
sulfonylurea	chloramphenicol	effect	the hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
sulfonylurea	monoamine oxidase inhibitors	effect	the hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
miconazole	hypoglycemic agents	effect	a potential interaction between oral miconazole and oral hypoglycemic agents leading to severe hypoglycemia has been reported .
Diclofenac	diuretics	effect	diuretics : diclofenac and other nsaids can inhibit the activity of diuretics .
sodium citrate	Coly-Mycin M	effect	curariform muscle relaxants ( eg , tubocurarine ) and other drugs , including ether , succinylcholine , gallamine , decamethonium and sodium citrate , potentiate the neuromuscular blocking effect and should be used with extreme caution in patients being treated with coly-mycin m parenteral .
beta-adrenergic blocking agents	calcium antagonists	advise	patients receiving beta-adrenergic blocking agents along with either oral or intravenous calcium antagonists should be monitored for possible atrioventricular conduction disturbances , left ventricular failure and hypotension .
tranquilizers	INAPSINE	effect	other cns depressant drugs ( e.g. barbiturates , tranquilizers , opioids and general anesthetics ) have additive or potentiating effects with inapsine .
barbiturates	INAPSINE	effect	other cns depressant drugs ( e.g. barbiturates , tranquilizers , opioids and general anesthetics ) have additive or potentiating effects with inapsine .
Levo-Dromoran	opioids	effect	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
narcotic analgesic	DILAUDID	effect	patients receiving other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative hypnotics , tricyclic antidepressants or other cns depressants ( including alcohol ) concomitantly with dilaudid may exhibit an additive cns depression .
Probenecid	barbiturates	mechanism	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti inflammatory agents , theophylline , and zidovudine ) .
Zalcitabine	ZDV	effect	zalcitabine also has no significant effect on the intracellular phosphorylation of zdv , as shown in vitro in peripheral blood mononuclear cells or in two other cell lines ( u937 and molt dg ) .
amphotericin	HIVID	effect	amphotericin , foscarnet , and aminoglycosides : drugs such as amphotericin , foscarnet , and aminoglycosides may increase the risk of developing peripheral neuropathy or other hivid associated adverse events by interfering with the renal clearance of zalcitabine ( thereby raising systemic exposure ) .
Isoflurane	NUROMAX	mechanism	isoflurane , enflurane , and halothane decrease the ed50 of nuromax by dg % to dg % .
enflurane	NUROMAX	mechanism	isoflurane , enflurane , and halothane decrease the ed50 of nuromax by dg % to dg % .
NUROMAX	aminoglycosides	effect	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
NUROMAX	anesthetics	effect	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
NUROMAX	polymyxins	effect	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
Rifampin	carvedilol	mechanism	inducers and inhibitors of hepatic metabolism : rifampin reduced plasma concentrations of carvedilol by about dg % .
agents with b-blocking properties	clonidine	advise	when concomitant treatment with agents with b-blocking properties and clonidine is to be terminated , the b blocking agent should be discontinued first .
contraceptives	nevirapine	advise	oral contraceptives and other hormonalmethods of birth control should not be usedas the sole method of contraception inwomen taking nevirapine , since nevirapinemay lower the plasma levels of thesemedications .
ritonavir	nevirapine	advise	a dose increase of lopinavir / ritonavir to dg / dg mg twice daily with food isrecommended in combination with nevirapine .
nevirapine	methadone	effect	abased on reports of narcotic withdrawal syndrome in patients treated with nevirapine and methadone concurrently , and evidence of decreased plasma concentrations of methadone .
bromocriptine mesylate	phenothiazines	effect	compounds in these categories result in a decreased efficacy of bromocriptine mesylate : phenothiazines , haloperidol , metoclopramide , pimozide .
dobutamine	nitroprusside	effect	preliminary studies indicate that the concomitant use of dobutamine and nitroprusside results in a higher cardiac output and , usually , a lower pulmonary wedge pressure than when either drug is used alone .
Kineret	etanercept	effect	in a study in which patients with active ra were treated for up to dg weeks with concurrent kineret and etanercept therapy , a dg % rate of serious infections was observed , which was higher than that observed with etanercept alone ( dg % ) .
ethanol	tiagabine	advise	because of the possible additive effects of drugs that may depress the nervous system , ethanol or triazolam should be used cautiously in combination with tiagabine .
diuretics	CAMPTOSAR	effect	in view of the potential risk of dehydration secondary to vomiting and / or diarrhea induced by camptosar , the physician may wish to withhold diuretics during dosing with camptosar and , certainly , during periods of active vomiting or diarrhea .
COUMARIN ANTICOAGULANTS	TRICOR	advise	oral anticoagulants caution should be exercised when coumarin anticoagulants are given in conjunction with tricor .
fenofibrate	atorvastatin	mechanism	concomitant administration of fenofibrate ( equivalent to dg mg tricor ) with atorvastatin ( dg mg ) once daily for dg days resulted in approximately dg % decrease ( range from dg % decrease to dg % increase ) in atorvastatin auc values in dg healthy males .
TRICOR	immunosuppressants	advise	the benefits and risks of using tricor with immunosuppressants and other potentially nephrotoxic agents should be carefully considered , and the lowest effective dose employed
methylxanthines	adrenergic agonists	effect	concomitant treatment with methylxanthines ( aminophylline , theophylline ) , steroids , or diuretics may potentiate any hypokalemic effect of adrenergic agonists .
non-potassium sparing diuretics	beta-agonists	effect	the ecg changes and / or hypokalemia that may result from the administration of non-potassium sparing diuretics ( such as loop or thiazide diuretics ) can be acutely worsened by beta-agonists , especially when the recommended dose of the beta agonist is exceeded .
loop diuretics	beta-agonists	effect	the ecg changes and / or hypokalemia that may result from the administration of non potassium sparing diuretics ( such as loop or thiazide diuretics ) can be acutely worsened by beta-agonists , especially when the recommended dose of the beta agonist is exceeded .
Ethoxzolamide	procainamide	effect	ethoxzolamide may increase the action of tricyclics , amphetamines , procainamide , and quinidine .
TAXOL	cisplatin	effect	in a phase i trial using escalating doses of taxol ( dg dg mg / m2 ) and cisplatin ( dg or dg mg / m2 ) given as sequential infusions , myelosuppression was more profound when taxol was given after cisplatin than with the alternate sequence ( ie , taxol before cisplatin ) .
bosentan	ketoconazole	mechanism	ketoconazole : co administration of bosentan dg mg b.i.d. and ketoconazole , a potent cyp3a4 inhibitor , increased the plasma concentrations of bosentan by approximately dg fold .
statins	TRACLEER	advise	patients using cyp3a4 metabolized statins should have cholesterol levels monitored after tracleer is initiated to see whether the statin dose needs adjustment .
esomeprazole	ketoconazole	mechanism	therefore , esomeprazole may interfere with the absorption of drugs where gastric ph is an important determinant of bioavailability ( eg , ketoconazole , iron salts and digoxin ) .
Perhexiline hydrogen maleate	Bezalip	advise	perhexiline hydrogen maleate or mao inhibitors ( with hepatotoxic potential ) must not be administered together with bezalip or bezalip retard .
Diphenhydramine hydrochloride	CNS depressants	effect	diphenhydramine hydrochloride has additive effects with alcohol and other cns depressants ( hypnotics , sedatives , tranquilizers , etc ) .
fluoxetine	5-HT1 agonists	effect	selective serotonin reuptake inhibitors ( ssris ) : ssris ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1 agonists .
paroxetine	5-HT1 agonists	effect	selective serotonin reuptake inhibitors ( ssris ) : ssris ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1 agonists .
sertraline	5-HT1 agonists	effect	selective serotonin reuptake inhibitors ( ssris ) : ssris ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1 agonists .
methotrexate	NSAIDs	mechanism	methotrexate : concomitant administration of methotrexate and some nsaids has been reported to reduce the clearance of methotrexate , enhancing the toxicity of methotrexate .
TORADOL	phenytoin	effect	antiepileptic drugs : sporadic cases of seizures have been reported during concomitant use of toradol and antiepileptic drugs ( phenytoin , carbamazepine ) .
progestin	phenytoin	effect	the effectiveness of progestin only pills is reduced by hepatic enzyme inducing drugs such as the anticonvulsants phenytoin , carbamazepine , and barbiturates , and the antituberculosis drug rifampin .
progestin	rifampin	effect	the effectiveness of progestin only pills is reduced by hepatic enzyme inducing drugs such as the anticonvulsants phenytoin , carbamazepine , and barbiturates , and the antituberculosis drug rifampin .
rifampin	corticosteroids	mechanism	hepatic enzyme inducers , inhibitors and substrates : drugs which induce cytochrome p450 dg ( cyp dg ) enzyme activity ( e.g. , barbiturates , phenytoin , carbamazepine , rifampin ) may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased .
corticosteroid	live vaccines	effect	vaccines : patients on corticosteroid therapy may exhibit a diminished response to toxoids and live or inactivated vaccines due to inhibition of antibody response .
corticosteroid	inactivated vaccines	effect	vaccines : patients on corticosteroid therapy may exhibit a diminished response to toxoids and live or inactivated vaccines due to inhibition of antibody response .
felodipine	phenobarbital	mechanism	anticonvulsants : in a pharmacokinetic study , maximum plasma concentrations of felodipine were considerably lower in epileptic patients on long term anticonvulsant therapy ( eg , phenytoin , carbamazepine , or phenobarbital ) than in healthy volunteers .
EPA	Ginkgo biloba	int	interactions may occur between epa supplements and aspirin and other non steroidal anti inflammatory drugs and herbs such as garlic ( allium sativum ) and ginkgo ( ginkgo biloba ) .
cyclosporine	caspofungin	mechanism	in two clinical studies , cyclosporine ( one dg mg / kg dose or two dg mg / kg doses ) increased the auc of caspofungin by approximately dg % .
loracarbef	probenecid	mechanism	probenecid : as with other b lactam antibiotics , renal excretion of loracarbef is inhibited by probenecid and resulted in an approximate dg % increase in the auc for loracarbef .
Lithium	diuretics	advise	lithium generally should not be given with diuretics because they reduce its renal clearance and add a high risk of lithium toxicity .
apomorphine	ondansetron	advise	5ht3 antagonists : based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron , the concomitant use of apomorphine with drugs of the 5ht3 antagonist class ( including , for example , ondansetron , granisetron , dolasetron , palonosetron , and alosetron ) is contraindicated .
apomorphine	dolasetron	advise	5ht3 antagonists : based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron , the concomitant use of apomorphine with drugs of the 5ht3 antagonist class ( including , for example , ondansetron , granisetron , dolasetron , palonosetron , and alosetron ) is contraindicated .
ketoconazole	ciclesonide	advise	therefore , ketoconazole should be administered with caution with intranasal ciclesonide .
alosetron	clarithromycin	advise	coadministration of alosetron and strong cyp3a4 inhibitors , such as clarithromycin , telithromycin , protease inhibitors , voriconazole , and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions .
DIAMOX	phenytoin	mechanism	diamox modifies phenytoin metabolism with increased serum levels of phenytoin .
Acetazolamide	sodium bicarbonate	effect	acetazolamide and sodium bicarbonate used concurrently increases the risk of renal calculus formation .
Cytadren	dexamethasone	mechanism	cytadren accelerates the metabolism of dexamethasone ;
digoxin	nifedipine	advise	digitalis : immediate release capsules : since there have been isolated reports of patients with elevated digoxin levels , and there is a possible interaction between digoxin and nifedipine , it is recommended that digoxin levels be monitored when initiating , adjusting , and discontinuing nifedipine to avoid possible over or under digitalization .
digoxin	nifedipine	int	digitalis : immediate release capsules : since there have been isolated reports of patients with elevated digoxin levels , and there is a possible interaction between digoxin and nifedipine , it is recommended that digoxin levels be monitored when initiating , adjusting , and discontinuing nifedipine to avoid possible over or under digitalization .
Auranofin	Myochrysine	advise	auranofin should be avoided by patients with a history of serious reaction to any gold medication , including solganal and myochrysine .
Auranofin	Cuprimine	advise	auranofin should not be used together with penicillamine ( depen , cuprimine ) , another arthritis medication .
Phospholine Iodide	succinylcholine	effect	phospholine iodide potentiates other cholinesterase inhibitors such as succinylcholine or organophosphate and carbamate insecticides .
buprenorphine	benzodiazepines	effect	there have been a number of reports in the post marketing experience of coma and death associated with the concomitant intravenous misuse of buprenorphine and benzodiazepines by addicts .
benzodiazepines	SUBUTEX	advise	patients should be warned of the potential danger of the intravenous self administration of benzodiazepines while under treatment with suboxone or subutex .
ERGAMISOL	alcohol	effect	ergamisol ( levamisole hydrochloride ) has been reported to produce antabuse like side effects when given concomitantly with alcohol .
Aprepitant	nefazodone	advise	consequently , concomitant administration of aprepitant with strong cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , nefazodone , troleandomycin , clarithromycin , ritonavir , nelfinavir ) should be approached with caution .
Aprepitant	aprepitant	mechanism	therefore , coadministration of aprepitant with drugs that strongly induce cyp3a4 activity ( e.g. , rifampin , carbamazepine , phenytoin ) may result in reduced plasma concentrations of aprepitant that may result in decreased efficacy of aprepitant .
Aprepitant	phenytoin	mechanism	coadministration of aprepitant with these drugs or other drugs that are known to be metabolized by cyp2c9 , such as phenytoin , may result in lower plasma concentrations of these drugs .
Aprepitant	dexamethasone	mechanism	corticosteroids : dexamethasone : aprepitant , when given as a regimen of 125mg with dexamethasone coadministered orally as dg mg on day dg , and aprepitant when given as dg mg / day with dexamethasone coadministered orally as dg mg on days dg through dg , increased the auc of dexamethasone , a cyp3a4 substrate by dg fold , on days dg and dg .
Ketoconazole	vitamin D	mechanism	ketoconazole : ketoconazole may inhibit both synthetic and catabolic enzymes of vitamin d .
desipramine	diazepam	effect	if desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative / hypnotics , careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines ( e.g. , chlordiazepoxide or diazepam ) are additive .
tricyclic antidepressants	cimetidine	mechanism	conversely , decreases in plasma levels of the tricyclic antidepressants have been reported upon discontinuation of cimetidine which may result in the loss of the therapeutic efficacy of the tricyclic antidepressant dg .
Antihistamines	heparin	effect	antihistamines may partially counteract the anticoagulation effects of heparin or warfarin .
Colchicine	vitamin B12	mechanism	colchicine para aminosalicylic acid and heavy alcohol intake for longer than dg weeks may produce malabsorption of vitamin b12 .
Bismuth subsalicylate	enoxacin	mechanism	bismuth : bismuth subsalicylate , given concomitantly with enoxacin or dg minutes following enoxacin administration , decreased enoxacin bioavailability by approximately dg % .
enoxacin	caffeine	mechanism	in a multiple dose study , enoxacin caused a dose related increase in the mean elimination half life of caffeine , thereby decreasing the clearance of caffeine by up to dg % and leading to a five fold increase in the auc and the half life of caffeine .
MAO inhibitors	hydrocodone	effect	the use of mao inhibitors or tricyclic antidepressants with hydrocodone preparations may increase the effect of either the antidepressant or hydrocodone .
terfenadine	erythromycin	effect	in addition , deaths have been reported rarely with concomitant administration of terfenadine and erythromycin .
erythromycin	disopyramide	int	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
erythromycin	bromocriptine	int	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
codeine	psychotropics	effect	the use of codeine may result in additive cns depressant effects when coadministered with alcohol , antihistamines , psychotropics or other drugs that produce cns depression .
dextromethorphan hydrobromide	antihistamines	effect	the use of dextromethorphan hydrobromide may result in additive cns depressant effects when coadministered with alcohol , antihistamines , psychotropics or other drugs that produce cns depression .
theophylline	sympathomimetic bronchodilators	effect	synergism between xanthine bronchodilators ( e.g. , theophylline ) , ephedrine , and other sympathomimetic bronchodilators has been reported .
phenytoin	methylphenidate	mechanism	the most commonly occurring drug interactions are listed below : drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2 antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
phenytoin	sodium valproate	mechanism	drugs that may either increase or decrease plasma phenytoin concentrations include : phenobarbital , vaiproic acid , and sodium valproate .
phenytoin	rifampin	effect	drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
NSAIDs	furosemide	effect	furosemide : clinical studies , as well as post marketing observations , have shown that nsaids can reduce the natriuretic effect of furosemide and thiazides in some patients .
AKINETON	quinidine	effect	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
anticholinergic	meperidine	effect	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
anticholinergic	quinidine	effect	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
anticholinergic	antihistamines	effect	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
vitamin D	corticosteroids	effect	corticosteroids : a relationship of functional antagonism exists between vitamin d analogues , which promote calcium absorption , and corticosteroids , which inhibit calcium absorption .
tetracycline class	penicillins	effect	since bacteriostatic drugs , such as the tetracycline class of antibiotics , may interfere with the bactericidal action of penicillins , it is not advisable to administer these drugs concomitantly .
ARAVA	warfarin	effect	warfarin : increased inr ( international normalized ratio ) when arava and warfarin were co administered has been rarely reported .
Sumatriptan	D.H.E. 45	advise	sumatriptan and d.h.e. 45 ( dihydroergotamine mesylate ) injection , usp should not be taken within dg hours of each other..
ergot alkaloid class	macrolide class	mechanism	macrolide antibiotics ( e. g. erythromycin and troleandomycin ) : agents of the ergot alkaloid class , of which d.h.e. dg ( dihydroergotamine mesylate ) injection , usp is a member , have been shown to interact with antibiotics of the macrolide class , resulting in increased plasma levels of unchanged alkaloids and peripheral vasoconstriction .
levothyroxine sodium	estrogens	mechanism	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen containing compounds , dg fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
labetalol	calcium antagonist	advise	care should be taken if labetalol is used concomitantly with calcium antagonists of the verapamil type .
ampicillin	allopurinol	effect	ampicillin / amoxicillin : an increase in the frequency of skin rash has been reported among patients receiving ampicillin or amoxicillin concurrently with allopurinol compared to patients who are not receiving both drugs .
PAH	procaine	effect	renal clearance measurements of pah can not be made with any significant accuracy in patients receiving sulfonamides , procaine , or thiazolesulfone .
Netilmicin	loop diuretics	advise	netilmicin should not be administered concomitantly with potent loop diuretics such as furosemide and ethacrynic acid as the potential for ototoxicity is enhanced by the combination .
ampicillin	allopurinol	effect	it is not known whether this potentiation of ampicillin rashes is due to allopurinol or the hyperuricemia present in these patients .
AUGMENTIN XR	contraceptives	effect	in common with other broad spectrum antibiotics , augmentin xr may reduce the efficacy of oral contraceptives
cefdinir	iron	mechanism	iron supplements and foods fortified with iron concomitant administration of cefdinir with a therapeutic iron supplement containing dg mg of elemental iron ( as feso4 ) or vitamins supplemented with dg mg of elemental iron reduced extent of absorption by dg % and dg % , respectively .
MAOIs	fluoxetine	effect	in patients receiving nonselective monoamine oxidase inhibitors ( maois ) ( e.g. , selegiline hydrochloride ) in combination with serotoninergic agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
MAOIs	sertraline	effect	in patients receiving nonselective monoamine oxidase inhibitors ( maois ) ( e.g. , selegiline hydrochloride ) in combination with serotoninergic agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
MAOIs	serotoninergic agents	effect	in patients receiving nonselective monoamine oxidase inhibitors ( maois ) ( e.g. , selegiline hydrochloride ) in combination with serotoninergic agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
dexfenfluramine	MAO inhibitor	advise	because dexfenfluramine is a serotonin releaser and reuptake inhibitor , dexfenfluramine should not be used concomitantly with a mao inhibitor .
ergotamine	FROVA	advise	due to a theoretical risk of a pharmacodynamic interaction , use of ergotamine containing or ergot type medications ( like dihydroergotamine or methysergide ) and frova within dg hours of each other should be avoided ( see a href= frova_od.htm # ci contraindications ) .
quinolones	cyclosporine	mechanism	elevated serum levels of cyclosporine have been reported with the concomitant use of some quinolones and cyclosporine .
nalidixic acid	warfarin	effect	quinolones , including nalidixic acid , may enhance the effects of the oral anticoagulant warfarin or its derivatives .
delavirdine	VIDEX	advise	to avoid this interaction , delavirdine or indinavir should be given dg hour prior to dosing with videx .
antacids	VIDEX	effect	antacids : concomitant administration of antacids containing magnesium or aluminum with videx chewable / dispersible buffered tablets or pediatric powder for oral solution may potentiate adverse events associated with the antacid components .
ketoconazole	VIDEX	advise	drugs whose absorption can be affected by the level of acidity in the stomach : drugs such as ketoconazole and itraconazole should be administered at least dg hours prior to dosing with videx .
ciprofloxacin	magnesium	mechanism	quinolone antibiotics : videx should be administered at least dg hours after or dg hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium , calcium , or aluminum .
Felbatol	valproate	mechanism	valproate : felbatol causes an increase in steady state valproate concentrations .
phenobarbital	felbamate	mechanism	phenobarbital : it appears that phenobarbital may reduce plasma felbamate concentrations .
Felbamate	gestodene	mechanism	felbamate treatment resulted in a dg % decrease in the gestodene auc dg dg , but no clinically relevant effect was observed on the pharmacokinetic parameters of ethinyl estradiol .
Ibandronate	vitamins	advise	ibandronate should be taken at least dg minutes before any oral medications containing multivalent cations ( including antacids , supplements or vitamins ) .
ZYVOX	sympathomimetic agents	effect	adrenergic agents : some individuals receiving zyvox may experience a reversible enhancement of the pressor response to indirect acting sympathomimetic agents , vasopressor or dopaminergic agents .
Pyrazolone Derivatives	aspirin	effect	pyrazolone derivatives ( phenylbutazone , oxyphenbutazone , and possibly dipyrone ) : concomitant administration with aspirin may increase the risk of gastrointestinal ulceration .
phenylbutazone	aspirin	effect	pyrazolone derivatives ( phenylbutazone , oxyphenbutazone , and possibly dipyrone ) : concomitant administration with aspirin may increase the risk of gastrointestinal ulceration .
oxyphenbutazone	aspirin	effect	pyrazolone derivatives ( phenylbutazone , oxyphenbutazone , and possibly dipyrone ) : concomitant administration with aspirin may increase the risk of gastrointestinal ulceration .
Antacids	pseudoephedrine	mechanism	antacids increase the rate of absorption of pseudoephedrine , while kaolin decreases it .
pseudoephedrine	kaolin	mechanism	antacids increase the rate of absorption of pseudoephedrine , while kaolin decreases it .
Nafazodone	Xanax	advise	nafazodone , fluvoxamine , cimetidine ( consider xanax dose reduction ) .
alprazolam	digoxin	mechanism	quinidine , verapamil , amiodarone , propafenone , indomethacin , itraconazole , alprazolam , and spironolactone raise the serum digoxin concentration due to a reduction in clearance and / or in volume of distribution of the drug , with the implication that digitalis intoxication may result .
kaolin	digoxin	mechanism	antacids , kaolin pectin , sulfasalazine , neomycin , cholestyramine , certain anticancer drugs , and metoclopramide may interfere with intestinal digoxin absorption , resulting in unexpectedly low serum concentrations .
TARCEVA	atazanavir	advise	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
Barbiturates	theophylline	effect	barbiturates may decrease the effectiveness of oral contraceptives , certain antibiotics , quinidine , theophylline , corticosteroids , anticoagulants , and beta blockers .
Piperacillin sodium	methotrexate	mechanism	methotrexate : piperacillin sodium may reduce the excretion of methotrexate .
Desyrel	buspirone HCl	effect	there is one report suggesting that the concomitant use of trazodone hydrochloride ( desyrel ) and buspirone hcl may have caused dg to dg fold elevations on sgpt ( alt ) in a few patients .
Codeine	tranquilizers	effect	codeine in combination with other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative hypnotics , or other cns depressants ( including alcohol ) has additive depressant effects .
fexofenadine hydrochloride	ketoconazole	mechanism	however , co administration of fexofenadine hydrochloride with either ketoconazole or erythromycin led to increased plasma concentrations of fexofenadine .
ALLEGRA	magnesium	advise	allegra should not be taken closely in time with aluminum and magnesium containing antacids .
phenytoin	bexarotene	mechanism	furthermore , rifampin , phenytoin , phenobarbital , and other inducers of cytochrome p450 dg may cause a reduction in plasma bexarotene concentrations .
TRACRIUM	isoflurane	effect	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
TRACRIUM	polymyxins	effect	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
TRACRIUM	lithium	effect	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
Iron	carbidopa	mechanism	iron salts may reduce the bioavailability of carbidopa and levodopa .
TRISENOX	amphotericin B	advise	caution is advised when trisenox is coadministered with other medications that can prolong the qt interval ( e.g. certain antiarrhythmics or thioridazine ) or lead to electrolyte abnormalities ( such as diuretics or amphotericin b ) .
guanethidine	ZEBETA	effect	patients receiving catecholamine depleting drugs , such as reserpine or guanethidine , should be closely monitored , because the added beta adrenergic blocking action of zebeta may produce excessive reduction of sympathetic activity .
nicotine	Clozapine	mechanism	phenytoin , nicotine , and rifampin may decrease clozapine plasma levels , resulting in a decrease in effectiveness of a previously effective clozapine dose .
Paroxetine	clozapine	mechanism	paroxetine produced only minor changes in the levels of clozapine and its metabolites .
Clozapine	fluvoxamine	advise	therefore , such combined treatment should be approached with caution and patients should be monitored closely when clozapine is combined with these drugs , particularly with fluvoxamine .
clozapine	quinidine	advise	therefore , co administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide and encainide ) , or that inhibit this enzyme ( e.g. , quinidine ) , should be approached with caution .
Etonogestrel	Tylenol	int	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo dur ) , and vitamin c .
Etonogestrel	Neoral	int	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo dur ) , and vitamin c .
Etonogestrel	Agenerase	int	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo dur ) , and vitamin c .
Etonogestrel	Fortovase	int	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo dur ) , and vitamin c .
Etonogestrel	prednisolone	int	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo dur ) , and vitamin c .
Etonogestrel	rifadin	int	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo dur ) , and vitamin c .
carbamazepine	progestins	mechanism	anticonvulsants ( carbamazepine , felbamate , phenobarbital , phenytoin , topiramate ) : increase the metabolism of ethinyl estradiol and / or some progestins , leading to possible decrease in contraceptive effectiveness .
phenobarbital	ethinyl estradiol	mechanism	anticonvulsants ( carbamazepine , felbamate , phenobarbital , phenytoin , topiramate ) : increase the metabolism of ethinyl estradiol and / or some progestins , leading to possible decrease in contraceptive effectiveness .
Anticonvulsants	ethinyl estradiol	mechanism	anticonvulsants ( carbamazepine , felbamate , phenobarbital , phenytoin , topiramate ) : increase the metabolism of ethinyl estradiol and / or some progestins , leading to possible decrease in contraceptive effectiveness .
Atorvastatin	ethinyl estradiol	mechanism	atorvastatin : atorvastatin increases the auc for norethindrone and ethinyl estradiol .
hormonal contraceptives	temazepam	mechanism	benzodiazepines : combination hormonal contraceptives may decrease the clearance of some benzodiazepines ( alprazolam , chlordiazepoxide , diazepam ) and increase the clearance of others ( lorazepam , oxazepam , temazepam ) .
hormonal contraceptives	cyclosporine	mechanism	cyclosporine : combination hormonal contraceptives may inhibit the metabolism of cyclosporine , leading to increased plasma concentrations ;
Acetaminophen	synthetic estrogens	mechanism	acetaminophen : may increase plasma concentration of synthetic estrogens , possibly by inhibiting conjugation .
combination hormonal contraceptives	caffeine	effect	ethanol / nutrition / herb interactions : food : cns effects of caffeine may be enhanced if combination hormonal contraceptives are used concurrently with caffeine .
Aminoglutethimide	progestins	mechanism	aminoglutethimide : may increase cyp metabolism of progestins leading to possible decrease in contraceptive effectiveness .
Corticosteroids	aspirin	effect	corticosteroids may increase the clearance of chronic high dose aspirin .
Aspirin	cortico-steroids	advise	aspirin should be used cautiously in conjunction with cortico-steroids in patients suffering from hypopro thrombinemia .
anticoagulants	corticosteroids	effect	there are reports of enhanced as well as diminished effects of anticoagulants when given concurrently with corticosteroids .
heparin sodium	warfarin sodium	advise	therefore , when heparin sodium is given with dicumarol or warfarin sodium , a period of at least dg hours after the last intravenous dose or dg hours after the last subcutaneous dose should elapse before blood is drawn if a valid prothrombin time is to be obtained .
tetracyclines	heparin sodium	effect	drugs decreasing heparin effect : digitalis , tetracyclines , nicotine , or antihistamines may partially counteract the anticoagulant action of heparin sodium .
anakinra	TNF-blocking agents	effect	therefore the , combination of anakinra with other tnf-blocking agents , including humira , may also result i n similar toxicities .
Clonidine	alcohol	effect	amitriptyline in combination with clonidine enhances the manifestation of corneal lesions in rats epidural injection clonidine may potentiate the cns depressive effect of alcohol , barbiturates or other sedating drugs .
Beta blockers	clonidine	effect	beta blockers may exacerbate the hypertensive response seen with clonidine withdrawl .
carbonic anhydrase inhibitors	salicylate	int	however , in patients treated with oral carbonic anhydrase inhibitors , rare instances of drug interactions have occurred with high dose salicylate therapy .
aspirin	ketoprofen	mechanism	however , in a study of dg normal subjects , concurrent administration of aspirin decreased ketoprofen protein binding and increased ketoprofen plasma clearance from dg l / kg / h without aspirin to dg l / kg / h with aspirin .
aspirin	ketoprofen	advise	therefore , concurrent use of aspirin and ketoprofen is not recommended .
bupropion	metoprolol	advise	therefore , co administration of bupropion with drugs that are metabolized by cyp2d6 isoenzyme including certain antidepressants ( e.g. , nortriptyline , imipramine , desipramine , paroxetine , fluoxetine , sertraline ) , antipsychotics ( e.g. , haloperidol , risperidone , thioridazine ) , beta blockers ( e.g. , metoprolol ) , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution and should be initiated at the lower end of the dose range of the concomitant medication .
bupropion	Type 1C antiarrhythmics	advise	therefore , co administration of bupropion with drugs that are metabolized by cyp2d6 isoenzyme including certain antidepressants ( e.g. , nortriptyline , imipramine , desipramine , paroxetine , fluoxetine , sertraline ) , antipsychotics ( e.g. , haloperidol , risperidone , thioridazine ) , beta blockers ( e.g. , metoprolol ) , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution and should be initiated at the lower end of the dose range of the concomitant medication .
bupropion	paroxetine	advise	therefore , co administration of bupropion with drugs that are metabolized by cyp2d6 isoenzyme including certain antidepressants ( e.g. , nortriptyline , imipramine , desipramine , paroxetine , fluoxetine , sertraline ) , antipsychotics ( e.g. , haloperidol , risperidone , thioridazine ) , beta blockers ( e.g. , metoprolol ) , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution and should be initiated at the lower end of the dose range of the concomitant medication .
bupropion	risperidone	advise	therefore , co administration of bupropion with drugs that are metabolized by cyp2d6 isoenzyme including certain antidepressants ( e.g. , nortriptyline , imipramine , desipramine , paroxetine , fluoxetine , sertraline ) , antipsychotics ( e.g. , haloperidol , risperidone , thioridazine ) , beta blockers ( e.g. , metoprolol ) , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution and should be initiated at the lower end of the dose range of the concomitant medication .
bupropion	levodopa	effect	levodopa and amantadine : limited clinical data suggest a higher incidence of adverse experiences in patients receiving bupropion concurrently with either levodopa or amantadine .
WELLBUTRIN	amantadine	advise	administration of wellbutrin tablets to patients receiving either levodopa or amantadine concurrently should be undertaken with caution , using small initial doses and small gradual dose increases .
WELLBUTRIN	antidepressants	advise	drugs that lower seizure threshold : concurrent administration of wellbutrin and agents ( e.g. , antipsychotics , other antidepressants , theophylline , systemic steroids , etc. ) that lower seizure threshold should be undertaken only with extreme caution .
alcohol	WELLBUTRIN	advise	the consumption of alcohol during treatment with wellbutrin should be minimized or avoided ( also see a href= bupropz_od.htm # ci contraindications )
Probenecid	acyclovir	mechanism	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti inflammatory agents , theophylline , and zidovudine ) .
Probenecid	furosemide	mechanism	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti inflammatory agents , theophylline , and zidovudine ) .
Probenecid	nonsteroidal anti-inflammatory	mechanism	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
VISTIDE	pentamidine	advise	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin b , foscarnet , intravenous pentamidine , vancomycin , and non steroidal anti inflammatory agents ] is contraindicated .
VISTIDE	non-steroidal anti-inflammatory agents	advise	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin b , foscarnet , intravenous pentamidine , vancomycin , and non-steroidal anti-inflammatory agents ] is contraindicated .
amphotericin	zalcitabine	mechanism	amphotericin , foscarnet , and aminoglycosides : drugs such as amphotericin , foscarnet , and aminoglycosides may increase the risk of developing peripheral neuropathy or other hivid associated adverse events by interfering with the renal clearance of zalcitabine ( thereby raising systemic exposure ) .
cimetidine	zalcitabine	mechanism	probenecid or cimetidine : concomitant administration of probenecid or cimetidine decreases the elimination of zalcitabine , most likely by inhibition of renal tubular secretion of zalcitabine .
WELLBUTRIN	cyclophosphamide	int	therefore , the potential exists for a drug interaction between wellbutrin and drugs that affect the cyp2b6 isoenzyme ( e.g. , orphenadrine and cyclophosphamide ) .
bupropion	phenobarbital	mechanism	while not systematically studied , certain drugs may induce the metabolism of bupropion ( e.g. , carbamazepine , phenobarbital , phenytoin ) .
EXTRANEAL	insulin	advise	however , appropriate monitoring of blood glucose should be performed when initiating extraneal in diabetic patients and insulin dosage should be adjusted if needed .
chlorprothixene	opioids	advise	if chlorprothixene is given concomitantly with opioids , the opioid dose should be reduced ( by approx. dg % ) , because chlorprothixene amplifies the therapeutic actions and side effects of opioids massively .
Dipyridamole	adenosine	mechanism	adenosine : dipyridamole has been reported to increase the plasma levels and cardiovascular effects of adenosine .
disopyramide	verapamil	advise	until data on possible interactions between verapamil and disopyramide phosphate are obtained , disopyramide should not be administered within dg hours before or dg hours after verapamil administration .
heparin	Activase	effect	in addition to bleeding associated with heparin and vitamin k antagonists , drugs that alter platelet function ( such as acetylsalicylic acid , dipyridamole and abciximab ) may increase the risk of bleeding if administered prior to , during , or after activase therapy .
alcohol	ABILIFY	advise	as with most psychoactive medications , patients should be advised to avoid alcohol while taking abilify
fluoxetine	aripiprazole	mechanism	inhibitors of cyp3a4 ( eg , ketoconazole ) or cyp2d6 ( eg , quinidine , fluoxetine , or paroxetine ) can inhibit aripiprazole elimination and cause increased blood levels .
FOSCAVIR	pentamidine	effect	concomitant treatment of four patients in the united kingdom with foscavir and intravenous pentamidine may have caused hypocalcemia ;
ketoconazole	cinacalcet	mechanism	co administration of ketoconazole , a strong inhibitor of cyp3a4 , increased cinacalcet exposure following a single dg mg dose of sensipar by dg fold .
central nervous system depressants	heroin	effect	in combination with other central nervous system depressants , heroin may still kill even experienced users , particularly if their tolerance to the drug has reduced or the strength of their usual dose has increased .
quinolones	caffeine	mechanism	other quinolones have demonstrated moderate to marked interference with the metabolism of caffeine , resulting in a reduced clearance , a prolongation of plasma half life , and an increase in symptoms that accompany high levels of caffeine .
Sucralfate	lomefloxacin	mechanism	sucralfate administered dg hours before lomefloxacin resulted in a slower absorption ( mean c max decreased by dg % and mean t max increased by dg hour ) and a lesser extent of absorption ( mean auc decreased by approximately dg % ) .
narcotics	ketamine	effect	prolonged recovery time may occur if barbiturates and / or narcotics are used concurrently with ketamine .
glimepiride	aspirin	advise	before taking glimepiride , tell your doctor if you are taking any of the following medicines : aspirin or another salicylate such as magnesium / choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto bismol ) ;
terfenadine	macrolide antibiotics	effect	serious cardiac dysrhythmias , some resulting in death , have occurred in patients receiving terfenadine concomitantly with other macrolide antibiotics .
Erythromycin	triazolam	effect	triazolam : erythromycin has been reported to decrease the clearance of triazolam and , thus , may increase the pharmacologic effect of triazolam .
erythromycin	anticoagulants	effect	anticoagulants : there have been reports of increased anticoagulant effects when erythromycin and oral anticoagulants were used concomitantly .
baclofen	morphine	effect	interactions attributed to the combined use of baclofen injection and epidural morphine include hypotension and dyspnea .
Barbiturates	fludrocortisone acetate	mechanism	barbiturates , phenytoin , or rifampin increased metabolic clearance of fludrocortisone acetate because of the induction of hepatic enzymes .
Beta-blockers	insulin	effect	beta-blockers , clonidine , lithium salts , and alcohol may either potentiate or weaken the blood glucose lowering effect of insulin .
L-methionine	acetaminophen	effect	acetaminophen and methotrexate l-methionine may decrease hepatic toxicity in those with acetaminophen overdosage or in those taking methotrexate .
Flurbiprofen	propranolol	int	flurbiprofen did not affect the pharmacokinetic profile of either drug , and the mechanism under lying the interference with propranolols hypotensive effect is unknown .
flurbiprofen	cimetidine	mechanism	cimetidine , ranitidine : in normal volunteers ( n=9 ) , pretreatment with cimetidine or ranitidine did not affect flurbiprofen pharmacokinetics except that a small ( dg % ) but statistically significant increase in the area under the serum concentration curve of flurbiprofen resulted with cimetidine .
nonsteroidal anti-inflammatory drugs	potassium-sparing diuretics	effect	other nonsteroidal anti-inflammatory drugs that inhibit prostaglandin synthesis have been shown to interfere with thiazide diuretics in some studies and with potassium-sparing diuretics .
azithromycin	warfarin	advise	however , prudent medical practice dictates careful monitoring of prothrombin time in all patients treated with azithromycin and warfarin concomitantly .
azithromycin	rifabutin	mechanism	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim / sulfamethoxazole or zidovudine .
SUSTIVA	itraconazole	mechanism	sustiva has the potential to decrease plasma concentrations of itraconazole and ketoconazole .
Thyroid preparations	digitalis	effect	digitalis : thyroid preparations may potentiate the toxic effects of digitalis .
Simulect	mycophenolate mofetil	mechanism	total body clearance of simulect was reduced by an average dg % and dg % when azathioprine and mycophenolate mofetil , respectively , were added to a regimen consisting of cyclosporine , usp ( modified ) and corticosteroids .
carbenicillin indanyl sodium	probenecid	mechanism	geocillin ( carbenicillin indanyl sodium ) blood levels may be increased and prolonged by concurrent administration of probenecid .
Duloxetine	TCAs	advise	therefore , co administration of duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain antidepressants ( tricyclic antidepressants [ tcas ] , such as nortriptyline , amitriptyline , and imipramine ) , phenothiazines and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution .
ISUPREL	halothane	advise	isuprel should be used with caution , if at all , when potent inhalational anesthetics such as halothane are employed because of potential to sensitize the myocardium to effects of sympathomimetic amines .
b-lactam antibiotics	cefditoren pivoxil	mechanism	probenecid : as with other b-lactam antibiotics , co administration of probenecid with cefditoren pivoxil resulted in an increase in the plasma exposure of cefditoren , with a dg % increase in mean cmax , a dg % increase in mean auc , and a dg % increase in half life .
quinine	TIKOSYN	advise	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
digoxin	dofetilide	effect	in patients , the concomitant administration of digoxin with dofetilide was associated with a higher occurrence of torsade de pointes .
caffeine	sedative-hypnotics	effect	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative-hypnotics , or other cns depressants , causing increased cns depression .
caffeine	CNS depressants	effect	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative hypnotics , or other cns depressants , causing increased cns depression .
Butalbital	tranquilizers	effect	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative hypnotics , or other cns depressants , causing increased cns depression .
Butalbital	sedative-hypnotics	effect	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative-hypnotics , or other cns depressants , causing increased cns depression .
Butalbital	CNS depressants	effect	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative hypnotics , or other cns depressants , causing increased cns depression .
diuretics	Lotensin	effect	diuretics : patients on diuretics , especially those in whom diuretic therapy was recently instituted , may occasionally experience an excessive reduction of blood pressure after initiation of therapy with lotensin .
ACE inhibitors	lithium	mechanism	lithium : increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ace inhibitors during therapy with lithium .
theophylline	quinolone	effect	there have been reports of theophylline related side effects in patients on concomitant theophylline quinolone therapy .
Quinolones	caffeine	mechanism	quinolones have also been shown to interfere with the metabolism of caffeine .
Quinolones	warfarin	effect	quinolones , including cinoxacin , may enhance the effects of oral anticoagulants , such as warfarin or its derivatives .
epinephrine	tricyclic antidepressants	effect	the administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe , prolonged hypertension .
norepinephrine	monoamine oxidase inhibitors	effect	the administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe , prolonged hypertension .
anesthetics	calcium channel blockers	advise	when used concomitantly , anesthetics and calcium channel blockers should be titrated carefully .
triazolam	diltiazem	mechanism	the elimination half life of midazolam and triazolam also increased ( dg dg fold ) during coadministration with diltiazem .
diltiazem	triazolam	effect	these pharmacokinetic effects seen during diltiazem coadministration can result in increased clinical effects ( e.g. , prolonged sodation ) of both midazolam and triazolam .
diltiazem	lovastatin	mechanism	in a ten subject study , coadministration of diltiazem ( dg mg bid ) with lovastatin resulted in a dg dg times increase in mean lovastatin auc and cmax vs. lovastatin alone ;
Cholestyramine	thiazide diuretics	mechanism	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
Cholestyramine	tetracycline	mechanism	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
Cholestyramine	penicillin G	mechanism	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
aminoglycoside	antibiotics	effect	in vitro mixing of an aminoglycoside with beta lactamtype antibiotics ( penicillins or cephalosporins ) may result in a significant mutual inactivation .
aminoglycoside	penicillins	effect	in vitro mixing of an aminoglycoside with beta lactamtype antibiotics ( penicillins or cephalosporins ) may result in a significant mutual inactivation .
aminoglycoside	penicillin	mechanism	even when an aminoglycoside and a penicillin type drug are administered separately by different routes , a reduction in aminoglycoside serum half life or serum levels has been reported in patients with impaired renal function and in some patients with normal renal function .
ezetimibe	cholestyramine	effect	the incremental ldl c reduction due to adding ezetimibe to cholestyramine may be reduced by this interaction .
fenofibrate	ezetimibe	mechanism	fenofibrate : in a pharmacokinetic study , concomitant fenofibrate administration increased total ezetimibe concentrations approximately dg fold .
sulfamethizole	teniposide	mechanism	in a study in which dg different drugs were tested , therapeutically relevant concentrations of tolbutamide , sodium salicylate and sulfamethizole displaced protein bound teniposide in fresh human serum to a small but significant extent .
Salicylates	anticoagulant drugs	effect	salicylates given concomitantly with anticoagulant drugs may predispose to systemic bleeding .
Salicylate	thyroxine	mechanism	salicylate competes with a number of drugs for protein binding sites , notably penicillin , thiopental , thyroxine , triiodothyronine , phenytoin , sulfinpyrazone , naproxen , warfarin , methotrexate , and possibly corticosteroids .
cyclosporin	methylprednisolone	mechanism	mutual inhibition of metabolism occurs with concurrent use of cyclosporin and methylprednisolone ;
lithium	Neulasta	advise	patients receiving lithium and neulasta should have more frequent monitoring of neutrophil counts .
warfarin	oxandrolone	advise	furthermore , in patients receiving both drugs , careful monitoring of the inr or pt , and adjustment of the warfarin dosage if indicated are recommended when the oxandrolone dose is changed or discontinued .
anticholinergic drugs	meperidine	effect	the following agents may increase certain actions or side effects of anticholinergic drugs : amantadine , antiarrhythmic agents of class i ( e.g. , quinidine ) , antihistamines , antipsychotic agents ( e.g. , phenothiazines ) , benzodiazepines , mao inhibitors , narcotic analgesics ( e.g. , meperidine ) , nitrates and nitrites , sympathomimetic agents , tricyclic antidepressants , and other drugs having anticholinergic activity .
Anticholinergics	antiglaucoma agents	effect	anticholinergics antagonize the effects of antiglaucoma agents .
antacids	anticholinergic agents	mechanism	because antacids may interfere with the absorption of anticholinergic agents , simultaneous use of these drugs should be avoided .
loop diuretics	metolazone	effect	diuretics : furosemide and probably other loop diuretics given concomitantly with metolazone can cause unusually large or prolonged losses of fluid and electrolytes .
Diuretic	curariform drugs	effect	curariform drugs : diuretic induced hypokalemia may enhance neuromuscular blocking effects of curariform drugs ( such as tubocurarine ) the most serious effect would be respiratory depression which could proceed to apnea .
ERGOMAR	vasoconstrictor drugs	effect	the pressor effects of ergomar and other vasoconstrictor drugs can combine to cause dangerous hypertension .
fluvoxamine	Ropivacaine	int	thus strong inhibitors of cytochrome p4501a2 , such as fluvoxamine , given concomitantly during administration of ropivacaine , can interact with ropivacaine leading to increased ropivacaine plasma levels .
lithium	meloxicam	mechanism	in a study conducted in healthy subjects , mean pre dose lithium concentration and auc were increased by dg % in subjects receiving lithium doses ranging from dg to dg mg bid with meloxicam dg mg qd as compared to subjects receiving lithium alone .
NIMBEX	lincomycin	effect	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
NIMBEX	procainamide	effect	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
nondepolarizing agents	tetracyclines	effect	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
nondepolarizing agents	lincomycin	effect	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
nondepolarizing neuromuscular blocking agents	phenytoin	effect	resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or carbamazepine .
carbamazepine	NIMBEX	effect	while the effects of chronic phenytoin or carbamazepine therapy on the action of nimbex are unknown , slightly shorter durations of neuromuscular block may be anticipated and infusion rate requirements may be higher .
succinylcholine	NIMBEX	effect	infusion requirements of nimbex in patients administered succinylcholine prior to infusions of nimbex were comparable to or slightly greater than when succinylcholine was not administered .
isoflurane	NIMBEX	advise	in long surgical procedures during enflurane or isoflurane anesthesia , less frequent maintenance dosing , lower maintenance doses , or reduced infusion rates of nimbex may be necessary .
Barbiturates	theophylline	int	barbiturates may decrease the effectiveness of oral contraceptives , certain antibiotics , quinidine , theophylline , corticosteroids , anticoagulants , and beta blockers .
Barbiturates	beta blockers	int	barbiturates may decrease the effectiveness of oral contraceptives , certain antibiotics , quinidine , theophylline , corticosteroids , anticoagulants , and beta blockers .
NEXAVAR	doxorubicin	mechanism	concomitant treatment with nexavar resulted in a dg % increase in the auc of doxorubicin .
doxorubicin	NEXAVAR	advise	caution is recommended when administering doxorubicin with nexavar .
Sympathomimetics	mecamylamine	effect	sympathomimetics may reduce the antihypertensive effects of methyldopa , mecamylamine , reserpine and veratrum alkaloids .
TOLECTIN	anticoagulants	advise	therefore , caution should be exercised when administering tolectin to patients on anticoagulants .
beta adrenergic aerosol bronchodilators	Alupent	advise	other beta adrenergic aerosol bronchodilators should not be used concomitantly with alupent ( metaproterenol sulfate usp ) because they may have additive effects .
Triprolidine	central nervous system depressants	effect	triprolidine may enhance the sedative effects of central nervous system depressants including alcohol , barbiturates , hypnotics , narcotic analgesics , sedatives , and tranquillisers .
Triprolidine	barbiturates	effect	triprolidine may enhance the sedative effects of central nervous system depressants including alcohol , barbiturates , hypnotics , narcotic analgesics , sedatives , and tranquillisers .
Triprolidine	narcotic analgesics	effect	triprolidine may enhance the sedative effects of central nervous system depressants including alcohol , barbiturates , hypnotics , narcotic analgesics , sedatives , and tranquillisers .
Triprolidine	sedatives	effect	triprolidine may enhance the sedative effects of central nervous system depressants including alcohol , barbiturates , hypnotics , narcotic analgesics , sedatives , and tranquillisers .
selective serotonin reuptake inhibitors	ELDEPRYL	effect	severe toxicity has also been reported in patients receiving the combination of tricyclic antidepressants and eldepryl and selective serotonin reuptake inhibitors and eldepryl .
Dexbrompheniramine	CNS depressants	int	dexbrompheniramine can interact with alcohol or other cns depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
TOBI	(beta)-agonists	effect	in clinical studies of tobi , patients taking tobi concomitantly with dornase alfa ( pulmozyme , genentech ) , (beta)-agonists , inhaled corticosteroids , other anti pseudomonal antibiotics , or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole .
diuretics	aminoglycoside	effect	some diuretics can enhance aminoglycoside toxicity by altering antibiotic concentrations in serum and tissue .
Nalidixic acid	melphalan	effect	drug interactions there are no known drug / drug interactions with oral alkeran vaccinations with live organism vaccines are not recommended in immunocompromised individuals nalidixic acid together with high dose intravenous melphalan has caused deaths in children due to haemorrhagic enterocolitis .
melphalan	cyclosporin	effect	impaired renal function has been described in bone marrow transplant patients who were conditioned with high dose intravenous melphalan and who subsequently received cyclosporin to prevent graft versus host disease
DIPRIVAN	meperidine	effect	the induction dose requirements of diprivan injectable emulsion may be reduced in patients with intramuscular or intravenous premedication , particularly with narcotics ( eg , morphine , meperidine , and fentanyl , etc . )
DIPRIVAN	analgesic agents	advise	during maintenance of anesthesia or sedation , the rate of diprivan injectable emulsion administration should be adjusted according to the desired level of anesthesia or sedation and may be reduced in the presence of supplemental analgesic agents ( eg , nitrous oxide or opioids ) .
magnesium-aluminum hydroxide	digoxin	mechanism	mexitil does not alter serum digoxin levels but magnesium-aluminum hydroxide , when used to treat gastrointestinal symptoms due to mexitil , has been reported to lower serum digoxin levels .
Theophylline	Mexitil	mechanism	this increase was observed at the first test point which was the second day after starting mexitil . theophylline plasma levels returned to pre mexitil values within dg hours after discontinuing mexitil . if mexitil and theophylline are to be used concurrently , theophylline blood levels should be monitored , particularly when the mexitil dose is changed .
caffeine	Mexitil	mechanism	additionally , in one controlled study in five normal subjects and seven patients , the clearance of caffeine was decreased dg % following the administration of mexitil .
phenobarbital	Mexitil	mechanism	when phenytoin or other hepatic enzyme inducers such as rifampin and phenobarbital have been taken concurrently with mexitil , lowered mexitil plasma levels have been reported .
Mephenytoin	anti-infective medicines	effect	mephenytoin may also affect the effects of other drugs , which include some steroid medications , warfarin , certain heart medicines , birth control pills , anti-infective medicines , furosemide and theophylline please note that mephenytoin may interact with other drugs that are not listed here .
morphine	CNS depressants	effect	use with other central nervous system depressants : the depressant effects of morphine are potentiated by the presence of other cns depressants such as alcohol , sedatives , antihistaminics , or psychotropic drugs .
Ritalin	coumarin anticoagulants	mechanism	human pharmacologic studies have shown that ritalin may inhibit the metabolism of coumarin anticoagulants , anticonvulsants ( phenobarbital , diphenylhydantoin , primidone ) , phenylbutazone , and tricyclic drugs ( imipramine , clomipramine , desipramine ) .
Ritalin	tricyclic drugs	mechanism	human pharmacologic studies have shown that ritalin may inhibit the metabolism of coumarin anticoagulants , anticonvulsants ( phenobarbital , diphenylhydantoin , primidone ) , phenylbutazone , and tricyclic drugs ( imipramine , clomipramine , desipramine ) .
SUTENT	itraconazole	mechanism	co administration of sutent with strong inhibitors of the cyp3a4 family ( e.g. , ketoconazole , itraconazole , clarithromycin , atazanavir , indinavir , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , voriconizole ) may increases sunitinib concentrations .
SUTENT	ritonavir	mechanism	co administration of sutent with strong inhibitors of the cyp3a4 family ( e.g. , ketoconazole , itraconazole , clarithromycin , atazanavir , indinavir , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , voriconizole ) may increases sunitinib concentrations .
SUTENT	dexamethasone	mechanism	co administration of sutent with inducers of the cyp3a4 family ( e.g. , dexamethasone , phenytoin , carbamazepine , rifampin , rifabutin , rifapentin , phenobarbital , st. johns wort ) may decrease sunitinib concentrations .
SUTENT	phenytoin	mechanism	co administration of sutent with inducers of the cyp3a4 family ( e.g. , dexamethasone , phenytoin , carbamazepine , rifampin , rifabutin , rifapentin , phenobarbital , st. johns wort ) may decrease sunitinib concentrations .
SUTENT	carbamazepine	mechanism	co administration of sutent with inducers of the cyp3a4 family ( e.g. , dexamethasone , phenytoin , carbamazepine , rifampin , rifabutin , rifapentin , phenobarbital , st. johns wort ) may decrease sunitinib concentrations .
anticoagulant	glutethimide	effect	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under dosage .
anticoagulant	alcohol	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ;
anticoagulant	nalidixic acid	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
anticoagulant	oxolinic acid	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
anticoagulant	oxyphenbutazone	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
anticoagulant	quinidine	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
anticoagulant	sulfonamides	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
anticoagulants	hypoglycemic agents	mechanism	oral anticoagulants may potentiate the hypoglycemic action of hypoglycemic agents , eg , tolbutamide and chlorpropamide , by inhibiting their metabolism in the liver .
anticoagulants	phenytoin	mechanism	because oral anticoagulants may interfere with the hepatic metabolism of phenytoin , toxic levels of the anticonvulsant may occur when an oral anticoagulant and phenytoin are administered concurrently .
NSAIDs	ALIMTA	advise	patients with mild to moderate renal insufficiency should avoid taking nsaids with short elimination half lives for a period of dg days before , the day of , and dg days following administration of alimta .
doxorubicin	ZANOSAR	advise	a reduction of the doxorubicin dosage should be considered in patients receiving zanosar concurrently .
EVISTA	indomethacin	advise	caution should be used when evista is coadministered with other highly protein bound drugs , such as clofibrate , indomethacin , naproxen , ibuprofen , diazepam , and diazoxide .
EVISTA	naproxen	advise	caution should be used when evista is coadministered with other highly protein bound drugs , such as clofibrate , indomethacin , naproxen , ibuprofen , diazepam , and diazoxide .
EVISTA	ibuprofen	advise	caution should be used when evista is coadministered with other highly protein bound drugs , such as clofibrate , indomethacin , naproxen , ibuprofen , diazepam , and diazoxide .
Sulfamethizole	barbiturates	effect	sulfamethizole may increase the effects of barbiturates , tolbutamide , and uricosurics .
Sulfacetamide	silver	int	sulfacetamide preparations are incompatible with silver preparations .
Dopamine antagonists	Permax	advise	dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthines ) or metoclopramide , ordinarily should not be administered concurrently with permax ( a dopamine agonist ) ;
contraceptives	vitamin A	mechanism	drug interactions : women on oral contraceptives have shown a significant increase in plasma vitamin a levels .
metoclopramide	hypnotics	effect	additive sedative effects can occur when metoclopramide is given with alcohol , sedatives , hypnotics , narcotics , or tranquilizers .
metoclopramide	narcotics	effect	additive sedative effects can occur when metoclopramide is given with alcohol , sedatives , hypnotics , narcotics , or tranquilizers .
phenytoin	corticosteroids	mechanism	drugs that induce hepatic enzymes such as phenobarbital , phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response .
salicylate	corticosteroid	effect	this could lead to decreased salicylate serum levels or increase the risk of salicylate toxicity when corticosteroid is withdrawn .
Methscopolamine	MAO inhibitors	int	methscopolamine may interact with antidepressants ( tricyclic type ) , mao inhibitors ( e.g. , phenelzine , linezolid , tranylcypromine , isocarboxazid , selegiline , furazolidone ) , quinidine , amantadine , antihistamines ( e.g. , diphenhydramine ) , other anticholinergics , potassium chloride supplements , antacids , absorbent type anti diarrhea medicines ( e.g. , kaolin pectin ) , phenothiazines ( e.g. , chlorpromazine , promethazine ) .
Methscopolamine	quinidine	int	methscopolamine may interact with antidepressants ( tricyclic type ) , mao inhibitors ( e.g. , phenelzine , linezolid , tranylcypromine , isocarboxazid , selegiline , furazolidone ) , quinidine , amantadine , antihistamines ( e.g. , diphenhydramine ) , other anticholinergics , potassium chloride supplements , antacids , absorbent type anti diarrhea medicines ( e.g. , kaolin pectin ) , phenothiazines ( e.g. , chlorpromazine , promethazine ) .
FELDENE	lithium	mechanism	plasma levels of piroxicam are depressed to approximately dg % of their normal values when feldene is administered in conjunction with aspirin ( dg mg / day ) , but concomitant administration of antacids has no effect on piroxicam plasma levels . nonsteroidal anti inflammatory agents , including feldene , have been reported to increase steady state plasma lithium levels .
paliperidone	centrally acting drugs	advise	given the primary cns effects of paliperidone , invega should be used with caution in combination with other centrally acting drugs and alcohol .
Matulane	sympathomimetic drugs	advise	because matulane exhibits some monoamine oxidase inhibitory activity , sympathomimetic drugs , tricyclic antidepressant drugs ( e.g. , amitriptyline hcl , imipramine hcl ) and other drugs and foods with known high tyramine content , such as wine , yogurt , ripe cheese and bananas , should be avoided .
Matulane	amitriptyline HCl	advise	because matulane exhibits some monoamine oxidase inhibitory activity , sympathomimetic drugs , tricyclic antidepressant drugs ( e.g. , amitriptyline hcl , imipramine hcl ) and other drugs and foods with known high tyramine content , such as wine , yogurt , ripe cheese and bananas , should be avoided .
Matulane	imipramine HCl	advise	because matulane exhibits some monoamine oxidase inhibitory activity , sympathomimetic drugs , tricyclic antidepressant drugs ( e.g. , amitriptyline hcl , imipramine hcl ) and other drugs and foods with known high tyramine content , such as wine , yogurt , ripe cheese and bananas , should be avoided .
Matulane	tyramine	advise	because matulane exhibits some monoamine oxidase inhibitory activity , sympathomimetic drugs , tricyclic antidepressant drugs ( e.g. , amitriptyline hcl , imipramine hcl ) and other drugs and foods with known high tyramine content , such as wine , yogurt , ripe cheese and bananas , should be avoided .
Phenothiazines	alcohol	effect	phenothiazines are capable of potentiating cns depressants ( e.g. , barbiturates , anesthetics , opiates , alcohol , etc . )
pantoprazole	warfarin	effect	there have been postmarketing reports of increased inr and prothrombin time in patients receiving proton pump inhibitors , including pantoprazole , and warfarin concomitantly .
amphotericin B	digitalis	effect	digitalis glycosides : amphotericin b induced hypokalemia may potentiate digitalis toxicity .
Sonata	ethanol	effect	cns active drugs ethanol : sonata dg mg potentiated the cns impairing effects of ethanol dg g / kg on balance testing and reaction time for dg hour after ethanol administration and on the digit symbol substitution test ( dsst ) , symbol copying test , and the variability component of the divided attention test for dg hours after ethanol administration .
Sonata	imipramine	effect	imipramine : coadministration of single doses of sonata dg mg and imipramine dg mg produced additive effects on decreased alertness and impaired psychomotor performance for dg to dg hours after administration .
Sonata	thioridazine	effect	thioridazine : coadministration of single doses of sonata dg mg and thioridazine dg mg produced additive effects on decreased alertness and impaired psychomotor performance for dg to dg hours after administration .
dopamine HCl	cyclopropane	advise	therefore , extreme caution should be exercised when administering dopamine hcl to patients receiving cyclopropane or halogenated hydrocarbon anesthetics .
phenytoin	dopamine HCl	effect	administration of phenytoin to patients receiving dopamine hcl has been reported to lead to hypotension and bradycardia .
dopamine HCl	phenytoin	advise	it is suggested that in patients receiving dopamine hcl , alternatives to phenytoin should be used if anticonvulsant therapy is needed .
piperazine	pyrantel	effect	pyrantel ( e.g. , antiminth ) taking piperazine and pyrantel together may decrease the effects of piperazine .
valdecoxib	ketoconazole	mechanism	plasma exposure ( auc ) to valdecoxib was increased dg % when coadministered with fluconazole and dg % when coadministered with ketoconazole .
neomycin	vitamin B-12	mechanism	oral neomycin inhibits the gastrointestinal absorption of penicillin v , oral vitamin b-12 , methotrexate and dg fluorouracil .
clonazepam	propantheline	mechanism	in a study in which the dg mg clonazepam orally disintegrating tablet was administered with and without propantheline ( an anticholinergic agent with multiple effects on the gi tract ) to healthy volunteers , the auc of clonazepam was dg % lower and the cmax of clonazepam was dg % lower when the orally disintegrating tablet was given with propantheline compared to when it was given alone .
proton pump inhibitors	warfarin	advise	patients treated with proton pump inhibitors and warfarin concomitantly should be monitored for increases in inr and prothrombin time .
Thiabendazole	theophylline	mechanism	thiabendazole may compete with other drugs , such as theophylline , for sites of metabolism in the liver , thus elevating the serum levels of such compounds to potentially toxic levels .
valproic acid	temozolomide	mechanism	administration of valproic acid decreases oral clearance of temozolomide by about dg % .
Vasopressors	halothane	effect	vasopressors , particularly metaraminol , may cause serious cardiac arrhythmias during halothane anesthesia and therefore should be used only with great caution or not at all .
metaraminol	halothane	effect	vasopressors , particularly metaraminol , may cause serious cardiac arrhythmias during halothane anesthesia and therefore should be used only with great caution or not at all .
sympathomimetic pressor amines	MAOI	effect	mao inhibitors the pressor effect of sympathomimetic pressor amines is markedly potentiated in patients receiving monoamine oxidase inhibitors ( maoi ) .
Vitamin B1	Stavudine	int	interactions for vitamin b1 ( thiamine ) : loop diuretics , oral contraceptives , stavudine , tricyclic antidepressants
Probenecid	riboflavin	mechanism	probenecid concurrent use decreases gastrointestinal absorption of riboflavin ;
Mequitazine	MAOIs	int	mequitazine can interact with cns depressant , antichlolinergic , tca , maois , and alcohol .
cyclophosphamide	phenobarbital	mechanism	the rate of metabolism and the leukopenic activity of cyclophosphamide reportedly are increased by chronic administration of high doses of phenobarbital .
contraceptives	Myfortic	advise	therefore , it is recommended that oral contraceptives are co administered with myfortic with caution and additional birth control methods be considered .
MEPERIDINE	PHENOTHIAZINES	advise	interaction with other central nervous system depressants : meperidine should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic analgesics , general anesthetics , phenothiazines , other tranquilizers , sedative hypnotics ( including barbiturates ) , tricyclic antidepressants and other cns depressants ( including alcohol ) .
MEPERIDINE	TRANQUILIZERS	advise	interaction with other central nervous system depressants : meperidine should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic analgesics , general anesthetics , phenothiazines , other tranquilizers , sedative hypnotics ( including barbiturates ) , tricyclic antidepressants and other cns depressants ( including alcohol ) .
MEPERIDINE	ALCOHOL	advise	interaction with other central nervous system depressants : meperidine should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic analgesics , general anesthetics , phenothiazines , other tranquilizers , sedative hypnotics ( including barbiturates ) , tricyclic antidepressants and other cns depressants ( including alcohol ) .
FLOMAX	cimetidine	advise	therefore , flomax capsules should be used with caution in combination with cimetidine , particularly at doses higher than dg mg .
Sanctura	vancomycin	mechanism	drugs eliminated by active tubular secretion : although studies to assess drug drug interactions with sanctura have not been conducted , sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion ( e.g. digoxin , procainamide , pancuronium , morphine , vancomycin , metformin and tenofovir ) .
mazindol	tranylcypromine	advise	you can not take mazindol if you have taken a monoamine oxidase inhibitor ( maoi ) such as isocarboxazid ( marplan ) , tranylcypromine ( parnate ) , or phenelzine ( nardil ) in the last dg days .
mazindol	Parnate	advise	you can not take mazindol if you have taken a monoamine oxidase inhibitor ( maoi ) such as isocarboxazid ( marplan ) , tranylcypromine ( parnate ) , or phenelzine ( nardil ) in the last dg days .
insulin	mazindol	advise	changes in insulin and other diabetes drug therapies may be necessary during treatment with mazindol .
Mazindol	Ismelin	effect	mazindol may reduce the effects of guanethidine ( ismelin ) .
ergotamine	sumatriptan	advise	because there is a theoretical basis that these effects may be additive , use of ergotamine containing or ergot type medications ( like dihydroergotamine or methysergide ) and sumatriptan within dg hours of each other should be avoided .
dihydroergotamine	sumatriptan	advise	because there is a theoretical basis that these effects may be additive , use of ergotamine containing or ergot type medications ( like dihydroergotamine or methysergide ) and sumatriptan within dg hours of each other should be avoided .
magnesium	SKELID	mechanism	the bioavailability of skelid is decreased dg % by calcium , when calcium and skelid are administered at the same time , and dg % by some aluminum or magnesium containing antacids , when administered dg hour before skelid .
Miochol	suprofen	effect	other eye drops or medications such as acetylcholine chloride ( miochol ) and carbachol ( carboptic , isopto carbachol ) may decrease the effects of suprofen ophthalmic .
sympathomimetic pressor amines	monoamine oxidase inhibitors	effect	mao inhibitors : the pressor effect of sympathomimetic pressor amines is markedly potentiated in patients receiving monoamine oxidase inhibitors ( maoi ) .
paricalcitol	ketoconazole	advise	a multiple dose drug drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol auc0 . since paricalcitol is partially metabolized by cyp3a and ketoconazole le is known to be a strong inhibitor of cytochrome p450 3a enzyme , care should be taken while dosing paricalcitol with ketoconazole and other strong p450 3a inhibitors including atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin or voriconazole .
paricalcitol	nefazodone	advise	a multiple dose drug drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol auc0 . since paricalcitol is partially metabolized by cyp3a and ketoconazole le is known to be a strong inhibitor of cytochrome p450 3a enzyme , care should be taken while dosing paricalcitol with ketoconazole and other strong p450 3a inhibitors including atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin or voriconazole .
paricalcitol	voriconazole	advise	a multiple dose drug drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol auc0 . since paricalcitol is partially metabolized by cyp3a and ketoconazole le is known to be a strong inhibitor of cytochrome p450 3a enzyme , care should be taken while dosing paricalcitol with ketoconazole and other strong p450 3a inhibitors including atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin or voriconazole .
5-FU	ELOXATIN	mechanism	increases of 5-fu plasma concentrations by approximately dg % have been observed with doses of dg mg / m2 eloxatin dosed every dg weeks .
beta blockers	clonidine	advise	if replacing clonidine by beta blocker therapy , the introduction of beta blockers should be delayed for several days after clonidine administration has stopped .
quinidine	pramipexole	mechanism	other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g. , cimetidine , ranitidine , diltiazem , triamterene , verapamil , quinidine , and quinine ) decreases the oral clearance of pramipexole by about dg % , while those secreted by the anionic transport system ( e.g. , cephalosporins , penicillins , indomethacin , hydrochlorothiazide , and chlorpropamide ) are likely to have little effect on the oral clearance of pramipexole .
cephalosporins	pramipexole	mechanism	other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g. , cimetidine , ranitidine , diltiazem , triamterene , verapamil , quinidine , and quinine ) decreases the oral clearance of pramipexole by about dg % , while those secreted by the anionic transport system ( e.g. , cephalosporins , penicillins , indomethacin , hydrochlorothiazide , and chlorpropamide ) are likely to have little effect on the oral clearance of pramipexole .
chlorpropamide	pramipexole	mechanism	other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g. , cimetidine , ranitidine , diltiazem , triamterene , verapamil , quinidine , and quinine ) decreases the oral clearance of pramipexole by about dg % , while those secreted by the anionic transport system ( e.g. , cephalosporins , penicillins , indomethacin , hydrochlorothiazide , and chlorpropamide ) are likely to have little effect on the oral clearance of pramipexole .
VESIcare	ketoconazole	advise	do not exceed a dg mg daily dose of vesicare when administered with therapeutic doses of ketoconazole or other potent cyp3a4 inhibitors .
phenobarbital	montelukast	advise	it is reasonable to employ appropriate clinical monitoring when potent cytochrome p450 enzyme inducers , such as phenobarbital or rifampin , are co administered with montelukast .
azole-type antifungal agents	terfenadine	advise	due to the chemical similarity of other azole-type antifungal agents ( including fluconazole , metronidazole , and miconazole ) to ketoconazole , and itraconazole , concomitant use of these products with terfenadine is not recommended pending full examination of potential interactions .
Tetracycline	penicillin	effect	tetracycline , a bacteriostatic antibiotic , may antagonize the bactericidal effect of penicillin and concurrent use of these drugs should be avoided .
fluvoxamine	anagrelide	mechanism	it is known that cyp1a2 is inhibited by several medicinal products , including fluvoxamine , and such medicinal products could theoretically adversely influence the clearance of anagrelide .
Anagrelide	theophylline	mechanism	anagrelide demonstrates some limited inhibitory activity towards cyp1a2 which may present a theoretical potential for interaction with other coadministered medicinal products sharing that clearance mechanism e.g. theophylline .
Anagrelide	aspirin	effect	anagrelide alone had no effect on platelet aggregation , but did slightly enhance the inhibition of platelet aggregation by aspirin .
alcohol	phentermine hydrochloride	int	concomitant use of alcohol with phentermine hydrochloride may result in an adverse drug interaction .
AGGRASTAT	aspirin	effect	the use of aggrastat , in combination with heparin and aspirin , has been associated with an increase in bleeding compared to heparin and aspirin alone ( see
midazolam	macrolide antibiotics	advise	drug interactions : inhibitors of cyp3a4 isozymes : caution is advised when midazolam is administered concomitantly with drugs that are known to inhibit the cytochrome p450 dg enzyme system ( ie , some drugs in the drug classes of azole antimycotics , protease inhibitors , calcium channel antagonists , and macrolide antibiotics ) .
itraconazole	midazolam	mechanism	drugs such as erythromycin , diltiazem , verapamil , ketoconazole , fluconazole and itraconazole were shown to significantly increase the c max and auc of orally administered midazolam .
cimetidine	opioid analgesics	effect	in addition , cns toxicity has been reported ( confusion , disorientation , respiratory depression , apnea , seizures ) following coadministration of cimetidine with opioid analgesics ;
levomepromazine	opioids	effect	dosages of concomitantly administered opioids should be reduced by approximately half , because levomepromazine amplifies the therapeutic actions and side effects of opioids .
midazolam	fluvoxamine	mechanism	other potentially important drug interactions : benzodiazepines : benzodiazepines metabolized by hepatic oxidation ( e.g. , alprazolam , midazolam , triazolam elc. ) should be used with caution because the clearance of these drugs is likely to be reduced by fluvoxamine .
XENICAL	vitamin E acetate	mechanism	xenical inhibited absorption of a vitamin e acetate supplement by approximately dg % .
Probenecid	meropenem	mechanism	probenecid competes with meropenem for active tubular secretion and thus inhibits the renal excretion of meropenem .
erythromycin	DETROL LA	advise	for patients receiving ketoconazole or other potent cyp3a4 inhibitors such as other azole antifungals ( eg , itraconazole , miconazole ) or macrolide antibiotics ( eg , erythromycin , clarithromycin ) or cyclosporine or vinblastine , the recommended dose of detrol la is dg mg daily .
trimetrexate	rifabutin	effect	agents that might be coadministered with trimetrexate in aids patients for other indications that could elicit this activity include erythromycin , rifampin , rifabutin , ketoconazole , and fluconazole .
cimetidine	trimetrexate	mechanism	in vitro perfusion of isolated rat liver has shown that cimetidine caused a significant reduction in trimetrexate metabolism and that acetaminophen altered the relative concentration of trimetrexate metabolites possibly by competing for sulfate metabolites .
ZOLINZA	HDAC inhibitors	effect	other hdac inhibitors severe thrombocytopenia and gastrointestinal bleeding have been reported with concomitant use of zolinza and other hdac inhibitors ( e.g. , valproic acid ) .
SSRI	TCA	int	the extent to which ssri tca interactions may pose clinical problems will depend on the degree of inhibition , and the pharmacokinetics of the ssri involved .
Imipramine hydrochloride	CNS depressant drugs	effect	imipramine hydrochloride may potentiate the effects of cns depressant drugs .
Anticoagulants	TNKase	effect	anticoagulants ( such as heparin and vitamin k antagonists ) and drugs that alter platelet function ( such as acetylsalicylic acid , dipyridamole , and gp iib / iiia inhibitors ) may increase the risk of bleeding if administered prior to , during , or after tnkase therapy .
nondepolarizing agents	magnesium	int	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as mivacron include certain antibiotics ( e.g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
nondepolarizing agents	anesthetics	int	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as mivacron include certain antibiotics ( e.g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
MIVACRON	quinidine	int	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as mivacron include certain antibiotics ( e.g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
nondepolarizing agents	polymyxins	int	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as mivacron include certain antibiotics ( e.g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
NUROMAX	lithium	effect	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
NUROMAX	magnesium	effect	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
digoxin	COREG	effect	both digoxin and coreg slow av conduction .
clonidine	agents with b-blocking properties	effect	clonidine : concomitant administration of clonidine with agents with b-blocking properties may potentiate blood pressure and heart rate lowering effects .
Nevirapine	rifampin	advise	nevirapine and rifampin should not beadministered concomitantly becausedecreases in nevirapine plasmaconcentrations may reduce the efficacy ofthe drug .
bromocriptine mesylate	pimozide	effect	compounds in these categories result in a decreased efficacy of bromocriptine mesylate : phenothiazines , haloperidol , metoclopramide , pimozide .
probenecid	nitrofurantoin	mechanism	uricosuric drugs , such as probenecid and sulfinpyrazone , can inhibit renal tubular secretion of nitrofurantoin .
tiagabine	phenytoin	mechanism	phenytoin : population pharmacokinetic analyses indicate that tiagabine clearance is dg % greater in patients taking phenytoin with or without other enzyme inducing aeds .
laxative	CAMPTOSAR	effect	it would be expected that laxative use during therapy with camptosar would worsen the incidence or severity of diarrhea , but this has not been studied .
diuretics	adrenergic agonists	effect	concomitant treatment with methylxanthines ( aminophylline , theophylline ) , steroids , or diuretics may potentiate any hypokalemic effect of adrenergic agonists .
neuromuscular blocking agents	phenytoin	effect	the neuromuscular blocking effect of mivacron may be enhanced by drugs that reduce plasma cholinesterase activity ( e.g. , chronically administered oral contraceptives , glucocorticoids , or certain monoamine oxidase inhibitors ) or by drugs that irreversibly inhibit plasma cholinesterase . resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or carbamazepine .
DIFLUCAN	rifampin	advise	depending on clinical circumstances , consideration should be given to increasing the dose of diflucan when it is administered with rifampin .
fluconazole	cisapride	mechanism	a controlled study found that concomitant fluconazole dg mg once daily and cisapride dg mg four times a day yielded a significant increase in cisapride plasma levels and prolongation of qtc interval .
fluconazole	cisapride	advise	the combined use of fluconazole with cisapride is contraindicated .
fluconazole	rifabutin	effect	rifabutin : there have been reports of uveitis in patients to whom fluconazole and rifabutin were coadministered .
midazolam	fluconazole	effect	this effect on midazolam appears to be more pronounced following oral administration of fluconazole than with fluconazole administered intravenously .
DIFLUCAN	glyburide	mechanism	diflucan reduces the metabolism of tolbutamide , glyburide , and glipizide and increases the plasma concentration of these agents .
aspirin	Streptokinase	effect	the addition of aspirin to streptokinase causes a minimal increase in the risk of minor bleeding ( dg % vs. dg % ) , but does not appear to increase the incidence of major bleeding ( see
quinolones	iron	mechanism	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable / buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
Grepafloxacin	caffeine	mechanism	caffeine theobromine grepafloxacin , like other quinolones , may inhibit the metabolism of caffeine and theobromine .
digoxin	perindopril	mechanism	digoxin : a controlled pharmacokinetic study has shown no effect on plasma digoxin concentrations when coadministered with aceon tablets , but an effect of digoxin on the plasma concentration of perindopril / perindoprilat has not been excluded .
ALFENTA	CNS depressants	effect	both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when alfenta is administered in combination with other cns depressants such as barbiturates , tranquilizers , opioids , or inhalation general anesthetics .
rifampicin	isradipine	mechanism	if rifampicin therapy is required , isradipine concentrations and therapeutic effects are likely to be markedly reduced or abolished as a consequence of increased metabolism and higher clearance of isradipine .
rifampicin	isradipine	mechanism	rifampicin : in a study in healthy volunteers , a six day course of rifampicin at dg mg / day followed by a single dg mg dose of isradipine resulted in a reduction in isradipine levels to below detectable limits .
INDOCIN	lithium	mechanism	capsules indocin dg mg t.i.d. produced a clinically relevant elevation of plasma lithium and reduction in renal lithium clearance in psychiatric patients and normal subjects with steady state plasma lithium concentrations .
diflunisal	INDOCIN	advise	therefore , diflunisal and indocin should not be used concomitantly .
Exjade	aluminum	advise	although deferasirox has a lower affinity for aluminum than for iron , exjade should not be taken with aluminum containing antacid preparations .
naproxen sodium	methotrexate	mechanism	naproxen , naproxen sodium and other nsaids have been reported to reduce the tubular secretion of methotrexate in an animal model , possibly increasing the toxicity of methotrexate .
antiparkinsonian drug	amitriptyline	effect	the concurrent use of two or more drugs with anticholinergic activity such as an antipsychotic drug ( eg , chlorpromazine ) , an antiparkinsonian drug ( eg , trihexyphenidyl ) , and / or a tricyclic antidepressant ( eg , amitriptyline ) commonly results in excessive anticholinergic effects , including dry mouth and associated dental complications , blurred vision , and , in patients exposed to high temperature and humidity , hyperpyrexia .
trihexyphenidyl	tricyclic antidepressant	effect	the concurrent use of two or more drugs with anticholinergic activity such as an antipsychotic drug ( eg , chlorpromazine ) , an antiparkinsonian drug ( eg , trihexyphenidyl ) , and / or a tricyclic antidepressant ( eg , amitriptyline ) commonly results in excessive anticholinergic effects , including dry mouth and associated dental complications , blurred vision , and , in patients exposed to high temperature and humidity , hyperpyrexia .
chlorpromazine	amitriptyline	effect	the concurrent use of two or more drugs with anticholinergic activity such as an antipsychotic drug ( eg , chlorpromazine ) , an antiparkinsonian drug ( eg , trihexyphenidyl ) , and / or a tricyclic antidepressant ( eg , amitriptyline ) commonly results in excessive anticholinergic effects , including dry mouth and associated dental complications , blurred vision , and , in patients exposed to high temperature and humidity , hyperpyrexia .
caffeine	phenytoin	advise	based on adult data , lower doses of caffeine may be needed following coadministration of drugs which are reported to decrease caffeine elimination ( e.g. , cimetidine and ketoconazole ) and higher caffeine doses may be needed following coadministration of drugs that increase caffeine elimination ( e.g. , phenobarbital and phenytoin ) .
EQUETROTM	delavirdine	mechanism	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( dg ) , oxcarbazepine , phenytoin ( dg ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( dg ) , ziprasidone , and zonisamide .
EQUETROTM	felbamate	mechanism	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( dg ) , oxcarbazepine , phenytoin ( dg ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( dg ) , ziprasidone , and zonisamide .
EQUETROTM	oxcarbazepine	mechanism	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( dg ) , oxcarbazepine , phenytoin ( dg ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( dg ) , ziprasidone , and zonisamide .
EQUETROTM	Phenytoin	mechanism	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( dg ) , oxcarbazepine , phenytoin ( dg ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( dg ) , ziprasidone , and zonisamide .
EQUETROTM	primidone	mechanism	agents with increased levels in the presence of carbamazepine : equetrotm increases the plasma levels of the following agents : clomipramine hcl , phenytoin ( dg ) , and primidone thus , if a patient has been titrated to a stable dosage on one of the agents in this category , and then begins a course of the treatment with equetrotm , it is reasonable to expect that a dose decrease for the concomitant agent may be necessary .
anti-malarial drugs	carbamazepine	effect	additionally , anti-malarial drugs , such as chloroquine and mefloquine , may antagonize the activity of carbamazepine .
EQUETROTM	isoniazid	mechanism	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( dg ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( dg ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( dg ) , verapamil , zileuton .
L-arginine	sildenafil citrate	effect	sildenafil citrate theoretically , l-arginine supplements taken concomitantly with sildenafil citrate , may potentiate the effects of the drug .
Dimenhydrinate	apomorphine	effect	dimenhydrinate may decrease emetic response to apomorphine .
CRIXIVAN	delavirdine	advise	dose reduction of crixivan to dg mg every dg hours should be considered when taking delavirdine dg mg three times a day .
Indinavir	nevirapine	mechanism	indinavir concentrations may be decreased in the presence of nevirapine .
atorvastatin	CRIXIVAN	advise	use lowest possible dose of atorvastatin with careful monitoring , or consider hmg coa reductase inhibitors that are not primarily metabolized by cyp3a4 , such as pravastatin , fluvastatin , or rosuvastatin in combination with crixivan .
CRIXIVAN	itraconazole	advise	dose reduction of crixivan to dg mg every dg hours is recommended when administering itraconazole concurrently .
Vardenafil	indinavir	advise	vardenafil dose should not exceed a maximum of dg mg in a dg hour period in patients receiving concomitant indinavir therapy .
vitamin D analogues	corticosteroids	mechanism	corticosteroids : a relationship of functional antagonism exists between vitamin d analogues , which promote calcium absorption , and corticosteroids , which inhibit calcium absorption .
Magnesium	vitamin D	advise	magnesium : magnesium containing preparations ( eg , antacids ) may cause hypermagnesemia and should therefore not be taken during therapy with vitamin d by patients on chronic renal dialysis .
thiazides	vitamin D	effect	some reports have shown that the concomitant administration of thiazides with vitamin d causes hypercalcemia .
Ibogaine	morphine	effect	ibogaine attenuates , but dg mc potentiates , the acute locomotor effects of morphine ;
Dexamethasone	EGF	effect	dexamethasone and retinyl acetate similarly inhibit and stimulate egf or insulin induced proliferation of prostatic epithelium .
glucocorticoids	EGF	effect	these results suggest that both dexamethasone and retinyl acetate , and possibly other glucocorticoids and retinoids , may regulate the proliferation of prostate epithelium by a dose dependent modification of the activity of insulin and egf .
retinoids	EGF	effect	these results suggest that both dexamethasone and retinyl acetate , and possibly other glucocorticoids and retinoids , may regulate the proliferation of prostate epithelium by a dose dependent modification of the activity of insulin and egf .
cypermethrin	allopurinol	effect	thus , the results suggest that cypermethrin exposure of rats results in free radical mediated tissue damage , as indicated by elevated cerebral and hepatic lipid peroxidation , which was prevented by allopurinol and vitamin e .
neurotensin	tuftsin	effect	on the contrary , neurotensin and tuftsin were agonists in induction of analgesia .
halothane	ketamine	mechanism	however , halothane anesthetic requirement ( i.e. , mac ) was depressed in a dose dependent fashion as much as dg % dg dg hours and as much as dg % dg dg hours after injection of ketamine , dg mg / kg , im .
ketamine	halothane	mechanism	the half life of ketamine in plasma and brain was longer in the presence of halothane than when ketamine was given alone .
lapatinib	Herceptin	effect	although it was previously reported that lapatinib combined with herceptin improved the progression free survival rate compared with lapatinib alone for patients with herceptin refractory her2 positive metastatic breast cancer , the mechanism is purported to be an antiproliferative effect relating to the synergism of these two agents .
lapatinib	Herceptin	effect	in an in vitro assay , lapatinib induced her2 expression at the cell surface of her2 positive breast cancer cell lines , leading to the enhancement of herceptin mediated adcc .
calcium	nonheme iron	mechanism	in conclusion , we demonstrated an isolated effect of calcium ( as chloride ) on absorption of dg mg of iron provided as nonheme ( as sulfate ) and heme ( as crbc ) iron .
calcium	heme iron	mechanism	in conclusion , we demonstrated an isolated effect of calcium ( as chloride ) on absorption of dg mg of iron provided as nonheme ( as sulfate ) and heme ( as crbc ) iron .
docetaxel	sunitinib	effect	when cells were exposed to docetaxel followed by sunitinib , synergism was observed .
levothyroxine	simeticone	int	the authors report the case of an infant with confirmed congenital hypothyroidism on levothyroxine who experienced a possible drug interaction with simeticone .
AAV2	chondroitin ABC lyase	effect	aav2 mediated retinal transduction is improved by co injection of heparinase iii or chondroitin abc lyase .
ticagrelor	aspirin	effect	the fda has approved ticagrelor ( brilinta astrazeneca ) , an oral antiplatelet drug , for use with low dose aspirin to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome ( acs ) .
dasatinib	paclitaxel	effect	the role of p27 ( kip1 ) in dasatinib enhanced paclitaxel cytotoxicity in human ovarian cancer cells .
dasatinib	paclitaxel	effect	studies with forced expression and sirna knockdown of bcl dg and cdk1 suggest that dasatinib mediated induction of p27 ( kip1 ) enhanced paclitaxel induced apoptosis by negatively regulating bcl dg and cdk1 expression .
glycine	glutamate	effect	the successive application of glycine ( dg or dg mg / kg egg weight ( e.w. ) and glutamate ( dg mg / kg e.w. ) in a dg min interval significantly increased the activation of spontaneous motility of dg day old chick embryos in comparison with the effect of glutamate alone .
Implanon	antiretroviral	effect	implanon failure in an hiv positive woman on antiretroviral therapy resulting in two ectopic pregnancies .
tamoxifen	fluoxetine	advise	it is better to avoid prescribing isoenzyme cyp dg inhibitors to women treated with tamoxifen for breast cancer , especially ssri antidepressants such as paroxetine and fluoxetine .
hemantane	doxycycline	effect	acute administration of hemantane or doxycycline failed to influence locomotion in mice , while their combination normalized motor activity .
Moxifloxacin	sucralfate	mechanism	moxifloxacin and lomefloxacin reacts faster with sucralfate and gelusil in acidic media whereas with erythromycin in basic media and multi minerals in neutral media .
Lomefloxacin	erythromycin	mechanism	moxifloxacin and lomefloxacin reacts faster with sucralfate and gelusil in acidic media whereas with erythromycin in basic media and multi minerals in neutral media .
Lomefloxacin	multi-minerals	mechanism	moxifloxacin and lomefloxacin reacts faster with sucralfate and gelusil in acidic media whereas with erythromycin in basic media and multi-minerals in neutral media .
Rifampin	amprenavir	mechanism	rifampin markedly increases the metabolic clearance of amprenavir , and coadministration is contraindicated .
Amprenavir	rifabutin	mechanism	amprenavir significantly decreases clearance of rifabutin and dg o desacetylrifabutin , and the combination is poorly tolerated .
Amprenavir	rifabutin	mechanism	amprenavir significantly increased the area under the curve at steady state ( auc ( ss ) ) of rifabutin by dg fold and the auc ( ss ) of dg o desacetylrifabutin by dg fold .
Rifampin	amprenavir	mechanism	rifampin significantly decreased the auc ( ss ) of amprenavir by dg % , but amprenavir had no effect on rifampin pharmacokinetics .
iron	cobalt	mechanism	additional iron significantly inhibited the absorption of cobalt in both dietary cobalt treatments .
estradiol	endotoxin	effect	exogenous estradiol also appeared to influence the percentage of endotoxin induced deaths in a dose dependent manner .
fluoxetine	cisapride	mechanism	coadministration of fluoxetine significantly decreased cisapride plasma concentrations .
METH	SCH-23390	effect	using in situ hybridization , we observed that meth caused a rapid and transient dose dependent increase in arc mrna level in the striatum and cortex that was abolished by pretreatment with the specific dopamine d1 receptor antagonist sch-23390 but not by an atypical neuroleptic clozapine .
naloxone	morphine	effect	intraventricular injection of naloxone at doses of dg to dg micrograms equally antagonized in a dose dependent manner the tail flick inhibition induced by intraventricular beta endorphin and morphine .
Diazepam	morphine	effect	diazepam at doses of dg mg / kg and dg mg / kg injected with morphine was found to decrease the antinociceptive effect of morphine .
diazepam	indomethacin	effect	similarly , diazepam decreased the antinociceptive effect of metamizol ( only in the tail flick test ) and indomethacin .
theophylline	phenytoin	mechanism	this report describes two cases in which theophylline clearance accelerated markedly with concomitant phenytoin administration .
Methamphetamine	pargyline	effect	methamphetamine , like mptp , produced depletions of striatal dopamine but these actions were potentiated by pargyline pretreatment .
Vitamin D3	arsenate	mechanism	vitamin d3 administration to rachitic chicks was effective in significantly elevating duodenal arsenate absorption , acting primarily to enhance serosal transport .
sirolimus	diltiazem	mechanism	results : the geometric mean ( dg % confidence interval ) whole blood sirolimus area under the plasma concentration time curve increased dg % ( dg % dg % ) , from dg to dg ng x h / ml , and maximum concentration increased dg % ( dg % dg % ) , from dg to dg ng / ml , with diltiazem coadministration , whereas the mean elimination half life of sirolimus decreased slightly , from dg to dg hours .
Morphine	ADL 8-2698	effect	morphine prolonged gastrointestinal transit time from dg to dg minutes ( p = .005 ) ; this was prevented by adl 8-2698 ( p = .004 ) .
fluvoxamine	tolbutamide	mechanism	results : during treatment with fluvoxamine , there was a statistically significant decrease in the median of the total clearance of tolbutamide , from dg ml / h to dg ml / h , among the volunteers who received dg mg / d .
SUTENT	indinavir	mechanism	co administration of sutent with strong inhibitors of the cyp3a4 family ( e.g. , ketoconazole , itraconazole , clarithromycin , atazanavir , indinavir , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , voriconizole ) may increases sunitinib concentrations .
anticoagulant	paraldehyde	effect	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under dosage .
anticoagulant	vitamin C	effect	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under dosage .
anticoagulant	allopurinol	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
anticoagulant	disulfiram	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
anticoagulant	anesthetics	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
anticoagulant	triclofos sodium	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
anticoagulant	trimethoprim	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
anticoagulant	sulfamethoxazole	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
anticoagulants	tolbutamide	mechanism	oral anticoagulants may potentiate the hypoglycemic action of hypoglycemic agents , eg , tolbutamide and chlorpropamide , by inhibiting their metabolism in the liver .
anticoagulants	chlorpropamide	mechanism	oral anticoagulants may potentiate the hypoglycemic action of hypoglycemic agents , eg , tolbutamide and chlorpropamide , by inhibiting their metabolism in the liver .
Melatonin	progestin	int	melatonin may interact with the following drugs : aspirin and other nsaids ( may lower melatonin levels ) , fluvoxamine ( bioavailability of oral melatonin is increased with coadministration ) , beta blockers ( may decrease melatonin levels ) , fluoxetine ( reports of psychotic episodes when coadministered ) , progestin ( coadministration of melatonin with progestin can inhibit ovarian function in women ) , benzodiazepenes and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects ) , and corticosteroids ( coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids ) .
terbinafine	warfarin	effect	there have been spontaneous reports of increase or decrease in prothrombin times in patients concomitantly taking oral terbinafine and warfarin , however , a causal relationship between lamisil tablets and these changes has not been established .
metoclopramide	Permax	advise	dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthines ) or metoclopramide , ordinarily should not be administered concurrently with permax ( a dopamine agonist ) ;
metoclopramide	monoamine oxi-dase inhibitors	advise	the finding that metoclopramide releases catecholamines in patients with essential hypertension suggests that it should be used cautiously , if at all , in patients receiving monoamine oxi-dase inhibitors .
phenytoin	corticosteroid	mechanism	drugs that induce hepatic enzymes such as phenobarbital , phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response .
troleandomycin	corticosteroids	mechanism	drugs such as troleandomycin and ketoconazole may inhibit the metabolism of corticosteroids and thus decrease their clearance .
ketoconazole	retapamulin	mechanism	co administration of oral ketoconazole dg mg twice daily increased retapamulin geometric mean auc ( dg dg ) and cmax by dg % after topical application of retapamulin ointment , dg % on the abraded skin of healthy adult males .
Methscopolamine	tricyclic	int	methscopolamine may interact with antidepressants ( tricyclic type ) , mao inhibitors ( e.g. , phenelzine , linezolid , tranylcypromine , isocarboxazid , selegiline , furazolidone ) , quinidine , amantadine , antihistamines ( e.g. , diphenhydramine ) , other anticholinergics , potassium chloride supplements , antacids , absorbent type anti diarrhea medicines ( e.g. , kaolin pectin ) , phenothiazines ( e.g. , chlorpromazine , promethazine ) .
Methscopolamine	pectin	int	methscopolamine may interact with antidepressants ( tricyclic type ) , mao inhibitors ( e.g. , phenelzine , linezolid , tranylcypromine , isocarboxazid , selegiline , furazolidone ) , quinidine , amantadine , antihistamines ( e.g. , diphenhydramine ) , other anticholinergics , potassium chloride supplements , antacids , absorbent type anti diarrhea medicines ( e.g. , kaolin pectin ) , phenothiazines ( e.g. , chlorpromazine , promethazine ) .
Methscopolamine	linezolid	int	methscopolamine may interact with antidepressants ( tricyclic type ) , mao inhibitors ( e.g. , phenelzine , linezolid , tranylcypromine , isocarboxazid , selegiline , furazolidone ) , quinidine , amantadine , antihistamines ( e.g. , diphenhydramine ) , other anticholinergics , potassium chloride supplements , antacids , absorbent type anti diarrhea medicines ( e.g. , kaolin pectin ) , phenothiazines ( e.g. , chlorpromazine , promethazine ) .
TRENTAL	platelet aggregation inhibitors	effect	although a causal relationship has not been established , there have been reports of bleeding and / or prolonged prothrombin time in patients treated with trental with and without anticoagulants or platelet aggregation inhibitors .
phenobarbital	mifepristone	mechanism	john s wort , and certain anticonvulsants ( phenytoin , phenobarbital , carbamazepine ) may induce mifepristone metabolism ( lowering serum levels of mifepristone ) .
anticonvulsants	mifepristone	mechanism	john s wort , and certain anticonvulsants ( phenytoin , phenobarbital , carbamazepine ) may induce mifepristone metabolism ( lowering serum levels of mifepristone ) .
CYLERT	antiepileptic medications	effect	decreased seizure threshold has been reported in patients receiving cylert concomitantly with antiepileptic medications .
methylergonovine maleate	vasoconstrictors	advise	caution should be exercised when methergine ( methylergonovine maleate ) is used concurrently with other vasoconstrictors or ergot alkaloids .
Phenothiazines	anesthetics	effect	phenothiazines are capable of potentiating cns depressants ( e.g. , barbiturates , anesthetics , opiates , alcohol , etc . )
pantoprazole	iron	mechanism	because of profound and long lasting inhibition of gastric acid secretion , pantoprazole may interfere with absorption of drugs where gastric ph is an important determinant of their bioavailability ( eg , ketoconazole , ampicillin esters , and iron salts ) .
Sulfoxone	barbiturates	effect	sulfoxone may increase the effects of barbiturates , tolbutamide , and uricosurics .
Sulfoxone	uricosurics	effect	sulfoxone may increase the effects of barbiturates , tolbutamide , and uricosurics .
thiabendazole	xanthine derivatives	advise	therefore , when concomitant use of thiabendazole and xanthine derivatives is anticipated , it may be necessary to monitor blood levels and / or reduce the dosage of such compounds .
Cyclophosphamide	Cerubidine	effect	cyclophosphamide used concurrently with cerubidine may also result in increased cardiotoxicity .
Methysergide	narcotic analgesics	effect	methysergide may reverse the analgesic activity of narcotic analgesics .
Thiamine	Contraceptives	int	interactions for vitamin b1 ( thiamine ) : loop diuretics , oral contraceptives , stavudine , tricyclic antidepressants
riboflavin	probenecid	effect	requirements for riboflavin may be increased in patients receiving probenecid .
levonorgesterol	mycophenolate mofetil	mechanism	however , in a drug drug interaction study , mean levonorgesterol auc was decreased by dg % when coadministered with mycophenolate mofetil .
roxithromycin	terfenadine	advise	although such a reaction has not been demonstrated with roxithromycin , concomitant administration of roxithromycin with terfenadine or astemizole is not recommended .
tetracyclines	iron	mechanism	absorption of tetracyclines is impaired by antacids containing aluminum , calcium or magnesium , and iron containing preparations .
Sanctura	procainamide	mechanism	drugs eliminated by active tubular secretion : although studies to assess drug drug interactions with sanctura have not been conducted , sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion ( e.g. digoxin , procainamide , pancuronium , morphine , vancomycin , metformin and tenofovir ) .
mazindol	phenelzine	advise	you can not take mazindol if you have taken a monoamine oxidase inhibitor ( maoi ) such as isocarboxazid ( marplan ) , tranylcypromine ( parnate ) , or phenelzine ( nardil ) in the last dg days .
sumatriptan succinate	MAO-A inhibitors	advise	therefore , the use of sumatriptan succinate tablets in patients receiving mao-a inhibitors is contraindicated . selective serotonin reuptake inhibitors ( ssris ) ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with sumatriptan .
mercaptopurine	TABLOID	effect	there is usually complete cross resistance between purinethol ( mercaptopurine ) and tabloid brand thioguanine .
ethoxzolamide	corticosteroids	effect	coadministration of ethoxzolamide with other diuretics , amphotericin b , and corticosteroids may cause hypokalemia .
Cevimeline	beta adrenergic antagonists	advise	cevimeline should be administered with caution to patients taking beta adrenergic antagonists , because of the possibility of conduction disturbances .
bosentan	cyclosporine A	mechanism	steady state bosentan plasma concentrations were dg to dg fold higher than in the absence of cyclosporine a .
tacrolimus	bosentan	advise	caution should be exercised if tacrolimus and bosentan are used together .
Bosentan	lovastatin	mechanism	bosentan is also expected to reduce plasma concentrations of other statins that have significant metabolism by cyp3a4 , such as lovastatin and atorvastatin .
Bosentan	atorvastatin	mechanism	bosentan is also expected to reduce plasma concentrations of other statins that have significant metabolism by cyp3a4 , such as lovastatin and atorvastatin .
esomeprazole	digoxin	mechanism	therefore , esomeprazole may interfere with the absorption of drugs where gastric ph is an important determinant of bioavailability ( eg , ketoconazole , iron salts and digoxin ) .
anticoagulant	Bezalip	advise	for this reason , the dose of the anticoagulant should be reduced by dg dg % at the start of treatment with bezalip or bezalip retard and then titrated according to the blood clotting parameters
Cyclopentolate	pilocarpine	effect	cyclopentolate may interfere with the anti glaucoma action of carbachol or pilocarpine ;
lithium	TORADOL	mechanism	the effect of toradol on plasma lithium has not been studied , but cases of increased lithium plasma levels during toradol therapy have been reported .
salicylate	ketorolac	mechanism	in vitro studies indicate that , at therapeutic concentrations of salicylate ( dg m g / ml ) , the binding of ketorolac was reduced from approximately dg % to dg % , representing a potential twofold increase in unbound ketorolac plasma levels .
mercaptopurine	Thioguanine	effect	there is usually complete cross resistance between purinethol ( mercaptopurine ) and tabloid brand thioguanine .
Zemplar	ketoconazole	advise	dose adjustment of zemplar capsules may be required , and ipth and serum calcium concentrations should be closely monitored if a patient initiates or discontinues therapy with a strong cyp3a4 inhibitor such as ketoconazole .
Beta blockers	clonidine	effect	beta blockers may exacerbate the rebound hypertension which can follow the withdrawal of clonidine .
sirolimus	MYCAMINE	advise	patients receiving sirolimus or nifedipine in combination with mycamine should be monitored for sirolimus or nifedipine toxicity and sirolimus or nifedipine dosage should be reduced if necessary .
neuroleptics	MIRAPEX	effect	dopamine antagonists : since pramipexole is a dopamine agonist , it is possible that dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of mirapex .
phenothiazines	MIRAPEX	effect	dopamine antagonists : since pramipexole is a dopamine agonist , it is possible that dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of mirapex .
triamterene	pramipexole	mechanism	other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g. , cimetidine , ranitidine , diltiazem , triamterene , verapamil , quinidine , and quinine ) decreases the oral clearance of pramipexole by about dg % , while those secreted by the anionic transport system ( e.g. , cephalosporins , penicillins , indomethacin , hydrochlorothiazide , and chlorpropamide ) are likely to have little effect on the oral clearance of pramipexole .
penicillins	pramipexole	mechanism	other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g. , cimetidine , ranitidine , diltiazem , triamterene , verapamil , quinidine , and quinine ) decreases the oral clearance of pramipexole by about dg % , while those secreted by the anionic transport system ( e.g. , cephalosporins , penicillins , indomethacin , hydrochlorothiazide , and chlorpropamide ) are likely to have little effect on the oral clearance of pramipexole .
methadone	PEG-Intron	mechanism	in a pharmacokinetic study of dg chronic hepatitis c patients concomitantly receiving methadone , treatment with peg-intron once weekly for dg weeks was associated with a mean increase of dg % in methadone auc ;
terfenadine	itraconazole	mechanism	itraconazole : torsades de pointes and elevated parent terfenadine levels have been reported during concomitant use of terfenadine and itraconazole in clinical trials of itraconazole and from foreign post marketing sources .
opioids	pegvisomant	mechanism	in clinical studies , patients on opioids often needed higher serum pegvisomant concentrations to achieve appropriate igf i suppression compared with patients not receiving opioids .
Monoamine oxidase inhibitors	sympathomimetic amines	effect	monoamine oxidase inhibitors or tricyclic antidepressants may potentiate the action of sympathomimetic amines .
olprinone	anagrelide	effect	the effects of medicinal products with similar properties such as inotropes milrinone , enoximone , amrinone , olprinone and cilostazol may be exacerbated by anagrelide .
midazolam	calcium channel antagonists	advise	drug interactions : inhibitors of cyp3a4 isozymes : caution is advised when midazolam is administered concomitantly with drugs that are known to inhibit the cytochrome p450 dg enzyme system ( ie , some drugs in the drug classes of azole antimycotics , protease inhibitors , calcium channel antagonists , and macrolide antibiotics ) .
verapamil	midazolam	mechanism	drugs such as erythromycin , diltiazem , verapamil , ketoconazole , fluconazole and itraconazole were shown to significantly increase the c max and auc of orally administered midazolam .
VERSED Syrup	ketamine	effect	the sedative effect of versed syrup is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly narcotics ( eg , morphine , meperidine and fentanyl ) , propofol , ketamine , nitrous oxide , secobarbital and droperidol .
VERSED Syrup	nitrous oxide	effect	the sedative effect of versed syrup is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly narcotics ( eg , morphine , meperidine and fentanyl ) , propofol , ketamine , nitrous oxide , secobarbital and droperidol .
VERSED Syrup	secobarbital	effect	the sedative effect of versed syrup is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly narcotics ( eg , morphine , meperidine and fentanyl ) , propofol , ketamine , nitrous oxide , secobarbital and droperidol .
levomepromazine	barbiturates	effect	additive sedative effects and confusional states may emerge if levomepromazine is given with benzodiazepines or barbiturates .
amphetamine	levomepromazine	effect	caffeine and / or stimulantes of the ephedrine / amphetamine type may counteract the specific actions of levomepromazine .
ascorbic acid	bishydroxycoumarin	mechanism	limited evidence suggests that ascorbic acid may influence the intensity and duration of action of bishydroxycoumarin .
Benzodiazepines	fluvoxamine	mechanism	other potentially important drug interactions : benzodiazepines : benzodiazepines metabolized by hepatic oxidation ( e.g. , alprazolam , midazolam , triazolam elc. ) should be used with caution because the clearance of these drugs is likely to be reduced by fluvoxamine .
fluvoxamine maleate	warfarin	mechanism	warfarin : when fluvoxamine maleate ( dg mg tid ) was administered concomitantly with warfarin for two weeks , warfarin plasma concentrations increased by dg % and prothrombin times were prolonged .
anticoagulants	Fluvoxamine	advise	thus patients receiving oral anticoagulants and fluvoxamine tablets should have their prothrombin time monitored and their anticoagulant dose adjusted accordingly .
Fluvoxamine	MAOIs	advise	therefore , it is recommended that fluvoxamine tablets not be used in combination with maois , or within dg days of discontinuing treatment with a maoi .
astemizole	ketoconazole	mechanism	terfenadine , astemizole and cisapride are all metabolized by the cytochrome p450iiia4 isozyme , and it has been demonstrated that ketoconazole , a potent inhibitor of iiia4 , blocks the metabolism of these drugs , resulting in increased plasma concentrations of parent drug .
beta-carotene	XENICAL	mechanism	fat soluble vitamin supplements and analogues : a pharmacokinetic interaction study showed a dg % reduction in beta-carotene supplement absorption when concomitantly administered with xenical .
miconazole	DETROL LA	advise	for patients receiving ketoconazole or other potent cyp3a4 inhibitors such as other azole antifungals ( eg , itraconazole , miconazole ) or macrolide antibiotics ( eg , erythromycin , clarithromycin ) or cyclosporine or vinblastine , the recommended dose of detrol la is dg mg daily .
trimetrexate	rifampin	effect	agents that might be coadministered with trimetrexate in aids patients for other indications that could elicit this activity include erythromycin , rifampin , rifabutin , ketoconazole , and fluconazole .
ZOLINZA	valproic acid	effect	other hdac inhibitors severe thrombocytopenia and gastrointestinal bleeding have been reported with concomitant use of zolinza and other hdac inhibitors ( e.g. , valproic acid ) .
diphosphonate	Calcitonin (salmon)	effect	however , in patients with paget 's disease prior diphosphonate use appears to reduce the anti resorptive response to calcitonin (salmon) nasal spray .
Scopolamine	sedatives	advise	scopolamine should be used with care in patients taking other drugs that are capable of causing cns effects such as sedatives , tranquilizers , or alcohol .
Trilostane	mitotane	int	trilostane may interact with aminoglutethimide or mitotane ( causing too great a decrease in adrenal function ) .
neuromuscular blocking agents	carbamazepine	effect	the neuromuscular blocking effect of mivacron may be enhanced by drugs that reduce plasma cholinesterase activity ( e.g. , chronically administered oral contraceptives , glucocorticoids , or certain monoamine oxidase inhibitors ) or by drugs that irreversibly inhibit plasma cholinesterase . resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or carbamazepine .
DIFLUCAN	cyclosporine	mechanism	cyclosporine : diflucan may significantly increase cyclosporine levels in renal transplant patients with or without renal impairment .
Rifampin	DIFLUCAN	mechanism	rifampin : rifampin enhances the metabolism of concurrently administered diflucan .
fluconazole	terfenadine	advise	the coadministration of fluconazole at doses lower than dg mg / day with terfenadine should be carefully monitored .
Streptokinase	anticoagulants	effect	use of anticoagulants and antiplatelet agents streptase , streptokinase , alone or in combination with antiplatelet agents and anticoagulants , may cause bleeding complications .
quinolones	calcium	mechanism	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable / buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
procaine hydrochloride	anticholinesterase agents	effect	anticholinesterases : concurrent use of procaine hydrochloride and anticholinesterase agents may result in increased systemic toxicity since anticholinesterases inhibit the breakdown of procaine hydrochloride .
Hyaluronidase	procaine hydrochloride	mechanism	hyaluronidase : hyaluronidase may increase the diffusion rate of procaine hydrochloride , resulting in a decreased time of onset , but an increase in systemic toxicity .
procaine hydrochloride	neuromuscular blocking agents	effect	neuromuscular blocking agents ( such as suxamethonium chloride ) : concurrent use of procaine hydrochloride and neuromuscular blocking agents may result in prolongation or enhancement of the neuromuscular blockade .
diuretics	ACEON	effect	diuretics : patients on diuretics , and especially those started recently , may occasionally experience an excessive reduction of blood pressure after initiation of aceon tablets therapy .
digoxin	perindoprilat	mechanism	digoxin : a controlled pharmacokinetic study has shown no effect on plasma digoxin concentrations when coadministered with aceon tablets , but an effect of digoxin on the plasma concentration of perindopril / perindoprilat has not been excluded .
diuretics	ACEON	advise	if diuretics can not be interrupted , close medical supervision should be provided with the first dose of aceon tablets , for at least two hours and until blood pressure has stabilized for another hour .
Posicor	terfenadine	mechanism	posicor inhibits some of the liver 's ability to metabolize some other drugs terfenadine , astemizole , cisapride , cyclosporine , and tricyclic antidepressants .
Posicor	cisapride	mechanism	posicor inhibits some of the liver 's ability to metabolize some other drugs terfenadine , astemizole , cisapride , cyclosporine , and tricyclic antidepressants .
Posicor	tricyclic antidepressants	mechanism	posicor inhibits some of the liver 's ability to metabolize some other drugs terfenadine , astemizole , cisapride , cyclosporine , and tricyclic antidepressants .
ALFENTA	tranquilizers	effect	both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when alfenta is administered in combination with other cns depressants such as barbiturates , tranquilizers , opioids , or inhalation general anesthetics .
fentanyl	beta blocker	effect	fentanyl anesthesia : severe hypotension has been reported during fentanyl anesthesia with concomitant use of a beta blocker and a calcium channel blocker .
diflunisal	indomethacin	mechanism	in normal volunteers receiving indomethacin , the administration of diflunisal decreased the renal clearance and significantly increased the plasma levels of indomethacin .
INDOCIN	methotrexate	advise	caution should be used if indocin is administered simultaneously with methotrexate .
non-steroidal anti-inflammatory drugs	cyclosporine	effect	administration of non-steroidal anti-inflammatory drugs concomitantly with cyclosporine has been associated with an increase in cyclosporine induced toxicity , possibly due to decreased synthesis of renal prostacyclin .
diuretics	INDOCIN	effect	most of the above effects concerning diuretics have been attributed , at least in part , to mechanisms involving inhibition of prostaglandin synthesis by indocin .
trihexyphenidyl	amitriptyline	effect	the concurrent use of two or more drugs with anticholinergic activity such as an antipsychotic drug ( eg , chlorpromazine ) , an antiparkinsonian drug ( eg , trihexyphenidyl ) , and / or a tricyclic antidepressant ( eg , amitriptyline ) commonly results in excessive anticholinergic effects , including dry mouth and associated dental complications , blurred vision , and , in patients exposed to high temperature and humidity , hyperpyrexia .
antipsychotic drug	amitriptyline	effect	the concurrent use of two or more drugs with anticholinergic activity such as an antipsychotic drug ( eg , chlorpromazine ) , an antiparkinsonian drug ( eg , trihexyphenidyl ) , and / or a tricyclic antidepressant ( eg , amitriptyline ) commonly results in excessive anticholinergic effects , including dry mouth and associated dental complications , blurred vision , and , in patients exposed to high temperature and humidity , hyperpyrexia .
chlorpromazine	antiparkinsonian drug	effect	the concurrent use of two or more drugs with anticholinergic activity such as an antipsychotic drug ( eg , chlorpromazine ) , an antiparkinsonian drug ( eg , trihexyphenidyl ) , and / or a tricyclic antidepressant ( eg , amitriptyline ) commonly results in excessive anticholinergic effects , including dry mouth and associated dental complications , blurred vision , and , in patients exposed to high temperature and humidity , hyperpyrexia .
quinidine	flecainide	mechanism	drugs that inhibit cytochrome p450iid6 , such as quinidine , might increase the plasma concentrations of flecainide in patients that are on chronic flecainide therapy ;
TAMBOCOR	propranolol	mechanism	in a study involving healthy subjects receiving tambocor and propranolol concurrently , plasma flecainide levels were increased about dg % and propranolol levels were increased about dg % compared to control values .
caffeine	cimetidine	advise	based on adult data , lower doses of caffeine may be needed following coadministration of drugs which are reported to decrease caffeine elimination ( e.g. , cimetidine and ketoconazole ) and higher caffeine doses may be needed following coadministration of drugs that increase caffeine elimination ( e.g. , phenobarbital and phenytoin ) .
Boric acid	idoxuridine	mechanism	boric acid may interact with the idoxuridine preparation causing a gritty substance to form or may interact with the preservative in the idoxuridine preparation causing a toxic effect in the eye .
EQUETROTM	quetiapine	mechanism	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( dg ) , oxcarbazepine , phenytoin ( dg ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( dg ) , ziprasidone , and zonisamide .
EQUETROTM	tiagabine	mechanism	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( dg ) , oxcarbazepine , phenytoin ( dg ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( dg ) , ziprasidone , and zonisamide .
EQUETROTM	buspirone	mechanism	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( dg ) , oxcarbazepine , phenytoin ( dg ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( dg ) , ziprasidone , and zonisamide .
EQUETROTM	valproate	mechanism	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( dg ) , oxcarbazepine , phenytoin ( dg ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( dg ) , ziprasidone , and zonisamide .
EQUETROTM	clobazam	mechanism	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( dg ) , oxcarbazepine , phenytoin ( dg ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( dg ) , ziprasidone , and zonisamide .
EQUETROTM	Acetazolamide	mechanism	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( dg ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( dg ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( dg ) , verapamil , zileuton .
EQUETROTM	cimetidine	mechanism	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( dg ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( dg ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( dg ) , verapamil , zileuton .
EQUETROTM	troleandomycin	mechanism	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( dg ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( dg ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( dg ) , verapamil , zileuton .
EQUETROTM	dalfopristin	mechanism	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( dg ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( dg ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( dg ) , verapamil , zileuton .
tricyclic antidepressants	cimetidine	mechanism	increases in plasma levels of tricyclic antidepressants , and in the frequency and severity of side effects , particularly anticholinergic , have been reported when cimetidine was added to the drug regimen .
ethchlorvynol	amitriptyline HCl	effect	transient delirium has been reported in patients who were treated with one gram of ethchlorvynol and dg dg mg of amitriptyline hcl .
estradiol	noradrenaline	effect	endothelium intact aortic rings from high estradiol rats were supersensitive to noradrenaline when compared to vehicle , progesterone and progesterone + high estradiol treated rats ( pd2 values = 7.77+ / dg , 7.21+ / dg , 6.93+ / dg and 7.22+ / dg , respectively ) .
Barbiturates	coumarin drugs	advise	barbiturates and glutethimide should not be administered to patients receiving coumarin drugs .
ethanol	acetaldehyde	effect	these results suggest that the hepatoxicity of ethanol in alcoholic beverages is enhanced by interaction with its congeners and acetaldehyde ;
phenobarbital	acetaminophen	effect	coingestion of acetaminophen with theophylline , phenobarbital with acetaminophen , and valproic acid with phenobarbital at high to toxic concentrations decreases the binding of the target drug .
Rifampin	warfarin	int	rifampin and warfarin : a drug interaction .
rifampin	warfarin	mechanism	withdrawal of rifampin decreased the warfarin requirement by dg % .
retinyl acetate	insulin	effect	these results suggest that both dexamethasone and retinyl acetate , and possibly other glucocorticoids and retinoids , may regulate the proliferation of prostate epithelium by a dose dependent modification of the activity of insulin and egf .
trovafloxacin	morphine	mechanism	previous studies have demonstrated a significant reduction in the oral bioavailability of trovafloxacin and ciprofloxacin when administered concomitantly with an intravenous opiate such as morphine .
ciprofloxacin	opiate	mechanism	previous studies have demonstrated a significant reduction in the oral bioavailability of trovafloxacin and ciprofloxacin when administered concomitantly with an intravenous opiate such as morphine .
4-methylpyrazole	1,3-difluoro-2-propanol	effect	we conclude that the prophylactic and antidotal properties of 4-methylpyrazole seen in animals treated with 1,3-difluoro-2-propanol derive from its capacity to inhibit the nad+ dependent oxidation responsible for converting 1,3-difluoro-2-propanol to dg , dg difluoroacetone in the committed step of the toxic pathway .
Cypermethrin	allopurinol	effect	cypermethrin induced oxidative stress in rat brain and liver is prevented by vitamin e or allopurinol .
cypermethrin	Vitamin E	effect	thus , the results suggest that cypermethrin exposure of rats results in free radical mediated tissue damage , as indicated by elevated cerebral and hepatic lipid peroxidation , which was prevented by allopurinol and vitamin e .
N-methyllevallorphan	loperamide	effect	n-methyllevallorphan ( dg mg / kg , s.c. ) completely antagonized the inhibitory effect of loperamide and partly antagonized the effect of morphine .
neurotensin	enkephalins	effect	interaction on the antinociceptive effect between neurotensin and enkephalins or tuftsin .
Verapamil	bombesin	effect	verapamil also significantly decreased the incidence of lymphatic invasion of adenocarcinomas , which was enhanced by bombesin .
clopidogrel	esomeprazole	advise	regulatory agencies state that the combination of clopidogrel and the cyp2c19 inhibitors omeprazole and esomeprazole should be avoided .
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine	effect	in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine / vehicle treated animals , almost dg % loss of tyrosine hydroxylase positive norepinephrine neurons was found in locus coeruleus / a5 / a7 noradrenaline cell groups , whereas the extent of neuronal loss was lower than dg % of control values in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine / 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine treated monkeys .
cinacalcet	darbepoetin	effect	reduction of pth by cinacalcet is associated with a decrease in darbepoetin requirement .
calcium	iron	mechanism	however , the evidence for a calcium effect on iron absorption mainly comes from studies that did not isolate the effect of calcium from that of other dietary components , because it was detected in single meal studies .
PGF2alpha	oxytocin	effect	there is thus an enhancement effect of pgf2alpha upon the reaction of placental vessels to oxytocin in vitro .
ABT-737	DZNep	effect	in addition , dznep insensitivity might be associated with overexpression of bcl dg , and the combination of abt-737 and dznep could synergistically induced apoptosis .
quinidine	precocene I	effect	furafylline and sulfaphenazole had no effect , while quinidine appeared to augment precocene i toxicity .
Brilinta	aspirin	effect	the fda has approved ticagrelor ( brilinta astrazeneca ) , an oral antiplatelet drug , for use with low dose aspirin to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome ( acs ) .
dasatinib	paclitaxel	effect	treatment of hey xenograft bearing mice with dasatinib plus paclitaxel inhibited tumor growth more than treatment with either agent alone ( average tumor volume per mouse , dasatinib + paclitaxel vs paclitaxel : dg vs. dg cm3 , difference = dg cm3 , dg % confidence interval [ ci ] = dg to dg cm3 , p = .014 ) ;
dasatinib	paclitaxel	effect	inhibition of src family and abl kinases with either sirnas or dasatinib enhances paclitaxel sensitivity of ovarian cancer cells through p27 ( kip1 ) mediated suppression of bcl dg and cdk1 expression .
antidepressant	tamoxifen	advise	if in certain cases , an antidepressant is considered necessary , it may be advisable to replace tamoxifen with anastrozole .
Ticlopidine	ketamine	mechanism	ticlopidine treatment increased the mean area under the plasma concentration time curve extrapolated to infinity ( auc ( dg ) ) of oral ketamine by dg fold , whereas itraconazole treatment did not increase the exposure to s ketamine .
Warfarin	citalopram	effect	warfarin users who initiated citalopram , fluoxetine , paroxetine , amitriptyline , or mirtazapine had an increased risk of hospitalization for gastrointestinal bleeding .
Warfarin	fluoxetine	effect	warfarin users who initiated citalopram , fluoxetine , paroxetine , amitriptyline , or mirtazapine had an increased risk of hospitalization for gastrointestinal bleeding .
Warfarin	paroxetine	effect	warfarin users had an increased odds ratio of gastrointestinal bleeding upon initiation of citalopram ( or = dg [ dg % ci , dg dg ] ) , fluoxetine ( or = dg [ dg % ci , dg dg ] ) , paroxetine ( or = dg [ dg % ci , dg dg ] ) , amitriptyline ( or = dg [ dg % ci , dg dg ] ) .
Warfarin	amitriptyline	effect	warfarin users had an increased odds ratio of gastrointestinal bleeding upon initiation of citalopram ( or = dg [ dg % ci , dg dg ] ) , fluoxetine ( or = dg [ dg % ci , dg dg ] ) , paroxetine ( or = dg [ dg % ci , dg dg ] ) , amitriptyline ( or = dg [ dg % ci , dg dg ] ) .
Moxifloxacin	erythromycin	mechanism	moxifloxacin and lomefloxacin reacts faster with sucralfate and gelusil in acidic media whereas with erythromycin in basic media and multi minerals in neutral media .
Moxifloxacin	multi-minerals	mechanism	moxifloxacin and lomefloxacin reacts faster with sucralfate and gelusil in acidic media whereas with erythromycin in basic media and multi-minerals in neutral media .
Amprenavir	25-O-desacetylrifabutin	mechanism	amprenavir significantly increased the area under the curve at steady state ( auc ( ss ) ) of rifabutin by dg fold and the auc ( ss ) of 25-o-desacetylrifabutin by dg fold .
naloxone	morphine	effect	the doses of naloxone required to antagonize the effects of ( ) nanm were more than dg times higher than those required to antagonize the effects of morphine .
estradiol	endotoxin	mechanism	the serum estrogen concentrations of estradiol + endotoxin treated rats decreased by dg % , while those of the endotoxin treated rats increased ( dg to dg fold ) .
Etofibrate	heparin	effect	etofibrate elicited dg % enhancement of post heparin lipolytic activity and dg % increase of 3h triglyceride fractional clearance rate compared with placebo treatment .
clindamycin	gentamicin	int	interaction of clindamycin and gentamicin in vitro .
trichlorfon	coumaphos	effect	the treatment of ewes with an intravenous ( iv ) injection of trichlorfon , insufficient to produce significant inhibition of erythrocyte acetylcholinesterase ( ache ) activity , appeared to produce additive effects with those produced by subsequent treatment with dg mg of coumaphos / kg / day .
phenobarbital sodium	coumaphos	effect	in ewes given dg mg of phenobarbital sodium / kg for dg days intraperitoneally ( ip ) , the anticholinesterase effect of dg mg of coumaphos / kg was significantly reduced and signs of toxicity were not present .
theophylline	CGS21680	effect	however , the antagonism of the theophylline induced anxiogenic effects by cgs21680 was only observed in the time spent in the light zone , and dpcpx induced anxiogenic effects were neither reversed by cgs dg nor by cpa .
amiodarone	digoxin	mechanism	during amiodarone administration , systemic clearance of digoxin was reduced from dg + / dg ml / min ( mean + / standard deviation ) to dg + / dg ml / min ( p less than dg ) .
Midazolam	indomethacin	effect	midazolam used at doses of dg mg / kg and dg mg / kg decreased the antinociceptive effect of morphine , metamizol ( only in the tail flick test ) and indomethacin .
MPTP	pargyline	effect	it was observed that mptp induced long lasting depletions of striatal dopamine concentrations and this neurotoxic effect could be prevented by pargyline pretreatment .
MPTP	amphetamine	effect	the mptp induced neuronal damage produced a tolerance to the disruptive effects of amphetamine and a supersensitivity to the disruptive effects of apomorphine in rats responding in a schedule controlled paradigm .
indinavir	didanosine	mechanism	concurrent administration of indinavir and didanosine significantly reduces the level of exposure to indinavir , but it is unclear how soon after didanosine administration indinavir may be given safely .
indinavir	didanosine	mechanism	median gastric ph was significantly higher when indinavir was taken after didanosine administration ;
ofloxacin	KRM-1648	effect	when combined with ofloxacin , krm-1648 exhibited strong synergistic activity while only additive effects were observed with the combination of rifampicin ( or rifabutin ) and ofloxacin .
diltiazem	sirolimus	mechanism	pharmacokinetic interaction between single oral doses of diltiazem and sirolimus in healthy volunteers .
ADL 8-2698	morphine	effect	adl 8-2698 , a trans dg , dg dimethyl dg ( dg hydroxyphenyl ) piperidine , prevents gastrointestinal effects of intravenous morphine without affecting analgesia .
99mTc-methylene diphosphonate	gentamicin	effect	therapeutic drug monitoring can avoid iatrogenic alterations caused by 99mtc-methylene diphosphonate ( mdp ) gentamicin interaction .
cocaine	norepinephrine	effect	the uptake inhibitors cocaine and desipramine ( dg mumol / liter ) potentiated the positive inotropic effects of norepinephrine in nonfailing myocardium ( p < dg ) but not in functional class iv myocardium .
PROLEUKIN	interferon-alfa	effect	hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose proleukin and antineoplastic agents , specifically , dacarbazine , cis platinum , tamoxifen and interferon-alfa .
Gleevec	ketoconazole	advise	drugs that may alter imatinib plasma concentrations drugs that may increase imatinib plasma concentrations : caution is recommended when administering gleevec with inhibitors of the cyp3a4 family ( e.g. , ketoconazole , itraconazole , erythromycin , clarithromycin ) .
Gleevec	dihydropyridine calcium channel blockers	mechanism	gleevec will increase plasmaconcentration of other cyp3a4 metabolized drugs ( e.g. , triazolo benzodiazepines , dihydropyridine calcium channel blockers , certain hmg coa reductase inhibitors , etc. ) .
Gleevec	ketoconazole	mechanism	there is a significant increase in exposure to imatinib when gleevec is coadministered with ketoconazole ( cyp3a4 inhibitor ) .
rifampin	Gleevec	mechanism	pretreatment of healthy volunteers with multiple doses of rifampin followed by a single dose of gleevec , increased gleevec oral dose clearance by dg fold , which significantly ( p dg ) decreased mean cmax and auc ( dg dg ) .
Gleevec	simvastatin	mechanism	drugs that may have their plasma concentration altered by gleevec gleevec increases the mean cmax and auc of simvastatin ( cyp3a4 substrate ) dg and dg fold , respectively , suggesting an inhibition of the cyp3a4 by gleevec .
Gleevec	pimozide	advise	particular caution is recommended when administering gleevec with cyp3a4 substrates that have a narrow therapeutic window ( e.g. , cyclosporine or pimozide ) .
amantadine	central nervous system stimulants	advise	careful observation is required when amantadine is administered concurrently with central nervous system stimulants .
fibrate	lovastatin	effect	fulminant rhabdomyolysis has been seen as early as three weeks after initiation of combined therapy with another fibrate and lovastatin but may be seen after several months .
ciprofloxacin	antacids	advise	this time window is different than for other oral formulations of ciprofloxacin , which are usually administered dg hours before or dg hours after antacids .
methotrexate	ciprofloxacin	mechanism	methotrexate renal tubular transport of methotrexate may be inhibited by concomitant administration of ciprofloxacin , potentially leading to increased plasma levels of methotrexate .
methotrexate	ciprofloxacin	advise	therefore , patients under methotrexate therapy should be carefully monitored when concomitant ciprofloxacin therapy is indicated .
ciprofloxacin	zinc	mechanism	multivalent cation containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation containing products such as magnesium or aluminum antacids , sucralfate , videx chewable / buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
quinolone	antacids	mechanism	multivalent cation containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation containing products such as magnesium or aluminum antacids , sucralfate , videx chewable / buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
quinolone	sucralfate	mechanism	multivalent cation containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation containing products such as magnesium or aluminum antacids , sucralfate , videx chewable / buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
pimozide	saquinavir	mechanism	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
alfentanyl	saquinavir	mechanism	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
quinidine	saquinavir	mechanism	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
warfarin	saquinavir	mechanism	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
phenytoin	saquinavir	mechanism	coadministration with compounds that are potent inducers of cyp3a4 ( eg , phenobarbital , phenytoin , dexamethasone , carbamazepine ) may result in decreased plasma levels of saquinavir .
alprazolam	psychotropic medications	effect	the benzodiazepines , including alprazolam , produce additive cns depressant effects when co administered with other psychotropic medications , anticonvulsants , antihistaminics , ethanol , and other drugs which themselves produce cns depression .
desipramine	alprazolam	mechanism	the steady state plasma concentrations of imipramine and desipramine have been reported to be increased an average of dg % and dg % , respectively , by the concomitant administration of alprazolam tablets in doses up to dg mg / day .
alprazolam	nicardipine	int	data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following : ergotamine , cyclosporine , amiodarone , nicardipine , and nifedipine .
alprazolam	diltiazem	int	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
alprazolam	erythromycin	int	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
nonsteroial anti-inflammatory drugs	cyclosporine	mechanism	cyclosporine : administration of nonsteroial anti-inflammatory drugs concomitantly with cyclosporine has been associated with an increase in cyclosporine induced toxicity , possibly due to decreased synthesis of renal prostacyclin .
indomethacin	diflunisal	effect	in some patients the combined use of indomethacin and diflunisal has been associated with fatal gastrointestinal hemorrhage .
diflunisal	aspirin	mechanism	aspirin : in normal volunteers , a small decrease in diflunisal levels was observed when multiple doses of diflunisal and aspirin were administered concomitantly .
diflunisal	sulindac	mechanism	sulindac : the concomitant administration of diflunisal and sulindac in normal volunteers resulted in lowering of the plasma levels of the active sulindac sulfide metabolite by approximately one third .
Diflunisal	furosemide	effect	diflunisal decreased the hyperuricemic effect of furosemide .
antacids	diflunisal	mechanism	antacids : concomitant administration of antacids may reduce plasma levels of diflunisal .
bepridil hydrochloride	digoxin	mechanism	digoxin : in controlled studies in healthy volunteers , bepridil hydrochloride either had no effect ( one study ) or was associated with modest increases , about dg % ( two studies ) in steady state serum digoxin concentrations .
ALPHAGAN P	CNS depressants	advise	although specific drug interaction studies have not been conducted with alphagan p , the possibility of an additive or potentiating effect with cns depressants ( alcohol , barbiturates , opiates , sedatives , or anesthetics ) should be considered .
ALPHAGAN P	barbiturates	advise	although specific drug interaction studies have not been conducted with alphagan p , the possibility of an additive or potentiating effect with cns depressants ( alcohol , barbiturates , opiates , sedatives , or anesthetics ) should be considered .
ALPHAGAN P	sedatives	advise	although specific drug interaction studies have not been conducted with alphagan p , the possibility of an additive or potentiating effect with cns depressants ( alcohol , barbiturates , opiates , sedatives , or anesthetics ) should be considered .
HMG-CoA reductase inhibitor	ketoconazole	advise	caution should be exercised if an hmg-coa reductase inhibitor is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones , such as ketoconazole , spironolactone , and cimetidine .
Histamine H2 antagonists	Cimetidine	mechanism	histamine h2 antagonists : cimetidine inhibits cyp3a4 and can increase serum amiodarone levels .
erythromycin	budesonide	advise	if treatment with inhibitors of cyp3a4 activity ( such as ketoconazole , intraconazole , ritonavir , indinavir , saquinavir , erythromycin , etc. ) is indicated , reduction of the budesonide dose should be considered .
coumarin	fondaparinux	mechanism	in an in vitro study in human liver microsomes , inhibition of cyp2a6 hydroxylation of coumarin by fondaparinux ( dg m m m i.e. , dg mg / l ) was dg dg % .
leucovorin	methotrexate	effect	however , high doses of leucovorin may reduce the efficacy of intrathecally administered methotrexate .
aspirin	fenoprofen	mechanism	the coadministration of aspirin decreases the biologic half life of fenoprofen because of an increase in metabolic clearance that results in a greater amount of hydroxylated fenoprofen in the urine .
phenobarbital	fenoprofen	mechanism	chronic administration of phenobarbital , a known enzyme inducer , may be associated with a decrease in the plasma half life of fenoprofen .
Amphetamines	meperidine	effect	meperidine : amphetamines potentiate the analgesic effect of meperidine .
Amphetamines	veratrum alkaloids	effect	veratrum alkaloids : amphetamines inhibit the hypotensive effect of veratrum alkaloids .
d-amphetamine	desipramine	mechanism	d-amphetamine with desipramine or protriptyline and possibly other tricyclics cause striking and sustained increases in the concentration of d-amphetamine in the brain ;
ethambutol	aluminum hydroxide	mechanism	the results of a study of coadministration of ethambutol ( dg mg / kg ) with an aluminum hydroxide containing antacid to dg patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of ethambutol of approximately dg % and dg % , respectively , suggesting that the oral absorption of ethambutol may be reduced by these antacid products .
azole antifungal agents	isoniazid	mechanism	plasma concentrations of azole antifungal agents are reduced when given concurrently with isoniazid .
Itraconazole	hypoglycemic agents	advise	blood glucose concentrations should be carefully monitored when itraconazole and oral hypoglycemic agents are coadministered .
astemizole	itraconazole	advise	based on the chemical resemblance of itraconazole and ketoconazole , coadministration of astemizole with itraconazole is contraindicated .
ketoconazole	cisapride	mechanism	human pharmacokinetics data indicate that oral ketoconazole potently inhibits the metabolism of cisapride resulting in an eight fold increase in the mean auc of cisapride .
thiazide diuretics	digitalis	effect	( concurrent use with thiazide diuretics may enhance the possibility of digitalis toxicity associated with hypokalemia . )
fentanyl	clarithromycin	mechanism	the concomitant use of transdermal fentanyl with ritonavir or other potent dg inhibitors such as ketoconazole , itraconazole , troleandomycin , clarithromycin , nelfinavir , and nefazadone may result in an increase in fentanyl plasma concentrations .
fentanyl	skeletal muscle relaxants	effect	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
fentanyl	alcohol	effect	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
DURAGESIC	MAOI	advise	mao inhibitors : duragesic is not recommended for use in patients who have received maoi within dg days because severe and unpredictable potentiation by mao inhibitors has been reported with opioid analgesics
Tagamet	metronidazole	mechanism	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
lithium	CELEBREX	advise	patients on lithium treatment should be closely monitored when celebrex is introduced or withdrawn .
nonsteroidal anti-inflammatory drugs	ACE inhibitors	int	experience with nonsteroidal anti-inflammatory drugs ( nsaids ) suggests the potential for interactions with furosemide and ace inhibitors .
captopril	diuretic	effect	the possibility of hypotensive effects with captopril can be minimized by either discontinuing the diuretic or increasing the salt intake approximately one week prior to initiation of treatment with captopril ( captopril tablets , usp ) or initiating therapy with small doses ( dg or dg mg ) .
Beta-adrenergic blocking drugs	captopril	effect	beta-adrenergic blocking drugs add some further antihypertensive effect to captopril , but the overall response is less than additive .
indomethacin	captopril	effect	inhibitors of endogenous prostaglandin synthesis it has been reported that indomethacin may reduce the antihypertensive effect of captopril , especially in cases of low renin hypertension .
sulfonylureas	nonsteroidal anti-inflammatory agents	effect	the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
sulfonylureas	salicylates	effect	the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
miconazole	hypoglycemic agents	effect	a potential interaction between oral miconazole and oral hypoglycemic agents leading to severe hypoglycemia has been reported .
methyldopa	sulfapyridine	effect	methyldopa ( e.g. , aldomet ) use of methyldopa with sulfapyridine may increase the chance of side effects affecting the liver and / or the blood
barbiturates	contraceptives	effect	interactions may occur with the following : adrenocorticoids ( cortisone like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
Dexbrompheniramine	anticholinergics	effect	dexbrompheniramine can interact with alcohol or other cns depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
anastrozole	tamoxifen	mechanism	co administration of anastrozole and tamoxifen resulted in a reduction of anastrozole plasma levels by dg % compared with those achieved with anastrozole alone .
COPEGUS	didanosine	advise	nucleoside analogues didanosine co administration of copegus and didanosine is not recommended .
Vardenafil	indinavir	advise	it is recommended not to exceed a single dg mg vardenafil dose in a dg hour period when used in combination with indinavir .
nitrates	vardenafil	mechanism	in vivo studies : nitrates : the blood pressure lowering effects of sublingual nitrates ( dg mg ) taken dg and dg hours after vardenafil and increases in heart rate when taken at dg , dg and dg hours were potentiated by a dg mg dose of vardenafil in healthy middle aged subjects .
INSPRA	NSAIDs	advise	therefore , when inspra and nsaids are used concomitantly , patients should be observed to determine whether the desired effect on blood pressure is obtained .
tricyclic antidepressants	phenothiazines	advise	therefore , co administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme , including other antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( eg , propafenone , flecainide , and encainide ) , or that inhibit this enzyme ( eg , quinidine ) , should be approached with caution .
tricyclic antidepressants	encainide	advise	therefore , co administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme , including other antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( eg , propafenone , flecainide , and encainide ) , or that inhibit this enzyme ( eg , quinidine ) , should be approached with caution .
tricyclic antidepressants	cimetidine	mechanism	in addition , higher than expected steady state serum concentrations of tricyclic antidepressants have been observed when therapy is initiated in patients already taking cimetidine .
reserpine	tricyclic antidepressant	effect	administration of reserpine during therapy with a tricyclic antidepressant has been shown to produce a stimulating effect in some depressed patients .
histamine H2-receptor antagonists	IRESSA	mechanism	drugs that cause significant sustained elevation in gastric ph ( histamine h2-receptor antagonists such as ranitidine or cimetidine ) may reduce plasma concentrations of iressa and therefore potentially may reduce efficacy .
Benzthiazide	lithium	int	benzthiazide may interact with alcohol , blood thinners , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , nsaids like aleve or ibuprofen , and high blood pressure medications .
Benzthiazide	NSAIDs	int	benzthiazide may interact with alcohol , blood thinners , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , nsaids like aleve or ibuprofen , and high blood pressure medications .
ELSPAR	methotrexate	effect	tissue culture and animal studies indicate that elspar can diminish or abolish the effect of methotrexate on malignant cells.14 this effect on methotrexate activity persists as long as plasma asparagine levels are suppressed .
VIOXX	warfarin	effect	in post marketing experience , bleeding events have been reported , predominantly in the elderly , in association with increases in prothrombin time in patients receiving vioxx concurrently with warfarin .
tetracyclines	penicillins	effect	bacteriostatic antibiotics : chloramphenicol , erythromycins , sulfonamides , or tetracyclines may interfere with the bactericidal effect of penicillins .
anileridine	anesthetics	advise	caution should be observed when anileridine is coadministered with other opioids , sedatives , phenothiazines , or anesthetics , as these agents may increase respiratory and circulatory depression .
iron	norfloxacin	advise	multivitamins , or other products containing iron or zinc , antacids or sucralfate should not be administered concomitantly with , or within dg hours of , the administration of norfloxacin , because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin .
NSAIDs	ACE-inhibitors	advise	this interaction should be given consideration in patients taking nsaids concomitantly with ace-inhibitors .
Phenylbutazone	etodolac	mechanism	phenylbutazone : phenylbutazone causes increase ( by about dg % ) in the free fraction of etodolac .
NSAIDs	methotrexate	mechanism	cyclosporine , digoxin , methotrexate lodine , like other nsaids , through effects on renal prostaglandins , may cause changes in the elimination of these drugs leading to elevated serum levels of cyclosporine , digoxin , methotrexate , and increased toxicity .
phenobarbital	Mefloquine	effect	in patients taking an anticonvulsant ( eg , valproic acid , carbamazepine , phenobarbital or phenytoin ) , the concomitant use of mefloquine may reduce seizure control by lowering the plasma levels of the anticonvulsant .
anticonvulsant	Mefloquine	effect	in patients taking an anticonvulsant ( eg , valproic acid , carbamazepine , phenobarbital or phenytoin ) , the concomitant use of mefloquine may reduce seizure control by lowering the plasma levels of the anticonvulsant .
Mefloquine	anti-arrhythmic	effect	this appears to be the only clinically relevant interaction of this kind with mefloquine , although theoretically , coadministration of other drugs known to alter cardiac conduction ( eg , anti-arrhythmic or beta adrenergic blocking agents , calcium channel blockers , antihistamines or h1 blocking agents , tricyclic antidepressants and phenothiazines ) might also contribute to a prolongation of the qtc interval .
Mefloquine	H1-blocking agents	effect	this appears to be the only clinically relevant interaction of this kind with mefloquine , although theoretically , coadministration of other drugs known to alter cardiac conduction ( eg , anti arrhythmic or beta adrenergic blocking agents , calcium channel blockers , antihistamines or h1-blocking agents , tricyclic antidepressants and phenothiazines ) might also contribute to a prolongation of the qtc interval .
quinidine	doxepin	mechanism	inhibitors or substrates of cyp2d6 ( i.e. , quinidine , selective serotonin reuptake inhibitors [ ssris ] ) may increase the plasma concentration of doxepin when administered concomitantly .
IOPIDINE	alcohol	advise	although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of iopidine dg % ophthalmic solution , the possibility of an additive or potentiating effect with cns depressants ( alcohol , barbiturates , opiates , sedatives , anesthetics ) should be considered .
apraclonidine	beta-blockers	advise	since apraclonidine may reduce pulse and blood pressure , caution in using drugs such as beta-blockers ( ophthalmic and systemic ) , antihypertensives , and cardiac glycosides is advised .
verapamil	Adenocard	effect	digoxin and verapamil use may be rarely associated with ventricular fibrillation when combined with adenocard .
Adenosine	dipyridamole	effect	adenosine effects are potentiated by dipyridamole .
Antizol	phenytoin	mechanism	reciprocal interactions may occur with concomitant use of antizol and drugs that increase or inhibit the cytochrome p450 system ( e.g. , phenytoin , carbamazepine , cimetidine , ketoconazole ) , though this has not been studied
sucralfate	furosemide	effect	tablets simultaneous administration of sucralfate and furosemide tablets may reduce the natriuretic and antihypertensive effects of furosemide .
furosemide	sucralfate	advise	the intake of furosemide and sucralfate should be separated by at least two hours .
Furosemide	antihypertensive drugs	effect	furosemide may add to or potentiate the therapeutic effect of other antihypertensive drugs .
MAOI antidepressants	amphetamine	mechanism	mao inhibitors : maoi antidepressants , as well as a metabolite of furazolidone , slow amphetamine metabolism .
dicyclomine	cisapride	effect	anticholinergics : concurrent administration of certain anticholinergic compounds , such as belladonna alkaloids and dicyclomine , would be expected to compromise the beneficial effects of cisapride .
TCAs	SSRIs	advise	nevertheless , caution is indicated in the co administration of tcas with any of the ssris and also in switching from one class to the other .
TCA	fluoxetine	advise	of particular importance , sufficient time must elapse before initiating tcatreatment in a patient being withdrawn from fluoxetine , given the long half life of the parent and active metabolite ( at least dg weeks may be necessary ) .
tricyclic antidepressants	guanethidine	effect	several tricyclic antidepressants have been reported to block the pharmacologic effects of guanethidine , clonidine , or similar agents , and such an effect may be anticipated with cmi because of its structural similarity to other tricyclic antidepressants .
tricyclic antidepressants	methylphenidate	mechanism	plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors ( e.g. , cimetidine , fluoxetine ) and decreased by the concomitant administration of hepatic enzyme inducers ( e.g. , barbiturates , phenytoin ) , and such an effect may be anticipated with cmi as well .
fluoxetine	CMI	mechanism	plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors ( e.g. , cimetidine , fluoxetine ) and decreased by the concomitant administration of hepatic enzyme inducers ( e.g. , barbiturates , phenytoin ) , and such an effect may be anticipated with cmi as well .
Ethopropazine	alcohol	effect	ethopropazine may interact with alcohol or other cns depressants , causing increased sedative effects .
quinolones	theophylline	mechanism	however , the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline , interfere with the metabolism of caffeine , and enhance the effects of the oral anticoagulant warfarin and its derivatives , and has been associated with transient elevations in serum creatinine in patients receiving systemic cyclosporine concomitantly .
sulfonylurea	salicylates	effect	the hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
butorphanol	alcohol	effect	concurrent use of butorphanol with central nervous system depressants ( e.g. , alcohol , barbiturates , tranquilizers , and antihistamines ) may result in increased central nervous system depressant effects .
STADOL NS	nasal vasoconstrictor	effect	therefore , a slower onset can be anticipated if stadol ns is administered concomitantly with , or immediately following , a nasal vasoconstrictor .
Epinephrine	isoproterenol	advise	epinephrine should not be administered concomitantly with other sympathomimetic drugs ( such as isoproterenol ) because of possible additive effects and increased toxicity .
NSAID	methotrexate	effect	patients who begin taking diclofenac or who increase their diclofenac dose or any other nsaid while taking digoxin , methotrexate , or cyclosporine may develop toxicity characteristics for these drugs .
diclofenac	methotrexate	effect	patients who begin taking diclofenac or who increase their diclofenac dose or any other nsaid while taking digoxin , methotrexate , or cyclosporine may develop toxicity characteristics for these drugs .
NSAID	digoxin	effect	patients who begin taking diclofenac or who increase their diclofenac dose or any other nsaid while taking digoxin , methotrexate , or cyclosporine may develop toxicity characteristics for these drugs .
Diclofenac	lithium	mechanism	lithium : diclofenac decreases lithium renal clearance and increases lithium plasma levels .
Phenothiazine-related compounds	beta-adrenergic blocking agents	mechanism	phenothiazine-related compounds and beta-adrenergic blocking agents may have additive hypotensite effects due to the inhibition of each other s metabolism .
Levo-Dromoran	antihistamines	effect	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
nalbuphine	Levo-Dromoran	advise	interactions with mixed agonist / antagonist opioid analgesics : agonist / antagonist analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as levo-dromoran .
butorphanol	Levo-Dromoran	advise	interactions with mixed agonist / antagonist opioid analgesics : agonist / antagonist analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as levo-dromoran .
phenothiazines	DILAUDID	effect	patients receiving other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative hypnotics , tricyclic antidepressants or other cns depressants ( including alcohol ) concomitantly with dilaudid may exhibit an additive cns depression .
tricyclic antidepressants	DILAUDID	effect	patients receiving other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative hypnotics , tricyclic antidepressants or other cns depressants ( including alcohol ) concomitantly with dilaudid may exhibit an additive cns depression .
Probenecid	angiotensin-converting enzyme inhibitors	mechanism	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti inflammatory agents , theophylline , and zidovudine ) .
Probenecid	bumetanide	mechanism	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti inflammatory agents , theophylline , and zidovudine ) .
Probenecid	clofibrate	mechanism	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti inflammatory agents , theophylline , and zidovudine ) .
VISTIDE	gentamicin	advise	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin b , foscarnet , intravenous pentamidine , vancomycin , and non steroidal anti inflammatory agents ] is contraindicated .
VISTIDE	amikacin	advise	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin b , foscarnet , intravenous pentamidine , vancomycin , and non steroidal anti inflammatory agents ] is contraindicated .
VISTIDE	vancomycin	advise	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin b , foscarnet , intravenous pentamidine , vancomycin , and non steroidal anti inflammatory agents ] is contraindicated .
Chlorthalidone	antihypertensive drugs	effect	chlorthalidone may add to or potentiate the action of other antihypertensive drugs .
CASODEX	anticoagulant	advise	it is recommended that if casodex is started in patients already receiving coumarin anticoagulants , prothrombin times should be closely monitored and adjustment of the anticoagulant dose may be necessary .
NUROMAX	procainamide	effect	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
NUROMAX	clindamycin	effect	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
NUROMAX	carbamazepine	effect	as with some other nondepolarizing neuromuscular blocking agents , the time of onset of neuromuscular block induced by nuromax is lengthened and the duration of block is shortened in patients receiving phenytoin or carbamazepine .
quinidine	carvedilol	effect	poor metabolizers of debrisoquin : interactions of carvedilol with strong inhibitors of cyp2d6 ( such as quinidine , fluoxetine , paroxetine , and propafenone ) have not been studied , but these drugs would be expected to increase blood levels of the r ( + ) enantiomer of carvedilol .
cyclosporine	carvedilol	advise	due to wide interindividual variability in the dose adjustment required , it is recommended that cyclosporine concentrations be monitored closely after initiation of carvedilol therapy and that the dose of cyclosporine be adjusted as appropriate .
COREG	verapamil	advise	as with other agents with b blocking properties , if coreg is to be administered orally with calcium channel blockers of the verapamil or diltiazem type , it is recommended that ecg and blood pressure be monitored .
Bromocriptine mesylate	dopamine antagonists	int	bromocriptine mesylate may interact with dopamine antagonists , butyrophenones , and certain other agents .
bromocriptine mesylate	ergot alkaloids	advise	concomitant use of bromocriptine mesylate with other ergot alkaloids is not recommended .
dobutamine	b-blocking drug	effect	animal studies indicate that dobutamine may be ineffective if the patient has recently received a b-blocking drug .
tiagabine	primidone	mechanism	phenobarbital ( primidone ) : population pharmacokinetic analyses indicate that tiagabine clearance is dg % greater in patients taking phenobarbital ( primidone ) with or without other enzyme inducing aeds .
triazolam	tiagabine	advise	because of the possible additive effects of drugs that may depress the nervous system , ethanol or triazolam should be used cautiously in combination with tiagabine .
fenofibrate	pravastatin	mechanism	concomitant administration of fenofibrate ( equivalent to 145mg tricor ) with pravastatin ( dg mg ) once daily for dg days has been shown to increase the mean cmax and auc values for pravastatin by dg % ( range from dg % decrease to dg % increase ) and dg % ( range from dg % decrease to dg % increase ) , respectively , and for dg hydroxy iso pravastatin by dg % ( range from dg % decrease to dg % increase ) and dg % ( range from dg % decrease to dg % increase ) , respectively in dg healthy adults .
TRICOR	atorvastatin	mechanism	concomitant administration of fenofibrate ( equivalent to dg mg tricor ) with atorvastatin ( dg mg ) once daily for dg days resulted in approximately dg % decrease ( range from dg % decrease to dg % increase ) in atorvastatin auc values in dg healthy males .
aminophylline	adrenergic agonists	effect	concomitant treatment with methylxanthines ( aminophylline , theophylline ) , steroids , or diuretics may potentiate any hypokalemic effect of adrenergic agonists .
beta-agonists	non-potassium sparing diuretics	advise	although the clinical significance of these effects is not known , caution is advised in the co administration of beta-agonists with non-potassium sparing diuretics .
beta2-agonists	tricyclic antidepressants	advise	brovana , as with other beta2-agonists , should be administered with extreme caution to patients being treated with monoamine oxidase inhibitors , tricyclic antidepressants , or drugs known to prolong the qtc interval because the action of adrenergic agonists on the cardiovascular system may be potentiated by these agents .
clarithromycin	pimozide	advise	concomitant administration of clarithromycin with pimozide is contraindicated .
esomeprazole	diazepam	mechanism	coadministration of esomeprazole dg mg and diazepam , a cyp2c19 substrate , resulted in a dg % decrease in clearance of diazepam .
anticoagulant	Bezalip	advise	for this reason , the dose of the anticoagulant should be reduced by dg dg % at the start of treatment with bezalip or bezalip retard and then titrated according to the blood clotting parameters
insulin	Bezalip retard	effect	the action of sulphonylureas and insulin may be enhanced by bezalip or bezalip retard .
Bezalip retard	cholestryramine	advise	when bezalip or bezalip retard is used concurrently with anion exchange resins ( e.g. cholestryramine ) , an interval of at least dg hours should be maintained between the two medicines , since the absorption of bezalip or bezalip retard is impaired
dihydroergotamine	AXERT	advise	because there is a theoretical basis that these effects may be additive , use of ergotamine containing or ergot type medications ( like dihydroergotamine or methysergide ) and axert within dg hours of each other should be avoided .
erythromycin	almotriptan	advise	although the interaction between almotriptan and other potent cyp3a4 inhibitors ( e.g. , itraconazole , ritonavir , and erythromycin ) has not been studied , increased exposures to almotriptan may be expected when almotriptan is used concomitantly with these medications .
itraconazole	almotriptan	advise	although the interaction between almotriptan and other potent cyp3a4 inhibitors ( e.g. , itraconazole , ritonavir , and erythromycin ) has not been studied , increased exposures to almotriptan may be expected when almotriptan is used concomitantly with these medications .
5-HT1B/1D agonists	AXERT	advise	other dg ht1b / 1d agonists concomitant use of other 5-ht1b/1d agonists within dg hours of treatment with axert is contraindicated .
almotriptan	verapamil	mechanism	verapamil : coadministration of almotriptan and verapamil resulted in a dg % increase in plasma concentrations of almotriptan .
TORADOL	probenecid	mechanism	probenecid : concomitant administration of toradol oral and probenecid resulted in decreased clearance of ketorolac and significant increases in ketorolac plasma levels ( total auc increased approximately threefold from dg to dg m g / h / ml ) and terminal half life increased approximately twofold from dg to dg hours .
Rifampin	losartan	mechanism	rifampin , an inducer of drug metabolism , decreased the concentrations of losartan and its active metabolite .
diazoxide	hydralazine	effect	profound hypotensive episodes may occur when diazoxide infection and hydralazine are used concomitantly .
lithium	insulin	effect	beta blockers , clonidine , lithium salts , and alcohol may either potentiate or weaken the blood glucose lowering effect of insulin .
erythromycin	corticosteroids	mechanism	drugs which inhibit cyp dg ( e.g. , ketoconazole , macrolide antibiotics such as erythromycin ) have the potential to result in increased plasma concentrations of corticosteroids .
Macrolide antibiotics	corticosteroid	mechanism	antibiotics : macrolide antibiotics have been reported to cause a significant decrease in corticosteroid clearance .
Corticosteroids	live attenuated vaccines	effect	corticosteroids may also potentiate the replication of some organisms contained in live attenuated vaccines .
levobupivacaine	phenobarbital	mechanism	although no clinical studies have been conducted , it is likely that the metabolism of levobupivacaine may be affected by the known cyp3a4 inducers ( such as phenytoin , phenobarbital , rifampin ) , cyp3a4 inhibitors ( azole antimycotics e.g. , ketoconazole ;
levobupivacaine	ketoconazole	mechanism	although no clinical studies have been conducted , it is likely that the metabolism of levobupivacaine may be affected by the known cyp3a4 inducers ( such as phenytoin , phenobarbital , rifampin ) , cyp3a4 inhibitors ( azole antimycotics e.g. , ketoconazole ;
praziquantel	albendazole sulfoxide	mechanism	praziquantel : in the fed state , praziquantel ( dg mg / kg ) increased mean maximum plasma concentration and area under the curve of albendazole sulfoxide by about dg % in healthy subjects ( n=10 ) compared with a separate group of subjects ( n=6 ) given albendazole alone .
Clidinium	phenothiazines	effect	clidinium may decrease the effect of phenothiazines , levodopa , and ketoconazole .
zaleplon	promethazine	mechanism	promethazine : coadministration of a single dose of zaleplon and promethazine ( dg and dg mg , respectively ) resulted in a dg % decrease in maximal plasma concentrations of zaleplon , but no change in the area under the plasma concentration time curve .
dopamine HCl	halogenated hydrocarbon anesthetics	advise	therefore , extreme caution should be exercised when administering dopamine hcl to patients receiving cyclopropane or halogenated hydrocarbon anesthetics .
vasopressor	oxytocic drugs	effect	the concomitant use of vasopressors , vasoconstricting agents ( such as ergonovine ) and some oxytocic drugs may result in severe hypertension .
ergonovine	oxytocic drugs	effect	the concomitant use of vasopressors , vasoconstricting agents ( such as ergonovine ) and some oxytocic drugs may result in severe hypertension .
dopamine HCl	diuretic agents	effect	concurrent administration of low dose dopamine hcl and diuretic agents may produce an additive or potentiating effect on urine flow .
Valdecoxib	S-warfarin	mechanism	valdecoxib caused a statistically significant increase in plasma exposures of r warfarin and s-warfarin ( dg % and dg % , respectively ) , and in the pharmacodynamic effects ( prothrombin time , measured as inr ) of warfarin .
glyburide	valdecoxib	advise	because changes in glucose concentrations with valdecoxib coadministration were within the normal variability and individual glucose concentrations were above or near dg mg / dl , dose adjustment for glyburide ( dg mg qd and dg mg bid ) with valdecoxib coadministration ( up to dg mg qd ) is not indicated .
aspirin	valdecoxib	effect	aspirin : concomitant administration of aspirin with valdecoxib may result in an increased risk of gi ulceration and complications compared to valdecoxib alone .
contraceptive	valdecoxib	advise	these increased exposures of norethindrone and ethinyl estradiol should be taken into consideration when selecting an oral contraceptive for women taking valdecoxib .
probenecid	ertapenem	advise	because of the small effect on half life , the coadministration with probenecid to extend the half life of ertapenem is not recommended .
neomycin	methotrexate	mechanism	oral neomycin inhibits the gastrointestinal absorption of penicillin v , oral vitamin b dg , methotrexate and dg fluorouracil .
neomycin sulfate	coumarin	effect	oral neomycin sulfate may enhance the effect of coumarin in anticoagulants by decreasing vitamin k availability .
doxapram	sympathomimetic	effect	administration of doxapram to patients who are receiving sympathomimetic or monoamine oxidase inhibiting drugs may result in an additive pressor effect .
clonazepam	propantheline	mechanism	in a study in which the dg mg clonazepam orally disintegrating tablet was administered with and without propantheline ( an anticholinergic agent with multiple effects on the gi tract ) to healthy volunteers , the auc of clonazepam was dg % lower and the cmax of clonazepam was dg % lower when the orally disintegrating tablet was given with propantheline compared to when it was given alone .
carbamazepine	clonazepam	mechanism	cytochrome p dg inducers , such as phenytoin , carbamazepine and phenobarbital , induce clonazepam metabolism , causing an approximately dg % decrease in plasma clonazepam levels .
diuretics	PRINIVIL	effect	hypotension patients on diuretic therapy : patients on diuretics , and especially those in whom diuretic therapy was recently instituted , may occasionally experience an excessive reduction of blood pressure after initiation of therapy with prinivil .
PRINIVIL	spironolactone	effect	use of prinivil with potassium sparing diuretics ( e.g. , spironolactone , triamterene , or amiloride ) , potassium supplements , or potassium containing salt substitutes may lead to significant increases in serum potassium .
benzodiazepines	narcotics	effect	the actions of the benzodiazepines may be potentiated by barbiturates , narcotics , phenothiazines , monoamine oxidase inhibitors or other antidepressants .
estazolam	ketoconazole	advise	consequently , estazolam should be avoided in patients receiving ketoconazole and itraconazole , which are very potent inhibitors of cyp3a .
benzodiazepines	fluvoxamine	mechanism	the following are examples of drugs known to inhibit the metabolism of other related benzodiazepines , presumably through inhibition of cyp3a : nefazodone , fluvoxamine , cimetidine , diltiazem , isoniazide , and some macrolide antibiotics .
nelfinavir	didanosine	advise	therefore , nelfinavir should be administered ( with food ) one hour after or more than two hours before didanosine .
rifabutin	VIRACEPT	mechanism	rifabutin : coadministration of rifabutin and viracept resulted in a dg % decrease in nelfinavir plasma auc and a dg % increase in rifabutin plasma a.c .
VIRACEPT	amiodarone	advise	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
VIRACEPT	Antimycobacterial agents	advise	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
VIRACEPT	rifampin	advise	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
Bile acid binding resins	phosphate	mechanism	bile acid binding resins may also interfere with the absorption of oral phosphate supplements and hydrocortisone .
FACTIVE	contraceptive	mechanism	concomitant administration of factive and calcium carbonate , cimetidine , omeprazole , or an estrogen / progesterone oral contraceptive produced minor changes in the pharmacokinetics of gemifloxacin , which were considered to be without clinical significance .
aluminum	FACTIVE	advise	magnesium and / or aluminum containing antacids , products containing ferrous sulfate ( iron ) , multivitamin preparations containing zinc or other metal cations , or videx ( didanosine ) chewable / buffered tablets or the pediatric powder for oral solution should not be taken within dg hours before or dg hours after factive .
rifampin	caspofungin	mechanism	a drug drug interaction study with rifampin in healthy volunteers has shown a dg % decrease in caspofungin trough concentrations .
dexamethasone	CANCIDAS	mechanism	in addition , results from regression analyses of patient pharmacokinetic data suggest that co administration of other inducers of drug clearance ( efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine ) with cancidas may result in clinically meaningful reductions in caspofungin concentrations .
CANCIDAS	efavirenz	advise	when cancidas is co administered with inducers of drug clearance , such as efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine , use of a daily dose of dg mg of cancidas should be considered
CANCIDAS	phenytoin	advise	when cancidas is co administered with inducers of drug clearance , such as efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine , use of a daily dose of dg mg of cancidas should be considered
CANCIDAS	cyclosporine	effect	there were transient increases in liver alt and ast when cancidas and cyclosporine were co administered .
vitamin A	acitretin	advise	vitamin a and oral retinoids : concomitant administration of vitamin a and / or other oral retinoids with acitretin must be avoided because of the risk of hypervitaminosis a .
acitretin	progestin	effect	however , it has been established that acitretin interferes with the contraceptive effect of microdosed progestin minipill preparations .
indomethacin	MIDAMOR	effect	since indomethacin and potassium sparing diuretics , including midamor , may each be associated with increased serum potassium levels , the potential effects on potassium kinetics and renal function should be considered when these agents are administered concurrently .
butyrophenones	APOKYN	effect	dopamine antagonists : since apomorphine is a dopamine agonist , it is possible that dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
PLETAL	omeprazole	advise	since pletal is extensively metabolized by cytochrome p dg isoenzymes , caution should be exercised when pletal is coadministered with inhibitors of c.p.a. such as ketoconazole and erythromycin or inhibitors of cyp2c19 such as omeprazole .
phenytoin	coumarin	mechanism	presumably , phenytoin acts as a stimulator of coumarin metabolism and has been reported to cause decreased serum levels of the coumarin anticoagulants and increased prothrombin proconvertin concentrations .
aspirin	carbonic anhydrase inhibitors	advise	caution is advised in patients receiving concomitant high dose aspirin and carbonic anhydrase inhibitors , as anorexia , tachypnea , lethargy and coma have been rarely reported due to a possible drug interaction .
Acetazolamide	methenamine	effect	acetazolamide may prevent the urinary antiseptic effect of methenamine .
Auranofin	Solganal	advise	auranofin should be avoided by patients with a history of serious reaction to any gold medication , including solganal and myochrysine .
aminoglycosides	MAXIPIME	advise	renal function should be monitored carefully if high doses of aminoglycosides are to be administered with maxipime because of the increased potential of nephrotoxicity and ototoxicity of aminoglycoside antibiotics .
thiazide diuretics	LEVULAN KERASTICK	effect	it is , however , possible that concomitant use of other known photosensitizing agents such as griseofulvin , thiazide diuretics , sulfonylureas , phenothiazines , sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the levulan kerastick for topical solution .
phenothiazines	LEVULAN KERASTICK	effect	it is , however , possible that concomitant use of other known photosensitizing agents such as griseofulvin , thiazide diuretics , sulfonylureas , phenothiazines , sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the levulan kerastick for topical solution .
Aprepitant	midazolam	mechanism	aprepitant increased the auc of midazolam by dg % on day dg and decreased the auc of midazolam by dg % on day dg relative to the dosing of aprepitant on days dg through dg .
aprepitant	diltiazem	mechanism	diltiazem : in patients with mild to moderate hypertension , administration of aprepitant once daily , as a tablet formulation comparable to dg mg of the capsule formulation , with diltiazem dg mg dg times daily for dg days , resulted in a dg fold increase of aprepitant auc and a simultaneous dg fold increase of diltiazem auc .
Cholestyramine	fat soluble vitamins	mechanism	interactions for vitamin d analogues ( vitamin d2 , vitamin d3 , calcitriol , and calcidiol ) : cholestyramine : cholestyramine has been reported to reduce intestinal absorption of fat soluble vitamins ;
vitamin D analogues	corticosteroids	mechanism	corticosteroids : a relationship of functional antagonism exists between vitamin d analogues , which promote calcium absorption , and corticosteroids , which inhibit calcium absorption .
Magnesium	vitamin D	advise	magnesium : magnesium containing preparations ( eg , antacids ) may cause hypermagnesemia and should therefore not be taken during therapy with vitamin d by patients on chronic renal dialysis .
phenytoin	calcitriol	mechanism	phenytoin / phenobarbital : the coadministration of phenytoin or phenobarbital will not affect plasma concentrations of vitamin d , but may reduce endogenous plasma levels of calcitriol / ergocalcitriol by accelerating metabolism .
desipramine hydrochloride	hypnotics	effect	if desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative / hypnotics , careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines ( e.g. , chlordiazepoxide or diazepam ) are additive .
Catecholamine-depleting drugs	beta-blocking agents	effect	catecholamine-depleting drugs , such as reserpine , may have an additive effect when given with beta-blocking agents .
Sympathomimetic amines	mecamylamine	effect	sympathomimetic amines may reduce the antihypertensive effects of reserpine , veratrum alkaloids , methyldopa and mecamylamine .
Enoxacin	methylxanthines	mechanism	caffeine : enoxacin is a potent inhibitor of the cytochrome p dg isozymes responsible for the metabolism of methylxanthines .
Enoxacin	methylxanthines	mechanism	theophylline : enoxacin is a potent inhibitor of the cytochrome p dg isozymes responsible for the metabolism of methylxanthines .
erythromycin	cisapride	effect	there have been postmarketing reports of drug interactions when erythromycin is coadministered with cisapride , resulting in qt prolongation , cardiac arrythmias , ventricular tachycardia , ventricular fibrulation , and torsades de pointes , most like due to inhibition of hepatic metabolism of cisapride by erythromycin .
lovastatin	erythromycin	advise	patients receiving concomitant lovastatin and erythromycin should be carefully monitored ;
Erythromycin	triazolam	mechanism	erythromycin has been reported to decrease the clearance of triazolam and midazolam and thus may increase the pharmacologic effect of these benzodiazepines .
erythromycin	hexobarbital	int	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
ephedrine	sympathomimetic bronchodilators	effect	synergism between xanthine bronchodilators ( e.g. , theophylline ) , ephedrine , and other sympathomimetic bronchodilators has been reported .
phenytoin	amiodarone	mechanism	the most commonly occurring drug interactions are listed below : drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2 antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
phenytoin	halothane	mechanism	the most commonly occurring drug interactions are listed below : drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2 antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
phenytoin	digitoxin	effect	drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
phenytoin	doxycycline	effect	drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
Ponstel	aspirin	advise	aspirin : as with other nsaids , concomitant administration of ponstel and aspirin is not generally recommended because of the potential of increased adverse effects .
NSAIDs	methotrexate	mechanism	methotrexate : nsaids have been reported to competitively inhibit methotrexate accumulation in rabbit kidney slices .
NSAIDs	lithium	mechanism	lithium : nsaids have produced an elevation of plasma lithium levels and a reduction in renal lithium clearance .
Cholestyramine	fat soluble vitamins	mechanism	interactions for vitamin d analogues ( vitamin d2 , vitamin d3 , calcitriol , and calcidiol ) : cholestyramine : cholestyramine has been reported to reduce intestinal absorption of fat soluble vitamins ;
alcohol	ethchlorvynol	effect	other depressasnts such as alcohol , barbiturates , and maois may enhance cns depression when administered with ethchlorvynol .
cholestyramine	leflunomide	mechanism	cholestyramine and charcoal administration of cholestyramine or activated charcoal in patients ( n=13 ) and volunteers ( n=96 ) resulted in a rapid and significant decrease in plasma m1 ( the active metabolite of leflunomide ) concentration .
dihydroergotamine mesylate	peripheral vasoconstrictors	effect	vasoconstrictors : d.h.e. dg ( dihydroergotamine mesylate ) injection , usp should not be used with peripheral vasoconstrictors because the combination may cause synergistic elevation of blood pressure .
Nicotine	ergot	effect	nicotine : nicotine may provoke vasoconstriction in some patients , predisposing to a greater ischemic response to ergot therapy .
levothyroxine sodium	aluminum hydoxide	mechanism	levothyroxine sodium absorption : the following agents may bind and decrease absorption of levothyroxine sodium from the gastrointestinal tract : aluminum hydoxide , cholestyramine resin , colestipol hydrochloride , ferrous sulfate , sodium polystyrene sulfonate , soybean flour ( e.g. , infant formula ) , sucralfate .
levothyroxine sodium	androgens	mechanism	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen containing compounds , dg fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
levothyroxine sodium	phenytoin	mechanism	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen containing compounds , dg fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
levothyroxine sodium	asparaginase	mechanism	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen containing compounds , dg fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
thiazide diuretics	allopurinol	advise	although a causal mechanism and a cause and effect relationship have not been established , current evidence suggests that renal function should be monitored in patients on thiazide diuretics and allopurinol even in the absence of renal failure , and dosage levels should be even more conservatively adjusted in those patients on such combined therapy if diminished renal function is detected..
allopurinol	chlorpropamide	effect	the risk of hypoglycemia secondary to this mechanism may be increased if allopurinol and chlorpropamide are given concomitantly in the presence of renal insufficiency .
Lithium	diuretics	mechanism	lithium generally should not be given with diuretics because they reduce its renal clearance and add a high risk of lithium toxicity .
ibuprofen	methotrexate	effect	this may indicate that ibuprofen could enhance the toxicity of methotrexate .
PAH	sulfonamides	effect	renal clearance measurements of pah can not be made with any significant accuracy in patients receiving sulfonamides , procaine , or thiazolesulfone .
dolasetron	cimetidine	mechanism	blood levels of hydrodolasetron increased dg % when dolasetron was coadministered with cimetidine ( nonselective inhibitor of cytochrome p dg ) for dg days , and decreased dg % with coadministration of rifampin ( potent inducer of cytochrome p dg ) for dg days .
OMNICEF	antacid	advise	if antacids are required during omnicef therapy , omnicef should be taken at least dg hours before or after the antacid .
b-lactam antibiotics	cefdinir	mechanism	probenecid : as with other b-lactam antibiotics , probenecid inhibits the renal excretion of cefdinir , resulting in an approximate doubling in a.c. a dg % increase in peak cefdinir plasma levels , and a dg % prolongation in the apparent elimination half life .
cefdinir	iron	mechanism	iron supplements and foods fortified with iron concomitant administration of cefdinir with a therapeutic iron supplement containing dg mg of elemental iron ( as feso4 ) or vitamins supplemented with dg mg of elemental iron reduced extent of absorption by dg % and dg % , respectively .
BREVIBLOC	succinylcholine	advise	although the interactions observed in these studies do not appear to be of major clinical importance , brevibloc should be titrated with caution in patients being treated concurrently with digoxin , morphine , succinylcholine or warfarin .
selegiline hydrochloride	paroxetine	effect	in patients receiving nonselective monoamine oxidase inhibitors ( maois ) ( e.g. , selegiline hydrochloride ) in combination with serotoninergic agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
SSRIs	dihydroergotamine	effect	a rare , but serious , constellation of symptoms , termed serotonin syndrome , has been reported with the concomitant use of selective serotonin reuptake inhibitors ( ssris ) and agents for migraine therapy , such as imitrex ( sumatriptan succinate ) and dihydroergotamine .
methysergide	FROVA	advise	due to a theoretical risk of a pharmacodynamic interaction , use of ergotamine containing or ergot type medications ( like dihydroergotamine or methysergide ) and frova within dg hours of each other should be avoided ( see a href= frova_od.htm # ci contraindications ) .
chloroquine	cyclosporin	mechanism	cyclosporin : after introduction of chloroquine ( oral form ) , a sudden increase in serum cyclosporin level has been reported .
VIDEX	ciprofloxacin	advise	quinolone antibiotics : videx should be administered at least dg hours after or dg hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium , calcium , or aluminum .
cephalexin	metformin	mechanism	metformin : in healthy subjects given single dg mg doses of cephalexin and metformin , plasma metformin mean cmax and auc increased by an average of dg % and dg % , respectively , and metformin mean renal clearance decreased by dg % .
dantrolene sodium	calcium channel blockers	advise	it is recommended that the combination of intravenous dantrolene sodium and calcium channel blockers , such as verapamil , not be used together during the management of malignant hyperthermia crisis until the relevance of these findings to humans is established .
HYDROXYZINE	BARBITURATES	effect	the potentiating action of hydroxyzine must be considered when the drug is used in conjunction with central nervous system depressants such as narcotics , non narcotic analgesics and barbiturates .
Nimotop	antihypertensive compounds	effect	in europe , nimotop was observed to occasionally intensify the effect of antihypertensive compounds taken concomitantly by patients suffering from hypertension ;
clonidine	insulin	effect	beta blockers , clonidine , lithium salts , and alcohol may either potentiate or weaken the blood glucose lowering effect of insulin .
alcohol	insulin	effect	beta blockers , clonidine , lithium salts , and alcohol may either potentiate or weaken the blood glucose lowering effect of insulin .
corticosteroids	amphotericin B	advise	amphotericin b injection and potassium depleting agents : when corticosteroids are administered concomitantly with potassium depleting agents ( e.g. , amphotericin b , diuretics ) , patients should be observed closely for development of hypokalemia .
amphotericin B	hydrocortisone	effect	in addition , there have been cases reported in which concomitant use of amphotericin b and hydrocortisone was followed by cardiac enlargement and congestive heart failure .
nonsteroidal antiinflammatory agents	corticosteroids	effect	nonsteroidal anti inflammatory agents ( nsaids ) : concomitant use of aspirin ( or other nonsteroidal antiinflammatory agents ) and corticosteroids increases the risk of gastrointestinal side effects .
salicylates	corticosteroids	mechanism	the clearance of salicylates may be increased with concurrent use of corticosteroids .
corticosteroids	antidiabetic agents	effect	antidiabetics : because corticosteroids may increase blood glucose concentrations , dosage adjustments of antidiabetic agents may be required .
felodipine	phenytoin	mechanism	anticonvulsants : in a pharmacokinetic study , maximum plasma concentrations of felodipine were considerably lower in epileptic patients on long term anticonvulsant therapy ( eg , phenytoin , carbamazepine , or phenobarbital ) than in healthy volunteers .
Clidinium	ketoconazole	effect	clidinium may decrease the effect of phenothiazines , levodopa , and ketoconazole .
rifampin	zaleplon	mechanism	multiple dose administration of the potent cyp3a4 inducer rifampin ( dg mg every dg hours , q24h , for dg days ) , however , reduced zaleplon cmax and auc by approximately dg % .
Sonata	cimetidine	mechanism	concomitant administration of sonata ( dg mg ) and cimetidine ( dg mg ) produced an dg % increase in the mean cmax and auc of zaleplon .
dopamine	propranolol	effect	it has been reported that results of studies in animals indicate that dopamine induced ventricular arrhythmias during anesthesia can be reversed by propranolol .
dopamine	metoprolol	effect	cardiac effects of dopamine are antagonized by beta adrenergic blocking agents , such as propranolol and metoprolol .
NSAIDs	thiazides	effect	furosemide : clinical studies , as well as post marketing observations , have shown that nsaids can reduce the natriuretic effect of furosemide and thiazides in some patients .
valdecoxib	dextromethorphan	mechanism	coadministration with valdecoxib ( dg mg bid for dg days ) resulted in a significant increase in dextromethorphan plasma levels suggesting that , at these doses , valdecoxib is a weak inhibitor of dg .
Valdecoxib	warfarin	effect	valdecoxib caused a statistically significant increase in plasma exposures of r warfarin and s warfarin ( dg % and dg % , respectively ) , and in the pharmacodynamic effects ( prothrombin time , measured as inr ) of warfarin .
lansoprazole	iron	mechanism	therefore , it is theoretically possible that lansoprazole may interfere with the absorption of drugs where gastric ph is an important determinant of bioavailability ( e.g. ketoconazole , ampicillin esters , iron salts , digoxin ) .
Felbatol	carbamazepine	mechanism	carbamazepine : felbatol causes a decrease in the steady state carbamazepine plasma concentrations and an increase in the steady state carbamazepine epoxide plasma concentration .
Phenytoin	Felbatol	mechanism	effects of other antiepileptic drugs on felbatol phenytoin : phenytoin causes an approximate doubling of the clearance of felbatol ( felbamate ) at steady state and , therefore , the addition of phenytoin causes an approximate dg % decrease in the steady state trough concentrations of felbatol as compared to the same dose of felbatol given as monotherapy .
carbamazepine	Felbatol	mechanism	carbamazepine : carbamazepine causes an approximate dg % increase in the clearance of felbatol at steady state and , therefore , the addition of carbamazepine results in an approximate dg % decrease in the steady state trough concentrations of felbatol as compared to the same dose of felbatol given as monotherapy .
rifampicin	exemestane	mechanism	co medications that induce cyp dg ( e.g. , rifampicin , phenytoin , carbamazepine , phenobarbital , or st. john s wort ) may significantly decrease exposure to exemestane .
Amprenavir	ritonavir	advise	appropriate laboratory testing should be considered prior to initiating combination therapy with amprenavir and ritonavir and at periodic intervals or if any clinical signs or symptoms of hyperlipidemia or elevated liver function tests occur during therapy .
Indinavir	amprenavir	mechanism	indinavir steady state cmax , a.c. and cmin were decreased by dg % , dg % , and dg % , respectively , by concomitant amprenavir .
RAPTIVA	immunosuppressive drugs	advise	raptiva should not be used with other immunosuppressive drugs .
linezolid	adrenergic	int	therefore , linezolid has the potential for interaction with adrenergic and serotonergic agents .
ZYVOX	vasopressor	effect	adrenergic agents : some individuals receiving zyvox may experience a reversible enhancement of the pressor response to indirect acting sympathomimetic agents , vasopressor or dopaminergic agents .
ZYVOX	serotonergic agents	effect	patients who are treated with zyvox and concomitant serotonergic agents should be closely observed for signs and symptoms of serotonin syndrome ( e.g. , cognitive dysfunction , hyperpyrexia , hyperreflexia , incoordination ) .
warfarin	flutamide	effect	increases in prothrombin time have been noted in patients receiving long term warfarin therapy after flutamide was initiated .
dipyrone	aspirin	effect	pyrazolone derivatives ( phenylbutazone , oxyphenbutazone , and possibly dipyrone ) : concomitant administration with aspirin may increase the risk of gastrointestinal ulceration .
antihistamines	alcohol	effect	concomitant use of antihistamines with alcohol , tricyclic antidepressants , barbiturates , or other central nervous system depressants may have an additive effect .
veratrum alkaloids	sympathomimetics	effect	the antihypertensive effects of methyldopa , mecamylamine , reserpine , and veratrum alkaloids may be reduced by sympathomimetics .
amiodarone	digoxin	mechanism	quinidine , verapamil , amiodarone , propafenone , indomethacin , itraconazole , alprazolam , and spironolactone raise the serum digoxin concentration due to a reduction in clearance and / or in volume of distribution of the drug , with the implication that digitalis intoxication may result .
spironolactone	digoxin	mechanism	quinidine , verapamil , amiodarone , propafenone , indomethacin , itraconazole , alprazolam , and spironolactone raise the serum digoxin concentration due to a reduction in clearance and / or in volume of distribution of the drug , with the implication that digitalis intoxication may result .
Lofexidine	alcohol	effect	lofexidine may enhance the cns depressive effects of alcohol , barbiturates and other sedatives
Lofexidine	sedatives	effect	lofexidine may enhance the cns depressive effects of alcohol , barbiturates and other sedatives
TARCEVA	voriconazole	advise	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
TARCEVA	nefazodone	advise	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
TARCEVA	nelfinavir	advise	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
TARCEVA	saquinavir	advise	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
TARCEVA	telithromycin	advise	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
rifampicin	erlotinib	mechanism	pre treatment with the cyp3a4 inducer rifampicin decreased erlotinib auc by about dg / dg .
digoxin	ketoconazole	advise	it is , therefore , advisable to monitor digoxin concentrations in patients receiving ketoconazole .
imidazole compounds	coumarin	effect	when taken orally , imidazole compounds like ketoconazole may enhance the anticoagulant effect of coumarin like drugs .
ketoconazole	loratadine	mechanism	after the coadministration of dg mg oral ketoconazole twice daily and one dg mg dose of loratadine to dg subjects , the auc and cmax of loratadine averaged dg % ( dg s.d. ) and dg % ( dg s.d. ) , respectively , of those obtained after co treatment with placebo .
ENABLEX	ketoconazole	advise	the daily dose of enablex should not exceed dg mg when coadministered with potent cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , ritonavir , nelfinavir , clarithromycin and nefazadone ) .
ENABLEX	nelfinavir	advise	the daily dose of enablex should not exceed dg mg when coadministered with potent cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , ritonavir , nelfinavir , clarithromycin and nefazadone ) .
ENABLEX	clarithromycin	advise	the daily dose of enablex should not exceed dg mg when coadministered with potent cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , ritonavir , nelfinavir , clarithromycin and nefazadone ) .
ENABLEX	tricyclic antidepressants	advise	caution should be taken when enablex is used concomitantly with medications that are predominantly metabolized by cyp2d6 and which have a narrow therapeutic window , such as flecainide , thioridazine and tricyclic antidepressants ( see clinical pharmacology ) .
non-steroidal anti-inflammatory agent	thiazide diuretics	effect	non steroidal anti inflammatory drugs : in some patients , the administration of a non steroidal anti inflammatory agent can reduce the diuretic , natriuretic , and antihypertensive effects of loop , potassium sparing and thiazide diuretics .
colestipol	thiazide diuretics	mechanism	cholestyramine and colestipol resins : cholestytamine and colestipol resins have the potential of binding thiazide diuretics and reducing diuretic absorption from the gastrointestinal tract
monoamine oxidase inhibitors	antidiabetic drugs	effect	certain drugs , including nonsteroidal anti inflammatory agents ( nsaids ) , salicylates , monoamine oxidase inhibitors , and non selective beta adrenergic blocking agents may potentiate the hypoglycemic action of starlix and other oral antidiabetic drugs .
non-selective beta-adrenergic-blocking agents	antidiabetic drugs	effect	certain drugs , including nonsteroidal anti inflammatory agents ( nsaids ) , salicylates , monoamine oxidase inhibitors , and non-selective beta-adrenergic-blocking agents may potentiate the hypoglycemic action of starlix and other oral antidiabetic drugs .
thyroid products	antidiabetic drugs	effect	certain drugs including thiazides , corticosteroids , thyroid products , and sympathomimetics may reduce the hypoglycemic action of starlix and other oral antidiabetic drugs .
sympathomimetics	Starlix	effect	certain drugs including thiazides , corticosteroids , thyroid products , and sympathomimetics may reduce the hypoglycemic action of starlix and other oral antidiabetic drugs .
thiazides	antidiabetic drugs	effect	certain drugs including thiazides , corticosteroids , thyroid products , and sympathomimetics may reduce the hypoglycemic action of starlix and other oral antidiabetic drugs .
buspirone	warfarin	effect	however , there has been one report of prolonged prothrombin time when buspirone was added to the regimen of a patient treated with warfarin .
calcium blockers	digitalis preparations	mechanism	digoxin : some calcium blockers may increase the concentration of digitalis preparations in the blood .
digoxin	nicardipine HCl	advise	nicardipine hcl usually does not alter the plasma levels of digoxin , however , serum digoxin levels should be evaluated after concomitant therapy with nicardipine hcl is initiated .
risperidone	levodopa	effect	dopamine d2 receptor antagonists ( e.g. , phenothiazines , butyrophenones , risperidone ) and isoniazid may reduce the therapeutic effects of levodopa .
ZEBETA	clonidine	advise	in patients receiving concurrent therapy with clonidine , if therapy is to be discontinued , it is suggested that zebeta be discontinued for several days before the withdrawal of clonidine .
ZEBETA	verapamil	advise	zebeta should be used with care when myocardial depressants or inhibitors of av conduction , such as certain calcium antagonists ( particularly of the phenylalkylamine [ verapamil ] and benzothiazepine [ diltiazem ] classes ) , or antiarrhythmic agents , such as disopyramide , are used concurrently .
Amphetamines	tricyclic antidepressants	effect	amphetamines may enhance the effects of tricyclic antidepressants .
ergot-type medications	naratriptan	advise	because there is a theoretical basis that these effects may be additive , use of ergotamine containing or ergot-type medications ( like dihydroergotamine or methysergide ) and naratriptan within dg hours is contraindicated .
SPRYCEL	itraconazole	mechanism	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
SPRYCEL	atazanavir	mechanism	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
SPRYCEL	nefazodone	mechanism	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
H2 blockers	SPRYCEL	advise	the use of antacids should be considered in place of h2 blockers or proton pump inhibitors in patients receiving sprycel therapy .
quinidine	SPRYCEL	advise	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
ergotamine	SPRYCEL	advise	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
clozapine	Type 1C antiarrhythmics	advise	therefore , co administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide and encainide ) , or that inhibit this enzyme ( e.g. , quinidine ) , should be approached with caution .
clozapine	encainide	advise	therefore , co administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide and encainide ) , or that inhibit this enzyme ( e.g. , quinidine ) , should be approached with caution .
Etonogestrel	antifungals	int	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo dur ) , and vitamin c .
Etonogestrel	Sandimmune	int	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo dur ) , and vitamin c .
Etonogestrel	Crixivan	int	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo dur ) , and vitamin c .
felbamate	progestins	mechanism	anticonvulsants ( carbamazepine , felbamate , phenobarbital , phenytoin , topiramate ) : increase the metabolism of ethinyl estradiol and / or some progestins , leading to possible decrease in contraceptive effectiveness .
phenytoin	ethinyl estradiol	mechanism	anticonvulsants ( carbamazepine , felbamate , phenobarbital , phenytoin , topiramate ) : increase the metabolism of ethinyl estradiol and / or some progestins , leading to possible decrease in contraceptive effectiveness .
hormonal contraceptives	chlordiazepoxide	mechanism	benzodiazepines : combination hormonal contraceptives may decrease the clearance of some benzodiazepines ( alprazolam , chlordiazepoxide , diazepam ) and increase the clearance of others ( lorazepam , oxazepam , temazepam ) .
hormonal contraceptives	oxazepam	mechanism	benzodiazepines : combination hormonal contraceptives may decrease the clearance of some benzodiazepines ( alprazolam , chlordiazepoxide , diazepam ) and increase the clearance of others ( lorazepam , oxazepam , temazepam ) .
Nevirapine	combination hormonal contraceptives	mechanism	non nucleoside reverse transcriptase inhibitors ( nnrtis ) : nevirapine may decrease plasma levels of combination hormonal contraceptives ;
ritonavir	combination hormonal contraceptives	mechanism	protease inhibitors : amprenavir , lopinavir , nelfinavir , and ritonavir have been shown to decrease plasma levels of combination hormonal contraceptives ;
Combination hormonal contraceptives	selegiline	mechanism	selegiline : combination hormonal contraceptives may increase the serum concentration of selegiline .
troleandomycin	corticosteroids	mechanism	drugs such as troleandomycin and ketoconazole may inhibit the metabolism of corticosteroids and thus decrease their clearance .
acetylsalicylic acid	heparin sodium	effect	platelet inhibitors : drugs such as acetylsalicylic acid , dextran , phenylbutazone , ibuprofen , indomethacin , dipyridamole , hydroxychloroquine and others that interfere with platelet aggregation reactions ( the main hemostatic defense of heparinized patients ) may induce bleeding and should be used with caution in patients receiving heparin sodium .
dextran	heparin sodium	effect	platelet inhibitors : drugs such as acetylsalicylic acid , dextran , phenylbutazone , ibuprofen , indomethacin , dipyridamole , hydroxychloroquine and others that interfere with platelet aggregation reactions ( the main hemostatic defense of heparinized patients ) may induce bleeding and should be used with caution in patients receiving heparin sodium .
hydroxychloroquine	heparin sodium	effect	platelet inhibitors : drugs such as acetylsalicylic acid , dextran , phenylbutazone , ibuprofen , indomethacin , dipyridamole , hydroxychloroquine and others that interfere with platelet aggregation reactions ( the main hemostatic defense of heparinized patients ) may induce bleeding and should be used with caution in patients receiving heparin sodium .
beta-blocker	clonidine	advise	should it be decided to discontinue therapy in patients receiving beta-blockers and clonidine concurrently , the beta-blocker should be discontinued slowly over several days before the gradual withdrawal of clonidine .
Clonidine	barbiturates	effect	amitriptyline in combination with clonidine enhances the manifestation of corneal lesions in rats epidural injection clonidine may potentiate the cns depressive effect of alcohol , barbiturates or other sedating drugs .
Hydrochlorothiazide	ketoprofen	effect	diuretic : hydrochlorothiazide , given concomitantly with ketoprofen , produces a reduction in urinary potassium and chloride excretion compared to hydrochlorothiazide alone .
ketoprofen	lithium	advise	it is recommended that plasma lithium levels be monitored when ketoprofen is coadministered with lithium .
bupropion	amantadine	effect	levodopa and amantadine : limited clinical data suggest a higher incidence of adverse experiences in patients receiving bupropion concurrently with either levodopa or amantadine .
tetracyclines	penicillin	advise	since bacteriostatic drugs may interfere with the bactericidal action of penicillin , it is advisable to avoid giving tetracyclines in conjunction with penicillin .
Chlorprothixene	lithium	mechanism	chlorprothixene may increase the plasma level of concomitantly given lithium .
phenytoin	Norpace	mechanism	if phenytoin or other hepatic enzyme inducers are taken concurrently with norpace or norpace cr , lower plasma levels of disopyramide may occur .
guanfacine	CNS-depressant drug	effect	the potential for increased sedation when guanfacine is given with other cns-depressant drug should be appreciated .
timolol	guanfacine	effect	noncardioselective beta blockers ( nadolol , porpranolol , timolol ) may exacerbate rebound hypertension when guanfacine is withdrawn .
aripiprazole	quinidine	mechanism	quinidine : coadministration of a dg mg single dose of aripiprazole with quinidine ( dg mg / day for dg days ) , a potent inhibitor of cyp2d6 , increased the auc of aripiprazole by dg % but decreased the auc of its active metabolite , dehydroaripiprazole , by dg % .
aripiprazole	antihypertensive agents	effect	dg adrenergic receptor antagonism , aripiprazole has the potential to enhance the effect of certain antihypertensive agents .
carbamazepine	aripiprazole	advise	when carbamazepine is added to aripiprazole therapy , aripiprazole dose should be doubled .
FOSCAVIR	amphotericin B	advise	because of foscarnets tendency to cause renal impairment , the use of foscavir should be avoided in combination with potentially nephrotoxic drugs such as aminoglycosides , amphotericin b and intravenous pentamidine unless the potential benefits outweigh the risks to the patient .
heroin	central nervous system depressants	effect	toxicology studies of heroin related deaths reveal frequent involvement of other central nervous system depressants , including alcohol , benzodiazepines such as diazepam ( valium ) , and , to a rising degree , methadone .
heroin	benzodiazepines	effect	toxicology studies of heroin related deaths reveal frequent involvement of other central nervous system depressants , including alcohol , benzodiazepines such as diazepam ( valium ) , and , to a rising degree , methadone .
antacids	lomefloxacin	mechanism	magnesium and aluminum containing antacids , administered concomitantly with lomefloxacin , significantly decreased the bioavailability ( dg % ) of lomefloxacin .
glimepiride	salicylate	advise	before taking glimepiride , tell your doctor if you are taking any of the following medicines : aspirin or another salicylate such as magnesium / choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto bismol ) ;
glimepiride	Trilisate	advise	before taking glimepiride , tell your doctor if you are taking any of the following medicines : aspirin or another salicylate such as magnesium / choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto bismol ) ;
erythromycin	bromocriptine	int	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
erythromycin	astemizole	int	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
terfenadine	dirithromycin	mechanism	in one man , the c max of terfenadine was dg ng / ml with terfenadine alone and dg ng / ml with terfenadine plus dirithromycin .
azithromycin	nelfinavir	advise	although a dose adjustment of azithromycin is not recommended when administered in combination with nelfinavir , close monitoring for known side effects of azithromycin , such as liver enzyme abnormalities and hearing impairment , is warranted .
azithromycin	theophylline	mechanism	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim / sulfamethoxazole or zidovudine .
azithromycin	cetirizine	mechanism	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim / sulfamethoxazole or zidovudine .
L-phenylalanine	selegiline	effect	selegiline l-phenylalanine and the selective mao inhibitor selegiline may have synergistic antidepressant activity if used concomitantly .
SUSTIVA	clarithromycin	effect	in uninfected volunteers , dg % developed rash while receiving sustiva and clarithromycin .
ritonavir	SUSTIVA	advise	a dose increase of lopinavir / ritonavir to dg / dg mg ( dg capsules or dg ml ) twice daily taken with food is recommended when used in combination with sustiva .
efavirenz	contraceptives	advise	because the potential interaction of efavirenz with oral contraceptives has not been fully characterized , a reliable method of barrier contraception should be used in addition to oral contraceptives .
irbesartan	aliskiren	mechanism	co administration of irbesartan reduced aliskiren cmax up to dg % after multiple dosing .
aliskiren	furosemide	mechanism	furosemide : when aliskiren was co administered with furosemide , the auc and cmax of furosemide were reduced by about dg % and dg % , respectively .
metformin	Acarbose	mechanism	however , the peak plasma level of metformin was reduced by approximately dg % when taking acarbose due to a slight delay in the absorption of metformin .
Intestinal adsorbents	Acarbose	mechanism	intestinal adsorbents ( e. g. , charcoal ) and digestive enzyme preparations containing carbohydrate splitting enzymes ( e. g. , amylase , pancreatin ) may reduce the effect of acarbose and should not be taken concomitantly .
Bentiromide	thiazide diuretics	int	bentiromide may interact with acetaminophen ( e.g. , tylenol ) , chloramphenicol ( e.g. , chloromycetin ) , local anesthetics ( e.g. , benzocaine and lidocaine ) , para aminobenzoic acid ( paba ) containing preparations ( e.g. , sunscreens and some multivitamins ) , procainamide ( e.g. , pronestyl ) , sulfonamides ( sulfa medicines ) , thiazide diuretics ( use of these medicines during the test period will affect the test results ) , and pancreatic supplements ( use of pancreatic supplements may give false test results ) .
Bentiromide	benzocaine	int	bentiromide may interact with acetaminophen ( e.g. , tylenol ) , chloramphenicol ( e.g. , chloromycetin ) , local anesthetics ( e.g. , benzocaine and lidocaine ) , para aminobenzoic acid ( paba ) containing preparations ( e.g. , sunscreens and some multivitamins ) , procainamide ( e.g. , pronestyl ) , sulfonamides ( sulfa medicines ) , thiazide diuretics ( use of these medicines during the test period will affect the test results ) , and pancreatic supplements ( use of pancreatic supplements may give false test results ) .
cholestyramine	thyroid hormones	advise	therefore , dg to dg hours should elapse between administration of cholestyramine and thyroid hormones .
levothyroxine	estrogens	mechanism	in a patient with a nonfunctioning thyroid gland who is receiving thyroid replacement therapy , free levothyroxine may be decreased when estrogens are started thus increasing thyroid requirements .
lithium	angiotensin II receptor antagonists	mechanism	lithium reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with ace inhibitors , and with some angiotensin ii receptor antagonists .
lithium	ATACAND	mechanism	an increase in serum lithium concentration has been reported during concomitant administration of lithium with atacand , so careful monitoring of serum lithium levels is recommended during concomitant use .
Duloxetine	thioridazine	advise	because of the risk of serious ventricular arrhythmias and sudden death potentially associated with elevated plasma levels of thioridazine , duloxetine and thioridazine should not be co administered .
Duloxetine	nortriptyline	advise	therefore , co administration of duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain antidepressants ( tricyclic antidepressants [ tcas ] , such as nortriptyline , amitriptyline , and imipramine ) , phenothiazines and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution .
Duloxetine	imipramine	advise	therefore , co administration of duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain antidepressants ( tricyclic antidepressants [ tcas ] , such as nortriptyline , amitriptyline , and imipramine ) , phenothiazines and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution .
Duloxetine	phenothiazines	advise	therefore , co administration of duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain antidepressants ( tricyclic antidepressants [ tcas ] , such as nortriptyline , amitriptyline , and imipramine ) , phenothiazines and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution .
Duloxetine	Type 1C antiarrhythmics	advise	therefore , co administration of duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain antidepressants ( tricyclic antidepressants [ tcas ] , such as nortriptyline , amitriptyline , and imipramine ) , phenothiazines and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution .
Cimetidine	TIKOSYN	mechanism	cimetidine at dg mg bid ( the usual prescription dose ) co administered with tikosyn ( dg mcg bid ) for dg days has been shown to increase dofetilide plasma levels by dg % .
diltiazem	TIKOSYN	advise	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
nefazadone	TIKOSYN	advise	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
acetaminophen	narcotic analgesic	effect	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative hypnotics , or other cns depressants , causing increased cns depression .
acetaminophen	sedative-hypnotics	effect	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative-hypnotics , or other cns depressants , causing increased cns depression .
caffeine	alcohol	effect	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative hypnotics , or other cns depressants , causing increased cns depression .
caffeine	tranquilizers	effect	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative hypnotics , or other cns depressants , causing increased cns depression .
Butalbital	anesthetics	effect	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative hypnotics , or other cns depressants , causing increased cns depression .
amyl nitrite	alcohol	effect	taking amyl nitrite after drinking alcohol may worsen side effects and may cause severe hypotension and cardiovascular collapse .
quinolones	cyclosporine	mechanism	elevated cyclosporine serum levels have been reported with the concomitant use of quinolones and cyclosporine .
quinolones	didanosine	mechanism	also , concomitant administration of quinolones with products containing iron , multivitamins containing zinc , or videx ( didanosine ) chewable / buffered tablets or the pediatric powder for oral solution may result in low urine levels .
epinephrine	monoamine oxidase inhibitors	effect	the administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe , prolonged hypertension .
diltiazem	cimetidine	advise	patients currently receiving diltiazem therapy should be carefully monitored for a change in pharmacological effect when initiating and discontinuing therapy with cimetidine .
diltiazem	midazolam	mechanism	studies showed that diltiazem increased the auc of midazolam and triazolam by dg dg fold and the cmax by dg fold , compared to placebo .
rifampin	diltiazem	mechanism	coadministration of rifampin with diltiazem lowered the diltiazem plasma concentrations to undetectable levels .
Cholestyramine	progestins	mechanism	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
Cholestyramine	phenobarbital	mechanism	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
danazol	lovastatin	effect	danazol : the risk of myopathy / rhabdomyolysis is increased by concomitant administration of danazol particularly with higher doses of lovastatin ( see warnings , myopathy / rhabdomyolysis ) .
verapamil	HMG-CoA reductase inhibitor class	effect	amiodarone or verapamil : the risk of myopathy / rhabdomyolysis is increased when either amiodarone or verapamil is used concomitantly with a closely related member of the hmg-coa reductase inhibitor class ( see warnings , myopathy / rhabdomyolysis ) .
pimozide	citalopram	effect	pimozide and celexa in a controlled study , a single dose of pimozide dg mg co administered with racemic citalopram dg mg given once daily for dg days was associated with a mean increase in qtc values of approximately dg msec compared to pimozide given alone .
antidiabetic agents	VELCADE	advise	patients on oral antidiabetic agents receiving velcade treatment may require close monitoring of their blood glucose levels and adjustment of the dose of their antidiabetic medication .
minoxidil	guanethidine	effect	interaction with guanethidine : although minoxidil does not itself cause orthostatic hypotension , its administration to patients already receiving guanethidine can result in profound orthostatic effects .
Salicylate	sulfinpyrazone	mechanism	salicylate competes with a number of drugs for protein binding sites , notably penicillin , thiopental , thyroxine , triiodothyronine , phenytoin , sulfinpyrazone , naproxen , warfarin , methotrexate , and possibly corticosteroids .
phenobarbital	methylprednisolone	advise	drugs that induce hepatic enzymes such as phenobarbital , phenytoin , and rifampin may increase the clearance of methylprednisolone and may require increased in methylprednisolone dose to achieve the desired response .
Oxandrolone	hypoglycemic agents	mechanism	oral hypoglycemic agents oxandrolone may inhibit the metabolism of oral hypoglycemic agents .
anticholinergic drugs	nitrates	effect	the following agents may increase certain actions or side effects of anticholinergic drugs : amantadine , antiarrhythmic agents of class i ( e.g. , quinidine ) , antihistamines , antipsychotic agents ( e.g. , phenothiazines ) , benzodiazepines , mao inhibitors , narcotic analgesics ( e.g. , meperidine ) , nitrates and nitrites , sympathomimetic agents , tricyclic antidepressants , and other drugs having anticholinergic activity .
anticholinergic drugs	quinidine	effect	the following agents may increase certain actions or side effects of anticholinergic drugs : amantadine , antiarrhythmic agents of class i ( e.g. , quinidine ) , antihistamines , antipsychotic agents ( e.g. , phenothiazines ) , benzodiazepines , mao inhibitors , narcotic analgesics ( e.g. , meperidine ) , nitrates and nitrites , sympathomimetic agents , tricyclic antidepressants , and other drugs having anticholinergic activity .
methsuximide	phenytoin	mechanism	since celontin ( methsuximide ) may interact with concurrently administered antiepileptic drugs , periodic serum level determinations of these drugs may be necessary ( eg methsuximide may increase the plasma concentrations of phenytoin and phenobarbital ) .
Furosemide	metolazone	effect	diuretics : furosemide and probably other loop diuretics given concomitantly with metolazone can cause unusually large or prolonged losses of fluid and electrolytes .
Methenamine	metolazone	effect	methenamine : efficacy may be decreased due to urinary alkalizing effect of metolazone .
ketoconazole	ropivacaine	mechanism	coadministration of a selective and potent inhibitor of cyp3a4 , ketoconazole ( dg mg bid for dg days with ropivacaine infusion administered dg hour after ketoconazole ) caused a dg % reduction in in vivo plasma clearance of ropivacaine .
aspirin	meloxicam	mechanism	aspirin : concomitant administration of aspirin ( dg mg tid ) to healthy volunteers tended to increase the auc ( dg % ) and cmax ( dg % ) of meloxicam .
cholestyramine	meloxicam	mechanism	cholestyramine : pretreatment for four days with cholestyramine significantly increased the clearance of meloxicam by dg % .
nondepolarizing agents	lithium	effect	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
nondepolarizing agents	quinidine	effect	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
NIMBEX	bacitracin	effect	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
phenytoin	NIMBEX	effect	while the effects of chronic phenytoin or carbamazepine therapy on the action of nimbex are unknown , slightly shorter durations of neuromuscular block may be anticipated and infusion rate requirements may be higher .
nitrous oxide	NIMBEX	effect	isoflurane or enflurane administered with nitrous oxide / oxygen to achieve dg mac [ minimum alveolar concentration ] may prolong the clinically effective duration of action of initial and maintenance doses of nimbex and decrease the required infusion rate of nimbex .
Barbiturates	corticosteroids	int	barbiturates may decrease the effectiveness of oral contraceptives , certain antibiotics , quinidine , theophylline , corticosteroids , anticoagulants , and beta blockers .
terazosin	ProAmatine	effect	proamatine. alpha adrenergic blocking agents , such as prazosin , terazosin , and doxazosin , can antagonize the effects of proamatine. potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of desglymidodrine ( a base ) is due to active tubular secretion by the base secreting system also responsible for the secretion of such drugs as metformin , cimetidine , ranitidine , procainamide , triamterene , flecainide , and quinidine .
John's Wort	hormonal contraceptive agents	effect	john's wort with hormonal contraceptive agents may reduce the effectiveness of the contraception and up to one month after discontinuation of these concomitant therapies .
MAO inhibitors	pseudoephedrine	effect	mao inhibitors and beta adrenergic blockers increase the effects of pseudoephedrine .
Leukine	lithium	effect	drugs which may potentiate the myeloproliferative effects of leukine , such as lithium and corticosteroids , should be used with caution .
Leukine	corticosteroids	effect	drugs which may potentiate the myeloproliferative effects of leukine , such as lithium and corticosteroids , should be used with caution .
gemfibrozil	rosiglitazone	mechanism	an inhibitor of cyp2c8 ( such as gemfibrozil ) may increase the auc of rosiglitazone and an inducer of cyp2c8 ( such as rifampin ) may decrease the auc of rosiglitazone .
Beta adrenergic agonists	monoamine oxidase inhibitors	advise	beta adrenergic agonists should be administered with caution to patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants , since the action of beta adrenergic agonists on the vascular system may be potentiated .
anticholinergic drugs	triprolidine	effect	the effects of anticholinergic drugs , such as atropine and tricyclic antidepressants may be enhanced by the concomitant administration of triprolidine .
tricyclic antidepressants	triprolidine	effect	the effects of anticholinergic drugs , such as atropine and tricyclic antidepressants may be enhanced by the concomitant administration of triprolidine .
ZADAXIN	immunomodulating drugs	advise	caution should be exercised when administering zadaxin therapy in combination with other immunomodulating drugs .
TOBI	corticosteroids	effect	in clinical studies of tobi , patients taking tobi concomitantly with dornase alfa ( pulmozyme , genentech ) , ( beta ) agonists , inhaled corticosteroids , other anti pseudomonal antibiotics , or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole .
mexiletine	fluvoxamine	mechanism	in a formal , single dose interaction study ( n = dg males ) the clearance of mexiletine was decreased by dg % following the coadministration of fluvoxamine , an inhibitor of cyp1a2 .
Mexitil	theophylline	mechanism	concurrent use of mexitil and theophylline may lead to increased plasma theophylline levels .
phenytoin	Mexitil	mechanism	when phenytoin or other hepatic enzyme inducers such as rifampin and phenobarbital have been taken concurrently with mexitil , lowered mexitil plasma levels have been reported .
short-acting beta adrenergic aerosol bronchodilators	MAXAIR AUTOHALER	advise	other short-acting beta adrenergic aerosol bronchodilators should not be used concomitantly with maxair autohaler because they may have additive effects .
Mephenytoin	furosemide	effect	mephenytoin may also affect the effects of other drugs , which include some steroid medications , warfarin , certain heart medicines , birth control pills , anti infective medicines , furosemide and theophylline please note that mephenytoin may interact with other drugs that are not listed here .
Ritalin	phenobarbital	mechanism	human pharmacologic studies have shown that ritalin may inhibit the metabolism of coumarin anticoagulants , anticonvulsants ( phenobarbital , diphenylhydantoin , primidone ) , phenylbutazone , and tricyclic drugs ( imipramine , clomipramine , desipramine ) .
SUTENT	rifabutin	mechanism	co administration of sutent with inducers of the cyp3a4 family ( e.g. , dexamethasone , phenytoin , carbamazepine , rifampin , rifabutin , rifapentin , phenobarbital , st. johns wort ) may decrease sunitinib concentrations .
SUTENT	rifapentin	mechanism	co administration of sutent with inducers of the cyp3a4 family ( e.g. , dexamethasone , phenytoin , carbamazepine , rifampin , rifabutin , rifapentin , phenobarbital , st. johns wort ) may decrease sunitinib concentrations .
anticoagulant	diuretics	effect	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under dosage .
anticoagulant	rifampin	effect	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under dosage .
anticoagulant	adrenocortical steroids	effect	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom bin time response , in man significantly include : adrenocortical steroids ;
anticoagulant	diazoxide	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
anticoagulant	aminosalicylic acid	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
anticoagulant	influenza virus vaccine	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
anticoagulant	methyldopa	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
anticoagulant	prolonged narcotics	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
anticoagulant	quinine	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
anticoagulant	sulindac	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
non-steroidal anti-inflammatory drugs	anticoagulants	effect	drugs that reduce the number of blood platelets by causing bone marrow depression ( such as antineoplastic agents ) or drugs which inhibit platelet function ( eg , aspirin and other non-steroidal anti-inflammatory drugs , dipyridamole , hydrochloroquine , clofibrate , dextran ) may increase the bleeding tendency produced by anticoagulants without altering prothrombin time determinations .
clofibrate	anticoagulants	effect	drugs that reduce the number of blood platelets by causing bone marrow depression ( such as antineoplastic agents ) or drugs which inhibit platelet function ( eg , aspirin and other non steroidal anti inflammatory drugs , dipyridamole , hydrochloroquine , clofibrate , dextran ) may increase the bleeding tendency produced by anticoagulants without altering prothrombin time determinations .
antineoplastic agents	anticoagulants	effect	drugs that reduce the number of blood platelets by causing bone marrow depression ( such as antineoplastic agents ) or drugs which inhibit platelet function ( eg , aspirin and other non steroidal anti inflammatory drugs , dipyridamole , hydrochloroquine , clofibrate , dextran ) may increase the bleeding tendency produced by anticoagulants without altering prothrombin time determinations .
antiplatelet medication	anticoagulant medication	advise	the beneficial effects on arterial thrombus formation from combined therapy with antiplatelet and anticoagulant medication must be weighed against an increased risk of inducing hemorrhage .
amiloride	ACE inhibitors	effect	use of potassium sparing diuretics ( spironolactone , triamterene , amiloride ) or potassium supplements concomitantly with ace inhibitors can increase the risk of hyperkalemia .
tigecycline	warfarin	advise	prothrombin time or other suitable anticoagulation test should be monitored if tigecycline is administered with warfarin .
Melatonin	benzodiazepenes	int	melatonin may interact with the following drugs : aspirin and other nsaids ( may lower melatonin levels ) , fluvoxamine ( bioavailability of oral melatonin is increased with coadministration ) , beta blockers ( may decrease melatonin levels ) , fluoxetine ( reports of psychotic episodes when coadministered ) , progestin ( coadministration of melatonin with progestin can inhibit ovarian function in women ) , benzodiazepenes and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects ) , and corticosteroids ( coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids ) .
Streptozocin	doxorubicin	mechanism	streptozocin has been reported to prolong the elimination half life of doxorubicin and may lead to severe bone marrow suppression ;
Cholestyramine	raloxifene	mechanism	cholestyramine : cholestyramine causes a dg % reduction in the absorption and enterohepatic cycling of raloxifene and should not be coadministered with evista .
EVISTA	warfarin	advise	if evista is given concurrently with warfarin , prothrombin time should be monitored .
Sulfamethizole	tolbutamide	effect	sulfamethizole may increase the effects of barbiturates , tolbutamide , and uricosurics .
Sulfamethizole	uricosurics	effect	sulfamethizole may increase the effects of barbiturates , tolbutamide , and uricosurics .
metoclopramide	anticholinergic drugs	effect	the effects of metoclopramide on gastrointestinal motility are antagonized by anticholinergic drugs and narcotic analgesics .
metoclopramide	narcotic analgesics	effect	the effects of metoclopramide on gastrointestinal motility are antagonized by anticholinergic drugs and narcotic analgesics .
Methscopolamine	amantadine	int	methscopolamine may interact with antidepressants ( tricyclic type ) , mao inhibitors ( e.g. , phenelzine , linezolid , tranylcypromine , isocarboxazid , selegiline , furazolidone ) , quinidine , amantadine , antihistamines ( e.g. , diphenhydramine ) , other anticholinergics , potassium chloride supplements , antacids , absorbent type anti diarrhea medicines ( e.g. , kaolin pectin ) , phenothiazines ( e.g. , chlorpromazine , promethazine ) .
Methscopolamine	anticholinergics	int	methscopolamine may interact with antidepressants ( tricyclic type ) , mao inhibitors ( e.g. , phenelzine , linezolid , tranylcypromine , isocarboxazid , selegiline , furazolidone ) , quinidine , amantadine , antihistamines ( e.g. , diphenhydramine ) , other anticholinergics , potassium chloride supplements , antacids , absorbent type anti diarrhea medicines ( e.g. , kaolin pectin ) , phenothiazines ( e.g. , chlorpromazine , promethazine ) .
Methscopolamine	phenothiazines	int	methscopolamine may interact with antidepressants ( tricyclic type ) , mao inhibitors ( e.g. , phenelzine , linezolid , tranylcypromine , isocarboxazid , selegiline , furazolidone ) , quinidine , amantadine , antihistamines ( e.g. , diphenhydramine ) , other anticholinergics , potassium chloride supplements , antacids , absorbent type anti diarrhea medicines ( e.g. , kaolin pectin ) , phenothiazines ( e.g. , chlorpromazine , promethazine ) .
Methscopolamine	chlorpromazine	int	methscopolamine may interact with antidepressants ( tricyclic type ) , mao inhibitors ( e.g. , phenelzine , linezolid , tranylcypromine , isocarboxazid , selegiline , furazolidone ) , quinidine , amantadine , antihistamines ( e.g. , diphenhydramine ) , other anticholinergics , potassium chloride supplements , antacids , absorbent type anti diarrhea medicines ( e.g. , kaolin pectin ) , phenothiazines ( e.g. , chlorpromazine , promethazine ) .
Methscopolamine	phenelzine	int	methscopolamine may interact with antidepressants ( tricyclic type ) , mao inhibitors ( e.g. , phenelzine , linezolid , tranylcypromine , isocarboxazid , selegiline , furazolidone ) , quinidine , amantadine , antihistamines ( e.g. , diphenhydramine ) , other anticholinergics , potassium chloride supplements , antacids , absorbent type anti diarrhea medicines ( e.g. , kaolin pectin ) , phenothiazines ( e.g. , chlorpromazine , promethazine ) .
L-glutamine	indomethacin	effect	indomethacin concomitant use of l-glutamine and indomethacin may ameliorate increased intestinal permeability caused by indomethacin .
methotrexate	L-glutamine	effect	methotrexate there is one report that methotrexate may decrease the possible effectiveness of supplemental l-glutamine for chemotherapy induced mucositis .
ZEMURON	succinylcholine	advise	if zemuron is administered following administration of succinylcholine , it should not be given until recovery from succinylcholine has been observed .
phenytoin	mifepristone	mechanism	john s wort , and certain anticonvulsants ( phenytoin , phenobarbital , carbamazepine ) may induce mifepristone metabolism ( lowering serum levels of mifepristone ) .
cimetidine	mebendazole	mechanism	preliminary evidence suggests that cimetidine inhibits mebendazole metabolism and may result in an increase in plasma concentrations of mebendazole .
pantoprazole	ketoconazole	mechanism	because of profound and long lasting inhibition of gastric acid secretion , pantoprazole may interfere with absorption of drugs where gastric ph is an important determinant of their bioavailability ( eg , ketoconazole , ampicillin esters , and iron salts ) .
adrenergic agents	tricyclic antidepressants	effect	the pressor response of adrenergic agents may also be potentiated by tricyclic antidepressants .
digoxin	sulfasalazine	mechanism	reduced absorption of folic acid and digoxin have been reported when those agents were administered concomitantly with sulfasalazine .
Cerezyme	ZAVESCA	advise	combination therapy with cerezyme ( imiglucerase ) and zavesca is not indicated .
FLOMAX	alpha-adrenergic blocking agents	advise	however , interactions may be expected and flomax capsules should not be used in combination with other alpha-adrenergic blocking agents .
Lamivudine	zalcitabine	effect	lamivudine and zalcitabine may inhibit the intracellular phosphorylation of one another .
rimantadine HCl	Cimetidine	mechanism	when a single dg mg dose of rimantadine hcl was administered one hour after the initiation of cimetidine ( dg mg four times a day ) , the apparent total rimantadine clearance of this single dose in normal healthy adults was reduced by dg % ( compared to the apparent total rimantadine clearance in the same subjects in the absence of cimetidine ) .
acetaminophen	rimantadine	mechanism	coadministration with acetaminophen reduced the peak concentration and auc values for rimantadine by approximately dg % .
tetracyclines	magnesium	mechanism	absorption of tetracyclines is impaired by antacids containing aluminum , calcium or magnesium , and iron containing preparations .
Sanctura	morphine	mechanism	drugs eliminated by active tubular secretion : although studies to assess drug drug interactions with sanctura have not been conducted , sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion ( e.g. digoxin , procainamide , pancuronium , morphine , vancomycin , metformin and tenofovir ) .
mazindol	monoamine oxidase inhibitor	advise	you can not take mazindol if you have taken a monoamine oxidase inhibitor ( maoi ) such as isocarboxazid ( marplan ) , tranylcypromine ( parnate ) , or phenelzine ( nardil ) in the last dg days .
mazindol	isocarboxazid	advise	you can not take mazindol if you have taken a monoamine oxidase inhibitor ( maoi ) such as isocarboxazid ( marplan ) , tranylcypromine ( parnate ) , or phenelzine ( nardil ) in the last dg days .
BUSULFEX	phenytoin	mechanism	since the pharmacokinetics of busulfex were studied in patients treated with phenytoin , the clearance of busulfex at the recommended dose may be lower and exposure ( auc ) higher in patients not treated with phenytoin .
acetaminophen	BUSULFEX	mechanism	because busulfan is eliminated from the body via conjugation with glutathione , use of acetaminophen prior to ( dg hours ) or concurrent with busulfex may result in reduced busulfan clearance based upon the known property of acetaminophen to decrease glutathione levels in the blood and tissues .
sertraline	sumatriptan	effect	therefore , the use of sumatriptan succinate tablets in patients receiving mao a inhibitors is contraindicated . selective serotonin reuptake inhibitors ( ssris ) ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with sumatriptan .
sumatriptan	SSRI	advise	if concomitant treatment with sumatriptan and an ssri is clinically warranted , appropriate observation of the patient is advised .
aminosalicylate derivatives	thioguanine	mechanism	as there is in vitro evidence that aminosalicylate derivatives ( e.g. , olsalazine , mesalazine , or sulphasalazine ) inhibit the tpmt enzyme , they should be administered with caution to patients receiving concurrent thioguanine therapy .
olsalazine	thioguanine	mechanism	as there is in vitro evidence that aminosalicylate derivatives ( e.g. , olsalazine , mesalazine , or sulphasalazine ) inhibit the tpmt enzyme , they should be administered with caution to patients receiving concurrent thioguanine therapy .
mesalazine	thioguanine	mechanism	as there is in vitro evidence that aminosalicylate derivatives ( e.g. , olsalazine , mesalazine , or sulphasalazine ) inhibit the tpmt enzyme , they should be administered with caution to patients receiving concurrent thioguanine therapy .
Isopto Carbachol	suprofen	effect	other eye drops or medications such as acetylcholine chloride ( miochol ) and carbachol ( carboptic , isopto carbachol ) may decrease the effects of suprofen ophthalmic .
paricalcitol	clarithromycin	advise	a multiple dose drug drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol auc0 . since paricalcitol is partially metabolized by cyp3a and ketoconazole le is known to be a strong inhibitor of cytochrome p450 3a enzyme , care should be taken while dosing paricalcitol with ketoconazole and other strong p450 3a inhibitors including atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin or voriconazole .
paricalcitol	saquinavir	advise	a multiple dose drug drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol auc0 . since paricalcitol is partially metabolized by cyp3a and ketoconazole le is known to be a strong inhibitor of cytochrome p450 3a enzyme , care should be taken while dosing paricalcitol with ketoconazole and other strong p450 3a inhibitors including atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin or voriconazole .
zidovudine	ZERIT	advise	therefore , use of zidovudine in combination with zerit should be avoided .
stavudine	doxorubicin	effect	in vitro data indicate that the phosphorylation of stavudine is also inhibited at relevant concentrations by doxorubicin and ribavirin .
Thiazide drugs	tubocurarine	effect	thiazide drugs may increase the responsiveness of tubocurarine .
Lithium	thiazides	mechanism	lithium renal clearance is reduced by thiazides , increasing the risk of lithium toxicity .
indomethacin	pramipexole	mechanism	other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g. , cimetidine , ranitidine , diltiazem , triamterene , verapamil , quinidine , and quinine ) decreases the oral clearance of pramipexole by about dg % , while those secreted by the anionic transport system ( e.g. , cephalosporins , penicillins , indomethacin , hydrochlorothiazide , and chlorpropamide ) are likely to have little effect on the oral clearance of pramipexole .
FLUOTHANE	non-depolarising muscle relaxant	effect	fluothane augments the action of non-depolarising muscle relaxants and the muscle relaxant effects of aminoglycosides .
FLUOTHANE	aminoglycosides	effect	fluothane augments the action of non depolarising muscle relaxants and the muscle relaxant effects of aminoglycosides .
adrenaline	FLUOTHANE	advise	caution should be exercised during the administration of adrenaline to patients anaesthetised with fluothane as arrhythmias may be precipitated .
alcohol	mirtazapine	mechanism	alcohol : concomitant administration of alcohol ( equivalent to dg g ) had a minimal effect on plasma levels of mirtazapine ( dg mg ) in dg healthy male subjects .
terfenadine	macrolide antibiotics	advise	concomitant administration of terfenadine with clarithromycin , erythromycin , or troleandomycin is contraindicated : pending full characterization of potential interactions , concomitant administration of terfenadine with other macrolide antibiotics , including azithromycin , is not recommended .
terfenadine	troleandomycin	advise	concomitant administration of terfenadine with clarithromycin , erythromycin , or troleandomycin is contraindicated : pending full characterization of potential interactions , concomitant administration of terfenadine with other macrolide antibiotics , including azithromycin , is not recommended .
valdecoxib	fluconazole	mechanism	concomitant single dose administration of valdecoxib dg mg with multiple doses of ketoconazole and fluconazole produced a significant increase in exposure of valdecoxib .
valdecoxib	fluconazole	mechanism	plasma exposure ( auc ) to valdecoxib was increased dg % when coadministered with fluconazole and dg % when coadministered with ketoconazole .
valdecoxib	omeprazole	mechanism	coadministration with valdecoxib increased exposure of omeprazole ( auc ) by dg % .
valdecoxib	diazepam	effect	although the magnitude of changes in diazepam plasma exposure when coadministered with valdecoxib were not sufficient to warrant dosage adjustments , patients may experience enhanced sedative side effects caused by increased exposure of diazepam under this circumstance .
doxapram	muscle relaxant drugs	effect	in patients who have received muscle relaxants , doxapram may temporarily mask the residual effects of muscle relaxant drugs .
phenobarbital	clonazepam	mechanism	cytochrome p dg inducers , such as phenytoin , carbamazepine and phenobarbital , induce clonazepam metabolism , causing an approximately dg % decrease in plasma clonazepam levels .
benzodiazepine class	narcotics	effect	pharmacodynamic interactions : the cns depressant action of the benzodiazepine class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate hypnotics , antianxiety agents , the phenothiazines , thioxanthene and butyrophenone classes of antipsychotic agents , monoamine oxidase inhibitors and the tricyclic antidepressants , and by other anticonvulsant drugs .
benzodiazepine class	barbiturates	effect	pharmacodynamic interactions : the cns depressant action of the benzodiazepine class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate hypnotics , antianxiety agents , the phenothiazines , thioxanthene and butyrophenone classes of antipsychotic agents , monoamine oxidase inhibitors and the tricyclic antidepressants , and by other anticonvulsant drugs .
benzodiazepine class	phenothiazines classes of antipsychotic agents	effect	pharmacodynamic interactions : the cns depressant action of the benzodiazepine class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate hypnotics , antianxiety agents , the phenothiazines , thioxanthene and butyrophenone classes of antipsychotic agents , monoamine oxidase inhibitors and the tricyclic antidepressants , and by other anticonvulsant drugs .
fluconazole	midazolam	mechanism	drugs such as erythromycin , diltiazem , verapamil , ketoconazole , fluconazole and itraconazole were shown to significantly increase the c max and auc of orally administered midazolam .
carbamazepine	midazolam	mechanism	inducers of cyp3a4 isozymes : cytochrome p450 inducers , such as rifampin , carbamazepine , and phenytoin , induce metabolism and caused a markedly decreased c max and auc of oral midazolam in adult studies .
opioids	levomepromazine	effect	dosages of concomitantly administered opioids should be reduced by approximately half , because levomepromazine amplifies the therapeutic actions and side effects of opioids .
levomepromazine	anticholinergic drugs	advise	exert particular caution in combining levomepromazine with other anticholinergic drugs ( tricyclic antidepressants and antiparkinsonian agents ) : particularly the elderly may develop delirium , high fever , severe obstipation , even ileus and glaucoma .
levomepromazine	antiparkinsonian-agents	advise	exert particular caution in combining levomepromazine with other anticholinergic drugs ( tricyclic antidepressants and antiparkinsonian-agents ) : particularly the elderly may develop delirium , high fever , severe obstipation , even ileus and glaucoma .
ephedrine	levomepromazine	effect	caffeine and / or stimulantes of the ephedrine / amphetamine type may counteract the specific actions of levomepromazine .
oxycodone hydrochloride	CNS depressants	effect	the cns depressant effects of oxycodone hydrochloride may be additive with that of other cns depressants..
fluvoxamine	astemizole	advise	consequently , it is recommended that fluvoxamine not be used in combination with either terbinafine , astemizole , or cisapride .
alprazolam	fluvoxamine	effect	moreover , as noted with alprazolam , the effect of fluvoxamine may even be more pronounced when it is administered at higher doses .
Fluvoxamine	MAOI	advise	therefore , it is recommended that fluvoxamine tablets not be used in combination with maois , or within dg days of discontinuing treatment with a maoi .
cisapride	ketoconazole	mechanism	terfenadine , astemizole and cisapride are all metabolized by the cytochrome p450iiia4 isozyme , and it has been demonstrated that ketoconazole , a potent inhibitor of iiia4 , blocks the metabolism of these drugs , resulting in increased plasma concentrations of parent drug .
phenytoin	ondansetron	mechanism	phenytoin , carbamazepine , and rifampicin : in patients treated with potent inducers of cyp3a4 ( i.e. , phenytoin , carbamazepine , and rifampicin ) , the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased .
carbamazepine	ondansetron	mechanism	phenytoin , carbamazepine , and rifampicin : in patients treated with potent inducers of cyp3a4 ( i.e. , phenytoin , carbamazepine , and rifampicin ) , the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased .
rifampicin	ondansetron	mechanism	phenytoin , carbamazepine , and rifampicin : in patients treated with potent inducers of cyp3a4 ( i.e. , phenytoin , carbamazepine , and rifampicin ) , the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased .
ondansetron	tramadol	effect	however , on the basis of available data , no dosage adjustment for ondansetron is recommended for patients on these drugs.1 , dg tramadol : although no pharmacokinetic drug interaction between ondansetron and tramadol has been observed , data from dg small studies indicate that ondansetron may be associated with an increase in patient controlled administration of tramadol.4 , dg chemotherapy : tumor response to chemotherapy in the p dg mouse leukemia model is not affected by ondansetron .
Ketoconazole	tolterodine	mechanism	cyp3a4 inhibitors : ketoconazole , an inhibitor of the drug metabolizing enzyme cyp3a4 , significantly increased plasma concentrations of tolterodine when coadministered to subjects who were poor metabolizers ( see clinical pharmacology , variability in metabolism and drug drug interactions ) .
itraconazole	DETROL LA	advise	for patients receiving ketoconazole or other potent cyp3a4 inhibitors such as other azole antifungals ( eg , itraconazole , miconazole ) or macrolide antibiotics ( eg , erythromycin , clarithromycin ) or cyclosporine or vinblastine , the recommended dose of detrol la is dg mg daily .
ketoconazole	trimetrexate	mechanism	based on an in vitro rat liver model , nitrogen substituted imidazole drugs ( clotrimazole , ketoconazole , miconazole ) were potent , non competitive inhibitors of trimetrexate metabolism .
heparin	TNKase	effect	anticoagulants ( such as heparin and vitamin k antagonists ) and drugs that alter platelet function ( such as acetylsalicylic acid , dipyridamole , and gp iib / iiia inhibitors ) may increase the risk of bleeding if administered prior to , during , or after tnkase therapy .
MIVACRON	aminoglycosides	int	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as mivacron include certain antibiotics ( e.g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
MIVACRON	tetracyclines	int	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as mivacron include certain antibiotics ( e.g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
nondepolarizing agents	aminoglycosides	int	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as mivacron include certain antibiotics ( e.g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
MIVACRON	colistin	int	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as mivacron include certain antibiotics ( e.g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
MIVACRON	magnesium	int	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as mivacron include certain antibiotics ( e.g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
MIVACRON	anesthetics	int	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as mivacron include certain antibiotics ( e.g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
nondepolarizing agents	tetracyclines	int	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as mivacron include certain antibiotics ( e.g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
nondepolarizing agents	bacitracin	int	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as mivacron include certain antibiotics ( e.g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
DIFLUCAN	theophylline	advise	careful monitoring of serum theophylline concentrations in patients receiving diflucan and theophylline is recommended .
fluconazole	terfenadine	advise	the combined use of fluconazole at doses of dg mg or greater with terfenadine is contraindicated .
DIFLUCAN	coumarin-type anticoagulants	effect	coumarin type anticoagulants : prothrombin time may be increased in patients receiving concomitant diflucan and coumarin-type anticoagulants .
methyldopa	antihypertensive drugs	effect	when methyldopa is used with other antihypertensive drugs , potentiation of antihypertensive effect may occur .
methyldopa	ferrous sulfate	mechanism	several studies demonstrate a decrease in the bioavailability of methyldopa when it is ingested with ferrous sulfate or ferrous gluconate .
methyldopa	ferrous gluconate	advise	coadministration of methyldopa with ferrous sulfate or ferrous gluconate is not recommended .
quinolones	zinc	mechanism	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable / buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
quinolones	VIDEX	mechanism	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable / buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
quinolone antimicrobial	warfarin	advise	however , because some quinolones have been reported to enhance the effects of warfarin or its derivatives , prothrombin time or other suitable anticoagulation test should be monitored closely if a quinolone antimicrobial is administered with warfarin or its derivatives .
procaine hydrochloride	sulfonamides	effect	sulfonamides : concurrent use of procaine hydrochloride and sulfonamides may result in a reduction of the antibacterial action of the sulfonamide .
perindopril	gentamicin	int	gentamicin : animal data have suggested the possibility of interaction between perindopril and gentamicin .
Vindesine	Killed virus vaccines	int	vindesine can interact with the drugs of the following categories : blood dyscrasia : can cause unpredictable myelotoxicity bone marrow depressants : can cause a predictable dose related myelotoxicity radiation therapy : may cause marrow depression neurotoxic medications : can cause neurologic toxicity phenytoin : can increase seizure activity live virus vaccines : may potentiate the replication of the vaccine virus , may increase the side effects of the vaccination , and decrease patient 's response to the vaccine mitomycin c : may cause shortness of breath and bronchospasm killed virus vaccines : may decrease patient 's response to the vaccine
Posicor	astemizole	mechanism	posicor inhibits some of the liver 's ability to metabolize some other drugs terfenadine , astemizole , cisapride , cyclosporine , and tricyclic antidepressants .
Posicor	cyclosporine	mechanism	posicor inhibits some of the liver 's ability to metabolize some other drugs terfenadine , astemizole , cisapride , cyclosporine , and tricyclic antidepressants .
DITROPAN XL	ketoconazole	mechanism	mean oxybutynin chloride plasma concentrations were approximately dg fold higher when ditropan xl was administered with ketoconazole , a potent cyp3a4 inhibitor .
antimycotic agents	oxybutynin	mechanism	other inhibitors of the cytochrome p450 dg enzyme system , such as antimycotic agents ( e.g. , itraconazole and miconazole ) or macrolide antibiotics ( e.g. , erythromycin and clarithromycin ) , may alter oxybutynin mean pharmacokinetic parameters ( i.e. , cmax and auc ) .
cimetidine	isradipine	mechanism	cimetidine : in a study in healthy volunteers , a one week course of cimetidine at dg mg b.i.d. with a single dg mg dose of isradipine on the sixth day showed an increase in isradipine mean peak plasma concentrations ( dg % ) and significant increase in area under the curve ( dg % ) .
INDOCIN	lithium	advise	as a consequence , when indocin and lithium are given concomitantly , the patient should be carefully observed for signs of lithium toxicity .
triamterene	INDOCIN	effect	it has been reported that the addition of triamterene to a maintenance schedule of indocin resulted in reversible acute renal failure in two of four healthy volunteers .
INDOCIN	anticoagulant	advise	however , when any additional drug , including indocin , is added to the treatment of patients on anticoagulant therapy , the patients should be observed for alterations of the prothrombin time .
antipsychotic drug	tricyclic antidepressant	effect	the concurrent use of two or more drugs with anticholinergic activity such as an antipsychotic drug ( eg , chlorpromazine ) , an antiparkinsonian drug ( eg , trihexyphenidyl ) , and / or a tricyclic antidepressant ( eg , amitriptyline ) commonly results in excessive anticholinergic effects , including dry mouth and associated dental complications , blurred vision , and , in patients exposed to high temperature and humidity , hyperpyrexia .
TAMBOCOR	digoxin	mechanism	during administration of multiple oral doses of tambocor to healthy subjects stabilized on a maintenance dose of digoxin , a dg % dg % increase in plasma digoxin levels occurred at six hours postdose .
5-fluorouracil	leucovorin	mechanism	leucovorin : the concentration of 5-fluorouracil is increased and its toxicity may be enhanced by leucovorin .
caffeine	ketoconazole	advise	based on adult data , lower doses of caffeine may be needed following coadministration of drugs which are reported to decrease caffeine elimination ( e.g. , cimetidine and ketoconazole ) and higher caffeine doses may be needed following coadministration of drugs that increase caffeine elimination ( e.g. , phenobarbital and phenytoin ) .
caffeine	phenobarbital	advise	based on adult data , lower doses of caffeine may be needed following coadministration of drugs which are reported to decrease caffeine elimination ( e.g. , cimetidine and ketoconazole ) and higher caffeine doses may be needed following coadministration of drugs that increase caffeine elimination ( e.g. , phenobarbital and phenytoin ) .
Azlocillin	netilmicin	advise	azlocillin should not be administered concomitantly with amikacin , ciprofloxacin , gentamicin , netilmicin , or tobramycin .
idoxuridine	boric acid	advise	when you are using idoxuridine , it is especially important that your health care professional know if you are using the following : eye product containing boric acid .
EQUETROTM	desipramine	mechanism	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( dg ) , oxcarbazepine , phenytoin ( dg ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( dg ) , ziprasidone , and zonisamide .
EQUETROTM	doxycycline	mechanism	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( dg ) , oxcarbazepine , phenytoin ( dg ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( dg ) , ziprasidone , and zonisamide .
EQUETROTM	ethosuximide	mechanism	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( dg ) , oxcarbazepine , phenytoin ( dg ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( dg ) , ziprasidone , and zonisamide .
EQUETROTM	felodipine	mechanism	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( dg ) , oxcarbazepine , phenytoin ( dg ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( dg ) , ziprasidone , and zonisamide .
EQUETROTM	haloperidol	mechanism	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( dg ) , oxcarbazepine , phenytoin ( dg ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( dg ) , ziprasidone , and zonisamide .
EQUETROTM	zonisamide	mechanism	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( dg ) , oxcarbazepine , phenytoin ( dg ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( dg ) , ziprasidone , and zonisamide .
EQUETROTM	citalopram	mechanism	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( dg ) , oxcarbazepine , phenytoin ( dg ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( dg ) , ziprasidone , and zonisamide .
EQUETROTM	alcohol	advise	because of its primary cns effect , caution should be used when equetrotm is taken with other centrally acting drugs and alcohol .
EQUETROTM	niacinamide	mechanism	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( dg ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( dg ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( dg ) , verapamil , zileuton .
EQUETROTM	protease inhibitors	mechanism	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( dg ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( dg ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( dg ) , verapamil , zileuton .
EQUETROTM	valproate	mechanism	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( dg ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( dg ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( dg ) , verapamil , zileuton .
EQUETROTM	clarithromycin	mechanism	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( dg ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( dg ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( dg ) , verapamil , zileuton .
EQUETROTM	erythromycin	mechanism	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( dg ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( dg ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( dg ) , verapamil , zileuton .
EQUETROTM	primidone	mechanism	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( dg ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
Indinavir	didanosine	advise	indinavir and didanosine formulations containing buffer should be administered at least one hour apart on an empty stomach .
antiarrhythmics	CRIXIVAN	advise	caution is warranted and therapeutic concentration monitoring is recommended for antiarrhythmics when coadministered with crixivan .
Cholestyramine	fat soluble vitamins	mechanism	interactions for vitamin d analogues ( vitamin d2 , vitamin d3 , calcitriol , and calcidiol ) : cholestyramine : cholestyramine has been reported to reduce intestinal absorption of fat soluble vitamins ;
amitriptyline HCl	anticholinergic	effect	hyperpyrexia has been reported when amitriptyline hcl is administered with anticholinergic agents or with neuroleptic drugs , particularly during hot weather .
tricyclic antidepressants	anticholinergic	effect	paralytic ileus may occur in patients taking tricyclic antidepressants in combination with anticholinergic type drugs .
Cimetidine	tricyclic antidepressants	mechanism	cimetidine is reported to reduce hepatic metabolism of certain tricyclic antidepressants , thereby delaying elimination and increasing steady state concentrations of these drugs .
Sildenafil	short-acting nitrates	advise	sildenafil is contraindicated in patients using long acting nitrates or who may need to use short-acting nitrates , because the combination may cause a sharp fall of the blood pressure .
alcohol	3-hydroxy-1,4-benzodiazepine	mechanism	the results raise the possibility that the ethanolysis reaction may occur in the stomach of people who consume alcohol and 3-hydroxy-1,4-benzodiazepine on a regular basis .
warfarin	rifampin	int	the drug interaction between warfarin and rifampin is not well known .
rifampin	warfarin	mechanism	the concomitant administration of rifampin and warfarin resulted in the need for an unusually high maintenance dose of warfarin ( dg mg per day ) in order to produce a therapeutic effect .
dexamethasone	EGF	effect	although neither dexamethasone nor retinyl acetate affected the proliferation of prostatic epithelium in rpmi1640 containing transferrin alone , they modify the mitogenic effect of egf and insulin .
retinyl acetate	insulin	effect	although neither dexamethasone nor retinyl acetate affected the proliferation of prostatic epithelium in rpmi1640 containing transferrin alone , they modify the mitogenic effect of egf and insulin .
retinoids	insulin	effect	these results suggest that both dexamethasone and retinyl acetate , and possibly other glucocorticoids and retinoids , may regulate the proliferation of prostate epithelium by a dose dependent modification of the activity of insulin and egf .
dexamethasone	EGF	effect	these results suggest that both dexamethasone and retinyl acetate , and possibly other glucocorticoids and retinoids , may regulate the proliferation of prostate epithelium by a dose dependent modification of the activity of insulin and egf .
retinyl acetate	EGF	effect	these results suggest that both dexamethasone and retinyl acetate , and possibly other glucocorticoids and retinoids , may regulate the proliferation of prostate epithelium by a dose dependent modification of the activity of insulin and egf .
Loperamide	dmPGE2	effect	loperamide and morphine ( dg and dg mg / kg , s.c. ) inhibited the dmpge2 ( dg mg / kg , p.o. ) induced diarrhea in cecectomized rats .
Imexon	dacarbazine	effect	imexon and dacarbazine show additive effects in vitro but not in vivo in human a375 melanoma cells .
acetyl-l-carnitine	alpha-lipoic acid	effect	( ii ) acetyl-l-carnitine elicits a significant protective effect on deb induced toxicity , which was potentiated by alpha-lipoic acid .
prostaglandin F2alpha	oxytocin	int	in vitro interaction of prostaglandin f2alpha and oxytocin in placental vessels .
PGF2alpha	oxytocin	effect	pgf2alpha produced significantly increased vasoconstriction after a single administration of oxytocin .
quinpirole	amphetamine	effect	in female rats , neonatal quinpirole treatment enhanced amphetamine locomotor sensitization compared with quinpirole free controls sensitized to amphetamine .
piperine	ibuprofen	effect	from this study it can be concluded that piperine can be used as a bioenhancer along with ibuprofen .
glycine	glutamate	effect	interaction between glycine and glutamate in the development of spontaneous motility in chick embryos .
methylglyoxal	piperacillin	effect	distinct and statistically significant synergism was observed between methylglyoxal and piperacillin by disc diffusion tests when compared with their individual effects .
Warfarin	amitriptyline	effect	warfarin users who initiated citalopram , fluoxetine , paroxetine , amitriptyline , or mirtazapine had an increased risk of hospitalization for gastrointestinal bleeding .
Warfarin	fluoxetine	effect	warfarin users had an increased odds ratio of gastrointestinal bleeding upon initiation of citalopram ( or = dg [ dg % ci , dg dg ] ) , fluoxetine ( or = dg [ dg % ci , dg dg ] ) , paroxetine ( or = dg [ dg % ci , dg dg ] ) , amitriptyline ( or = dg [ dg % ci , dg dg ] ) .
dexmedetomidine	ephedrine	effect	in the hot plate test in mice , co administration of dg g / kg dexmedetomidine with dg mg / kg ephedrine intraperitoneally not only enhanced , but also prolonged the duration of antinociception induced by dexmedetomidine .
Innovar Vet	ouabain	effect	in a comparison of digitalis tolerance in dogs anesthetized with ketamine , innovar vet , or pentobarbital , the dosage of ouabain needed to cause ventricular tachycardia was significantly higher , as was the ld50 of ouabain , with ketamine or innovar than with pentobarbital .
ouabain	ketamine	effect	ventricular tachycardia induced by ouabain was generally converted to sinus rhythm following administration of innovar , ketamine , or droperidol but not after administration of fentayl alone or after pentobarbital .
ouabain	droperidol	effect	ventricular tachycardia induced by ouabain was generally converted to sinus rhythm following administration of innovar , ketamine , or droperidol but not after administration of fentayl alone or after pentobarbital .
Macrolide antibiotics	atorvastatin	mechanism	conclusions : macrolide antibiotics inhibit the metabolism of hmg coa reductase inhibitors that are metabolized by cyp3a4 ( i.e. , atorvastatin , cerivastatin , lovastatin , simvastatin ) .
Macrolide antibiotics	simvastatin	mechanism	conclusions : macrolide antibiotics inhibit the metabolism of hmg coa reductase inhibitors that are metabolized by cyp3a4 ( i.e. , atorvastatin , cerivastatin , lovastatin , simvastatin ) .
picrotoxin	phenazepam	effect	[ the gaba ergic system and brain edema ] it has been shown in rats with experimental toxic and traumatic edemas that picrotoxin ( dg mg / kg ) removes the antiedematous action of diazepam , phenazepam , phenibut and amizyl and reduces the action of phentolamine .
(-)-NANM	naloxone	effect	in monkeys , the effects of (-)-nanm , but not ( + ) nanm or pcp , were antagonized by naloxone ;
iron	cobalt	mechanism	consequently , the effect of iron on the retention of cobalt was lower than on absorption .
carbamazepine	tricyclic antidepressant	effect	we report the case of an adolescent with altered consciousness caused by carbamazepine overdose with a positive tricyclic antidepressant level to alert clinicians to the cross reactivity of carbamazepine with a toxicology screen for tricyclic antidepressants .
nitrate	sildenafil	effect	however , patients with moderate to severe cardiovascular disease or those taking nitrate therapy are at increased risk for potentially serious cardiovascular adverse effects with sildenafil therapy .
Cytochalasin D	carbachol	effect	cytochalasin d inhibited the carbachol stimulated intracellular ca ( 2+ ) concentration ( [ ca ( 2+ ) ] ( i ) ) increase due to release from the ca ( 2+ ) store .
naloxone	beta-endorphin	effect	intrathecal injection of naloxone at doses of dg to dg micrograms caused a dose related blockade of the inhibition of the tail flick response induced by intraventricular injection of beta-endorphin , and a high dose of naloxone ( dg micrograms ) completely blocked the tail flick inhibition induced by intraventricular beta-endorphin ( dg micrograms ) .
antifungal agents	clonazepam	advise	although clinical studies have not been performed , based on the involvement of the cytochrome p dg 3a family in clonazepam metabolism , inhibitors of this enzyme system , notably oral antifungal agents , should be used cautiously in patients receiving clonazepam .
benzodiazepine class	alcohol	effect	pharmacodynamic interactions : the cns depressant action of the benzodiazepine class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate hypnotics , antianxiety agents , the phenothiazines , thioxanthene and butyrophenone classes of antipsychotic agents , monoamine oxidase inhibitors and the tricyclic antidepressants , and by other anticonvulsant drugs .
benzodiazepine class	butyrophenone classes of antipsychotic agents	effect	pharmacodynamic interactions : the cns depressant action of the benzodiazepine class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate hypnotics , antianxiety agents , the phenothiazines , thioxanthene and butyrophenone classes of antipsychotic agents , monoamine oxidase inhibitors and the tricyclic antidepressants , and by other anticonvulsant drugs .
lithium	ACE inhibitor	effect	lithium toxicity was usually reversible upon discontinuation of lithium and the ace inhibitor .
diuretic	PRINIVIL	effect	when a diuretic is added to the therapy of a patient receiving prinivil , an additional antihypertensive effect is usually observed .
NSAIDs	lisinopril	effect	reports suggest that nsaids may diminish the antihypertensive effect of ace inhibitors , including lisinopril .
NSAIDs	ACE inhibitors	advise	this interaction should be given consideration in patients taking nsaids concomitantly with ace inhibitors .
benzodiazepines	nefazodone	mechanism	the following are examples of drugs known to inhibit the metabolism of other related benzodiazepines , presumably through inhibition of cyp3a : nefazodone , fluvoxamine , cimetidine , diltiazem , isoniazide , and some macrolide antibiotics .
benzodiazepines	isoniazide	mechanism	the following are examples of drugs known to inhibit the metabolism of other related benzodiazepines , presumably through inhibition of cyp3a : nefazodone , fluvoxamine , cimetidine , diltiazem , isoniazide , and some macrolide antibiotics .
Anticoagulants	cefixime	effect	warfarin and anticoagulants : increased prothrombin time , with or without clinical bleeding , has been reported when cefixime is administered concomitantly .
dorzolamide	carbonic anhydrase inhibitors	effect	although acid base and electrolyte disturbances were not reported in the clinical trials with dorzolamide , these disturbances have been reported with oral carbonic anhydrase inhibitors and have , in some instances , resulted in drug interactions ( e.g. , toxicity associated with high dose salicylate therapy ) .
VIRACEPT	ergot derivatives	advise	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
ENBREL	anakinra	effect	in a study in which patients with active ra were treated for up to dg weeks with concurrent enbrel and anakinra therapy , a dg % rate of serious infections was observed , which was higher than that observed with enbrel alone ( dg % ) .
Videx	FACTIVE	advise	magnesium and / or aluminum containing antacids , products containing ferrous sulfate ( iron ) , multivitamin preparations containing zinc or other metal cations , or videx ( didanosine ) chewable / buffered tablets or the pediatric powder for oral solution should not be taken within dg hours before or dg hours after factive .
carbamazepine	CANCIDAS	mechanism	in addition , results from regression analyses of patient pharmacokinetic data suggest that co administration of other inducers of drug clearance ( efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine ) with cancidas may result in clinically meaningful reductions in caspofungin concentrations .
diethylpropion	antihypertensive drugs	int	conversely , diethylpropion may interfere with antihypertensive drugs ( i.e. , guanethidine , a methyldopa ) .
methotrexate	acitretin	advise	consequently , the combination of methotrexate with acitretin is also contraindicated .
coumarin anticoagulants	phenytoin	mechanism	conversely , the coumarin anticoagulants have been reported to increase the serum levels and prolong the serum half life of phenytoin by inhibiting its metabolism .
alosetron	protease inhibitors	advise	coadministration of alosetron and strong cyp3a4 inhibitors , such as clarithromycin , telithromycin , protease inhibitors , voriconazole , and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions .
alosetron	voriconazole	advise	coadministration of alosetron and strong cyp3a4 inhibitors , such as clarithromycin , telithromycin , protease inhibitors , voriconazole , and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions .
alosetron	hydralazine	effect	although not studied with alosetron , inhibition of n acetyltransferase may have clinically relevant consequences for drugs such as isoniazid , procainamide , and hydralazine .
Fluvoxamine	alosetron	mechanism	fluvoxamine increased mean alosetron plasma concentrations ( auc ) approximately dg fold and prolonged the half life by approximately dg fold .
Acetazolamide	lithium	mechanism	acetazolamide increases lithium excretion and the lithium may be decreased .
Acetazolamide	folic acid antagonists	effect	acetazolamide may increase the effects of other folic acid antagonists .
Aminoglutethimide	coumarin	effect	aminoglutethimide diminishes the effect of coumarin and warfarin .
Aminoglutethimide	warfarin	effect	aminoglutethimide diminishes the effect of coumarin and warfarin .
quinidine	nifedipine	mechanism	quinidine : immediate release capsules : there have been rare reports of an interaction between quinidine and nifedipine ( with a decreased plasma level of quinidine ) .
Auranofin	gold medication	advise	auranofin should be avoided by patients with a history of serious reaction to any gold medication , including solganal and myochrysine .
sulfonamides	LEVULAN KERASTICK	effect	it is , however , possible that concomitant use of other known photosensitizing agents such as griseofulvin , thiazide diuretics , sulfonylureas , phenothiazines , sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the levulan kerastick for topical solution .
Midazolam	morphine	effect	midazolam used at doses of dg mg / kg and dg mg / kg decreased the antinociceptive effect of morphine , metamizol ( only in the tail flick test ) and indomethacin .
cimetidine	verografine	mechanism	[ the effect of cimetidine on the renal excretion of verografin and iodamide in dogs ] the intravenous injection of cimetidine in a dose of dg mg / kg enhanced verografine and iodamide excretion in chronic canine experiments .
Misonidazole	CCNU	effect	misonidazole protects mouse tumour and normal tissues from the toxicity of oral ccnu .
sirolimus	diltiazem	mechanism	apparent oral clearance and volume of distribution of sirolimus decreased with dg % and dg % , respectively , when sirolimus was given with diltiazem .
atracurium	gentamycin	effect	at dg % recovery of fade , hoof twitch was dg + / dg % for atracurium alone and dg + / dg % for atracurium plus gentamycin .
thiabendazole	melarsoprol	effect	among the risk factors studied , two appear to increase the risk of are : the prescription of thiabendazole to treat strongyloidiasis during the melarsoprol cure and the bad general clinical conditions of patients .
benzodiazepine class	tricyclic antidepressants	effect	pharmacodynamic interactions : the cns depressant action of the benzodiazepine class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate hypnotics , antianxiety agents , the phenothiazines , thioxanthene and butyrophenone classes of antipsychotic agents , monoamine oxidase inhibitors and the tricyclic antidepressants , and by other anticonvulsant drugs .
non-steroidal anti-inflammatory drugs	lisinopril	effect	non steroidal anti inflammatory agents : in some patients with compromised renal function who are being treated with non-steroidal anti-inflammatory drugs , the co administration of lisinopril may result in a further deterioration of renal function .
benzodiazepines	anticonvulsants	effect	the action of the benzodiazepines may be potentiated by anticonvulsants , antihistamines , alcohol , barbiturates , monoamine oxidase inhibitors , narcotics , phenothiazines , psychotropic medications , or other drugs that produce cns depression .
estazolam	barbiturates	mechanism	while no in vivo drug drug interaction studies were conducted between estazolam and inducers of cyp3a , compounds that are potent cyp3a inducers ( such as carbamazepine , phenytoin , rifampin , and barbiturates ) would be expected to decrease estazolam concentrations .
saquinavir	VIRACEPT	mechanism	saquinavir : coadministration of saquinavir ( using an experimental soft gelatin capsule formulation of saquinavir 1200mg ) with viracept resulted in an dg % increase in nelfinavir plasma auc and a dg fold increase in saquinavir plasma a.c .
rifabutin	VIRACEPT	advise	it is recommended that the dose of rifabutin be reduced to one half the usual dose when administered with viracept .
VIRACEPT	rifampin	advise	viracept and rifampin should not be coadministered .
VIRACEPT	OVCON-35	mechanism	ethinyl estradiol and norethindrone : coadministration of viracept with ovcon-35 resulted in a dg % decrease in ethinyl estradiol and an dg % decrease in norethindrone plasma concentrations .
VIRACEPT	triazolam	advise	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
chlorothiazide	colestipol hydrochloride	mechanism	studies in humans show that the absorption of chlorothiazide as reflected in urinary excretion is markedly decreased even when administered one hour before colestipol hydrochloride .
hydrochlorothiazide	colestipol hydrochloride	mechanism	the absorption of tetracycline , furosemide , penicillin g , hydrochlorothiazide , and gemfibrozil was significantly decreased when given simultaneously with colestipol hydrochloride ;
digitalis preparations	colestipol hydrochloride	effect	particular caution should be observed with digitalis preparations since there are conflicting results for the effect of colestipol hydrochloride on the availability of digoxin and digitoxin .
colestipol hydrochloride	digitoxin	mechanism	particular caution should be observed with digitalis preparations since there are conflicting results for the effect of colestipol hydrochloride on the availability of digoxin and digitoxin .
colestipol hydrochloride	propranolol	mechanism	repeated doses of colestipol hydrochloride given prior to a single dose of propranolol in human trials have been reported to decrease propranolol absorption .
REVIA	disulfiram	effect	the safety and efficacy of concomitant use of revia and disulfiram is unknown , and the concomitant use of two potentially hepatotoxic medications is not ordinarily recommended unless the probable benefits outweigh the known risks .
REVIA	thioridazine	effect	lethargy and somnolence have been reported following doses of revia and thioridazine .
REVIA	opioid	effect	in an emergency situation when opioid analgesia must be administered to a patient receiving revia , the amount of opioid required may be greater than usual , and the resulting respiratory depression may be deeper and more prolonged .
FACTIVE	cimetidine	mechanism	concomitant administration of factive and calcium carbonate , cimetidine , omeprazole , or an estrogen / progesterone oral contraceptive produced minor changes in the pharmacokinetics of gemifloxacin , which were considered to be without clinical significance .
FACTIVE	progesterone	mechanism	concomitant administration of factive and calcium carbonate , cimetidine , omeprazole , or an estrogen / progesterone oral contraceptive produced minor changes in the pharmacokinetics of gemifloxacin , which were considered to be without clinical significance .
quinolones	warfarin	effect	however , because some quinolones have been reported to enhance the anticoagulant effects of warfarin or its derivatives in patients , the prothrombin time or other suitable coagulation test should be closely monitored if a quinolone antimicrobial is administered concomitantly with warfarin or its derivatives .
gemifloxacin	magnesium	mechanism	the absorption of oral gemifloxacin is significantly reduced by the concomitant administration of an antacid containing aluminum and magnesium .
EPA	aspirin	int	interactions may occur between epa supplements and aspirin and other non steroidal anti inflammatory drugs and herbs such as garlic ( allium sativum ) and ginkgo ( ginkgo biloba ) .
EPA	ginkgo	int	interactions may occur between epa supplements and aspirin and other non steroidal anti inflammatory drugs and herbs such as garlic ( allium sativum ) and ginkgo ( ginkgo biloba ) .
nevirapine	CANCIDAS	mechanism	in addition , results from regression analyses of patient pharmacokinetic data suggest that co administration of other inducers of drug clearance ( efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine ) with cancidas may result in clinically meaningful reductions in caspofungin concentrations .
acitretin	glibenclamide	effect	glibenclamide : in a study of dg healthy male volunteers , acitretin treatment potentiated the blood glucose lowering effect of glibenclamide ( a sulfonylurea similar to chlorpropamide ) in dg of the dg subjects .
nitazoxanide	warfarin	mechanism	therefore , caution should be used when administering nitazoxanide concurrently with other highly plasma protein bound drugs with narrow therapeutic indices , as competition for binding sites may occur ( e.g. , warfarin ) .
non-steroidal anti-inflammatory agent	loop diuretics	effect	in some patients , the administration of a non-steroidal anti-inflammatory agent can reduce the diuretic , natriuretic , and antihypertensive effects of loop , potassium sparing and thiazide diuretics .
non-steroidal anti-inflammatory agent	potassium-sparing diuretics	effect	in some patients , the administration of a non-steroidal anti-inflammatory agent can reduce the diuretic , natriuretic , and antihypertensive effects of loop , potassium sparing and thiazide diuretics .
antihypertensive medications	vasodilators	effect	antihypertensive medications and vasodilators : the following adverse events were experienced more commonly in patients receiving concomitant antihypertensive medications or vasodilators ( n = dg ) compared to patients not receiving these concomitant drugs ( n = dg ) : hypotension dg % vs dg % , myocardial infarction dg % vs dg % , serious pneumonia dg % vs dg % , serious falls dg % vs dg % , and bone and joint injuries dg % vs dg % .
metoclopramide	APOKYN	effect	dopamine antagonists : since apomorphine is a dopamine agonist , it is possible that dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
PLETAL	ketoconazole	advise	since pletal is extensively metabolized by cytochrome p dg isoenzymes , caution should be exercised when pletal is coadministered with inhibitors of c.p.a. such as ketoconazole and erythromycin or inhibitors of cyp2c19 such as omeprazole .
erythromycin	cilostazol	mechanism	pharmacokinetic studies have demonstrated that omeprazole and erythromycin significantly increased the systemic exposure of cilostazol and / or its major metabolites .
hydantoin antiepileptic	phenytoin	int	a two way interaction between the hydantoin antiepileptic , phenytoin , and the coumarin anticoagulants has been suggested .
hydantoin antiepileptic	coumarin anticoagulant	int	a two way interaction between the hydantoin antiepileptic , phenytoin , and the coumarin anticoagulants has been suggested .
DIAMOX	phenytoin	mechanism	diamox modifies phenytoin metabolism with increased serum levels of phenytoin .
docetaxel	troleandomycin	mechanism	in vitro studies have shown that the metabolism of docetaxel may be modified by the concomitant administration of compounds that induce , inhibit , or are metabolized by cytochrome p450 dg , such as cyclosporine , terfenadine , ketoconazole , erythromycin , and troleandomycin .
coumarin anticoagulants	nifedipine	effect	coumarin anticoagulants : there have been rare reports of increased prothrombin time in patients taking coumarin anticoagulants to whom nifedipine was administered .
Phospholine Iodide	cholinesterase inhibitors	effect	phospholine iodide potentiates other cholinesterase inhibitors such as succinylcholine or organophosphate and carbamate insecticides .
Phospholine Iodide	carbamate insecticide	effect	phospholine iodide potentiates other cholinesterase inhibitors such as succinylcholine or organophosphate and carbamate insecticides .
SUBUTEX	benzodiazepines	advise	subutex and suboxone should be prescribed with caution to patients on benzodiazepines or other drugs that act on the central nervous system , regardless of whether these drugs are taken on the advice of a physician or are taken as drugs of abuse .
levamisole	warfarin sodium	advise	because of reports of prolongation of the prothrombin time beyond the therapeutic range in patients taking concurrent levamisole and warfarin sodium , it is suggested that the prothrombin time be monitored carefully , and the dose of warfarin sodium or other coumarin like drugs should be adjusted accordingly , in patients taking both drugs .
Aprepitant	itraconazole	advise	consequently , concomitant administration of aprepitant with strong cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , nefazodone , troleandomycin , clarithromycin , ritonavir , nelfinavir ) should be approached with caution .
Aprepitant	troleandomycin	advise	consequently , concomitant administration of aprepitant with strong cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , nefazodone , troleandomycin , clarithromycin , ritonavir , nelfinavir ) should be approached with caution .
Aprepitant	rifampin	mechanism	rifampin : when a single dg mg dose of aprepitant was administered on day9 of a dg day regimen of dg mg / day of rifampin , a strong cyp3a4 inducer , the auc of aprepitant decreased approximately dg fold and the mean terminal half life decreased approximately dg fold .
antacids	vitamin D	advise	magnesium : magnesium containing preparations ( eg , antacids ) may cause hypermagnesemia and should therefore not be taken during therapy with vitamin d by patients on chronic renal dialysis .
Vitamin D	digitalis	advise	digitalis : vitamin d dosage must be determined with care in patients undergoing treatment with digitalis , as hypercalcemia in such patients may precipitate cardiac arrhythmias .
T.A.	SSRIs	advise	nevertheless , caution is indicated in the co administration of t.a. with any of the ssris and also in switching from one class to the other .
tricyclic antidepressants	fluoxetine	mechanism	there have been greater than two fold increases of previously stable plasma levels of tricyclic antidepressants when fluoxetine has been administered in combination with these agents .
Antihistamines	barbiturates	effect	antihistamines may enhance the effects of tricyclic antidepressants , barbiturates , alcohol , and other cns depressants .
MAO inhibitors	antihistamines	effect	mao inhibitors prolong and intensify the anticholinergic effects of antihistamines .
Sympathomimetic amines	reserpine	effect	sympathomimetic amines may reduce the antihypertensive effects of reserpine , veratrum alkaloids , methyldopa and mecamylamine .
Panretin	DEET	advise	patients who are applying panretin gel should not concurrently use products that contain deet ( n , n diethyl m toluamide ) , a common component of insect repellent products .
cetirizine	theophylline	mechanism	there was a small decrease in the clearance of cetirizine caused by a dg mg dose of theophylline ;
warfarin	enoxacin	advise	nevertheless , the prothrombin time or other suitable coagulation test should be monitored when warfarin or its derivatives and enoxacin are given concomitantly .
caffeine	enoxacin	mechanism	trough plasma enoxacin levels were also dg % higher when caffeine and enoxacin were administered concomitantly .
erythromycin	tacrolimus	int	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
dyphylline	probenecid	mechanism	concurrent administration of dyphylline and probenecid , which competes for tubular secretion , has been shown to increase the plasma half life of dyphylline .
phenytoin	phenothiazines	mechanism	the most commonly occurring drug interactions are listed below : drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2 antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
phenytoin	succinimides	mechanism	the most commonly occurring drug interactions are listed below : drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2 antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
phenytoin	chlordiazepoxide	mechanism	the most commonly occurring drug interactions are listed below : drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2 antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
phenytoin	estrogens	mechanism	the most commonly occurring drug interactions are listed below : drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2 antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
phenytoin	valproate	effect	similarly , the effects of phenytoin on phenobarbital , valproic acid and sodium plasma valproate concentrations are unpredictable
phenytoin	theophylline	effect	drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
phenytoin	coumarin	effect	drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
phenytoin	quinidine	effect	drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
NSAIDs	methotrexate	advise	caution should be used when nsaids are administered concomitantly with methotrexate .
AKINETON	meperidine	effect	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
AKINETON	tricyclic antidepressants	effect	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
anticholinergic	tricyclic antidepressants	effect	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
anticholinergic	antiarrhythmics	effect	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
ARAVA	rifampin	advise	because of the potential for arava levels to continue to increase with multiple dosing , caution should be used if patients are to be receiving both arava and rifampin .
Sumatriptan	D.H.E. 45	effect	sumatriptan : sumatriptan has been reported to cause coronary artery vasospasm , and its effect could be additive with d.h.e. 45 ( dihydroergotamine mesylate ) injection , usp .
D.H.E. 45	macrolide class	mechanism	macrolide antibiotics ( e. g. erythromycin and troleandomycin ) : agents of the ergot alkaloid class , of which d.h.e. 45 ( dihydroergotamine mesylate ) injection , usp is a member , have been shown to interact with antibiotics of the macrolide class , resulting in increased plasma levels of unchanged alkaloids and peripheral vasoconstriction .
levothyroxine sodium	ketamine	effect	ketamine : marked hypertension and tachycardia have been reported in association with concomitant administration of levothyroxine sodium and ketamine .
levothyroxine sodium	mefenamic acid	mechanism	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen containing compounds , dg fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
levothyroxine sodium	salicylates	mechanism	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen containing compounds , dg fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
levothyroxine sodium	clofibrate	mechanism	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen containing compounds , dg fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
amoxicillin	allopurinol	effect	ampicillin / amoxicillin : an increase in the frequency of skin rash has been reported among patients receiving ampicillin or amoxicillin concurrently with allopurinol compared to patients who are not receiving both drugs .
uricosuric agents	oxipurinol	mechanism	uricosuric agents : since the excretion of oxipurinol is similar to that of urate , uricosuric agents , which increase the excretion of urate , are also likely to increase the excretion of oxipurinol and thus lower the degree of inhibition of xanthine oxidase .
EDECRIN	cephalosporin antibiotics	effect	edecrin may increase the ototoxic potential of other drugs such as aminoglycoside and some cephalosporin antibiotics .
non- steroidal antiinflammatory agent	loop diuretics	effect	in some patients , the administration of a non- steroidal antiinflammatory agent can reduce the diuretic , natriuretic , and antihypertensive effects of loop , potassium sparing and thiazide diuretics .
Ibuprofen	methotrexate	mechanism	methotrexate : ibuprofen , as well as other nonsteroidal anti inflammatory drugs , probably reduces the tubular secretion of methotrexate based on in vitro studies in rabbit kidney slices .
broad-spectrum antibiotics	contraceptives	effect	in common with other broad-spectrum antibiotics , augmentin xr may reduce the efficacy of oral contraceptives
BREVIBLOC	warfarin	advise	although the interactions observed in these studies do not appear to be of major clinical importance , brevibloc should be titrated with caution in patients being treated concurrently with digoxin , morphine , succinylcholine or warfarin .
digoxin	BREVIBLOC	mechanism	when digoxin and brevibloc were concomitantly administered intravenously to normal volunteers , there was a dg dg % increase in digoxin blood levels at some time points .
selegiline hydrochloride	fluoxetine	effect	in patients receiving nonselective monoamine oxidase inhibitors ( maois ) ( e.g. , selegiline hydrochloride ) in combination with serotoninergic agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
monoamine oxidase inhibitors	fluvoxamine	effect	in patients receiving nonselective monoamine oxidase inhibitors ( maois ) ( e.g. , selegiline hydrochloride ) in combination with serotoninergic agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
dexfenfluramine	MAO inhibitor	advise	at least dg weeks should elapse between discontinuation of dexfenfluramine and initiation of treatment with a mao inhibitor .
selective serotonin reuptake inhibitors	dihydroergotamine	effect	a rare , but serious , constellation of symptoms , termed serotonin syndrome , has been reported with the concomitant use of selective serotonin reuptake inhibitors ( ssris ) and agents for migraine therapy , such as imitrex ( sumatriptan succinate ) and dihydroergotamine .
SSRIs	5-HT1 agonists	effect	selective serotonin reuptake inhibitors ( ssris ) ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1 agonists .
Quinolones	warfarin	effect	quinolones , including nalidixic acid , may enhance the effects of the oral anticoagulant warfarin or its derivatives .
Cimetidine	epirubicin	mechanism	cimetidine increased the auc of epirubicin by dg % .
Antacids	chloroquine	mechanism	antacids and kaolin : antacids and kaolin can reduce absorption of chloroquine ;
chloroquine	ampicillin	mechanism	ampicillin : in a study of healthy volunteers , chloroquine significantly reduced the bioavailability of ampicillin .
ciprofloxacin	didanosine	mechanism	the auc of ciprofloxacin was decreased an average of dg fold in dg healthy subjects given ciprofloxacin and didanosine placebo tablets concurrently .
quinolone antibiotics	calcium	mechanism	plasma concentrations of quinolone antibiotics are decreased when administered with antacids containing magnesium , calcium , or aluminum .
ciprofloxacin	calcium	mechanism	quinolone antibiotics : videx should be administered at least dg hours after or dg hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium , calcium , or aluminum .
ranitidine	alendronate	mechanism	intravenous ranitidine was shown to double the bioavailability of oral alendronate .
alprazolam	saquinavir	mechanism	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
dapsone	saquinavir	mechanism	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
oxyphenbutazone	androgens	mechanism	concurrent administration of oxyphenbutazone and androgens may result in elevated serum levels of oxyphenbutazone .
Flupenthixol	Ethanol	effect	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics arecoline eproxindine ethanol : flupenthixol and ethanol cause additive cns depression tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants
benzodiazepines	anticonvulsants	effect	the benzodiazepines , including alprazolam , produce additive cns depressant effects when co administered with other psychotropic medications , anticonvulsants , antihistaminics , ethanol , and other drugs which themselves produce cns depression .
alprazolam	ethanol	effect	the benzodiazepines , including alprazolam , produce additive cns depressant effects when co administered with other psychotropic medications , anticonvulsants , antihistaminics , ethanol , and other drugs which themselves produce cns depression .
benzodiazepines	ergotamine	int	data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following : ergotamine , cyclosporine , amiodarone , nicardipine , and nifedipine .
alprazolam	paroxetine	int	data from in vitro studies of alprazolam suggest a possible drug interaction with alprazolam for the following : sertraline and paroxetine .
diflunisal	acetaminophen	effect	concomitant administration of diflunisal and acetaminophen in dogs , but not in rats , at approximately dg times the recommended maximum human therapeutic dose of each ( dg to dg mg / kg / day of diflunisal / acetaminophen ) resulted in greater gastrointestinal toxicity than when either drug was administered alone .
indomethacin	diflunisal	advise	therefore , indomethacin and diflunisal should not be used concomitantly .
diflunisal	hydrochlorothiazide	mechanism	hydrochlorothiazide : in normal volunteers , concomitant administration of diflunisal and hydrochlorothiazide resulted in significantly increased plasma levels of hydrochlorothiazide .
BOTOX	curare-like compounds	advise	co administration of botox and aminoglycosides or other agents interfering with neuromuscular transmission ( e.g. , curare-like compounds ) should only be performed with caution as the effect of the toxin may be potentiated .
Anti-arrhythmics	bepridil hydrochloride	effect	anti-arrhythmics and tricyclic anti depressants could exaggerate the prolongation of the qt interval observed with bepridil hydrochloride .
HMG-CoA reductase inhibitor	cimetidine	advise	caution should be exercised if an hmg-coa reductase inhibitor is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones , such as ketoconazole , spironolactone , and cimetidine .
cerivastatin	erythromycin	mechanism	erythromycin : in hypercholesterolemic patients , steady state cerivastatin auc and cmax increased approximately dg % and dg % respectively after dg days with co administration of erythromycin , a known inhibitor of cytochrome p450 dg .
LEVSIN	monoamine oxidase (MAO) inhibitors	effect	additive adverse effects resulting from cholinergic blockade may occur when levsin is administered concomitantly with other antimuscarinics , amantadine , haloperidol , phenothiazines , monoamine oxidase (mao) inhibitors , tricyclic antidepressants or some antihistamines .
LEVSIN	antihistamines	effect	additive adverse effects resulting from cholinergic blockade may occur when levsin is administered concomitantly with other antimuscarinics , amantadine , haloperidol , phenothiazines , monoamine oxidase ( mao ) inhibitors , tricyclic antidepressants or some antihistamines .
ritonavir	budesonide	advise	if treatment with inhibitors of cyp3a4 activity ( such as ketoconazole , intraconazole , ritonavir , indinavir , saquinavir , erythromycin , etc. ) is indicated , reduction of the budesonide dose should be considered .
FLEXERIL	barbiturates	effect	flexeril may enhance the effects of alcohol , barbiturates , and other cns depressants .
epinephrine	monoamine oxidase inhibitors	effect	the administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe , prolonged hypertension .
Nalfon	loop diuretics	effect	patients treated with nalfon may be resistant to the effects of loop diuretics .
aspirin	Nalfon	mechanism	because nalfon has not been shown to produce any additional effect beyond that obtained with aspirin alone and because aspirin increases the rate of excretion of nalfon , the concomitant use of nalfon and salicylates is not recommended .
coumarin-type anticoagulants	Nalfon	effect	in patients receiving coumarin-type anticoagulants , the addition of nalfon to therapy could prolong the prothrombin time .
MAOI antidepressants	amphetamine	mechanism	mao inhibitors maoi antidepressants , as well as a metabolite of furazolidone , slow amphetamine metabolism .
Diuretic agents	lithium	mechanism	diuretic agents reduce the renal clearance of lithium and add a high risk of lithium toxicity .
Itraconazole	cisapride	advise	therefore concomitant administration of itraconazole with cisapride is contraindicated .
Itraconazole	digoxin	mechanism	coadministration of itraconazole and cyclosporine , tacrolimus or digoxin has led to increased plasma concentrations of the latter three drugs .
Cyclosporine	Itraconazole	advise	cyclosporine , tacrolimus and digoxin concentrations should be monitored at the initiation of itraconazole therapy and frequently thereafter , and the dose of these three drug products adjusted appropriately .
ketoconazole	astemizole	mechanism	another oral azole antifungal , ketoconazole , inhibits the metabolism of astemizole , resulting in elevated plasma concentrations of astemizole and its active metabolite desmethylastermizole which may prolong qt intervals .
ketoconazole	cisapride	effect	data suggest that coadministration of oral ketoconazole and cisapride can result in prolongation of the qt interval on the ecg .
fentanyl	ketoconazole	mechanism	the concomitant use of transdermal fentanyl with ritonavir or other potent dg inhibitors such as ketoconazole , itraconazole , troleandomycin , clarithromycin , nelfinavir , and nefazadone may result in an increase in fentanyl plasma concentrations .
DURAGESIC	opioids	effect	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
fentanyl	central nervous system depressants	effect	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
Tagamet	diazepam	mechanism	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
anticoagulant	Tagamet	advise	therefore , close monitoring of prothrombin time is recommended , and adjustment of the anticoagulant dose may be necessary when tagamet is administered concomitantly .
Tagamet	Theo-Dur	mechanism	however , a crossover study in healthy subjects receiving either tagamet dg mg q.i.d. or dg mg h.s. concomitantly with a dg mg b.i.d. dosage of theophylline ( theo-dur , key pharmaceuticals , inc. ) demonstrated less alteration in steady state theophylline peak serum levels with the dg mg h.s. regimen , particularly in subjects aged dg years and older .
CELEBREX	aspirin	advise	aspirin : celebrex can be used with low dose aspirin .
CELEBREX	warfarin	advise	however , caution should be used when administering celebrex with warfarin since these patients are at increased risk of bleeding complications .
celecoxib	fluconazole	int	clinical studies with celecoxib have identified potentially significant interactions with fluconazole and lithium .
diuretic	lithium	effect	if a diuretic is also used , it may increase the risk of lithium toxicity .
antacids	fosinopril	mechanism	antacids : in a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .
scopolamine	lorazepam	effect	injection : lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , mao inhibitors , and other antidepressants.when scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .
Lorazepam	antidepressants	effect	injection : lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , mao inhibitors , and other antidepressants.when scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .
benzodiazepines	phenothiazines	effect	injection : lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , mao inhibitors , and other antidepressants.when scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .
catecholamines	Bretylium Tosylate	effect	the pressor effects of catecholamines such as dopamine or norepinephrine are enhanced by bretylium tosylate .
lithium	HALDOL	effect	an encephalopathic syndrome ( characterized by weakness , lethargy , fever , tremulousness and confusion , extrapyramidal symptoms , leukocytosis , elevated serum enzymes , bun , and fbs ) followed by irreversible brain damage has occurred in a few patients treated with lithium plus haldol .
isoniazid	valproate	advise	plasma valproate concentration should be monitored when isoniazid and valproate are co administered , and appropriate dosage adjustments of valproate should be made .
Carbamazepine	isoniazid	advise	carbamazepine : isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels carbamazepine levels should be determined prior to concurrent administration with isoniazid , signs and symptoms of carbamazepine toxicity should be monitored closely , and appropriate dosage adjustment of the anticonvulsant should be made .
Ketoconazole	Isoniazid	int	ketoconazole : potential interaction of ketoconazole and isoniazid may exist .
anticoagulants	disulfiram	advise	it may be necessary to adjust the dosage of oral anticoagulants upon beginning or stopping disulfiram. since disulfiram may prolong prothrombin time .
Steroids	edetate calcium disodium	effect	steroids enhance the renal toxicity of edetate calcium disodium in animals. dg edetate calcium disodium interferes with the action of zinc insulin preparations by chelating the zinc. dg
Dexbrompheniramine	monoamine oxidase (MAO) inhibitors	effect	dexbrompheniramine can interact with alcohol or other cns depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase (mao) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
theophylline	PEGASYS	advise	theophylline serum levels should be monitored and appropriate dose adjustments considered for patients given both theophylline and pegasys .
phenobarbital	exemestane	mechanism	co medications that induce cyp dg ( e.g. , rifampicin , phenytoin , carbamazepine , phenobarbital , or st. john s wort ) may significantly decrease exposure to exemestane .
gabapentin	Maalox	mechanism	this decrease in bioavailability was about dg % when gabapentin was administered dg hours after maalox .
Corticotropin	diuretic	effect	corticotropin may accentuate the electrolyte loss associated with diuretic therapy .
Acellular vaccines	RAPTIVA	advise	acellular , live and live attenuated vaccines should not be administered during raptiva treatment .
calcium	Ibandronate	mechanism	products containing calcium and other multivalent cations ( such as aluminum , magnesium , iron ) are likely to interfere with absorption of ibandronate .
aspirin	Ibandronate	advise	however , since aspirin , nsaids , and bisphosphonates are all associated with gastrointestinal irritation , caution should be exercised in the concomitant use of aspirin or nsaids with ibandronate .
ZYVOX	antidepressants	effect	spontaneous reports of serotonin syndrome associated with co administration of zyvox and serotonergic agents , including antidepressants such as selective serotonin reuptake inhibitors ( ssris ) , have been reported .
Corticosteroids	aspirin	effect	corticosteroids : concomitant administration with aspirin may increase the risk of gastrointestinal ulceration and may reduce serum salicylate levels .
FLUDARA	pentostatin	advise	the use of fludara for injection in combination with pentostatin is not recommended due to the risk of severe pulmonary toxicity .
Chlorotrianisene	somatropin	int	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
Chlorotrianisene	warfarin	int	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
Chlorotrianisene	calcium	int	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
antihistamines	tricyclic antidepressants	effect	concomitant use of antihistamines with alcohol , tricyclic antidepressants , barbiturates , or other central nervous system depressants may have an additive effect .
antihistamines	central nervous system depressants	effect	concomitant use of antihistamines with alcohol , tricyclic antidepressants , barbiturates , or other central nervous system depressants may have an additive effect .
sympathomimetic drugs	monoamine oxidase inhibitors	effect	when sympathomimetic drugs are given to patients receiving monoamine oxidase inhibitors , hypertensive reactions , including hypertensive crises , may occur .
Beta-adrenergic blocking agents	sympathomimetics	int	beta-adrenergic blocking agents may also interact with sympathomimetics .
pseudoephedrine	digitalis	effect	increased ectopic pacemaker activity can occur when pseudoephedrine is used concomitantly with digitalis .
clarithromycin	digoxin	mechanism	erythromycin and clarithromycin ( and possibly other macrolide antibiotics ) and tetracycline may increase digoxin absorption in patients who inactivate digoxin by bacterial metabolism in the lower intestine , so that digitalis intoxication may result .
metoclopramide	digoxin	mechanism	antacids , kaolin pectin , sulfasalazine , neomycin , cholestyramine , certain anticancer drugs , and metoclopramide may interfere with intestinal digoxin absorption , resulting in unexpectedly low serum concentrations .
Lofexidine	barbiturates	effect	lofexidine may enhance the cns depressive effects of alcohol , barbiturates and other sedatives
TARCEVA	TAO	advise	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
TARCEVA	itraconazole	advise	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
TARCEVA	rifampicin	advise	if the tarceva dose is adjusted upward , the dose will need to be reduced upon discontinuation of rifampicin or other inducers .
Barbiturates	contraceptives	effect	barbiturates may decrease the effectiveness of oral contraceptives , certain antibiotics , quinidine , theophylline , corticosteroids , anticoagulants , and beta blockers .
NIZORAL	triazolam	mechanism	coadministration of nizoral tablets with midazolam or triazolam has resulted in elevated plasma concentrations of the latter two drugs .
ketoconazole	astemizole	effect	pharmacokinetic data indicate that oral ketoconazole inhibits the metabolism of astemizole , resulting in elevated plasma levels of astemizole and its active metabolite desmethylastemizole which may prolong qt intervals .
astemizole	ketoconazole	advise	coadministration of astemizole with ketoconazole tablets is therefore contraindicated .
ketoconazole	cisapride	advise	therefore concomitant administration of ketoconazole tablets with cisapride is contraindicated .
non-steroidal anti-inflammatory agent	potassium-sparing diuretics	effect	non steroidal anti inflammatory drugs : in some patients , the administration of a non steroidal anti inflammatory agent can reduce the diuretic , natriuretic , and antihypertensive effects of loop , potassium sparing and thiazide diuretics .
monoamine oxidase inhibitors	Starlix	effect	certain drugs , including nonsteroidal anti inflammatory agents ( nsaids ) , salicylates , monoamine oxidase inhibitors , and non selective beta adrenergic blocking agents may potentiate the hypoglycemic action of starlix and other oral antidiabetic drugs .
nonsteroidal anti-inflammatory agents	antidiabetic drugs	effect	certain drugs , including nonsteroidal anti-inflammatory agents ( nsaids ) , salicylates , monoamine oxidase inhibitors , and non selective beta adrenergic blocking agents may potentiate the hypoglycemic action of starlix and other oral antidiabetic drugs .
buspirone	digoxin	mechanism	in vitro , buspirone may displace less firmly bound drugs like digoxin .
Codeine	sedative-hypnotics	effect	codeine in combination with other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , or other cns depressants ( including alcohol ) has additive depressant effects .
erythromycin	fexofenadine	mechanism	these studies indicate that ketoconazole or erythromycin co administration enhances fexofenadine gastrointestinal absorption .
fexofenadine hydrochloride	Maalox	mechanism	drug interactions with antacids administration of dg mg of fexofenadine hydrochloride ( dg x dg mg capsule ) within dg minutes of an aluminum and magnesium containing antacid ( maalox ) decreased fexofenadine auc by dg % and cmax by dg % .
levodopa	papaverine	effect	in addition , the beneficial effects of levodopa in parkinsons disease have been reported to be reversed by phenytoin and papaverine .
Mineral oil	vitamin D preparations	mechanism	mineral oil interferes with the absorption of fat soluble vitamins , including vitamin d preparations .
aspirin	nizatidine	mechanism	in patients given very high doses ( dg mg ) of aspirin daily , increases in serum salicylate levels were seen when nizatidine , dg mg b.i.d. , was administered concurrently .
Urinary acidifying	amphetamines	mechanism	urinary acidifying agents decrease blood levels and increase excretion of amphetamines .
calcium channel blockers	organic nitrates	effect	marked symptomatic orthostatic hypotension has been reported when calcium channel blockers and organic nitrates were used in combination .
H2 blockers	dasatinib	effect	h2 blockers / proton pump inhibitors : long term suppression of gastric acid secretion by h2 blockers or proton pump inhibitors ( eg , famotidine and omeprazole ) is likely to reduce dasatinib exposure .
H2 blockers	SPRYCEL	advise	the concomitant use of h2 blockers or proton pump inhibitors with sprycel is not recommended .
sirolimus	SPRYCEL	advise	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
caffeine	Clozapine	mechanism	cimetidine , caffeine , and erythromycin may increase plasma levels of clozapine , potentially resulting in adverse effects .
clozapine	sertraline	mechanism	however , other published reports describe modest elevations ( less than two fold ) of clozapine and metabolite concentrations when clozapine was taken with paroxetine , fluoxetine , and sertraline .
clozapine	antidepressants	advise	therefore , co administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide and encainide ) , or that inhibit this enzyme ( e.g. , quinidine ) , should be approached with caution .
clozapine	psychotropic drug	advise	although it has not been established that there is an interaction between clozapine and benzodiazepines or other psychotropics , caution is advised when clozapine is initiated in patients taking a benzodiazepine or any other psychotropic drug .
Etonogestrel	acetaminophen	int	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo dur ) , and vitamin c .
Etonogestrel	Kaletra	int	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo dur ) , and vitamin c .
Etonogestrel	MS Contin	int	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo dur ) , and vitamin c .
Etonogestrel	phenylbutazone	int	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo dur ) , and vitamin c .
Etonogestrel	Prelone	int	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo dur ) , and vitamin c .
Etonogestrel	Trileptal	int	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo dur ) , and vitamin c .
topiramate	ethinyl estradiol	mechanism	anticonvulsants ( carbamazepine , felbamate , phenobarbital , phenytoin , topiramate ) : increase the metabolism of ethinyl estradiol and / or some progestins , leading to possible decrease in contraceptive effectiveness .
vitamin C	synthetic estrogens	mechanism	ascorbic acid : doses of ascorbic acid ( vitamin c ) dg g / day have been reported to increase plasma concentration of synthetic estrogens by ~47 % , possibly by inhibiting conjugation ;
Griseofulvin	combination hormonal contraceptives	mechanism	griseofulvin : griseofulvin may induce the metabolism of combination hormonal contraceptives causing menstrual changes ;
hormonal contraceptives	acetaminophen	mechanism	combination hormonal contraceptives may also decrease the plasma concentration of acetaminophen .
Ethinyl estradiol	prednisolone	mechanism	prednisolone : ethinyl estradiol may inhibit the metabolism of prednisolone , leading to increased plasma concentrations .
rifampin	corticosteroids	mechanism	drugs that induce hepatic enzymes such as phenobarbital , phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response .
heparin sodium	dicumarol	advise	therefore , when heparin sodium is given with dicumarol or warfarin sodium , a period of at least dg hours after the last intravenous dose or dg hours after the last subcutaneous dose should elapse before blood is drawn if a valid prothrombin time is to be obtained .
dipyridamole	heparin sodium	effect	platelet inhibitors : drugs such as acetylsalicylic acid , dextran , phenylbutazone , ibuprofen , indomethacin , dipyridamole , hydroxychloroquine and others that interfere with platelet aggregation reactions ( the main hemostatic defense of heparinized patients ) may induce bleeding and should be used with caution in patients receiving heparin sodium .
heparin	antithrombin III	effect	the anticoagulant effect of heparin is enhanced by concurrent treatment with antithrombin iii ( human ) in patients with hereditary antithrombin iii deficiency .
beta-blockers	epinephrine	effect	risk of anaphylactic reaction : although it is known that patients on beta-blockers may be refractory to epinephrine in the treatment of anaphylactic shock , beta-blockers can , in addition , interfere with the modulation of allergic reaction and lead to an increased severity and / or frequency of attacks .
Antihistamines	sedatives	effect	antihistamines may have additive effects with alcohol and other cns depressants , e.g. , hypnotics , sedatives , tranquilizers , antianxiety agents .
Antihistamines	tranquilizers	effect	antihistamines may have additive effects with alcohol and other cns depressants , e.g. , hypnotics , sedatives , tranquilizers , antianxiety agents .
clonidine	calcium channel blockers	advise	also , due to the potential for additive effects such as bradycardia and av block , caution is warranted in patients receiving clonidine with agents known to affect sinus node function or av nodal conduction ( e.g. , digitalis , calcium channel blockers , and beta blockers . )
clonidine	beta-blockers	advise	also , due to the potential for additive effects such as bradycardia and av block , caution is warranted in patients receiving clonidine with agents known to affect sinus node function or av nodal conduction ( e.g. , digitalis , calcium channel blockers , and beta-blockers . )
Ketoprofen	methotrexate	mechanism	methotrexate : ketoprofen , like other nsaids , may cause changes in the elimination of methotrexate leading to elevated serum levels of the drug and increased toxicity .
NSAIDs	methotrexate	mechanism	methotrexate : ketoprofen , like other nsaids , may cause changes in the elimination of methotrexate leading to elevated serum levels of the drug and increased toxicity .
bupropion	desipramine	mechanism	in a study of dg male subjects ( ages dg to dg years ) who were extensive metabolizers of the cyp2d6 isoenzyme , daily doses of bupropion given as dg mg twice daily followed by a single dose of dg mg desipramine increased the cmax , auc , and t1 / dg of desipramine by an average of approximately dg , dg and dg fold , respectively .
bupropion	phenelzine	effect	mao inhibitors : studies in animals demonstrate that the acute toxicity of bupropion is enhanced by the mao inhibitor phenelzine .
WELLBUTRIN	theophylline	advise	drugs that lower seizure threshold : concurrent administration of wellbutrin and agents ( e.g. , antipsychotics , other antidepressants , theophylline , systemic steroids , etc. ) that lower seizure threshold should be undertaken only with extreme caution .
alcohol	WELLBUTRIN	effect	alcohol : in post marketing experience , there have been rare reports of adverse neuropsychiatric events or reduced alcohol tolerance in patients who were drinking alcohol during treatment with wellbutrin .
phenytoin	doxycycline	mechanism	barbiturates , carbamazepine , and phenytoin decrease the half life of doxycycline .
chlorprothixene	tramadol	advise	avoid the concomitant use of chlorprothixene and tramadol ( ultram ) .
chlorprothixene	benzodiazepines	effect	consider additive sedative effects and confusional states to emerge , if chlorprothixene is given with benzodiazepines or barbituates .
Dipyridamole	cholinesterase inhibitors	effect	cholinesterase inhibitors : dipyridamole may counteract the anticholinesterase effect of cholinesterase inhibitors , thereby potentially aggravating myasthenia gravis .
guanfacine	phenobarbital	mechanism	the administration of guanfacine concomitantly with known microsomal enzyme inducer ( phenobarbital or phenytoin ) to two patients with renal impairment reportedly resulted in significant reductions in elimination half life and plasma concentration .
guanfacine	phenytoin	mechanism	the administration of guanfacine concomitantly with known microsomal enzyme inducer ( phenobarbital or phenytoin ) to two patients with renal impairment reportedly resulted in significant reductions in elimination half life and plasma concentration .
ketoconazole	aripiprazole	advise	when concomitant administration of ketoconazole with aripiprazole occurs , aripiprazole dose should be reduced to one half of its normal dose .
paroxetine	aripiprazole	mechanism	inhibitors of cyp3a4 ( eg , ketoconazole ) or cyp2d6 ( eg , quinidine , fluoxetine , or paroxetine ) can inhibit aripiprazole elimination and cause increased blood levels .
ketoconazole	aripiprazole	mechanism	ketoconazole : coadministration of ketoconazole ( dg mg / day for dg days ) with a dg mg single dose of aripiprazole increased the auc of aripiprazole and its active metabolite by dg % and dg % , respectively .
ipratropium bromide	anticholinergic medications	effect	anticholinergic agents : although ipratropium bromide is minimally absorbed into the systemic circulation , there is some potential for an additive interaction with concomitantly used anticholinergic medications .
aluminum	lomefloxacin	mechanism	antacids and sucralfate : sucralfate and antacids containing magnesium or aluminum , as well as formulations containing divalent and trivalent cations such as videx ( didanosine ) , chewable / buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability .
glimepiride	magnesium salicylate	advise	before taking glimepiride , tell your doctor if you are taking any of the following medicines : aspirin or another salicylate such as magnesium / choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto bismol ) ;
macrolides	terfenadine	advise	in addition , most macrolides are contraindicated in patients receiving terfenadine therapy who have pre existing cardiac abnormalities ( arrhythmia , bradycardia , qt c interval prolongation , ischemic heart disease , congestive heart failure , etc. ) or electrolyte disturbances .
dirithromycin	antacids	mechanism	antacids or h dg receptor antagonists : when dirithromycin is administered immediately following antacids or h dg receptor antagonists , the absorption of dirithromycin is slightly enhanced .
Erythromycin	triazolam	mechanism	triazolam : erythromycin has been reported to decrease the clearance of triazolam and , thus , may increase the pharmacologic effect of triazolam .
erythromycin	digoxin	mechanism	digoxin : concomitant administration of erythromycin and digoxin has been reported to result in elevated digoxin serum levels .
erythromycin	cyclosporine	int	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
erythromycin	valproate	int	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
erythromycin	terfenadine	int	thus , the interaction observed between erythromycin and terfenadine is not expected for dirithromycin .
steroids	aspirin	effect	rarely salicylate toxicity may occur in patients who discontinue steroids after concurrent high dose aspirin therapy .
lithium	insulin	effect	beta blockers , clonidine , lithium salts , and alcohol may either potentiate or weaken the blood glucose lowering effect of insulin .
Methionine	gentamicin	effect	gentamicin methionine may protect against the ototoxic effects of gentamicin .
nonsteroidal anti-inflammatory drugs	thiazide diuretics	effect	other nonsteroidal anti-inflammatory drugs that inhibit prostaglandin synthesis have been shown to interfere with thiazide diuretics in some studies and with potassium sparing diuretics .
flurbiprofen	hypoglycemic agents	effect	although there was a slight reduction in blood sugar concentrations during concomitant administration of flurbiprofen and hypoglycemic agents , there were no signs or symptoms of hypoglycemia .
Flurbiprofen	anti-coagulants	effect	anticoagulants : flurbiprofen like other nonsteroidal anti inflammatory drugs , has been shown to affect bleeding parameters in patients receiving anti-coagulants , and serious clinical bleeding has been reported .
flurbiprofen	aspirin	advise	concurrent use of flurbiprofen and aspirin is therefore not recommended .
nelfinavir	azithromycin	effect	co administration of nelfinavir at steady state with a single dose of azithromycin ( dg x dg mg tablets ) results in increased azithromycin serum concentrations .
azithromycin	trimethoprim	mechanism	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim / sulfamethoxazole or zidovudine .
efavirenz	azithromycin	mechanism	co administration with efavirenz or fluconazole had a modest effect on the pharmacokinetics of azithromycin .
lopinavir	SUSTIVA	advise	a dose increase of lopinavir / ritonavir to dg / dg mg ( dg capsules or dg ml ) twice daily taken with food is recommended when used in combination with sustiva .
SUSTIVA	ketoconazole	mechanism	sustiva has the potential to decrease plasma concentrations of itraconazole and ketoconazole .
atorvastatin	aliskiren	mechanism	co administration of atorvastatin resulted in about a dg % increase in aliskiren cmax and auc after multiple dosing .
pancreatin	Acarbose	mechanism	intestinal adsorbents ( e. g. , charcoal ) and digestive enzyme preparations containing carbohydrate splitting enzymes ( e. g. , amylase , pancreatin ) may reduce the effect of acarbose and should not be taken concomitantly .
charcoal	Acarbose	mechanism	intestinal adsorbents ( e. g. , charcoal ) and digestive enzyme preparations containing carbohydrate splitting enzymes ( e. g. , amylase , pancreatin ) may reduce the effect of acarbose and should not be taken concomitantly .
Bentiromide	multivitamins	int	bentiromide may interact with acetaminophen ( e.g. , tylenol ) , chloramphenicol ( e.g. , chloromycetin ) , local anesthetics ( e.g. , benzocaine and lidocaine ) , para aminobenzoic acid ( paba ) containing preparations ( e.g. , sunscreens and some multivitamins ) , procainamide ( e.g. , pronestyl ) , sulfonamides ( sulfa medicines ) , thiazide diuretics ( use of these medicines during the test period will affect the test results ) , and pancreatic supplements ( use of pancreatic supplements may give false test results ) .
thyroid	contraceptives	advise	therefore , patients without a functioning thyroid gland who are on thyroid replacement therapy may need to increase their thyroid dose if estrogens or estrogen containing oral contraceptives are given .
thyroid products	imipramine	effect	tricyclic antidepressants : use of thyroid products with imipramine and other tricyclic antidepressants may increase receptor sensitivity and enhance antidepressant activity transient cardiac arrhythmias have been observed .
Cardiac glycosides	bepridil hydrochloride	effect	cardiac glycosides could exaggerate the depression of av nodal conduction observed with bepridil hydrochloride .
contraceptive	atorvastatin	advise	these increases should be considered when selecting an oral contraceptive for a woman taking atorvastatin .
HMG-CoA reductase inhibitor	spironolactone	advise	caution should be exercised if an hmg-coa reductase inhibitor is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones , such as ketoconazole , spironolactone , and cimetidine .
LEVSIN	phenothiazines	effect	additive adverse effects resulting from cholinergic blockade may occur when levsin is administered concomitantly with other antimuscarinics , amantadine , haloperidol , phenothiazines , monoamine oxidase ( mao ) inhibitors , tricyclic antidepressants or some antihistamines .
amiodarone	digitalis	advise	on administration of oral amiodarone , the need for digitalis therapy should be reviewed and the dose reduced by approximately dg % or discontinued .
saquinavir	budesonide	advise	if treatment with inhibitors of cyp3a4 activity ( such as ketoconazole , intraconazole , ritonavir , indinavir , saquinavir , erythromycin , etc. ) is indicated , reduction of the budesonide dose should be considered .
FLEXERIL	MAO inhibitors	int	flexeril may have life threatening interactions with mao inhibitors .
FLEXERIL	CNS depressants	effect	flexeril may enhance the effects of alcohol , barbiturates , and other cns depressants .
Folic acid	phenobarbital	effect	folic acid in large amounts may counteract the antiepileptic effect of phenobarbital , phenytoin and primidone , and increase the frequency of seizures in susceptible pediatric patients .
epinephrine	tricyclic antidepressants	effect	the administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe , prolonged hypertension .
norepinephrine	tricyclic antidepressants	effect	the administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe , prolonged hypertension .
amphetamines	lithium carbonate	effect	lithium carbonate : the anorectic and stimulatory effects of amphetamines may be inhibited by lithium carbonate .
Adrenergic blockers	amphetamines	effect	adrenergic blockers adrenergic blockers are inhibited by amphetamines .
Amphetamines	phenytoin	mechanism	phenytoin : amphetamines may delay intestinal absorption of phenytoin ;
propoxyphene	amphetamine	effect	propoxyphene : in cases of propoxyphene overdosage , amphetamine cns stimulation is potentiated and fatal convulsions can occur .
Hydrochlorothiazide	non-steroidal anti-inflammatory agents	advise	therefore , when hydrochlorothiazide and non-steroidal anti-inflammatory agents are used concomitantly , the patient should be observed closely to determine if the desired effect of the diuretic is obtained .
Itraconazole	triazolam	mechanism	coadministration of itraconazole with oral midazolam or triazolam has resulted in elevated plasma concentrations of the latter two drugs .
Itraconazole	rifampin	mechanism	when itraconazole was coadministered with phenytoin , rifampin , or h2antagonists , reduced plasma concentrations of itraconazole were reported .
terfenadine	Itraconazole	mechanism	coadministration of terfenadine with itraconazole has led to elevated plasma concentrations of terfenadine , resulting in rare instances of life threatening cardiac dysrhythmias and one death .
itraconazole	astemizole	mechanism	in vitro data suggest that itraconazole , when compared to ketoconazole , has a less pronounced effect on the biotransformation system responsible for the metabolism of astemizole .
hypoglycemic medications	thiazide diuretic	advise	for adult onset diabetics , dosage adjustment of hypoglycemic medications may be necessary during and after thiazide diuretic therapy ;
steroidal anti-inflammatory agent	loop diuretics	effect	( in some patients , the steroidal anti-inflammatory agent can reduce the diuretic , natriuretic , and antihypertensive effects of loop , potassium sparing , and thiazide diuretics .
fentanyl	opioids	effect	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
MAO inhibitors	opioid analgesics	advise	mao inhibitors : duragesic is not recommended for use in patients who have received maoi within dg days because severe and unpredictable potentiation by mao inhibitors has been reported with opioid analgesics
Tagamet	phenytoin	mechanism	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
Tagamet	propranolol	mechanism	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
Tagamet	theophylline	mechanism	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
aspirin	CELEBREX	effect	however , concomitant administration of aspirin with celebrex may result in an increased rate of gi ulceration or other complications , compared to use of celebrex alone .
anticoagulants	thyroid	advise	patients stabilized on oral anticoagulants who are found to require thyroid replacement therapy should be watched very closely when thyroid is started .
Anticholinergic drugs	metoclopramide	mechanism	anticholinergic drugs may antagonize the effects of the drugs that alter gastrointestinal motility , such as metoclopramide .
fenoldopam	beta-blockers	advise	drug interactions with beta blockers : concomitant use of fenoldopam with beta-blockers should be avoided .
duloxetine	fluvoxamine	mechanism	inhibitors of cyp1a2 : concomitant use of duloxetine with fluvoxamine , an inhibitor of cyp1a2 , results in approximately a dg fold increase in auc and about a dg fold increase in cmax of duloxetine .
probenecid	cefditoren pivoxil	mechanism	probenecid : as with other b lactam antibiotics , co administration of probenecid with cefditoren pivoxil resulted in an increase in the plasma exposure of cefditoren , with a dg % increase in mean cmax , a dg % increase in mean auc , and a dg % increase in half life .
WelChol	verapamil	mechanism	welchol decreased the cmax and auc of sustained release verapamil ( calan sr ) by approximately dg % and dg % , respectively .
Nabilone	psychoactive drugs	advise	nabilone should be administered with caution to patients who are taking other psychoactive drugs or cns depressants , including alcohol , barbiturates and narcotic analgesics , or to those with a history of psychiatric disorder ( including manic depressive illness and schizophrenia ) .
Nabilone	barbiturates	advise	nabilone should be administered with caution to patients who are taking other psychoactive drugs or cns depressants , including alcohol , barbiturates and narcotic analgesics , or to those with a history of psychiatric disorder ( including manic depressive illness and schizophrenia ) .
Nabilone	alcohol	effect	nabilone has been shown to have an additive cns depressant effect when given with either diazepam , secobarbitone sodium , alcohol or codeine .
Ketoconazole	TIKOSYN	mechanism	ketoconazole at dg mg daily ( the maximum approved prescription dose ) co administered with tikosyn ( dg mcg bid ) for dg days has been shown to increase dofetilide cmax by dg % in males and dg % in females , and auc by dg % in males and dg % in females .
nabumetone	warfarin	advise	caution should be exercised when administering nabumetone with warfarin since interactions have been seen with other nsaids .
diuretics	captopril	effect	hypotension patients on diuretic therapy : patients on diuretics and especially those in whom diuretic therapy was recently instituted , as well as those on severe dietary salt restriction or dialysis , may occasionally experience a precipitous reduction of blood pressure usually within the first hour after receiving the initial dose of captopril .
Captopril	antihypertensive agents	effect	agents causing renin release captopril 's effect will be augmented by antihypertensive agents that cause renin release .
diuretic	fosinopril sodium	effect	the possibility of hypotensive effects can be minimized by either discontinuing the diuretic or increasing salt intake prior to initiation of treatment with fosinopril sodium .
antacid	fosinopril	mechanism	antacids : in a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .
phenytoin	sulfapyridine	effect	phenytoin ( e.g. , dilantin ) use of phenytoin with sulfapyridine may increase the chance of side effects affecting the liver and / or the side effects of phenytoin
lorazepam	alcohol	effect	tablets : the benzodiazepines , including lorazepam , produce cns depressant effects when administered with such medications as barbiturates or alcohol .
benzodiazepines	antidepressants	effect	injection : lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , mao inhibitors , and other antidepressants.when scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .
oxytocics	dinoprost	effect	oxytocin or other oxytocics ( concurrent use with dinoprost may result in uterine hypertonus , possibly causing uterine rupture or cervical laceration , especially in the absence of adequate cervical dilatation ;
nitroglycerin	INOmax	effect	although there are no study data to evaluate the possibility , nitric oxide donor compounds , including sodium nitroprusside and nitroglycerin , may have an additive effect with inomax on the risk of developing methemoglobinemia .
HALDOL	anesthetics	effect	as with other antipsychotic agents , it should be noted that haldol may be capable of potentiating cns depressants such as anesthetics , opiates , and alcohol .
HALDOL	opiates	effect	as with other antipsychotic agents , it should be noted that haldol may be capable of potentiating cns depressants such as anesthetics , opiates , and alcohol .
HALDOL	alcohol	effect	as with other antipsychotic agents , it should be noted that haldol may be capable of potentiating cns depressants such as anesthetics , opiates , and alcohol .
valproate	isoniazid	mechanism	valproate : a recent case study has shown a possible increase in the plasma level of valproate when co administered with isoniazid .
isoniazid	acetaminophen	mechanism	furthermore it has been proposed that isoniazid resulted in induction of p 450iie1 in the patients liver which , in turn , resulted in a greater proportion of the ingested acetaminophen being converted to the toxic metabolites .
pyridoxine	cisplatin	advise	however , it adversely affected response duration suggesting that pyridoxine should not be administered with hexalen and / or cisplatin.1
DISULFIRAM	PHENYTOIN	effect	since the concomitant administration of these two drugs can lead to phenytoin intoxication , prior to administering disulfiram to a patient on phenytoin therapy , a baseline phenytoin serum level should be obtained .
disulfiram	nitrites	effect	in rats , simultaneous ingestion of disulfiram and nitrite in the diet for dg weeks has been reported to cause tumors , and it has been suggested that disulfiram may react with nitrites in the rat stomach to form a nitrosamine , which is tumorigenic .
tamoxifen	anastrozole	advise	based on clinical and pharmacokinetic results from the atac trial , tamoxifen should not be administered with anastrozole ( see clinical pharmacology drug interactions and clinical pharmacology clinical studies adjuvant treatment of breast cancer in postmenopausal women subsections ) .
Ribavirin	zidovudine	effect	stavudine and zidovudine ribavirin can antagonize the in vitro antiviral activity of stavudine and zidovudine against hiv .
PRECEDEX	sedatives	effect	anesthetics / sedatives / hypnotics / opioids : co administration of precedex with anesthetics , sedatives , hypnotics , and opioids is likely to lead to an enhancement of effects .
vardenafil	ritonavir	mechanism	the interaction is a consequence of blocking hepatic metabolism of vardenafil by ritonavir , a highly potent cyp3a4 inhibitor , which also inhibits cyp2c9 .
Vardenafil	terazosin	effect	with simultaneous dosing of vardenafil dg mg and terazosin dg mg , dg of dg subjects experienced a standing systolic blood pressure of less than dg mm hg .
Vardenafil	ketoconazole	advise	since higher doses of ketoconazole ( dg mg daily ) may result in higher increases in cmax and auc , a single dg mg dose of vardenafil should not be exceeded in a dg hour period when used in combination with ketoconazole dg mg daily .
PROSTIN E2	oxytocic drugs	effect	prostin e2 may augment the activity of other oxytocic drugs .
eplerenone	fluconazole	mechanism	administration of eplerenone with other cyp3a4 inhibitors ( e.g. , erythromycin dg mg bid , verapamil dg mg qd , saquinavir dg mg tid , fluconazole dg mg qd ) resulted in increases in cmax of eplerenone ranging from dg to dg fold and auc from dg to dg fold .
nortriptyline	fluoxetine hydrochloride	mechanism	there have been greater than dg fold increases in previously stable plasma levels of other antidepressants , including nortriptyline , when fluoxetine hydrochloride has been administered in combination with these agents .
beta-adrenergic receptor blocking agents	Anesthetics	int	when administered concurrently , the following drugs may interact with beta-adrenergic receptor blocking agents : anesthetics , general : exaggeration of the hypotension induced by general anesthetics .
ethosuximide	antiepileptic drugs	int	since zarontin ( ethosuximide ) may interact with concurrently administered antiepileptic drugs , periodic serum level determinations of these drugs may be necessary ( eg , ethosuximide may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels ) .
warfarin	IRESSA	effect	international normalized ratio ( inr ) elevations and / or bleeding events have been reported in some patients taking warfarin while on iressa therapy .
Benzthiazide	blood thinner	int	benzthiazide may interact with alcohol , blood thinners , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , nsaids like aleve or ibuprofen , and high blood pressure medications .
Benzthiazide	norepinephrine	int	benzthiazide may interact with alcohol , blood thinners , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , nsaids like aleve or ibuprofen , and high blood pressure medications .
NSAIDs	furosemide	effect	furosemide : clinical studies , as well as post marketing observations , have shown that nsaids can reduce the natriuretic effect of furosemide and thiazides in some patients .
VIOXX	rifampin	mechanism	rifampin : co administration of vioxx with rifampin dg mg daily , a potent inducer of hepatic metabolism , produced an approximate dg % decrease in rofecoxib plasma concentrations .
sulfonamides	penicillins	effect	bacteriostatic antibiotics : chloramphenicol , erythromycins , sulfonamides , or tetracyclines may interfere with the bactericidal effect of penicillins .
iodine	Carbimazole	effect	iodine or iodine excess may decrease the effect of carbimazole , and an iodine deficiency can increase the effect of carbimazole .
Antithyroid agents	sodium iodide I131	effect	antithyroid agents may decrease thyroidal uptake of sodium iodide i131 , a rebound in uptake may occur up to dg days after sudden withdrawal of carbimazole .
eszopiclone	ethanol	effect	cns active drugs ethanol an additive effect on psychomotor performance was seen with coadministration of eszopiclone and ethanol dg g / kg for up to dg hours after ethanol administration .
Multivitamins	norfloxacin	advise	multivitamins , or other products containing iron or zinc , antacids or sucralfate should not be administered concomitantly with , or within dg hours of , the administration of norfloxacin , because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin .
Videx	norfloxacin	advise	videx ( didanosine ) chewable / buffered tablets or the pediatric powder for oral solution should not be administered concomitantly with , or within dg hours of , the administration of norfloxacin , because these products may interfere with absorption resulting in lower serum and urine levels of norfloxacin .
Quinolones	warfarin	effect	quinolones , including norfloxacin , may enhance the effects of oral anticoagulants , including warfarin or its derivatives or similar agents .
quinolones	glyburide	effect	the concomitant administration of quinolones including norfloxacin with glyburide ( a sulfonylurea agent ) has , on rare occasions , resulted in severe hypoglycemia .
probenecid	norfloxacin	mechanism	diminished urinary excretion of norfloxacin has been reported during the concomitant administration of probenecid and norfloxacin .
Lodine	methotrexate	mechanism	cyclosporine , digoxin , methotrexate lodine , like other nsaids , through effects on renal prostaglandins , may cause changes in the elimination of these drugs leading to elevated serum levels of cyclosporine , digoxin , methotrexate , and increased toxicity .
Mefloquine	phenothiazines	effect	this appears to be the only clinically relevant interaction of this kind with mefloquine , although theoretically , coadministration of other drugs known to alter cardiac conduction ( eg , anti arrhythmic or beta adrenergic blocking agents , calcium channel blockers , antihistamines or h1 blocking agents , tricyclic antidepressants and phenothiazines ) might also contribute to a prolongation of the qtc interval .
atropine	pralidoxime	advise	the following precautions should be kept in mind in the treatment of anticholinesterase poisoning although they do not bear directly on the use of atropine and pralidoxime .
Apraclonidine	MAO inhibitors	advise	apraclonidine should not be used in patients receiving mao inhibitors..
Tricyclic antidepressants	clonidine	effect	tricyclic antidepressants have been reported to blunt the hypotensive effect of systemic clonidine .
glipizide	fluconazole	mechanism	the mean percentage increase in the glipizide auc after fluconazole administration was dg % ( range : dg to dg ) .
adenosine	carbamazepine	effect	as the primary effect of adenosine is to decrease conduction through the a v node , higher degrees of heart block may be produced in the presence of carbamazepine .
Antizol	ethanol	mechanism	oral doses of antizol ( dg dg mg / kg ) , via alcohol dehydrogenase inhibition , significantly reduced the rate of elimination of ethanol ( by approximately dg % ) given to healthy volunteers in moderate doses .
Antizol	cimetidine	mechanism	reciprocal interactions may occur with concomitant use of antizol and drugs that increase or inhibit the cytochrome p450 system ( e.g. , phenytoin , carbamazepine , cimetidine , ketoconazole ) , though this has not been studied
furosemide	acetylsalicylic acid	effect	tablets , injection , and oral solution one study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency .
indomethacin	furosemide	effect	literature reports indicate that coadministration of indomethacin may reduce the natriuretic and antihypertensive effects of furosemide in some patients by inhibiting prostaglandin synthesis .
interferon beta-1a	TYSABRI	mechanism	after multiple dosing , interferon beta-1a ( avonex dg mcg im once weekly ) reduced tysabri clearance by approximately dg % .
ROMAZICON	benzodiazepine	effect	although romazicon exerts a slight intrinsic anticonvulsant effect , its abrupt suppression of the protective effect of a benzodiazepine agonist can give rise to convulsions in epileptic patients .
reserpine	amphetamines	mechanism	acidifying agents : gastrointestinal acidifying agents ( guanethidine , reserpine , glutamic acid hcl , ascorbic acid , fruit juices , etc. ) lower absorption of amphetamines .
Haloperidol	amphetamines	effect	haloperidol : haloperidol blocks dopamine and norepinephrine reuptake , thus inhibiting the central stimulant effects of amphetamines .
Amphetamines	norepinephrine	effect	norepinephrine : amphetamines enhance the adrenergic effect of norepinephrine .
Cimetidine	cisapride	mechanism	h2 receptor antagonists : cimetidine coadministration leads to an increased peak plasma concentration and auc of cisapride , there is no effect on cisapride absorption when it is coadministered with ranitidine .
Cisapride	quinidine	advise	cisapride should not be used concomitantly with other drugs known to prolong the qt interval : certain antiarrhythmics , including those of class ia ( such as quinidine and procainamide ) and class iii ( such as sotalol ) ;
Anafranil	warfarin	mechanism	because anafranil is highly bound to serum protein , the administration of anafranil to patients taking other drugs that are highly bound to protein ( e.g. , warfarin , digoxin ) may cause an increase in plasma concentrations of these drugs , potentially resulting in adverse effects .
CMI	haloperidol	mechanism	the plasma concentration of cmi has been reported to be increased by the concomitant administration of haloperidol ;
methylphenidate	CMI	mechanism	plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors ( e.g. , cimetidine , fluoxetine ) and decreased by the concomitant administration of hepatic enzyme inducers ( e.g. , barbiturates , phenytoin ) , and such an effect may be anticipated with cmi as well .
tricyclic antidepressants	barbiturates	mechanism	plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors ( e.g. , cimetidine , fluoxetine ) and decreased by the concomitant administration of hepatic enzyme inducers ( e.g. , barbiturates , phenytoin ) , and such an effect may be anticipated with cmi as well .
furosemide	FLOLAN	mechanism	in clinical trials , flolan was used with digoxin , diuretics , anticoagulants , oral vasodilators , and supplemental oxygen.in a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with flolan was initiated , apparent oral clearance values for furosemide ( n = dg ) and digoxin ( n = dg ) were decreased by dg % and dg % , respectively , on the second day of therapy and had returned to baseline values by day dg .
sulfonylurea	probenecid	effect	the hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
sulfonylurea	coumarins	effect	the hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
diclofenac	hypoglycemic agents	effect	a direct causal relationship has not been established , but physicians should consider the possibility that diclofenac may alter a diabetic patient s response to insulin or oral hypoglycemic agents .
phenobarbital	diclofenac	effect	phenobarbital toxicity has been reported to have occurred in a patient on chronic phenobarbital treatment following the initiation of diclofenac therapy .
diclofenac	tolbutamide	mechanism	protein binding in vitro , diclofenac interferes minimally or not at all with the protein binding of salicylic acid ( dg % decrease in binding ) , tolbutamide , prednisolone ( dg % decrease in binding ) , or warfarin .
diclofenac	prednisolone	mechanism	protein binding in vitro , diclofenac interferes minimally or not at all with the protein binding of salicylic acid ( dg % decrease in binding ) , tolbutamide , prednisolone ( dg % decrease in binding ) , or warfarin .
gallamine	Coly-Mycin M	effect	curariform muscle relaxants ( eg , tubocurarine ) and other drugs , including ether , succinylcholine , gallamine , decamethonium and sodium citrate , potentiate the neuromuscular blocking effect and should be used with extreme caution in patients being treated with coly-mycin m parenteral .
opioids	INAPSINE	effect	other cns depressant drugs ( e.g. barbiturates , tranquilizers , opioids and general anesthetics ) have additive or potentiating effects with inapsine .
Levo-Dromoran	alcohol	effect	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
Levo-Dromoran	anesthetics	effect	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
dezocine	Levo-Dromoran	advise	interactions with mixed agonist / antagonist opioid analgesics : agonist / antagonist analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as levo-dromoran .
pure agonist opioid analgesic	Levo-Dromoran	advise	interactions with mixed agonist / antagonist opioid analgesics : agonist / antagonist analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as levo-dromoran .
Probenecid	acetaminophen	mechanism	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti inflammatory agents , theophylline , and zidovudine ) .
Probenecid	benzodiazepines	mechanism	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti inflammatory agents , theophylline , and zidovudine ) .
Probenecid	zidovudine	mechanism	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti inflammatory agents , theophylline , and zidovudine ) .
VISTIDE	amphotericin B	advise	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin b , foscarnet , intravenous pentamidine , vancomycin , and non steroidal anti inflammatory agents ] is contraindicated .
foscarnet	zalcitabine	mechanism	amphotericin , foscarnet , and aminoglycosides : drugs such as amphotericin , foscarnet , and aminoglycosides may increase the risk of developing peripheral neuropathy or other hivid associated adverse events by interfering with the renal clearance of zalcitabine ( thereby raising systemic exposure ) .
zalcitabine	magnesium	advise	the clinical significance of this reduction is not known , hence zalcitabine is not recommended to be ingested simultaneously with magnesium / aluminum containing antacids .
Chlorthalidone	tubocurarine	effect	chlorthalidone and related drugs may increase the responsiveness to tubocurarine .
Chlorthalidone	norepinephrine	effect	chlorthalidone and related drugs may decrease arterial responsiveness to norepinephrine .
CASODEX	coumarin anticoagulants	advise	it is recommended that if casodex is started in patients already receiving coumarin anticoagulants , prothrombin times should be closely monitored and adjustment of the anticoagulant dose may be necessary .
halothane	NUROMAX	mechanism	isoflurane , enflurane , and halothane decrease the ed50 of nuromax by dg % to dg % .
NUROMAX	bacitracin	effect	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
digoxin	COREG	advise	therefore , increased monitoring of digoxin is recommended when initiating , adjusting , or discontinuing coreg .
COREG	diltiazem	effect	calcium channel blockers : isolated cases of conduction disturbance ( rarely with hemodynamic compromise ) have been observed when coreg is co administered with diltiazem .
COREG	diltiazem	advise	as with other agents with b blocking properties , if coreg is to be administered orally with calcium channel blockers of the verapamil or diltiazem type , it is recommended that ecg and blood pressure be monitored .
Nevirapine	ketoconazole	advise	nevirapine and ketoconazole should not beadministered concomitantly becausedecreases in ketoconazole plasmaconcentrations may reduce the efficacy of the drug .
bromocriptine mesylate	haloperidol	effect	compounds in these categories result in a decreased efficacy of bromocriptine mesylate : phenothiazines , haloperidol , metoclopramide , pimozide .
bromocriptine mesylate	metoclopramide	effect	compounds in these categories result in a decreased efficacy of bromocriptine mesylate : phenothiazines , haloperidol , metoclopramide , pimozide .
beta-blockers	BROVANA	effect	beta adrenergic receptor antagonists ( beta-blockers ) and brovana may interfere with the effect of each other when administered concurrently .
Beta-blockers	beta-agonists	effect	beta-blockers not only block the therapeutic effects of beta-agonists , but may produce severe bronchospasm in copd patients .
theophylline	adrenergic agonists	effect	concomitant treatment with methylxanthines ( aminophylline , theophylline ) , steroids , or diuretics may potentiate any hypokalemic effect of adrenergic agonists .
steroids	adrenergic agonists	effect	concomitant treatment with methylxanthines ( aminophylline , theophylline ) , steroids , or diuretics may potentiate any hypokalemic effect of adrenergic agonists .
BROVANA	monoamine oxidase inhibitors	advise	brovana , as with other beta2 agonists , should be administered with extreme caution to patients being treated with monoamine oxidase inhibitors , tricyclic antidepressants , or drugs known to prolong the qtc interval because the action of adrenergic agonists on the cardiovascular system may be potentiated by these agents .
BROVANA	tricyclic antidepressants	advise	brovana , as with other beta2 agonists , should be administered with extreme caution to patients being treated with monoamine oxidase inhibitors , tricyclic antidepressants , or drugs known to prolong the qtc interval because the action of adrenergic agonists on the cardiovascular system may be potentiated by these agents .
tricyclic antidepressants	adrenergic agonists	effect	brovana , as with other beta2 agonists , should be administered with extreme caution to patients being treated with monoamine oxidase inhibitors , tricyclic antidepressants , or drugs known to prolong the qtc interval because the action of adrenergic agonists on the cardiovascular system may be potentiated by these agents .
bosentan	cyclosporine A	advise	the concomitant administration of bosentan and cyclosporine a is contraindicated .
tacrolimus	bosentan	mechanism	co administration of tacrolimus and bosentan resulted in markedly increased plasma concentrations of bosentan in animals .
Bosentan	hypoglycemic agents	mechanism	bosentan is also expected to reduce plasma concentrations of other oral hypoglycemic agents that are predominantly metabolized by cyp2c9 or cyp3a4 .
bosentan	Ortho-Novum	mechanism	hormonal contraceptives , including oral , injectable , transdermal , and implantable contraceptives : an interaction study demonstrated that co administration of bosentan and the oral hormonal contraceptive ortho-novum produced average decreases of norethindrone and ethinyl estradiol levels of dg % and dg % , respectively .
Perhexiline hydrogen maleate	Bezalip retard	advise	perhexiline hydrogen maleate or mao inhibitors ( with hepatotoxic potential ) must not be administered together with bezalip or bezalip retard .
sulphonylureas	Bezalip	effect	the action of sulphonylureas and insulin may be enhanced by bezalip or bezalip retard .
Diphenhydramine hydrochloride	alcohol	effect	diphenhydramine hydrochloride has additive effects with alcohol and other cns depressants ( hypnotics , sedatives , tranquilizers , etc ) .
TNF antagonist	ORENCIA	effect	concurrent administration of a tnf antagonist with orencia has been associated with an increased risk of serious infections and no significant additional efficacy over use of the tnf antagonists alone .
SSRIs	5-HT1 agonists	effect	selective serotonin reuptake inhibitors ( ssris ) : ssris ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1 agonists .
TORADOL	probenecid	advise	therefore , concomitant use of toradol and probenecid is contraindicated .
TORADOL	antiepileptic drugs	effect	antiepileptic drugs : sporadic cases of seizures have been reported during concomitant use of toradol and antiepileptic drugs ( phenytoin , carbamazepine ) .
TORADOL	anticoagulants	advise	although these results do not indicate a significant interaction between toradol and warfarin or heparin , the administration of toradol to patients taking anticoagulants should be done extremely cautiously , and patients should be closely monitored .
colestipol	thiazide diuretics	effect	may interact with the following : cholestyramine , colestipol ( use with thiazide diuretics may prevent the diuretic from working properly ;
AED	oxcarbazepine	mechanism	in addition , several aed s that are cytochrome p450 inducers can decrease plasma concentrations of oxcarbazepine and mhd .
phenobarbital	Trileptal	mechanism	the increase of phenobarbital level , however , is small ( dg % ) when given with trileptal .
antihistamines	tranquilizers	effect	additive cns depression may occur when antihistamines are administered concomitantly with other cns depressants including barbiturates , tranquilizers , and alcohol .
antihistamines	CNS depressant drugs	advise	patients receiving antihistamines should be advised against the concurrent use of other cns depressant drugs .
antihypertensive drugs	diazoxide	effect	when other potent parental antihypertensive drugs , such as diazoxide , are used in combination with hydralazine , patients should be continuously observed for several hours for any excessive fall in blood pressure .
Aminoglutethimide	corticosteroids	effect	aminoglutethimide : aminoglutethimide may diminish adrenal suppression by corticosteroids .
cyclosporine	corticosteroids	effect	cyclosporine : increased activity of both cyclosporine and corticosteroids may occur when the two are used concurrently .
Ephedrine	corticosteroids	mechanism	ephedrine : ephedrine may enhance the metabolic clearance of corticosteroids , resulting in decreased blood levels and lessened physiologic activity , thus requiring an increase in corticosteroid dosage .
phenytoin	corticosteroids	mechanism	hepatic enzyme inducers , inhibitors and substrates : drugs which induce cytochrome p450 dg ( cyp dg ) enzyme activity ( e.g. , barbiturates , phenytoin , carbamazepine , rifampin ) may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased .
Aspirin	corticosteroids	advise	aspirin should be used cautiously in conjunction with corticosteroids in hypoprothrombinemia .
phenytoin	dexamethasone	mechanism	phenytoin : in post marketing experience , there have been reports of both increases and decreases in phenytoin levels with dexamethasone co administration , leading to alterations in seizure control .
vaccines	corticosteroid	advise	routine administration of vaccines or toxoids should be deferred until corticosteroid therapy is discontinued if possible .
corticosteroids	warfarin	effect	anticoagulants , oral : co administration of corticosteroids and warfarin usually results in inhibition of response to warfarin , although there have been some conflicting reports .
amphotericin B	Antineoplastic agents	effect	when administered concurrently , the following drugs may interact with amphotericin b : antineoplastic agents : may enhance the potential for renal toxicity , bronchospasm and hypotension .
amphotericin B	leukocyte transfusions	effect	leukocyte transfusions : acute pulmonary toxicity has been reported in patients receiving intravenous amphotericin b and leukocyte transfusions .
dexamethasone	albendazole	mechanism	dexamethasone : steady state trough concentrations of albendazole sulfoxide were about dg % higher when dg mg dexamethasone was coadministered with each dose of albendazole ( dg mg / kg / day ) in eight neurocysticercosis patients .
dopamine	beta-adrenergic blocking agents	effect	cardiac effects of dopamine are antagonized by beta-adrenergic blocking agents , such as propranolol and metoprolol .
dopamine HCl	alpha-adrenergic blocking agents	effect	the peripheral vasoconstriction caused by high doses of dopamine hcl is antagonized by alpha-adrenergic blocking agents .
halogenated hydrocarbon anesthetics	dopamine	effect	cyclopropane or halogenated hydrocarbon anesthetics increase cardiac autonomic irritability and may sensitize the myocardium to the action of certain intravenously administered catecholamines , such as dopamine .
etidronate	warfarin	effect	there have been isolated reports of patients experiencing increases in their prothrombin times when etidronate was added to warfarin therapy .
valdecoxib	phenytoin	mechanism	anticonvulsants ( phenytoin ) : steady state plasma exposure ( auc ) of valdecoxib ( dg mg bid for dg days ) was decreased by dg % when co administered with multiple doses ( dg mg qd for dg days ) of phenytoin ( a cyp dg inducer ) .
valdecoxib	glyburide	mechanism	coadministration of valdecoxib ( dg mg bid ( day dg ) and dg mg qd ( days dg dg ) ) with glyburide ( dg mg glyburide bid ) resulted in dg % increase in glyburide auc0 dg and a dg % increase in glyburide cmax leading to a dg % decrease in glucose auc0 dg .
neomycin	penicillin V	mechanism	oral neomycin inhibits the gastrointestinal absorption of penicillin v , oral vitamin b dg , methotrexate and dg fluorouracil .
probenecid	bumetanide	mechanism	this antagonistic effect of probenecid on bumetanide natriuresis is not due to a direct action on sodium excretion but is probably secondary to its inhibitory effect on renal tubular secretion of bumetanide .
phenytoin	clonazepam	mechanism	cytochrome p dg inducers , such as phenytoin , carbamazepine and phenobarbital , induce clonazepam metabolism , causing an approximately dg % decrease in plasma clonazepam levels .
benzodiazepine class	monoamine oxidase inhibitors	effect	pharmacodynamic interactions : the cns depressant action of the benzodiazepine class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate hypnotics , antianxiety agents , the phenothiazines , thioxanthene and butyrophenone classes of antipsychotic agents , monoamine oxidase inhibitors and the tricyclic antidepressants , and by other anticonvulsant drugs .
NSAIDs	ACE inhibitors	effect	reports suggest that nsaids may diminish the antihypertensive effect of ace inhibitors , including lisinopril .
clorazepate dipotassium	hexobarbital	effect	animal experience indicates that clorazepate dipotassium prolongs the sleeping time after hexobarbital or after ethyl alcohol , increases the inhibitory effects of chlorpromazine , but does not exhibit monoamine oxidase inhibition .
triamterene	dofetilide	advise	in addition , drugs that are actively secreted via this route ( e.g. , triamterene , metformin and amiloride ) should be co administered with care as they might increase dofetilide levels .
azole antifungal agents	TIKOSYN	advise	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
TIKOSYN	verapamil	mechanism	co administration of tikosyn with verapamil resulted in increases in dofetilide peak plasma levels of dg % , although overall exposure to dofetilide was not significantly increased .
verapamil	dofetilide	effect	in an analysis of the supraventricular arrhythmia and diamond patient populations , the concomitant administration of verapamil with dofetilide was associated with a higher occurrence of torsade de pointes .
acetaminophen	tranquilizers	effect	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative hypnotics , or other cns depressants , causing increased cns depression .
acetaminophen	CNS depressants	effect	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative hypnotics , or other cns depressants , causing increased cns depression .
Butalbital	chlordiazepoxide	effect	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative hypnotics , or other cns depressants , causing increased cns depression .
bitolterol	steroid	effect	this allows bitolterol to open air passages , increasing the effectiveness of the steroid .
Benazepril	beta-adrenergic blockers	effect	benazepril , like other ace inhibitors , has had less than additive effects with beta-adrenergic blockers , presumably because both drugs lower blood pressure by inhibiting parts of the renin angiotensin system
benzodiazepines	phenothiazines	effect	the actions of the benzodiazepines may be potentiated by barbiturates , narcotics , phenothiazines , monoamine oxidase inhibitors or other antidepressants .
benzodiazepines	narcotics	effect	the action of the benzodiazepines may be potentiated by anticonvulsants , antihistamines , alcohol , barbiturates , monoamine oxidase inhibitors , narcotics , phenothiazines , psychotropic medications , or other drugs that produce cns depression .
benzodiazepines	psychotropic medications	effect	the action of the benzodiazepines may be potentiated by anticonvulsants , antihistamines , alcohol , barbiturates , monoamine oxidase inhibitors , narcotics , phenothiazines , psychotropic medications , or other drugs that produce cns depression .
estazolam	carbamazepine	mechanism	while no in vivo drug drug interaction studies were conducted between estazolam and inducers of cyp3a , compounds that are potent cyp3a inducers ( such as carbamazepine , phenytoin , rifampin , and barbiturates ) would be expected to decrease estazolam concentrations .
VIRACEPT	cisapride	advise	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
furosemide	colestipol hydrochloride	mechanism	the absorption of tetracycline , furosemide , penicillin g , hydrochlorothiazide , and gemfibrozil was significantly decreased when given simultaneously with colestipol hydrochloride ;
Bile acid binding resins	hydrocortisone	mechanism	bile acid binding resins may also interfere with the absorption of oral phosphate supplements and hydrocortisone .
propranolol	COLESTID	advise	therefore , patients on propranolol should be observed when colestid tablets are either added or deleted from a therapeutic regimen .
FACTIVE	estrogen	mechanism	concomitant administration of factive and calcium carbonate , cimetidine , omeprazole , or an estrogen / progesterone oral contraceptive produced minor changes in the pharmacokinetics of gemifloxacin , which were considered to be without clinical significance .
FACTIVE	probenecid	mechanism	concomitant administration of factive with probenecid resulted in a dg % increase in systemic exposure to gemifloxacin .
quinolone antimicrobial	warfarin	advise	however , because some quinolones have been reported to enhance the anticoagulant effects of warfarin or its derivatives in patients , the prothrombin time or other suitable coagulation test should be closely monitored if a quinolone antimicrobial is administered concomitantly with warfarin or its derivatives .
gemifloxacin	aluminum	mechanism	the absorption of oral gemifloxacin is significantly reduced by the concomitant administration of an antacid containing aluminum and magnesium .
multivitamin preparations	FACTIVE	advise	magnesium and / or aluminum containing antacids , products containing ferrous sulfate ( iron ) , multivitamin preparations containing zinc or other metal cations , or videx ( didanosine ) chewable / buffered tablets or the pediatric powder for oral solution should not be taken within dg hours before or dg hours after factive .
phenytoin	CANCIDAS	mechanism	in addition , results from regression analyses of patient pharmacokinetic data suggest that co administration of other inducers of drug clearance ( efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine ) with cancidas may result in clinically meaningful reductions in caspofungin concentrations .
phenothiazines	diethylpropion	effect	concurrent use of phenothiazines may antagonize the anorectic effect of diethylpropion .
acitretin	tetracyclines	effect	tetracyclines : since both acitretin and tetracyclines can cause increased intracranial pressure , their combined use is contraindicated .
retinoids	acitretin	advise	vitamin a and oral retinoids : concomitant administration of vitamin a and / or other oral retinoids with acitretin must be avoided because of the risk of hypervitaminosis a .
oxyphenbutazone	androgens	mechanism	concurrent administration of oxyphenbutazone and androgens may result in elevated serum levels of oxyphenbutazone .
non-steroidal anti-inflammatory agent	thiazide diuretics	effect	in some patients , the administration of a non-steroidal anti-inflammatory agent can reduce the diuretic , natriuretic , and antihypertensive effects of loop , potassium sparing and thiazide diuretics .
indomethacin	potassium-sparing diuretics	effect	since indomethacin and potassium-sparing diuretics , including midamor , may each be associated with increased serum potassium levels , the potential effects on potassium kinetics and renal function should be considered when these agents are administered concurrently .
apomorphine	palonosetron	advise	5ht3 antagonists : based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron , the concomitant use of apomorphine with drugs of the 5ht3 antagonist class ( including , for example , ondansetron , granisetron , dolasetron , palonosetron , and alosetron ) is contraindicated .
PLETAL	erythromycin	advise	since pletal is extensively metabolized by cytochrome p dg isoenzymes , caution should be exercised when pletal is coadministered with inhibitors of c.p.a. such as ketoconazole and erythromycin or inhibitors of cyp2c19 such as omeprazole .
PEGANONE	phenacemide	advise	considerable caution should be exercised if peganone is administered concurrently with phenurone ( phenacemide ) since paranoid symptoms have been reported during therapy with this combination .
ciclesonide	ketoconazole	mechanism	in another drug interaction study , co administration of orally inhaled ciclesonide and oral ketoconazole , a potent inhibitor of cytochrome p450 dg , increased the exposure ( auc ) of des ciclesonide by approximately dg fold at steady state , while levels of ciclesonide remained unchanged .
alosetron	telithromycin	advise	coadministration of alosetron and strong cyp3a4 inhibitors , such as clarithromycin , telithromycin , protease inhibitors , voriconazole , and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions .
alosetron	itraconazole	advise	coadministration of alosetron and strong cyp3a4 inhibitors , such as clarithromycin , telithromycin , protease inhibitors , voriconazole , and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions .
alosetron	isoniazid	effect	although not studied with alosetron , inhibition of n acetyltransferase may have clinically relevant consequences for drugs such as isoniazid , procainamide , and hydralazine .
alosetron	fluvoxamine	advise	concomitant administration of alosetron and fluvoxamine is contraindicated .
Ketoconazole	alosetron	mechanism	ketoconazole increased mean alosetron plasma concentrations ( auc ) by dg % .
L-histidine	medroxyprogesterone acetate	effect	medroxyprogesterone acetate l-histidine was observed to enhance ( in tissue culture ) the effect of medroxyprogesterone acetate in reducing the number of human breast cancer cells that were in the s phase .
DIAMOX	primidone	advise	caution is advised when beginning , discontinuing , or changing the dose of diamox in patients receiving primidone .
docetaxel	cyclosporine	mechanism	in vitro studies have shown that the metabolism of docetaxel may be modified by the concomitant administration of compounds that induce , inhibit , or are metabolized by cytochrome p450 dg , such as cyclosporine , terfenadine , ketoconazole , erythromycin , and troleandomycin .
docetaxel	ketoconazole	mechanism	in vitro studies have shown that the metabolism of docetaxel may be modified by the concomitant administration of compounds that induce , inhibit , or are metabolized by cytochrome p450 dg , such as cyclosporine , terfenadine , ketoconazole , erythromycin , and troleandomycin .
nifedipine	beta-blocking agents	effect	beta adrenergic blocking agents : experience in over dg patients in a non comparative clinical trial has shown that concomitant administration of nifedipine and beta-blocking agents is usually well tolerated , but there have been occasional literature reports suggesting that the combination may increase the likelihood of congestive heart failure , severe hypotension or exacerbation of angina .
nifedipine	cimetidine	advise	if nifedipine therapy is initiated in a patient currently receiving cimetidine , cautious titration is advised .
Phospholine Iodide	organophosphate insecticide	effect	phospholine iodide potentiates other cholinesterase inhibitors such as succinylcholine or organophosphate and carbamate insecticides .
dexamethasone	Aprepitant	advise	the oral dexamethasone doses should be reduced by approximately dg % when coadministered with aprepitant , to achieve exposures of dexamethasone similar to those obtained when it is given without aprepitant .
S(-)warfarin	Aprepitant	mechanism	although there was no effect of aprepitant on the plasma auc of r ( + ) or s ( ) warfarin determined on day dg , there was a dg % decrease in s(-)warfarin ( a cyp2c9 substrate ) trough concentration accompanied by a dg % decrease in the prothrombin time ( reported as international normalized ratio or inr ) dg days after completion of dosing with aprepitant .
warfarin	Aprepitant	advise	in patients on chronic warfarin therapy , the prothrombin time ( inr ) should be closely monitored in the dg week period , particularly at dg to dg days , following initiation of the dg day regimen of aprepitant with each chemotherapy cycle .
tolbutamide	Aprepitant	mechanism	tolbutamide : aprepitant , when given as dg mg on day dg and dg mg / day on days dg and dg , decreased the auc of tolbutamide ( a cyp2c9 substrate ) by dg % on day dg , dg % on day dg , and dg % on day dg , when a single dose of tolbutamide dg mg was admini , stered orally prior to the administration of the dg day regimen of aprepitant and on days dg , dg , and dg .
Aprepitant	norethindrone	mechanism	oral contraceptives : aprepitant , when given once daily for dg days as a dg mg capsule with an oral contraceptive containing dg mcg of ethinyl estradiol and dg mg of norethindrone , decreased the auc of ethinyl estradiol by dg % , and decreased the auc of norethindrone by dg % ;
triazolam	Aprepitant	advise	the potential effects of increased plasma concentrations of midazolam or other benzodiazepines metabolized via cyp3a4 ( alprazolam , triazolam ) should be considered when coadministering these agents with aprepitant .
Aprepitant	ketoconazole	advise	consequently , concomitant administration of aprepitant with strong cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , nefazodone , troleandomycin , clarithromycin , ritonavir , nelfinavir ) should be approached with caution .
diltiazem	aprepitant	advise	because moderate cyp3a4 inhibitors ( e.g. , diltiazem ) result in dg fold increase in plasma concentrations of aprepitant , concomitant administration should also be approached with caution .
Aprepitant	rifampin	mechanism	therefore , coadministration of aprepitant with drugs that strongly induce cyp3a4 activity ( e.g. , rifampin , carbamazepine , phenytoin ) may result in reduced plasma concentrations of aprepitant that may result in decreased efficacy of aprepitant .
Aprepitant	ketoconazole	mechanism	ketoconazole : when a single dg mg dose of aprepitant was administered on day5 of a dg day regimen of dg mg / day of ketoconazole , a strong cyp3a4 inhibitor , the auc of aprepitant increased approximately dg fold and the mean terminal half life of aprepitant increased approximately dg fold .
Aprepitant	tolbutamide	mechanism	aprepitant has been shown to induce the metabolism of s ( ) warfarin and tolbutamide , which are metabolized through cyp2c9 .
aprepitant	paroxetine	mechanism	paroxetine : coadministration of once daily doses of aprepitant , as a tablet formulation comparable to dg mg or dg mg of the capsule formulation , with paroxetine dg mg once daily , resulted in a decrease in auc by approximately dg % and cmax , by approximately dg % of both aprepitant and paroxetine .
phenobarbital	calcitriol	mechanism	phenytoin / phenobarbital : the coadministration of phenytoin or phenobarbital will not affect plasma concentrations of vitamin d , but may reduce endogenous plasma levels of calcitriol / ergocalcitriol by accelerating metabolism .
thiazides	vitamin D	effect	some reports have shown that the concomitant administration of thiazides with vitamin d causes hypercalcemia .
desipramine hydrochloride	psychotropic agents	effect	if desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative / hypnotics , careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines ( e.g. , chlordiazepoxide or diazepam ) are additive .
reserpine	beta-blocking agents	effect	catecholamine depleting drugs , such as reserpine , may have an additive effect when given with beta-blocking agents .
acebutolol	catecholamine depletors	advise	patients treated with acebutolol plus catecholamine depletors should , therefore , be observed closely for evidence of marked bradycardia or hypotension which may present as vertigo , syncope / presyncope , or orthostatic changes in blood pressure without compensatory tachycardia .
sympathomimetics	beta adrenergic blockers	effect	effects of sympathomimetics are increased with mao inhibitors and beta adrenergic blockers .
enoxacin	fenbufen	effect	non steroidal anti inflammatory agents : seizures have been reported in patients taking enoxacin concomitantly with the nonsteroidal anti inflammatory drug fenbufen .
erythromycin	terfenadine	int	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
erythromycin	astemizole	int	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
erythromycin	cisapride	int	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
codeine	alcohol	effect	the use of codeine may result in additive cns depressant effects when coadministered with alcohol , antihistamines , psychotropics or other drugs that produce cns depression .
dextromethorphan hydrobromide	psychotropics	effect	the use of dextromethorphan hydrobromide may result in additive cns depressant effects when coadministered with alcohol , antihistamines , psychotropics or other drugs that produce cns depression .
phenytoin	alcohol	mechanism	the most commonly occurring drug interactions are listed below : drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2 antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
phenytoin	H2-antagonists	mechanism	the most commonly occurring drug interactions are listed below : drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
phenytoin	tolbutamide	mechanism	the most commonly occurring drug interactions are listed below : drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2 antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
phenytoin	cimetidine	mechanism	the most commonly occurring drug interactions are listed below : drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2 antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
phenytoin	diazepam	mechanism	the most commonly occurring drug interactions are listed below : drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2 antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
phenytoin	fluoxetine	mechanism	the most commonly occurring drug interactions are listed below : drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2 antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
phenytoin	carbamazepine	mechanism	drugs that may decrease plasma phenytoin concentrations include : carbamazepine , chronic alcohol abuse , reserpine
phenytoin	alcohol	mechanism	drugs that may decrease plasma phenytoin concentrations include : carbamazepine , chronic alcohol abuse , reserpine
phenytoin	estrogens	effect	drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
warfarin	NSAIDs	effect	warfarin : the effects of warfarin and nsaids on gi bleeding are synergistic , such that users of both drugs together have a risk of serious gi bleeding higher than users of either drug alone .
AKINETON	phenothiazines	effect	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
AKINETON	antiarrhythmics	effect	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
antacids	vitamin D	effect	magnesium : magnesium containing preparations ( eg , antacids ) may cause hypermagnesemia and should therefore not be taken during therapy with vitamin d by patients on chronic renal dialysis .
tetracyclines	contraceptives	effect	concurrent use of tetracyclines with oral contraceptives may render oral contraceptives less effective .
ergotamine	antibiotics	effect	vasospastic reactions have been reported with therapeutic doses of ergotamine containing drugs when co administered with these antibiotics .
levothyroxine sodium	5-fluorouracil	mechanism	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
labetalol HCl	tricyclic antidepressants	effect	in one survey , dg % of patients taking labetalol hcl in combination with tricyclic antidepressants experienced tremor , as compared to dg % reported to occur with labetalol hcl alone .
halothane	labetalol HCl	effect	synergism has been shown between halothane anesthesia and intravenously administered labetalol hcl .
Labetalol HCl	nitroglycerin	effect	labetalol hcl blunts the reflex tachycardia produced by nitroglycerin without preventing its hypotensive effect .
uricosuric agents	allopurinol	mechanism	the concomitant administration of uricosuric agents and allopurinol has been associated with a decrease in the excretion of oxypurines ( hypoxanthine and xanthine ) and an increase in urinary uric acid excretion compared with that observed with allopurinol alone .
cyclophosphamide	allopurinol	effect	cytotoxic agents : enhanced bone marrow suppression by cyclophosphamide and other cytotoxic agents has been reported among patients with neoplastic disease , except leukemia , in the presence of allopurinol .
allopurinol	azathioprine	advise	in patients receiving mercaptopurine ( purinethol ) or azathioprine ( imuran ) , the concomitant administration of dg dg mg of allopurinol per day will require a reduction in dose to approximately one third to one fourth of the usual dose of mercaptopurine or azathioprine .
allopurinol	dicumarol	mechanism	dicumarol : it has been reported that allopurinol prolongs the half life of the anticoagulant , dicumarol .
nonsteroidal anti-inflammatory agents	coumarin-type anticoagulants	effect	however , because bleeding has been reported when ibuprofen and other nonsteroidal anti-inflammatory agents have been administered to patients on coumarin-type anticoagulants , the physician should be cautious when administering ibuprofen to patients on anticoagulants .
ibuprofen	anticoagulants	advise	however , because bleeding has been reported when ibuprofen and other nonsteroidal anti inflammatory agents have been administered to patients on coumarin type anticoagulants , the physician should be cautious when administering ibuprofen to patients on anticoagulants .
nonsteroidal anti-inflammatory drugs	methotrexate	mechanism	methotrexate : ibuprofen , as well as other nonsteroidal anti-inflammatory drugs , probably reduces the tubular secretion of methotrexate based on in vitro studies in rabbit kidney slices .
Vardenafil	alpha-blocker	advise	based on these data , vardenafil should not be used in patients on alpha-blocker therapy .
Erythromycin	vardenafil	mechanism	erythromycin ( dg mg t.i.d ) produced a dg fold increase in vardenafil auc and a dg fold increase in cmax when co administered with vardenafil dg mg in healthy volunteers .
potassium-sparing antihypertensives	NSAIDs	effect	the administration of other potassium-sparing antihypertensives with nsaids has been shown to reduce the antihypertensive effect in some patients and result in severe hyperkalemia in patients with impaired renal function .
INSPRA	angiotensin II receptor antagonists	effect	ace inhibitors and angiotensin ii receptor antagonists ( hypertension ) in clinical studies of patients with hypertension , the addition of inspra dg to dg mg to ace inhibitors and angiotensin ii receptor antagonists increased mean serum potassium slightly ( about dg dg meq / l ) .
tricyclic antidepressants	propafenone	advise	therefore , co administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme , including other antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( eg , propafenone , flecainide , and encainide ) , or that inhibit this enzyme ( eg , quinidine ) , should be approached with caution .
ketoconazole	gefitinib	mechanism	substances that are potent inhibitors of cyp3a4 activity ( eg , ketoconazole and itraconazole ) decrease gefitinib metabolism and increase gefitinib plasma concentrations .
VIOXX	benazepril	effect	in patients with mild to moderate hypertension , administration of dg mg daily of vioxx with the ace inhibitor benazepril , dg to dg mg for dg weeks , was associated with an average increase in mean arterial pressure of about dg mm hg compared to ace inhibitor alone .
VIOXX	ACE inhibitors	advise	this interaction should be given consideration in patients taking vioxx concomitantly with ace inhibitors .
VIOXX	methotrexate	mechanism	at higher than recommended doses , vioxx dg mg administered once daily for dg days increased plasma concentrations by dg % as measured by auc0 24hr in patients receiving methotrexate dg to dg mg / week for rheumatoid arthritis .
Probenecid	ampicillin	mechanism	probenecid : may decrease renal tubular secretion of ampicillin resulting in increased blood levels and / or ampicillin toxicity .
levetiracetam	AEDs	mechanism	effect of aeds in pediatric patients there was about a dg % increase of apparent total body clearance of levetiracetam when it was co administered with enzyme inducing aeds .
norfloxacin	theophylline	effect	there have been reports of theophylline related side effects in patients on concomitant therapy with norfloxacin and theophylline .
nitrofurantoin	Norfloxacin	effect	the concomitant use of nitrofurantoin is not recommended since nitrofurantoin may antagonize the antibacterial effect of norfloxacin in the urinary tract .
zinc	norfloxacin	advise	multivitamins , or other products containing iron or zinc , antacids or sucralfate should not be administered concomitantly with , or within dg hours of , the administration of norfloxacin , because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin .
antacids	norfloxacin	advise	multivitamins , or other products containing iron or zinc , antacids or sucralfate should not be administered concomitantly with , or within dg hours of , the administration of norfloxacin , because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin .
NSAIDs	ACE-inhibitors	effect	ace-inhibitors reports suggest that nsaids may diminish the antihypertensive effect of ace-inhibitors .
Lodine	furosemide	effect	nevertheless , clinical studies , as well as postmarketing observations have shown that lodine can reduce the natriuretic effect of furosemide and thiazides in some patients .
NSAIDs	digoxin	mechanism	cyclosporine , digoxin , methotrexate lodine , like other nsaids , through effects on renal prostaglandins , may cause changes in the elimination of these drugs leading to elevated serum levels of cyclosporine , digoxin , methotrexate , and increased toxicity .
Mefloquine	live typhoid vaccines	effect	when mefloquine is taken concurrently with oral live typhoid vaccines , attenuation of immunization can not be excluded .
tricyclic antidepressant	cimetidine	mechanism	additionally , higher than expected tricyclic antidepressant levels have been observed when they are begun in patients already taking cimetidine .
tolazamide	doxepin	effect	tolazamide : a case of severe hypoglycemia has been reported in a type ii diabetic patient maintained on tolazamide ( dg gm / day ) dg days after the addition of doxepin ( dg mg / day ) .
IOPIDINE	barbiturates	advise	although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of iopidine dg % ophthalmic solution , the possibility of an additive or potentiating effect with cns depressants ( alcohol , barbiturates , opiates , sedatives , anesthetics ) should be considered .
sulfonylureas	chloramphenicol	effect	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti inflammatory agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
sulfonylureas	probenecid	effect	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti inflammatory agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
sulfonylureas	coumarins	effect	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti inflammatory agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
Adenocard	digitalis	effect	the use of adenocard in patients receiving digitalis may be rarely associated with ventricular fibrillation .
adenosine	dipyridamole	effect	thus , smaller doses of adenosine may be effective in the presence of dipyridamole .
Antizol	carbamazepine	mechanism	reciprocal interactions may occur with concomitant use of antizol and drugs that increase or inhibit the cytochrome p450 system ( e.g. , phenytoin , carbamazepine , cimetidine , ketoconazole ) , though this has not been studied
HEMABATE	oxytocic agents	effect	hemabate may augment the activity of other oxytocic agents .
Furosemide	tubocurarine	effect	furosemide has a tendency to antagonize the skeletal muscle relaxing effect of tubocurarine and may potentiate the action of succinylcholine .
Furosemide	norepinephrine	effect	furosemide may decrease arterial responsiveness to norepinephrine .
angiotensin converting enzyme inhibitors	azathioprine	effect	use with angiotensln converting enzyme inhibitors : the use of angiotensin converting enzyme inhibitors to control hypertension in patients on azathioprine has been reported to induce severe leukopenia .
ROMAZICON	cyclic antidepressants	effect	particular caution is necessary when using romazicon in cases of mixed drug overdosage since the toxic effects ( such as convulsions and cardiac dysrhythmias ) of other drugs taken in overdose ( especially cyclic antidepressants ) may emerge with the reversal of the benzodiazepine effect by flumazenil .
ROMAZICON	benzodiazepines	effect	romazicon blocks the central effects of benzodiazepines by competitive interaction at the receptor level .
amphetamines	lithium carbonate	effect	lithium carbonate : the stimulatory effects of amphetamines may be inhibited by lithium carbonate .
cimetidine	cisapride	mechanism	the gastrointestinal absorption of cimetidine and ranitidine is accelerated when they are coadministered with cisapride .
Cisapride	sotalol	advise	cisapride should not be used concomitantly with other drugs known to prolong the qt interval : certain antiarrhythmics , including those of class ia ( such as quinidine and procainamide ) and class iii ( such as sotalol ) ;
Anafranil	MAO inhibitors	advise	anafranil should not be used with mao inhibitors .
Anafranil	digoxin	mechanism	because anafranil is highly bound to serum protein , the administration of anafranil to patients taking other drugs that are highly bound to protein ( e.g. , warfarin , digoxin ) may cause an increase in plasma concentrations of these drugs , potentially resulting in adverse effects .
phenytoin	CMI	mechanism	plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors ( e.g. , cimetidine , fluoxetine ) and decreased by the concomitant administration of hepatic enzyme inducers ( e.g. , barbiturates , phenytoin ) , and such an effect may be anticipated with cmi as well .
tricyclic antidepressants	phenytoin	mechanism	plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors ( e.g. , cimetidine , fluoxetine ) and decreased by the concomitant administration of hepatic enzyme inducers ( e.g. , barbiturates , phenytoin ) , and such an effect may be anticipated with cmi as well .
Ethopropazine	chlorpromazine	mechanism	ethopropazine can interact with chlorpromazine , increasing the metabolism of chlorpromazine .
FLOLAN	diuretics	effect	additional reductions in blood pressure may occur when flolan is administered with diuretics , antihypertensive agents , or other vasodilators .
anticoagulants	FLOLAN	effect	when other antiplatelet agents or anticoagulants are used concomitantly , there is the potential for flolan to increase the risk of bleeding .
butorphanol	antihistamines	effect	concurrent use of butorphanol with central nervous system depressants ( e.g. , alcohol , barbiturates , tranquilizers , and antihistamines ) may result in increased central nervous system depressant effects .
STADOL NS	sumatriptan	mechanism	however , in another study in healthy volunteers , the pharmacokinetics of butorphanol were significantly altered ( dg % decrease in auc and dg % decrease in cmax ) when a dg mg dose of stadol ns was administered dg minute after a dg mg dose of sumatriptan nasal spray .
epinephrine	halothane	effect	administration of epinephrine to patients receiving cyclopropane or halogenated hydrocarbon general anesthetics such as halothane which sensitize the myocardium , may induce cardiac arrhythmia..
hypoglycemic agents	diclofenac	effect	there are rare reports , however , from marketing experiences , of changes in effects of insulin or oral hypoglycemic agents in the presence of diclofenac that necessitated changes in the doses of such agents .
diclofenac	warfarin	mechanism	protein binding in vitro , diclofenac interferes minimally or not at all with the protein binding of salicylic acid ( dg % decrease in binding ) , tolbutamide , prednisolone ( dg % decrease in binding ) , or warfarin .
diclofenac	cyclosporine	effect	ingestion of diclofenac may increase serum concentrations of digoxin and methotrexate and increase cyclosporine s nephrotoxicity .
diclofenac	cyclosporine	effect	patients who begin taking diclofenac or who increase their diclofenac dose or any other nsaid while taking digoxin , methotrexate , or cyclosporine may develop toxicity characteristics for these drugs .
tubocurarine	Coly-Mycin M	effect	curariform muscle relaxants ( eg , tubocurarine ) and other drugs , including ether , succinylcholine , gallamine , decamethonium and sodium citrate , potentiate the neuromuscular blocking effect and should be used with extreme caution in patients being treated with coly-mycin m parenteral .
decamethonium	Coly-Mycin M	effect	curariform muscle relaxants ( eg , tubocurarine ) and other drugs , including ether , succinylcholine , gallamine , decamethonium and sodium citrate , potentiate the neuromuscular blocking effect and should be used with extreme caution in patients being treated with coly-mycin m parenteral .
BETAGAN	epinephrine	effect	although betagan used alone has little or no effect on pupil size , mydriasis resulting from concomitant therapy with betagan and epinephrine may occur .
anesthetics	INAPSINE	effect	other cns depressant drugs ( e.g. barbiturates , tranquilizers , opioids and general anesthetics ) have additive or potentiating effects with inapsine .
Levo-Dromoran	sedatives	effect	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
cinoxacin	anticoagulants	effect	quinolones , including cinoxacin , may enhance the effects of oral anticoagulants , such as warfarin or its derivatives .
norepinephrine	tricyclic antidepressants	effect	the administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe , prolonged hypertension .
digitalis	Tiazac	effect	pharmacologic studies indicate that there may be additive effects in prolonging av conduction when using beta blockers or digitalis concomitantly with tiazac .
diltiazem hydrochloride	digoxin	mechanism	administration of diltiazem hydrochloride with digoxin in dg healthy male subjects increased plasma digoxin concentrations approximately dg % .
Cholestyramine	propranolol	mechanism	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
sumatriptan	fluvoxamine	advise	if concomitant treatment with sumatriptan and an ssri ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , citalopram , escitalopram ) is clinically warranted , appropriate observation of the patient is advised .
carbamazepine	escitalopram	mechanism	although trough citalopram plasma levels were unaffected , given the enzyme inducing properties of carbamazepine , the possibility that carbamazepine might increase the clearance of escitalopram should be considered if the two drugs are coadministered .
ezetimibe	cyclosporine	advise	patients who take both ezetimibe and cyclosporine should be carefully monitored .
anticoagulant	corticosteroids	effect	there are reports of enhanced as well as diminished effects of anticoagulant when given concurrently with corticosteroids .
methylprednisolone	cyclosporin	effect	convulsions have been reported with concurrent use of methylprednisolone and cyclosporin .
ketoconazole	methylprednisolone	mechanism	drugs such as troleandomycin and ketoconazole may inhibit the metabolism of methylprednisolone and thus decrease its clearance .
salicylate	methylprednisolone	effect	this could lead to decreased salicylate serum levels or increase the risk of salicylate toxicity when methylprednisolone is withdrawn .
sulfonamides	ganglion blockers	advise	patients receiving antibiotics and sulfonamides generally should not be treated with ganglion blockers .
Mecamylamine	alcohol	effect	the action of mecamylamine may be potentiated by anesthesia , other antihypertensive drugs and alcohol .
Anabolic steroids	anticoagulants	effect	anticoagulants anabolic steroids may increase sensitivity to oral anticoagulants .
oxandrolone	warfarin	mechanism	warfarin : a multidose study of oxandrolone , given as dg or dg mg bid in dg healthy subjects concurrently treated with warfarin , resulted in a mean increase in s warfarin half life from dg to dg hours and auc from dg to dg ng*hr / ml : similar increases in r warfarin half life and auc were also detected .
oxandrolone	warfarin	advise	when oxandrolone therapy is initiated in a patient already receiving treatment with warfarin , the inr or prothrombin time ( pt ) should be monitored closely and the dose of warfarin adjusted as necessary until a stable target inr or pt has been achieved .
anticholinergic drugs	benzodiazepines	effect	the following agents may increase certain actions or side effects of anticholinergic drugs : amantadine , antiarrhythmic agents of class i ( e.g. , quinidine ) , antihistamines , antipsychotic agents ( e.g. , phenothiazines ) , benzodiazepines , mao inhibitors , narcotic analgesics ( e.g. , meperidine ) , nitrates and nitrites , sympathomimetic agents , tricyclic antidepressants , and other drugs having anticholinergic activity .
Anticholinergic drugs	corticosteroids	effect	anticholinergic drugs in the presence of increased intraocular pressure may be hazardous when taken concurrently with agents such as corticosteroids .
methsuximide	antiepileptic drugs	advise	since celontin ( methsuximide ) may interact with concurrently administered antiepileptic drugs , periodic serum level determinations of these drugs may be necessary ( eg methsuximide may increase the plasma concentrations of phenytoin and phenobarbital ) .
antacid	TRITEC	mechanism	coadministration with a high dose of antacid ( dg meq ) results in a dg % decrease in plasma concentrations of ranitidine and may decrease plasma concentrations of bismuth from tritec .
norepinephrine	sodium bicarbonate	int	norepinephrine and dobutamine are incompatible with sodium bicarbonate solution .
cholinesterase inhibitors	anticholinergic medications	int	use with anticholinergics : because of their mechanism of action , cholinesterase inhibitors have the potential to interfere with the activity of anticholinergic medications .
NSAIDs	ACE inhibitors	advise	this interaction should be given consideration in patients taking nsaids concomitantly with ace inhibitors .
GH	corticosteroids	mechanism	these data suggest that gh administration may alter the clearance of compounds known to be metabolized by cp450 liver enzymes ( e.g. , corticosteroids , sex steroids , anticonvulsants , cyclosporin ) .
NIMBEX	aminoglycosides	effect	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
NIMBEX	magnesium	effect	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
pseudoephedrine	ProAmatine	effect	the use of drugs that stimulate alpha adrenergic receptors ( e.g. , phenylephrine , pseudoephedrine , ephedrine , phenylpropanolamine or dihydroergotamine ) may enhance or potentiate the pressor effects of proamatine . therefore , caution should be used when proamatine is administered concomitantly with agents that cause vasoconstriction .
doxazosin	ProAmatine	effect	proamatine. alpha adrenergic blocking agents , such as prazosin , terazosin , and doxazosin , can antagonize the effects of proamatine. potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of desglymidodrine ( a base ) is due to active tubular secretion by the base secreting system also responsible for the secretion of such drugs as metformin , cimetidine , ranitidine , procainamide , triamterene , flecainide , and quinidine .
Agonist/antagonist analgesics	Levo-Dromoran	advise	interactions with mixed agonist / antagonist opioid analgesics : agonist/antagonist analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as levo-dromoran .
buprenorphine	Levo-Dromoran	advise	interactions with mixed agonist / antagonist opioid analgesics : agonist / antagonist analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as levo-dromoran .
tranquilizers	DILAUDID	effect	patients receiving other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative hypnotics , tricyclic antidepressants or other cns depressants ( including alcohol ) concomitantly with dilaudid may exhibit an additive cns depression .
CNS depressants	DILAUDID	effect	patients receiving other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative hypnotics , tricyclic antidepressants or other cns depressants ( including alcohol ) concomitantly with dilaudid may exhibit an additive cns depression .
Probenecid	famotidine	mechanism	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti inflammatory agents , theophylline , and zidovudine ) .
VISTIDE	foscarnet	advise	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin b , foscarnet , intravenous pentamidine , vancomycin , and non steroidal anti inflammatory agents ] is contraindicated .
HIVID	didanosine	advise	concomitant use of hivid with didanosine is not recommended .
foscarnet	HIVID	effect	amphotericin , foscarnet , and aminoglycosides : drugs such as amphotericin , foscarnet , and aminoglycosides may increase the risk of developing peripheral neuropathy or other hivid associated adverse events by interfering with the renal clearance of zalcitabine ( thereby raising systemic exposure ) .
aminoglycosides	zalcitabine	mechanism	amphotericin , foscarnet , and aminoglycosides : drugs such as amphotericin , foscarnet , and aminoglycosides may increase the risk of developing peripheral neuropathy or other hivid associated adverse events by interfering with the renal clearance of zalcitabine ( thereby raising systemic exposure ) .
zalcitabine	antacids	advise	the clinical significance of this reduction is not known , hence zalcitabine is not recommended to be ingested simultaneously with magnesium / aluminum containing antacids .
zalcitabine	lamivudine	effect	these in vitro studies suggest that concomitant administration of zalcitabine and lamivudine in humans may result in sub therapeutic concentrations of active phosphorylated zalcitabine , which may lead to a decreased antiretroviral effect of zalcitabine .
zalcitabine	lamivudine	advise	concomitant use of zalcitabine and lamivudine is not recommended .
CASODEX	warfarin	mechanism	in vitro studies have shown casodex can displace coumarin anticoagulants , such as warfarin , from their protein binding sites .
NUROMAX	tetracyclines	effect	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
paroxetine	carvedilol	effect	poor metabolizers of debrisoquin : interactions of carvedilol with strong inhibitors of cyp2d6 ( such as quinidine , fluoxetine , paroxetine , and propafenone ) have not been studied , but these drugs would be expected to increase blood levels of the r ( + ) enantiomer of carvedilol .
propafenone	carvedilol	effect	poor metabolizers of debrisoquin : interactions of carvedilol with strong inhibitors of cyp2d6 ( such as quinidine , fluoxetine , paroxetine , and propafenone ) have not been studied , but these drugs would be expected to increase blood levels of the r ( + ) enantiomer of carvedilol .
UROXATRAL	alpha-blockers	advise	however , interactions may be expected , and uroxatral should not be used in combination with other alpha-blockers .
tiagabine	phenobarbital	mechanism	phenobarbital ( primidone ) : population pharmacokinetic analyses indicate that tiagabine clearance is dg % greater in patients taking phenobarbital ( primidone ) with or without other enzyme inducing aeds .
Tiagabine	valproate	mechanism	valproate : tiagabine causes a slight decrease ( about dg % ) in steady state valproate concentrations .
DOSTINEX	metoclopramide	advise	dostinex should not be administered concurrently with d2 antagonists , such as phenothiazines , butyrophenones , thioxanthines , or metoclopramide .
fenofibrate	bile acid binding resin	advise	therefore , fenofibrate should be taken at least dg hour before or dg dg hours after a bile acid binding resin to avoid impeding its absorption .
Beta-adrenergic receptor antagonists	BROVANA	effect	beta-adrenergic receptor antagonists ( beta blockers ) and brovana may interfere with the effect of each other when administered concurrently .
beta2-agonists	monoamine oxidase inhibitors	advise	brovana , as with other beta2-agonists , should be administered with extreme caution to patients being treated with monoamine oxidase inhibitors , tricyclic antidepressants , or drugs known to prolong the qtc interval because the action of adrenergic agonists on the cardiovascular system may be potentiated by these agents .
Ethoxzolamide	tricyclics	effect	ethoxzolamide may increase the action of tricyclics , amphetamines , procainamide , and quinidine .
ethoxzolamide	diuretics	effect	coadministration of ethoxzolamide with other diuretics , amphotericin b , and corticosteroids may cause hypokalemia .
bosentan	S-warfarin	mechanism	warfarin : co administration of bosentan dg mg b.i.d. for dg days decreased the plasma concentrations of both s-warfarin ( a cyp2c9 substrate ) and r warfarin ( a cyp3a4 substrate ) by dg and dg % , respectively .
Bezalip	anion-exchange resins	advise	when bezalip or bezalip retard is used concurrently with anion-exchange resins ( e.g. cholestryramine ) , an interval of at least dg hours should be maintained between the two medicines , since the absorption of bezalip or bezalip retard is impaired
Diphenhydramine hydrochloride	sedatives	effect	diphenhydramine hydrochloride has additive effects with alcohol and other cns depressants ( hypnotics , sedatives , tranquilizers , etc ) .
Diphenhydramine hydrochloride	tranquilizers	effect	diphenhydramine hydrochloride has additive effects with alcohol and other cns depressants ( hypnotics , sedatives , tranquilizers , etc ) .
Cyclopentolate	carbachol	effect	cyclopentolate may interfere with the anti glaucoma action of carbachol or pilocarpine ;
almotriptan	ketoconazole	mechanism	coadministration of almotriptan and the potent cyp3a4 inhibitor ketoconazole ( dg mg q.d. for dg days ) resulted in an approximately dg % increase in the area under the plasma concentration time curve and maximal plasma concentrations of almotriptan .
fluvoxamine	5-HT1 agonists	effect	selective serotonin reuptake inhibitors ( ssris ) : ssris ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1 agonists .
AXERT	SSRI	advise	if concomitant treatment with axert and an ssri is clinically warranted , appropriate observation of the patient is advised .
TORADOL	psychoactive drugs	effect	psychoactive drugs : hallucinations have been reported when toradol was used in patients taking psychoactive drugs ( fluoxetine , thiothixene , alprazolam ) .
TORADOL	thiothixene	effect	psychoactive drugs : hallucinations have been reported when toradol was used in patients taking psychoactive drugs ( fluoxetine , thiothixene , alprazolam ) .
cephalexin	metformin	advise	accordingly , careful patient monitoring and dose adjustment of metformin is recommended in patients concomitantly taking cephalexin and metformin .
Trileptal	contraceptive	mechanism	hormonal contraceptives co administration of trileptal with an oral contraceptive has been shown to influence the plasma concentrations of the two hormonal components , ethinylestradiol ( ee ) and levonorgestrel ( lng ) .
Trileptal	felodipine	mechanism	calcium antagonists : after repeated co administration of trileptal , the auc of felodipine was lowered by dg % [ dg % ci : dg dg ] .
antihistamines	barbiturates	effect	additive cns depression may occur when antihistamines are administered concomitantly with other cns depressants including barbiturates , tranquilizers , and alcohol .
MAO inhibitors	hydralazine	advise	mao inhibitors should be used with caution in patients receiving hydralazine .
antihypertensive drugs	hydralazine	effect	when other potent parental antihypertensive drugs , such as diazoxide , are used in combination with hydralazine , patients should be continuously observed for several hours for any excessive fall in blood pressure .
Propranolol	hydralazine	mechanism	propranolol increases hydralazines serum concentrations .
cimetidine	nimodipine	mechanism	a study in eight healthy volunteers has shown a dg % increase in mean peak nimodipine plasma concentrations and a dg % increase in mean area under the curve , after a one week course of cimetidine at dg , dg mg / day and nimodipine at dg mg / day .
Beta-blockers	insulin	effect	beta-blockers , clonidine , lithium salts , and alcohol may either potentiate or weaken the blood glucose lowering effect of insulin .
corticosteroids	diuretics	advise	amphotericin b injection and potassium depleting agents : when corticosteroids are administered concomitantly with potassium depleting agents ( e.g. , amphotericin b , diuretics ) , patients should be observed closely for development of hypokalemia .
macrolide antibiotics	corticosteroids	mechanism	drugs which inhibit cyp dg ( e.g. , ketoconazole , macrolide antibiotics such as erythromycin ) have the potential to result in increased plasma concentrations of corticosteroids .
anticholinesterase agents	corticosteroid	advise	if possible , anticholinesterase agents should be withdrawn at least dg hours before initiating corticosteroid therapy .
digoxin	VAPRISOL	mechanism	therefore , if digoxin is administered with vaprisol , the clinician should be alert to the possibility of increases in digoxin levels .
amphotericin B	flucytosine	effect	flucytosine : while a synergistic relationship with amphotericin b has been reported , concomitant use may increase the toxicity of flucytosine by possibly increasing its cellular uptake and / or impairing its renal excretion .
PAH	thiazolesulfone	effect	renal clearance measurements of pah can not be made with any significant accuracy in patients receiving sulfonamides , procaine , or thiazolesulfone .
Netilmicin	furosemide	advise	netilmicin should not be administered concomitantly with potent loop diuretics such as furosemide and ethacrynic acid as the potential for ototoxicity is enhanced by the combination .
allopurinol	ampicillin	effect	the concurrent administration of allopurinol and ampicillin increases substantially the incidence of rashes in patients receiving both drugs as compared to patients receiving ampicillin alone .
iron supplements	OMNICEF	advise	if iron supplements are required during omnicef therapy , omnicef should be taken at least dg hours before or after the supplement .
BREVIBLOC	dopamine	advise	additionally , brevibloc should not be used to control supraventricular tachycardia in the presence of agents which are vasoconstrictive and inotropic such as dopamine , epinephrine , and norepinephrine because of the danger of blocking cardiac contractility when systemic vascular resistance is high .
BREVIBLOC	norepinephrine	advise	additionally , brevibloc should not be used to control supraventricular tachycardia in the presence of agents which are vasoconstrictive and inotropic such as dopamine , epinephrine , and norepinephrine because of the danger of blocking cardiac contractility when systemic vascular resistance is high .
BREVIBLOC	morphine	mechanism	when intravenous morphine and brevibloc were concomitantly administered in normal subjects , no effect on morphine blood levels was seen , but brevibloc steady state blood levels were increased by dg % in the presence of morphine .
selegiline hydrochloride	venlafaxine	effect	in patients receiving nonselective monoamine oxidase inhibitors ( maois ) ( e.g. , selegiline hydrochloride ) in combination with serotoninergic agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
selective serotonin reuptake inhibitors	Imitrex	effect	a rare , but serious , constellation of symptoms , termed serotonin syndrome , has been reported with the concomitant use of selective serotonin reuptake inhibitors ( ssris ) and agents for migraine therapy , such as imitrex ( sumatriptan succinate ) and dihydroergotamine .
rifampin	MEPRON	advise	alternatives to rifampin should be considered during the course of pcp treatment with mepron .
fluvoxamine	5-HT1 agonists	effect	selective serotonin reuptake inhibitors ( ssris ) ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1 agonists .
quinolones	theophylline	effect	there have been reports of theophylline related side effects in patients on concomitant therapy with quinolones and theophylline .
Videx	quinolones	mechanism	and videx , ( didanosine ) , chewable / buffered tablets or the pediatric powder for oral solution may substantially interfere with the absorption of quinolones , resulting in systemic levels considerably lower than desired .
ELLENCE	calcium channel blockers	advise	concomitant use of ellence with other cardioactive compounds that could cause heart failure ( e.g. , calcium channel blockers ) , requires close monitoring of cardiac function throughout treatment .
indinavir	VIDEX	mechanism	interactions with other antiretroviral drugs : significant decreases in the auc of delavirdine ( dg % ) and indinavir ( dg % ) occurred following simultaneous administration of these agents with videx .
itraconazole	VIDEX	advise	drugs whose absorption can be affected by the level of acidity in the stomach : drugs such as ketoconazole and itraconazole should be administered at least dg hours prior to dosing with videx .
VIDEX	ganciclovir	mechanism	a dg ( dg ) % decrease in the steady state auc of ganciclovir was observed when videx was administered dg hours prior to ganciclovir , but not when the two drugs were administered simultaneously ( n = dg ) .
ciprofloxacin	aluminum	mechanism	quinolone antibiotics : videx should be administered at least dg hours after or dg hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium , calcium , or aluminum .
proton pump inhibitors	sucralfate	advise	therefore , proton pump inhibitors should be taken at least dg minutes prior to sucralfate .
felbamate	phenobarbital	mechanism	phenobarbital : coadministration of felbamate with phenobarbital causes an increase in phenobarbital plasma concentrations , in dg otherwise healthy male volunteers ingesting phenobarbital , the steady state trough ( cmin ) phenobarbital concentration was dg micrograms / ml .
Carbamazepine	Felbatol	mechanism	carbamazepine : carbamazepine causes an approximate dg % increase in the clearance of felbatol at steady state and , therefore , the addition of carbamazepine results in an approximate dg % decrease in the steady state trough concentrations of felbatol as compared to the same dose of felbatol given as monotherapy .
phenytoin	exemestane	mechanism	co medications that induce cyp dg ( e.g. , rifampicin , phenytoin , carbamazepine , phenobarbital , or st. john s wort ) may significantly decrease exposure to exemestane .
carbamazepine	exemestane	mechanism	co medications that induce cyp dg ( e.g. , rifampicin , phenytoin , carbamazepine , phenobarbital , or st. john s wort ) may significantly decrease exposure to exemestane .
amprenavir	methadone	mechanism	coadministration of amprenavir and methadone as compared to a non matched historicalcontrol group resulted in a dg % , dg % , and dg % decrease in serum amprenavir auc , cmax , andcmin , respectively .
morphine	Neurontin	mechanism	morphine : a literature article reported that when a dg mg controlled release morphine capsule was administered dg hours prior to a dg mg neurontin capsule ( n=12 ) , mean gabapentin auc increased by dg % compared to gabapentin administered without morphine .
gabapentin	Maalox	advise	it is recommended that gabapentin be taken at least dg hours following maalox administration .
phenytoin	aspirin	effect	phenytoin : serum phenytoin levels may be increased by aspirin .
Aspirin	antacids	advise	antacids : enteric coated aspirin should not be given concurrently with antacids , since an increase in the ph of the stomach may effect the enteric coating of the tablets .
Chlorotrianisene	bromocriptine	int	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
MAO inhibitors	antihistamines	effect	mao inhibitors prolong and intensify the effects of antihistamines .
REMICADE	anakinra	effect	other tnfa blocking agents ( including remicade ) used in combination with anakinra may also result in similar toxicities .
Cytosine arabinoside	flucytosine	effect	cytosine arabinoside , a cytostatic agent , has been reported to inactivate the antifungal activity of flucytosine by competitive inhibition .
TARCEVA	troleandomycin	advise	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
Ketoconazole	tacrolimus	mechanism	ketoconazole tablets may alter the metabolism of cyclosporine , tacrolimus , and methylprednisolone , resulting in elevated plasma concentrations of the latter drugs .
NIZORAL	midazolam	mechanism	coadministration of nizoral tablets with midazolam or triazolam has resulted in elevated plasma concentrations of the latter two drugs .
miconazole	hypoglycemic agents	effect	because severe hypoglycemia has been reported in patients concomitantly receiving oral miconazole ( an imidazole ) and oral hypoglycemic agents , such a potential interaction involving the latter agents when used concomitantly with ketoconazole tablets ( an imidazole ) can not be ruled out .
ketoconazole	phenytoin	advise	it is suggested to monitor both ketoconazole and phenytoin .
Ketoconazole	terfenadine	mechanism	the following drug interactions have been identified involving nizoral tablets and other drugs metabolized by the cytochrome p450 dg enzyme system : ketoconazole tablets inhibit the metabolism of terfenadine , resulting in an increased plasma concentration of terfenadine and a delay in the elimination of its acid metabolite .
ketoconazole	cisapride	effect	data suggest that coadministration of oral ketoconazole and cisapride can result in prolongation of the qt interval on the ecg .
Diuretic agents	lithium	mechanism	diuretic agents reduce the renal clearance of lithium and add a high risk of lithium toxicity .
thiazides	Starlix	effect	certain drugs including thiazides , corticosteroids , thyroid products , and sympathomimetics may reduce the hypoglycemic action of starlix and other oral antidiabetic drugs .
piperacillin	vecuronium	effect	vecuronium : when used in the perioperative period , piperacillin has been implicated in the prolongation of the neuromuscular blockade of vecuronium .
piperacillin	vecuronium	effect	in one controlled clinical study , the ureidopenicillins , including piperacillin , were reported to prolong the action of vecuronium .
Codeine	narcotic analgesics	effect	codeine in combination with other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative hypnotics , or other cns depressants ( including alcohol ) has additive depressant effects .
fexofenadine hydrochloride	erythromycin	mechanism	however , co administration of fexofenadine hydrochloride with either ketoconazole or erythromycin led to increased plasma concentrations of fexofenadine .
fexofenadine hydrochloride	antacid	mechanism	drug interactions with antacids administration of dg mg of fexofenadine hydrochloride ( dg x dg mg capsule ) within dg minutes of an aluminum and magnesium containing antacid ( maalox ) decreased fexofenadine auc by dg % and cmax by dg % .
itraconazole	bexarotene	mechanism	on the basis of the metabolism of bexarotene by cytochrome p450 dg , ketoconazole , itraconazole , erythromycin , gemfibrozil , grapefruit juice , and other inhibitors of cytochrome p450 dg would be expected to lead to an increase in plasma bexarotene concentrations .
erythromycin	bexarotene	mechanism	on the basis of the metabolism of bexarotene by cytochrome p450 dg , ketoconazole , itraconazole , erythromycin , gemfibrozil , grapefruit juice , and other inhibitors of cytochrome p450 dg would be expected to lead to an increase in plasma bexarotene concentrations .
Cimetidine	nicardipine HCl	mechanism	cimetidine : cimetidine increases nicardipine hcl plasma levels .
butyrophenones	levodopa	effect	dopamine d2 receptor antagonists ( e.g. , phenothiazines , butyrophenones , risperidone ) and isoniazid may reduce the therapeutic effects of levodopa .
phenothiazines	levodopa	effect	dopamine d2 receptor antagonists ( e.g. , phenothiazines , butyrophenones , risperidone ) and isoniazid may reduce the therapeutic effects of levodopa .
Iron	levodopa	mechanism	iron salts may reduce the bioavailability of carbidopa and levodopa .
thiazide diuretics	ergocalciferol	effect	administration of thiazide diuretics to hypoparathyroid patients who are concurrently being treated with ergocalciferol may cause hypercalcemia .
ZEBETA	beta-blocking agents	advise	zebeta should not be combined with other beta-blocking agents .
sympathomimetic amines	monoamine oxidase inhibitors	effect	hypertensive crises have resulted when sympathomimetic amines have been used concomitantly within14 days following use of monoamine oxidase inhibitors .
naratriptan	SSRI	advise	if concomitant treatment with naratriptan and an ssri is clinically warranted , appropriate observation of the patient is advised .
SPRYCEL	ketoconazole	mechanism	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
SPRYCEL	telithromycin	mechanism	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
proton pump inhibitors	SPRYCEL	advise	the use of antacids should be considered in place of h2 blockers or proton pump inhibitors in patients receiving sprycel therapy .
cisapride	SPRYCEL	advise	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
Phenytoin	Clozapine	mechanism	phenytoin , nicotine , and rifampin may decrease clozapine plasma levels , resulting in a decrease in effectiveness of a previously effective clozapine dose .
erythromycin	Clozapine	mechanism	cimetidine , caffeine , and erythromycin may increase plasma levels of clozapine , potentially resulting in adverse effects .
Clozapine	carbamazepine	advise	although concomitant use of clozapine and carbamazepine is not recommended , it should be noted that discontinuation of concomitant carbamazepine administration may result in an increase in clozapine plasma levels .
carbamazepine	Clozapine	mechanism	although concomitant use of clozapine and carbamazepine is not recommended , it should be noted that discontinuation of concomitant carbamazepine administration may result in an increase in clozapine plasma levels .
clozapine	paroxetine	mechanism	however , other published reports describe modest elevations ( less than two fold ) of clozapine and metabolite concentrations when clozapine was taken with paroxetine , fluoxetine , and sertraline .
clozapine	carbamazepine	advise	therefore , co administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide and encainide ) , or that inhibit this enzyme ( e.g. , quinidine ) , should be approached with caution .
clozapine	propafenone	advise	therefore , co administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide and encainide ) , or that inhibit this enzyme ( e.g. , quinidine ) , should be approached with caution .
calcium	EMCYT	mechanism	milk , milk products , and calcium rich foods or drugs may impair the absorption of emcyt .
Etonogestrel	Nizoral	int	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo dur ) , and vitamin c .
Etonogestrel	Norvir	int	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo dur ) , and vitamin c .
Etonogestrel	Viracept	int	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo dur ) , and vitamin c .
Etonogestrel	morphine	int	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo dur ) , and vitamin c .
Etonogestrel	Astramorph	int	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo dur ) , and vitamin c .
Etonogestrel	temazepam	int	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo dur ) , and vitamin c .
Etonogestrel	vitamin C	int	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo dur ) , and vitamin c .
hormonal contraceptives	lorazepam	mechanism	benzodiazepines : combination hormonal contraceptives may decrease the clearance of some benzodiazepines ( alprazolam , chlordiazepoxide , diazepam ) and increase the clearance of others ( lorazepam , oxazepam , temazepam ) .
phenobarbital	corticosteroids	mechanism	drugs that induce hepatic enzymes such as phenobarbital , phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response .
MAO inhibitors	antihistamines	effect	mao inhibitors prolong and intensify the anticholinergic effects of antihistamines .
anakinra	TNF-blocking agent	effect	anakinra : concurrent administration of anakinra ( an interleukin dg antagonist ) and another tnf-blocking agent has been associated with an increased risk of serious infections , an increased risk of neutropenia and no additional benefit compared to these medicinal products alone .
Clonidine hydrochloride	barbiturates	effect	clonidine hydrochloride may enhance the cns depressive effects of alcohol , barbiturates or other sedatives .
Amitriptyline	clonidine	effect	amitriptyline in combination with clonidine enhances the manifestation of corneal lesions in rats epidural injection clonidine may potentiate the cns depressive effect of alcohol , barbiturates or other sedating drugs .
fluphenazine	clonidine	effect	there is one reported case of a patient with acute delirium associated with the simultaneous use of fluphenazine and oral clonidine .
ketoprofen	warfarin	advise	because prostaglandina play an important role in hemostasis and ketoprofen has an effect on platelet function as well , concurent therapy with ketoprofen and warfarin requires close monitoring of patients on both drugs .
aspirin	ketoprofen	mechanism	however , in a study of dg normal subjects , concurrent administration of aspirin decreased ketoprofen protein binding and increased ketoprofen plasma clearance from dg l / kg / h without aspirin to dg l / kg / h with aspirin .
bupropion	thioridazine	advise	therefore , co administration of bupropion with drugs that are metabolized by cyp2d6 isoenzyme including certain antidepressants ( e.g. , nortriptyline , imipramine , desipramine , paroxetine , fluoxetine , sertraline ) , antipsychotics ( e.g. , haloperidol , risperidone , thioridazine ) , beta blockers ( e.g. , metoprolol ) , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution and should be initiated at the lower end of the dose range of the concomitant medication .
bupropion	imipramine	advise	therefore , co administration of bupropion with drugs that are metabolized by cyp2d6 isoenzyme including certain antidepressants ( e.g. , nortriptyline , imipramine , desipramine , paroxetine , fluoxetine , sertraline ) , antipsychotics ( e.g. , haloperidol , risperidone , thioridazine ) , beta blockers ( e.g. , metoprolol ) , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution and should be initiated at the lower end of the dose range of the concomitant medication .
bupropion	antipsychotics	advise	therefore , co administration of bupropion with drugs that are metabolized by cyp2d6 isoenzyme including certain antidepressants ( e.g. , nortriptyline , imipramine , desipramine , paroxetine , fluoxetine , sertraline ) , antipsychotics ( e.g. , haloperidol , risperidone , thioridazine ) , beta blockers ( e.g. , metoprolol ) , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution and should be initiated at the lower end of the dose range of the concomitant medication .
bupropion	carbamazepine	mechanism	while not systematically studied , certain drugs may induce the metabolism of bupropion ( e.g. , carbamazepine , phenobarbital , phenytoin ) .
tetracyclines	anticoagulant	advise	because tetracyclines have been shown to depress plasma prothrombin activity , patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage .
tetracyclines	aluminum	mechanism	absorption of tetracyclines is impaired by antacids containing aluminum , calcium , or magnesium , and iron containing preparations .
tetracyclines	calcium	mechanism	absorption of tetracyclines is impaired by antacids containing aluminum , calcium , or magnesium , and iron containing preparations .
Ocupress	beta-adrenergic blocking agent	advise	ocupress should be used with caution in patients who are receiving a beta-adrenergic blocking agent orally because of the potential for additive effects on systemic beta blockade .
chlorprothixene	barbituates	effect	consider additive sedative effects and confusional states to emerge , if chlorprothixene is given with benzodiazepines or barbituates .
chlorprothixene	anticholinergic drugs	advise	exert particular caution in combining chlorprothixene with other anticholinergic drugs ( tricyclic antidepressants and antiparkinsonian agents ) : particularly the elderly may develop delirium , high fever , severe obstipation , even ileus and glaucoma .
loxapine	lorazepam	effect	there have been rare reports of significant respiratory depression , stupor and / or hypotension with the concomitant use of loxapine and lorazepam .
nadolol	guanfacine	effect	noncardioselective beta blockers ( nadolol , porpranolol , timolol ) may exacerbate rebound hypertension when guanfacine is withdrawn .
FOSCAVIR	aminoglycosides	advise	because of foscarnets tendency to cause renal impairment , the use of foscavir should be avoided in combination with potentially nephrotoxic drugs such as aminoglycosides , amphotericin b and intravenous pentamidine unless the potential benefits outweigh the risks to the patient .
imidazoles	amphotericin B	effect	imidazoles ( e. g. , ketoconazole , miconazole , clotrimazole , fluconazole , etc. ) : in vitro and animal studies with the combination of amphotericin b and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin b .
levobupivacaine	phenytoin	mechanism	although no clinical studies have been conducted , it is likely that the metabolism of levobupivacaine may be affected by the known cyp3a4 inducers ( such as phenytoin , phenobarbital , rifampin ) , cyp3a4 inhibitors ( azole antimycotics e.g. , ketoconazole ;
MYOBLOC	aminoglycosides	advise	co administration of myobloc and aminoglycosides or other agents interfering with neuromuscular transmission ( e.g. , curare like compounds ) should only be performed with caution as the effect of the toxin may be potentiated .
ketoconazole	zaleplon	mechanism	other strong selective cyp3a4 inhibitors such as ketoconazole can also be expected to increase the exposure of zaleplon .
haloperidol	dopamine	effect	butyrophenones ( such as haloperidol ) and phenothiazines can suppress the dopaminergic renal and mesenteric vasodilation induced with low dose dopamine infusion .
phenothiazines	dopamine	effect	butyrophenones ( such as haloperidol ) and phenothiazines can suppress the dopaminergic renal and mesenteric vasodilation induced with low dose dopamine infusion .
dextromethorphan	valdecoxib	mechanism	even so dextromethorphan plasma concentrations in the presence of high doses of valdecoxib were almost dg fold lower than those seen in cyp dg poor metabolizers suggesting that dose adjustment is not necessary .
BEXTRA	lithium	advise	lithium serum concentrations should be monitored closely when initiating or changing therapy with bextra in patients receiving lithium .
Valdecoxib	R-warfarin	mechanism	valdecoxib caused a statistically significant increase in plasma exposures of r-warfarin and s warfarin ( dg % and dg % , respectively ) , and in the pharmacodynamic effects ( prothrombin time , measured as inr ) of warfarin .
BEXTRA	warfarin	advise	anticoagulant therapy should be monitored , particularly during the first few weeks , after initiating therapy with bextra in patients receiving warfarin or similar agents .
cinacalcet	amitriptyline	mechanism	amitriptyline : concurrent administration of dg mg or dg mg cinacalcet with dg mg amitriptyline increased amitriptyline exposure and nortriptyline ( active metabolite ) exposure by approximately dg % in cyp2d6 extensive metabolizers .
heroin	alcohol	effect	toxicology studies of heroin related deaths reveal frequent involvement of other central nervous system depressants , including alcohol , benzodiazepines such as diazepam ( valium ) , and , to a rising degree , methadone .
Cimetidine	quinolones	mechanism	cimetidine : cimetidine has been demonstrated to interfere with the elimination of other quinolones .
Quinolones	anticoagulant	effect	warfarin : quinolones may enhance the effects of the oral anticoagulant , warfarin , or its derivatives .
magnesium	lomefloxacin	mechanism	antacids and sucralfate : sucralfate and antacids containing magnesium or aluminum , as well as formulations containing divalent and trivalent cations such as videx ( didanosine ) , chewable / buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability .
Magnesium	lomefloxacin	mechanism	magnesium and aluminum containing antacids , administered concomitantly with lomefloxacin , significantly decreased the bioavailability ( dg % ) of lomefloxacin .
glimepiride	magnesium/choline salicylate	advise	before taking glimepiride , tell your doctor if you are taking any of the following medicines : aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto bismol ) ;
glimepiride	Magan	advise	before taking glimepiride , tell your doctor if you are taking any of the following medicines : aspirin or another salicylate such as magnesium / choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto bismol ) ;
erythromycin	carbamazepine	int	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
clonidine	insulin	effect	beta blockers , clonidine , lithium salts , and alcohol may either potentiate or weaken the blood glucose lowering effect of insulin .
alcohol	insulin	effect	beta blockers , clonidine , lithium salts , and alcohol may either potentiate or weaken the blood glucose lowering effect of insulin .
flurbiprofen	diuretics	advise	patients receiving flurbiprofen and furosemide or other diuretics should be observed closely to determine if the desired effect is obtained .
azithromycin	efavirenz	mechanism	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim / sulfamethoxazole or zidovudine .
azithromycin	indinavir	mechanism	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim / sulfamethoxazole or zidovudine .
L-phenylalanine	non-selective MAO inhibitors	effect	concomitant use of l-phenylalanine and non-selective mao inhibitors may cause hypertension .
Neuroleptic Drugs	L-phenylalanine	effect	neuroleptic drugs l-phenylalanine may potentiate the tardive dyskinesia side reactions of neuroleptic drugs if used concomitantly with them .
rifabutin	efavirenz	mechanism	drugs which induce cyp3a4 activity ( eg , phenobarbital , rifampin , rifabutin ) would be expected to increase the clearance of efavirenz resulting in lowered plasma concentrations .
Acarbose	digoxin	mechanism	acarbose has been shown to change the bioavailabillty digoxin when they are co administered , which may require digoxin dose adjustment .
Bentiromide	Pronestyl	int	bentiromide may interact with acetaminophen ( e.g. , tylenol ) , chloramphenicol ( e.g. , chloromycetin ) , local anesthetics ( e.g. , benzocaine and lidocaine ) , para aminobenzoic acid ( paba ) containing preparations ( e.g. , sunscreens and some multivitamins ) , procainamide ( e.g. , pronestyl ) , sulfonamides ( sulfa medicines ) , thiazide diuretics ( use of these medicines during the test period will affect the test results ) , and pancreatic supplements ( use of pancreatic supplements may give false test results ) .
thyroid products	tricyclic antidepressants	effect	tricyclic antidepressants : use of thyroid products with imipramine and other tricyclic antidepressants may increase receptor sensitivity and enhance antidepressant activity transient cardiac arrhythmias have been observed .
Thyroxine	norepinephrine	effect	vasopressors : thyroxine increases the adrenergic effect of catecholamines such as epinephrine and norepinephrine .
Anticholinergic agents	digoxin	mechanism	anticholinergic agents may affect gastrointestinal absorption of various drugs , such as slowly dissolving dosage forms of digoxin ;
antacids	anticholinergic agents	mechanism	because antacids may interfere with the absorption of anticholinergic agents , simultaneous use of these drugs should be avoided .
amiloride	dofetilide	advise	in addition , drugs that are actively secreted via this route ( e.g. , triamterene , metformin and amiloride ) should be co administered with care as they might increase dofetilide levels .
caffeine	narcotic analgesic	effect	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative hypnotics , or other cns depressants , causing increased cns depression .
caffeine	anesthetics	effect	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative hypnotics , or other cns depressants , causing increased cns depression .
bitolterol	steroid	advise	if you are also using a steroid inhaler , take bitolterol first and then wait about dg minutes before using the steroid inhaler .
quinolone class antimicrobial	nonsteroidal anti-inflammatory drug	effect	seizures have been reported in patients taking another quinolone class antimicrobial and the nonsteroidal anti-inflammatory drug fenbufen concurrently .
quinolone class antimicrobial	fenbufen	effect	seizures have been reported in patients taking another quinolone class antimicrobial and the nonsteroidal anti inflammatory drug fenbufen concurrently .
ETHYOL	antihypertensive medications	advise	special consideration should be given to the administration of ethyol in patients receiving antihypertensive medications or other drugs that could cause or potentiate hypotension .
Phenothiazines	epinephrine	effect	phenothiazines and butyrophenones may reduce or reverse the pressor effect of epinephrine .
cimetidine	diltiazem	mechanism	the effect may be mediated by cimetidines known inhibition of hepatic cytochrome p dg , the enzyme system responsible for the first pass metabolism of diltiazem .
anesthetics	calcium channel blockers	effect	the depression of cardiac contractility , conductivity , and automaticity as well as the vascular dilation associated with anesthetics may be potentiated by calcium channel blockers .
diltiazem	cyclosporine	int	a pharmacokinetic interaction between diltiazem and cyclosporine has been observed during studies involving renal and cardiac transplant patients .
cyclosporine	diltiazem	mechanism	in renal and cardiac transplant recipients , a reduction of cyclosporine dose ranging from dg % to dg % was necessary to maintain cyclosporine trough concentrations similar to those seen prior to the addition of diltiazem .
diltiazem	rifampin	advise	coadministration of diltiazem with rifampin or any known cyp3a4 inducer should be avoided when possible , and alternative therapy considered .
Cholestyramine	estrogens	mechanism	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
amiodarone	HMG-CoA reductase inhibitor class	effect	amiodarone or verapamil : the risk of myopathy / rhabdomyolysis is increased when either amiodarone or verapamil is used concomitantly with a closely related member of the hmg-coa reductase inhibitor class ( see warnings , myopathy / rhabdomyolysis ) .
coumarin anticoagulant	lovastatin	effect	also , bleeding and / or increased prothrombin time have been reported in a few patients taking coumarin anticoagulants concomitantly with lovastatin .
diazepam	valdecoxib	mechanism	plasma exposure of diazepam ( dg mg bid ) was increased by dg % following administration of valdecoxib ( dg mg bid ) for dg days , while plasma exposure of valdecoxib ( dg mg bid ) was not substantially increased following administration of diazepam ( dg mg bid ) for dg days .
cephalosporins	aminoglycosides	effect	although the occurrence has not been reported with cefizox , nephrotoxicity has been reported following concomitant administration of other cephalosporins and aminoglycosides .
neomycin sulfate	anticoagulants	effect	oral neomycin sulfate may enhance the effect of coumarin in anticoagulants by decreasing vitamin k availability .
probenecid	bumetanide	effect	probenecid : pretreatment with probenecid reduces both the natriuresis and hyperreninemia produced by bumetanide .
Indomethacin	bumetanide	effect	indomethacin : indomethacin blunts the increases in urine volume and sodium excretion seen during bumetanide treatment and inhibits the bumetanide induced increase in plasma renin activity .
benzodiazepine class	anticonvulsant drugs	effect	pharmacodynamic interactions : the cns depressant action of the benzodiazepine class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate hypnotics , antianxiety agents , the phenothiazines , thioxanthene and butyrophenone classes of antipsychotic agents , monoamine oxidase inhibitors and the tricyclic antidepressants , and by other anticonvulsant drugs .
benzodiazepine class	antianxiety agents	effect	pharmacodynamic interactions : the cns depressant action of the benzodiazepine class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate hypnotics , antianxiety agents , the phenothiazines , thioxanthene and butyrophenone classes of antipsychotic agents , monoamine oxidase inhibitors and the tricyclic antidepressants , and by other anticonvulsant drugs .
PRINIVIL	thiazide-type diuretics	effect	agents increasing serum potassium : prinivil attenuates potassium loss caused by thiazide-type diuretics .
lithium	ACE inhibitors	effect	lithium : lithium toxicity has been reported in patients receiving lithium concomitantly with drugs which cause elimination of sodium , including ace inhibitors .
lithium	escitalopram	effect	because lithium may enhance the serotonergic effects of escitalopram , caution should be exercised when lexapro and lithium are coadministered .
LEXAPRO	lithium	advise	because lithium may enhance the serotonergic effects of escitalopram , caution should be exercised when lexapro and lithium are coadministered .
selective serotonin reuptake inhibitor	sumatriptan	effect	sumatriptan there have been rare postmarketing reports describing patients with weakness , hyperreflexia , and incoordination following the use of a selective serotonin reuptake inhibitor ( ssri ) and sumatriptan .
sumatriptan	fluoxetine	advise	if concomitant treatment with sumatriptan and an ssri ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , citalopram , escitalopram ) is clinically warranted , appropriate observation of the patient is advised .
sumatriptan	citalopram	advise	if concomitant treatment with sumatriptan and an ssri ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , citalopram , escitalopram ) is clinically warranted , appropriate observation of the patient is advised .
escitalopram	citalopram	advise	concomitant administration with racemic citalopram citalopram since escitalopram is the active isomer of racemic citalopram ( celexa ) , the two agents should not be coadministered .
tolbutamide	teniposide	mechanism	in a study in which dg different drugs were tested , therapeutically relevant concentrations of tolbutamide , sodium salicylate and sulfamethizole displaced protein bound teniposide in fresh human serum to a small but significant extent .
sodium salicylate	teniposide	mechanism	in a study in which dg different drugs were tested , therapeutically relevant concentrations of tolbutamide , sodium salicylate and sulfamethizole displaced protein bound teniposide in fresh human serum to a small but significant extent .
Salicylate	penicillin	mechanism	salicylate competes with a number of drugs for protein binding sites , notably penicillin , thiopental , thyroxine , triiodothyronine , phenytoin , sulfinpyrazone , naproxen , warfarin , methotrexate , and possibly corticosteroids .
Salicylate	thiopental	mechanism	salicylate competes with a number of drugs for protein binding sites , notably penicillin , thiopental , thyroxine , triiodothyronine , phenytoin , sulfinpyrazone , naproxen , warfarin , methotrexate , and possibly corticosteroids .
Salicylate	warfarin	mechanism	salicylate competes with a number of drugs for protein binding sites , notably penicillin , thiopental , thyroxine , triiodothyronine , phenytoin , sulfinpyrazone , naproxen , warfarin , methotrexate , and possibly corticosteroids .
anticholinergic drugs	antipsychotic agents	effect	the following agents may increase certain actions or side effects of anticholinergic drugs : amantadine , antiarrhythmic agents of class i ( e.g. , quinidine ) , antihistamines , antipsychotic agents ( e.g. , phenothiazines ) , benzodiazepines , mao inhibitors , narcotic analgesics ( e.g. , meperidine ) , nitrates and nitrites , sympathomimetic agents , tricyclic antidepressants , and other drugs having anticholinergic activity .
Anticholinergic agents	digoxin	mechanism	anticholinergic agents may affect gastrointestinal absorption of various drugs , such as slowly dissolving dosage forms of digoxin ;
Anticholinergic drugs	metoclopramide	effect	anticholinergic drugs may antagonize the effects of drugs that alter gastrointestinal motility , such as metoclopramide .
Celontin	antiepileptic drugs	advise	since celontin ( methsuximide ) may interact with concurrently administered antiepileptic drugs , periodic serum level determinations of these drugs may be necessary ( eg methsuximide may increase the plasma concentrations of phenytoin and phenobarbital ) .
NSAIDs	angiotensin-converting enzyme (ACE) inhibitors	effect	ace inhibitors reports suggest that nsaids may diminish the antihypertensive effect of angiotensin-converting enzyme (ace) inhibitors .
furosemide	MOBIC	advise	nevertheless , during concomitant therapy with furosemide and mobic , patients should be observed closely for signs of declining renal function , as well as to assure diuretic efficacy .
MOBIC	warfarin	advise	warfarin : anticoagulant activity should be monitored , particularly in the first few days after initiating or changing mobic therapy in patients receiving warfarin or similar agents , since these patients are at an increased risk of bleeding .
GH	anticonvulsants	mechanism	these data suggest that gh administration may alter the clearance of compounds known to be metabolized by cp450 liver enzymes ( e.g. , corticosteroids , sex steroids , anticonvulsants , cyclosporin ) .
nondepolarizing agents	NIMBEX	effect	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
nondepolarizing agents	magnesium	effect	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
NIMBEX	antibiotics	effect	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
nondepolarizing agents	aminoglycosides	effect	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
NIMBEX	clindamycin	effect	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
NIMBEX	anesthetics	effect	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
nondepolarizing neuromuscular blocking agents	carbamazepine	effect	resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or carbamazepine .
Barbiturates	contraceptives	int	barbiturates may decrease the effectiveness of oral contraceptives , certain antibiotics , quinidine , theophylline , corticosteroids , anticoagulants , and beta blockers .
NEXAVAR	irinotecan	advise	caution is recommended when administering nexavar with compounds that are metabolized / eliminated predominantly by the ugt1a1 pathway ( e.g. irinotecan ) .
ProAmatine	cardiac glycosides	effect	when administered concomitantly with proamatine , cardiac glycosides may enhance or precipitate bradycardia , a.v .
phenylpropanolamine	ProAmatine	effect	the use of drugs that stimulate alpha adrenergic receptors ( e.g. , phenylephrine , pseudoephedrine , ephedrine , phenylpropanolamine or dihydroergotamine ) may enhance or potentiate the pressor effects of proamatine . therefore , caution should be used when proamatine is administered concomitantly with agents that cause vasoconstriction .
desglymidodrine	cimetidine	mechanism	proamatine. alpha adrenergic blocking agents , such as prazosin , terazosin , and doxazosin , can antagonize the effects of proamatine. potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of desglymidodrine ( a base ) is due to active tubular secretion by the base secreting system also responsible for the secretion of such drugs as metformin , cimetidine , ranitidine , procainamide , triamterene , flecainide , and quinidine .
desglymidodrine	flecainide	mechanism	proamatine. alpha adrenergic blocking agents , such as prazosin , terazosin , and doxazosin , can antagonize the effects of proamatine. potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of desglymidodrine ( a base ) is due to active tubular secretion by the base secreting system also responsible for the secretion of such drugs as metformin , cimetidine , ranitidine , procainamide , triamterene , flecainide , and quinidine .
desglymidodrine	quinidine	mechanism	proamatine. alpha adrenergic blocking agents , such as prazosin , terazosin , and doxazosin , can antagonize the effects of proamatine. potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of desglymidodrine ( a base ) is due to active tubular secretion by the base secreting system also responsible for the secretion of such drugs as metformin , cimetidine , ranitidine , procainamide , triamterene , flecainide , and quinidine .
SKELAXIN	alcohol	effect	skelaxin may enhance the effects of alcohol , barbiturates and other cns depressants .
Sympathomimetics	veratrum alkaloids	effect	sympathomimetics may reduce the antihypertensive effects of methyldopa , mecamylamine , reserpine and veratrum alkaloids .
TOLECTIN	warfarin	effect	however , increased prothrombin time and bleeding have been reported in patients on concomitant tolectin and warfarin therapy .
rifampin	rosiglitazone	mechanism	an inhibitor of cyp2c8 ( such as gemfibrozil ) may increase the auc of rosiglitazone and an inducer of cyp2c8 ( such as rifampin ) may decrease the auc of rosiglitazone .
Ethanol	abacavir	mechanism	ethanol decreases the elimination of abacavir causing an increase in overall exposure . the addition of methadone has no clinically significant effect on the pharmacokinetic properties of abacavir .
Beta adrenergic agonists	tricyclic antidepressants	advise	beta adrenergic agonists should be administered with caution to patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants , since the action of beta adrenergic agonists on the vascular system may be potentiated .
Triprolidine	hypnotics	effect	triprolidine may enhance the sedative effects of central nervous system depressants including alcohol , barbiturates , hypnotics , narcotic analgesics , sedatives , and tranquillisers .
atropine	triprolidine	effect	the effects of anticholinergic drugs , such as atropine and tricyclic antidepressants may be enhanced by the concomitant administration of triprolidine .
aspirin	Retavase	effect	in addition to bleeding associated with heparin and vitamin k antagonists , drugs that alter platelet function ( such as aspirin , dipyridamole , and abciximab ) may increase the risk of bleeding if administered prior to or after retavase therapy .
selegiline	meperidine	effect	the occurrence of stupor , muscular rigidity , severe agitation , and elevated temperature has been reported in some patients receiving the combination of selegiline and meperidine .
Dexbrompheniramine	alcohol	int	dexbrompheniramine can interact with alcohol or other cns depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
TOBI	urea	advise	tobi should not be administered concomitantly with ethacrynic acid , furosemide , urea , or mannitol .
TOBI	mannitol	advise	tobi should not be administered concomitantly with ethacrynic acid , furosemide , urea , or mannitol .
SYMLIN	anticholinergic agents	advise	due to its effects on gastric emptying , symlin therapy should not be considered for patients taking drugs that alter gastrointestinal motility ( e.g. , anticholinergic agents such as atropine ) and agents that slow the intestinal absorption of nutrients ( e.g. , alpha glucosidase inhibitors ) .
anticoagulants	methimazole	effect	anticoagulants ( oral ) : the activity of oral anticoagulants may be potentiated by anti vitamin k activity attributed to methimazole .
morphine	psychotropic drugs	effect	use with other central nervous system depressants : the depressant effects of morphine are potentiated by the presence of other cns depressants such as alcohol , sedatives , antihistaminics , or psychotropic drugs .
pentazocine	opioid agonist analgesic	advise	interaction with mixed agonist / antagonist opioid analgesics : agonist / antagonist analgesics ( i.e. , pentazocine , nalbuphine , butorphanol , or buprenorphine ) should not be administered to patients who have received or are receiving a course of therapy with a proof opioid agonist analgesic .
butorphanol	opioid agonist analgesic	advise	interaction with mixed agonist / antagonist opioid analgesics : agonist / antagonist analgesics ( i.e. , pentazocine , nalbuphine , butorphanol , or buprenorphine ) should not be administered to patients who have received or are receiving a course of therapy with a proof opioid agonist analgesic .
Ritalin	desipramine	mechanism	human pharmacologic studies have shown that ritalin may inhibit the metabolism of coumarin anticoagulants , anticonvulsants ( phenobarbital , diphenylhydantoin , primidone ) , phenylbutazone , and tricyclic drugs ( imipramine , clomipramine , desipramine ) .
anticoagulant	contraceptives	effect	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under dosage .
anticoagulant	primidone	effect	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under dosage .
anticoagulant	cholestyramine	effect	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under dosage .
anticoagulant	fenoprofen	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
anticoagulant	methylphenidate	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
anticoagulant	naproxen	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
anticoagulant	phenylbutazone	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
anticoagulant	salicylates	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
potassium	ACE inhibitors	effect	use of potassium sparing diuretics ( spironolactone , triamterene , amiloride ) or potassium supplements concomitantly with ace inhibitors can increase the risk of hyperkalemia .
Melatonin	NSAIDs	int	melatonin may interact with the following drugs : aspirin and other nsaids ( may lower melatonin levels ) , fluvoxamine ( bioavailability of oral melatonin is increased with coadministration ) , beta blockers ( may decrease melatonin levels ) , fluoxetine ( reports of psychotic episodes when coadministered ) , progestin ( coadministration of melatonin with progestin can inhibit ovarian function in women ) , benzodiazepenes and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects ) , and corticosteroids ( coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids ) .
thioxanthines	Permax	advise	dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthines ) or metoclopramide , ordinarily should not be administered concurrently with permax ( a dopamine agonist ) ;
phenobarbital	corticosteroids	mechanism	drugs that induce hepatic enzymes such as phenobarbital , phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response .
corticosteroids	anticoagulants	effect	the effect of corticosteroids on oral anticoagulants is variable .
Methscopolamine	antihistamines	int	methscopolamine may interact with antidepressants ( tricyclic type ) , mao inhibitors ( e.g. , phenelzine , linezolid , tranylcypromine , isocarboxazid , selegiline , furazolidone ) , quinidine , amantadine , antihistamines ( e.g. , diphenhydramine ) , other anticholinergics , potassium chloride supplements , antacids , absorbent type anti diarrhea medicines ( e.g. , kaolin pectin ) , phenothiazines ( e.g. , chlorpromazine , promethazine ) .
Methscopolamine	promethazine	int	methscopolamine may interact with antidepressants ( tricyclic type ) , mao inhibitors ( e.g. , phenelzine , linezolid , tranylcypromine , isocarboxazid , selegiline , furazolidone ) , quinidine , amantadine , antihistamines ( e.g. , diphenhydramine ) , other anticholinergics , potassium chloride supplements , antacids , absorbent type anti diarrhea medicines ( e.g. , kaolin pectin ) , phenothiazines ( e.g. , chlorpromazine , promethazine ) .
testolactone	anticoagulants	effect	when administered concurrently , testolactone may increase the effects of oral anticoagulants ;
L-glutamine	human growth hormone	mechanism	human growth hormone concomitant use of l-glutamine and human growth hormone may enhance nutrient absorption in those with severe short bowel syndrome .
Penicillin	probenecid	mechanism	penicillin blood levels may be prolonged by concurrent administration of probenecid which blocks the renal tubular secretion of penicillins .
reserpine	beta-blocking agents	effect	catecholamine depleting drugs ( e.g. , reserpine ) may have an additive effect when given with beta-blocking agents .
Pindolol	thioridazine	mechanism	pindolol has been shown to increase serum thioridazine levels when both drugs are co administered .
INVEGA	alcohol	advise	given the primary cns effects of paliperidone , invega should be used with caution in combination with other centrally acting drugs and alcohol .
Methergine	vasoconstrictors	advise	caution should be exercised when methergine ( methylergonovine maleate ) is used concurrently with other vasoconstrictors or ergot alkaloids .
Phenothiazines	barbiturates	effect	phenothiazines are capable of potentiating cns depressants ( e.g. , barbiturates , anesthetics , opiates , alcohol , etc . )
pantoprazole	ampicillin	mechanism	because of profound and long lasting inhibition of gastric acid secretion , pantoprazole may interfere with absorption of drugs where gastric ph is an important determinant of their bioavailability ( eg , ketoconazole , ampicillin esters , and iron salts ) .
Cerubidine	doxorubicin	advise	cerubidine should not be used in patients who have previously received the recommended maximum cumulative doses of doxorubicin or cerubidine .
propoxyphene	CNS depressants	effect	the cns depressant effect of propoxyphene is additive with that of other cns depressants , including alcohol .
digoxin	sitagliptin	mechanism	digoxin : there was a slight increase in the area under the curve ( auc , dg % ) and mean peak drug concentration ( cmax , dg % ) of digoxin with the co administration of dg mg sitagliptin for dg days .
Vitamin B1	Contraceptives	int	interactions for vitamin b1 ( thiamine ) : loop diuretics , oral contraceptives , stavudine , tricyclic antidepressants
Thiamine	Stavudine	int	interactions for vitamin b1 ( thiamine ) : loop diuretics , oral contraceptives , stavudine , tricyclic antidepressants
Myfortic	aluminum	mechanism	antacids : absorption of a single dose of myfortic was decreased when administered to dg stable renal transplant patients also taking magnesium aluminum containing antacids ( dg ml ) : the mean cmax and auc ( dg t ) values for mpa were dg % and dg % lower , respectively , than when myfortic was administered alone under fasting conditions .
Myfortic	mycophenolate mofetil	advise	azathioprine / mycophenolate mofetil : given that azathioprine and mycophenolate mofetil inhibit purine metabolism , it is recommended that myfortic not be administered concomitantly with azathioprine or mycophenolate mofetil .
MEPERIDINE	ANESTHETICS	advise	interaction with other central nervous system depressants : meperidine should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic analgesics , general anesthetics , phenothiazines , other tranquilizers , sedative hypnotics ( including barbiturates ) , tricyclic antidepressants and other cns depressants ( including alcohol ) .
macrolides	terfenadine	int	concomitant administrations not recommended : terfenadine and astemizole : certain macrolides interact with terfenadine and astemizole leading to increased serum concentrations of the latter .
roxithromycin	astemizole	advise	although such a reaction has not been demonstrated with roxithromycin , concomitant administration of roxithromycin with terfenadine or astemizole is not recommended .
cisapride	macrolide antibacterials	mechanism	cisapride , pimozide : other drugs such as cisapride or pimozide , which are metabolised by hepatic cyp3a isozymes have been associated with qt interval prolongation and / or cardiac arrythmias ( typically torsades de pointe ) as a result of increase in their serum level subsequent to interaction with significant inhibitors of the isozyme , including some macrolide antibacterials .
tetracyclines	contraceptives	effect	concurrent use of tetracyclines with oral contraceptives may render oral contraceptives less effective .
Sanctura	digoxin	mechanism	drugs eliminated by active tubular secretion : although studies to assess drug drug interactions with sanctura have not been conducted , sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion ( e.g. digoxin , procainamide , pancuronium , morphine , vancomycin , metformin and tenofovir ) .
DEMSER	CNS depressants	effect	concurrent use of demser with alcohol or other cns depressants can increase their sedative effects .
Mitotane	warfarin	mechanism	mitotane has been reported to accelerate the metabolism of warfarin by the mechanism of hepatic microsomal enzyme induction , leading to an increase in dosage requirements for warfarin .
Mitotane	coumarin-type anticoagulants	advise	therefore , physicians should closely monitor patients for a change in anticoagulant dosage requirements when administering mitotane to patients on coumarin-type anticoagulants .
aluminum	SKELID	mechanism	the bioavailability of skelid is decreased dg % by calcium , when calcium and skelid are administered at the same time , and dg % by some aluminum or magnesium containing antacids , when administered dg hour before skelid .
SKELID	indomethacin	mechanism	the bioavailability of skelid is increased dg dg fold by indomethacin but is not significantly altered by coadministration of diclofenac .
Carboptic	suprofen	effect	other eye drops or medications such as acetylcholine chloride ( miochol ) and carbachol ( carboptic , isopto carbachol ) may decrease the effects of suprofen ophthalmic .
acetylcholine chloride	suprofen	effect	other eye drops or medications such as acetylcholine chloride ( miochol ) and carbachol ( carboptic , isopto carbachol ) may decrease the effects of suprofen ophthalmic .
sympathomimetic pressor amines	MAOI	effect	mao inhibitors : the pressor effect of sympathomimetic pressor amines is markedly potentiated in patients receiving monoamine oxidase inhibitors ( maoi ) .
paricalcitol	telithromycin	advise	a multiple dose drug drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol auc0 . since paricalcitol is partially metabolized by cyp3a and ketoconazole le is known to be a strong inhibitor of cytochrome p450 3a enzyme , care should be taken while dosing paricalcitol with ketoconazole and other strong p450 3a inhibitors including atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin or voriconazole .
Calcium channel blockers	TENORMIN	effect	calcium channel blockers may also have an additive effect when given with tenormin .
butyrophenones	MIRAPEX	effect	dopamine antagonists : since pramipexole is a dopamine agonist , it is possible that dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of mirapex .
verapamil	pramipexole	mechanism	other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g. , cimetidine , ranitidine , diltiazem , triamterene , verapamil , quinidine , and quinine ) decreases the oral clearance of pramipexole by about dg % , while those secreted by the anionic transport system ( e.g. , cephalosporins , penicillins , indomethacin , hydrochlorothiazide , and chlorpropamide ) are likely to have little effect on the oral clearance of pramipexole .
cimetidine	pramipexole	mechanism	other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g. , cimetidine , ranitidine , diltiazem , triamterene , verapamil , quinidine , and quinine ) decreases the oral clearance of pramipexole by about dg % , while those secreted by the anionic transport system ( e.g. , cephalosporins , penicillins , indomethacin , hydrochlorothiazide , and chlorpropamide ) are likely to have little effect on the oral clearance of pramipexole .
miconazole	terfenadine	advise	due to the chemical similarity of other azole type antifungal agents ( including fluconazole , metronidazole , and miconazole ) to ketoconazole , and itraconazole , concomitant use of these products with terfenadine is not recommended pending full examination of potential interactions .
insulin	SOMAVERT	advise	acromegalic patients with diabetes mellitus being treated with insulin and / or oral hypoglycemic agents may require dose reductions of these therapeutic agents after the initiation of therapy with somavert .
enoximone	anagrelide	effect	the effects of medicinal products with similar properties such as inotropes milrinone , enoximone , amrinone , olprinone and cilostazol may be exacerbated by anagrelide .
midazolam	azole antimycotics	advise	drug interactions : inhibitors of cyp3a4 isozymes : caution is advised when midazolam is administered concomitantly with drugs that are known to inhibit the cytochrome p450 dg enzyme system ( ie , some drugs in the drug classes of azole antimycotics , protease inhibitors , calcium channel antagonists , and macrolide antibiotics ) .
ketoconazole	midazolam	mechanism	drugs such as erythromycin , diltiazem , verapamil , ketoconazole , fluconazole and itraconazole were shown to significantly increase the c max and auc of orally administered midazolam .
VERSED Syrup	morphine	effect	the sedative effect of versed syrup is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly narcotics ( eg , morphine , meperidine and fentanyl ) , propofol , ketamine , nitrous oxide , secobarbital and droperidol .
VERSED Syrup	droperidol	effect	the sedative effect of versed syrup is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly narcotics ( eg , morphine , meperidine and fentanyl ) , propofol , ketamine , nitrous oxide , secobarbital and droperidol .
rifampin	midazolam	mechanism	inducers of cyp3a4 isozymes : cytochrome p450 inducers , such as rifampin , carbamazepine , and phenytoin , induce metabolism and caused a markedly decreased c max and auc of oral midazolam in adult studies .
phenytoin	midazolam	mechanism	inducers of cyp3a4 isozymes : cytochrome p450 inducers , such as rifampin , carbamazepine , and phenytoin , induce metabolism and caused a markedly decreased c max and auc of oral midazolam in adult studies .
levomepromazine	benzodiazepines	effect	additive sedative effects and confusional states may emerge if levomepromazine is given with benzodiazepines or barbiturates .
Caffeine	levomepromazine	effect	caffeine and / or stimulantes of the ephedrine / amphetamine type may counteract the specific actions of levomepromazine .
Fluvoxamine	diazepam	advise	diazepam : the co administration of fluvoxamine tablets and diazepam is generally not advisable .
fluvoxamine	diazepam	mechanism	because fluvoxamine reduces the clearance of both diazepam and its active metabolite , n desmethyldiazepam , there is a strong likelihood of substantial accumulation of both species during chronic co administration .
theophylline	fluvoxamine maleate	advise	therefore , if theophylline is co administered with fluvoxamine maleate , its dose should be reduced to one third of the usual daily maintenance dose and plasma concentrations of theophylline should to monitored .
vitamin K	XENICAL	mechanism	therefore , as vitamin k absorption may be decreased with xenical , patients on chronic stable doses of warfarin who are prescribed xenical should be monitored closely for changes in coagulation parameters .
cyclosporine	DETROL LA	advise	for patients receiving ketoconazole or other potent cyp3a4 inhibitors such as other azole antifungals ( eg , itraconazole , miconazole ) or macrolide antibiotics ( eg , erythromycin , clarithromycin ) or cyclosporine or vinblastine , the recommended dose of detrol la is dg mg daily .
epinephrine	tricyclic antidepressants	advise	avoid the use of preparations such as decongestants and local anesthetics which contain any sympathomimetic amine ( e.g. , epinephrine , norepinephrine ) , since it has been reported that tricyclic antidepressants can potentiate the effects of catecholamines .
acetylsalicylic acid	TNKase	effect	anticoagulants ( such as heparin and vitamin k antagonists ) and drugs that alter platelet function ( such as acetylsalicylic acid , dipyridamole , and gp iib / iiia inhibitors ) may increase the risk of bleeding if administered prior to , during , or after tnkase therapy .
MIVACRON	clindamycin	int	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as mivacron include certain antibiotics ( e.g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
MIVACRON	sodium colistimethate	int	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as mivacron include certain antibiotics ( e.g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
MIVACRON	contraceptives	effect	the neuromuscular blocking effect of mivacron may be enhanced by drugs that reduce plasma cholinesterase activity ( e.g. , chronically administered oral contraceptives , glucocorticoids , or certain monoamine oxidase inhibitors ) or by drugs that irreversibly inhibit plasma cholinesterase . resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or carbamazepine .
DIFLUCAN	cyclosporine	advise	careful monitoring of cyclosporine concentrations and serum creatinine is recommended in patients receiving diflucan and cyclosporine .
DIFLUCAN	theophylline	mechanism	theophylline : diflucan increases the serum concentrations of theophylline .
rifabutin	fluconazole	advise	patients receiving rifabutin and fluconazole concomitantly should be carefully monitored .
fluconazole	tacrolimus	effect	tacrolimus : there have been reports of nephrotoxicity in patients to whom fluconazole and tacrolimus were coadministered .
DIFLUCAN	coumarin-type anticoagulants	advise	careful monitoring of prothrombin time in patients receiving diflucan and coumarin-type anticoagulants is recommended .
Streptase	anticoagulants	effect	use of anticoagulants and antiplatelet agents streptase , streptokinase , alone or in combination with antiplatelet agents and anticoagulants , may cause bleeding complications .
Streptokinase	antiplatelet agents	effect	use of anticoagulants and antiplatelet agents streptase , streptokinase , alone or in combination with antiplatelet agents and anticoagulants , may cause bleeding complications .
quinolones	didanosine	mechanism	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable / buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
macrolide antibiotics	oxybutynin	mechanism	other inhibitors of the cytochrome p450 dg enzyme system , such as antimycotic agents ( e.g. , itraconazole and miconazole ) or macrolide antibiotics ( e.g. , erythromycin and clarithromycin ) , may alter oxybutynin mean pharmacokinetic parameters ( i.e. , cmax and auc ) .
lymecycline	zinc	mechanism	the absorption of lymecycline may be affected by the simultaneous administration of indigestion remedies , iron or zinc supplements .
ALFENTA	opioids	effect	both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when alfenta is administered in combination with other cns depressants such as barbiturates , tranquilizers , opioids , or inhalation general anesthetics .
Cimetidine	ALFENTA	mechanism	cimetidine reduces the clearance of alfenta .
fentanyl	calcium channel blocker	effect	fentanyl anesthesia : severe hypotension has been reported during fentanyl anesthesia with concomitant use of a beta blocker and a calcium channel blocker .
INDOCIN	methotrexate	mechanism	indocin has been reported to decrease the tubular secretion of methotrexate and to potentiate its toxicity .
digoxin	Itraconazole	advise	cyclosporine , tacrolimus and digoxin concentrations should be monitored at the initiation of itraconazole therapy and frequently thereafter , and the dose of these three drug products adjusted appropriately .
HMG-CoA reductase inhibitors	immunosuppressive drugs	effect	rhabdomyolysis has been observed in patients receiving hmg-coa reductase inhibitors administered alone ( at recommended dosages ) or concomitantly with immunosuppressive drugs including cyclosporine .
phenytoin	Itraconazole	advise	therefore , plasma concentrations of phenytoin should also be monitored when it is given concurrently with itraconazole .
azole antifungal agents	hypoglycemic agents	effect	severe hypoglycemia has been reported in patients concomitantly receiving azole antifungal agents and oral hypoglycemic agents .
Itraconazole	quinidine	effect	tinnitus and decreased hearing have been reported in patients concomitantly receiving itraconazole and quinidine .
Itraconazole	dihydropyridine calcium channel blockers	effect	edema has been reported in patients concomitantly receiving itraconazole and dihydropyridine calcium channel blockers .
fentanyl	itraconazole	mechanism	the concomitant use of transdermal fentanyl with ritonavir or other potent dg inhibitors such as ketoconazole , itraconazole , troleandomycin , clarithromycin , nelfinavir , and nefazadone may result in an increase in fentanyl plasma concentrations .
diltiazem	fentanyl	mechanism	the concomitant use of other cyp3a4 inhibitors such as diltiazem and erythromycin with transdermal fentanyl may also result in an increase in fentanyl plasma concentrations , which could increase or prolong adverse drug effects and may cause serious respiratory depression .
DURAGESIC	tranquilizers	effect	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
PRINIVIL	lithium	advise	it is recommended that serum lithium levels be monitored frequently if prinivil is administered concomitantly with lithium .
clorazepate dipotassium	chlorpromazine	effect	animal experience indicates that clorazepate dipotassium prolongs the sleeping time after hexobarbital or after ethyl alcohol , increases the inhibitory effects of chlorpromazine , but does not exhibit monoamine oxidase inhibition .
benzodiazepines	monoamine oxidase inhibitors	effect	the actions of the benzodiazepines may be potentiated by barbiturates , narcotics , phenothiazines , monoamine oxidase inhibitors or other antidepressants .
anticoagulants	chlordiazepoxide	effect	although clinical studies have not established a cause and effect relationship , physicians should be aware that variable effects an blood coagulation have been reported very rarely in patients receiving oral anticoagulants and chlordiazepoxide .
HMG-CoA reductase inhibitors	Fentanyl	advise	experience with co administration of hmg-coa reductase inhibitors and fentanyl in patients is limited , therefore , consideration should be given to temporarily suspending use of hmg-coa reductase inhibitors in patients receiving fentanyl .
benzodiazepines	alcohol	effect	the action of the benzodiazepines may be potentiated by anticonvulsants , antihistamines , alcohol , barbiturates , monoamine oxidase inhibitors , narcotics , phenothiazines , psychotropic medications , or other drugs that produce cns depression .
ritonavir	VIRACEPT	mechanism	ritonavir : coadministration of ritonavir with viracept resulted in a dg % increase in nelfinavir plasma auc and very little change in ritonavir plasma a.c .
VIRACEPT	rifabutin	advise	drugs which require a dose reduction when coadminstered with viracept antimycobacterial agents : rifabutin
sulfasalazine	ENBREL	effect	patients in a clinical study who were on established therapy with sulfasalazine , to which enbrel was added , were noted to develop a mild decrease in mean neutrophil counts in comparison to groups treated with either enbrel ci or sulfasalazine alone .
penicillin G	colestipol hydrochloride	mechanism	the absorption of tetracycline , furosemide , penicillin g , hydrochlorothiazide , and gemfibrozil was significantly decreased when given simultaneously with colestipol hydrochloride ;
Sucralfate	FACTIVE	advise	sucralfate should not be taken within dg hours of factive .
efavirenz	CANCIDAS	mechanism	in addition , results from regression analyses of patient pharmacokinetic data suggest that co administration of other inducers of drug clearance ( efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine ) with cancidas may result in clinically meaningful reductions in caspofungin concentrations .
CANCIDAS	dexamethasone	advise	when cancidas is co administered with inducers of drug clearance , such as efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine , use of a daily dose of dg mg of cancidas should be considered
acitretin	ethanol	mechanism	ethanol : clinical evidence has shown that etretinate can be formed with concurrent ingestion of acitretin and ethanol .
methotrexate	etretinate	effect	methotrexate : an increased risk of hepatitis has been reported to result from combined use of methotrexate and etretinate .
androgens	insulin	effect	in diabetic patients , the metabolic effects of androgens may decrease blood glucose and therefore , insulin requirements .
MIDAMOR	non-steroidal anti-inflammatory agents	advise	therefore , when midamor and non-steroidal anti-inflammatory agents are used concomitantly , the patient should be observed closely to determine if the desired effect of the diuretic is obtained .
apomorphine	granisetron	advise	5ht3 antagonists : based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron , the concomitant use of apomorphine with drugs of the 5ht3 antagonist class ( including , for example , ondansetron , granisetron , dolasetron , palonosetron , and alosetron ) is contraindicated .
dopamine antagonists	metoclopramide	effect	dopamine antagonists : since apomorphine is a dopamine agonist , it is possible that dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
phenothiazines	APOKYN	effect	dopamine antagonists : since apomorphine is a dopamine agonist , it is possible that dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
neuroleptics	dopamine agonists	advise	patients with major psychotic disorders , treated with neuroleptics , should be treated with dopamine agonists only if the potential benefits outweigh the risks .
cilostazol	diltiazem	mechanism	population pharmacokinetic studies showed higher concentrations of cilostazol among patients concurrently treated with diltiazem , an inhibitor of c.p.a..
alosetron	ketoconazole	advise	caution should be used when alosetron and ketoconazole are administered concomitantly .
doxazosin	cimetidine	mechanism	in a placebo controlled trial in normal volunteers , the administration of a single dg mg dose of doxazosin on day dg of a four day regimen of oral cimetidine ( dg mg twice daily ) resulted in a dg % increase in mean auc of doxazosin ( p = dg ) , and a slight but not statistically significant increase in mean cmax and mean half life of doxazosin .
Acetazolamide	cyclosporine	mechanism	acetazolamide may elevate cyclosporine levels .
DIAMOX	primidone	mechanism	by decreasing the gastrointestinal absorption of primidone , diamox may decrease serum concentrations of primidone and its metabolites , with a consequent possible decrease in anticonvulsant effect .
Factrel	dopamine antagonists	effect	the response to factrel may be blunted by phenothiazines and dopamine antagonists which cause a rise in prolactin .
docetaxel	erythromycin	mechanism	in vitro studies have shown that the metabolism of docetaxel may be modified by the concomitant administration of compounds that induce , inhibit , or are metabolized by cytochrome p450 dg , such as cyclosporine , terfenadine , ketoconazole , erythromycin , and troleandomycin .
Auranofin	Depen	advise	auranofin should not be used together with penicillamine ( depen , cuprimine ) , another arthritis medication .
benzodiazepines	SUBOXONE	advise	patients should be warned of the potential danger of the intravenous self administration of benzodiazepines while under treatment with suboxone or subutex .
DURAGESIC	anesthetics	effect	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
fentanyl	hypnotics	effect	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
fentanyl	benzodiazepines	effect	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
Tagamet	theophylline	mechanism	however , a crossover study in healthy subjects receiving either tagamet dg mg q.i.d. or dg mg h.s. concomitantly with a dg mg b.i.d. dosage of theophylline ( theo dur , key pharmaceuticals , inc. ) demonstrated less alteration in steady state theophylline peak serum levels with the dg mg h.s. regimen , particularly in subjects aged dg years and older .
fluconazole	celecoxib	mechanism	fluconazole : concomitant administration of fluconazole at dg mg qd resulted in a two fold increase in celecoxib plasma concentration .
lithium	CELEBREX	mechanism	lithium : in a study conducted in healthy subjects , mean steady state lithium plasma levels increased approximately dg % in subjects receiving lithium dg mg bid with celebrex dg mg bid as compared to subjects receiving lithium alone .
NSAIDs	furosemide	int	experience with nonsteroidal anti inflammatory drugs ( nsaids ) suggests the potential for interactions with furosemide and ace inhibitors .
levamisole hydrochloride	alcohol	effect	ergamisol ( levamisole hydrochloride ) has been reported to produce antabuse like side effects when given concomitantly with alcohol .
contraceptives	Aprepitant	effect	therefore , the efficacy of oral contraceptives during administration of aprepitant may be reduced .
Aprepitant	midazolam	mechanism	midazolam : aprepitant increased the auc of midazolam , a sensitive cyp3a4 substrate , by dg fold on day dg and dg fold on day dg , when a single oral dose of midazolam dg mg was coadministered on day dg and day dg of a regimen of aprepitant dg mg on day dg and dg mg / day on days dg through dg .
midazolam	Aprepitant	advise	the potential effects of increased plasma concentrations of midazolam or other benzodiazepines metabolized via cyp3a4 ( alprazolam , triazolam ) should be considered when coadministering these agents with aprepitant .
benzodiazepines	Aprepitant	advise	the potential effects of increased plasma concentrations of midazolam or other benzodiazepines metabolized via cyp3a4 ( alprazolam , triazolam ) should be considered when coadministering these agents with aprepitant .
alprazolam	Aprepitant	advise	the potential effects of increased plasma concentrations of midazolam or other benzodiazepines metabolized via cyp3a4 ( alprazolam , triazolam ) should be considered when coadministering these agents with aprepitant .
Aprepitant	clarithromycin	advise	consequently , concomitant administration of aprepitant with strong cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , nefazodone , troleandomycin , clarithromycin , ritonavir , nelfinavir ) should be approached with caution .
major tranquilizers	desipramine	effect	both the sedative and anticholinergic effects of the major tranquilizers are also additive to those of desipramine .
cimetidine	tricyclic antidepressants	mechanism	concurrent administration of cimetidine and tricyclic antidepressants can produce clinically significant increases in the plasma levels of the tricyclic antidepressants .
doxylamine	CNS depressant drugs	effect	potential drug interactions for doxylamine include , increased sedation if doxylamine is combined with other cns depressant drugs .
desglymidodrine	triamterene	mechanism	proamatine. alpha adrenergic blocking agents , such as prazosin , terazosin , and doxazosin , can antagonize the effects of proamatine. potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of desglymidodrine ( a base ) is due to active tubular secretion by the base secreting system also responsible for the secretion of such drugs as metformin , cimetidine , ranitidine , procainamide , triamterene , flecainide , and quinidine .
Triprolidine	alcohol	effect	triprolidine may enhance the sedative effects of central nervous system depressants including alcohol , barbiturates , hypnotics , narcotic analgesics , sedatives , and tranquillisers .
dipyridamole	Retavase	effect	in addition to bleeding associated with heparin and vitamin k antagonists , drugs that alter platelet function ( such as aspirin , dipyridamole , and abciximab ) may increase the risk of bleeding if administered prior to or after retavase therapy .
vitamin K antagonists	Retavase	effect	in addition to bleeding associated with heparin and vitamin k antagonists , drugs that alter platelet function ( such as aspirin , dipyridamole , and abciximab ) may increase the risk of bleeding if administered prior to or after retavase therapy .
Dexbrompheniramine	monoamine oxidase (MAO) inhibitors	int	dexbrompheniramine can interact with alcohol or other cns depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase (mao) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
TOBI	aminoglycosides	effect	in clinical studies of tobi , patients taking tobi concomitantly with dornase alfa ( pulmozyme , genentech ) , ( beta ) agonists , inhaled corticosteroids , other anti pseudomonal antibiotics , or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole .
TOBI	furosemide	advise	tobi should not be administered concomitantly with ethacrynic acid , furosemide , urea , or mannitol .
DIPRIVAN	opioids	advise	during maintenance of anesthesia or sedation , the rate of diprivan injectable emulsion administration should be adjusted according to the desired level of anesthesia or sedation and may be reduced in the presence of supplemental analgesic agents ( eg , nitrous oxide or opioids ) .
aspirin	methazolamide	advise	caution is advised for patients receiving high dose aspirin and methazolamide concomitantly , as anorexia , tachypnea , lethargy , coma and death have been reported with concomitant use of high dose aspirin and carbonic anhydrase inhibitors .
SYMLIN	atropine	advise	due to its effects on gastric emptying , symlin therapy should not be considered for patients taking drugs that alter gastrointestinal motility ( e.g. , anticholinergic agents such as atropine ) and agents that slow the intestinal absorption of nutrients ( e.g. , alpha glucosidase inhibitors ) .
morphine	sedatives	effect	use with other central nervous system depressants : the depressant effects of morphine are potentiated by the presence of other cns depressants such as alcohol , sedatives , antihistaminics , or psychotropic drugs .
Agonist/antagonist analgesics	opioid agonist analgesic	advise	interaction with mixed agonist / antagonist opioid analgesics : agonist/antagonist analgesics ( i.e. , pentazocine , nalbuphine , butorphanol , or buprenorphine ) should not be administered to patients who have received or are receiving a course of therapy with a proof opioid agonist analgesic .
buprenorphine	opioid agonist analgesic	advise	interaction with mixed agonist / antagonist opioid analgesics : agonist / antagonist analgesics ( i.e. , pentazocine , nalbuphine , butorphanol , or buprenorphine ) should not be administered to patients who have received or are receiving a course of therapy with a proof opioid agonist analgesic .
SUTENT	ketoconazole	mechanism	co administration of sutent with strong inhibitors of the cyp3a4 family ( e.g. , ketoconazole , itraconazole , clarithromycin , atazanavir , indinavir , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , voriconizole ) may increases sunitinib concentrations .
SUTENT	saquinavir	mechanism	co administration of sutent with strong inhibitors of the cyp3a4 family ( e.g. , ketoconazole , itraconazole , clarithromycin , atazanavir , indinavir , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , voriconizole ) may increases sunitinib concentrations .
SUTENT	telithromycin	mechanism	co administration of sutent with strong inhibitors of the cyp3a4 family ( e.g. , ketoconazole , itraconazole , clarithromycin , atazanavir , indinavir , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , voriconizole ) may increases sunitinib concentrations .
SUTENT	phenobarbital	mechanism	co administration of sutent with inducers of the cyp3a4 family ( e.g. , dexamethasone , phenytoin , carbamazepine , rifampin , rifabutin , rifapentin , phenobarbital , st. johns wort ) may decrease sunitinib concentrations .
anticoagulant	antihistamines	effect	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under dosage .
anticoagulant	chloral hydrate	effect	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under dosage .
anticoagulant	vitamin K	effect	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under dosage .
anticoagulant	alcohol	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
lithium	ACE inhibitor	effect	lithium : increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving concomitant lithium and ace inhibitor therapy .
Fosinopril sodium	thiazide diuretics	effect	potassium supplements and potassium sparing diuretics : fosinopril sodium can attenuate potassium loss caused by thiazide diuretics .
ACE inhibitors	lithium	effect	lithium : increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ace inhibitors during therapy with lithium .
magnesium hydroxide	fosinopril	mechanism	antacids : in a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .
sulfonylureas	sulfonamides	effect	the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
sulfonylureas	probenecid	effect	the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
benzodiazepines	barbiturates	effect	injection : lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , mao inhibitors , and other antidepressants.when scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .
benzodiazepines	MAO inhibitors	effect	injection : lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , mao inhibitors , and other antidepressants.when scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .
benzodiazepines	ethyl alcohol	effect	injection : lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , mao inhibitors , and other antidepressants.when scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .
dopamine	Bretylium Tosylate	effect	the pressor effects of catecholamines such as dopamine or norepinephrine are enhanced by bretylium tosylate .
sodium nitroprusside	INOmax	effect	although there are no study data to evaluate the possibility , nitric oxide donor compounds , including sodium nitroprusside and nitroglycerin , may have an additive effect with inomax on the risk of developing methemoglobinemia .
antipsychotic agents	opiates	effect	as with other antipsychotic agents , it should be noted that haldol may be capable of potentiating cns depressants such as anesthetics , opiates , and alcohol .
rifampin	haloperidol	mechanism	in dg other schizophrenic patients treated with oral haloperidol and rifampin , discontinuation of rifampin produced a mean dg fold increase in haloperidol concentrations .
isoniazid	theophylline	mechanism	therophylline : a recent study has shown that concomitan administration of isoniazid and theophylline may cause elevated plasma levels of theophylline , and in some instances a slight decrease in the elimination of isoniazid .
acetaminophen	Isoniazid	effect	acetaminophen : a report of severe acetaminophen toxicity was reported in a patient receiving isoniazid .
isoniazid	acetaminophen	effect	it is believed that the toxicity may have resulted from a previously unrecognized interaction between isoniazid and acetaminophen and a molecular basis for this interaction has been proposed .
Isoniazid	phenytoin	mechanism	phenytoin : isoniazid may increase serum levels of phenytoin .
HEXALEN	antidepressants of the MAO inhibitor class	effect	concurrent administration of hexalen and antidepressants of the mao inhibitor class may cause severe orthostatic hypotension.cimetidine , an inhibitor of microsomal drug metabolism , increased altretamines half life and toxicity in a rat model .
HEXALEN	cisplatin	effect	data from a randomized trial of hexalen and cisplatin plus or minus pyridoxine in ovarian cancer indicated that pyridoxine significantly reduced neurotoxicity ;
pyridoxine	HEXALEN	advise	however , it adversely affected response duration suggesting that pyridoxine should not be administered with hexalen and / or cisplatin.1
Estrogen	ARIMIDEX	advise	estrogen containing therapies should not be used with arimidex as they may diminish its pharmacologic action .
PRECEDEX	opioids	effect	anesthetics / sedatives / hypnotics / opioids : co administration of precedex with anesthetics , sedatives , hypnotics , and opioids is likely to lead to an enhancement of effects .
PRECEDEX	anesthetic	advise	however , due to possible pharmacodynamic interactions , when co administered with precedex , a reduction in dosage of precedex on the concomitant anesthetic , sedative , hypnotic or opioid may be required .
Indinavir	Vardenafil	mechanism	hiv protease inhibitors : indinavir ( dg mg t.i.d. ) co administered with vardenafil dg mg resulted in a dg fold increase in vardenafil auc , a dg fold increase in vardenafil cmax and a dg fold increase in vardenafil half life .
Vardenafil	ritonavir	advise	consequently , it is recommended not to exceed a single dg mg vardenafil dose in a dg hour period when used in combination with ritonavir .
Vardenafil	tamsulosin	effect	two of dg subjects dosed simultaneously with vardenafil dg mg and tamsulosin dg mg experienced a standing systolic blood pressure below dg mm hg .
eplerenone	erythromycin	mechanism	administration of eplerenone with other cyp3a4 inhibitors ( e.g. , erythromycin dg mg bid , verapamil dg mg qd , saquinavir dg mg tid , fluconazole dg mg qd ) resulted in increases in cmax of eplerenone ranging from dg to dg fold and auc from dg to dg fold .
eplerenone	verapamil	mechanism	administration of eplerenone with other cyp3a4 inhibitors ( e.g. , erythromycin dg mg bid , verapamil dg mg qd , saquinavir dg mg tid , fluconazole dg mg qd ) resulted in increases in cmax of eplerenone ranging from dg to dg fold and auc from dg to dg fold .
eplerenone	saquinavir	mechanism	administration of eplerenone with other cyp3a4 inhibitors ( e.g. , erythromycin dg mg bid , verapamil dg mg qd , saquinavir dg mg tid , fluconazole dg mg qd ) resulted in increases in cmax of eplerenone ranging from dg to dg fold and auc from dg to dg fold .
INSPRA	lithium	advise	serum lithium levels should be monitored frequently if inspra is administered concomitantly with lithium .
tricyclic antidepressants	cimetidine	effect	serious anticholinergic symptoms ( severe dry mouth , urinary retention , blurred vision ) have been associated with elevations in the serum levels of tricyclic antidepressants when cimetidine is added to the drug regimen .
tricyclic antidepressants	Type 1C antiarrhythmics	advise	therefore , co administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme , including other antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( eg , propafenone , flecainide , and encainide ) , or that inhibit this enzyme ( eg , quinidine ) , should be approached with caution .
tricyclic antidepressants	quinidine	advise	therefore , co administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme , including other antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( eg , propafenone , flecainide , and encainide ) , or that inhibit this enzyme ( eg , quinidine ) , should be approached with caution .
cimetidine	tricyclic antidepressants	mechanism	in well controlled patients undergoing concurrent therapy with cimetidine , a decrease in the steady state serum concentrations of tricyclic antidepressants may occur when cime tidine therapy is discontinued .
Zarontin	antiepileptic drugs	int	since zarontin ( ethosuximide ) may interact with concurrently administered antiepileptic drugs , periodic serum level determinations of these drugs may be necessary ( eg , ethosuximide may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels ) .
antacids	lactulose	mechanism	results of preliminary studies in humans and rats suggest that nonabsorbable antacids given concurrently with lactulose may inhibit the desired lactulose induced drop in colonic ph .
ketoconazole	gefitinib	mechanism	substances that are potent inhibitors of cyp3a4 activity ( eg , ketoconazole and itraconazole ) decrease gefitinib metabolism and increase gefitinib plasma concentrations .
itraconazole	gefitinib	mechanism	substances that are potent inhibitors of cyp3a4 activity ( eg , ketoconazole and itraconazole ) decrease gefitinib metabolism and increase gefitinib plasma concentrations .
Benzthiazide	alcohol	int	benzthiazide may interact with alcohol , blood thinners , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , nsaids like aleve or ibuprofen , and high blood pressure medications .
VIOXX	methotrexate	advise	standard monitoring of methotrexate related toxicity should be continued if vioxx and methotrexate are administered concomitantly .
Chloramphenicol	penicillins	effect	bacteriostatic antibiotics : chloramphenicol , erythromycins , sulfonamides , or tetracyclines may interfere with the bactericidal effect of penicillins .
anileridine	sedatives	advise	caution should be observed when anileridine is coadministered with other opioids , sedatives , phenothiazines , or anesthetics , as these agents may increase respiratory and circulatory depression .
zopiclone	rifampicin	mechanism	drugs that induce cyp3a4 ( rifampicin ) racemic zopiclone exposure was decreased dg % by concomitant useof rifampicin , a potent inducer of cyp3a4 .
sucralfate	norfloxacin	advise	multivitamins , or other products containing iron or zinc , antacids or sucralfate should not be administered concomitantly with , or within dg hours of , the administration of norfloxacin , because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin .
cyclosporine	norfloxacin	mechanism	elevated serum levels of cyclosporine have been reported with concomitant use of cyclosporine with norfloxacin .
norfloxacin	glyburide	effect	the concomitant administration of quinolones including norfloxacin with glyburide ( a sulfonylurea agent ) has , on rare occasions , resulted in severe hypoglycemia .
NSAIDs	lithium	effect	thus , when nsaids and lithium are administered concurrently , subjects should be observed carefully for signs of lithium toxicity .
etodolac	warfarin	effect	however , caution should be exercised because there have been a few spontaneous reports of prolonged prothrombin times , with or without bleeding , in etodolac treated patients receiving concomitant warfarin therapy .
halofantrine	Mefloquine	advise	because of the danger of a potentially fatal prolongation of the qtc interval , halofantrine must not be given simultaneously with or subsequent to mefloquine .
pralidoxime	atropine	effect	when atropine and pralidoxime are used together , the signs of atropinization ( flushing , mydriasis , tachycardia , dryness of the mouth and nose ) may occur earlier than might be expected than when atropine is used alone because pralidoxime may potentiate the effect of atropine .
selective serotonin reuptake inhibitors	doxepin	mechanism	inhibitors or substrates of cyp2d6 ( i.e. , quinidine , selective serotonin reuptake inhibitors [ ssris ] ) may increase the plasma concentration of doxepin when administered concomitantly .
apraclonidine	cardiac glycosides	advise	since apraclonidine may reduce pulse and blood pressure , caution in using drugs such as beta blockers ( ophthalmic and systemic ) , antihypertensives , and cardiac glycosides is advised .
fluconazole	glipizide	int	the effect of concomitant administration of fluconazole and glipizide has been demonstrated in a placebo controlled crossover study in normal volunteers .
adenosine	caffeine	effect	the effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline .
methylxanthines	adenosine	advise	in the presence of these methylxanthines , larger doses of adenosine may be required or adenosine may not be effective .
methylxanthines	adenosine	advise	in the presence of these methylxanthines , larger doses of adenosine may be required or adenosine may not be effective .
furosemide	NSAIDs	effect	there are case reports of patients who developed increased bun , serum creatinine and serum potassium levels , and weight gain when furosemide was used in conjunction with nsaids .
Furosemide	succinylcholine	effect	furosemide has a tendency to antagonize the skeletal muscle relaxing effect of tubocurarine and may potentiate the action of succinylcholine .
azathioprine	allopurinol	mechanism	use with allopurinol : the principal pathway for detoxification of azathioprine is inhibited by allopurinol .
zopiclone	ROMAZICON	effect	the effects of nonbenzodiazepine agonists at benzodiazepine receptors , such as zopiclone , triazolopyridazines and others , are also blocked by romazicon .
guanethidine	amphetamines	mechanism	acidifying agents : gastrointestinal acidifying agents ( guanethidine , reserpine , glutamic acid hcl , ascorbic acid , fruit juices , etc. ) lower absorption of amphetamines .
Amphetamines	antihypertensives	effect	antihypertensives : amphetamines may antagonize the hypotensive effects of antihypertensives .
fluconazole	cisapride	mechanism	antifungals : in vitro and / or in vivo data indicate that fluconazole , itraconazole , and oral ketoconazole markedly inhibit the metabolism of cisapride , which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
Fluvoxamine	TCA	mechanism	fluvoxamine has also been shown to inhibit p450 dg , an isoform also involved in tcametabolism .
Anafranil	anticholinergic	advise	close supervision and careful adjustment of dosage are required when anafranil is administered with anticholinergic or sympathomimetic drugs .
tricyclic antidepressants	CMI	effect	several tricyclic antidepressants have been reported to block the pharmacologic effects of guanethidine , clonidine , or similar agents , and such an effect may be anticipated with cmi because of its structural similarity to other tricyclic antidepressants .
tricyclic antidepressants	cimetidine	mechanism	plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors ( e.g. , cimetidine , fluoxetine ) and decreased by the concomitant administration of hepatic enzyme inducers ( e.g. , barbiturates , phenytoin ) , and such an effect may be anticipated with cmi as well .
Ethopropazine	CNS depressants	effect	ethopropazine may interact with alcohol or other cns depressants , causing increased sedative effects .
quinolones	caffeine	mechanism	however , the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline , interfere with the metabolism of caffeine , and enhance the effects of the oral anticoagulant warfarin and its derivatives , and has been associated with transient elevations in serum creatinine in patients receiving systemic cyclosporine concomitantly .
barbiturates	chlorpropamide	effect	since animal studies suggest that the action of barbiturates may be prolonged by therapy with chlorpropamide , barbiturates should be employed with caution .
butorphanol	tranquilizers	effect	concurrent use of butorphanol with central nervous system depressants ( e.g. , alcohol , barbiturates , tranquilizers , and antihistamines ) may result in increased central nervous system depressant effects .
butorphanol	erythromycin	advise	it is not known if the effects of butorphanol are altered by concomitant medications that affect hepatic metabolism of drugs ( erythromycin , etc. ) , but physicians should be alert to the possibility that a smaller initial dose and longer intervals between doses may be needed .
vasopressors	monoamine oxidase (MAO) inhibitors	advise	all vasopressors should be used cautiously in patients taking monoamine oxidase (mao) inhibitors .
epinephrine	cyclopropane	effect	administration of epinephrine to patients receiving cyclopropane or halogenated hydrocarbon general anesthetics such as halothane which sensitize the myocardium , may induce cardiac arrhythmia..
Epinephrine	digitalis	advise	epinephrine also should be used cautiously with other drugs ( e.g. , digitalis , glycosides ) that sensitize the myocardium to the actions of sympathomimetic drugs .
Diuretic agents	epinephrine	effect	diuretic agents may decrease vascular response to pressor drugs such as epinephrine .
Epinephrine	guanethidine	effect	epinephrine may antagonize the neuron blockade produced by guanethidine resulting in decreased antihypertensive effect and requiring increased dosage of the latter .
NSAIDs	warfarin	advise	because prostaglandins play an important role in hemostasis , and nsaids affect platelet function as well , concurrent therapy with all nsaids , including diclofenac , and warfarin requires close monitoring of patients to be certain that no change in their anticoagulant dosage is required .
beta-adrenergic blocking agents	digitalis	effect	the concomitant use of beta-adrenergic blocking agents with digitalis and calcium antagonists may have additive effects on prolonging atrioventricular conduction time .
Levo-Dromoran	hypnotics	effect	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
sedative-hypnotics	DILAUDID	effect	patients receiving other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , tricyclic antidepressants or other cns depressants ( including alcohol ) concomitantly with dilaudid may exhibit an additive cns depression .
alcohol	DILAUDID	effect	patients receiving other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative hypnotics , tricyclic antidepressants or other cns depressants ( including alcohol ) concomitantly with dilaudid may exhibit an additive cns depression .
Probenecid	methotrexate	mechanism	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti inflammatory agents , theophylline , and zidovudine ) .
VISTIDE	aminoglycosides	advise	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin b , foscarnet , intravenous pentamidine , vancomycin , and non steroidal anti inflammatory agents ] is contraindicated .
VISTIDE	tobramycin	advise	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin b , foscarnet , intravenous pentamidine , vancomycin , and non steroidal anti inflammatory agents ] is contraindicated .
zalcitabine	aluminum	advise	the clinical significance of this reduction is not known , hence zalcitabine is not recommended to be ingested simultaneously with magnesium / aluminum containing antacids .
CASODEX	coumarin anticoagulant	mechanism	in vitro studies have shown casodex can displace coumarin anticoagulants , such as warfarin , from their protein binding sites .
NUROMAX	lincomycin	effect	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
NUROMAX	sodium colistimethate	effect	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
nondepolarizing neuromuscular blocking agents	carbamazepine	effect	as with some other nondepolarizing neuromuscular blocking agents , the time of onset of neuromuscular block induced by nuromax is lengthened and the duration of block is shortened in patients receiving phenytoin or carbamazepine .
fluoxetine	carvedilol	effect	poor metabolizers of debrisoquin : interactions of carvedilol with strong inhibitors of cyp2d6 ( such as quinidine , fluoxetine , paroxetine , and propafenone ) have not been studied , but these drugs would be expected to increase blood levels of the r ( + ) enantiomer of carvedilol .
digoxin	carvedilol	mechanism	digoxin : digoxin concentrations are increased by about dg % when digoxin and carvedilol are administered concomitantly .
Agents with b-blocking properties	insulin	effect	insulin or oral hypoglycemics : agents with b-blocking properties may enhance the blood sugar reducing effect of insulin and oral hypoglycemics .
cyclosporine	carvedilol	mechanism	cyclosporine : modest increases in mean trough cyclosporine concentrations were observed following initiation of carvedilol treatment in dg renal transplant patients suffering from chronic vascular rejection .
Clarithromycin	nevirapine	mechanism	clarithromycin exposure was significantly decreased by nevirapine ;
Methadone	nevirapine	advise	methadone levels may be decreased ; increased dosages may be required to prevent symptoms of opiate withdrawal. methadone maintained patients beginning nevirapine therapy should be monitored forevidence of withdrawal and methadone dose should be adjusted accordingly .
Kineret	etanercept	effect	two percent of patients treated concurrently with kineret and etanercept developed neutropenia ( anc dg x dg / l ) .
valproate	tiagabine	mechanism	valproate : the addition of tiagabine to patients taking valproate chronically had no effect on tiagabine pharmacokinetics , but valproate significantly decreased tiagabine binding in vitro from dg to dg % , which resulted in an increase of approximately dg % in the free tiagabine concentration .
CAMPTOSAR	antineoplastic agents	effect	the adverse effects of camptosar , such as myelosuppression and diarrhea , would be expected to be exacerbated by other antineoplastic agents having similar adverse effects .
CAMPTOSAR	dexamethasone	effect	lymphocytopenia has been reported in patients receiving camptosar , and it is possible that the administration of dexamethasone as antiemetic prophylaxis may have enhanced the likelihood of this effect .
Probenecid	cephalosporins	mechanism	probenecid may decrease renal tubular secretion of cephalosporins when used concurrently , resulting in increased and more prolonged cephalosporin blood levels .
TRICOR	pravastatin	mechanism	concomitant administration of fenofibrate ( equivalent to 145mg tricor ) with pravastatin ( dg mg ) once daily for dg days has been shown to increase the mean cmax and auc values for pravastatin by dg % ( range from dg % decrease to dg % increase ) and dg % ( range from dg % decrease to dg % increase ) , respectively , and for dg hydroxy iso pravastatin by dg % ( range from dg % decrease to dg % increase ) and dg % ( range from dg % decrease to dg % increase ) , respectively in dg healthy adults .
cyclosporine	TRICOR	effect	cyclosporine : because cyclosporine can produce nephrotoxicity with decreases in creatinine clearance and rises in serum creatinine , and because renal excretion is the primary elimination route of fibrate drugs including tricor , there is a risk that an interaction will lead to deterioration .
monoamine oxidase inhibitors	adrenergic agonists	effect	brovana , as with other beta2 agonists , should be administered with extreme caution to patients being treated with monoamine oxidase inhibitors , tricyclic antidepressants , or drugs known to prolong the qtc interval because the action of adrenergic agonists on the cardiovascular system may be potentiated by these agents .
cyclosporin	TAXOL	advise	hypersensitivity reactions : patients with a history of severe hypersensitivity reactions to products containing cremophor el ( eg , cyclosporin for injection concentrate and teniposide for injection concentrate ) should not be treated with taxol .
teniposide	TAXOL	advise	hypersensitivity reactions : patients with a history of severe hypersensitivity reactions to products containing cremophor el ( eg , cyclosporin for injection concentrate and teniposide for injection concentrate ) should not be treated with taxol .
TRACLEER	glyburide	advise	therefore , the concomitant administration of tracleer and glyburide is contraindicated , and alternative hypoglycemic agents should be considered .
bosentan	glyburide	mechanism	co administration of bosentan decreased the plasma concentrations of glyburide by approximately dg % .
hormonal contraceptives	TRACLEER	effect	therefore , hormonal contraceptives , including oral , injectable , transdermal , and implantable forms , may not be reliable when tracleer is co administered .
sulphonylureas	Bezalip retard	effect	the action of sulphonylureas and insulin may be enhanced by bezalip or bezalip retard .
immuno-suppressant	bezafibrate	effect	in isolated cases , a pronounced though reversible , impairment of renal function ( accompanied by a corresponding increase in the serum creatinine level ) has been reported in organ transplant patients receiving immuno-suppressant therapy and concomitant bezafibrate .
ergot-type medications	AXERT	advise	because there is a theoretical basis that these effects may be additive , use of ergotamine containing or ergot-type medications ( like dihydroergotamine or methysergide ) and axert within dg hours of each other should be avoided .
methysergide	AXERT	advise	because there is a theoretical basis that these effects may be additive , use of ergotamine containing or ergot type medications ( like dihydroergotamine or methysergide ) and axert within dg hours of each other should be avoided .
warfarin	ketorolac tromethamine	mechanism	warfarin , digoxin , salicylate , and heparin the in vitro binding of warfarin to plasma proteins is only slightly reduced by ketorolac tromethamine ( dg % control vs dg % ) when ketorolac plasma concentrations reach dg to10 m g / ml .
TORADOL	alprazolam	effect	psychoactive drugs : hallucinations have been reported when toradol was used in patients taking psychoactive drugs ( fluoxetine , thiothixene , alprazolam ) .
TORADOL	furosemide	effect	furosemide : toradol iv / im reduced the diuretic response to furosemide in normovolemic healthy subjects by approximately dg % ( mean sodium and urinary output decreased dg % ) .
Fluconazole	losartan	mechanism	fluconazole , an inhibitor of p450 dg , decreased active metabolite concentration and increased losartan concentration .
progestin	carbamazepine	effect	the effectiveness of progestin only pills is reduced by hepatic enzyme inducing drugs such as the anticonvulsants phenytoin , carbamazepine , and barbiturates , and the antituberculosis drug rifampin .
progestin	barbiturates	effect	the effectiveness of progestin only pills is reduced by hepatic enzyme inducing drugs such as the anticonvulsants phenytoin , carbamazepine , and barbiturates , and the antituberculosis drug rifampin .
HYDROXYZINE	NARCOTICS	effect	the potentiating action of hydroxyzine must be considered when the drug is used in conjunction with central nervous system depressants such as narcotics , non narcotic analgesics and barbiturates .
antihistamines	CNS depressants	effect	additive cns depression may occur when antihistamines are administered concomitantly with other cns depressants including barbiturates , tranquilizers , and alcohol .
Monoamine oxidase (MAO) inhibitors	antihistamines	effect	monoamine oxidase (mao) inhibitors prolong and intensify the anticholinergic effects of antihistamines .
anticoagulant	cimetidine	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
anticoagulant	indomethacin	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
anticoagulant	metronidazole	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
anticoagulant	miconazole	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
anticoagulant	anabolic steroids	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
anticoagulant	pyrazolones	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
anticoagulant	antibiotics	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
anticoagulant	chymotrypsin	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
spironolactone	ACE inhibitors	effect	use of potassium sparing diuretics ( spironolactone , triamterene , amiloride ) or potassium supplements concomitantly with ace inhibitors can increase the risk of hyperkalemia .
probenecid	ALIMTA	mechanism	concomitant administration of substances that are also tubularly secreted ( e.g. , probenecid ) could potentially result in delayed clearance of alimta .
ibuprofen	ALIMTA	advise	although ibuprofen ( dg mg qid ) can be administered with alimta in patients with normal renal function ( creatinine clearance dg ml / min ) , caution should be used when administering ibuprofen concurrently with alimta to patients with mild to moderate renal insufficiency ( creatinine clearance from dg to dg ml / min ) .
Cholestyramine	corticosteroids	mechanism	cholestyramine : cholestyramine may increase the clearance of corticosteroids .
carbamazepine	corticosteroids	mechanism	hepatic enzyme inducers , inhibitors and substrates : drugs which induce cytochrome p450 dg ( cyp dg ) enzyme activity ( e.g. , barbiturates , phenytoin , carbamazepine , rifampin ) may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased .
anticholinesterase agents	corticosteroids	effect	anticholinesterases : concomitant use of anticholinesterase agents and corticosteroids may produce severe weakness in patients with myasthenia gravis .
digoxin	conivaptan	mechanism	digoxin : coadministration of digoxin , a p glycoprotein substrate , with oral conivaptan resulted in a reduction in clearance and an increase in digoxin cmax and auc values .
felodipine	carbamazepine	mechanism	anticonvulsants : in a pharmacokinetic study , maximum plasma concentrations of felodipine were considerably lower in epileptic patients on long term anticonvulsant therapy ( eg , phenytoin , carbamazepine , or phenobarbital ) than in healthy volunteers .
ranitidine	ceftibuten	mechanism	however , dg mg of ranitidine q12h for dg days increased the ceftibuten c max by dg % and ceftibuten auc by dg % .
Amantadine	clidinium	effect	amantadine , tricyclic antidepressants , and maois may increase anticholinergic effect of clidinium .
Clidinium	levodopa	effect	clidinium may decrease the effect of phenothiazines , levodopa , and ketoconazole .
MYOBLOC	curare-like compounds	advise	co administration of myobloc and aminoglycosides or other agents interfering with neuromuscular transmission ( e.g. , curare-like compounds ) should only be performed with caution as the effect of the toxin may be potentiated .
Cyclopropane	dopamine	effect	cyclopropane or halogenated hydrocarbon anesthetics increase cardiac autonomic irritability and may sensitize the myocardium to the action of certain intravenously administered catecholamines , such as dopamine .
NSAIDs	furosemide	effect	furosemide : clinical studies , as well as post marketing observations , have shown that nsaids can reduce the natriuretic effect of furosemide and thiazides in some patients .
BEXTRA	ACE-inhibitors	advise	this interaction should be given consideration in patients taking bextra concomitantly with ace-inhibitors .
Indomethacin	bumetanide	mechanism	indomethacin : indomethacin blunts the increases in urine volume and sodium excretion seen during bumetanide treatment and inhibits the bumetanide induced increase in plasma renin activity .
benzodiazepine class	nonbarbiturate hypnotics	effect	pharmacodynamic interactions : the cns depressant action of the benzodiazepine class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate hypnotics , antianxiety agents , the phenothiazines , thioxanthene and butyrophenone classes of antipsychotic agents , monoamine oxidase inhibitors and the tricyclic antidepressants , and by other anticonvulsant drugs .
diuretic	PRINIVIL	advise	if it is necessary to continue the diuretic , initiate therapy with prinivil at a dose of dg mg daily , and provide close medical supervision after the initial dose until blood pressure has stabilized .
ACE inhibitor	diuretic	advise	studies with ace inhibitors in combination with diuretics indicate that the dose of the ace inhibitor can be reduced when it is given with a diuretic .
clorazepate dipotassium	ethyl alcohol	effect	animal experience indicates that clorazepate dipotassium prolongs the sleeping time after hexobarbital or after ethyl alcohol , increases the inhibitory effects of chlorpromazine , but does not exhibit monoamine oxidase inhibition .
benzodiazepines	barbiturates	effect	the actions of the benzodiazepines may be potentiated by barbiturates , narcotics , phenothiazines , monoamine oxidase inhibitors or other antidepressants .
benzodiazepines	antihistamines	effect	the action of the benzodiazepines may be potentiated by anticonvulsants , antihistamines , alcohol , barbiturates , monoamine oxidase inhibitors , narcotics , phenothiazines , psychotropic medications , or other drugs that produce cns depression .
benzodiazepines	phenothiazines	effect	the action of the benzodiazepines may be potentiated by anticonvulsants , antihistamines , alcohol , barbiturates , monoamine oxidase inhibitors , narcotics , phenothiazines , psychotropic medications , or other drugs that produce cns depression .
estazolam	phenytoin	mechanism	while no in vivo drug drug interaction studies were conducted between estazolam and inducers of cyp3a , compounds that are potent cyp3a inducers ( such as carbamazepine , phenytoin , rifampin , and barbiturates ) would be expected to decrease estazolam concentrations .
estazolam	itraconazole	advise	consequently , estazolam should be avoided in patients receiving ketoconazole and itraconazole , which are very potent inhibitors of cyp3a .
carbamazepine	SUPRAX	mechanism	carbamazepine : elevated carbamazepine levels have been reported in postmarketing experience when suprax is administered concomitantly .
VIRACEPT	astemizole	advise	because a similar interaction is likely , viracept should also not be administered concurrently with astemizole .
ketoconazole	VIRACEPT	mechanism	ketoconazole : coadministration of ketoconazole with viracept resulted in a dg % increase in nelfinavir plasma a.c .
VIRACEPT	Antiarrhythmics	advise	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
VIRACEPT	Antihistamines	advise	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
VIRACEPT	terfenadine	advise	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
VIRACEPT	Benzodiazepines	advise	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
VIRACEPT	Antimycobacterial agents	advise	drugs which require a dose reduction when coadminstered with viracept antimycobacterial agents : rifabutin
ENBREL	anakinra	effect	two percent of patients treated concurrently with enbrel and anakinra developed neutropenia ( anc dg x dg / l ) .
colestipol hydrochloride	digoxin	mechanism	particular caution should be observed with digitalis preparations since there are conflicting results for the effect of colestipol hydrochloride on the availability of digoxin and digitoxin .
iron	FACTIVE	advise	magnesium and / or aluminum containing antacids , products containing ferrous sulfate ( iron ) , multivitamin preparations containing zinc or other metal cations , or videx ( didanosine ) chewable / buffered tablets or the pediatric powder for oral solution should not be taken within dg hours before or dg hours after factive .
zinc	FACTIVE	advise	magnesium and / or aluminum containing antacids , products containing ferrous sulfate ( iron ) , multivitamin preparations containing zinc or other metal cations , or videx ( didanosine ) chewable / buffered tablets or the pediatric powder for oral solution should not be taken within dg hours before or dg hours after factive .
didanosine	FACTIVE	advise	magnesium and / or aluminum containing antacids , products containing ferrous sulfate ( iron ) , multivitamin preparations containing zinc or other metal cations , or videx ( didanosine ) chewable / buffered tablets or the pediatric powder for oral solution should not be taken within dg hours before or dg hours after factive .
rifampin	CANCIDAS	advise	patients on rifampin should receive dg mg of cancidas daily .
CANCIDAS	carbamazepine	advise	when cancidas is co administered with inducers of drug clearance , such as efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine , use of a daily dose of dg mg of cancidas should be considered
CANCIDAS	tacrolimus	mechanism	cancidas reduced the blood auc0 dg of tacrolimus by approximately dg % , peak blood concentration ( cmax ) by dg % , and dg hour blood concentration ( c12hr ) by dg % in healthy subjects when tacrolimus ( dg doses of dg mg / kg dg hours apart ) was administered on the 10th day of cancidas dg mg daily , as compared to results from a control period in which tacrolimus was administered alone .
b-lactam antibiotics	probenecid	mechanism	probenecid : as with other b-lactam antibiotics , renal excretion of loracarbef is inhibited by probenecid and resulted in an approximate dg % increase in the auc for loracarbef .
diethylpropion	guanethidine	int	conversely , diethylpropion may interfere with antihypertensive drugs ( i.e. , guanethidine , a methyldopa ) .
diethylpropion	a-methyldopa	int	conversely , diethylpropion may interfere with antihypertensive drugs ( i.e. , guanethidine , a-methyldopa ) .
apomorphine	ondansetron	effect	5ht3 antagonists : based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron , the concomitant use of apomorphine with drugs of the 5ht3 antagonist class ( including , for example , ondansetron , granisetron , dolasetron , palonosetron , and alosetron ) is contraindicated .
PEGANONE	Phenurone	advise	considerable caution should be exercised if peganone is administered concurrently with phenurone ( phenacemide ) since paranoid symptoms have been reported during therapy with this combination .
alosetron	cimetidine	advise	concomitant administration of alosetron and moderate cyp1a2 inhibitors , including quinolone antibiotics and cimetidine , has not been evaluated , but should be avoided unless clinically necessary because of similar potential drug interactions .
L-histidine	H1 blockers	effect	h1 and h2 blockers although not reported , l-histidine , via its metabolism to histamine , might decrease the efficacy of h1 and h2 blockers .
L-histidine	H2 blockers	effect	h1 and h2 blockers although not reported , l-histidine , via its metabolism to histamine , might decrease the efficacy of h1 and h2 blockers .
Acetazolamide	quinidine	mechanism	acetazolamide reduces urinary excretion of quinidine and may enhance its effect .
Factrel	phenothiazines	effect	the response to factrel may be blunted by phenothiazines and dopamine antagonists which cause a rise in prolactin .
digoxin	digoxin	mechanism	extended release tablets : administration of nifedipine with digoxin increased digoxin levels in dg of dg normal volunteers .
Auranofin	penicillamine	advise	auranofin should not be used together with penicillamine ( depen , cuprimine ) , another arthritis medication .
griseofulvin	LEVULAN KERASTICK	effect	it is , however , possible that concomitant use of other known photosensitizing agents such as griseofulvin , thiazide diuretics , sulfonylureas , phenothiazines , sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the levulan kerastick for topical solution .
tetracyclines	LEVULAN KERASTICK	effect	it is , however , possible that concomitant use of other known photosensitizing agents such as griseofulvin , thiazide diuretics , sulfonylureas , phenothiazines , sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the levulan kerastick for topical solution .
buprenorphine	benzodiazepines	int	based on anecdotal reports , there may be an interaction between buprenorphine and benzodiazepines .
SUBOXONE	benzodiazepines	advise	subutex and suboxone should be prescribed with caution to patients on benzodiazepines or other drugs that act on the central nervous system , regardless of whether these drugs are taken on the advice of a physician or are taken as drugs of abuse .
methylprednisolone	Aprepitant	advise	the iv methylprednisolone dose should be reduced by approximately dg % , and the oral methylprednisolone dose should be reduced by approximately dg % when coadministered with aprepitant to achieve exposures of methylprednisolone similar to those obtained when it is given without aprepitant .
Aprepitant	contraceptives	advise	although a dg day regimen of aprepitant given concomitantly with oral contraceptives has not been studied , alternative or back up methods of contraception should be used .
beta-adrenoceptor blocking agents	INDOCIN	effect	blunting of the antihypertensive effect of beta-adrenoceptor blocking agents by non steroidal antiinflammatory drugs including indocin has been reported .
INDOCIN	NSAIDs	advise	the concomitant use of indocin with other nsaids is not recommended due to the increased possibility of gastrointestinal toxicity , with little or no increase in efficacy .
warfarin-type anticoagulant	griseofulvin	advise	patients on warfarin-type anticoagulant therapy may require dosage adjustment of the anticoagulant during and after griseofulvin therapy .
barbiturates	griseofulvin	effect	concomitant use of barbiturates usually depresses griseofulvin activity and may necessitate raising the dosage .
griseofulvin	contraceptives	effect	the concomitant administration of griseofulvin has been reported to reduce the efficacy of oral contraceptives and to increase the incidence of breakthrough bleeding .
Probenecid	naproxen	mechanism	probenecid given concurrently increases naproxen anion plasma levels and extends its plasma half life significantly .
naproxen	methotrexate	advise	caution should be used if naproxen is administered concomitantly with methotrexate .
Naproxen	propranolol	effect	naproxen and other nsaids can reduce the antihypertensive effect of propranolol and other beta blockers .
NSAIDs	propranolol	effect	naproxen and other nsaids can reduce the antihypertensive effect of propranolol and other beta blockers .
verapamil	TAMBOCOR	advise	because both of these drugs have negative inotropic properties and the effects of coadministration with tambocor are unknown , neither disopyramide nor verapamil should be administered concurrently with tambocor unless , in the judgment of the physician , the benefits of this combination outweigh the risks .
Azlocillin	amikacin	advise	azlocillin should not be administered concomitantly with amikacin , ciprofloxacin , gentamicin , netilmicin , or tobramycin .
EQUETROTM	Acetaminophen	mechanism	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( dg ) , oxcarbazepine , phenytoin ( dg ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( dg ) , ziprasidone , and zonisamide .
EQUETROTM	lamotrigine	mechanism	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( dg ) , oxcarbazepine , phenytoin ( dg ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( dg ) , ziprasidone , and zonisamide .
EQUETROTM	levothyroxine	mechanism	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( dg ) , oxcarbazepine , phenytoin ( dg ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( dg ) , ziprasidone , and zonisamide .
EQUETROTM	mirtazapine	mechanism	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( dg ) , oxcarbazepine , phenytoin ( dg ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( dg ) , ziprasidone , and zonisamide .
EQUETROTM	praziquantel	mechanism	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( dg ) , oxcarbazepine , phenytoin ( dg ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( dg ) , ziprasidone , and zonisamide .
EQUETROTM	risperidone	mechanism	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( dg ) , oxcarbazepine , phenytoin ( dg ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( dg ) , ziprasidone , and zonisamide .
EQUETROTM	clonazepam	mechanism	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( dg ) , oxcarbazepine , phenytoin ( dg ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( dg ) , ziprasidone , and zonisamide .
mefloquine	carbamazepine	effect	additionally , anti malarial drugs , such as chloroquine and mefloquine , may antagonize the activity of carbamazepine .
EQUETROTM	propoxyphene	mechanism	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( dg ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( dg ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( dg ) , verapamil , zileuton .
EQUETROTM	verapamil	mechanism	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( dg ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( dg ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( dg ) , verapamil , zileuton .
EQUETROTM	diltiazem	mechanism	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( dg ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( dg ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( dg ) , verapamil , zileuton .
EQUETROTM	Phenytoin	mechanism	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( dg ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
CRIXIVAN	atazanavir	advise	combinations of these drugs have not been studied and coadministration of crixivan and atazanavir is not recommended .
HMG-CoA reductase inhibitors	CRIXIVAN	advise	use lowest possible dose of atorvastatin with careful monitoring , or consider hmg-coa reductase inhibitors that are not primarily metabolized by cyp3a4 , such as pravastatin , fluvastatin , or rosuvastatin in combination with crixivan .
antacids	vitamin D	advise	magnesium : magnesium containing preparations ( eg , antacids ) may cause hypermagnesemia and should therefore not be taken during therapy with vitamin d by patients on chronic renal dialysis .
phenobarbital	calcitriol	mechanism	phenytoin / phenobarbital : the coadministration of phenytoin or phenobarbital will not affect plasma concentrations of vitamin d , but may reduce endogenous plasma levels of calcitriol / ergocalcitriol by accelerating metabolism .
tricyclic antidepressants	cimetidine	mechanism	discontinuation of cimetidine in well controlled patients receiving tricyclic antidepressants and cimetidine may decrease the plasma levels and efficacy of the antidepressants .
Sildenafil	long-acting nitrates	advise	sildenafil is contraindicated in patients using long-acting nitrates or who may need to use short acting nitrates , because the combination may cause a sharp fall of the blood pressure .
Azithromycin	zidovudine	mechanism	azithromycin had no significant impact on the cmax and auc of zidovudine , although it significantly decreased the zidovudine tmax by dg % and increased the intracellular exposure to phosphorylated zidovudine by dg % .
Chloral hydrate	anticoagulant agents	int	chloral hydrate and methaqualone interact pharmacologically with orally administered anticoagulant agents , but the effect is not clinically significant .
Theophylline	acetaminophen	mechanism	theophylline decreased the binding of acetaminophen by a net change of dg % ( percentage increase in fdf , dg % ) at dg micromol / l ;
cholestyramine	fluvastatin	effect	although this effect was noted even when cholestyramine was given dg hours prior to fluvastatin , this regimen did not result in diminished efficacy .
dexamethasone	insulin	effect	these results suggest that both dexamethasone and retinyl acetate , and possibly other glucocorticoids and retinoids , may regulate the proliferation of prostate epithelium by a dose dependent modification of the activity of insulin and egf .
4-methylpyrazole	1,3-difluoro-2-propanol	effect	prior administration of 4-methylpyrazole ( dg mg kg ( dg ) body weight ) was shown to prevent the conversion of 1,3-difluoro-2-propanol ( dg mg kg ( dg ) body weight ) to ( ) erythro fluorocitrate in vivo and to eliminate the fluoride and citrate elevations seen in 1,3-difluoro-2-propanol intoxicated animals .
allopurinol	cypermethrin	effect	pretreatment of rats with allopurinol ( dg mg / kg , ip ) or vitamin e ( dg mg / kg per day , ig , for dg days and a dose of dg mg / kg on the 4th day ) provided significant protection against the elevation of tbars levels in cerebral and hepatic tissues , induced by single high dose of oral cypermethrin administration within dg h .
Vitamin E	cypermethrin	effect	pretreatment of rats with allopurinol ( dg mg / kg , ip ) or vitamin e ( dg mg / kg per day , ig , for dg days and a dose of dg mg / kg on the 4th day ) provided significant protection against the elevation of tbars levels in cerebral and hepatic tissues , induced by single high dose of oral cypermethrin administration within dg h .
Pantoprazole	clopidogrel	mechanism	pantoprazole has a much weaker effect on clopidogrel 's pharmacokinetics and on platelet reactivity during concomitant use .
clopidogrel	omeprazole	advise	regulatory agencies state that the combination of clopidogrel and the cyp2c19 inhibitors omeprazole and esomeprazole should be avoided .
ketamine	halothane	int	interaction of ketamine and halothane in rats .
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine	effect	these behavioural observations were consistent with in vivo positron emission tomography dopamine transporter imaging data , and with post mortem stereological counts of midbrain dopaminergic neurons , as well as striatal intensity measurements of dopamine transporter and tyrosine hydroxylase immunoreactivity , which were all significantly higher in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine / 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine treated animals than in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine / vehicle treated monkeys .
3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	effect	the 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine treatment also had a significant effect on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced loss of norepinephrine neurons in the locus coeruleus and adjoining a5 and a7 noradrenaline cell groups .
Calcium	nonheme iron	mechanism	calcium doses dg mg diminished nonheme iron absorption by an average of dg % .
docetaxel	sunitinib	effect	the molecular basis of this synergism is that the signaling pathways that were initially activated by docetaxel exposure were efficiently suppressed by the subsequent exposure to sunitinib .
ABT	precocene I	effect	abt decreased the toxicity of precocene i , increased exposure to parent compound , and decreased metabolite levels in a dose dependent manner .
methylglyoxal	amikacin	effect	synergism was also noted when methylglyoxal was combined with carbenicillin and amikacin .
antiretroviral	Implanon	effect	we present an interesting case of an hiv positive woman on antiretroviral therapy having tubal pregnancies on two separate occasions with implanon in place .
Paroxetine	endoxifen	mechanism	paroxetine and fluoxetine reduce the plasma concentration of endoxifen by about dg % .
S-ketamine	ticlopidine	effect	exposure to oral s-ketamine is unaffected by itraconazole but greatly increased by ticlopidine .
celecoxib	doxorubicin	effect	we found antagonism between celecoxib and the four drugs in the breast cancer cells mcf7 following all incubation schedules and between celecoxib and doxorubicin in all cell lines except for two combinations in hct116 cells .
mirtazapine	warfarin	effect	also mirtazapine , which is not believed to interact with warfarin , increased the risk of gi bleeding ( or = dg [ dg % ci , dg dg ] ) .
Ephedrine	dexmedetomidine	effect	ephedrine enhances the antinociceptive effect of dexmedetomidine in mice .
Lomefloxacin	gelusil	mechanism	moxifloxacin and lomefloxacin reacts faster with sucralfate and gelusil in acidic media whereas with erythromycin in basic media and multi minerals in neutral media .
Macrolide antibiotics	lovastatin	mechanism	conclusions : macrolide antibiotics inhibit the metabolism of hmg coa reductase inhibitors that are metabolized by cyp3a4 ( i.e. , atorvastatin , cerivastatin , lovastatin , simvastatin ) .
Clarithromycin	simvastatin	mechanism	discussion : clarithromycin is a potent inhibitor of cyp3a4 , the major enzyme responsible for simvastatin metabolism .
penicillins	probenecid	mechanism	( dg , dg ) , the higher serum concentrations of penicillins and cephaloridine reached after administration of probenecid are due not only to slower renal elimination but also to an altered distribution in the body .
cephaloridine	probenecid	mechanism	( dg , dg ) , the higher serum concentrations of penicillins and cephaloridine reached after administration of probenecid are due not only to slower renal elimination but also to an altered distribution in the body .
(-)-NANM	morphine	effect	in both species , (-)-nanm , but not ( + ) nanm , antagonized the rate decreasing effects of morphine on fi and fr responding .
carbamazepine	tricyclic antidepressants	advise	we report the case of an adolescent with altered consciousness caused by carbamazepine overdose with a positive tricyclic antidepressant level to alert clinicians to the cross reactivity of carbamazepine with a toxicology screen for tricyclic antidepressants .
Buforin II	azithromycin	effect	buforin ii may be active in inhibiting cryptosporidium parvum growth in vitro upon combination with either azithromycin or minocycline .
Buforin II	minocycline	effect	buforin ii may be active in inhibiting cryptosporidium parvum growth in vitro upon combination with either azithromycin or minocycline .
theophylline	CGS 21680	effect	the anxiogenic effects of theophylline were reduced by pretreatment with cgs 21680 , an a2 selective agonist , but not by n6 cyclopentyladenosine ( cpa ) , an a1 selective agonist .
acetaminophen	caffeine	effect	increased hepatotoxicity of acetaminophen by concomitant administration of caffeine in the rat .
naloxone	beta-endorphin	effect	intraventricular injection of naloxone at doses of dg to dg micrograms equally antagonized in a dose dependent manner the tail flick inhibition induced by intraventricular beta-endorphin and morphine .
Midazolam	metamizol	effect	midazolam used at doses of dg mg / kg and dg mg / kg decreased the antinociceptive effect of morphine , metamizol ( only in the tail flick test ) and indomethacin .
Echistatin	contortrostatin	effect	echistatin alone had no effect on tyrosine phosphorylation in t24 cells , but dose dependently inhibits the effects of contortrostatin when both are added simultaneously .
phenytoin	theophylline	effect	with combined use , clinicians should be aware , when phenytoin is added , of the potential for reexacerbation of pulmonary symptomatology due to lowered serum theophylline concentrations .
ADL-8-2698	opioid	effect	adl-8-2698 is a novel peripherally restricted opioid antagonist that may selectively prevent opioid induced gastrointestinal effects without reversing analgesia .
ADL 8-2698	morphine	effect	we conclude that adl 8-2698 prevents morphine induced increases in gastrointestinal transit time by means of selective peripheral opioid anitagonism without affecting central opioid analgesia .
gentamicin	99mTc-MDP	mechanism	due to its nephrotoxicity , gentamicin may cause abnormal renal uptake to be seen on 99mtc-mdp bone scintigraphy .
gentamycin	atracurium	int	interaction of gentamycin and atracurium in anaesthetised horses .
Aprepitant	phenytoin	mechanism	therefore , coadministration of aprepitant with drugs that strongly induce cyp3a4 activity ( e.g. , rifampin , carbamazepine , phenytoin ) may result in reduced plasma concentrations of aprepitant that may result in decreased efficacy of aprepitant .
desipramine	benzodiazepines	effect	if desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative / hypnotics , careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines ( e.g. , chlordiazepoxide or diazepam ) are additive .
Antihistamines	warfarin	effect	antihistamines may partially counteract the anticoagulation effects of heparin or warfarin .
Doxylamine	epinephrine	effect	doxylamine may enhance the effects of epinephrine .
beta-adrenergic antagonists	alpha-adrenergic stimulants	effect	exaggerated hypertensive responses have been reported from the combined use of beta-adrenergic antagonists and alpha-adrenergic stimulants , including those contained in proprietary cold remedies and vasoconstrictive nasal drops .
para-aminosalicylic acid	vitamin B12	mechanism	colchicine para-aminosalicylic acid and heavy alcohol intake for longer than dg weeks may produce malabsorption of vitamin b12 .
alcohol	vitamin B12	mechanism	colchicine para aminosalicylic acid and heavy alcohol intake for longer than dg weeks may produce malabsorption of vitamin b12 .
theophylline	cetirizine	mechanism	in a multiple dose study of theophylline ( dg mg once daily for dg days ) and cetirizine ( dg mg once daily for dg days ) , a dg % decrease in the clearance of cetirizine was observed .
sodium nitroprusside	hypotensive drugs	effect	the hypotensive effect of sodium nitroprusside is augmented by that of most other hypotensive drugs , including ganglionic blocking agents , negative inotropic agents , and inhaled anesthetics .
aluminum hydroxide	enoxacin	mechanism	antacids containing aluminum hydroxide and magnesium hydroxide reduce the oral absorption of enoxacin by dg % .
Quinolones	R-warfarin	mechanism	warfarin : quinolones , including enoxacin , decrease the clearance of r-warfarin , the less active isomer of racemic warfarin .
caffeine	enoxacin	effect	caffeine related adverse effects have occurred in patients consuming caffeine while on therapy with enoxacin .
narcotic analgesics	hydrocodone	effect	patients receiving other narcotic analgesics , antipsychotics , antianxiety agents , or other cns depressants ( including alcohol ) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive cns depression .
erythromycin	ergotamine	effect	concurrent use of erythromycin and ergotamine or dihydroergotamine has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia .
erythromycin	cyclosporine	int	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
erythromycin	phenytoin	int	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
codeine	antihistamines	effect	the use of codeine may result in additive cns depressant effects when coadministered with alcohol , antihistamines , psychotropics or other drugs that produce cns depression .
dextromethorphan	monoamine oxidase inhibitors	effect	serious toxicity may result if dextromethorphan is coadministered with monoamine oxidase inhibitors ( maois ) .
dextromethorphan hydrobromide	alcohol	effect	the use of dextromethorphan hydrobromide may result in additive cns depressant effects when coadministered with alcohol , antihistamines , psychotropics or other drugs that produce cns depression .
phenytoin	ethosuximide	mechanism	the most commonly occurring drug interactions are listed below : drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2 antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
phenytoin	contraceptives	effect	drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
NSAIDs	lithium	advise	thus , when nsaids and lithium are administered concurrently , subjects should be observed carefully for signs of lithium toxicity .
NSAIDs	thiazides	effect	furosemide : clinical studies , as well as post marketing observations , have shown that nsaids can reduce the natriuretic effect of furosemide and thiazides in some patients .
thiazides	vitamin D	effect	some reports have shown that the concomitant administration of thiazides with vitamin d causes hypercalcemia .
activated charcoal	leflunomide	mechanism	cholestyramine and charcoal administration of cholestyramine or activated charcoal in patients ( n=13 ) and volunteers ( n=96 ) resulted in a rapid and significant decrease in plasma m1 ( the active metabolite of leflunomide ) concentration .
Sumatriptan	dihydroergotamine mesylate	effect	sumatriptan : sumatriptan has been reported to cause coronary artery vasospasm , and its effect could be additive with d.h.e. dg ( dihydroergotamine mesylate ) injection , usp .
Sumatriptan	dihydroergotamine mesylate	advise	sumatriptan and d.h.e. dg ( dihydroergotamine mesylate ) injection , usp should not be taken within dg hours of each other..
dihydroergotamine mesylate	macrolide class	mechanism	macrolide antibiotics ( e. g. erythromycin and troleandomycin ) : agents of the ergot alkaloid class , of which d.h.e. dg ( dihydroergotamine mesylate ) injection , usp is a member , have been shown to interact with antibiotics of the macrolide class , resulting in increased plasma levels of unchanged alkaloids and peripheral vasoconstriction .
levothyroxine sodium	anabolic hormones	mechanism	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen containing compounds , dg fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
labetalol HCl	nitroglycerin	effect	if labetalol hcl is used with nitroglycerin in patients with angina pectoris , additional antihypertensive effects may occur .
labetalol HCl	halothane	effect	during controlled hypotensive anesthesia using labetalol hcl in association with halothane , high concentrations ( dg % or above ) of halothane should not be used because the degree of hypotension will be increased and because of the possibility of a large reduction in cardiac output and an increase in central venous pressure .
ibuprofen	methotrexate	advise	caution should be used if ibuprofen is administered concomitantly with methotrexate .
ibuprofen	furosemide	effect	furosemide : clinical studies , as well as random observations , have shown that ibuprofen can reduce the natriuretic effect of furosemide and thiazides in some patients .
dolasetron	rifampin	mechanism	blood levels of hydrodolasetron increased dg % when dolasetron was coadministered with cimetidine ( nonselective inhibitor of cytochrome p dg ) for dg days , and decreased dg % with coadministration of rifampin ( potent inducer of cytochrome p dg ) for dg days .
cefdinir	Maalox TC	mechanism	antacids ( aluminum or magnesium containing ) : concomitant administration of dg mg cefdinir capsules with dg ml maalox tc suspension reduces the rate ( cmax ) and extent ( auc ) of absorption by approximately dg % .
MAOIs	paroxetine	effect	in patients receiving nonselective monoamine oxidase inhibitors ( maois ) ( e.g. , selegiline hydrochloride ) in combination with serotoninergic agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
monoamine oxidase inhibitors	fluoxetine	effect	in patients receiving nonselective monoamine oxidase inhibitors ( maois ) ( e.g. , selegiline hydrochloride ) in combination with serotoninergic agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
frovatriptan	SSRI	advise	if concomitant treatment with frovatriptan and an ssri is clinically warranted , appropriate observation of the patient is advised .
kaolin	chloroquine	mechanism	antacids and kaolin : antacids and kaolin can reduce absorption of chloroquine ;
ciprofloxacin	didanosine	mechanism	in a single subject given one dose of ciprofloxacin dg hours after a dose of didanosine placebo tablets , a greater than dg % reduction in the auc of ciprofloxacin was observed .
magnesium	VIDEX	effect	antacids : concomitant administration of antacids containing magnesium or aluminum with videx chewable / dispersible buffered tablets or pediatric powder for oral solution may potentiate adverse events associated with the antacid components .
calcium	alendronate	mechanism	products containing calcium and other multivalent cations likely will interfere with absorption of alendronate .
multivalent cations	alendronate	mechanism	products containing calcium and other multivalent cations likely will interfere with absorption of alendronate .
felbamate	valproate	mechanism	increasing the felbamate dose to dg mg / day increased the steadystate valproate cmin to dg dg micrograms / ml .
Phenytoin	felbamate	mechanism	effects of other antiepileptic drugs on felbatol phenytoin : phenytoin causes an approximate doubling of the clearance of felbatol ( felbamate ) at steady state and , therefore , the addition of phenytoin causes an approximate dg % decrease in the steady state trough concentrations of felbatol as compared to the same dose of felbatol given as monotherapy .
cimetidine	gabapentin	mechanism	cimetidine : in the presence of cimetidine at dg mg qid ( n=12 ) the mean apparent oral clearance of gabapentin fell by dg % and creatinine clearance fell by dg % .
cimetidine	gabapentin	mechanism	thus cimetidine appeared to alter the renal excretion of both gabapentin and creatinine , an endogenous marker of renal function .
gabapentin	cimetidine	mechanism	this small decrease in excretion of gabapentin by cimetidine is not expected to be of clinical importance .
iron	Ibandronate	mechanism	products containing calcium and other multivalent cations ( such as aluminum , magnesium , iron ) are likely to interfere with absorption of ibandronate .
NSAIDs	Ibandronate	advise	however , since aspirin , nsaids , and bisphosphonates are all associated with gastrointestinal irritation , caution should be exercised in the concomitant use of aspirin or nsaids with ibandronate .
Ibandronate	antacids	advise	ibandronate should be taken at least dg minutes before any oral medications containing multivalent cations ( including antacids , supplements or vitamins ) .
ZYVOX	serotonergic agents	effect	spontaneous reports of serotonin syndrome associated with co administration of zyvox and serotonergic agents , including antidepressants such as selective serotonin reuptake inhibitors ( ssris ) , have been reported .
ZYVOX	selective serotonin reuptake inhibitors	effect	spontaneous reports of serotonin syndrome associated with co administration of zyvox and serotonergic agents , including antidepressants such as selective serotonin reuptake inhibitors ( ssris ) , have been reported .
EULEXIN	warfarin	advise	therefore , close monitoring of prothrombin time is recommended and adjustment of the anticoagulant dose may be necessary when eulexin capsules are administered concomitantly with warfarin .
Chlorotrianisene	antidepressants	int	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
Chlorotrianisene	aspirin	int	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
Chlorotrianisene	nicotine	int	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
Aprepitant	methylprednisolone	mechanism	aprepitant , when given as a regimen of dg mg on day dg and dg mg / day on days dg and dg , increased the auc of methylprednisolone , a cyp3a4 substrate , by dg fold on day dg and by dg fold on day dg , when methylprednisolone was coadministered intravenously as dg mg on day dg and orally as dg mg on days dg and dg .
Aprepitant	midazolam	mechanism	aprepitant increased the auc of midazolam by dg % on day dg and decreased the auc of midazolam by dg % on day dg relative to the dosing of aprepitant on days dg through dg .
Aprepitant	ritonavir	advise	consequently , concomitant administration of aprepitant with strong cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , nefazodone , troleandomycin , clarithromycin , ritonavir , nelfinavir ) should be approached with caution .
Aprepitant	dexamethasone	mechanism	corticosteroids : dexamethasone : aprepitant , when given as a regimen of 125mg with dexamethasone coadministered orally as dg mg on day dg , and aprepitant when given as dg mg / day with dexamethasone coadministered orally as dg mg on days dg through dg , increased the auc of dexamethasone , a cyp3a4 substrate by dg fold , on days dg and dg .
SSRI	TCA	int	the extent to which ssri tca interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the ssri involved .
desipramine hydrochloride	tranquilizers	effect	if desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative / hypnotics , careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines ( e.g. , chlordiazepoxide or diazepam ) are additive .
desipramine	chlordiazepoxide	effect	if desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative / hypnotics , careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines ( e.g. , chlordiazepoxide or diazepam ) are additive .
Sympathomimetic amines	veratrum alkaloids	effect	sympathomimetic amines may reduce the antihypertensive effects of reserpine , veratrum alkaloids , methyldopa and mecamylamine .
zinc	quinolone	mechanism	or with multivitamins containing zinc may substantially interfere with drug absorption and result in insufficient plasma and tissue quinolone concentrations .
magnesium hydroxide	enoxacin	mechanism	antacids containing aluminum hydroxide and magnesium hydroxide reduce the oral absorption of enoxacin by dg % .
enoxacin	ranitidine	mechanism	the oral bioavailability of enoxacin is reduced by dg % with coadministration of ranitidine .
Enoxacin	digoxin	mechanism	digoxin : enoxacin may raise serum digoxin levels in some individuals .
antianxiety agents	hydrocodone	effect	patients receiving other narcotic analgesics , antipsychotics , antianxiety agents , or other cns depressants ( including alcohol ) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive cns depression .
alcohol	hydrocodone	effect	patients receiving other narcotic analgesics , antipsychotics , antianxiety agents , or other cns depressants ( including alcohol ) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive cns depression .
Erythromycin	terfenadine	mechanism	erythromycin has been reported to significantly alter the metabolism of nonsedating antihistamines terfenadine and astemizole when taken concomitantly .
erythromycin	anticoagulants	effect	there have been reports of increased anticoagulant effects when erythromycin and oral anticoagulants were used concomitantly .
erythromycin	alfentanil	int	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
xanthine bronchodilators	sympathomimetic bronchodilators	effect	synergism between xanthine bronchodilators ( e.g. , theophylline ) , ephedrine , and other sympathomimetic bronchodilators has been reported .
NSAIDs	aspirin	advise	aspirin : as with other nsaids , concomitant administration of ponstel and aspirin is not generally recommended because of the potential of increased adverse effects .
NSAIDs	ACE inhibitors	effect	ace inhibitors : reports suggest that nsaids may diminish the antihypertensive effect of ace inhibitors .
anticholinergic	narcotic analgesics	effect	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
AKINETON	antihistamines	effect	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
anticholinergic	phenothiazines	effect	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
ARAVA	rifampin	mechanism	rifampin : following concomitant administration of a single dose of arava to subjects receiving multiple doses of rifampin , m1 peak levels were increased ( ~40 % ) over those seen when arava was given alone .
ARAVA	methotrexate	effect	in a small ( n=30 ) combination study of arava with methotrexate , a dg to dg fold elevation in liver enzymes was seen in dg of dg patients .
levothyroxine sodium	sucralfate	mechanism	levothyroxine sodium absorption : the following agents may bind and decrease absorption of levothyroxine sodium from the gastrointestinal tract : aluminum hydoxide , cholestyramine resin , colestipol hydrochloride , ferrous sulfate , sodium polystyrene sulfonate , soybean flour ( e.g. , infant formula ) , sucralfate .
levothyroxine sodium	cholestyramine	mechanism	levothyroxine sodium absorption : the following agents may bind and decrease absorption of levothyroxine sodium from the gastrointestinal tract : aluminum hydoxide , cholestyramine resin , colestipol hydrochloride , ferrous sulfate , sodium polystyrene sulfonate , soybean flour ( e.g. , infant formula ) , sucralfate .
levothyroxine sodium	colestipol hydrochloride	mechanism	levothyroxine sodium absorption : the following agents may bind and decrease absorption of levothyroxine sodium from the gastrointestinal tract : aluminum hydoxide , cholestyramine resin , colestipol hydrochloride , ferrous sulfate , sodium polystyrene sulfonate , soybean flour ( e.g. , infant formula ) , sucralfate .
levothyroxine sodium	perphenazine	mechanism	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen containing compounds , dg fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
levothyroxine sodium	estrogen-containing compounds	mechanism	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , dg fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
Cimetidine	labetalol HCl	mechanism	cimetidine has been shown to increase the bioavailability of labetalol hcl .
Chlorpropamide	allopurinol	mechanism	chlorpropamide : chlorpropamides plasma half life may be prolonged by allopurinol , since allopurinol and chlorpropamide may compete for excretion in the renal tubule .
allopurinol	chlorpropamide	mechanism	chlorpropamide : chlorpropamides plasma half life may be prolonged by allopurinol , since allopurinol and chlorpropamide may compete for excretion in the renal tubule .
EDECRIN	aminoglycoside	effect	edecrin may increase the ototoxic potential of other drugs such as aminoglycoside and some cephalosporin antibiotics .
Ibuprofen	lithium	mechanism	lithium : ibuprofen produced an elevation of plasma lithium levels and a reduction in renal lithium clearance in a study of eleven normal volunteers .
ibuprofen	thiazides	effect	furosemide : clinical studies , as well as random observations , have shown that ibuprofen can reduce the natriuretic effect of furosemide and thiazides in some patients .
Probenecid	PAH	mechanism	probenecid depresses tubular secretion of certain weak acids such as pah .
Netilmicin	ethacrynic acid	advise	netilmicin should not be administered concomitantly with potent loop diuretics such as furosemide and ethacrynic acid as the potential for ototoxicity is enhanced by the combination .
BREVIBLOC	digoxin	advise	although the interactions observed in these studies do not appear to be of major clinical importance , brevibloc should be titrated with caution in patients being treated concurrently with digoxin , morphine , succinylcholine or warfarin .
BREVIBLOC	verapamil	advise	caution should be exercised when considering the use of brevibloc and verapamil in patients with depressed myocardial function .
MAOIs	venlafaxine	effect	in patients receiving nonselective monoamine oxidase inhibitors ( maois ) ( e.g. , selegiline hydrochloride ) in combination with serotoninergic agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
selegiline hydrochloride	sertraline	effect	in patients receiving nonselective monoamine oxidase inhibitors ( maois ) ( e.g. , selegiline hydrochloride ) in combination with serotoninergic agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
monoamine oxidase inhibitors	sertraline	effect	in patients receiving nonselective monoamine oxidase inhibitors ( maois ) ( e.g. , selegiline hydrochloride ) in combination with serotoninergic agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
MAO inhibitor	dexfenfluramine	advise	at least dg days should elapse between discontinuation of a mao inhibitor and initiation of treatment with dexfenfluramine .
antihistamines	barbiturates	effect	concomitant use of antihistamines with alcohol , tricyclic antidepressants , barbiturates , or other central nervous system depressants may have an additive effect .
TNFa-blocking agents	anakinra	effect	other tnfa-blocking agents ( including remicade ) used in combination with anakinra may also result in similar toxicities .
Propantheline	digoxin	mechanism	propantheline and diphenoxylate , by decreasing gut motility , may increase digoxin absorption .
diphenoxylate	digoxin	mechanism	propantheline and diphenoxylate , by decreasing gut motility , may increase digoxin absorption .
Antacids	digoxin	mechanism	antacids , kaolin pectin , sulfasalazine , neomycin , cholestyramine , certain anticancer drugs , and metoclopramide may interfere with intestinal digoxin absorption , resulting in unexpectedly low serum concentrations .
ketoconazole	phenytoin	mechanism	concomitant administration of ketoconazole tablets with phenytoin may alter the metabolism of one or both of the drugs .
non-steroidal anti-inflammatory agent	loop diuretics	effect	non steroidal anti inflammatory drugs : in some patients , the administration of a non steroidal anti inflammatory agent can reduce the diuretic , natriuretic , and antihypertensive effects of loop , potassium sparing and thiazide diuretics .
Starlix	tolbutamide	mechanism	starlix is a potential inhibitor of the cyp2c9 isoenzyme in vivo as indicated by its ability to inhibit the in vitro metabolism of tolbutamide .
non-selective beta-adrenergic-blocking agents	Starlix	effect	certain drugs , including nonsteroidal anti inflammatory agents ( nsaids ) , salicylates , monoamine oxidase inhibitors , and non-selective beta-adrenergic-blocking agents may potentiate the hypoglycemic action of starlix and other oral antidiabetic drugs .
NSAIDs	Starlix	effect	certain drugs , including nonsteroidal anti inflammatory agents ( nsaids ) , salicylates , monoamine oxidase inhibitors , and non selective beta adrenergic blocking agents may potentiate the hypoglycemic action of starlix and other oral antidiabetic drugs .
thyroid products	Starlix	effect	certain drugs including thiazides , corticosteroids , thyroid products , and sympathomimetics may reduce the hypoglycemic action of starlix and other oral antidiabetic drugs .
non-depolarizing muscle relaxants	piperacillin	effect	due to their similar mechanism of action , it is expected that the neuromuscular blockade produced by any of the non-depolarizing muscle relaxants could be prolonged in the presence of piperacillin .
probenecid	PIPRACIL	mechanism	probenecid : the oral combination of probenecid before intramuscular injection of pipracil produces an increase in piperacillin peak serum level of about dg % .
Codeine	alcohol	effect	codeine in combination with other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative hypnotics , or other cns depressants ( including alcohol ) has additive depressant effects .
ketoconazole	fexofenadine	mechanism	this observed increase in the bioavailability of fexofenadine may be due to transport related effects , such as p glycoprotein. in vivo animal studies also suggest that in addition to enhancing absorption , ketoconazole decreases fexofenadine gastrointestinal secretion , while erythromycin may also decrease biliary excretion .
rifampin	bexarotene	mechanism	furthermore , rifampin , phenytoin , phenobarbital , and other inducers of cytochrome p450 dg may cause a reduction in plasma bexarotene concentrations .
TRACRIUM	aminoglycosides	effect	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
isoniazid	levodopa	effect	dopamine d2 receptor antagonists ( e.g. , phenothiazines , butyrophenones , risperidone ) and isoniazid may reduce the therapeutic effects of levodopa .
Dopamine D2 receptor antagonists	levodopa	effect	dopamine d2 receptor antagonists ( e.g. , phenothiazines , butyrophenones , risperidone ) and isoniazid may reduce the therapeutic effects of levodopa .
levodopa	phenytoin	effect	in addition , the beneficial effects of levodopa in parkinsons disease have been reported to be reversed by phenytoin and papaverine .
ZEBETA	myocardial depressants	advise	zebeta should be used with care when myocardial depressants or inhibitors of av conduction , such as certain calcium antagonists ( particularly of the phenylalkylamine [ verapamil ] and benzothiazepine [ diltiazem ] classes ) , or antiarrhythmic agents , such as disopyramide , are used concurrently .
ZEBETA	calcium antagonists	advise	zebeta should be used with care when myocardial depressants or inhibitors of av conduction , such as certain calcium antagonists ( particularly of the phenylalkylamine [ verapamil ] and benzothiazepine [ diltiazem ] classes ) , or antiarrhythmic agents , such as disopyramide , are used concurrently .
ergotamine	naratriptan	advise	because there is a theoretical basis that these effects may be additive , use of ergotamine containing or ergot type medications ( like dihydroergotamine or methysergide ) and naratriptan within dg hours is contraindicated .
naratriptan	5-HT1 agonists	advise	because their vasospastic effects may be additive , coadministration of naratriptan and other 5-ht1 agonists within dg hours of each other is not recommended .
SPRYCEL	erythromycin	mechanism	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
alfentanil	SPRYCEL	advise	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
ergot alkaloids	SPRYCEL	advise	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
dihydroergotamine	SPRYCEL	advise	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
clozapine	flecainide	advise	therefore , co administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide and encainide ) , or that inhibit this enzyme ( e.g. , quinidine ) , should be approached with caution .
Clozapine	antihypertensive drugs	effect	clozapine may potentiate the hypotensive effects of antihypertensive drugs and the anticholinergic effects of atropine type drugs .
Etonogestrel	Topamax	int	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo dur ) , and vitamin c .
Etonogestrel	Felbatol	int	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo dur ) , and vitamin c .
Etonogestrel	Gris-PEG	int	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo dur ) , and vitamin c .
Etonogestrel	Lipitor	int	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo dur ) , and vitamin c .
Etonogestrel	Atromid-S	int	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo dur ) , and vitamin c .
Etonogestrel	ampicillin	int	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo dur ) , and vitamin c .
Etonogestrel	Kadian	int	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo dur ) , and vitamin c .
Etonogestrel	theophylline	int	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo dur ) , and vitamin c .
Etonogestrel	Tegretol	int	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo dur ) , and vitamin c .
felbamate	ethinyl estradiol	mechanism	anticonvulsants ( carbamazepine , felbamate , phenobarbital , phenytoin , topiramate ) : increase the metabolism of ethinyl estradiol and / or some progestins , leading to possible decrease in contraceptive effectiveness .
hormonal contraceptives	alprazolam	mechanism	benzodiazepines : combination hormonal contraceptives may decrease the clearance of some benzodiazepines ( alprazolam , chlordiazepoxide , diazepam ) and increase the clearance of others ( lorazepam , oxazepam , temazepam ) .
hormonal contraceptives	clofibric acid	mechanism	clofibric acid : combination hormonal contraceptives may increase the clearance of clofibric acid .
hormonal contraceptives	morphine	mechanism	morphine : combination hormonal contraceptives may increase the clearance of morphine .
nelfinavir	combination hormonal contraceptives	mechanism	protease inhibitors : amprenavir , lopinavir , nelfinavir , and ritonavir have been shown to decrease plasma levels of combination hormonal contraceptives ;
Amprenavir	combination hormonal contraceptives	mechanism	protease inhibitors : amprenavir , lopinavir , nelfinavir , and ritonavir have been shown to decrease plasma levels of combination hormonal contraceptives ;
Indinavir	combination hormonal contraceptives	mechanism	indinavir has been shown to increase plasma levels of combination hormonal contraceptives .
Rifampin	ethinyl estradiol	mechanism	rifampin : rifampin increases the metabolism of ethinyl estradiol and some progestins ( norethindrone ) resulting in decreased contraceptive effectiveness and increased menstrual irregularities .
hormonal contraceptives	salicylic acid	mechanism	salicylic acid : combination hormonal contraceptives may increase the clearance of salicylic acid .
nortriptyline	combination hormonal contraceptives	mechanism	tricyclic antidepressants ( amitriptyline , imipramine , nortriptyline ) : metabolism may be inhibited by combination hormonal contraceptives , increasing plasma levels of antidepressant ;
Tricyclic antidepressants	combination hormonal contraceptives	mechanism	tricyclic antidepressants ( amitriptyline , imipramine , nortriptyline ) : metabolism may be inhibited by combination hormonal contraceptives , increasing plasma levels of antidepressant ;
salicylate	corticosteroid	effect	this could lead to decreased salicylate serum levels or increase the risk of salicylate toxicity when corticosteroid is withdrawn .
antihistamines	heparin sodium	effect	drugs decreasing heparin effect : digitalis , tetracyclines , nicotine , or antihistamines may partially counteract the anticoagulant action of heparin sodium .
reserpine	beta-blocking	effect	catecholamine depleting drugs ( e.g. , reserpine ) may have an additive effect when given with beta-blocking agents .
Antihistamines	antianxiety agents	effect	antihistamines may have additive effects with alcohol and other cns depressants , e.g. , hypnotics , sedatives , tranquilizers , antianxiety agents .
anakinra	HUMIRA	effect	therefore the , combination of anakinra with other tnf blocking agents , including humira , may also result i n similar toxicities .
Narcotic analgesics	clonidine	effect	narcotic analgesics may potentiate the hypotensive effects of clonidine .
bupropion	beta-blockers	advise	therefore , co administration of bupropion with drugs that are metabolized by cyp2d6 isoenzyme including certain antidepressants ( e.g. , nortriptyline , imipramine , desipramine , paroxetine , fluoxetine , sertraline ) , antipsychotics ( e.g. , haloperidol , risperidone , thioridazine ) , beta-blockers ( e.g. , metoprolol ) , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution and should be initiated at the lower end of the dose range of the concomitant medication .
bupropion	flecainide	advise	therefore , co administration of bupropion with drugs that are metabolized by cyp2d6 isoenzyme including certain antidepressants ( e.g. , nortriptyline , imipramine , desipramine , paroxetine , fluoxetine , sertraline ) , antipsychotics ( e.g. , haloperidol , risperidone , thioridazine ) , beta blockers ( e.g. , metoprolol ) , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution and should be initiated at the lower end of the dose range of the concomitant medication .
WELLBUTRIN	steroids	advise	drugs that lower seizure threshold : concurrent administration of wellbutrin and agents ( e.g. , antipsychotics , other antidepressants , theophylline , systemic steroids , etc. ) that lower seizure threshold should be undertaken only with extreme caution .
tetracyclines	iron	mechanism	absorption of tetracyclines is impaired by antacids containing aluminum , calcium , or magnesium , and iron containing preparations .
tetracycline	contraceptives	effect	concurrent use of tetracycline may render oral contraceptives less effective .
chlorprothixene	tricyclic antidepressants	advise	exert particular caution in combining chlorprothixene with other anticholinergic drugs ( tricyclic antidepressants and antiparkinsonian agents ) : particularly the elderly may develop delirium , high fever , severe obstipation , even ileus and glaucoma .
Norpace	quinidine	mechanism	concomitant administration of norpace and quinidine resulted in slight increases in plasma disopyramide levels and slight decreases in plasma quinidine levels .
TCAs	guanfacine	effect	tcas decrease the hypotensive effect of guanfacine .
acetylsalicylic acid	Activase	int	in addition to bleeding associated with heparin and vitamin k antagonists , drugs that alter platelet function ( such as acetylsalicylic acid , dipyridamole and abciximab ) may increase the risk of bleeding if administered prior to , during , or after activase therapy .
ABILIFY	alcohol	advise	drug drug interactions given the primary cns effects of aripiprazole , caution should be used when abilify is taken in combination with other centrally acting drugs and alcohol .
carbamazepine	aripiprazole	mechanism	carbamazepine : coadministration of carbamazepine ( dg mg bid ) , a potent cyp3a4 inducer , with aripiprazole ( dg mg qd ) resulted in an approximate dg % decrease in cmax and auc values of both aripiprazole and its active metabolite , dehydro aripiprazole .
quinidine	aripiprazole	mechanism	inhibitors of cyp3a4 ( eg , ketoconazole ) or cyp2d6 ( eg , quinidine , fluoxetine , or paroxetine ) can inhibit aripiprazole elimination and cause increased blood levels .
ATROVENT	anticholinergic	advise	caution is therefore advised in the coadministration of atrovent inhalation aerosol with other anticholinergic containing drugs .
Sensipar	itraconazole	advise	dose adjustment of sensipar may be required and pth and serum calcium concentrations should be closely monitored if a patient initiates or discontinues therapy with a strong cyp3a4 inhibitor ( e.g. , ketoconazole , erythromycin , itraconazole ;
cyclosporine	quinolone class	mechanism	cyclosporine : elevated serum levels of cyclosporine have been reported with concomitant use of cyclosporine with other members of the quinolone class .
Sucralfate	lomefloxacin	mechanism	antacids and sucralfate : sucralfate and antacids containing magnesium or aluminum , as well as formulations containing divalent and trivalent cations such as videx ( didanosine ) , chewable / buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability .
antacid	lomefloxacin	mechanism	separating the doses of antacid and lomefloxacin minimizes this decrease in bioavailability ;
glimepiride	salsalate	advise	before taking glimepiride , tell your doctor if you are taking any of the following medicines : aspirin or another salicylate such as magnesium / choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto bismol ) ;
erythromycin	disopyramide	int	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
nonsteroidal anti-inflammatory drugs	furosemide	effect	diuretics : studies in normal volunteers have shown that flurbiprofen like other nonsteroidal anti-inflammatory drugs , can interfere with the effects of furosemide .
flurbiprofen	furosemide	advise	patients receiving flurbiprofen and furosemide or other diuretics should be observed closely to determine if the desired effect is obtained .
flurbiprofen	anticoagulants	advise	the physician should be cautious when administering flurbiprofen to patients taking anticoagulants .
azithromycin	triazolam	mechanism	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim / sulfamethoxazole or zidovudine .
azithromycin	zidovudine	mechanism	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim / sulfamethoxazole or zidovudine .
azithromycin	fluconazole	mechanism	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim / sulfamethoxazole or zidovudine .
beta-adrenoceptor blocking agents	nonsteroidal anti-inflammatory drugs	effect	blunting of the antihypertensive effect of beta-adrenoceptor blocking agents by nonsteroidal anti-inflammatory drugs has been reported .
sodium nitroprusside	anesthetics	effect	the hypotensive effect of sodium nitroprusside is augmented by that of most other hypotensive drugs , including ganglionic blocking agents , negative inotropic agents , and inhaled anesthetics .
theophylline	enoxacin	effect	theophylline related adverse effects have occurred in patients when theophylline and enoxacin were coadministered .
CNS depressants	hydrocodone	effect	patients receiving other narcotic analgesics , antipsychotics , antianxiety agents , or other cns depressants ( including alcohol ) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive cns depression .
tricyclic antidepressants	hydrocodone	effect	the use of mao inhibitors or tricyclic antidepressants with hydrocodone preparations may increase the effect of either the antidepressant or hydrocodone .
Erythromycin	theophylline	effect	erythromycin use in patients who are receiving high doses of theophylline may be associated with an increase in serum theophylline levels and potential theophylline toxicity .
theophylline	erythromycin	advise	in case of theophylline toxicity and / or elevated serum theophylline levels , the dose of theophylline should be reduced while the patient is receiving concomitant erythromycin therapy .
Erythromycin	astemizole	mechanism	erythromycin has been reported to significantly alter the metabolism of nonsedating antihistamines terfenadine and astemizole when taken concomitantly .
cisapride	erythromycin	mechanism	there have been postmarketing reports of drug interactions when erythromycin is coadministered with cisapride , resulting in qt prolongation , cardiac arrythmias , ventricular tachycardia , ventricular fibrulation , and torsades de pointes , most like due to inhibition of hepatic metabolism of cisapride by erythromycin .
Acarbose	metformin	mechanism	however , the peak plasma level of metformin was reduced by approximately dg % when taking acarbose due to a slight delay in the absorption of metformin .
Bentiromide	acetaminophen	int	bentiromide may interact with acetaminophen ( e.g. , tylenol ) , chloramphenicol ( e.g. , chloromycetin ) , local anesthetics ( e.g. , benzocaine and lidocaine ) , para aminobenzoic acid ( paba ) containing preparations ( e.g. , sunscreens and some multivitamins ) , procainamide ( e.g. , pronestyl ) , sulfonamides ( sulfa medicines ) , thiazide diuretics ( use of these medicines during the test period will affect the test results ) , and pancreatic supplements ( use of pancreatic supplements may give false test results ) .
Bentiromide	Tylenol	int	bentiromide may interact with acetaminophen ( e.g. , tylenol ) , chloramphenicol ( e.g. , chloromycetin ) , local anesthetics ( e.g. , benzocaine and lidocaine ) , para aminobenzoic acid ( paba ) containing preparations ( e.g. , sunscreens and some multivitamins ) , procainamide ( e.g. , pronestyl ) , sulfonamides ( sulfa medicines ) , thiazide diuretics ( use of these medicines during the test period will affect the test results ) , and pancreatic supplements ( use of pancreatic supplements may give false test results ) .
Bentiromide	anesthetics	int	bentiromide may interact with acetaminophen ( e.g. , tylenol ) , chloramphenicol ( e.g. , chloromycetin ) , local anesthetics ( e.g. , benzocaine and lidocaine ) , para aminobenzoic acid ( paba ) containing preparations ( e.g. , sunscreens and some multivitamins ) , procainamide ( e.g. , pronestyl ) , sulfonamides ( sulfa medicines ) , thiazide diuretics ( use of these medicines during the test period will affect the test results ) , and pancreatic supplements ( use of pancreatic supplements may give false test results ) .
Bentiromide	para-aminobenzoic acid	int	bentiromide may interact with acetaminophen ( e.g. , tylenol ) , chloramphenicol ( e.g. , chloromycetin ) , local anesthetics ( e.g. , benzocaine and lidocaine ) , para-aminobenzoic acid ( paba ) containing preparations ( e.g. , sunscreens and some multivitamins ) , procainamide ( e.g. , pronestyl ) , sulfonamides ( sulfa medicines ) , thiazide diuretics ( use of these medicines during the test period will affect the test results ) , and pancreatic supplements ( use of pancreatic supplements may give false test results ) .
Diphenoxylate HCl	MAO inhibitors	int	diphenoxylate hcl and atropine sulfate may interact with mao inhibitors in studies with male rats , diphenoxylate hydrochloride was found to inhibit the hepatic microsomal enzyme system at a dose of dg mg / kg / day .
thyroid preparation	anesthetic	effect	ketamine : when administered to patients on a thyroid preparation , this parenteral anesthetic may cause hypertension and tachycardia .
Thyroxine	epinephrine	effect	vasopressors : thyroxine increases the adrenergic effect of catecholamines such as epinephrine and norepinephrine .
Cholestyramine	T3	mechanism	cholestyramine : cholestyramine binds both t4 and t3 in the intestine , thus impairing absorption of these thyroid hormones .
Paroxetine	duloxetine	mechanism	paroxetine ( dg mg qd ) increased the concentration of duloxetine ( dg mg qd ) by about dg % , and greater degrees of inhibition are expected with higher doses of paroxetine .
iloprost	antihypertensive agents	effect	however , iloprost has the potential to increase the hypotensive effect of vasodilators and antihypertensive agents .
Nabilone	narcotic analgesics	advise	nabilone should be administered with caution to patients who are taking other psychoactive drugs or cns depressants , including alcohol , barbiturates and narcotic analgesics , or to those with a history of psychiatric disorder ( including manic depressive illness and schizophrenia ) .
Nabilone	secobarbitone sodium	effect	nabilone has been shown to have an additive cns depressant effect when given with either diazepam , secobarbitone sodium , alcohol or codeine .
TIKOSYN	cimetidine	advise	if a patient requires tikosyn and anti ulcer therapy , it is suggested that omeprazole , ranitidine , or antacids ( aluminum and magnesium hydroxides ) be used as alternatives to cimetidine , as these agents have no effect on the pharmacokinetic profile of tikosyn .
butalbital	monoamine oxidase (MAO) inhibitors	effect	the cns effects of butalbital may be enhanced by monoamine oxidase (mao) inhibitors .
acetaminophen	chlordiazepoxide	effect	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative hypnotics , or other cns depressants , causing increased cns depression .
diuretic	Lotensin	advise	the possibility of hypotensive effects with lotensin can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with lotensin .
cinoxacin	caffeine	advise	although this interaction has not been reported with cinoxacin , caution should be exercised when cinoxacin is given concomitantly with caffeine containing products .
Antacids	quinolones	mechanism	antacids or sucralfate substantially interfere with the absorption of some quinolones , resulting in low urine levels .
sucralfate	quinolones	mechanism	antacids or sucralfate substantially interfere with the absorption of some quinolones , resulting in low urine levels .
quinolones	zinc	mechanism	also , concomitant administration of quinolones with products containing iron , multivitamins containing zinc , or videx ( didanosine ) chewable / buffered tablets or the pediatric powder for oral solution may result in low urine levels .
quinolones	Videx	mechanism	also , concomitant administration of quinolones with products containing iron , multivitamins containing zinc , or videx ( didanosine ) chewable / buffered tablets or the pediatric powder for oral solution may result in low urine levels .
cinoxacin	warfarin	effect	quinolones , including cinoxacin , may enhance the effects of oral anticoagulants , such as warfarin or its derivatives .
diltiazem	carbamazepine	mechanism	concomitant administration of diltiazem with carbamazepine has been reported to result in elevated serum levels of carbamazepine ( dg % to dg % increase ) , resulting in toxicity in some cases .
diltiazem	triazolam	mechanism	studies showed that diltiazem increased the auc of midazolam and triazolam by dg dg fold and the cmax by dg fold , compared to placebo .
Cholestyramine	warfarin	mechanism	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
Cholestyramine	thyroxine	mechanism	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
anticoagulants	lovastatin	advise	it is recommended that in patients taking anticoagulants , prothrombin time be determined before starting lovastatin and frequently enough during early therapy to insure that no significant alteration of prothrombin time occurs .
alcohol	LEXAPRO	advise	alcohol although lexapro did not potentiate the cognitive and motor effects of alcohol in a clinical trial , as with other psychotropic medications , the use of alcohol by patients taking lexapro is not recommended .
sumatriptan	SSRI	advise	if concomitant treatment with sumatriptan and an ssri ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , citalopram , escitalopram ) is clinically warranted , appropriate observation of the patient is advised .
sumatriptan	sertraline	advise	if concomitant treatment with sumatriptan and an ssri ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , citalopram , escitalopram ) is clinically warranted , appropriate observation of the patient is advised .
citalopram	cimetidine	mechanism	cimetidine in subjects who had received dg days of dg mg / day racemic citalopram , combined administration of dg mg / day cimetidine for dg days resulted in an increase in citalopram auc and cmax of dg % and dg % , respectively .
ezetimibe	cyclosporine	mechanism	cyclosporine : the total ezetimibe level increased dg fold in one renal transplant patient receiving multiple medications , including cyclosporine .
SALICYLATE DRUGS	DISALCID	effect	aspirin and other salicylate drugs will be additive to disalcid and may increase plasma concentrations of salicylic acid to toxic levels .
Salicylate	phenytoin	mechanism	salicylate competes with a number of drugs for protein binding sites , notably penicillin , thiopental , thyroxine , triiodothyronine , phenytoin , sulfinpyrazone , naproxen , warfarin , methotrexate , and possibly corticosteroids .
sulfamethoxazole	warfarin	effect	it has been reported that sulfamethoxazole may prolong the prothrombin time in patients who are receiving the anticoagulant warfarin .
phenytoin	methylprednisolone	advise	drugs that induce hepatic enzymes such as phenobarbital , phenytoin , and rifampin may increase the clearance of methylprednisolone and may require increased in methylprednisolone dose to achieve the desired response .
rifampin	methylprednisolone	mechanism	drugs that induce hepatic enzymes such as phenobarbital , phenytoin , and rifampin may increase the clearance of methylprednisolone and may require increased in methylprednisolone dose to achieve the desired response .
anticholinergic drugs	nitrites	effect	the following agents may increase certain actions or side effects of anticholinergic drugs : amantadine , antiarrhythmic agents of class i ( e.g. , quinidine ) , antihistamines , antipsychotic agents ( e.g. , phenothiazines ) , benzodiazepines , mao inhibitors , narcotic analgesics ( e.g. , meperidine ) , nitrates and nitrites , sympathomimetic agents , tricyclic antidepressants , and other drugs having anticholinergic activity .
anticholinergic drugs	narcotic analgesics	effect	the following agents may increase certain actions or side effects of anticholinergic drugs : amantadine , antiarrhythmic agents of class i ( e.g. , quinidine ) , antihistamines , antipsychotic agents ( e.g. , phenothiazines ) , benzodiazepines , mao inhibitors , narcotic analgesics ( e.g. , meperidine ) , nitrates and nitrites , sympathomimetic agents , tricyclic antidepressants , and other drugs having anticholinergic activity .
methsuximide	phenobarbital	mechanism	since celontin ( methsuximide ) may interact with concurrently administered antiepileptic drugs , periodic serum level determinations of these drugs may be necessary ( eg methsuximide may increase the plasma concentrations of phenytoin and phenobarbital ) .
Salicylates	MYKROX	effect	salicylates and other non steroidal anti inflammatory drugs : may decrease the antihypertensive effects of mykrox tablets .
Metolazone	anticoagulants	effect	anticoagulants : metolazone , as well as other thiazide like diuretics , may affect the hypoprothrombinemic response to anticoagulants ;
Ropivacaine	anesthetics	advise	ropivacaine should be used with caution in patients receiving other local anesthetics or agents structurally related to amide type local anesthetics , since the toxic effects of these drugs are additive .
ropivacaine	fluvoxamine	mechanism	in vivo , the plasma clearance of ropivacaine was reduced by dg % during coadministration of fluvoxamine ( dg mg bid for dg days ) , a selective and potent cyp1a2 inhibitor .
cholinesterase inhibitors	cholinergic agonists	effect	use with cholinomimetics and other cholinesterase inhibitors : a synergistic effect may be expected when cholinesterase inhibitors are given concurrently with succinylcholine , similar neuromuscular blocking agents or cholinergic agonists such as bethanechol .
NSAIDs	lithium	mechanism	lithium : in clinical trials , nsaids have produced an elevation of plasma lithium levels and a reduction in renal lithium clearance .
MOBIC	warfarin	advise	caution should be used when administering mobic with warfarin since patients on warfarin may experience changes in inr and an increased risk of bleeding complications when a new medication is introduced .
aspirin	MOBIC	effect	concomitant administration of low dose aspirin with mobic may result in an increased rate of gi ulceration or other complications , compared to use of mobic alone .
GH	sex steroids	mechanism	these data suggest that gh administration may alter the clearance of compounds known to be metabolized by cp450 liver enzymes ( e.g. , corticosteroids , sex steroids , anticonvulsants , cyclosporin ) .
NIMBEX	succinylcholine	effect	administration of dg mg / kg ( dg x ed95 ) nimbex at dg % or dg % recovery following an intubating dose of succinylcholine ( dg mg / kg ) produced dg % neuromuscular block .
NIMBEX	tetracyclines	effect	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
NIMBEX	lithium	effect	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
NIMBEX	quinidine	effect	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
nondepolarizing agents	polymyxins	effect	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
Isoflurane	NIMBEX	effect	isoflurane or enflurane administered with nitrous oxide / oxygen to achieve dg mac [ minimum alveolar concentration ] may prolong the clinically effective duration of action of initial and maintenance doses of nimbex and decrease the required infusion rate of nimbex .
CNS depression-producing drugs	methyprylon	effect	concurrent use of alcohol and other cns depression-producing drugs may increase the cns depressant effects of methyprylon or these other medications .
Barbiturates	anticoagulants	int	barbiturates may decrease the effectiveness of oral contraceptives , certain antibiotics , quinidine , theophylline , corticosteroids , anticoagulants , and beta blockers .
phenylephrine	ProAmatine	effect	the use of drugs that stimulate alpha adrenergic receptors ( e.g. , phenylephrine , pseudoephedrine , ephedrine , phenylpropanolamine or dihydroergotamine ) may enhance or potentiate the pressor effects of proamatine . therefore , caution should be used when proamatine is administered concomitantly with agents that cause vasoconstriction .
desglymidodrine	ranitidine	mechanism	proamatine. alpha adrenergic blocking agents , such as prazosin , terazosin , and doxazosin , can antagonize the effects of proamatine. potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of desglymidodrine ( a base ) is due to active tubular secretion by the base secreting system also responsible for the secretion of such drugs as metformin , cimetidine , ranitidine , procainamide , triamterene , flecainide , and quinidine .
SKELAXIN	CNS depressants	effect	skelaxin may enhance the effects of alcohol , barbiturates and other cns depressants .
vigabatrin	carbamazepine	mechanism	a study published in dg found that vigabatrin causes a statistically significant increase in plasma clearance of carbamazepine .
abciximab	Retavase	effect	in addition to bleeding associated with heparin and vitamin k antagonists , drugs that alter platelet function ( such as aspirin , dipyridamole , and abciximab ) may increase the risk of bleeding if administered prior to or after retavase therapy .
TOBI	dornase alfa	effect	in clinical studies of tobi , patients taking tobi concomitantly with dornase alfa ( pulmozyme , genentech ) , ( beta ) agonists , inhaled corticosteroids , other anti pseudomonal antibiotics , or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole .
TOBI	PULMOZYME	effect	in clinical studies of tobi , patients taking tobi concomitantly with dornase alfa ( pulmozyme , genentech ) , ( beta ) agonists , inhaled corticosteroids , other anti pseudomonal antibiotics , or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole .
Pilocarpine	beta adrenergic antagonists	advise	pilocarpine should be administered with caution to patients taking beta adrenergic antagonists because of the possibility of conduction disturbances .
DIPRIVAN	fentanyl	effect	the induction dose requirements of diprivan injectable emulsion may be reduced in patients with intramuscular or intravenous premedication , particularly with narcotics ( eg , morphine , meperidine , and fentanyl , etc . )
metronidazole	warfarin	effect	oral metronidazole has been reported to potentiate the anticoagulant effect of coumarin and warfarin , resulting in a prolongation of prothrombin time .
aspirin	carbonic anhydrase inhibitors	effect	caution is advised for patients receiving high dose aspirin and methazolamide concomitantly , as anorexia , tachypnea , lethargy , coma and death have been reported with concomitant use of high dose aspirin and carbonic anhydrase inhibitors .
cimetidine	Mexitil	mechanism	concurrent administration of cimetidine and mexitil has been reported to increase , decrease , or leave unchanged mexitil plasma levels ;
rifampin	Mexitil	mechanism	when phenytoin or other hepatic enzyme inducers such as rifampin and phenobarbital have been taken concurrently with mexitil , lowered mexitil plasma levels have been reported .
Mephenytoin	steroid medications	effect	mephenytoin may also affect the effects of other drugs , which include some steroid medications , warfarin , certain heart medicines , birth control pills , anti infective medicines , furosemide and theophylline please note that mephenytoin may interact with other drugs that are not listed here .
neuroleptics	morphine	effect	use of neuroleptics in conjunction with oral morphine may increase the risk of respiratory depression , hypotension and profound sedation or coma .
nalbuphine	opioid agonist analgesic	advise	interaction with mixed agonist / antagonist opioid analgesics : agonist / antagonist analgesics ( i.e. , pentazocine , nalbuphine , butorphanol , or buprenorphine ) should not be administered to patients who have received or are receiving a course of therapy with a proof opioid agonist analgesic .
Ritalin	diphenylhydantoin	mechanism	human pharmacologic studies have shown that ritalin may inhibit the metabolism of coumarin anticoagulants , anticonvulsants ( phenobarbital , diphenylhydantoin , primidone ) , phenylbutazone , and tricyclic drugs ( imipramine , clomipramine , desipramine ) .
Ritalin	clomipramine	mechanism	human pharmacologic studies have shown that ritalin may inhibit the metabolism of coumarin anticoagulants , anticonvulsants ( phenobarbital , diphenylhydantoin , primidone ) , phenylbutazone , and tricyclic drugs ( imipramine , clomipramine , desipramine ) .
SUTENT	atazanavir	mechanism	co administration of sutent with strong inhibitors of the cyp3a4 family ( e.g. , ketoconazole , itraconazole , clarithromycin , atazanavir , indinavir , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , voriconizole ) may increases sunitinib concentrations .
SUTENT	nefazodone	mechanism	co administration of sutent with strong inhibitors of the cyp3a4 family ( e.g. , ketoconazole , itraconazole , clarithromycin , atazanavir , indinavir , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , voriconizole ) may increases sunitinib concentrations .
SUTENT	nelfinavir	mechanism	co administration of sutent with strong inhibitors of the cyp3a4 family ( e.g. , ketoconazole , itraconazole , clarithromycin , atazanavir , indinavir , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , voriconizole ) may increases sunitinib concentrations .
anticoagulant	ethchlorvynol	effect	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under dosage .
anticoagulant	haloperidol	effect	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under dosage .
anticoagulant	meprobamate	effect	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under dosage .
anticoagulant	antacids	effect	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under dosage .
anticoagulant	warfarin sodium	effect	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under dosage .
anticoagulant	carbamazepine	effect	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under dosage .
cholestyramine	anticoagulants	mechanism	for example , since cholestyramine may reduce the gastrointestinal absorption of both the oral anticoagulants and vitamin k , the net effects are unpredictable .
cholestyramine	vitamin K	mechanism	for example , since cholestyramine may reduce the gastrointestinal absorption of both the oral anticoagulants and vitamin k , the net effects are unpredictable .
anticoagulant	cinchophen	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
anticoagulant	dextran	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
anticoagulant	dextrothyroxine	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
anticoagulant	diflunisal	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
anticoagulant	ethacrynic acid	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
anticoagulant	ibuprofen	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
anticoagulant	amiodarone	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
anticoagulant	phenytoin	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
anticoagulant	tolbutamide	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
anticoagulant	warfarin sodium	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
anticoagulant	chloral hydrate	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
dipyridamole	anticoagulants	effect	drugs that reduce the number of blood platelets by causing bone marrow depression ( such as antineoplastic agents ) or drugs which inhibit platelet function ( eg , aspirin and other non steroidal anti inflammatory drugs , dipyridamole , hydrochloroquine , clofibrate , dextran ) may increase the bleeding tendency produced by anticoagulants without altering prothrombin time determinations .
triamterene	ACE inhibitors	effect	use of potassium sparing diuretics ( spironolactone , triamterene , amiloride ) or potassium supplements concomitantly with ace inhibitors can increase the risk of hyperkalemia .
diuretic	lithium	effect	if a diuretic is also used , the risk of lithium toxicity may be increased .
NSAIDs	ALIMTA	advise	in the absence of data regarding potential interaction between alimta and nsaids with longer half lives , all patients taking these nsaids should interrupt dosing for at least dg days before , the day of , and dg days following alimta administration .
melatonin	progestin	effect	melatonin may interact with the following drugs : aspirin and other nsaids ( may lower melatonin levels ) , fluvoxamine ( bioavailability of oral melatonin is increased with coadministration ) , beta blockers ( may decrease melatonin levels ) , fluoxetine ( reports of psychotic episodes when coadministered ) , progestin ( coadministration of melatonin with progestin can inhibit ovarian function in women ) , benzodiazepenes and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects ) , and corticosteroids ( coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids ) .
Melatonin	aspirin	int	melatonin may interact with the following drugs : aspirin and other nsaids ( may lower melatonin levels ) , fluvoxamine ( bioavailability of oral melatonin is increased with coadministration ) , beta blockers ( may decrease melatonin levels ) , fluoxetine ( reports of psychotic episodes when coadministered ) , progestin ( coadministration of melatonin with progestin can inhibit ovarian function in women ) , benzodiazepenes and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects ) , and corticosteroids ( coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids ) .
Terbinafine	rifampin	mechanism	terbinafine clearance is increased dg % by rifampin , a cyp450 enzyme inducer , and decreased dg % by cimetidine , a cyp450 enzyme inhibitor .
EVISTA	clofibrate	advise	caution should be used when evista is coadministered with other highly protein bound drugs , such as clofibrate , indomethacin , naproxen , ibuprofen , diazepam , and diazoxide .
EVISTA	diazepam	advise	caution should be used when evista is coadministered with other highly protein bound drugs , such as clofibrate , indomethacin , naproxen , ibuprofen , diazepam , and diazoxide .
butyrophenones	Permax	advise	dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthines ) or metoclopramide , ordinarily should not be administered concurrently with permax ( a dopamine agonist ) ;
metoclopramide	insulin	advise	because the action of metoclopramide will influence the delivery of food to the intestines and thus the rate of absorption , insulin dosage or timing of dosage may require adjustment .
ketoconazole	corticosteroids	mechanism	drugs such as troleandomycin and ketoconazole may inhibit the metabolism of corticosteroids and thus decrease their clearance .
Aspirin	corticosteroids	advise	aspirin should be used cautiously in conjunction with corticosteroids in patients suffering from hypoprothrombinemia .
anticoagulants	corticosteroids	effect	there are reports of enhanced as well as diminished effects of anticoagulants when given concurrently with corticosteroids .
melatonin	corticosteroids	effect	melatonin may interact with the following drugs : aspirin and other nsaids ( may lower melatonin levels ) , fluvoxamine ( bioavailability of oral melatonin is increased with coadministration ) , beta blockers ( may decrease melatonin levels ) , fluoxetine ( reports of psychotic episodes when coadministered ) , progestin ( coadministration of melatonin with progestin can inhibit ovarian function in women ) , benzodiazepenes and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects ) , and corticosteroids ( coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids ) .
Melatonin	fluvoxamine	int	melatonin may interact with the following drugs : aspirin and other nsaids ( may lower melatonin levels ) , fluvoxamine ( bioavailability of oral melatonin is increased with coadministration ) , beta blockers ( may decrease melatonin levels ) , fluoxetine ( reports of psychotic episodes when coadministered ) , progestin ( coadministration of melatonin with progestin can inhibit ovarian function in women ) , benzodiazepenes and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects ) , and corticosteroids ( coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids ) .
Terbinafine	cyclosporine	mechanism	terbinafine increases the clearance of cyclosporine by dg % .
EVISTA	diazoxide	advise	caution should be used when evista is coadministered with other highly protein bound drugs , such as clofibrate , indomethacin , naproxen , ibuprofen , diazepam , and diazoxide .
metoclopramide	alcohol	effect	additive sedative effects can occur when metoclopramide is given with alcohol , sedatives , hypnotics , narcotics , or tranquilizers .
digoxin	metoclopramide	mechanism	absorption of drugs from the stomach may be diminished ( e.g. , digoxin ) by metoclopramide , whereas the rate and / or extent of absorption of drugs from the small bowel may be increased ( e.g. , acetaminophen , tetracycline , levodopa , ethanol , cyclosporine ) .
Corticosteroids	aspirin	mechanism	corticosteroids may increase the clearance of chronic high dose aspirin .
Methscopolamine	diphenhydramine	int	methscopolamine may interact with antidepressants ( tricyclic type ) , mao inhibitors ( e.g. , phenelzine , linezolid , tranylcypromine , isocarboxazid , selegiline , furazolidone ) , quinidine , amantadine , antihistamines ( e.g. , diphenhydramine ) , other anticholinergics , potassium chloride supplements , antacids , absorbent type anti diarrhea medicines ( e.g. , kaolin pectin ) , phenothiazines ( e.g. , chlorpromazine , promethazine ) .
Methscopolamine	isocarboxazid	int	methscopolamine may interact with antidepressants ( tricyclic type ) , mao inhibitors ( e.g. , phenelzine , linezolid , tranylcypromine , isocarboxazid , selegiline , furazolidone ) , quinidine , amantadine , antihistamines ( e.g. , diphenhydramine ) , other anticholinergics , potassium chloride supplements , antacids , absorbent type anti diarrhea medicines ( e.g. , kaolin pectin ) , phenothiazines ( e.g. , chlorpromazine , promethazine ) .
TRENTAL	anticoagulants	effect	although a causal relationship has not been established , there have been reports of bleeding and / or prolonged prothrombin time in patients treated with trental with and without anticoagulants or platelet aggregation inhibitors .
bacteriostatic antibiotics	penicillins	effect	concurrent administration of bacteriostatic antibiotics ( e.g. , erythromycin , tetracycline ) may diminish the bactericidal effects of penicillins by slowing the rate of bacterial growth .
ketoconazole	mifepristone	mechanism	although specific drug or food interactions with mifepristone have not been studied , on the basis of this drug s metabolism by cyp dg , it is possible that ketoconazole , itraconazole , erythromycin , and grapefruit juice may inhibit its metabolism ( increasing serum levels of mifepristone ) .
carbamazepine	mifepristone	mechanism	john s wort , and certain anticonvulsants ( phenytoin , phenobarbital , carbamazepine ) may induce mifepristone metabolism ( lowering serum levels of mifepristone ) .
Methergine	ergot alkaloids	advise	caution should be exercised when methergine ( methylergonovine maleate ) is used concurrently with other vasoconstrictors or ergot alkaloids .
indinavir	megestrol acetate	advise	administration of a higher dose of indinavir should be considered when coadministering with megestrol acetate .
Mequitazine	antichlolinergic	int	mequitazine can interact with cns depressant , antichlolinergic , tca , maois , and alcohol .
Mequitazine	TCA	int	mequitazine can interact with cns depressant , antichlolinergic , tca , maois , and alcohol .
Mequitazine	alcohol	int	mequitazine can interact with cns depressant , antichlolinergic , tca , maois , and alcohol .
Cyclophosphamide	succinylcholine chloride	effect	cyclophosphamide treatment , which causes a marked and persistent inhibition of cholinesterase activity , potentiates the effect of succinylcholine chloride .
Myfortic	magnesium	mechanism	antacids : absorption of a single dose of myfortic was decreased when administered to dg stable renal transplant patients also taking magnesium aluminum containing antacids ( dg ml ) : the mean cmax and auc ( dg t ) values for mpa were dg % and dg % lower , respectively , than when myfortic was administered alone under fasting conditions .
Myfortic	antacids	advise	it is recommended that myfortic and antacids not be administered simultaneously .
Myfortic	cholestyramine	advise	therefore , do not administer myfortic with cholestyramine or other agents that may interfere with enterohepatic recirculation or drugs that may bind bile acids , for example bile acid sequestrates or oral activated charcoal , because of the potential to reduce the efficacy of myfortic .
MEPERIDINE	SEDATIVE-HYPNOTICS	advise	interaction with other central nervous system depressants : meperidine should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic analgesics , general anesthetics , phenothiazines , other tranquilizers , sedative-hypnotics ( including barbiturates ) , tricyclic antidepressants and other cns depressants ( including alcohol ) .
MEPERIDINE	TRICYCLIC ANTIDEPRESSANTS	advise	interaction with other central nervous system depressants : meperidine should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic analgesics , general anesthetics , phenothiazines , other tranquilizers , sedative hypnotics ( including barbiturates ) , tricyclic antidepressants and other cns depressants ( including alcohol ) .
pimozide	macrolide antibacterials	mechanism	cisapride , pimozide : other drugs such as cisapride or pimozide , which are metabolised by hepatic cyp3a isozymes have been associated with qt interval prolongation and / or cardiac arrythmias ( typically torsades de pointe ) as a result of increase in their serum level subsequent to interaction with significant inhibitors of the isozyme , including some macrolide antibacterials .
rimantadine	aspirin	mechanism	peak plasma concentrations and auc of rimantadine were reduced approximately dg % in the presence of aspirin .
tetracycline class drugs	penicillin	advise	since bacteriostatic drugs may interfere with the bactericidal action of penicillin , it is advisable to avoid giving tetracycline class drugs in conjunction with penicillin .
tetracyclines	aluminum	mechanism	absorption of tetracyclines is impaired by antacids containing aluminum , calcium or magnesium , and iron containing preparations .
tetracyclines	calcium	mechanism	absorption of tetracyclines is impaired by antacids containing aluminum , calcium or magnesium , and iron containing preparations .
Sanctura	tenofovir	mechanism	drugs eliminated by active tubular secretion : although studies to assess drug drug interactions with sanctura have not been conducted , sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion ( e.g. digoxin , procainamide , pancuronium , morphine , vancomycin , metformin and tenofovir ) .
DEMSER	alcohol	effect	concurrent use of demser with alcohol or other cns depressants can increase their sedative effects .
mazindol	Nardil	advise	you can not take mazindol if you have taken a monoamine oxidase inhibitor ( maoi ) such as isocarboxazid ( marplan ) , tranylcypromine ( parnate ) , or phenelzine ( nardil ) in the last dg days .
MAO-A inhibitors	sumatriptan	mechanism	mao-a inhibitors reduce sumatriptan clearance , significantly increasing systemic exposure .
SSRIs	sumatriptan	effect	therefore , the use of sumatriptan succinate tablets in patients receiving mao a inhibitors is contraindicated . selective serotonin reuptake inhibitors ( ssris ) ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with sumatriptan .
fluoxetine	sumatriptan	effect	therefore , the use of sumatriptan succinate tablets in patients receiving mao a inhibitors is contraindicated . selective serotonin reuptake inhibitors ( ssris ) ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with sumatriptan .
PURINETHOL	TABLOID	effect	there is usually complete cross resistance between purinethol ( mercaptopurine ) and tabloid brand thioguanine .
PURINETHOL	Thioguanine	effect	there is usually complete cross resistance between purinethol ( mercaptopurine ) and tabloid brand thioguanine .
carbachol	suprofen	effect	other eye drops or medications such as acetylcholine chloride ( miochol ) and carbachol ( carboptic , isopto carbachol ) may decrease the effects of suprofen ophthalmic .
ketoconazole	paricalcitol	mechanism	a multiple dose drug drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol auc0 . since paricalcitol is partially metabolized by cyp3a and ketoconazole le is known to be a strong inhibitor of cytochrome p450 3a enzyme , care should be taken while dosing paricalcitol with ketoconazole and other strong p450 3a inhibitors including atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin or voriconazole .
paricalcitol	ritonavir	advise	a multiple dose drug drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol auc0 . since paricalcitol is partially metabolized by cyp3a and ketoconazole le is known to be a strong inhibitor of cytochrome p450 3a enzyme , care should be taken while dosing paricalcitol with ketoconazole and other strong p450 3a inhibitors including atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin or voriconazole .
fat-soluble vitamins	cholestyramine	mechanism	drugs that impair intestinal absorption of fat-soluble vitamins , such as cholestyramine , may interfere with the absorption of zemplar capsules .
reserpine	beta-blocking agent	effect	catecholamine depleting drugs ( eg , reserpine ) may have an additive effect when given with beta-blocking agents .
indomethacin	beta blockers	effect	concomitant use of prostaglandin synthase inhibiting drugs , eg , indomethacin , may decrease the hypotensive effects of beta blockers .
CHEMET	CaNa 2 EDTA	advise	concomitant administration of chemet with other chelation therapy , such as cana 2 edta is not recommended .
Thiazide diuretics	phenothiazines	effect	thiazide diuretics may accentuate the orthostatic hypotension that may occur with phenothiazines .
propranolol	phenothiazines	mechanism	concomitant administration of propranolol with phenothiazines results in increased plasma levels of both drugs .
Sirolimus	MYCAMINE	mechanism	sirolimus auc was increased by dg % with no effect on cmax in the presence of steady state mycamine compared with sirolimus alone .
Nifedipine	MYCAMINE	mechanism	nifedipine auc and cmax were increased by dg % and dg % , respectively , in the presence of steady state mycamine compared with nifedipine alone .
diltiazem	pramipexole	mechanism	other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g. , cimetidine , ranitidine , diltiazem , triamterene , verapamil , quinidine , and quinine ) decreases the oral clearance of pramipexole by about dg % , while those secreted by the anionic transport system ( e.g. , cephalosporins , penicillins , indomethacin , hydrochlorothiazide , and chlorpropamide ) are likely to have little effect on the oral clearance of pramipexole .
REMERON	diazepam	effect	however , the impairment of motor skills produced by remeron has been shown to be additive with those caused by diazepam .
REMERON	alcohol	effect	however , the impairment of cognitive and motor skills produced by remeron were shown to be additive with those produced by alcohol .
tricyclic antidepressants	sympathomimetic amines	effect	monoamine oxidase inhibitors or tricyclic antidepressants may potentiate the action of sympathomimetic amines .
milrinone	anagrelide	effect	the effects of medicinal products with similar properties such as inotropes milrinone , enoximone , amrinone , olprinone and cilostazol may be exacerbated by anagrelide .
nelfinavir	midazolam	mechanism	although not studied , the potent cytochrome p450 dg inhibitors ritonavir and nelfinavir may cause intense and prolonged sedation and respiratory depression due to a decrease in plasma clearance of midazolam .
Methscopolamine	potassium chloride	int	methscopolamine may interact with antidepressants ( tricyclic type ) , mao inhibitors ( e.g. , phenelzine , linezolid , tranylcypromine , isocarboxazid , selegiline , furazolidone ) , quinidine , amantadine , antihistamines ( e.g. , diphenhydramine ) , other anticholinergics , potassium chloride supplements , antacids , absorbent type anti diarrhea medicines ( e.g. , kaolin pectin ) , phenothiazines ( e.g. , chlorpromazine , promethazine ) .
Methscopolamine	absorbent-type anti-diarrhea medicines	int	methscopolamine may interact with antidepressants ( tricyclic type ) , mao inhibitors ( e.g. , phenelzine , linezolid , tranylcypromine , isocarboxazid , selegiline , furazolidone ) , quinidine , amantadine , antihistamines ( e.g. , diphenhydramine ) , other anticholinergics , potassium chloride supplements , antacids , absorbent-type anti-diarrhea medicines ( e.g. , kaolin pectin ) , phenothiazines ( e.g. , chlorpromazine , promethazine ) .
Methscopolamine	tranylcypromine	int	methscopolamine may interact with antidepressants ( tricyclic type ) , mao inhibitors ( e.g. , phenelzine , linezolid , tranylcypromine , isocarboxazid , selegiline , furazolidone ) , quinidine , amantadine , antihistamines ( e.g. , diphenhydramine ) , other anticholinergics , potassium chloride supplements , antacids , absorbent type anti diarrhea medicines ( e.g. , kaolin pectin ) , phenothiazines ( e.g. , chlorpromazine , promethazine ) .
Methscopolamine	selegiline	int	methscopolamine may interact with antidepressants ( tricyclic type ) , mao inhibitors ( e.g. , phenelzine , linezolid , tranylcypromine , isocarboxazid , selegiline , furazolidone ) , quinidine , amantadine , antihistamines ( e.g. , diphenhydramine ) , other anticholinergics , potassium chloride supplements , antacids , absorbent type anti diarrhea medicines ( e.g. , kaolin pectin ) , phenothiazines ( e.g. , chlorpromazine , promethazine ) .
paliperidone	alcohol	advise	given the primary cns effects of paliperidone , invega should be used with caution in combination with other centrally acting drugs and alcohol .
proton pump inhibitors	warfarin	effect	there have been postmarketing reports of increased inr and prothrombin time in patients receiving proton pump inhibitors , including pantoprazole , and warfarin concomitantly .
megestrol acetate	indinavir	mechanism	a pharmacokinetic study demonstrated that coadministration of megestrol acetate and indinavir results in a significant decrease in the pharmacokinetic parameters ( ~36 % for cmax and ~28 % for auc ) of indinavir .
sympathomimetic pressor amines	monoamine oxidase inhibitors	effect	mao inhibitors the pressor effect of sympathomimetic pressor amines is markedly potentiated in patients receiving monoamine oxidase inhibitors ( maoi ) .
Cerubidine	doxorubicin	effect	use of cerubidine in a patient who has previously received doxorubicin increases the risk of cardiotoxicity .
propoxyphene	alcohol	effect	the cns depressant effect of propoxyphene is additive with that of other cns depressants , including alcohol .
ZAVESCA	Cerezyme	mechanism	while co administration of zavesca appeared to increase the clearance of cerezyme by dg % , these results are not conclusive because of the small number of subjects studied and because patients took variable doses of cerezyme .
Thiamine	Loop Diuretics	int	interactions for vitamin b1 ( thiamine ) : loop diuretics , oral contraceptives , stavudine , tricyclic antidepressants
Myfortic	azathioprine	advise	azathioprine / mycophenolate mofetil : given that azathioprine and mycophenolate mofetil inhibit purine metabolism , it is recommended that myfortic not be administered concomitantly with azathioprine or mycophenolate mofetil .
MEPERIDINE	BARBITURATES	advise	interaction with other central nervous system depressants : meperidine should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic analgesics , general anesthetics , phenothiazines , other tranquilizers , sedative hypnotics ( including barbiturates ) , tricyclic antidepressants and other cns depressants ( including alcohol ) .
warfarin	FLOMAX	advise	therefore , caution should be exercised with concomitant administration of warfarin and flomax capsules .
reserpine	beta-blocking agents	effect	catecholamine depleting drugs ( e.g. , reserpine ) may have an additive effect when given with beta-blocking agents .
lamivudine	zalcitabine	advise	therefore , use of lamivudine in combination with zalcitabine is not recommended
tetracycline	methoxyflurane	effect	the concurrent use of tetracycline and methoxyflurane has been reported to result in fatal renal toxicity .
Sanctura	pancuronium	mechanism	drugs eliminated by active tubular secretion : although studies to assess drug drug interactions with sanctura have not been conducted , sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion ( e.g. digoxin , procainamide , pancuronium , morphine , vancomycin , metformin and tenofovir ) .
Sanctura	metformin	mechanism	drugs eliminated by active tubular secretion : although studies to assess drug drug interactions with sanctura have not been conducted , sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion ( e.g. digoxin , procainamide , pancuronium , morphine , vancomycin , metformin and tenofovir ) .
DEMSER	phenothiazines	advise	caution should be observed in administering demser to patients receiving phenothiazines or haloperidol because the extrapyramidal effects of these drugs can be expected to be potentiated by inhibition of catecholamine synthesis .
DEMSER	haloperidol	advise	caution should be observed in administering demser to patients receiving phenothiazines or haloperidol because the extrapyramidal effects of these drugs can be expected to be potentiated by inhibition of catecholamine synthesis .
Mazindol	guanethidine	effect	mazindol may reduce the effects of guanethidine ( ismelin ) .
Phenytoin	busulfan	mechanism	phenytoin increases the clearance of busulfan by dg % or more , possibly due to the induction of glutathione s transferase .
SKELID	calcium	mechanism	the bioavailability of skelid is decreased dg % by calcium , when calcium and skelid are administered at the same time , and dg % by some aluminum or magnesium containing antacids , when administered dg hour before skelid .
Vasopressors	halothane	effect	vasopressors , particularly metaraminol , may cause serious cardiac arrhythmias during halothane anesthesia and therefore should be used only with great caution or not at all .
paricalcitol	atazanavir	advise	a multiple dose drug drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol auc0 . since paricalcitol is partially metabolized by cyp3a and ketoconazole le is known to be a strong inhibitor of cytochrome p450 3a enzyme , care should be taken while dosing paricalcitol with ketoconazole and other strong p450 3a inhibitors including atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin or voriconazole .
erythromycin	dihydroergotamine	effect	concurrent use of erythromycin and ergotamine or dihydroergotamine has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia .
erythromycin	valproate	int	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
erythromycin	lovastatin	int	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
dapsone	clofazimine	advise	if leprosy associated inflammatory reactions develop in patients being treated with dapsone and clofazimine , it is still advisable to continue treatment with both drugs .
phenytoin	isoniazid	mechanism	the most commonly occurring drug interactions are listed below : drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2 antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
phenytoin	salicylates	mechanism	the most commonly occurring drug interactions are listed below : drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2 antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
phenytoin	dicumarol	mechanism	the most commonly occurring drug interactions are listed below : drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2 antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
serotonin reuptake inhibitor drug	MAOI	effect	in patients receiving another serotonin reuptake inhibitor drug in combination with monoamine oxidase inhibitors ( maoi ) , there have been reports of serious , sometimes fatal , reactions including hyperthermia , rigidity , myoclonus , autonomic instability with possible rapid fluctuations of vital signs , and mental status changes that include extreme agitation progressing to delirium and coma .
fluvoxamine	alprazolam	int	although it has not been definitively demonstrated that fluvoxamine is a potent iiia4 inhibitor , it is likely to be , given the substantial interaction of fluvoxamine with alprazolam .
fluvoxamine	terbinafine	advise	consequently , it is recommended that fluvoxamine not be used in combination with either terbinafine , astemizole , or cisapride .
fluvoxamine	cisapride	advise	consequently , it is recommended that fluvoxamine not be used in combination with either terbinafine , astemizole , or cisapride .
rifampicin	ondansetron	mechanism	phenytoin , carbamazepine , and rifampicin : in patients treated with potent inducers of cyp3a4 ( i.e. , phenytoin , carbamazepine , and rifampicin ) , the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased .
clarithromycin	DETROL LA	advise	for patients receiving ketoconazole or other potent cyp3a4 inhibitors such as other azole antifungals ( eg , itraconazole , miconazole ) or macrolide antibiotics ( eg , erythromycin , clarithromycin ) or cyclosporine or vinblastine , the recommended dose of detrol la is dg mg daily .
ketoconazole	DETROL LA	advise	for patients receiving ketoconazole or other potent cyp3a4 inhibitors such as other azole antifungals ( eg , itraconazole , miconazole ) or macrolide antibiotics ( eg , erythromycin , clarithromycin ) or cyclosporine or vinblastine , the recommended dose of detrol la is dg mg daily .
trimetrexate	fluconazole	effect	agents that might be coadministered with trimetrexate in aids patients for other indications that could elicit this activity include erythromycin , rifampin , rifabutin , ketoconazole , and fluconazole .
clotrimazole	trimetrexate	mechanism	based on an in vitro rat liver model , nitrogen substituted imidazole drugs ( clotrimazole , ketoconazole , miconazole ) were potent , non competitive inhibitors of trimetrexate metabolism .
ZOLINZA	coumarin-derivative anticoagulants	effect	coumarin derivative anticoagulants : prolongation of prothrombin time ( pt ) and international normalized ratio ( inr ) were observed in patients receiving zolinza concomitantly with coumarin-derivative anticoagulants .
sympathomimetic amine	tricyclic antidepressants	advise	avoid the use of preparations such as decongestants and local anesthetics which contain any sympathomimetic amine ( e.g. , epinephrine , norepinephrine ) , since it has been reported that tricyclic antidepressants can potentiate the effects of catecholamines .
norepinephrine	tricyclic antidepressants	advise	avoid the use of preparations such as decongestants and local anesthetics which contain any sympathomimetic amine ( e.g. , epinephrine , norepinephrine ) , since it has been reported that tricyclic antidepressants can potentiate the effects of catecholamines .
decongestants	tricyclic antidepressants	advise	avoid the use of preparations such as decongestants and local anesthetics which contain any sympathomimetic amine ( e.g. , epinephrine , norepinephrine ) , since it has been reported that tricyclic antidepressants can potentiate the effects of catecholamines .
anesthetics	tricyclic antidepressants	advise	avoid the use of preparations such as decongestants and local anesthetics which contain any sympathomimetic amine ( e.g. , epinephrine , norepinephrine ) , since it has been reported that tricyclic antidepressants can potentiate the effects of catecholamines .
vitamin K antagonists	TNKase	effect	anticoagulants ( such as heparin and vitamin k antagonists ) and drugs that alter platelet function ( such as acetylsalicylic acid , dipyridamole , and gp iib / iiia inhibitors ) may increase the risk of bleeding if administered prior to , during , or after tnkase therapy .
succinylcholine	nondepolarizing agents	effect	prior administration of succinylcholine can potentiate the neuromuscular blocking effects of nondepolarizing agents .
nondepolarizing agents	antibiotics	int	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as mivacron include certain antibiotics ( e.g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
paricalcitol	itraconazole	advise	a multiple dose drug drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol auc0 . since paricalcitol is partially metabolized by cyp3a and ketoconazole le is known to be a strong inhibitor of cytochrome p450 3a enzyme , care should be taken while dosing paricalcitol with ketoconazole and other strong p450 3a inhibitors including atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin or voriconazole .
cholestyramine	Zemplar	mechanism	drugs that impair intestinal absorption of fat soluble vitamins , such as cholestyramine , may interfere with the absorption of zemplar capsules .
nifedipine	MYCAMINE	advise	patients receiving sirolimus or nifedipine in combination with mycamine should be monitored for sirolimus or nifedipine toxicity and sirolimus or nifedipine dosage should be reduced if necessary .
Thiazides	norepinephrine	effect	thiazides may decrease arterial responsiveness to norepinephrine .
dopamine antagonists	MIRAPEX	effect	dopamine antagonists : since pramipexole is a dopamine agonist , it is possible that dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of mirapex .
thioxanthenes	MIRAPEX	effect	dopamine antagonists : since pramipexole is a dopamine agonist , it is possible that dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of mirapex .
ranitidine	pramipexole	mechanism	other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g. , cimetidine , ranitidine , diltiazem , triamterene , verapamil , quinidine , and quinine ) decreases the oral clearance of pramipexole by about dg % , while those secreted by the anionic transport system ( e.g. , cephalosporins , penicillins , indomethacin , hydrochlorothiazide , and chlorpropamide ) are likely to have little effect on the oral clearance of pramipexole .
alcohol	REMERON SolTab	advise	accordingly , patients should be advised to avoid alcohol while taking remeron soltab. diazepam : concomitant administration of diazepam ( dg mg ) had a minimal effect on plasma levels of mirtazapine ( dg mg ) in dg healthy subjects .
MIVACRON	polymyxins	int	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as mivacron include certain antibiotics ( e.g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
nondepolarizing agents	clindamycin	int	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as mivacron include certain antibiotics ( e.g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
MIVACRON	glucocorticoids	effect	the neuromuscular blocking effect of mivacron may be enhanced by drugs that reduce plasma cholinesterase activity ( e.g. , chronically administered oral contraceptives , glucocorticoids , or certain monoamine oxidase inhibitors ) or by drugs that irreversibly inhibit plasma cholinesterase . resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or carbamazepine .
DIFLUCAN	phenytoin	mechanism	phenytoin : diflucan increases the plasma concentrations of phenytoin .
azole antifungals	terfenadine	effect	terfenadine : because of the occurrence of serious cardiac dysrhythmias secondary to prolongation of the qtc interval in patients receiving azole antifungals in conjunction with terfenadine , interaction studies have been performed .
midazolam	fluconazole	mechanism	short acting benzodiazepines : following oral administration of midazolam , fluconazole resulted in substantial increases in midazolam concentrations and psychomotor effects .
short-acting benzodiazepines	fluconazole	advise	if short-acting benzodiazepines , which are metabolized by the cytochrome p450 system , are concomitantly administered with fluconazole , consideration should be given to decreasing the benzodiazepine dosage , and the patients should be appropriately monitored .
quinolones	aluminum	mechanism	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable / buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
phenytoin	phenobarbital	effect	similarly , the effects of phenytoin on phenobarbital , valproic acid and sodium plasma valproate concentrations are unpredictable
phenytoin	anticoagulants	effect	drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
phenytoin	corticosteroids	effect	drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
phenytoin	vitamin D	effect	drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
Ponstel	furosemide	advise	during concomitant therapy of ponstel with furosemide , the patient should be observed closely for signs of renal failure , as well as to assure diuretic efficacy .
NSAIDs	lithium	mechanism	lithium : nsaids have produced an elevation of plasma lithium levels and a reduction in renal lithium clearance .
AKINETON	antipsychotics	effect	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
AKINETON	narcotic analgesics	effect	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
Ketoconazole	vitamin D	mechanism	ketoconazole : ketoconazole may inhibit both synthetic and catabolic enzymes of vitamin d .
terfenadine	clarithromycin	advise	concomitant administration of terfenadine with clarithromycin , erythromycin , or troleandomycin is contraindicated : pending full characterization of potential interactions , concomitant administration of terfenadine with other macrolide antibiotics , including azithromycin , is not recommended .
terfenadine	erythromycin	advise	concomitant administration of terfenadine with clarithromycin , erythromycin , or troleandomycin is contraindicated : pending full characterization of potential interactions , concomitant administration of terfenadine with other macrolide antibiotics , including azithromycin , is not recommended .
terfenadine	azithromycin	advise	concomitant administration of terfenadine with clarithromycin , erythromycin , or troleandomycin is contraindicated : pending full characterization of potential interactions , concomitant administration of terfenadine with other macrolide antibiotics , including azithromycin , is not recommended .
hypoglycemic	SOMAVERT	advise	acromegalic patients with diabetes mellitus being treated with insulin and / or oral hypoglycemic agents may require dose reductions of these therapeutic agents after the initiation of therapy with somavert .
digitalis	sympathomimetic amines	effect	aramine should be used with caution in digitalized patients , since the combination of digitalis and sympathomimetic amines may cause ectopic arrhythmias .
sucralfate	anagrelide	mechanism	there is a single case report , which suggests that sucralfate may interfere with anagrelide absorption .
Anticholinergics	opioid analgesics	effect	anticholinergics or other medications with anticholinergic activity when used concurrently with opioid analgesics may result in increased risk of urinary retention and / or severe constipation , which may lead to paralytic ileus .
oxymorphone	propofol	effect	it has been reported that the incidence of bradycardia was increased when oxymorphone was combined with propofol for induction of anesthesia .
serotonin reuptake inhibitor drug	monoamine oxidase inhibitors	effect	in patients receiving another serotonin reuptake inhibitor drug in combination with monoamine oxidase inhibitors ( maoi ) , there have been reports of serious , sometimes fatal , reactions including hyperthermia , rigidity , myoclonus , autonomic instability with possible rapid fluctuations of vital signs , and mental status changes that include extreme agitation progressing to delirium and coma .
SSRIs	Imitrex	effect	a rare , but serious , constellation of symptoms , termed serotonin syndrome , has been reported with the concomitant use of selective serotonin reuptake inhibitors ( ssris ) and agents for migraine therapy , such as imitrex ( sumatriptan succinate ) and dihydroergotamine .
vitamin B12	folic acid	int	medications can interfere with folate utilization , including : anticonvulsant medications ( such as phenytoin , and primidone ) metformin ( sometimes prescribed to control blood sugar in type dg diabetes ) sulfasalazine ( used to control inflammation associated with crohns disease and ulcerative colitis ) triamterene ( a diuretic ) methotrexate there has been concern about the interaction between vitamin b12 and folic acid .
ergot-type medications	FROVA	advise	due to a theoretical risk of a pharmacodynamic interaction , use of ergotamine containing or ergot-type medications ( like dihydroergotamine or methysergide ) and frova within dg hours of each other should be avoided ( see a href= frova_od.htm # ci contraindications ) .
fluoxetine	5-HT1 agonists	effect	selective serotonin reuptake inhibitors ( ssris ) ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1 agonists .
sertraline	5-HT1 agonists	effect	selective serotonin reuptake inhibitors ( ssris ) ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1 agonists .
theophylline	quinolone	mechanism	elevated plasma levels of theophylline have been reported with concomitant quinolone use .
Nitrofurantoin	nalidixic acid	effect	nitrofurantoin interferes with the therapeutic action of nalidixic acid .
delavirdine	VIDEX	mechanism	interactions with other antiretroviral drugs : significant decreases in the auc of delavirdine ( dg % ) and indinavir ( dg % ) occurred following simultaneous administration of these agents with videx .
aluminum	VIDEX	effect	antacids : concomitant administration of antacids containing magnesium or aluminum with videx chewable / dispersible buffered tablets or pediatric powder for oral solution may potentiate adverse events associated with the antacid components .
D.H.E. 45	peripheral vasoconstrictors	effect	vasoconstrictors : d.h.e. 45 ( dihydroergotamine mesylate ) injection , usp should not be used with peripheral vasoconstrictors because the combination may cause synergistic elevation of blood pressure .
propranolol	ergotamine	effect	beta blockers : although the results of a clinical study did not indicate a safe problem associated with the administration of d.h.e. dg ( dihydroergotamine mesylate ) injection , usp to subjects already receiving propranolol , there have been reports that propranolol may potentiate the vasoconstrictive action of ergotamine by blocking the vasodilating property of epinephrine .
5-HT1 agonists	SSRIs	effect	ssris : weakness hyperreflexia , and incoordination have been reported rarely when 5-ht1 agonists have been co administered with ssris ( e. g .
levothyroxine sodium	ferrous sulfate	mechanism	levothyroxine sodium absorption : the following agents may bind and decrease absorption of levothyroxine sodium from the gastrointestinal tract : aluminum hydoxide , cholestyramine resin , colestipol hydrochloride , ferrous sulfate , sodium polystyrene sulfonate , soybean flour ( e.g. , infant formula ) , sucralfate .
levothyroxine sodium	sodium polystyrene sulfonate	mechanism	levothyroxine sodium absorption : the following agents may bind and decrease absorption of levothyroxine sodium from the gastrointestinal tract : aluminum hydoxide , cholestyramine resin , colestipol hydrochloride , ferrous sulfate , sodium polystyrene sulfonate , soybean flour ( e.g. , infant formula ) , sucralfate .
levothyroxine sodium	methadone	mechanism	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen containing compounds , dg fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
allopurinol	thiazide diuretics	effect	thiazide diuretics : the reports that the concomitant use of allopurinol and thiazide diuretics may contribute to the enhancement of allopurinol toxicity in some patients have been reviewed in an attempt to establish a cause and effect relationship and a mechanism of causation .
cytotoxic agents	allopurinol	effect	cytotoxic agents : enhanced bone marrow suppression by cyclophosphamide and other cytotoxic agents has been reported among patients with neoplastic disease , except leukemia , in the presence of allopurinol .
Allopurinol	azathioprine	mechanism	mercaptopurine / azathioprine : allopurinol inhibits the enzymatic oxidation of mercaptopurine and azathioprine to dg thiouric acid .
allopurinol	mercaptopurine	advise	in patients receiving mercaptopurine ( purinethol ) or azathioprine ( imuran ) , the concomitant administration of dg dg mg of allopurinol per day will require a reduction in dose to approximately one third to one fourth of the usual dose of mercaptopurine or azathioprine .
ethacrynic acid	warfarin	mechanism	a number of drugs , including ethacrynic acid , have been shown to displace warfarin from plasma protein ;
non- steroidal antiinflammatory agent	thiazide diuretics	effect	in some patients , the administration of a non- steroidal antiinflammatory agent can reduce the diuretic , natriuretic , and antihypertensive effects of loop , potassium sparing and thiazide diuretics .
ibuprofen	coumarin-type anticoagulants	effect	however , because bleeding has been reported when ibuprofen and other nonsteroidal anti inflammatory agents have been administered to patients on coumarin-type anticoagulants , the physician should be cautious when administering ibuprofen to patients on anticoagulants .
aspirin	nonsteroidal anti-inflammatory agents	effect	aspirin : animal studies wshow that aspirin given with nonsteroidal anti-inflammatory agents , including ibuprofen , yields a net decrease in anti inflammatory activity with lowered blood levels of the non aspirin drug .
probenecid	PAH	effect	therefore , patients receiving probenecid will have erroneously low erpf and tm pah values .
cefdinir	iron	mechanism	the reddish color is due to the formation of a nonabsorbable complex between cefdinir or its breakdown products and iron in the gastrointestinal tract .
probenecid	cefdinir	mechanism	probenecid : as with other b lactam antibiotics , probenecid inhibits the renal excretion of cefdinir , resulting in an approximate doubling in a.c. a dg % increase in peak cefdinir plasma levels , and a dg % prolongation in the apparent elimination half life .
reserpine	beta blocking agents	effect	catecholamine depleting drugs , e.g. , reserpine , may have an additive effect when given with beta blocking agents .
BREVIBLOC	morphine	advise	although the interactions observed in these studies do not appear to be of major clinical importance , brevibloc should be titrated with caution in patients being treated concurrently with digoxin , morphine , succinylcholine or warfarin .
BREVIBLOC	warfarin	mechanism	brevibloc concentrations were equivocally higher when given with warfarin , but this is not likely to be clinically important .
MAOIs	fluvoxamine	effect	in patients receiving nonselective monoamine oxidase inhibitors ( maois ) ( e.g. , selegiline hydrochloride ) in combination with serotoninergic agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
monoamine oxidase inhibitors	paroxetine	effect	in patients receiving nonselective monoamine oxidase inhibitors ( maois ) ( e.g. , selegiline hydrochloride ) in combination with serotoninergic agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
monoamine oxidase inhibitors	venlafaxine	effect	in patients receiving nonselective monoamine oxidase inhibitors ( maois ) ( e.g. , selegiline hydrochloride ) in combination with serotoninergic agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
SSRIs	sumatriptan succinate	effect	a rare , but serious , constellation of symptoms , termed serotonin syndrome , has been reported with the concomitant use of selective serotonin reuptake inhibitors ( ssris ) and agents for migraine therapy , such as imitrex ( sumatriptan succinate ) and dihydroergotamine .
rifampin	MEPRON	mechanism	rifampin : coadministration of rifampin and mepron suspension results in a significant decrease in average steady state plasma atovaquone concentrations .
paroxetine	5-HT1 agonists	effect	selective serotonin reuptake inhibitors ( ssris ) ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1 agonists .
diazepam	fluvoxamine	advise	accordingly , diazepam and fluvoxamine should not ordinarily be co administered .
phenytoin	ondansetron	mechanism	phenytoin , carbamazepine , and rifampicin : in patients treated with potent inducers of cyp3a4 ( i.e. , phenytoin , carbamazepine , and rifampicin ) , the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased .
carbamazepine	ondansetron	mechanism	phenytoin , carbamazepine , and rifampicin : in patients treated with potent inducers of cyp3a4 ( i.e. , phenytoin , carbamazepine , and rifampicin ) , the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased .
azole antifungals	DETROL LA	advise	for patients receiving ketoconazole or other potent cyp3a4 inhibitors such as other azole antifungals ( eg , itraconazole , miconazole ) or macrolide antibiotics ( eg , erythromycin , clarithromycin ) or cyclosporine or vinblastine , the recommended dose of detrol la is dg mg daily .
imipramine	barbiturates	mechanism	the plasma concentration of imipramine may increase when the drug is given concomitantly with hepatic enzyme inhibitors ( e.g. , cimetidine , fluoxetine ) and decrease by concomitant administration of hepatic enzyme inducers ( e.g. , barbiturates , phenytoin ) , and adjustment of the dosage of imipramine may therefore be necessary .
Scopolamine	tranquilizers	advise	scopolamine should be used with care in patients taking other drugs that are capable of causing cns effects such as sedatives , tranquilizers , or alcohol .
dipyridamole	TNKase	effect	anticoagulants ( such as heparin and vitamin k antagonists ) and drugs that alter platelet function ( such as acetylsalicylic acid , dipyridamole , and gp iib / iiia inhibitors ) may increase the risk of bleeding if administered prior to , during , or after tnkase therapy .
nondepolarizing agents	procainamide	int	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as mivacron include certain antibiotics ( e.g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
Didanosine	quinolones	mechanism	and videx , ( didanosine ) , chewable / buffered tablets or the pediatric powder for oral solution may substantially interfere with the absorption of quinolones , resulting in systemic levels considerably lower than desired .
Quinolones	caffeine	mechanism	quinolones have been shown to interfere with the metabolism of caffeine .
Cimetidine	ELLENCE	advise	cimetidine treatment should be stopped during treatment with ellence .
Cimetidine	chloroquine	mechanism	cimetidine : cimetidine can inhibit the metabolism of chloroquine , increasing its plasma level .
quinolone antibiotics	aluminum	mechanism	plasma concentrations of quinolone antibiotics are decreased when administered with antacids containing magnesium , calcium , or aluminum .
indinavir	VIDEX	advise	to avoid this interaction , delavirdine or indinavir should be given dg hour prior to dosing with videx .
lansoprazole	ketoconazole	mechanism	therefore , it is theoretically possible that lansoprazole may interfere with the absorption of drugs where gastric ph is an important determinant of bioavailability ( e.g. ketoconazole , ampicillin esters , iron salts , digoxin ) .
lansoprazole	ampicillin	mechanism	therefore , it is theoretically possible that lansoprazole may interfere with the absorption of drugs where gastric ph is an important determinant of bioavailability ( e.g. ketoconazole , ampicillin esters , iron salts , digoxin ) .
lansoprazole	theophylline	mechanism	when lansoprazole was administered concomitantly with theophylline ( cyp1a2 , cyp3a ) , a minor increase ( dg % ) in the clearance of theophylline was seen .
Felbatol	antiepileptic drugs	mechanism	use in conjunction with other antiepileptic drugs : the addition of felbatol to antiepileptic drugs ( aeds ) affects the steady state plasma concentrations of aeds .
Felbatol	AEDs	mechanism	use in conjunction with other antiepileptic drugs : the addition of felbatol to antiepileptic drugs ( aeds ) affects the steady state plasma concentrations of aeds .
Felbatol	phenytoin	mechanism	specific effects of felbatol on other antiepileptic drugs phenytoin : felbatol causes an increase in steady state phenytoin plasma concentrations .
felbamate	phenytoin	mechanism	increasing the felbamate dose to dg mg / day in six of these subjects increased the steady state phenytoin cmin to dg dg micrograms / ml .
Saquinavir	amprenavir	mechanism	saquinavir steady state cmax , a.c. and cmin were increased dg % , decreased dg % , and decreased dg % , respectively , by concomitant amprenavir .
Hydrocodone	gabapentin	mechanism	hydrocodone increases gabapentin auc values by dg % .
ZYVOX	serotonergic agents	advise	if any signs or symptoms occur physicians should consider discontinuation of either one or both agents ( zyvox or concomitant serotonergic agents ) .
Chlorotrianisene	corticosteroids	int	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
Chlorotrianisene	dantrolene	int	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
fluvoxamine	Xanax	advise	nafazodone , fluvoxamine , cimetidine ( consider xanax dose reduction ) .
beta-adrenergic blockers	digoxin	effect	although beta-adrenergic blockers or calcium channel blockers and digoxin may be useful in combination to control atrial fibrillation , their additive effects on av node conduction can result in advanced or complete heart block .
propafenone	digoxin	mechanism	quinidine , verapamil , amiodarone , propafenone , indomethacin , itraconazole , alprazolam , and spironolactone raise the serum digoxin concentration due to a reduction in clearance and / or in volume of distribution of the drug , with the implication that digitalis intoxication may result .
VIDEX	ganciclovir	mechanism	ganciclovir : administration of videx dg hours prior to or concurrent with oral ganciclovir was associated with a dg ( dg ) % increase in the steady state auc of didanosine ( n = dg ) .
felbamate	phenytoin	advise	in order to maintain phenytoin levels , limit adverse experiences , and achieve the felbamate dose of dg mg / day , a phenytoin dose reduction of approximately dg % was necessary for eight of these dg subjects .
carbamazepine	felbamate	mechanism	the carbamazepine steady state cmin decreased dg % to dg dg micrograms / ml when felbamate ( dg mg / day , divided into three doses ) was coadministered .
naproxen sodium	Neurontin	mechanism	naproxen : coadministration ( n=18 ) of naproxen sodium capsules ( dg mg ) with neurontin ( dg mg ) appears to increase the amount of gabapentin absorbed by dg % to dg % .
norethindrone	gabapentin	mechanism	the cmax of norethindrone was dg % higher when it was coadministered with gabapentin ;
magnesium	Ibandronate	mechanism	products containing calcium and other multivalent cations ( such as aluminum , magnesium , iron ) are likely to interfere with absorption of ibandronate .
Aspirin	sulfinpyrazone	effect	uricosuric agents : aspirin may decrease the effects of probenecid , sulfinpyrazone , and phenylbutazone .
Aspirin	phenylbutazone	effect	uricosuric agents : aspirin may decrease the effects of probenecid , sulfinpyrazone , and phenylbutazone .
Aspirin	nonsteroidal anti-inflammatory	advise	nonsteroidal antiinflammatory agents : aspirin is contraindicated in patients who are hypersensitive to nonsteroidal anti-inflammatory agents .
Phenobarbital	aspirin	mechanism	phenobarbital : decreases aspirin effectiveness by enzyme induction .
Propranolol	aspirins	effect	propranolol : may decrease aspirins anti inflammatory action by competing for the same receptors .
Chlorotrianisene	tamoxifen	int	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
Chlorotrianisene	cyclosporine	int	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
methyldopa	sympathomimetics	effect	the antihypertensive effects of methyldopa , mecamylamine , reserpine , and veratrum alkaloids may be reduced by sympathomimetics .
mecamylamine	sympathomimetics	effect	the antihypertensive effects of methyldopa , mecamylamine , reserpine , and veratrum alkaloids may be reduced by sympathomimetics .
Potassium-depleting diuretics	digitalis	effect	potassium-depleting diuretics are a major contributing factor to digitalis toxicity .
verapamil	digoxin	mechanism	quinidine , verapamil , amiodarone , propafenone , indomethacin , itraconazole , alprazolam , and spironolactone raise the serum digoxin concentration due to a reduction in clearance and / or in volume of distribution of the drug , with the implication that digitalis intoxication may result .
Quinidine	digoxin	mechanism	quinidine , verapamil , amiodarone , propafenone , indomethacin , itraconazole , alprazolam , and spironolactone raise the serum digoxin concentration due to a reduction in clearance and / or in volume of distribution of the drug , with the implication that digitalis intoxication may result .
sulfasalazine	digoxin	mechanism	antacids , kaolin pectin , sulfasalazine , neomycin , cholestyramine , certain anticancer drugs , and metoclopramide may interfere with intestinal digoxin absorption , resulting in unexpectedly low serum concentrations .
Barbiturates	quinidine	effect	barbiturates may decrease the effectiveness of oral contraceptives , certain antibiotics , quinidine , theophylline , corticosteroids , anticoagulants , and beta blockers .
ketoconazole	coumarin	effect	when taken orally , imidazole compounds like ketoconazole may enhance the anticoagulant effect of coumarin like drugs .
imidazole drugs	coumarin drugs	advise	in simultaneous treatment with imidazole drugs and coumarin drugs , the anticoagulant effect should be carefully titrated and monitored .
ENABLEX	thioridazine	advise	caution should be taken when enablex is used concomitantly with medications that are predominantly metabolized by cyp2d6 and which have a narrow therapeutic window , such as flecainide , thioridazine and tricyclic antidepressants ( see clinical pharmacology ) .
Codeine	CNS depressants	effect	codeine in combination with other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative hypnotics , or other cns depressants ( including alcohol ) has additive depressant effects .
isosorbide dinitrate	vasodilators	effect	the vasodilating effects of isosorbide dinitrate may be additive with those of other vasodilators .
fexofenadine hydrochloride	aluminum	mechanism	drug interactions with antacids administration of dg mg of fexofenadine hydrochloride ( dg x dg mg capsule ) within dg minutes of an aluminum and magnesium containing antacid ( maalox ) decreased fexofenadine auc by dg % and cmax by dg % .
ALLEGRA	aluminum	advise	allegra should not be taken closely in time with aluminum and magnesium containing antacids .
gemfibrozil	Targretin	advise	concomitant administration of gemfibrozil with targretin capsules is not recommended .
TRACRIUM	enflurane	effect	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
TRACRIUM	antibiotics	effect	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
TRACRIUM	procainamide	effect	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
TRISENOX	antiarrhythmics	advise	caution is advised when trisenox is coadministered with other medications that can prolong the qt interval ( e.g. certain antiarrhythmics or thioridazine ) or lead to electrolyte abnormalities ( such as diuretics or amphotericin b ) .
quinolones	sucralfate	mechanism	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable / buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
quinolones	warfarin	effect	however , because some quinolones have been reported to enhance the effects of warfarin or its derivatives , prothrombin time or other suitable anticoagulation test should be monitored closely if a quinolone antimicrobial is administered with warfarin or its derivatives .
quinolones	antidiabetic agent	effect	antidiabetic agents : disturbances of blood glucose , including hyperglycemia and hypoglycemia , have been reported in patients treated concomitantly with quinolones and an antidiabetic agent .
Grepafloxacin	theophylline	mechanism	theophylline : grepafloxacin is a competitive inhibitor of the metabolism of theophylline .
grepafloxacin	theophylline	mechanism	serum theophylline concentrations increase when grepafloxacin is initiated in a patient maintained on theophylline .
anticholinesterases	procaine hydrochloride	mechanism	anticholinesterases : concurrent use of procaine hydrochloride and anticholinesterase agents may result in increased systemic toxicity since anticholinesterases inhibit the breakdown of procaine hydrochloride .
procaine hydrochloride	CNS depressant medications	effect	cns depressant medications : concurrent use of procaine hydrochloride and cns depressant medications may result in additive depressant effects .
Vindesine	Phenytoin	int	vindesine can interact with the drugs of the following categories : blood dyscrasia : can cause unpredictable myelotoxicity bone marrow depressants : can cause a predictable dose related myelotoxicity radiation therapy : may cause marrow depression neurotoxic medications : can cause neurologic toxicity phenytoin : can increase seizure activity live virus vaccines : may potentiate the replication of the vaccine virus , may increase the side effects of the vaccination , and decrease patient 's response to the vaccine mitomycin c : may cause shortness of breath and bronchospasm killed virus vaccines : may decrease patient 's response to the vaccine
TRISENOX	thioridazine	advise	caution is advised when trisenox is coadministered with other medications that can prolong the qt interval ( e.g. certain antiarrhythmics or thioridazine ) or lead to electrolyte abnormalities ( such as diuretics or amphotericin b ) .
Mineral oil	fat-soluble vitamins	mechanism	mineral oil interferes with the absorption of fat-soluble vitamins , including vitamin d preparations .
ZEBETA	phenylalkylamine	advise	zebeta should be used with care when myocardial depressants or inhibitors of av conduction , such as certain calcium antagonists ( particularly of the phenylalkylamine [ verapamil ] and benzothiazepine [ diltiazem ] classes ) , or antiarrhythmic agents , such as disopyramide , are used concurrently .
ZEBETA	diltiazem	advise	zebeta should be used with care when myocardial depressants or inhibitors of av conduction , such as certain calcium antagonists ( particularly of the phenylalkylamine [ verapamil ] and benzothiazepine [ diltiazem ] classes ) , or antiarrhythmic agents , such as disopyramide , are used concurrently .
isosorbide mononitrate	vasodilators	effect	the vasodilating effects of isosorbide mononitrate may be additive with those of other vasodilators .
SPRYCEL	ritonavir	mechanism	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
proton pump inhibitors	dasatinib	effect	h2 blockers / proton pump inhibitors : long term suppression of gastric acid secretion by h2 blockers or proton pump inhibitors ( eg , famotidine and omeprazole ) is likely to reduce dasatinib exposure .
fentanyl	SPRYCEL	advise	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
MAO inhibitor	escitalopram	advise	wait dg weeks after stopping an mao inhibitor before starting escitalopram .
Vindesine	Mitomycin-C	int	vindesine can interact with the drugs of the following categories : blood dyscrasia : can cause unpredictable myelotoxicity bone marrow depressants : can cause a predictable dose related myelotoxicity radiation therapy : may cause marrow depression neurotoxic medications : can cause neurologic toxicity phenytoin : can increase seizure activity live virus vaccines : may potentiate the replication of the vaccine virus , may increase the side effects of the vaccination , and decrease patient 's response to the vaccine mitomycin-c : may cause shortness of breath and bronchospasm killed virus vaccines : may decrease patient 's response to the vaccine
volatile inhalation anesthetics	ALFENTA	mechanism	limited clinical experience indicates that requirements for volatile inhalation anesthetics are reduced by dg to dg % for the first sixty ( dg ) minutes following alfenta induction the concomitant use of erythromycin with alfenta can significantly inhibit alfenta clearance and may increase the risk of prolonged or delayed respiratory depression .
INDOCIN	diflunisal	effect	in some patients , combined use of indocin and diflunisal has been associated with fatal gastrointestinal hemorrhage .
NSAIDs	cyclosporine	advise	nsaids should be used with caution in patients taking cyclosporine , and renal function should be carefully monitored .
INDOCIN	loop diuretics	effect	in some patients , the administration of indocin can reduce the diuretic , natriuretic , and antihypertensive effects of loop , potassium sparing , and thiazide diuretics .
NSAIDs	methotrexate	mechanism	naproxen , naproxen sodium and other nsaids have been reported to reduce the tubular secretion of methotrexate in an animal model , possibly increasing the toxicity of methotrexate .
naproxen	aspirin	advise	concomitant administration of naproxen and aspirin is not recommended because naproxen is displaced from its binding sites during the concomitant administration of aspirin , resulting in lower plasma concentrations and peak plasma levels .
NSAIDs	beta-blockers	effect	naproxen and other nsaids can reduce the antihypertensive effect of propranolol and other beta-blockers .
chlorpromazine	tricyclic antidepressant	effect	the concurrent use of two or more drugs with anticholinergic activity such as an antipsychotic drug ( eg , chlorpromazine ) , an antiparkinsonian drug ( eg , trihexyphenidyl ) , and / or a tricyclic antidepressant ( eg , amitriptyline ) commonly results in excessive anticholinergic effects , including dry mouth and associated dental complications , blurred vision , and , in patients exposed to high temperature and humidity , hyperpyrexia .
phenytoin	flecainide	mechanism	limited data in patients receiving known enzyme inducers ( phenytoin , phenobarbital , carbamazepine ) indicate only a dg % increase in the rate of flecainide elimination .
leucovorin	fluorouracil	effect	deaths from severe enterocolitis , diarrhea , and dehydration have been reported in elderly patients receiving weekly leucovorin and fluorouracil .
EQUETROTM	alprazolam	mechanism	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( dg ) , oxcarbazepine , phenytoin ( dg ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( dg ) , ziprasidone , and zonisamide .
EQUETROTM	dicumarol	mechanism	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( dg ) , oxcarbazepine , phenytoin ( dg ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( dg ) , ziprasidone , and zonisamide .
EQUETROTM	lorazepam	mechanism	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( dg ) , oxcarbazepine , phenytoin ( dg ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( dg ) , ziprasidone , and zonisamide .
indomethacin	digoxin	mechanism	quinidine , verapamil , amiodarone , propafenone , indomethacin , itraconazole , alprazolam , and spironolactone raise the serum digoxin concentration due to a reduction in clearance and / or in volume of distribution of the drug , with the implication that digitalis intoxication may result .
macrolide antibiotics	digoxin	mechanism	erythromycin and clarithromycin ( and possibly other macrolide antibiotics ) and tetracycline may increase digoxin absorption in patients who inactivate digoxin by bacterial metabolism in the lower intestine , so that digitalis intoxication may result .
tetracycline	digoxin	mechanism	erythromycin and clarithromycin ( and possibly other macrolide antibiotics ) and tetracycline may increase digoxin absorption in patients who inactivate digoxin by bacterial metabolism in the lower intestine , so that digitalis intoxication may result .
Erythromycin	digoxin	mechanism	erythromycin and clarithromycin ( and possibly other macrolide antibiotics ) and tetracycline may increase digoxin absorption in patients who inactivate digoxin by bacterial metabolism in the lower intestine , so that digitalis intoxication may result .
neomycin	digoxin	mechanism	antacids , kaolin pectin , sulfasalazine , neomycin , cholestyramine , certain anticancer drugs , and metoclopramide may interfere with intestinal digoxin absorption , resulting in unexpectedly low serum concentrations .
Thyroid	digoxin	advise	thyroid administration to a digitalized , hypothyroid patient may increase the dose requirement of digoxin .
thiazide diuretics	dihydrotachysterol	effect	administration of thiazide diuretics to hypoparathyroid patients who are concurrently being treated with dihydrotachysterol may cause hypercalcemia .
Lofexidine	anti-hypertensive drug	effect	lofexidine may enhance the effects of anti hypertensive drug therapy
ketoconazole	erlotinib	mechanism	co treatment with the potent cyp3a4 inhibitor ketoconazole increases erlotinib auc by dg / dg .
TARCEVA	clarithromycin	advise	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
escitalopram	non-selective MAO inhibitor	advise	wait dg weeks after stopping escitalopram before starting a non-selective mao inhibitor .
CEFOTAN	aminoglycoside	effect	if cefotan and an aminoglycoside are used concomitantly , renal function should be carefully monitored , because nephrotoxicity may be potentiated .
Etonogestrel	atorvastatin	int	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo dur ) , and vitamin c .
Etonogestrel	Invirase	int	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo dur ) , and vitamin c .
Etonogestrel	tetracycline	int	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo dur ) , and vitamin c .
Etonogestrel	anticonvulsants	int	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo dur ) , and vitamin c .
TARCEVA	indinavir	advise	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
TARCEVA	ritonavir	advise	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
Barbiturates	antibiotics	effect	barbiturates may decrease the effectiveness of oral contraceptives , certain antibiotics , quinidine , theophylline , corticosteroids , anticoagulants , and beta blockers .
Barbiturates	anticoagulants	effect	barbiturates may decrease the effectiveness of oral contraceptives , certain antibiotics , quinidine , theophylline , corticosteroids , anticoagulants , and beta blockers .
Ketoconazole	methylprednisolone	mechanism	ketoconazole tablets may alter the metabolism of cyclosporine , tacrolimus , and methylprednisolone , resulting in elevated plasma concentrations of the latter drugs .
rifampin	ketoconazole	mechanism	concomitant administration of rifampin with ketoconazole tablets reduces the blood levels of the latter .
ENABLEX	flecainide	advise	caution should be taken when enablex is used concomitantly with medications that are predominantly metabolized by cyp2d6 and which have a narrow therapeutic window , such as flecainide , thioridazine and tricyclic antidepressants ( see clinical pharmacology ) .
Diuretic agents	lithium	mechanism	diuretic agents reduce the renal clearance of lithium and add a high risk of lithium toxicity .
Cholestytamine	thiazide diuretics	mechanism	cholestyramine and colestipol resins : cholestytamine and colestipol resins have the potential of binding thiazide diuretics and reducing diuretic absorption from the gastrointestinal tract
NSAIDs	antidiabetic drugs	effect	certain drugs , including nonsteroidal anti inflammatory agents ( nsaids ) , salicylates , monoamine oxidase inhibitors , and non selective beta adrenergic blocking agents may potentiate the hypoglycemic action of starlix and other oral antidiabetic drugs .
MIVACRON	antibiotics	int	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as mivacron include certain antibiotics ( e.g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
nondepolarizing agents	colistin	int	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as mivacron include certain antibiotics ( e.g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
MIVACRON	monoamine oxidase inhibitors	effect	the neuromuscular blocking effect of mivacron may be enhanced by drugs that reduce plasma cholinesterase activity ( e.g. , chronically administered oral contraceptives , glucocorticoids , or certain monoamine oxidase inhibitors ) or by drugs that irreversibly inhibit plasma cholinesterase . resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or carbamazepine .
phenytoin	MIVACRON	effect	while the effects of chronic phenytoin or carbamazepine therapy on the action of mivacron are unknown , slightly shorter durations of neuromuscular block may be anticipated and infusion rate requirements may be higher .
carbamazepine	MIVACRON	effect	while the effects of chronic phenytoin or carbamazepine therapy on the action of mivacron are unknown , slightly shorter durations of neuromuscular block may be anticipated and infusion rate requirements may be higher .
succinylcholine	MIVACRON	advise	evidence of spontaneous recovery from succinylcholine should be observed before the administration of mivacron .
DIFLUCAN	hypoglycemic agents	effect	these are described in greater detail below : oral hypoglycemics , coumarin type anticoagulants , phenytoin , cyclosporine , rifampin , theophylline , terfenadine , cisapride , astemizole , rifabutin , tacrolimus , short acting benzodiazepines , oral hypoglycemics : clinically significant hypoglycemia may be precipitated by the use of diflucan with oral hypoglycemic agents ;
salicylates	Starlix	effect	certain drugs , including nonsteroidal anti inflammatory agents ( nsaids ) , salicylates , monoamine oxidase inhibitors , and non selective beta adrenergic blocking agents may potentiate the hypoglycemic action of starlix and other oral antidiabetic drugs .
salicylates	antidiabetic drugs	effect	certain drugs , including nonsteroidal anti inflammatory agents ( nsaids ) , salicylates , monoamine oxidase inhibitors , and non selective beta adrenergic blocking agents may potentiate the hypoglycemic action of starlix and other oral antidiabetic drugs .
nonsteroidal anti-inflammatory agents	Starlix	effect	certain drugs , including nonsteroidal anti-inflammatory agents ( nsaids ) , salicylates , monoamine oxidase inhibitors , and non selective beta adrenergic blocking agents may potentiate the hypoglycemic action of starlix and other oral antidiabetic drugs .
corticosteroids	antidiabetic drugs	effect	certain drugs including thiazides , corticosteroids , thyroid products , and sympathomimetics may reduce the hypoglycemic action of starlix and other oral antidiabetic drugs .
piperacillin	aminoglycoside	effect	aminoglycosides : the mixing of piperacillin with an aminoglycoside in vitro can result in substantial inactivation of the aminoglycoside .
fexofenadine hydrochloride	magnesium	mechanism	drug interactions with antacids administration of dg mg of fexofenadine hydrochloride ( dg x dg mg capsule ) within dg minutes of an aluminum and magnesium containing antacid ( maalox ) decreased fexofenadine auc by dg % and cmax by dg % .
Targretin	gemfibrozil	mechanism	concomitant administration of targretin capsules and gemfibrozil resulted in substantial increases in plasma concentrations of bexarotene , probably at least partially related to cytochrome p450 dg inhibition by gemfibrozil .
cyclosporine	nicardipine	advise	plasma concentrations of cyclosporine should therefore be closely monitored , and its dosage reduced accordingly , in patients treated with nicardipine .
TRACRIUM	succinylcholine	advise	tracrium should not be administered until a patient has recovered from succinylcholine induced neuromuscular block .
TRACRIUM	halothane	effect	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
succinylcholine	TRACRIUM	effect	the prior administration of succinylcholine does not enhance the duration , but quickens the onset and may increase the depth , of neuromuscular block induced by tracrium .
metoclopramide	levodopa	mechanism	although metoclopramide may increase the bioavailability of levodopa by increasing gastric emptying , metoclopramide may also adversely affect disease control by its dopamine receptor antagonistic properties .
TRISENOX	diuretics	advise	caution is advised when trisenox is coadministered with other medications that can prolong the qt interval ( e.g. certain antiarrhythmics or thioridazine ) or lead to electrolyte abnormalities ( such as diuretics or amphotericin b ) .
ZEBETA	benzothiazepine	advise	zebeta should be used with care when myocardial depressants or inhibitors of av conduction , such as certain calcium antagonists ( particularly of the phenylalkylamine [ verapamil ] and benzothiazepine [ diltiazem ] classes ) , or antiarrhythmic agents , such as disopyramide , are used concurrently .
rifampin	ZEBETA	mechanism	concurrent use of rifampin increases the metabolic clearance of zebeta , resulting in a shortened elimination half life of zebeta .
Amphetamines	antihypertensives	effect	amphetamines may decrease the hypotensive effect of antihypertensives .
SPRYCEL	indinavir	mechanism	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
SPRYCEL	nelfinavir	mechanism	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
antacid	SPRYCEL	advise	if antacid therapy is needed , the antacid dose should be administered at least dg hours prior to or dg hours after the dose of sprycel .
omeprazole	dasatinib	effect	h2 blockers / proton pump inhibitors : long term suppression of gastric acid secretion by h2 blockers or proton pump inhibitors ( eg , famotidine and omeprazole ) is likely to reduce dasatinib exposure .
proton pump inhibitors	SPRYCEL	advise	the concomitant use of h2 blockers or proton pump inhibitors with sprycel is not recommended .
astemizole	SPRYCEL	advise	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
terfenadine	SPRYCEL	advise	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
cyclosporine	SPRYCEL	advise	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
pimozide	SPRYCEL	advise	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
clozapine	fluoxetine	mechanism	however , other published reports describe modest elevations ( less than two fold ) of clozapine and metabolite concentrations when clozapine was taken with paroxetine , fluoxetine , and sertraline .
clozapine	benzodiazepine	advise	although it has not been established that there is an interaction between clozapine and benzodiazepines or other psychotropics , caution is advised when clozapine is initiated in patients taking a benzodiazepine or any other psychotropic drug .
Etonogestrel	Dilantin	int	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo dur ) , and vitamin c .
Anticonvulsants	progestins	mechanism	anticonvulsants ( carbamazepine , felbamate , phenobarbital , phenytoin , topiramate ) : increase the metabolism of ethinyl estradiol and / or some progestins , leading to possible decrease in contraceptive effectiveness .
ascorbic acid	synthetic estrogens	mechanism	ascorbic acid : doses of ascorbic acid ( vitamin c ) dg g / day have been reported to increase plasma concentration of synthetic estrogens by ~47 % , possibly by inhibiting conjugation ;
Atorvastatin	norethindrone	mechanism	atorvastatin : atorvastatin increases the auc for norethindrone and ethinyl estradiol .
hormonal contraceptives	benzodiazepines	mechanism	benzodiazepines : combination hormonal contraceptives may decrease the clearance of some benzodiazepines ( alprazolam , chlordiazepoxide , diazepam ) and increase the clearance of others ( lorazepam , oxazepam , temazepam ) .
Rifampin	norethindrone	mechanism	rifampin : rifampin increases the metabolism of ethinyl estradiol and some progestins ( norethindrone ) resulting in decreased contraceptive effectiveness and increased menstrual irregularities .
Ethinyl estradiol	theophylline	mechanism	theophylline : ethinyl estradiol may inhibit the metabolism of theophylline , leading to increased plasma concentrations .
imipramine	combination hormonal contraceptives	mechanism	tricyclic antidepressants ( amitriptyline , imipramine , nortriptyline ) : metabolism may be inhibited by combination hormonal contraceptives , increasing plasma levels of antidepressant ;
rifampin	corticosteroid	advise	drugs that induce hepatic enzymes such as phenobarbital , phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response .
Etonogestrel	clofibrate	int	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo dur ) , and vitamin c .
Etonogestrel	antibiotics	int	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo dur ) , and vitamin c .
Etonogestrel	Theo-Dur	int	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
Etonogestrel	Phenobarbital	int	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo dur ) , and vitamin c .
carbamazepine	ethinyl estradiol	mechanism	anticonvulsants ( carbamazepine , felbamate , phenobarbital , phenytoin , topiramate ) : increase the metabolism of ethinyl estradiol and / or some progestins , leading to possible decrease in contraceptive effectiveness .
topiramate	progestins	mechanism	anticonvulsants ( carbamazepine , felbamate , phenobarbital , phenytoin , topiramate ) : increase the metabolism of ethinyl estradiol and / or some progestins , leading to possible decrease in contraceptive effectiveness .
hormonal contraceptives	diazepam	mechanism	benzodiazepines : combination hormonal contraceptives may decrease the clearance of some benzodiazepines ( alprazolam , chlordiazepoxide , diazepam ) and increase the clearance of others ( lorazepam , oxazepam , temazepam ) .
lopinavir	combination hormonal contraceptives	mechanism	protease inhibitors : amprenavir , lopinavir , nelfinavir , and ritonavir have been shown to decrease plasma levels of combination hormonal contraceptives ;
Rifampin	progestins	mechanism	rifampin : rifampin increases the metabolism of ethinyl estradiol and some progestins ( norethindrone ) resulting in decreased contraceptive effectiveness and increased menstrual irregularities .
Acitretin	progestin	effect	acitretin : interferes with the contraceptive effect of microdosed progestin containing minipill preparations .
amitriptyline	combination hormonal contraceptives	mechanism	tricyclic antidepressants ( amitriptyline , imipramine , nortriptyline ) : metabolism may be inhibited by combination hormonal contraceptives , increasing plasma levels of antidepressant ;
phenytoin	corticosteroid	advise	drugs that induce hepatic enzymes such as phenobarbital , phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response .
phenylbutazone	heparin sodium	effect	platelet inhibitors : drugs such as acetylsalicylic acid , dextran , phenylbutazone , ibuprofen , indomethacin , dipyridamole , hydroxychloroquine and others that interfere with platelet aggregation reactions ( the main hemostatic defense of heparinized patients ) may induce bleeding and should be used with caution in patients receiving heparin sodium .
DIFLUCAN	terfenadine	mechanism	another study at a dg mg and dg mg daily dose of fluconazole demonstrated that diflucan taken in doses of dg mg per day or greater significantly increases plasma levels of terfenadine when taken concomitantly .
fluconazole	astemizole	mechanism	astemizole : the use of fluconazole in patients concurrently taking astemizole or other drugs metabolized by the cytochrome p450 system may be associated with elevations in serum levels of these drugs .
Fluconazole	levonorgestrel	mechanism	fluconazole tablets coadministered with ethinyl estradiol and levonorgestrel containing oral contraceptives produced an overall mean increase in ethinyl estradiol and levonorgestrel levels ;
DIFLUCAN	glipizide	mechanism	diflucan reduces the metabolism of tolbutamide , glyburide , and glipizide and increases the plasma concentration of these agents .
fluconazole	warfarin	effect	in post marketing experience , as with other azole antifungals , bleeding events ( bruising , epistaxis , gastrointestinal bleeding , hematuria , and melena ) have been reported in association with increases in prothrombin time in patients receiving fluconazole concurrently with warfarin .
Streptase	antiplatelet agents	effect	use of anticoagulants and antiplatelet agents streptase , streptokinase , alone or in combination with antiplatelet agents and anticoagulants , may cause bleeding complications .
methyldopa	lithium	advise	when methyldopa and lithium are given concomitantly the patient should be carefully monitored for symptoms of lithium toxicity .
quinolones	magnesium	mechanism	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable / buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
quinolones	cyclosporine	mechanism	in addition , other quinolones have been reported to decrease the cyp3a4 mediated metabolism of cyclosporine .
ketoconazole	corticosteroids	mechanism	drugs such as troleandomycin and ketoconazole may inhibit the metabolism of corticosteroids and thus decrease their clearance .
Digitalis	heparin sodium	effect	drugs decreasing heparin effect : digitalis , tetracyclines , nicotine , or antihistamines may partially counteract the anticoagulant action of heparin sodium .
calcium antagonists	beta-adrenergic blocking agents	advise	literature reports suggest that oral calcium antagonists may be used in combination with beta-adrenergic blocking agents when heart function is normal , but should be avoided in patients with impaired cardiac function .
Antihistamines	CNS depressants	effect	antihistamines may have additive effects with alcohol and other cns depressants , e.g. , hypnotics , sedatives , tranquilizers , antianxiety agents .
antibiotics	anticholinesterase	advise	these antibiotics should be used in the myasthenic patient only where definitely indicated , and then careful adjustment should be made of adjunctive anticholinesterase dosage .
Nonsteroidal anti-inflammatory agents	lithium	mechanism	lithium : nonsteroidal anti-inflammatory agents have been reported to increase steadystate plasma lithium levels .
bupropion	antidepressants	advise	therefore , co administration of bupropion with drugs that are metabolized by cyp2d6 isoenzyme including certain antidepressants ( e.g. , nortriptyline , imipramine , desipramine , paroxetine , fluoxetine , sertraline ) , antipsychotics ( e.g. , haloperidol , risperidone , thioridazine ) , beta blockers ( e.g. , metoprolol ) , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution and should be initiated at the lower end of the dose range of the concomitant medication .
bupropion	propafenone	advise	therefore , co administration of bupropion with drugs that are metabolized by cyp2d6 isoenzyme including certain antidepressants ( e.g. , nortriptyline , imipramine , desipramine , paroxetine , fluoxetine , sertraline ) , antipsychotics ( e.g. , haloperidol , risperidone , thioridazine ) , beta blockers ( e.g. , metoprolol ) , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution and should be initiated at the lower end of the dose range of the concomitant medication .
ibuprofen	heparin sodium	effect	platelet inhibitors : drugs such as acetylsalicylic acid , dextran , phenylbutazone , ibuprofen , indomethacin , dipyridamole , hydroxychloroquine and others that interfere with platelet aggregation reactions ( the main hemostatic defense of heparinized patients ) may induce bleeding and should be used with caution in patients receiving heparin sodium .
indomethacin	heparin sodium	effect	platelet inhibitors : drugs such as acetylsalicylic acid , dextran , phenylbutazone , ibuprofen , indomethacin , dipyridamole , hydroxychloroquine and others that interfere with platelet aggregation reactions ( the main hemostatic defense of heparinized patients ) may induce bleeding and should be used with caution in patients receiving heparin sodium .
beta-adrenergic blocking agents	calcium antagonist	effect	hypotension , av conduction disturbances , and left ventricular failure have been reported in some patients receiving beta-adrenergic blocking agents when an oral calcium antagonist was added to the treatment regimen .
Antihistamines	alcohol	effect	antihistamines may have additive effects with alcohol and other cns depressants , e.g. , hypnotics , sedatives , tranquilizers , antianxiety agents .
interleukin-1 antagonist	TNF-blocking agent	effect	anakinra : concurrent administration of anakinra ( an interleukin-1 antagonist ) and another tnf-blocking agent has been associated with an increased risk of serious infections , an increased risk of neutropenia and no additional benefit compared to these medicinal products alone .
Clonidine hydrochloride	sedatives	effect	clonidine hydrochloride may enhance the cns depressive effects of alcohol , barbiturates or other sedatives .
Clonidine	sedating drugs	effect	amitriptyline in combination with clonidine enhances the manifestation of corneal lesions in rats epidural injection clonidine may potentiate the cns depressive effect of alcohol , barbiturates or other sedating drugs .
Probenecid	ketoprofen	mechanism	probenecid : probenecid increases both free and bound ketoprofen by reducing the plasma clearance of ketoprofen to about one third , as well as decreasing its protein binding .
ketoprofen	probenecid	advise	therefore , the combination of ketoprofen and probenecid is not recommended .
bupropion	fluoxetine	advise	therefore , co administration of bupropion with drugs that are metabolized by cyp2d6 isoenzyme including certain antidepressants ( e.g. , nortriptyline , imipramine , desipramine , paroxetine , fluoxetine , sertraline ) , antipsychotics ( e.g. , haloperidol , risperidone , thioridazine ) , beta blockers ( e.g. , metoprolol ) , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution and should be initiated at the lower end of the dose range of the concomitant medication .
tetracyclines	magnesium	mechanism	absorption of tetracyclines is impaired by antacids containing aluminum , calcium , or magnesium , and iron containing preparations .
tetracycline	Penthrane	effect	the concurrent use of tetracycline and penthrane ( methoxyflurane ) has been reported to result in fatal renal toxicity .
beta-blocker	reserpine	advise	close observation of the patient is recommended when a beta-blocker is administered to patients receiving catecholamine depleting drugs such as reserpine , because of possible additive effects and the production of hypotension and / or marked bradycardia , which may produce vertigo , syncope , or postural hypotension .
chlorprothixene	opioids	effect	if chlorprothixene is given concomitantly with opioids , the opioid dose should be reduced ( by approx. dg % ) , because chlorprothixene amplifies the therapeutic actions and side effects of opioids massively .
phenytoin	Norpace CR	mechanism	if phenytoin or other hepatic enzyme inducers are taken concurrently with norpace or norpace cr , lower plasma levels of disopyramide may occur .
Noncardioselective beta-blockers	guanfacine	effect	noncardioselective beta-blockers ( nadolol , porpranolol , timolol ) may exacerbate rebound hypertension when guanfacine is withdrawn .
dipyridamole	Activase	effect	in addition to bleeding associated with heparin and vitamin k antagonists , drugs that alter platelet function ( such as acetylsalicylic acid , dipyridamole and abciximab ) may increase the risk of bleeding if administered prior to , during , or after activase therapy .
vitamin K antagonists	Activase	effect	in addition to bleeding associated with heparin and vitamin k antagonists , drugs that alter platelet function ( such as acetylsalicylic acid , dipyridamole and abciximab ) may increase the risk of bleeding if administered prior to , during , or after activase therapy .
Robinul	anticholinergics	effect	the concurrent use of robinul injection with other anticholinergics or medications with anticholinergic activity , such as phenothiazines , antiparkinson drugs , or tricyclic antidepressants , may intensify the antimuscarinic effects and may result in an increase in anticholinergic side effects .
Robinul	tricyclic antidepressants	effect	the concurrent use of robinul injection with other anticholinergics or medications with anticholinergic activity , such as phenothiazines , antiparkinson drugs , or tricyclic antidepressants , may intensify the antimuscarinic effects and may result in an increase in anticholinergic side effects .
FOSCAVIR	pentamidine	advise	because of foscarnets tendency to cause renal impairment , the use of foscavir should be avoided in combination with potentially nephrotoxic drugs such as aminoglycosides , amphotericin b and intravenous pentamidine unless the potential benefits outweigh the risks to the patient .
Cocaine	heroin	effect	cocaine sometimes proves to be fatal when used in combination with heroin .
Tetracycline	penicillin	effect	tetracycline , a bacteriostatic antibiotic , may antagonize the bactercidal effect of penicillin and concurrent use of these drugs should be avoided .
glimepiride	Arthropan	advise	before taking glimepiride , tell your doctor if you are taking any of the following medicines : aspirin or another salicylate such as magnesium / choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto bismol ) ;
erythromycin	ergotamine	effect	ergotamine : concurrent use of erythromycin and ergotamine or dihydroergotamine has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia .
erythromycin	alfentanil	int	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
flurbiprofen	beta-blocker	advise	patients taking both flurbiprofen and a beta-blocker should be monitored to ensure that a satisfactory hypotensive effect is achieved .
aspirin	flurbiprofen	mechanism	aspirin : concurrent administration of aspirin and flurbiprofen resulted in dg % lower serum flurbiprofen concentrations .
Flurbiprofen	propranolol	effect	flurbiprofen pretreatment attenuated the hypotensive effect of a single dose of propranolol but not atenolol .
azithromycin	carbamazepine	mechanism	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim / sulfamethoxazole or zidovudine .
azithromycin	midazolam	mechanism	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim / sulfamethoxazole or zidovudine .
rifampin	efavirenz	mechanism	drugs which induce cyp3a4 activity ( eg , phenobarbital , rifampin , rifabutin ) would be expected to increase the clearance of efavirenz resulting in lowered plasma concentrations .
Bentiromide	chloramphenicol	int	bentiromide may interact with acetaminophen ( e.g. , tylenol ) , chloramphenicol ( e.g. , chloromycetin ) , local anesthetics ( e.g. , benzocaine and lidocaine ) , para aminobenzoic acid ( paba ) containing preparations ( e.g. , sunscreens and some multivitamins ) , procainamide ( e.g. , pronestyl ) , sulfonamides ( sulfa medicines ) , thiazide diuretics ( use of these medicines during the test period will affect the test results ) , and pancreatic supplements ( use of pancreatic supplements may give false test results ) .
atropine sulfate	MAO inhibitors	int	diphenoxylate hcl and atropine sulfate may interact with mao inhibitors in studies with male rats , diphenoxylate hydrochloride was found to inhibit the hepatic microsomal enzyme system at a dose of dg mg / kg / day .
Duloxetine	amitriptyline	advise	therefore , co administration of duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain antidepressants ( tricyclic antidepressants [ tcas ] , such as nortriptyline , amitriptyline , and imipramine ) , phenothiazines and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution .
Duloxetine	propafenone	advise	therefore , co administration of duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain antidepressants ( tricyclic antidepressants [ tcas ] , such as nortriptyline , amitriptyline , and imipramine ) , phenothiazines and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution .
Isoproterenol hydrochloride	epinephrine	advise	isoproterenol hydrochloride injection and epinephrine should not be administered simultaneously because both drugs are direct cardiac stimulants and their combined effects may induce serious arrhythmias .
ISUPREL	anesthetics	advise	isuprel should be used with caution , if at all , when potent inhalational anesthetics such as halothane are employed because of potential to sensitize the myocardium to effects of sympathomimetic amines .
famotidine	cefditoren pivoxil	mechanism	h2 receptor antagonists : co administration of a single dose of intravenously administered famotidine ( dg mg ) reduced the oral absorption of a single dg mg dose of cefditoren pivoxil administered following a meal , as evidenced by a dg % decrease in mean cmax and a dg % decrease in mean auc .
Nabilone	codeine	effect	nabilone has been shown to have an additive cns depressant effect when given with either diazepam , secobarbitone sodium , alcohol or codeine .
HCTZ	dofetilide	mechanism	in patients receiving hctz alone , dofetilide auc increased by dg % and cmax by dg % .
protease inhibitors	TIKOSYN	advise	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
acetaminophen	anesthetics	effect	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative hypnotics , or other cns depressants , causing increased cns depression .
bupropion	nortriptyline	advise	therefore , co administration of bupropion with drugs that are metabolized by cyp2d6 isoenzyme including certain antidepressants ( e.g. , nortriptyline , imipramine , desipramine , paroxetine , fluoxetine , sertraline ) , antipsychotics ( e.g. , haloperidol , risperidone , thioridazine ) , beta blockers ( e.g. , metoprolol ) , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution and should be initiated at the lower end of the dose range of the concomitant medication .
bupropion	sertraline	advise	therefore , co administration of bupropion with drugs that are metabolized by cyp2d6 isoenzyme including certain antidepressants ( e.g. , nortriptyline , imipramine , desipramine , paroxetine , fluoxetine , sertraline ) , antipsychotics ( e.g. , haloperidol , risperidone , thioridazine ) , beta blockers ( e.g. , metoprolol ) , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution and should be initiated at the lower end of the dose range of the concomitant medication .
WELLBUTRIN	levodopa	advise	administration of wellbutrin tablets to patients receiving either levodopa or amantadine concurrently should be undertaken with caution , using small initial doses and small gradual dose increases .
WELLBUTRIN	antipsychotics	advise	drugs that lower seizure threshold : concurrent administration of wellbutrin and agents ( e.g. , antipsychotics , other antidepressants , theophylline , systemic steroids , etc. ) that lower seizure threshold should be undertaken only with extreme caution .
WELLBUTRIN	orphenadrine	int	therefore , the potential exists for a drug interaction between wellbutrin and drugs that affect the cyp2b6 isoenzyme ( e.g. , orphenadrine and cyclophosphamide ) .
bupropion	phenytoin	mechanism	while not systematically studied , certain drugs may induce the metabolism of bupropion ( e.g. , carbamazepine , phenobarbital , phenytoin ) .
Barbiturates	doxycycline	mechanism	barbiturates , carbamazepine , and phenytoin decrease the half life of doxycycline .
chlorprothixene	Ultram	advise	avoid the concomitant use of chlorprothixene and tramadol ( ultram ) .
chlorprothixene	antiparkinsonian agents	advise	exert particular caution in combining chlorprothixene with other anticholinergic drugs ( tricyclic antidepressants and antiparkinsonian agents ) : particularly the elderly may develop delirium , high fever , severe obstipation , even ileus and glaucoma .
Butalbital	narcotic analgesic	effect	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative hypnotics , or other cns depressants , causing increased cns depression .
Potassium-Sparing Diuretics	thiazide diuretics	effect	potassium supplements and potassium-sparing diuretics lotensin can attenuate potassium loss caused by thiazide diuretics .
cinoxacin	nonsteroidal anti-inflammatory agents	advise	physicians are provided this information to increase awareness of the potential for serious interactions when cinoxacin and certain nonsteroidal anti-inflammatory agents are administered concomitantly .
quinolones	iron	mechanism	also , concomitant administration of quinolones with products containing iron , multivitamins containing zinc , or videx ( didanosine ) chewable / buffered tablets or the pediatric powder for oral solution may result in low urine levels .
cyclosporine	diltiazem	advise	if these agents are to be administered concurrently , cyclosporine concentrations should be monitored , especially when diltiazem therapy is initiated , adjusted , or discontinued .
Cholestyramine	digitalis	mechanism	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
cholestyramine	digitalis	mechanism	cholestyramine resin may interfere with the pharmacokinetics of drugs that undergo enterohepatic circulation , the discontinuance of cholestyramine resin could pose a hazard to health if a potentially toxic drug such as digitalis has been filtrated to a maintenance level while the patient was taking cholestyramine resin .
escitalopram	desipramine	mechanism	however , there are limited in vivo data suggesting a modest cyp2d6 inhibitory effect for escitalopram , i.e. , coadministration of escitalopram ( dg mg / day for dg days ) with the tricyclic antidepressant desipramine ( single dose of dg mg ) , a substrate for cyp2d6 , resulted in a dg % increase in cmax and a dg % increase in auc of desipramine .
LEXAPRO	metoprolol	mechanism	metoprolol administration of dg mg / day lexapro for dg days in healthy volunteers resulted in a dg % increase in cmax and dg % increase in auc of the beta adrenergic blocker metoprolol ( given in a single dose of dg mg ) .
psychotropic drugs	NSAID	effect	epidemiological studies of the case control and cohort design that have demonstrated an association between use of psychotropic drugs that interfere with serotonin reuptake and the occurrence of upper gastrointestinal bleeding have also shown that concurrent use of an nsaid or aspirin potentiated the risk of bleeding .
psychotropic drugs	aspirin	effect	epidemiological studies of the case control and cohort design that have demonstrated an association between use of psychotropic drugs that interfere with serotonin reuptake and the occurrence of upper gastrointestinal bleeding have also shown that concurrent use of an nsaid or aspirin potentiated the risk of bleeding .
Angiomax	heparin	effect	in clinical trials in patients undergoing ptca / pci , co administration of angiomax with heparin , warfarin , thrombolytics or glycoprotein iib / iiia inhibitors was associated with increased risks of major bleeding events compared to patients not receiving these concomitant medications .
ZETIA	fibrates	advise	co administration of zetia with fibrates is not recommended until use in patients is studied .
guanethidine	minoxidil	advise	if at all possible guanethidine should be discontinued well before minoxidil is begun .
ASPIRIN	DISALCID	effect	aspirin and other salicylate drugs will be additive to disalcid and may increase plasma concentrations of salicylic acid to toxic levels .
Salicylate	methotrexate	mechanism	salicylate competes with a number of drugs for protein binding sites , notably penicillin , thiopental , thyroxine , triiodothyronine , phenytoin , sulfinpyrazone , naproxen , warfarin , methotrexate , and possibly corticosteroids .
Salicylate	corticosteroids	mechanism	salicylate competes with a number of drugs for protein binding sites , notably penicillin , thiopental , thyroxine , triiodothyronine , phenytoin , sulfinpyrazone , naproxen , warfarin , methotrexate , and possibly corticosteroids .
Sulfamethoxazole	phenytoin	mechanism	sulfamethoxazole may inhibit the hepatic metabolism of phenytoin .
sulfamethoxazole	phenytoin	mechanism	at a dg g dose , sulfamethoxazole produced a slight but significant increase in the half life of phenytoin but did not produce a corresponding decrease in the metabolic clearance rate .
phenobarbital	methylprednisolone	mechanism	drugs that induce hepatic enzymes such as phenobarbital , phenytoin , and rifampin may increase the clearance of methylprednisolone and may require increased in methylprednisolone dose to achieve the desired response .
Methylprednisolone	aspirin	mechanism	methylprednisolone may increase the clearance of chronic high dose aspirin .
ketoconazole	mometasone furoate	mechanism	however , ketoconazole , a potent inhibitor of cytochrome p450 dg , may increase plasma levels of mometasone furoate during concomitant dosing .
anticholinergic drugs	antiarrhythmic agents of class I	effect	the following agents may increase certain actions or side effects of anticholinergic drugs : amantadine , antiarrhythmic agents of class i ( e.g. , quinidine ) , antihistamines , antipsychotic agents ( e.g. , phenothiazines ) , benzodiazepines , mao inhibitors , narcotic analgesics ( e.g. , meperidine ) , nitrates and nitrites , sympathomimetic agents , tricyclic antidepressants , and other drugs having anticholinergic activity .
Non-Steroidal Anti-Inflammatory Drugs	MYKROX	effect	salicylates and other non-steroidal anti-inflammatory drugs : may decrease the antihypertensive effects of mykrox tablets .
Diuretic	tubocurarine	effect	curariform drugs : diuretic induced hypokalemia may enhance neuromuscular blocking effects of curariform drugs ( such as tubocurarine ) the most serious effect would be respiratory depression which could proceed to apnea .
ERGOMAR	triacetyloleandomycin	mechanism	the effects of ergomar may be potentiated by triacetyloleandomycin which inhibits the metabolism of ergotamine .
antacid	ranitidine	mechanism	coadministration with a high dose of antacid ( dg meq ) results in a dg % decrease in plasma concentrations of ranitidine and may decrease plasma concentrations of bismuth from tritec .
dobutamine	sodium bicarbonate	int	norepinephrine and dobutamine are incompatible with sodium bicarbonate solution .
cholinesterase inhibitors	neuromuscular blocking agents	effect	use with cholinomimetics and other cholinesterase inhibitors : a synergistic effect may be expected when cholinesterase inhibitors are given concurrently with succinylcholine , similar neuromuscular blocking agents or cholinergic agonists such as bethanechol .
cholinesterase inhibitors	bethanechol	effect	use with cholinomimetics and other cholinesterase inhibitors : a synergistic effect may be expected when cholinesterase inhibitors are given concurrently with succinylcholine , similar neuromuscular blocking agents or cholinergic agonists such as bethanechol .
NSAIDs	thiazide diuretics	effect	furosemide : clinical studies , as well as post marketing observations , have shown that nsaids can reduce the natriuretic effect of furosemide and thiazide diuretics in some patients .
lithium	MOBIC	advise	patients on lithium treatment should be closely monitored when mobic is introduced or withdrawn .
meloxicam	aspirin	advise	however , as with other nsaids , concomitant administration of meloxicam and aspirin is not generally recommended because of the potential for increased adverse effects .
GH	antipyrine	mechanism	limited published data indicate that gh treatment increases cytochrome p450 ( cp450 ) mediated antipyrine clearance in man .
GH	cyclosporin	mechanism	these data suggest that gh administration may alter the clearance of compounds known to be metabolized by cp450 liver enzymes ( e.g. , corticosteroids , sex steroids , anticonvulsants , cyclosporin ) .
nondepolarizing agents	antibiotics	effect	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
nondepolarizing agents	clindamycin	effect	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
disopyramide phosphate	erythromycin	mechanism	patients taking disopyramide phosphate and erythromycin concomitantly may develop increased serum concentrations of disopyramide resulting in excessive widening of the qrs complex and / or prolongation of the q t interval .
ABILIFY	centrally acting drugs	advise	drug drug interactions given the primary cns effects of aripiprazole , caution should be used when abilify is taken in combination with other centrally acting drugs and alcohol .
carbamazepine	aripiprazole	advise	when carbamazepine is withdrawn from the combination therapy , aripiprazole dose should then be reduced .
carbamazepine	aripiprazole	mechanism	agents that induce cyp3a4 ( eg , carbamazepine ) could cause an increase in aripiprazole clearance and lower blood levels .
ketoconazole	aripiprazole	mechanism	inhibitors of cyp3a4 ( eg , ketoconazole ) or cyp2d6 ( eg , quinidine , fluoxetine , or paroxetine ) can inhibit aripiprazole elimination and cause increased blood levels .
Robinul	phenothiazines	effect	the concurrent use of robinul injection with other anticholinergics or medications with anticholinergic activity , such as phenothiazines , antiparkinson drugs , or tricyclic antidepressants , may intensify the antimuscarinic effects and may result in an increase in anticholinergic side effects .
Robinul	antiparkinson drugs	effect	the concurrent use of robinul injection with other anticholinergics or medications with anticholinergic activity , such as phenothiazines , antiparkinson drugs , or tricyclic antidepressants , may intensify the antimuscarinic effects and may result in an increase in anticholinergic side effects .
Robinul	potassium chloride	mechanism	concomitant administration of robinul injection and potassium chloride in a wax matrix may increase the severity of potassium chloride induced gastrointestinal lesions as a result of a slower gastrointestinal transit time .
Sensipar	ketoconazole	advise	dose adjustment of sensipar may be required and pth and serum calcium concentrations should be closely monitored if a patient initiates or discontinues therapy with a strong cyp3a4 inhibitor ( e.g. , ketoconazole , erythromycin , itraconazole ;
Sensipar	erythromycin	advise	dose adjustment of sensipar may be required and pth and serum calcium concentrations should be closely monitored if a patient initiates or discontinues therapy with a strong cyp3a4 inhibitor ( e.g. , ketoconazole , erythromycin , itraconazole ;
heroin	diazepam	effect	toxicology studies of heroin related deaths reveal frequent involvement of other central nervous system depressants , including alcohol , benzodiazepines such as diazepam ( valium ) , and , to a rising degree , methadone .
didanosine	lomefloxacin	mechanism	antacids and sucralfate : sucralfate and antacids containing magnesium or aluminum , as well as formulations containing divalent and trivalent cations such as videx ( didanosine ) , chewable / buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability .
aluminum	lomefloxacin	mechanism	magnesium and aluminum containing antacids , administered concomitantly with lomefloxacin , significantly decreased the bioavailability ( dg % ) of lomefloxacin .
glimepiride	choline salicylate	advise	before taking glimepiride , tell your doctor if you are taking any of the following medicines : aspirin or another salicylate such as magnesium / choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto bismol ) ;
dirithromycin	H 2 -receptor antagonists	mechanism	antacids or h dg receptor antagonists : when dirithromycin is administered immediately following antacids or h 2 -receptor antagonists , the absorption of dirithromycin is slightly enhanced .
erythromycin	hexobarbital	int	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
erythromycin	phenytoin	int	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
nondepolarizing agents	sodium colistemethate	effect	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
enflurane	NIMBEX	effect	isoflurane or enflurane administered with nitrous oxide / oxygen to achieve dg mac [ minimum alveolar concentration ] may prolong the clinically effective duration of action of initial and maintenance doses of nimbex and decrease the required infusion rate of nimbex .
alcohol	methyprylon	effect	concurrent use of alcohol and other cns depression producing drugs may increase the cns depressant effects of methyprylon or these other medications .
desglymidodrine	metformin	mechanism	proamatine. alpha adrenergic blocking agents , such as prazosin , terazosin , and doxazosin , can antagonize the effects of proamatine. potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of desglymidodrine ( a base ) is due to active tubular secretion by the base secreting system also responsible for the secretion of such drugs as metformin , cimetidine , ranitidine , procainamide , triamterene , flecainide , and quinidine .
desglymidodrine	procainamide	mechanism	proamatine. alpha adrenergic blocking agents , such as prazosin , terazosin , and doxazosin , can antagonize the effects of proamatine. potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of desglymidodrine ( a base ) is due to active tubular secretion by the base secreting system also responsible for the secretion of such drugs as metformin , cimetidine , ranitidine , procainamide , triamterene , flecainide , and quinidine .
Thalidomide	barbiturates	effect	thalidomide has been reported to enhance the sedative activity of barbiturates , alcohol , chlorpromazine , and reserpine .
beta adrenergic blockers	pseudoephedrine	effect	mao inhibitors and beta adrenergic blockers increase the effects of pseudoephedrine .
TOLECTIN	methotrexate	advise	caution should be used if tolectin is administered concomitantly with methotrexate .
Grepafloxacin	theobromine	mechanism	caffeine theobromine grepafloxacin , like other quinolones , may inhibit the metabolism of caffeine and theobromine .
quinolones	theobromine	mechanism	caffeine theobromine grepafloxacin , like other quinolones , may inhibit the metabolism of caffeine and theobromine .
theophylline	grepafloxacin	advise	when initiating a multi day course of grepafloxacin in a patient maintained on theophylline , the theophylline maintenance dose should be halved for the period of concurrent use of grepafloxacin and monitoring of serum theophylline concentrations should be initiated as a guide to further dosage adjustments .
Vindesine	Live virus vaccines	int	vindesine can interact with the drugs of the following categories : blood dyscrasia : can cause unpredictable myelotoxicity bone marrow depressants : can cause a predictable dose related myelotoxicity radiation therapy : may cause marrow depression neurotoxic medications : can cause neurologic toxicity phenytoin : can increase seizure activity live virus vaccines : may potentiate the replication of the vaccine virus , may increase the side effects of the vaccination , and decrease patient 's response to the vaccine mitomycin c : may cause shortness of breath and bronchospasm killed virus vaccines : may decrease patient 's response to the vaccine
oxybutynin	anticholinergic drugs	effect	the concomitant use of oxybutynin with other anticholinergic drugs or with other agents which produce dry mouth , constipation , somnolence ( drowsiness ) , and / or other anticholinergic like effects may increase the frequency and / or severity of such effects .
itraconazole	oxybutynin	mechanism	other inhibitors of the cytochrome p450 dg enzyme system , such as antimycotic agents ( e.g. , itraconazole and miconazole ) or macrolide antibiotics ( e.g. , erythromycin and clarithromycin ) , may alter oxybutynin mean pharmacokinetic parameters ( i.e. , cmax and auc ) .
miconazole	oxybutynin	mechanism	other inhibitors of the cytochrome p450 dg enzyme system , such as antimycotic agents ( e.g. , itraconazole and miconazole ) or macrolide antibiotics ( e.g. , erythromycin and clarithromycin ) , may alter oxybutynin mean pharmacokinetic parameters ( i.e. , cmax and auc ) .
lymecycline	iron	mechanism	the absorption of lymecycline may be affected by the simultaneous administration of indigestion remedies , iron or zinc supplements .
contraceptives	lymecycline	effect	oral contraceptives may be less effective while you are taking lymecycline .
ALFENTA	barbiturates	effect	both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when alfenta is administered in combination with other cns depressants such as barbiturates , tranquilizers , opioids , or inhalation general anesthetics .
beta-adrenoceptor blocking agents	non-steroidal antiinflammatory drugs	effect	blunting of the antihypertensive effect of beta-adrenoceptor blocking agents by non-steroidal antiinflammatory drugs including indocin has been reported .
Naproxen	methotrexate	mechanism	naproxen , naproxen sodium and other nsaids have been reported to reduce the tubular secretion of methotrexate in an animal model , possibly increasing the toxicity of methotrexate .
Naproxen	beta-blockers	effect	naproxen and other nsaids can reduce the antihypertensive effect of propranolol and other beta-blockers .
antiparkinsonian drug	tricyclic antidepressant	effect	the concurrent use of two or more drugs with anticholinergic activity such as an antipsychotic drug ( eg , chlorpromazine ) , an antiparkinsonian drug ( eg , trihexyphenidyl ) , and / or a tricyclic antidepressant ( eg , amitriptyline ) commonly results in excessive anticholinergic effects , including dry mouth and associated dental complications , blurred vision , and , in patients exposed to high temperature and humidity , hyperpyrexia .
antipsychotic drug	trihexyphenidyl	effect	the concurrent use of two or more drugs with anticholinergic activity such as an antipsychotic drug ( eg , chlorpromazine ) , an antiparkinsonian drug ( eg , trihexyphenidyl ) , and / or a tricyclic antidepressant ( eg , amitriptyline ) commonly results in excessive anticholinergic effects , including dry mouth and associated dental complications , blurred vision , and , in patients exposed to high temperature and humidity , hyperpyrexia .
phenobarbital	flecainide	mechanism	limited data in patients receiving known enzyme inducers ( phenytoin , phenobarbital , carbamazepine ) indicate only a dg % increase in the rate of flecainide elimination .
carbamazepine	flecainide	mechanism	limited data in patients receiving known enzyme inducers ( phenytoin , phenobarbital , carbamazepine ) indicate only a dg % increase in the rate of flecainide elimination .
capecitabine	phenprocoumon	effect	coumarin anticoagulants altered coagulation parameters and / or bleeding have been reported in patients taking capecitabine concomitantly with coumarin derivative anticoagulants such as warfarin and phenprocoumon .
coumarin-derivative anticoagulants	capecitabine	advise	patients taking coumarin-derivative anticoagulants concomitantly with capecitabine should be monitored regularly for alterations in their coagulation parameters ( pt or inr ) .
Azlocillin	ciprofloxacin	advise	azlocillin should not be administered concomitantly with amikacin , ciprofloxacin , gentamicin , netilmicin , or tobramycin .
Azlocillin	gentamicin	advise	azlocillin should not be administered concomitantly with amikacin , ciprofloxacin , gentamicin , netilmicin , or tobramycin .
EQUETROTM	diazepam	mechanism	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( dg ) , oxcarbazepine , phenytoin ( dg ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( dg ) , ziprasidone , and zonisamide .
EQUETROTM	amitriptyline	mechanism	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( dg ) , oxcarbazepine , phenytoin ( dg ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( dg ) , ziprasidone , and zonisamide .
EQUETROTM	methadone	mechanism	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( dg ) , oxcarbazepine , phenytoin ( dg ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( dg ) , ziprasidone , and zonisamide .
EQUETROTM	nortriptyline	mechanism	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( dg ) , oxcarbazepine , phenytoin ( dg ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( dg ) , ziprasidone , and zonisamide .
EQUETROTM	contraceptives	mechanism	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( dg ) , oxcarbazepine , phenytoin ( dg ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( dg ) , ziprasidone , and zonisamide .
EQUETROTM	bupropion	mechanism	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( dg ) , oxcarbazepine , phenytoin ( dg ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( dg ) , ziprasidone , and zonisamide .
EQUETROTM	Phenytoin	mechanism	agents with increased levels in the presence of carbamazepine : equetrotm increases the plasma levels of the following agents : clomipramine hcl , phenytoin ( dg ) , and primidone thus , if a patient has been titrated to a stable dosage on one of the agents in this category , and then begins a course of the treatment with equetrotm , it is reasonable to expect that a dose decrease for the concomitant agent may be necessary .
carbamazepine	lithium	effect	pharmacological / pharmacodynamic interactions with carbamazepine concomitant administration of carbamazepine and lithium may increase the risk of neurotoxic side effects .
chloroquine	carbamazepine	effect	additionally , anti malarial drugs , such as chloroquine and mefloquine , may antagonize the activity of carbamazepine .
EQUETROTM	centrally acting drugs	advise	because of its primary cns effect , caution should be used when equetrotm is taken with other centrally acting drugs and alcohol .
EQUETROTM	azole antifungals	mechanism	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( dg ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( dg ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( dg ) , verapamil , zileuton .
EQUETROTM	fluvoxamine	mechanism	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( dg ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( dg ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( dg ) , verapamil , zileuton .
EQUETROTM	ketoconazole	mechanism	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( dg ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( dg ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( dg ) , verapamil , zileuton .
methadone	ZIAGEN	mechanism	in a study of dg hiv infected patients receiving methadone maintenance therapy ( dg mg and dg mg daily ) with dg mg of ziagen twice daily ( twice the currently recommended dose ) , oral methadone clearance increased dg % ( dg % ci dg % to dg % ) .
Triprolidine	tranquillisers	effect	triprolidine may enhance the sedative effects of central nervous system depressants including alcohol , barbiturates , hypnotics , narcotic analgesics , sedatives , and tranquillisers .
tricyclic antidepressants	ELDEPRYL	effect	severe toxicity has also been reported in patients receiving the combination of tricyclic antidepressants and eldepryl and selective serotonin reuptake inhibitors and eldepryl .
selegiline	sympathomimetic medication	effect	one case of hypertensive crisis has been reported in a patient taking the recommended doses of selegiline and a sympathomimetic medication ( ephedrine ) .
atropine	pralidoxime	effect	when atropine and pralidoxime are used together , the signs of atropinization ( flushing , mydriasis , tachycardia , dryness of the mouth and nose ) may occur earlier than might be expected when atropine is used alone .
TOBI	ethacrynic acid	advise	tobi should not be administered concomitantly with ethacrynic acid , furosemide , urea , or mannitol .
DIPRIVAN	narcotics	effect	the induction dose requirements of diprivan injectable emulsion may be reduced in patients with intramuscular or intravenous premedication , particularly with narcotics ( eg , morphine , meperidine , and fentanyl , etc . )
DIPRIVAN	nitrous oxide	advise	during maintenance of anesthesia or sedation , the rate of diprivan injectable emulsion administration should be adjusted according to the desired level of anesthesia or sedation and may be reduced in the presence of supplemental analgesic agents ( eg , nitrous oxide or opioids ) .
Mexitil	theophylline	advise	this increase was observed at the first test point which was the second day after starting mexitil . theophylline plasma levels returned to pre mexitil values within dg hours after discontinuing mexitil . if mexitil and theophylline are to be used concurrently , theophylline blood levels should be monitored , particularly when the mexitil dose is changed .
EQUETROTM	nefazodone	mechanism	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( dg ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( dg ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( dg ) , verapamil , zileuton .
EQUETROTM	danazol	mechanism	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( dg ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( dg ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( dg ) , verapamil , zileuton .
EQUETROTM	rifampin	mechanism	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( dg ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
CRIXIVAN	indinavir	effect	crixivan may not be effective due to decreased indinavir concentrations in patients taking these agents concomitantly .
phenytoin	calcitriol	mechanism	phenytoin / phenobarbital : the coadministration of phenytoin or phenobarbital will not affect plasma concentrations of vitamin d , but may reduce endogenous plasma levels of calcitriol / ergocalcitriol by accelerating metabolism .
estradiol	noradrenaline	effect	aortic rings with intact endothelium from the high dose ( dg mg / kg / day ) estradiol group were supersensitive to noradrenaline compared to the vehicle or low dose ( dg microg / kg / day ) estradiol groups ( pd2 values = 7.86+ / dg , 7.30+ / dg and 7.35+ / dg , respectively ) .
methaqualone	anticoagulant agents	int	chloral hydrate and methaqualone interact pharmacologically with orally administered anticoagulant agents , but the effect is not clinically significant .
ibogaine	morphine	effect	both ibogaine and dg mc block morphine induced and nicotine induced dopamine release in the nucleus accumbens ;
ibogaine	nicotine	effect	both ibogaine and dg mc block morphine induced and nicotine induced dopamine release in the nucleus accumbens ;
acetaminophen	theophylline	effect	coingestion of acetaminophen with theophylline , phenobarbital with acetaminophen , and valproic acid with phenobarbital at high to toxic concentrations decreases the binding of the target drug .
retinyl acetate	insulin	effect	dexamethasone and retinyl acetate similarly inhibit and stimulate egf or insulin induced proliferation of prostatic epithelium .
dexamethasone	insulin	effect	although neither dexamethasone nor retinyl acetate affected the proliferation of prostatic epithelium in rpmi1640 containing transferrin alone , they modify the mitogenic effect of egf and insulin .
dexamethasone	EGF	effect	higher concentrations of dexamethasone ( dg ( dg ) dg ( dg ) m ) or retinyl acetate ( dg x dg ( dg ) dg ( dg ) m ) enhance the mitogenic activity of egf .
thiosulfate	cisplatin	mechanism	this study demonstrates that concurrent administration of thiosulfate permits at least a twofold increase in dose and total exposure to cisplatin .
neurotensin	tuftsin	effect	interaction on the antinociceptive effect between neurotensin and enkephalins or tuftsin .
neurotensin	enkephalins	effect	it was shown that neurotensin antagonized evidently the antinociceptive effect of enkephalins and their analogue .
perchlorate	pertechnetate	mechanism	an intravenous injection of perchlorate given later also produces a complete and immediately beginning depletion of pertechnetate already accumulated in the thyroid , within a period of dg min after 99m tco dg injection with a corresponding increase in blood levels .
GSLS	inactivated AI vaccines	effect	in experiment dg , the same regimen of gsls was administered to chickens inoculated with inactivated ai vaccines , and an enhanced serum antibody response to ai vaccination was also observed .
Lapatinib	herceptin	effect	lapatinib enhances herceptin mediated antibody dependent cellular cytotoxicity by up regulation of cell surface her2 expression .
Herceptin	lapatinib	effect	furthermore , we present a case report in which a second herceptin treatment following lapatinib resulted in the marked shrinkage of multiple metastatic tumors in her2 positive breast cancer .
Calcium	heme iron	mechanism	calcium is the only known component in the diet that may affect absorption of both nonheme and heme iron .
DZNep	ABT-737	effect	we also found that bcl dg was overexpressed in dznep insensitive cells , and cotreatment with dznep and abt-737 , a bcl dg family inhibitor , synergistically inhibited growth and induced apoptosis of dznep insensitive mm cells .
ketamine	propofol	effect	based on this experience , we suggest that low dose ketamine added to propofol may be associated with prevention of ea in children with a history of ea with propofol tiva .
methylglyoxal	carbenicillin	effect	synergism was also noted when methylglyoxal was combined with carbenicillin and amikacin .
tamoxifen	paroxetine	advise	it is better to avoid prescribing isoenzyme cyp dg inhibitors to women treated with tamoxifen for breast cancer , especially ssri antidepressants such as paroxetine and fluoxetine .
midazolam	cyclosporine	mechanism	systemic and apparent oral midazolam clearance were dg % ( dg dg vs. dg dg ml / min , p = dg ) and dg % ( dg dg vs. dg dg ml / min , p = dg ) , respectively , lower in cyclosporine treated patients ( n = dg ) than in matched tacrolimus treated patients ( n = dg ) .
S-ketamine	ticlopidine	advise	the findings suggest that the dosage of s-ketamine should be reduced in patients receiving ticlopidine .
Warfarin	paroxetine	effect	warfarin users who initiated citalopram , fluoxetine , paroxetine , amitriptyline , or mirtazapine had an increased risk of hospitalization for gastrointestinal bleeding .
terfenadine	dirithromycin	effect	the mean qt c interval ( msec ) was dg with terfenadine alone and dg with terfenadine plus dirithromycin .
phenytoin	fludrocortisone acetate	mechanism	barbiturates , phenytoin , or rifampin increased metabolic clearance of fludrocortisone acetate because of the induction of hepatic enzymes .
rifampin	fludrocortisone acetate	mechanism	barbiturates , phenytoin , or rifampin increased metabolic clearance of fludrocortisone acetate because of the induction of hepatic enzymes .
L-methionine	methotrexate	effect	acetaminophen and methotrexate l-methionine may decrease hepatic toxicity in those with acetaminophen overdosage or in those taking methotrexate .
flurbiprofen	furosemide	effect	diuretics : studies in normal volunteers have shown that flurbiprofen like other nonsteroidal anti inflammatory drugs , can interfere with the effects of furosemide .
macrolides	warfarin	effect	concurrent use of macrolides and warfarin in clinical practice has been associated with increased anticoagulant effects .
azithromycin	atorvastatin	mechanism	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim / sulfamethoxazole or zidovudine .
azithromycin	sulfamethoxazole	mechanism	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim / sulfamethoxazole or zidovudine .
azithromycin	didanosine	mechanism	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim / sulfamethoxazole or zidovudine .
anticonvulsants	Mephenytoin	int	some anticonvulsants may interact with mephenytoin .
Mephenytoin	theophylline	effect	mephenytoin may also affect the effects of other drugs , which include some steroid medications , warfarin , certain heart medicines , birth control pills , anti infective medicines , furosemide and theophylline please note that mephenytoin may interact with other drugs that are not listed here .
morphine	alcohol	effect	use with other central nervous system depressants : the depressant effects of morphine are potentiated by the presence of other cns depressants such as alcohol , sedatives , antihistaminics , or psychotropic drugs .
morphine	antihistaminics	effect	use with other central nervous system depressants : the depressant effects of morphine are potentiated by the presence of other cns depressants such as alcohol , sedatives , antihistaminics , or psychotropic drugs .
Ritalin	guanethidine	effect	ritalin may decrease the hypotensive effect of guanethidine .
SUTENT	rifampin	mechanism	co administration of sutent with inducers of the cyp3a4 family ( e.g. , dexamethasone , phenytoin , carbamazepine , rifampin , rifabutin , rifapentin , phenobarbital , st. johns wort ) may decrease sunitinib concentrations .
anticoagulant	adrenocortical steroids	effect	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under dosage .
anticoagulant	griseofulvin	effect	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under dosage .
anticoagulant	chlordiazepoxide	effect	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under dosage .
Chloral hydrate	anticoagulant	mechanism	chloral hydrate may cause an increased prothrombin response by displacing the anticoagulant from protein binding sites or a diminished prothrombin response through increased metabolism of the unbound drug by hepatic enzyme induction , thus leading to inter patient variation in ultimate prothrombin effect .
anticoagulant	clofibrate	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
anticoagulant	glucagon	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
anticoagulant	phenyramidol	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
anticoagulant	thyroid drugs	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
anticoagulant	bromelains	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
aspirin	anticoagulants	effect	drugs that reduce the number of blood platelets by causing bone marrow depression ( such as antineoplastic agents ) or drugs which inhibit platelet function ( eg , aspirin and other non steroidal anti inflammatory drugs , dipyridamole , hydrochloroquine , clofibrate , dextran ) may increase the bleeding tendency produced by anticoagulants without altering prothrombin time determinations .
hydrochloroquine	anticoagulants	effect	drugs that reduce the number of blood platelets by causing bone marrow depression ( such as antineoplastic agents ) or drugs which inhibit platelet function ( eg , aspirin and other non steroidal anti inflammatory drugs , dipyridamole , hydrochloroquine , clofibrate , dextran ) may increase the bleeding tendency produced by anticoagulants without altering prothrombin time determinations .
potassium-sparing diuretics	ACE inhibitors	effect	use of potassium-sparing diuretics ( spironolactone , triamterene , amiloride ) or potassium supplements concomitantly with ace inhibitors can increase the risk of hyperkalemia .
ACE inhibitors	lithium	effect	lithium : increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ace inhibitors during therapy with lithium .
Melatonin	fluoxetine	int	melatonin may interact with the following drugs : aspirin and other nsaids ( may lower melatonin levels ) , fluvoxamine ( bioavailability of oral melatonin is increased with coadministration ) , beta blockers ( may decrease melatonin levels ) , fluoxetine ( reports of psychotic episodes when coadministered ) , progestin ( coadministration of melatonin with progestin can inhibit ovarian function in women ) , benzodiazepenes and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects ) , and corticosteroids ( coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids ) .
Cholestyramine	EVISTA	advise	cholestyramine : cholestyramine causes a dg % reduction in the absorption and enterohepatic cycling of raloxifene and should not be coadministered with evista .
neuroleptics	Permax	advise	dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthines ) or metoclopramide , ordinarily should not be administered concurrently with permax ( a dopamine agonist ) ;
phenothiazines	Permax	advise	dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthines ) or metoclopramide , ordinarily should not be administered concurrently with permax ( a dopamine agonist ) ;
metoclopramide	acetaminophen	mechanism	absorption of drugs from the stomach may be diminished ( e.g. , digoxin ) by metoclopramide , whereas the rate and / or extent of absorption of drugs from the small bowel may be increased ( e.g. , acetaminophen , tetracycline , levodopa , ethanol , cyclosporine ) .
rifampin	corticosteroids	mechanism	drugs that induce hepatic enzymes such as phenobarbital , phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response .
Methscopolamine	antacids	int	methscopolamine may interact with antidepressants ( tricyclic type ) , mao inhibitors ( e.g. , phenelzine , linezolid , tranylcypromine , isocarboxazid , selegiline , furazolidone ) , quinidine , amantadine , antihistamines ( e.g. , diphenhydramine ) , other anticholinergics , potassium chloride supplements , antacids , absorbent type anti diarrhea medicines ( e.g. , kaolin pectin ) , phenothiazines ( e.g. , chlorpromazine , promethazine ) .
Methscopolamine	kaolin	int	methscopolamine may interact with antidepressants ( tricyclic type ) , mao inhibitors ( e.g. , phenelzine , linezolid , tranylcypromine , isocarboxazid , selegiline , furazolidone ) , quinidine , amantadine , antihistamines ( e.g. , diphenhydramine ) , other anticholinergics , potassium chloride supplements , antacids , absorbent type anti diarrhea medicines ( e.g. , kaolin pectin ) , phenothiazines ( e.g. , chlorpromazine , promethazine ) .
Methscopolamine	furazolidone	int	methscopolamine may interact with antidepressants ( tricyclic type ) , mao inhibitors ( e.g. , phenelzine , linezolid , tranylcypromine , isocarboxazid , selegiline , furazolidone ) , quinidine , amantadine , antihistamines ( e.g. , diphenhydramine ) , other anticholinergics , potassium chloride supplements , antacids , absorbent type anti diarrhea medicines ( e.g. , kaolin pectin ) , phenothiazines ( e.g. , chlorpromazine , promethazine ) .
Nonsteroidal anti-inflammatory agents	lithium	mechanism	plasma levels of piroxicam are depressed to approximately dg % of their normal values when feldene is administered in conjunction with aspirin ( dg mg / day ) , but concomitant administration of antacids has no effect on piroxicam plasma levels . nonsteroidal anti-inflammatory agents , including feldene , have been reported to increase steady state plasma lithium levels .
simvastatin	clarithromycin	effect	rhabdomyolysis secondary to a drug interaction between simvastatin and clarithromycin .
probenecid	cloxacillin	mechanism	this might be explained by a blockade by probenecid of the elimination of cloxacillin by the liver .
naloxone	(-)-NANM	effect	the doses of naloxone required to antagonize the effects of (-)-nanm were more than dg times higher than those required to antagonize the effects of morphine .
cobalt	iron	mechanism	interactions of cobalt and iron in absorption and retention .
iron	cobalt	mechanism	additional iron significantly inhibited the absorption of cobalt in both dietary cobalt treatments .
tripelennamine	pentazocine	effect	dose response curves ( derived from the results of using the tablets as well as pure powders ) showed that tripelennamine was responsible for the inhibitory activity , which was partially antagonized by pentazocine .
TAM	1,25(OH)2D3	effect	our data suggest that tam significantly potentiates the reduction in cell number induced by 1,25(oh)2d3 alone .
1,25(OH)2D3	TAM	effect	combined treatment with 1,25(oh)2d3 and tam enhances the degree of apoptosis assessed using morphological markers that identify chromatin and nuclear matrix protein condensation .
acetaminophen	caffeine	effect	careful observations on hepatotoxicity are suggested when acetaminophen is prescribed with caffeine .
Cytochalasin D	carbachol	effect	cytochalasin d at dg microm preferentially blocked the secretory effect of carbachol and its synergism with camp , whereas it had no effect on histamine or camp stimulated acid secretion within dg min .
naloxone	morphine	effect	on the other hand , intrathecal naloxone ( dg dg micrograms ) had only a very weak effect on the tail flick inhibition induced by intraventricular morphine ( dg micrograms ) .
Indinavir	didanosine	advise	indinavir may be taken with a light meal dg h following the administration of dg mg of didanosine .
azithromycin	sildenafil	mechanism	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim / sulfamethoxazole or zidovudine .
indinavir	SUSTIVA	mechanism	increasing the indinavir dose to dg mg every dg hours does not compensate for the increased indinavir metabolism due to sustiva .
phenobarbital	efavirenz	mechanism	drugs which induce cyp3a4 activity ( eg , phenobarbital , rifampin , rifabutin ) would be expected to increase the clearance of efavirenz resulting in lowered plasma concentrations .
SUSTIVA	ritonavir	advise	monitoring of liver enzymes is recommended when sustiva is used in combination with ritonavir .
anticonvulsant	efavirenz	mechanism	potential for reduction in anticonvulsant and / or efavirenz plasma levels ;
Bentiromide	procainamide	int	bentiromide may interact with acetaminophen ( e.g. , tylenol ) , chloramphenicol ( e.g. , chloromycetin ) , local anesthetics ( e.g. , benzocaine and lidocaine ) , para aminobenzoic acid ( paba ) containing preparations ( e.g. , sunscreens and some multivitamins ) , procainamide ( e.g. , pronestyl ) , sulfonamides ( sulfa medicines ) , thiazide diuretics ( use of these medicines during the test period will affect the test results ) , and pancreatic supplements ( use of pancreatic supplements may give false test results ) .
Bentiromide	sulfonamides	int	bentiromide may interact with acetaminophen ( e.g. , tylenol ) , chloramphenicol ( e.g. , chloromycetin ) , local anesthetics ( e.g. , benzocaine and lidocaine ) , para aminobenzoic acid ( paba ) containing preparations ( e.g. , sunscreens and some multivitamins ) , procainamide ( e.g. , pronestyl ) , sulfonamides ( sulfa medicines ) , thiazide diuretics ( use of these medicines during the test period will affect the test results ) , and pancreatic supplements ( use of pancreatic supplements may give false test results ) .
Bentiromide	PABA	int	bentiromide may interact with acetaminophen ( e.g. , tylenol ) , chloramphenicol ( e.g. , chloromycetin ) , local anesthetics ( e.g. , benzocaine and lidocaine ) , para aminobenzoic acid ( paba ) containing preparations ( e.g. , sunscreens and some multivitamins ) , procainamide ( e.g. , pronestyl ) , sulfonamides ( sulfa medicines ) , thiazide diuretics ( use of these medicines during the test period will affect the test results ) , and pancreatic supplements ( use of pancreatic supplements may give false test results ) .
rifampicin	ofloxacin	effect	when combined with ofloxacin , krm dg exhibited strong synergistic activity while only additive effects were observed with the combination of rifampicin ( or rifabutin ) and ofloxacin .
GL	antibiotics	effect	the antimicrobial combinations of gl with four antibiotics resulted in additive effect in most instances , synergism in two instances , and antagonism in two instances .
GL	cefazolin	effect	synergism was observed when gl was combined with cefazolin against bacillus subtilis and klebsiella oxytoca .
Misonidazole	CCNU	effect	misonidazole reduced the antitumour activity of oral ccnu by dose modifying factors ( dmf ) of dg dg .
Misonidazole	CCNU	mechanism	misonidazole has a complex effect on oral ccnu pharmacokinetics .
aspirin	nicotinic acid	mechanism	aspirin : concomitant aspirin may decrease the metabolic clearance of nicotinic acid .
Geocillin	probenecid	mechanism	geocillin ( carbenicillin indanyl sodium ) blood levels may be increased and prolonged by concurrent administration of probenecid .
Duloxetine	tricyclic antidepressants	advise	therefore , co administration of duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain antidepressants ( tricyclic antidepressants [ tcas ] , such as nortriptyline , amitriptyline , and imipramine ) , phenothiazines and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution .
Nabilone	CNS depressants	advise	nabilone should be administered with caution to patients who are taking other psychoactive drugs or cns depressants , including alcohol , barbiturates and narcotic analgesics , or to those with a history of psychiatric disorder ( including manic depressive illness and schizophrenia ) .
cephalosporins	aminoglycoside antibiotics	effect	increased nephrotoxicity has been reported following concomitant administration of cephalosporins and aminoglycoside antibiotics .
serotonin reuptake inhibitors	TIKOSYN	advise	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
amiodarone	TIKOSYN	advise	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
cannabinoids	TIKOSYN	advise	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
norfloxacin	TIKOSYN	advise	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
zafirlukast	TIKOSYN	advise	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
dofetilide	thiazide diuretics	mechanism	the mean clearances of dofetilide were dg % and dg % lower in patients on thiazide diuretics and inhibitors of tubular organic cation transport , respectively .
Butalbital	alcohol	effect	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative hypnotics , or other cns depressants , causing increased cns depression .
ACE inhibitors	beta-adrenergic blockers	effect	benazepril , like other ace inhibitors , has had less than additive effects with beta-adrenergic blockers , presumably because both drugs lower blood pressure by inhibiting parts of the renin angiotensin system
Quinolones	anticoagulants	effect	quinolones , including cinoxacin , may enhance the effects of oral anticoagulants , such as warfarin or its derivatives .
beta-blockers	Tiazac	effect	pharmacologic studies indicate that there may be additive effects in prolonging av conduction when using beta-blockers or digitalis concomitantly with tiazac .
cimetidine	diltiazem	mechanism	a study in six healthy volunteers has shown a significant increase in peak diltiazem plasma levels ( dg % ) and auc ( dg % ) after a dg week course of cimetidine dg mg / day and a single dose of diltiazem 60mg .
digoxin	diltiazem hydrochloride	advise	since there have been conflicting results regarding the effect of digoxin levels , it is recommended that digoxin levels be monitored when initiating , adjusting , and discontinuing diltiazem hydrochloride therapy to avoid possible over or under digitalization .
EQUETROTM	protease inhibitors	mechanism	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( dg ) , oxcarbazepine , phenytoin ( dg ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( dg ) , ziprasidone , and zonisamide .
EQUETROTM	triazolam	mechanism	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( dg ) , oxcarbazepine , phenytoin ( dg ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( dg ) , ziprasidone , and zonisamide .
EQUETROTM	warfarin	mechanism	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( dg ) , oxcarbazepine , phenytoin ( dg ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( dg ) , ziprasidone , and zonisamide .
EQUETROTM	cyclosporin	mechanism	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( dg ) , oxcarbazepine , phenytoin ( dg ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( dg ) , ziprasidone , and zonisamide .
diltiazem hydrochloride	propranolol	mechanism	administration of diltiazem hydrochloride concomitantly with propranolol in five normal volunteers resulted in increased propranolol levels in all subjects and bioavailability of propranolol was increased approximately dg % .
propranolol	diltiazem	mechanism	in vitro , propranolol appears to be displaced from its binding sites by diltiazem .
Cholestyramine	phenylbutazone	mechanism	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
HMG-CoA reductase inhibitor	warfarin	effect	however , another hmg-coa reductase inhibitor has been found to produce a less than two second increase in prothrombin time in healthy volunteers receiving low doses of warfarin .
psychotropic medications	LEXAPRO	advise	alcohol although lexapro did not potentiate the cognitive and motor effects of alcohol in a clinical trial , as with other psychotropic medications , the use of alcohol by patients taking lexapro is not recommended .
sumatriptan	escitalopram	advise	if concomitant treatment with sumatriptan and an ssri ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , citalopram , escitalopram ) is clinically warranted , appropriate observation of the patient is advised .
escitalopram	Celexa	advise	concomitant administration with racemic citalopram citalopram since escitalopram is the active isomer of racemic citalopram ( celexa ) , the two agents should not be coadministered .
aminoglycoside	cephalosporins	effect	in vitro mixing of an aminoglycoside with beta lactamtype antibiotics ( penicillins or cephalosporins ) may result in a significant mutual inactivation .
methotrexate	teniposide	mechanism	an increase in intracellular levels of methotrexate was observed in vitro in the presence of teniposide .
Salicylate	triiodothyronine	mechanism	salicylate competes with a number of drugs for protein binding sites , notably penicillin , thiopental , thyroxine , triiodothyronine , phenytoin , sulfinpyrazone , naproxen , warfarin , methotrexate , and possibly corticosteroids .
EQUETROTM	Clomipramine HCl	mechanism	agents with increased levels in the presence of carbamazepine : equetrotm increases the plasma levels of the following agents : clomipramine hcl , phenytoin ( dg ) , and primidone thus , if a patient has been titrated to a stable dosage on one of the agents in this category , and then begins a course of the treatment with equetrotm , it is reasonable to expect that a dose decrease for the concomitant agent may be necessary .
EQUETROTM	loratadine	mechanism	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( dg ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( dg ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( dg ) , verapamil , zileuton .
EQUETROTM	nicotinamide	mechanism	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( dg ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( dg ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( dg ) , verapamil , zileuton .
EQUETROTM	fluoxetine	mechanism	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( dg ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( dg ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( dg ) , verapamil , zileuton .
EQUETROTM	methsuximide	mechanism	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( dg ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
Salicylate	naproxen	mechanism	salicylate competes with a number of drugs for protein binding sites , notably penicillin , thiopental , thyroxine , triiodothyronine , phenytoin , sulfinpyrazone , naproxen , warfarin , methotrexate , and possibly corticosteroids .
phenytoin	methylprednisolone	mechanism	drugs that induce hepatic enzymes such as phenobarbital , phenytoin , and rifampin may increase the clearance of methylprednisolone and may require increased in methylprednisolone dose to achieve the desired response .
troleandomycin	methylprednisolone	mechanism	drugs such as troleandomycin and ketoconazole may inhibit the metabolism of methylprednisolone and thus decrease its clearance .
Aspirin	corticosteroids	advise	aspirin should be used cautiously in conjunction with corticosteroids in patients suffering from hypoprothrombinemia .
antibiotics	ganglion blockers	advise	patients receiving antibiotics and sulfonamides generally should not be treated with ganglion blockers .
Mecamylamine	antihypertensive drugs	effect	the action of mecamylamine may be potentiated by anesthesia , other antihypertensive drugs and alcohol .
anticholinergic drugs	amantadine	effect	the following agents may increase certain actions or side effects of anticholinergic drugs : amantadine , antiarrhythmic agents of class i ( e.g. , quinidine ) , antihistamines , antipsychotic agents ( e.g. , phenothiazines ) , benzodiazepines , mao inhibitors , narcotic analgesics ( e.g. , meperidine ) , nitrates and nitrites , sympathomimetic agents , tricyclic antidepressants , and other drugs having anticholinergic activity .
anticholinergic drugs	sympathomimetic agents	effect	the following agents may increase certain actions or side effects of anticholinergic drugs : amantadine , antiarrhythmic agents of class i ( e.g. , quinidine ) , antihistamines , antipsychotic agents ( e.g. , phenothiazines ) , benzodiazepines , mao inhibitors , narcotic analgesics ( e.g. , meperidine ) , nitrates and nitrites , sympathomimetic agents , tricyclic antidepressants , and other drugs having anticholinergic activity .
anticholinergic drugs	phenothiazines	effect	the following agents may increase certain actions or side effects of anticholinergic drugs : amantadine , antiarrhythmic agents of class i ( e.g. , quinidine ) , antihistamines , antipsychotic agents ( e.g. , phenothiazines ) , benzodiazepines , mao inhibitors , narcotic analgesics ( e.g. , meperidine ) , nitrates and nitrites , sympathomimetic agents , tricyclic antidepressants , and other drugs having anticholinergic activity .
Diuretic	digitalis	effect	digitalis glycosides : diuretic induced hypokalemia can increase the sensitivity of the myocardium to digitalis .
TRITEC	clarithromycin	mechanism	coadministration of tritec with clarithromycin resulted in increased plasma ranitidine concentrations ( dg % ) , increased plasma bismuth trough concentrations ( dg % ) , and increased dg hydroxy clarithromycin plasma concentrations ( dg % ) .
cholinesterase inhibitors	succinylcholine	effect	use with cholinomimetics and other cholinesterase inhibitors : a synergistic effect may be expected when cholinesterase inhibitors are given concurrently with succinylcholine , similar neuromuscular blocking agents or cholinergic agonists such as bethanechol .
NSAIDs	aspirin	advise	however , as with other nsaids , concomitant administration of meloxicam and aspirin is not generally recommended because of the potential for increased adverse effects .
Trimethoprim	phenytoin	mechanism	trimethoprim may inhibit the hepatic metabolism of phenytoin .
Trimethoprim	phenytoin	mechanism	trimethoprim , given at a common clinical dosage , increased the phenytoin half life by dg % and decreased the phenytoin metabolic clearance rate by dg % .
Trimethoprim	phenytoin	mechanism	trimethoprim , given at a common clinical dosage , increased the phenytoin half life by dg % and decreased the phenytoin metabolic clearance rate by dg % .
nondepolarizing agents	anesthetics	effect	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
nondepolarizing agents	procainamide	effect	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
NIMBEX	colistin	effect	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
nitrous oxide	NIMBEX	effect	isoflurane or enflurane administered with nitrous oxide / oxygen to achieve dg mac [ minimum alveolar concentration ] may prolong the clinically effective duration of action of initial and maintenance doses of nimbex and decrease the required infusion rate of nimbex .
Isoflurane	NIMBEX	effect	isoflurane or enflurane administered with nitrous oxide / oxygen to achieve dg mac [ minimum alveolar concentration ] may prolong the clinically effective duration of action of initial and maintenance doses of nimbex and decrease the required infusion rate of nimbex .
enflurane	NIMBEX	effect	isoflurane or enflurane administered with nitrous oxide / oxygen to achieve dg mac [ minimum alveolar concentration ] may prolong the clinically effective duration of action of initial and maintenance doses of nimbex and decrease the required infusion rate of nimbex .
Barbiturates	antibiotics	int	barbiturates may decrease the effectiveness of oral contraceptives , certain antibiotics , quinidine , theophylline , corticosteroids , anticoagulants , and beta blockers .
Barbiturates	quinidine	int	barbiturates may decrease the effectiveness of oral contraceptives , certain antibiotics , quinidine , theophylline , corticosteroids , anticoagulants , and beta blockers .
Alpha-adrenergic blocking agents	ProAmatine	effect	proamatine. alpha-adrenergic blocking agents , such as prazosin , terazosin , and doxazosin , can antagonize the effects of proamatine. potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of desglymidodrine ( a base ) is due to active tubular secretion by the base secreting system also responsible for the secretion of such drugs as metformin , cimetidine , ranitidine , procainamide , triamterene , flecainide , and quinidine .
prazosin	ProAmatine	effect	proamatine. alpha adrenergic blocking agents , such as prazosin , terazosin , and doxazosin , can antagonize the effects of proamatine. potential for drug interactions : it appears possible , although there is no supporting experimental evidence , that the high renal clearance of desglymidodrine ( a base ) is due to active tubular secretion by the base secreting system also responsible for the secretion of such drugs as metformin , cimetidine , ranitidine , procainamide , triamterene , flecainide , and quinidine .
EQUETROTM	theophylline	mechanism	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( dg ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
Tadalafil	indinavir	advise	tadalafil dose should not exceed a maximum of dg mg in a dg hour period in patients receiving concomitant indinavir therapy .
SSRI	TCA	effect	the extent to which ssri tca interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the ssri involved .
phenytoin	quetiapine	mechanism	this study demonstrated that the potent cytochrome p450 enzyme inducer phenytoin did indeed have a marked effect on the metabolism of quetiapine , resulting in a dg fold increase in clearance when administered concomitantly to patients with dsm iv diagnosed schizophrenia , schizoaffective disorder , or bipolar disorder .
DCG-IV	PCP	effect	the effects of dcg-iv were very strong and completely depressed the pcp induced hyperlocomotion .
18-MC	nicotine	effect	both ibogaine and 18-mc block morphine induced and nicotine induced dopamine release in the nucleus accumbens ;
ibogaine	cocaine	effect	only ibogaine enhances cocaine induced increases in accumbal dopamine .
valproic acid	phenobarbital	effect	coingestion of acetaminophen with theophylline , phenobarbital with acetaminophen , and valproic acid with phenobarbital at high to toxic concentrations decreases the binding of the target drug .
temazepam	ethanol	mechanism	acid catalyzed ethanolysis of temazepam in anhydrous and aqueous ethanol solutions .
temazepam	ethanol	mechanism	in addition to this pharmacological interaction , this report describes a novel chemical reaction between temazepam ( a benzodiazepine ) and ethanol under acidic conditions similar to those found in vivo , resulting in a dg ethoxylated product .
antiretroviral drugs	antineoplastic drugs	advise	however , careful attention must be directed to cross toxicity and possible pharmacokinetic interactions between antiretroviral and antineoplastic drugs .
rifampin	warfarin	effect	the effect of rifampin on the warfarin requirement of our patient appeared to be maximal dg to dg days after the initiation of rifampin and extended a similar length of time after rifampin withdrawal .
Cholestyramine	fluvastatin	mechanism	cholestyramine , an anionic binding resin , has a considerable effect in lowering the rate and extent of fluvastatin bioavailability .
retinyl acetate	EGF	effect	dexamethasone and retinyl acetate similarly inhibit and stimulate egf or insulin induced proliferation of prostatic epithelium .
Dexamethasone	EGF	effect	dexamethasone at dg ( dg ) m or retinyl acetate at about dg x dg ( dg ) m inhibits proliferation stimulated by egf .
trovafloxacin	opiate	mechanism	previous studies have demonstrated a significant reduction in the oral bioavailability of trovafloxacin and ciprofloxacin when administered concomitantly with an intravenous opiate such as morphine .
ciprofloxacin	morphine	mechanism	previous studies have demonstrated a significant reduction in the oral bioavailability of trovafloxacin and ciprofloxacin when administered concomitantly with an intravenous opiate such as morphine .
Cypermethrin	vitamin E	effect	cypermethrin induced oxidative stress in rat brain and liver is prevented by vitamin e or allopurinol .
verapamil	bombesin	effect	suppression by verapamil of bombesin enhanced peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane in wistar rats .
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine	effect	after dg weeks of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment , all 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine / vehicle treated animals displayed parkinsonian symptoms , whereas none of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine / 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine treated monkeys were significantly affected .
3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	effect	our data demonstrate that chronic treatment with the metabotropic glutamate receptor dg antagonist , 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine , significantly reduces 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity towards dopaminergic and noradrenergic cell groups in non human primates .
minocycline	fosfomycin	effect	the combination of minocycline and fosfomycin can be synergistic against mrsa .
docetaxel	sunitinib	effect	sunitinib as a single agent exhibits anti proliferative effects in vitro in nsclc cell lines with egfr t790m and k ras mutations but the sequential administration of docetaxel followed by sunitinib is superior to sunitinib followed by docetaxel and concurrent administration .
sunitinib	docetaxel	effect	although single or concurrent use of sunitinib and docetaxel has some anti proliferative effects , the sequential administrations of both drugs remarkably enhanced anti tumor activity .
ketoconazole	panobinostat	mechanism	in the presence of ketoconazole , there was dg and dg fold increase in c ( max ) and auc of panobinostat , respectively .
neomycin	ACTH	effect	studies in rats have shown that neomycin administration attenuates certain types of adrenocortical steroid dependent hypertension , including acth hypertension .
amlodipine	valsartan	effect	we have demonstrated appropriateness of inhospital administration of fixed amlodipine / valsartan combination as an approach allowing to achieve target bp in shorter time , with the use of fewer antihypertensive drugs , and diminishing concealed inefficacy of treatment .
amlodipine	valsartan	effect	but the use of fixed combination amlodipine / valsartan compared with traditional therapy was associated with lower clinical and self measured bp , quicker achievement of target bp ( 5.8+ / dg and 9.2+ / dg days , respectively , dg ) , lesser number of antihypertensive drugs ( 2.5+ / dg and 3.0+ / dg days , respectively ) , lower rate of concealed inefficacy of treatment ( dg and dg % , respectively , dg ) .
lenalidomide	CCI-779	effect	the preclinical combination of lenalidomide with the mtor inhibitor cci-779 has displayed synergy in vitro and represents a novel combination in mm .
Sympathomimetics	methyldopa	effect	sympathomimetics may reduce the antihypertensive effects of methyldopa , mecamylamine , reserpine and veratrum alkaloids .
Sympathomimetics	reserpine	effect	sympathomimetics may reduce the antihypertensive effects of methyldopa , mecamylamine , reserpine and veratrum alkaloids .
TOLECTIN	methotrexate	mechanism	tolectin and other nonsteroidal anti inflammatory drugs have been reported to reduce the tubular secretion of methotrexate in an animal model , possibly enhancing the toxicity of methotrexate .
meperidine	MAOIs	int	this is typical of the interaction of meperidine and maois .
TOBI	anti-pseudomonal antibiotics	effect	in clinical studies of tobi , patients taking tobi concomitantly with dornase alfa ( pulmozyme , genentech ) , ( beta ) agonists , inhaled corticosteroids , other anti-pseudomonal antibiotics , or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole .
metronidazole	coumarin	effect	oral metronidazole has been reported to potentiate the anticoagulant effect of coumarin and warfarin , resulting in a prolongation of prothrombin time .
Ritalin	primidone	mechanism	human pharmacologic studies have shown that ritalin may inhibit the metabolism of coumarin anticoagulants , anticonvulsants ( phenobarbital , diphenylhydantoin , primidone ) , phenylbutazone , and tricyclic drugs ( imipramine , clomipramine , desipramine ) .
anticoagulant	alcohol	effect	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under dosage .
anticoagulant	ranitidine	effect	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under dosage .
lithium	FELDENE	advise	it is recommended that plasma lithium levels be monitored when initiating , adjusting and discontinuing feldene .
TRENTAL	theophylline	mechanism	concomitant administration of trental and theophylline containing drugs leads to increased theophylline levels and theophylline toxicity in some individuals .
methotrexate	L-glutamine	effect	in another report , nine patients with breast cancer were reported to have decreased symptoms of methotrexate related toxicity when given supplemental l-glutamine at a dose of dg gram / kilogram / day .
erythromycin	penicillins	effect	concurrent administration of bacteriostatic antibiotics ( e.g. , erythromycin , tetracycline ) may diminish the bactericidal effects of penicillins by slowing the rate of bacterial growth .
vancomycin	anesthetic agents	effect	concomitant administration of vancomycin and anesthetic agents has been associated with erythema and histamine like flushing and anaphylactoid reactions .
INVEGA	centrally acting drugs	advise	given the primary cns effects of paliperidone , invega should be used with caution in combination with other centrally acting drugs and alcohol .
Metopirone	acetaminophen	effect	metopirone inhibits the glucuronidation of acetaminophen and could possibly potentiate acetaminophen toxicity .
Sulfoxone	tolbutamide	effect	sulfoxone may increase the effects of barbiturates , tolbutamide , and uricosurics .
imiglucerase	ZAVESCA	advise	combination therapy with cerezyme ( imiglucerase ) and zavesca is not indicated .
Thiamine	Tricyclic Antidepressants	int	interactions for vitamin b1 ( thiamine ) : loop diuretics , oral contraceptives , stavudine , tricyclic antidepressants
Alcohol	riboflavin	mechanism	interactions for vitamin b2 ( riboflavin ) : alcohol impairs the intestinal absorption of riboflavin
Mequitazine	CNS depressant	int	mequitazine can interact with cns depressant , antichlolinergic , tca , maois , and alcohol .
celecoxib	anti-cancer drugs	effect	interaction of celecoxib with different anti-cancer drugs is antagonistic in breast but not in other cancer cells .
Warfarin	citalopram	effect	warfarin users had an increased odds ratio of gastrointestinal bleeding upon initiation of citalopram ( or = dg [ dg % ci , dg dg ] ) , fluoxetine ( or = dg [ dg % ci , dg dg ] ) , paroxetine ( or = dg [ dg % ci , dg dg ] ) , amitriptyline ( or = dg [ dg % ci , dg dg ] ) .
dexmedetomidine	ephedrine	effect	we concluded that the combined administration of dexmedetomidine with ephedrine may have beneficial effects in the treatment of pain without causing sedation , which limits the use of dexmedetomidine as an analgesic in humans .
pentobarbital	ouabain	effect	in a comparison of digitalis tolerance in dogs anesthetized with ketamine , innovar vet , or pentobarbital , the dosage of ouabain needed to cause ventricular tachycardia was significantly higher , as was the ld50 of ouabain , with ketamine or innovar than with pentobarbital .
ouabain	Innovar	effect	ventricular tachycardia induced by ouabain was generally converted to sinus rhythm following administration of innovar , ketamine , or droperidol but not after administration of fentayl alone or after pentobarbital .
Moxifloxacin	gelusil	mechanism	moxifloxacin and lomefloxacin reacts faster with sucralfate and gelusil in acidic media whereas with erythromycin in basic media and multi minerals in neutral media .
picrotoxin	phenibut	effect	[ the gaba ergic system and brain edema ] it has been shown in rats with experimental toxic and traumatic edemas that picrotoxin ( dg mg / kg ) removes the antiedematous action of diazepam , phenazepam , phenibut and amizyl and reduces the action of phentolamine .
picrotoxin	phentolamine	effect	[ the gaba ergic system and brain edema ] it has been shown in rats with experimental toxic and traumatic edemas that picrotoxin ( dg mg / kg ) removes the antiedematous action of diazepam , phenazepam , phenibut and amizyl and reduces the action of phentolamine .
Haloperidol	(+)-NANM	effect	haloperidol reduced or eliminated the increases in fi responding produced by intermediate doses of either (+)-nanm or pcp in pigeons , but did not antagonize the decreases in fi or fr responding produced by high doses of pcp or either stereoisomer of nanm .
Haloperidol	PCP	effect	haloperidol reduced or eliminated the increases in fi responding produced by intermediate doses of either ( + ) nanm or pcp in pigeons , but did not antagonize the decreases in fi or fr responding produced by high doses of pcp or either stereoisomer of nanm .
Fe	cobalt	mechanism	the lower rate of absorption in the groups receiving dg mg fe instead of dg mg of fe per kg diet resulted in a decreased renal excretion of cobalt .
ouabain	PTX	effect	in the presence of ouabain ( dg ( dg ) m ) , ptx ( dg ( dg ) m ) failed to cause the first contraction ;
ouabain	PTX	effect	exposure of the muscle to ouabain ( dg ( dg ) m ) markedly increased the ptx induced release .
digoxin	amiodarone	mechanism	these alterations in digoxin pharmacokinetics produced by amiodarone explain the increase in serum digoxin level that has been observed when this drug combination has been used clinically .
cimetidine	iodamide	mechanism	[ the effect of cimetidine on the renal excretion of verografin and iodamide in dogs ] the intravenous injection of cimetidine in a dose of dg mg / kg enhanced verografine and iodamide excretion in chronic canine experiments .
MPTP	apomorphine	effect	the mptp induced neuronal damage produced a tolerance to the disruptive effects of amphetamine and a supersensitivity to the disruptive effects of apomorphine in rats responding in a schedule controlled paradigm .
ethanol	disulfiram	effect	core temperature was decreased in rats in a dose dependent manner when ethanol was administered to rats treated with disulfiram dg hours before the ethanol challenge .
CCNU	misonidazole	mechanism	we propose these pharmacokinetic changes to be the underlying mechanism for the reduction of oral ccnu cytotoxicity by misonidazole .
atracurium	gentamycin	effect	recovery of hoof twitch from dg % to dg % took dg + / dg min for atracurium alone and dg + / dg min for atracurium plus gentamycin ( p = dg ) .
Myfortic	live attenuated vaccines	advise	live vaccines : during treatment with myfortic , the use of live attenuated vaccines should be avoided and patients should be advised that vaccinations may be less effective .
Myfortic	activated charcoal	advise	therefore , do not administer myfortic with cholestyramine or other agents that may interfere with enterohepatic recirculation or drugs that may bind bile acids , for example bile acid sequestrates or oral activated charcoal , because of the potential to reduce the efficacy of myfortic .
MEPERIDINE	NARCOTIC ANALGESICS	advise	interaction with other central nervous system depressants : meperidine should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic analgesics , general anesthetics , phenothiazines , other tranquilizers , sedative hypnotics ( including barbiturates ) , tricyclic antidepressants and other cns depressants ( including alcohol ) .
MEPERIDINE	CNS DEPRESSANTS	advise	interaction with other central nervous system depressants : meperidine should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic analgesics , general anesthetics , phenothiazines , other tranquilizers , sedative hypnotics ( including barbiturates ) , tricyclic antidepressants and other cns depressants ( including alcohol ) .
paclitaxel	HERCEPTIN	mechanism	administration of paclitaxel in combination with herceptin resulted in a two fold decrease in herceptin clearance in a non human primate study and in a dg fold increase in herceptin serum levels in clinical studies .
Sanctura	anticholinergic agents	effect	the concomitant use of sanctura with other anticholinergic agents that produce dry mouth , constipation , and other anticholinergic pharmacological effects may increase the frequency and / or severity of such effects .
mazindol	MAOI	advise	you can not take mazindol if you have taken a monoamine oxidase inhibitor ( maoi ) such as isocarboxazid ( marplan ) , tranylcypromine ( parnate ) , or phenelzine ( nardil ) in the last dg days .
Selective serotonin reuptake inhibitors	sumatriptan	effect	therefore , the use of sumatriptan succinate tablets in patients receiving mao a inhibitors is contraindicated . selective serotonin reuptake inhibitors ( ssris ) ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with sumatriptan .
anticoagulant	barbiturates	effect	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under dosage .
anticoagulant	mefenamic acid	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
anticoagulant	monoamine oxidase inhibitors	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
anticoagulant	pentoxifylline	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
fluvoxamine	sumatriptan	effect	therefore , the use of sumatriptan succinate tablets in patients receiving mao a inhibitors is contraindicated . selective serotonin reuptake inhibitors ( ssris ) ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with sumatriptan .
sulphasalazine	thioguanine	mechanism	as there is in vitro evidence that aminosalicylate derivatives ( e.g. , olsalazine , mesalazine , or sulphasalazine ) inhibit the tpmt enzyme , they should be administered with caution to patients receiving concurrent thioguanine therapy .
metaraminol	halothane	effect	vasopressors , particularly metaraminol , may cause serious cardiac arrhythmias during halothane anesthesia and therefore should be used only with great caution or not at all .
adrenergic agents	tricyclic antidepressants	effect	the pressor response of adrenergic agents may also be potentiated by tricyclic antidepressants .
paricalcitol	indinavir	advise	a multiple dose drug drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol auc0 . since paricalcitol is partially metabolized by cyp3a and ketoconazole le is known to be a strong inhibitor of cytochrome p450 3a enzyme , care should be taken while dosing paricalcitol with ketoconazole and other strong p450 3a inhibitors including atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin or voriconazole .
Zidovudine	stavudine	effect	zidovudine competitively inhibits the intracellular phosphorylation of stavudine .
guanethidine	phenothiazines	effect	antihypertensive effects of guanethidine and related compounds may be counteracted when phenothiazines are used concomitantly .
Thiazides	antihypertensive drugs	effect	thiazides may add to or potentiate the action of other antihypertensive drugs .
metoclopramide	MIRAPEX	effect	dopamine antagonists : since pramipexole is a dopamine agonist , it is possible that dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of mirapex .
anticoagulant	ranitidine	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
anticoagulant	sulfinpyrazone	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
anticoagulant	chlorpropamide	effect	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium o
anticoagulant	phenytoin	mechanism	because oral anticoagulants may interfere with the hepatic metabolism of phenytoin , toxic levels of the anticonvulsant may occur when an oral anticoagulant and phenytoin are administered concurrently .
dextran	anticoagulants	effect	drugs that reduce the number of blood platelets by causing bone marrow depression ( such as antineoplastic agents ) or drugs which inhibit platelet function ( eg , aspirin and other non steroidal anti inflammatory drugs , dipyridamole , hydrochloroquine , clofibrate , dextran ) may increase the bleeding tendency produced by anticoagulants without altering prothrombin time determinations .
antibacterial drugs	contraceptives	effect	concurrent use of antibacterial drugs with oral contraceptives may render oral contraceptives less effective .
Melatonin	corticosteroids	int	melatonin may interact with the following drugs : aspirin and other nsaids ( may lower melatonin levels ) , fluvoxamine ( bioavailability of oral melatonin is increased with coadministration ) , beta blockers ( may decrease melatonin levels ) , fluoxetine ( reports of psychotic episodes when coadministered ) , progestin ( coadministration of melatonin with progestin can inhibit ovarian function in women ) , benzodiazepenes and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects ) , and corticosteroids ( coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids ) .
Melatonin	beta blockers	int	melatonin may interact with the following drugs : aspirin and other nsaids ( may lower melatonin levels ) , fluvoxamine ( bioavailability of oral melatonin is increased with coadministration ) , beta blockers ( may decrease melatonin levels ) , fluoxetine ( reports of psychotic episodes when coadministered ) , progestin ( coadministration of melatonin with progestin can inhibit ovarian function in women ) , benzodiazepenes and other sedating drugs ( may result in additive sedation and an increased incidence of adverse effects ) , and corticosteroids ( coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids ) .
Terbinafine	caffeine	mechanism	terbinafine decreases the clearance of caffeine by dg % .
Terbinafine	cimetidine	mechanism	terbinafine clearance is increased dg % by rifampin , a cyp450 enzyme inducer , and decreased dg % by cimetidine , a cyp450 enzyme inhibitor .
Cimetidine	pramipexole	mechanism	cimetidine : cimetidine , a known inhibitor of renal tubular secretion of organic bases via the cationic transport system , caused a dg % increase in pramipexole auc and a dg % increase in half life ( n= dg ) .
quinine	pramipexole	mechanism	other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g. , cimetidine , ranitidine , diltiazem , triamterene , verapamil , quinidine , and quinine ) decreases the oral clearance of pramipexole by about dg % , while those secreted by the anionic transport system ( e.g. , cephalosporins , penicillins , indomethacin , hydrochlorothiazide , and chlorpropamide ) are likely to have little effect on the oral clearance of pramipexole .
hydrochlorothiazide	pramipexole	mechanism	other drugs eliminated via renal secretion : population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system ( e.g. , cimetidine , ranitidine , diltiazem , triamterene , verapamil , quinidine , and quinine ) decreases the oral clearance of pramipexole by about dg % , while those secreted by the anionic transport system ( e.g. , cephalosporins , penicillins , indomethacin , hydrochlorothiazide , and chlorpropamide ) are likely to have little effect on the oral clearance of pramipexole .
phenobarbital	montelukast	advise	it is reasonable to employ appropriate clinical monitoring when potent cytochrome p450 enzyme inducers , such as phenobarbital or rifampin , are co administered with montelukast .
rifampin	montelukast	advise	it is reasonable to employ appropriate clinical monitoring when potent cytochrome p450 enzyme inducers , such as phenobarbital or rifampin , are co administered with montelukast .
diazepam	REMERON SolTab	advise	accordingly , patients should be advised to avoid diazepam and other similar drugs while taking remeron soltab .
ketoconazole	terfenadine	effect	ketoconazole : spontaneous adverse reaction reports of patients taking concomitant ketoconazole with recommended doses of terfenadine demonstrate qt interval prolongation and rare serious cardiac events , e.g .
ketoconazole	terfenadine	advise	concomitant administration of ketoconazole and terfenadine is contraindicated .
itraconazole	terfenadine	advise	concomitant administration of itraconazole and terfenadine is contraindicated .
fluconazole	terfenadine	advise	due to the chemical similarity of other azole type antifungal agents ( including fluconazole , metronidazole , and miconazole ) to ketoconazole , and itraconazole , concomitant use of these products with terfenadine is not recommended pending full examination of potential interactions .
metronidazole	terfenadine	advise	due to the chemical similarity of other azole type antifungal agents ( including fluconazole , metronidazole , and miconazole ) to ketoconazole , and itraconazole , concomitant use of these products with terfenadine is not recommended pending full examination of potential interactions .
erythromycin	terfenadine	mechanism	macrolides : clinical drug interaction studies indicate that erythromycin and clarithromycin can exert an effect on terfenadine metabolism by a mechanism which may be similar to that of ketoconazole , but to a lesser extent .
amrinone	anagrelide	effect	the effects of medicinal products with similar properties such as inotropes milrinone , enoximone , amrinone , olprinone and cilostazol may be exacerbated by anagrelide .
cilostazol	anagrelide	effect	the effects of medicinal products with similar properties such as inotropes milrinone , enoximone , amrinone , olprinone and cilostazol may be exacerbated by anagrelide .
VERSED Syrup	narcotics	effect	the sedative effect of versed syrup is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly narcotics ( eg , morphine , meperidine and fentanyl ) , propofol , ketamine , nitrous oxide , secobarbital and droperidol .
VERSED Syrup	meperidine	effect	the sedative effect of versed syrup is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly narcotics ( eg , morphine , meperidine and fentanyl ) , propofol , ketamine , nitrous oxide , secobarbital and droperidol .
streptozocin	phenytoin	effect	the concurrent use of streptozocin and phenytoin has been reported in one case to result in reduced streptozocin cytotoxicity .
metoclopramide	sedatives	effect	additive sedative effects can occur when metoclopramide is given with alcohol , sedatives , hypnotics , narcotics , or tranquilizers .
metoclopramide	tranquilizers	effect	additive sedative effects can occur when metoclopramide is given with alcohol , sedatives , hypnotics , narcotics , or tranquilizers .
phenobarbital	corticosteroid	mechanism	drugs that induce hepatic enzymes such as phenobarbital , phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response .
rifampin	corticosteroid	mechanism	drugs that induce hepatic enzymes such as phenobarbital , phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response .
coumarin-type anticoagulants	FELDENE	int	although this has not occurred in in vitro studies with coumarin-type anticoagulants , interactions with coumarin-type anticoagulants have been reported with feldene since marketing , therefore , physicians should closely monitor patients for a change in dosage requirements when administering feldene to patients on coumarin-type anticoagulants and other highly protein bound drugs .
FELDENE	coumarin-type anticoagulants	advise	although this has not occurred in in vitro studies with coumarin-type anticoagulants , interactions with coumarin-type anticoagulants have been reported with feldene since marketing , therefore , physicians should closely monitor patients for a change in dosage requirements when administering feldene to patients on coumarin-type anticoagulants and other highly protein bound drugs .
FELDENE	aspirin	mechanism	plasma levels of piroxicam are depressed to approximately dg % of their normal values when feldene is administered in conjunction with aspirin ( dg mg / day ) , but concomitant administration of antacids has no effect on piroxicam plasma levels . nonsteroidal anti inflammatory agents , including feldene , have been reported to increase steady state plasma lithium levels .
L-glutamine	paclitaxel	effect	paclitaxel in one report , l-glutamine at a dose of dg grams three times daily , given dg hours after receiving paclitaxel , appeared to prevent the development of myalgia and arthralgia , adverse reactions of paclitaxel .
tetracycline	penicillins	effect	concurrent administration of bacteriostatic antibiotics ( e.g. , erythromycin , tetracycline ) may diminish the bactericidal effects of penicillins by slowing the rate of bacterial growth .
itraconazole	mifepristone	mechanism	although specific drug or food interactions with mifepristone have not been studied , on the basis of this drug s metabolism by cyp dg , it is possible that ketoconazole , itraconazole , erythromycin , and grapefruit juice may inhibit its metabolism ( increasing serum levels of mifepristone ) .
erythromycin	mifepristone	mechanism	although specific drug or food interactions with mifepristone have not been studied , on the basis of this drug s metabolism by cyp dg , it is possible that ketoconazole , itraconazole , erythromycin , and grapefruit juice may inhibit its metabolism ( increasing serum levels of mifepristone ) .
Paliperidone	levodopa	effect	paliperidone may antagonize the effect of levodopa and other dopamine agonists .
Paliperidone	dopamine agonists	effect	paliperidone may antagonize the effect of levodopa and other dopamine agonists .
Matulane	tricyclic antidepressant	advise	because matulane exhibits some monoamine oxidase inhibitory activity , sympathomimetic drugs , tricyclic antidepressant drugs ( e.g. , amitriptyline hcl , imipramine hcl ) and other drugs and foods with known high tyramine content , such as wine , yogurt , ripe cheese and bananas , should be avoided .
Phenothiazines	CNS depressants	effect	phenothiazines are capable of potentiating cns depressants ( e.g. , barbiturates , anesthetics , opiates , alcohol , etc . )
Phenothiazines	opiates	effect	phenothiazines are capable of potentiating cns depressants ( e.g. , barbiturates , anesthetics , opiates , alcohol , etc . )
Metopirone	phenytoin	mechanism	the metabolism of metopirone is accelerated by phenytoin ;
VERSED Syrup	fentanyl	effect	the sedative effect of versed syrup is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly narcotics ( eg , morphine , meperidine and fentanyl ) , propofol , ketamine , nitrous oxide , secobarbital and droperidol .
levomepromazine	tricyclic antidepressants	advise	exert particular caution in combining levomepromazine with other anticholinergic drugs ( tricyclic antidepressants and antiparkinsonian agents ) : particularly the elderly may develop delirium , high fever , severe obstipation , even ileus and glaucoma .
alprazolam	fluvoxamine	mechanism	other potentially important drug interactions : benzodiazepines : benzodiazepines metabolized by hepatic oxidation ( e.g. , alprazolam , midazolam , triazolam elc. ) should be used with caution because the clearance of these drugs is likely to be reduced by fluvoxamine .
fluvoxamine maleate	alprazolam	mechanism	alprazolam : when fluvoxamine maleate ( dg mg qd ) and alprazolam ( dg mg q.d. were co administered to steady state , plasma concentration and other pharmacokinetics parameters ( auc , cmax , t1 / dg , ) of alprazolam were approximately twice those observed when alprazolam was administered alone ;
fluvoxamine	diazepam	advise	evidence supporting the conclusion that it is inadvisable to co administer fluvoxamine and diazepam is derived from a study in which healthy volunteers taking dg mg / day of fluvoxamine were administered a single oral dose of dg mg of diazepam .
Fluvoxamine	MAOI	advise	after stopping fluvoxamine tablets , at least dg weeks should be allowed before starting a maoi .
Terfenadine	ketoconazole	mechanism	terfenadine , astemizole and cisapride are all metabolized by the cytochrome p450iiia4 isozyme , and it has been demonstrated that ketoconazole , a potent inhibitor of iiia4 , blocks the metabolism of these drugs , resulting in increased plasma concentrations of parent drug .
probenecid	meropenem	advise	therefore , the coadministration of probenecid with meropenem is not recommended .
meropenem	valproic acid	mechanism	there is evidence that meropenem may reduce serum levels of valproic acid to subtherapeutic levels ( therapeutic range considered to be dg to dg g / ml total valproate ) .
macrolide antibiotics	DETROL LA	advise	for patients receiving ketoconazole or other potent cyp3a4 inhibitors such as other azole antifungals ( eg , itraconazole , miconazole ) or macrolide antibiotics ( eg , erythromycin , clarithromycin ) or cyclosporine or vinblastine , the recommended dose of detrol la is dg mg daily .
trimetrexate	ketoconazole	effect	agents that might be coadministered with trimetrexate in aids patients for other indications that could elicit this activity include erythromycin , rifampin , rifabutin , ketoconazole , and fluconazole .
imidazole drugs	trimetrexate	mechanism	based on an in vitro rat liver model , nitrogen substituted imidazole drugs ( clotrimazole , ketoconazole , miconazole ) were potent , non competitive inhibitors of trimetrexate metabolism .
ZOLINZA	coumarin derivatives	advise	physicians should carefully monitor pt and inr in patients concurrently administered zolinza and coumarin derivatives .
imipramine	fluoxetine	mechanism	the plasma concentration of imipramine may increase when the drug is given concomitantly with hepatic enzyme inhibitors ( e.g. , cimetidine , fluoxetine ) and decrease by concomitant administration of hepatic enzyme inducers ( e.g. , barbiturates , phenytoin ) , and adjustment of the dosage of imipramine may therefore be necessary .
MIVACRON	bacitracin	int	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as mivacron include certain antibiotics ( e.g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
MIVACRON	lincomycin	int	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as mivacron include certain antibiotics ( e.g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
MIVACRON	procainamide	int	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as mivacron include certain antibiotics ( e.g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
nondepolarizing agents	sodium colistimethate	int	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as mivacron include certain antibiotics ( e.g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
fluconazole	cisapride	effect	cisapride : there have been reports of cardiac events , including torsade de pointes in patients to whom fluconazole and cisapride were coadministered .
DIFLUCAN	glyburide	effect	one fatality has been reported from hypoglycemia in association with combined diflucan and glyburide use .
Fluconazole	ethinyl estradiol	mechanism	fluconazole tablets coadministered with ethinyl estradiol and levonorgestrel containing oral contraceptives produced an overall mean increase in ethinyl estradiol and levonorgestrel levels ;
anesthetics	methyldopa	advise	patients may require reduced doses of anesthetics when on methyldopa .
methyldopa	ferrous sulfate	advise	coadministration of methyldopa with ferrous sulfate or ferrous gluconate is not recommended .
quinolones	iron	mechanism	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable / buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
grepafloxacin	theophylline	mechanism	drugs metabolized by cytochrome p450 enzymes the drug interaction study evaluating the effect of grepafloxacin on theophylline indicates that grepafloxacin inhibits theophylline metabolism , which is mediated by cyp1a2 .
nonsteroidal anti inflammatory drug	quinolone	effect	nonsteroidal anti inflammatory drugs ( nsaids ) : the concomitant administration of a nonsteroidal anti inflammatory drug with a quinolone may increase the risks of cns stimulation and convulsions .
quinolones	caffeine	mechanism	caffeine theobromine grepafloxacin , like other quinolones , may inhibit the metabolism of caffeine and theobromine .
acetazolamide	procaine hydrochloride	mechanism	acetazolamide : concurrent use of acetazolamide and procaine hydrochloride may extend the plasma half life of procaine .
diuretic	perindopril	effect	the possibility of hypotensive effects can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with perindopril .
erythromycin	oxybutynin	mechanism	other inhibitors of the cytochrome p450 dg enzyme system , such as antimycotic agents ( e.g. , itraconazole and miconazole ) or macrolide antibiotics ( e.g. , erythromycin and clarithromycin ) , may alter oxybutynin mean pharmacokinetic parameters ( i.e. , cmax and auc ) .
clarithromycin	oxybutynin	mechanism	other inhibitors of the cytochrome p450 dg enzyme system , such as antimycotic agents ( e.g. , itraconazole and miconazole ) or macrolide antibiotics ( e.g. , erythromycin and clarithromycin ) , may alter oxybutynin mean pharmacokinetic parameters ( i.e. , cmax and auc ) .
ALFENTA	anesthetics	effect	both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when alfenta is administered in combination with other cns depressants such as barbiturates , tranquilizers , opioids , or inhalation general anesthetics .
erythromycin	ALFENTA	mechanism	limited clinical experience indicates that requirements for volatile inhalation anesthetics are reduced by dg to dg % for the first sixty ( dg ) minutes following alfenta induction the concomitant use of erythromycin with alfenta can significantly inhibit alfenta clearance and may increase the risk of prolonged or delayed respiratory depression .
INDOCIN	digoxin	advise	therefore , when indocin and digoxin are used concomitantly , serum digoxin levels should be closely monitored .
INDOCIN	thiazide diuretics	effect	in some patients , the administration of indocin can reduce the diuretic , natriuretic , and antihypertensive effects of loop , potassium sparing , and thiazide diuretics .
Metopirone	acetaminophen	mechanism	metopirone inhibits the glucuronidation of acetaminophen and could possibly potentiate acetaminophen toxicity .
folic acid	sulfasalazine	mechanism	reduced absorption of folic acid and digoxin have been reported when those agents were administered concomitantly with sulfasalazine .
Vitamin B1	Loop Diuretics	int	interactions for vitamin b1 ( thiamine ) : loop diuretics , oral contraceptives , stavudine , tricyclic antidepressants
Vitamin B1	Tricyclic Antidepressants	int	interactions for vitamin b1 ( thiamine ) : loop diuretics , oral contraceptives , stavudine , tricyclic antidepressants
SPIRIVA	anticholinergic	advise	however , the co administration of spiriva with other anticholinergic containing drugs ( e.g. , ipratropium ) has not been studied and is therefore not recommended .
SPIRIVA	ipratropium	advise	however , the co administration of spiriva with other anticholinergic containing drugs ( e.g. , ipratropium ) has not been studied and is therefore not recommended .
macrolides	astemizole	int	concomitant administrations not recommended : terfenadine and astemizole : certain macrolides interact with terfenadine and astemizole leading to increased serum concentrations of the latter .
tetracyclines	anticoagulant	advise	because tetracyclines have been shown to depress plasma prothrombin activity , patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage .
mazindol	Marplan	advise	you can not take mazindol if you have taken a monoamine oxidase inhibitor ( maoi ) such as isocarboxazid ( marplan ) , tranylcypromine ( parnate ) , or phenelzine ( nardil ) in the last dg days .
Itraconazole	busulfan	mechanism	itraconazole decreases busulfan clearance by up to dg % , and may produce aucs dg m min in some patients .
ergot-type medications	sumatriptan	advise	because there is a theoretical basis that these effects may be additive , use of ergotamine containing or ergot-type medications ( like dihydroergotamine or methysergide ) and sumatriptan within dg hours of each other should be avoided .
INDOCIN	triamterene	advise	indocin and triamterene should not be administered together .
INDOCIN	potassium-sparing diuretics	effect	the potential effects of indocin and potassium-sparing diuretics on potassium kinetics and renal function should be considered when these agents are administered concurrently .
INDOCIN	losartan	effect	indocin can reduce the antihypertensive effects of captopril and losartan .
anticoagulants	INDOCIN	effect	in post marketing experience , bleeding has been reported in patients on concomitant treatment with anticoagulants and indocin .
INDOCIN	anticoagulants	advise	caution should be exercised when indocin and anticoagulants are administered concomitantly .
INDOCIN	probenecid	mechanism	when indocin is given to patients receiving probenecid , the plasma levels of indomethacin are likely to be increased .
NSAIDs	ACE inhibitors	effect	the use of nsaids in patients who are receiving ace inhibitors may potentiate renal disease states .
chlorpromazine	trihexyphenidyl	effect	the concurrent use of two or more drugs with anticholinergic activity such as an antipsychotic drug ( eg , chlorpromazine ) , an antiparkinsonian drug ( eg , trihexyphenidyl ) , and / or a tricyclic antidepressant ( eg , amitriptyline ) commonly results in excessive anticholinergic effects , including dry mouth and associated dental complications , blurred vision , and , in patients exposed to high temperature and humidity , hyperpyrexia .
amiodarone	flecainide	mechanism	when amiodarone is added to flecainide therapy , plasma flecainide levels may increase two fold or more in some patients , if flecainide dosage is not reduced .
disopyramide	TAMBOCOR	advise	because both of these drugs have negative inotropic properties and the effects of coadministration with tambocor are unknown , neither disopyramide nor verapamil should be administered concurrently with tambocor unless , in the judgment of the physician , the benefits of this combination outweigh the risks .
beta blockers	flecainide	effect	nevertheless , the possibility of additive negative inotropic effects of beta blockers and flecainide should be recognized .
Caffeine	ketoprofen	effect	caffeine administered concurrently with ketoprofen reduced the urine volume in dg healthy volunteers .
Azlocillin	tobramycin	advise	azlocillin should not be administered concomitantly with amikacin , ciprofloxacin , gentamicin , netilmicin , or tobramycin .
EQUETROTM	midazolam	mechanism	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( dg ) , oxcarbazepine , phenytoin ( dg ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( dg ) , ziprasidone , and zonisamide .
EQUETROTM	topiramate	mechanism	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( dg ) , oxcarbazepine , phenytoin ( dg ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( dg ) , ziprasidone , and zonisamide .
EQUETROTM	tramadol	mechanism	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( dg ) , oxcarbazepine , phenytoin ( dg ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( dg ) , ziprasidone , and zonisamide .
methysergide	sumatriptan	advise	because there is a theoretical basis that these effects may be additive , use of ergotamine containing or ergot type medications ( like dihydroergotamine or methysergide ) and sumatriptan within dg hours of each other should be avoided .
paroxetine	sumatriptan	effect	therefore , the use of sumatriptan succinate tablets in patients receiving mao a inhibitors is contraindicated . selective serotonin reuptake inhibitors ( ssris ) ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with sumatriptan .
Aspirin	SKELID	mechanism	aspirin may decrease bioavailability of skelid by up to dg % when taken dg hours after skelid .
paricalcitol	nelfinavir	advise	a multiple dose drug drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol auc0 . since paricalcitol is partially metabolized by cyp3a and ketoconazole le is known to be a strong inhibitor of cytochrome p450 3a enzyme , care should be taken while dosing paricalcitol with ketoconazole and other strong p450 3a inhibitors including atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin or voriconazole .
stavudine	ribavirin	effect	in vitro data indicate that the phosphorylation of stavudine is also inhibited at relevant concentrations by doxorubicin and ribavirin .
beta blocker	clonidine	advise	if the two drugs are coadministered , the beta blocker should be withdrawn several days before the gradual withdrawal of clonidine .
rifampin	montelukast	advise	it is reasonable to employ appropriate clinical monitoring when potent cytochrome p450 enzyme inducers , such as phenobarbital or rifampin , are co administered with montelukast .
FLUOTHANE	tubocurarine	effect	fluothane may augment the hypotension caused by the ganglionic blocking effect of tubocurarine .
diazepam	mirtazapine	mechanism	accordingly , patients should be advised to avoid alcohol while taking remeron soltab. diazepam : concomitant administration of diazepam ( dg mg ) had a minimal effect on plasma levels of mirtazapine ( dg mg ) in dg healthy subjects .
ketoconazole	terfenadine	mechanism	pharmacokinetic data indicate that ketoconazole markedly inhibits the metabolism of terfenadine , resulting in elevated plasma terfenadine levels .
clarithromycin	terfenadine	mechanism	macrolides : clinical drug interaction studies indicate that erythromycin and clarithromycin can exert an effect on terfenadine metabolism by a mechanism which may be similar to that of ketoconazole , but to a lesser extent .
AGGRASTAT	heparin	effect	the use of aggrastat , in combination with heparin and aspirin , has been associated with an increase in bleeding compared to heparin and aspirin alone ( see
midazolam	protease inhibitors	advise	drug interactions : inhibitors of cyp3a4 isozymes : caution is advised when midazolam is administered concomitantly with drugs that are known to inhibit the cytochrome p450 dg enzyme system ( ie , some drugs in the drug classes of azole antimycotics , protease inhibitors , calcium channel antagonists , and macrolide antibiotics ) .
diltiazem	midazolam	mechanism	drugs such as erythromycin , diltiazem , verapamil , ketoconazole , fluconazole and itraconazole were shown to significantly increase the c max and auc of orally administered midazolam .
erythromycin	midazolam	mechanism	drugs such as erythromycin , diltiazem , verapamil , ketoconazole , fluconazole and itraconazole were shown to significantly increase the c max and auc of orally administered midazolam .
VERSED Syrup	propofol	effect	the sedative effect of versed syrup is accentuated by any concomitantly administered medication which depresses the central nervous system , particularly narcotics ( eg , morphine , meperidine and fentanyl ) , propofol , ketamine , nitrous oxide , secobarbital and droperidol .
ritonavir	midazolam	mechanism	although not studied , the potent cytochrome p450 dg inhibitors ritonavir and nelfinavir may cause intense and prolonged sedation and respiratory depression due to a decrease in plasma clearance of midazolam .
alcohol	pentazocine	advise	usage with alcohol : due to the potential for increased cns depressants effects , alcohol should be used with caution in patients who are currently receiving pentazocine .
EQUETROTM	itraconazole	mechanism	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( dg ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( dg ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( dg ) , verapamil , zileuton .
EQUETROTM	quinine	mechanism	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( dg ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( dg ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( dg ) , verapamil , zileuton .
EQUETROTM	quinupristin	mechanism	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( dg ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( dg ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( dg ) , verapamil , zileuton .
EQUETROTM	zileuton	mechanism	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( dg ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( dg ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( dg ) , verapamil , zileuton .
EQUETROTM	doxorubicin HCL	mechanism	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( dg ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
EQUETROTM	felbamate	mechanism	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( dg ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
L-arginine	cyclosporin	effect	cyclosporine l-arginine may counteract the antinaturetic effect of cyclosporin .
L-arginine	ibuprofen	mechanism	ibuprofen l-arginine may increase the absorption of ibuprofen if taken concomitantly .
indinavir	efavirenz	mechanism	increasing the indinavir dose to dg mg every dg hours does not compensate for the increased indinavir metabolism due to efavirenz .
rifabutin	CRIXIVAN	advise	dose reduction of rifabutin to half the standard dose and a dose increase of crixivan to dg mg ( three dg mg capsules ) every dg hours are recommended when rifabutin and crixivan are coadministered .
Sildenafil	indinavir	advise	sildenafil dose should not exceed a maximum of dg mg in a dg hour period in patients receiving concomitant indinavir therapy .
TCAs	SSRIs	advise	nevertheless , caution is indicated in the coadministration of tcas with any of the ssris and also in switching from one class to the other .
tricyclic antidepressants	cimetidine	effect	clinically significant effects have been reported with the tricyclic antidepressants when used concomitantly with cimetidine .
Azithromycin	zidovudine	mechanism	azithromycin had no significant impact on the cmax and auc of zidovudine , although it significantly decreased the zidovudine tmax by dg % and increased the intracellular exposure to phosphorylated zidovudine by dg % .
warfarin	sedatives	int	clinical implications of warfarin interactions with five sedatives .
triazolam	fluvoxamine	mechanism	other potentially important drug interactions : benzodiazepines : benzodiazepines metabolized by hepatic oxidation ( e.g. , alprazolam , midazolam , triazolam elc. ) should be used with caution because the clearance of these drugs is likely to be reduced by fluvoxamine .
alprazolam	Fluvoxamine	advise	this interaction , which has not been investigated using higher doses of fluvoxamine , may be more pronounced if a dg mg daily dose is co administered , particularly since fluvoxamine exhibits non linear pharmacokinetics over the dosage range dg dg mg. if alprazolam is co administered with fluvoxamine tablets , the initial alprazolam dosage should be at least halved and titration to the lowest effective dose is recommended .
fluvoxamine	N-desmethyldiazepam	mechanism	because fluvoxamine reduces the clearance of both diazepam and its active metabolite , n-desmethyldiazepam , there is a strong likelihood of substantial accumulation of both species during chronic co administration .
XENICAL	cyclosporine	mechanism	cyclosporine : preliminary data from a xenical and cyclosporine drug interaction study indicate a reduction in cyclosporine plasma levels when xenical was coadministered with cyclosporine .
warfarin	XENICAL	advise	therefore , as vitamin k absorption may be decreased with xenical , patients on chronic stable doses of warfarin who are prescribed xenical should be monitored closely for changes in coagulation parameters .
vinblastine	DETROL LA	advise	for patients receiving ketoconazole or other potent cyp3a4 inhibitors such as other azole antifungals ( eg , itraconazole , miconazole ) or macrolide antibiotics ( eg , erythromycin , clarithromycin ) or cyclosporine or vinblastine , the recommended dose of detrol la is dg mg daily .
trimetrexate	erythromycin	effect	agents that might be coadministered with trimetrexate in aids patients for other indications that could elicit this activity include erythromycin , rifampin , rifabutin , ketoconazole , and fluconazole .
miconazole	trimetrexate	mechanism	based on an in vitro rat liver model , nitrogen substituted imidazole drugs ( clotrimazole , ketoconazole , miconazole ) were potent , non competitive inhibitors of trimetrexate metabolism .
glutethimide	coumarin drugs	advise	barbiturates and glutethimide should not be administered to patients receiving coumarin drugs .
18-MC	morphine	effect	ibogaine attenuates , but 18-mc potentiates , the acute locomotor effects of morphine ;
Valproic acid	phenobarbital	mechanism	valproic acid diminished binding of phenobarbital by a net change of dg % ( percentage increase in fdf , dg % ) at dg micromol / l .
Rifampin	warfarin	mechanism	rifampin has been reported to increase the warfarin requirements in human subjects ingesting these agents simultaneously .
rifampin	warfarin	mechanism	this effect may be mediated by the ability of rifampin to induce microsomal enzymes and , thus , the catabolism of warfarin .
Dexamethasone	insulin	effect	dexamethasone and retinyl acetate similarly inhibit and stimulate egf or insulin induced proliferation of prostatic epithelium .
retinyl acetate	EGF	effect	dexamethasone at dg ( dg ) m or retinyl acetate at about dg x dg ( dg ) m inhibits proliferation stimulated by egf .
retinyl acetate	EGF	effect	higher concentrations of dexamethasone ( dg ( dg ) dg ( dg ) m ) or retinyl acetate ( dg x dg ( dg ) dg ( dg ) m ) enhance the mitogenic activity of egf .
retinyl acetate	insulin	effect	however , retinyl acetate stimulated , but did not significantly inhibit , proliferation in the presence of insulin .
glucocorticoids	insulin	effect	these results suggest that both dexamethasone and retinyl acetate , and possibly other glucocorticoids and retinoids , may regulate the proliferation of prostate epithelium by a dose dependent modification of the activity of insulin and egf .
N-methyllevallorphan	morphine	effect	n-methyllevallorphan ( dg mg / kg , s.c. ) completely antagonized the inhibitory effect of loperamide and partly antagonized the effect of morphine .
cisplatin	sodium thiosulfate	effect	high dose cisplatin with sodium thiosulfate protection .
Sodium thiosulfate	cisplatin	effect	sodium thiosulfate is a neutralizing agent for cisplatin that protects against renal damage .
neurotensin	tuftsin	effect	it is concluded that neurotensin modulates in an opposite way the function of the enkephalinergic neurons and the central action of tuftsin .
ketamine	halothane	effect	it is concluded that ketamine is not a short acting drug and that concomitant use with halothane would be expected to prolong further the duration of its action on the central nervous system .
Calcium	nonheme iron	mechanism	calcium is the only known component in the diet that may affect absorption of both nonheme and heme iron .
calcium	heme iron	mechanism	a calcium dose of dg mg diminished absorption of dg mg heme iron by dg % .
dasatinib	paclitaxel	effect	hey cells treated with dasatinib plus paclitaxel formed fewer colonies than did cells treated with either agent alone .
piperine	ibuprofen	effect	in the present study piperine ( dg mg / kg ) significantly increased the dose dependent antinociceptive activity of ibuprofen evaluated by both acetic acid writhing and formalin test , when it was administered with ibuprofen .
Ibuprofen	piperine	mechanism	ibuprofen plasma concentration was also increased when it was administered with piperine .
ibuprofen	piperine	mechanism	the synergistic antinociception activity of ibuprofen when administered with piperine can be attributed to increased plasma concentration of ibuprofen .
CRM197	doxorubicin	effect	crm197 induced apoptosis , and furthermore , the combination of crm197 plus doxorubicin enhanced cytotoxicity in a t all cell line .
antidepressant drugs	hypoglycemic agents	int	treatment with antidepressant drugs can directly interfere with blood glucose levels or may interact with hypoglycemic agents .
Warfarin	mirtazapine	effect	warfarin users who initiated citalopram , fluoxetine , paroxetine , amitriptyline , or mirtazapine had an increased risk of hospitalization for gastrointestinal bleeding .
imipramine	cimetidine	mechanism	the plasma concentration of imipramine may increase when the drug is given concomitantly with hepatic enzyme inhibitors ( e.g. , cimetidine , fluoxetine ) and decrease by concomitant administration of hepatic enzyme inducers ( e.g. , barbiturates , phenytoin ) , and adjustment of the dosage of imipramine may therefore be necessary .
imipramine	phenytoin	mechanism	the plasma concentration of imipramine may increase when the drug is given concomitantly with hepatic enzyme inhibitors ( e.g. , cimetidine , fluoxetine ) and decrease by concomitant administration of hepatic enzyme inducers ( e.g. , barbiturates , phenytoin ) , and adjustment of the dosage of imipramine may therefore be necessary .
Scopolamine	alcohol	advise	scopolamine should be used with care in patients taking other drugs that are capable of causing cns effects such as sedatives , tranquilizers , or alcohol .
Trilostane	aminoglutethimide	int	trilostane may interact with aminoglutethimide or mitotane ( causing too great a decrease in adrenal function ) .
nondepolarizing agents	lithium	int	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as mivacron include certain antibiotics ( e.g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
nondepolarizing agents	quinidine	int	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as mivacron include certain antibiotics ( e.g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
MIVACRON	lithium	int	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as mivacron include certain antibiotics ( e.g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
nondepolarizing agents	lincomycin	int	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as mivacron include certain antibiotics ( e.g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
picrotoxin	diazepam	effect	[ the gaba ergic system and brain edema ] it has been shown in rats with experimental toxic and traumatic edemas that picrotoxin ( dg mg / kg ) removes the antiedematous action of diazepam , phenazepam , phenibut and amizyl and reduces the action of phentolamine .
picrotoxin	amizyl	effect	[ the gaba ergic system and brain edema ] it has been shown in rats with experimental toxic and traumatic edemas that picrotoxin ( dg mg / kg ) removes the antiedematous action of diazepam , phenazepam , phenibut and amizyl and reduces the action of phentolamine .
Amprenavir	rifabutin	effect	amprenavir plus rifabutin was poorly tolerated , and dg of dg subjects discontinued therapy .
pentazocine	tripelennamine	effect	twelve strains of staphylococcus aureus ( a frequent cause of infection in heroin , but not in pentazocine and tripelennamine , addicts ) were completely inhibited by the drug combination .
ouabain	phentolamine	effect	when ouabain was applied to the muscle in the presence of phentolamine , both first and second contractile responses to ptx were abolished .
naloxone	beta-endorphin	effect	intrathecal injection of naloxone at doses of dg to dg micrograms caused a dose related blockade of the inhibition of the tail flick response induced by intraventricular injection of beta-endorphin , and a high dose of naloxone ( dg micrograms ) completely blocked the tail flick inhibition induced by intraventricular beta-endorphin ( dg micrograms ) .
diazepam	metamizol	effect	similarly , diazepam decreased the antinociceptive effect of metamizol ( only in the tail flick test ) and indomethacin .
Flavoridin	contortrostatin	effect	flavoridin alone was found to have no effect on cas , but can completely block contortrostatin induced phosphorylation of this protein in mda mb dg cells .
rifabutin	ofloxacin	effect	when combined with ofloxacin , krm dg exhibited strong synergistic activity while only additive effects were observed with the combination of rifampicin ( or rifabutin ) and ofloxacin .
diltiazem	sirolimus	mechanism	conclusions : single dose diltiazem coadministration leads to higher sirolimus exposure , presumably by inhibition of the first pass metabolism of sirolimus .
DIFLUCAN	phenytoin	advise	careful monitoring of phenytoin concentrations in patients receiving diflucan and phenytoin is recommended .
tacrolimus	fluconazole	advise	patients receiving tacrolimus and fluconazole concomitantly should be carefully monitored .
DIFLUCAN	tolbutamide	mechanism	diflucan reduces the metabolism of tolbutamide , glyburide , and glipizide and increases the plasma concentration of these agents .
fluconazole	ethinyl estradiol	mechanism	while there is evidence that fluconazole can inhibit the metabolism of ethinyl estradiol and levonorgestrel , there is no evidence that fluconazole is a net inducer of ethinyl estradiol or levonorgestrel metabolism .
fluconazole	levonorgestrel	mechanism	while there is evidence that fluconazole can inhibit the metabolism of ethinyl estradiol and levonorgestrel , there is no evidence that fluconazole is a net inducer of ethinyl estradiol or levonorgestrel metabolism .
DIFLUCAN	sulfonylurea oral hypoglycemic agents	advise	when diflucan is used concomitantly with these or other sulfonylurea oral hypoglycemic agents , blood glucose concentrations should be carefully monitored and the dose of the sulfonylurea should be adjusted as necessary .
methyldopa	ferrous gluconate	mechanism	several studies demonstrate a decrease in the bioavailability of methyldopa when it is ingested with ferrous sulfate or ferrous gluconate .
quinolones	multivitamins	mechanism	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable / buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
isradipine	cimetidine	advise	if isradipine therapy is initiated in a patient currently receiving cimetidine careful monitoring for adverse reactions is advised and downward dose adjustment may be required .
sirolimus	diltiazem	advise	because of the pronounced intersubject variability in the extent of the sirolimus diltiazem interaction , whole blood sirolimus concentrations should be monitored closely in patients treated with the two drugs .
lead	alcohol	effect	these results suggest that exposure to environmental lead may alter the biological and behavioral responsiveness of an animal to alcohol .
desipramine	norepinephrine	effect	the uptake inhibitors cocaine and desipramine ( dg mumol / liter ) potentiated the positive inotropic effects of norepinephrine in nonfailing myocardium ( p < dg ) but not in functional class iv myocardium .
INDOCIN	digoxin	mechanism	indocin given concomitantly with digoxin has been reported to increase the serum concentration and prolong the half life of digoxin .
INDOCIN	potassium-sparing diuretics	effect	in some patients , the administration of indocin can reduce the diuretic , natriuretic , and antihypertensive effects of loop , potassium sparing , and thiazide diuretics .
aspirin	indomethacin	mechanism	in a study in normal volunteers , it was found that chronic concurrent administration of dg g of aspirin per day decreases indomethacin blood levels approximately dg % .
INDOCIN	captopril	effect	indocin can reduce the antihypertensive effects of captopril and losartan .
naproxen	aspirin	advise	concomitant administration of naproxen and aspirin is not recommended because naproxen is displaced from its binding sites during the concomitant administration of aspirin , resulting in lower plasma concentrations and peak plasma levels .
antipsychotic drug	antiparkinsonian drug	effect	the concurrent use of two or more drugs with anticholinergic activity such as an antipsychotic drug ( eg , chlorpromazine ) , an antiparkinsonian drug ( eg , trihexyphenidyl ) , and / or a tricyclic antidepressant ( eg , amitriptyline ) commonly results in excessive anticholinergic effects , including dry mouth and associated dental complications , blurred vision , and , in patients exposed to high temperature and humidity , hyperpyrexia .
cimetidine	flecainide	mechanism	in healthy subjects receiving cimetidine ( dg gm daily ) for one week , plasma flecainide levels increased by about dg % and half life increased by about dg % .
TAMBOCOR	propranolol	effect	the effects of concomitant administration of tambocor and propranolol on the pr interval were less than additive .
capecitabine	coumarin-derivative anticoagulants	effect	coumarin anticoagulants altered coagulation parameters and / or bleeding have been reported in patients taking capecitabine concomitantly with coumarin-derivative anticoagulants such as warfarin and phenprocoumon .
EQUETROTM	glucocorticoids	mechanism	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( dg ) , oxcarbazepine , phenytoin ( dg ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( dg ) , ziprasidone , and zonisamide .
EQUETROTM	itraconazole	mechanism	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( dg ) , oxcarbazepine , phenytoin ( dg ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( dg ) , ziprasidone , and zonisamide .
EQUETROTM	olanzapine	mechanism	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( dg ) , oxcarbazepine , phenytoin ( dg ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( dg ) , ziprasidone , and zonisamide .
EQUETROTM	theophylline	mechanism	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( dg ) , oxcarbazepine , phenytoin ( dg ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( dg ) , ziprasidone , and zonisamide .
EQUETROTM	ziprasidone	mechanism	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( dg ) , oxcarbazepine , phenytoin ( dg ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( dg ) , ziprasidone , and zonisamide .
EQUETROTM	clozapine	mechanism	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( dg ) , oxcarbazepine , phenytoin ( dg ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( dg ) , ziprasidone , and zonisamide .
EQUETROTM	delavirdine	mechanism	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( dg ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( dg ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( dg ) , verapamil , zileuton .
EQUETROTM	Cisplatin	mechanism	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( dg ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
EQUETROTM	phenobarbital	mechanism	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( dg ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
L-arginine	nitrates	effect	organic nitrates l-arginine supplements theoretically may potentiate the effects of organic nitrates if taken concomitantly .
indinavir	ritonavir	effect	preliminary clinical data suggest that the incidence of nephrolithiasis is higher in patients receiving indinavir in combination with ritonavir than those receiving crixivan dg mg q8h .
Vitamin D	digitalis	advise	digitalis : vitamin d dosage must be determined with care in patients undergoing treatment with digitalis , as hypercalcemia in such patients may precipitate cardiac arrhythmias .
Ketoconazole	vitamin D	mechanism	ketoconazole : ketoconazole may inhibit both synthetic and catabolic enzymes of vitamin d .
18-MC	morphine	effect	both ibogaine and 18-mc block morphine induced and nicotine induced dopamine release in the nucleus accumbens ;
Acetaminophen	theophylline	mechanism	acetaminophen diminished the binding of theophylline to human serum by a net change of dg % ( percentage increase in free drug fraction [ fdf ] , dg % ) at dg micromol / l and by a net change of dg % ( percentage increase in fdf , dg % ) at dg micromol / l .
InsP(3)	RR	effect	administering insp(3) together with rr ( dg dg microm ) inhibited insp(3) induced responses ( both ca ( 2+ ) and current responses ) in a dose dependent fashion .
RR	InsP(3)	effect	pretreatment of megakaryocytes with extracellular rr ( dg microm ) also inhibited insp(3) induced responses .
retinyl acetate	EGF	effect	although neither dexamethasone nor retinyl acetate affected the proliferation of prostatic epithelium in rpmi1640 containing transferrin alone , they modify the mitogenic effect of egf and insulin .
morphine	dmPGE2	effect	loperamide and morphine ( dg and dg mg / kg , s.c. ) inhibited the dmpge2 ( dg mg / kg , p.o. ) induced diarrhea in cecectomized rats .
omeprazole	clopidogrel	mechanism	concomitant use of omeprazole and clopidogrel was found to decrease the exposure ( auc ) to clopidogrel 's active metabolite by dg % and to sharply increase platelet reactivity , as a result of inhibition by omeprazole of cyp2c19 , a cytochrome p450 ( cyp ) enzyme .
sunitinib	docetaxel	int	synergistic interaction between sunitinib and docetaxel is sequence dependent in human non small lung cancer with egfr tkis resistant mutation .
AAV2	heparinase III	effect	aav2 mediated retinal transduction is improved by co injection of heparinase iii or chondroitin abc lyase .
fluoxetine	endoxifen	mechanism	paroxetine and fluoxetine reduce the plasma concentration of endoxifen by about dg % .
tamoxifen	SSRI antidepressants	advise	it is better to avoid prescribing isoenzyme cyp dg inhibitors to women treated with tamoxifen for breast cancer , especially ssri antidepressants such as paroxetine and fluoxetine .
dexmedetomidine	ephedrine	effect	at the same time , the locomotor inhibitory effect of dexmedetomidine was counteracted by ephedrine .
ketamine	ouabain	effect	in a comparison of digitalis tolerance in dogs anesthetized with ketamine , innovar vet , or pentobarbital , the dosage of ouabain needed to cause ventricular tachycardia was significantly higher , as was the ld50 of ouabain , with ketamine or innovar than with pentobarbital .
Lomefloxacin	sucralfate	mechanism	moxifloxacin and lomefloxacin reacts faster with sucralfate and gelusil in acidic media whereas with erythromycin in basic media and multi minerals in neutral media .
macrolide antibiotics	hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase inhibitors	effect	the concomitant administration of macrolide antibiotics and other hydroxymethylglutaryl coenzyme a (hmg-coa) reductase inhibitors have resulted in previous reports of rhabdomyolysis .
Macrolide antibiotics	cerivastatin	mechanism	conclusions : macrolide antibiotics inhibit the metabolism of hmg coa reductase inhibitors that are metabolized by cyp3a4 ( i.e. , atorvastatin , cerivastatin , lovastatin , simvastatin ) .
Amprenavir	25-O-desacetylrifabutin	mechanism	amprenavir significantly decreases clearance of rifabutin and 25-o-desacetylrifabutin , and the combination is poorly tolerated .
estradiol	endotoxin	effect	injection of estradiol dg min before a nonlethal dose of endotoxin changed the serum sex steroid hormone response of male rats to endotoxin .
clindamycin	gentamicin	effect	combinations of clindamycin and gentamicin were indifferent for dg strains and synergistic for dg strains .
clindamycin	gentamicin	effect	combinations of clindamycin and gentamicin were indifferent for dg and synergistic for dg of the resistant strains .
Physostigmine	alcohol	effect	physostigmine pretreatment augmented the depressant effect of alcohol on the early components p1 and n1 , while attenuating alcohol 's influence on components p2 and p3 .
Physostigmine	alcohol	effect	physostigmine pretreatment augmented the depressant effect of alcohol on the early components p1 and n1 , while attenuating alcohol 's influence on components p2 and p3 .
Amiodarone	digoxin	mechanism	amiodarone is known to raise serum digoxin levels .
theophylline	phenytoin	mechanism	enhanced theophylline clearance secondary to phenytoin therapy .
gentamycin	atracurium	effect	it was concluded that , although gentamycin did augment the neuromuscular blockade of atracurium , the effect was minimal .
atracurium	gentamycin	effect	recovery from dg % twitch to dg % fade recovery took dg + / dg min for atracurium alone and dg + / dg min for atracurium plus gentamycin .
Fluvoxamine	tolbutamide	mechanism	fluvoxamine inhibits the cyp2c9 catalyzed biotransformation of tolbutamide .
